word,frequency,log frequency
the,27763,10.231459477945954
of,27383,10.21767766186868
and,21769,9.988242218400936
in,15260,9.632990304838447
to,12421,9.427143867544194
a,8646,9.064852065227576
with,8145,9.005159521036145
for,6085,8.713582005421628
is,5621,8.634264863002075
patients,4838,8.484256691169973
The,4635,8.441391477999955
was,4150,8.330863613224745
that,3796,8.241703159729818
were,3280,8.09559870137819
asthma,3169,8.06117135969092
are,3135,8.050384453067021
on,3051,8.02322468471667
as,3009,8.009363076630045
by,2995,8.00469951054955
be,2777,7.9291264873067995
influenza,2742,7.91644286012226
stroke,2644,7.880048200971577
from,2368,7.769800996003896
or,2324,7.751045117971802
an,2248,7.717796211013582
infarction,2104,7.651595573857601
this,2064,7.6324011266014535
have,2030,7.615791072035833
acute,2005,7.60339933974067
myocardial,1984,7.592870287844818
disease,1825,7.509335266016592
In,1706,7.441906728051625
SARS-CoV-2,1699,7.4377951216719325
COVID-19,1673,7.422373700986824
at,1626,7.3938782901077555
clinical,1591,7.372118028337787
has,1570,7.358830898342354
study,1504,7.315883504509785
risk,1485,7.3031700512368
after,1471,7.293697720601438
been,1432,7.266827347520591
not,1357,7.213031659834869
A,1355,7.2115567333138015
We,1346,7.204892510204673
treatment,1343,7.202661196523238
may,1239,7.122059881629142
This,1230,7.114769448366463
which,1216,7.103322062526113
than,1208,7.0967213784947605
virus,1207,7.095893221097532
pandemic,1203,7.0925737159746784
between,1153,7.050122520269059
can,1149,7.046647277848756
infection,1083,6.9874902470009905
severe,1060,6.966024187106113
these,1053,6.959398512133975
we,1038,6.945051063725834
during,1036,6.943122422819428
respiratory,1006,6.913737350659685
but,986,6.893656354602635
more,975,6.882437470997847
children,958,6.86484777797086
had,957,6.863803391452954
2,951,6.85751406254539
Background,922,6.826545223556594
cases,891,6.792344427470809
mortality,886,6.786716950605081
health,880,6.779921907472252
also,874,6.773080375655535
associated,865,6.762729506931879
their,848,6.742880635791903
vaccine,847,6.741700694652055
factors,842,6.7357800142423265
studies,838,6.731018100482083
coronary,835,6.727431724850855
coronavirus,814,6.70196036600254
group,813,6.70073110954781
data,804,6.6895992691789665
therapy,789,6.670766320845874
most,767,6.642486801367256
used,754,6.625392368007956
years,742,6.60934924316738
results,741,6.608000625296087
all,734,6.598509028614515
care,730,6.593044534142437
symptoms,725,6.586171654854675
who,724,6.584791392385716
use,722,6.582025138892826
it,719,6.577861357721047
other,701,6.55250788703459
high,699,6.54965074223381
control,692,6.539585955617669
such,672,6.51025834052315
diagnosis,664,6.498282149476434
management,642,6.464588303689961
age,627,6.440946540632921
patient,619,6.428105272684596
among,619,6.428105272684596
vaccination,617,6.424869023905388
ischemic,609,6.411818267709897
time,606,6.406879986069314
review,604,6.403574197934815
1,599,6.395261598115449
early,598,6.393590753950631
no,597,6.391917113392602
first,596,6.39024066706535
its,591,6.3818160174060985
viral,589,6.3784261836515865
using,587,6.375024819828097
different,581,6.364750756851911
increased,574,6.352629396319567
both,574,6.352629396319567
significant,568,6.342121418721152
compared,567,6.340359303727752
one,557,6.322565239927284
syndrome,557,6.322565239927284
To,555,6.318968113746434
those,554,6.317164686747284
ventricular,552,6.313548046277095
only,550,6.309918278226516
new,549,6.3080984415095305
However,549,6.3080984415095305
two,545,6.300785794663244
rate,543,6.297109319933935
left,539,6.289715570908998
should,538,6.2878585601617845
including,537,6.285998094508865
important,532,6.2766434893416445
well,525,6.263398262591624
will,505,6.22455842927536
population,505,6.22455842927536
potential,502,6.218600119691729
present,499,6.212606095751519
3,489,6.192362489474872
viruses,488,6.1903154058531475
less,488,6.1903154058531475
analysis,485,6.184148890937483
higher,483,6.180016653652572
testing,482,6.1779441140506
significantly,479,6.171700597410915
there,476,6.16541785423142
could,472,6.156978985585555
about,470,6.152732694704104
against,470,6.152732694704104
human,470,6.152732694704104
vaccines,461,6.133398042996649
development,457,6.124683390894205
evidence,457,6.124683390894205
artery,455,6.12029741895095
case,453,6.115892125483034
role,452,6.113682179832232
response,451,6.111467339502679
current,451,6.111467339502679
hospital,446,6.100318952020064
p,445,6.09807428216624
test,445,6.09807428216624
function,444,6.095824562432225
within,439,6.0844994130751715
effective,437,6.07993319509559
infections,435,6.075346031088684
days,430,6.063785208687608
number,430,6.063785208687608
groups,428,6.059123195581797
strokes,427,6.056784013228625
outcomes,424,6.049733455231958
when,421,6.042632833682381
effects,420,6.040254711277414
cardiac,419,6.037870919922137
showed,419,6.037870919922137
found,411,6.018593214496234
into,410,6.016157159698354
reported,408,6.0112671744041615
positive,405,6.003887067106539
These,404,6.0014148779611505
2019,403,5.998936561946683
death,401,5.993961427306569
It,398,5.986452005284438
changes,397,5.983936280687191
common,392,5.971261839790462
blood,392,5.971261839790462
diagnostic,390,5.966146739123692
transmission,388,5.961005339623274
cause,388,5.961005339623274
H1N1,387,5.958424693029782
without,385,5.953243334287785
heart,385,5.953243334287785
95,383,5.948034989180646
medical,382,5.945420608606575
cells,381,5.942799375126701
research,380,5.940171252720432
-,380,5.940171252720432
due,379,5.937536205082426
available,379,5.937536205082426
based,378,5.934894195619588
chronic,374,5.924255797414532
increase,372,5.918893854273146
tests,368,5.908082938168931
airway,368,5.908082938168931
over,368,5.908082938168931
our,366,5.902633333401366
detection,364,5.8971538676367405
severity,364,5.8971538676367405
novel,364,5.8971538676367405
AMI,363,5.8944028342648505
MI,363,5.8944028342648505
findings,363,5.8944028342648505
public,360,5.886104031450156
levels,359,5.883322388488279
prevention,359,5.883322388488279
specific,356,5.87493073085203
caused,356,5.87493073085203
incidence,354,5.869296913133774
system,354,5.869296913133774
outcome,353,5.8664680569332965
low,352,5.863631175598097
onset,352,5.863631175598097
individuals,349,5.855071922202427
information,345,5.84354441703136
major,344,5.840641657373398
samples,344,5.840641657373398
developed,343,5.8377304471659395
effect,343,5.8377304471659395
impact,342,5.834810737062605
diseases,340,5.8289456176102075
cell,338,5.823045895483019
rates,338,5.823045895483019
identified,338,5.823045895483019
There,335,5.814130531825066
observed,330,5.799092654460526
prevalence,329,5.796057750765372
trials,329,5.796057750765372
performed,326,5.786897381366708
provide,324,5.780743515792329
many,323,5.777652323222656
CI,323,5.777652323222656
immune,321,5.771441123130016
strategies,319,5.765191102784844
lower,318,5.762051382780177
some,318,5.762051382780177
total,317,5.75890177387728
period,317,5.75890177387728
three,316,5.755742213586912
whether,313,5.746203190540153
months,312,5.7430031878094825
related,311,5.739792912179234
spread,311,5.739792912179234
primary,311,5.739792912179234
Although,310,5.736572297479192
following,309,5.733341276897746
measures,307,5.726847747587197
therapeutic,305,5.720311776607412
through,305,5.720311776607412
2009,305,5.720311776607412
level,304,5.717027701406222
countries,303,5.713732805509369
recent,301,5.707110264748875
need,301,5.707110264748875
global,301,5.707110264748875
possible,301,5.707110264748875
identify,296,5.69035945432406
they,296,5.69035945432406
complications,296,5.69035945432406
morbidity,295,5.68697535633982
subjects,294,5.683579767338681
assess,292,5.676753802268282
aim,292,5.676753802268282
model,289,5.666426688112432
several,286,5.655991810819852
activity,285,5.652489180268651
evaluate,281,5.638354669333745
Asthma,280,5.634789603169249
illness,278,5.627621113690637
rapid,278,5.627621113690637
imaging,277,5.6240175061873385
10,276,5.62040086571715
adults,275,5.616771097666572
report,275,5.616771097666572
before,274,5.6131281063880705
6,274,5.6131281063880705
year,274,5.6131281063880705
Objective,273,5.60947179518496
large,270,5.598421958998375
4,270,5.598421958998375
women,269,5.594711379601839
differences,269,5.594711379601839
inflammation,268,5.5909869805108565
determine,267,5.58724865840025
people,267,5.58724865840025
efficacy,265,5.579729825986222
anterior,263,5.572154032177765
methods,262,5.568344503761097
outbreak,261,5.564520407322694
emergency,261,5.564520407322694
association,261,5.564520407322694
considered,260,5.560681631015528
improve,259,5.556828061699537
5,259,5.556828061699537
better,259,5.556828061699537
sensitivity,258,5.552959584921617
history,258,5.552959584921617
life,257,5.54907608489522
mean,256,5.545177444479562
known,256,5.545177444479562
mechanisms,255,5.541263545158426
treated,255,5.541263545158426
each,254,5.537334267018537
drugs,254,5.537334267018537
type,254,5.537334267018537
flow,253,5.53338948872752
often,253,5.53338948872752
shown,252,5.529429087511423
future,251,5.5254529391317835
method,251,5.5254529391317835
how,250,5.521460917862246
demonstrated,249,5.517452896464707
suggest,248,5.5134287461649825
B,247,5.5093883366279774
approach,246,5.5053315359323625
further,244,5.497168225293202
reduce,243,5.493061443340548
hours,241,5.484796933490655
intervention,241,5.484796933490655
epidemic,240,5.480638923341991
lung,240,5.480638923341991
exercise,239,5.476463551931511
characteristics,238,5.472270673671475
knowledge,238,5.472270673671475
confirmed,237,5.4680601411351315
failure,237,5.4680601411351315
Our,237,5.4680601411351315
asthmatic,236,5.4638318050256105
understanding,236,5.4638318050256105
similar,236,5.4638318050256105
protein,235,5.459585514144159
P,235,5.459585514144159
because,234,5.455321115357702
events,234,5.455321115357702
vs,232,5.44673737166631
respectively,232,5.44673737166631
RNA,232,5.44673737166631
greater,231,5.442417710521793
evaluated,231,5.442417710521793
infarct,231,5.442417710521793
normal,231,5.442417710521793
bronchial,230,5.438079308923196
limited,229,5.43372200355424
size,229,5.43372200355424
conditions,228,5.429345628954441
models,228,5.429345628954441
highly,227,5.424950017481403
article,226,5.420534999272286
antiviral,226,5.420534999272286
being,226,5.420534999272286
purpose,225,5.41610040220442
effectiveness,225,5.41610040220442
included,225,5.41610040220442
seasonal,224,5.4116460518550396
interventions,224,5.4116460518550396
brain,224,5.4116460518550396
long-term,224,5.4116460518550396
would,223,5.407171771460119
Influenza,223,5.407171771460119
phase,223,5.407171771460119
value,222,5.402677381872279
guidelines,221,5.3981627015177525
factor,219,5.389071729816501
prognosis,219,5.389071729816501
quality,219,5.389071729816501
aimed,219,5.389071729816501
right,218,5.384495062789089
2020,217,5.37989735354046
antibodies,216,5.375278407684165
12,215,5.3706380281276624
remains,215,5.3706380281276624
20,214,5.365976015021851
if,213,5.3612921657094255
while,213,5.3612921657094255
studied,212,5.356586274672012
reduced,211,5.351858133476067
general,211,5.351858133476067
exposure,211,5.351858133476067
assessed,210,5.3471075307174685
surveillance,210,5.3471075307174685
pressure,209,5.342334251964811
cerebral,209,5.342334251964811
responses,209,5.342334251964811
addition,209,5.342334251964811
antibody,209,5.342334251964811
deaths,209,5.342334251964811
result,208,5.337538079701318
any,208,5.337538079701318
assessment,207,5.332718793265369
worldwide,206,5.327876168789581
tested,206,5.327876168789581
presence,206,5.327876168789581
Health,206,5.327876168789581
out,206,5.327876168789581
n,206,5.327876168789581
agents,205,5.3230099791384085
causes,205,5.3230099791384085
reperfusion,204,5.318119993844216
various,203,5.313205979041787
likely,203,5.313205979041787
Stroke,203,5.313205979041787
negative,203,5.313205979041787
strains,202,5.308267697401205
cardiovascular,202,5.308267697401205
pulmonary,201,5.303304908059076
elderly,201,5.303304908059076
detected,200,5.298317366548036
infected,199,5.293304824724492
did,199,5.293304824724492
presented,197,5.2832037287379885
might,197,5.2832037287379885
them,197,5.2832037287379885
15,196,5.278114659230517
very,196,5.278114659230517
drug,196,5.278114659230517
describe,196,5.278114659230517
inflammatory,195,5.272999558563747
especially,193,5.262690188904886
obtained,192,5.2574953720277815
admission,192,5.2574953720277815
strategy,190,5.247024072160486
Patients,190,5.247024072160486
per,190,5.247024072160486
work,190,5.247024072160486
monitoring,189,5.241747015059643
healthcare,189,5.241747015059643
still,188,5.236441962829949
particularly,188,5.236441962829949
previous,188,5.236441962829949
evaluation,187,5.231108616854587
recovery,187,5.231108616854587
increasing,187,5.231108616854587
regarding,186,5.225746673713202
practice,186,5.225746673713202
needed,186,5.225746673713202
literature,185,5.220355825078324
assay,185,5.220355825078324
occurred,185,5.220355825078324
elevation,185,5.220355825078324
initial,184,5.214935757608986
however,184,5.214935757608986
status,184,5.214935757608986
functional,184,5.214935757608986
30,182,5.204006687076795
follow-up,181,5.198497031265826
young,181,5.198497031265826
social,181,5.198497031265826
As,179,5.187385805840755
community,178,5.181783550292085
develop,177,5.176149732573829
mild,177,5.176149732573829
investigate,177,5.176149732573829
course,176,5.170483995038151
multiple,176,5.170483995038151
objective,175,5.1647859739235145
relationship,175,5.1647859739235145
investigated,175,5.1647859739235145
under,174,5.159055299214529
made,174,5.159055299214529
even,174,5.159055299214529
help,174,5.159055299214529
improved,173,5.153291594497779
atrial,173,5.153291594497779
process,173,5.153291594497779
season,173,5.153291594497779
late,172,5.147494476813453
peak,172,5.147494476813453
underlying,172,5.147494476813453
world,172,5.147494476813453
second,171,5.14166355650266
criteria,171,5.14166355650266
All,171,5.14166355650266
revealed,171,5.14166355650266
older,171,5.14166355650266
secondary,170,5.135798437050262
genetic,169,5.1298987149230735
discussed,169,5.1298987149230735
RT-PCR,168,5.123963979403259
examined,168,5.123963979403259
areas,168,5.123963979403259
complex,168,5.123963979403259
Here,167,5.117993812416755
conducted,167,5.117993812416755
fibrillation,167,5.117993812416755
ST,167,5.117993812416755
same,166,5.111987788356544
include,166,5.111987788356544
support,166,5.111987788356544
approaches,166,5.111987788356544
features,166,5.111987788356544
wall,165,5.10594547390058
standard,165,5.10594547390058
aged,165,5.10594547390058
described,164,5.099866427824199
collected,164,5.099866427824199
leading,164,5.099866427824199
China,164,5.099866427824199
United,164,5.099866427824199
up,164,5.099866427824199
assays,164,5.099866427824199
CT,164,5.099866427824199
show,163,5.093750200806762
four,163,5.093750200806762
received,163,5.093750200806762
main,162,5.087596335232384
reaction,162,5.087596335232384
individual,160,5.075173815233827
score,160,5.075173815233827
useful,160,5.075173815233827
symptom,159,5.0689042022202315
specificity,159,5.0689042022202315
currently,159,5.0689042022202315
therapies,159,5.0689042022202315
appropriate,159,5.0689042022202315
avian,159,5.0689042022202315
laboratory,158,5.062595033026967
order,158,5.062595033026967
since,158,5.062595033026967
50,158,5.062595033026967
day,158,5.062595033026967
populations,158,5.062595033026967
gene,158,5.062595033026967
infectious,158,5.062595033026967
performance,157,5.056245805348308
direct,157,5.056245805348308
index,157,5.056245805348308
protection,156,5.049856007249537
thrombolysis,156,5.049856007249537
pneumonia,156,5.049856007249537
admitted,156,5.049856007249537
frequency,156,5.049856007249537
prevent,156,5.049856007249537
poor,155,5.043425116919247
asymptomatic,155,5.043425116919247
million,155,5.043425116919247
tissue,154,5.0369526024136295
importance,154,5.0369526024136295
established,154,5.0369526024136295
ischemia,154,5.0369526024136295
immunity,153,5.030437921392435
change,153,5.030437921392435
ratio,153,5.030437921392435
systems,153,5.030437921392435
inferior,153,5.030437921392435
required,153,5.030437921392435
chest,152,5.0238805208462765
area,152,5.0238805208462765
humans,151,5.017279836814924
host,151,5.017279836814924
angioplasty,150,5.0106352940962555
range,150,5.0106352940962555
influence,149,5.003946305945459
0001,149,5.003946305945459
physical,149,5.003946305945459
burden,149,5.003946305945459
parameters,149,5.003946305945459
surgery,149,5.003946305945459
lead,148,4.997212273764115
difference,148,4.997212273764115
States,148,4.997212273764115
small,148,4.997212273764115
provides,148,4.997212273764115
allergic,148,4.997212273764115
24,147,4.990432586778736
Objectives,147,4.990432586778736
ECG,147,4.990432586778736
H5N1,147,4.990432586778736
molecular,147,4.990432586778736
persons,146,4.983606621708336
hospitalization,146,4.983606621708336
condition,146,4.983606621708336
7,145,4.976733742420574
14,145,4.976733742420574
pathogenesis,145,4.976733742420574
recurrent,145,4.976733742420574
obstruction,145,4.976733742420574
optimal,145,4.976733742420574
environmental,145,4.976733742420574
survival,145,4.976733742420574
During,145,4.976733742420574
must,145,4.976733742420574
strain,144,4.969813299576001
defined,144,4.969813299576001
across,144,4.969813299576001
decreased,144,4.969813299576001
additional,144,4.969813299576001
affected,144,4.969813299576001
IgG,143,4.962844630259907
25,143,4.962844630259907
detect,142,4.955827057601261
weeks,142,4.955827057601261
diagnosed,142,4.955827057601261
hospitals,142,4.955827057601261
improvement,142,4.955827057601261
OR,142,4.955827057601261
depression,141,4.948759890378168
safety,141,4.948759890378168
critical,141,4.948759890378168
discuss,141,4.948759890378168
key,141,4.948759890378168
Therefore,140,4.941642422609304
either,140,4.941642422609304
100,140,4.941642422609304
education,139,4.9344739331306915
outbreaks,139,4.9344739331306915
serum,139,4.9344739331306915
plasma,139,4.9344739331306915
recommended,138,4.927253685157205
school,138,4.927253685157205
few,138,4.927253685157205
given,138,4.927253685157205
where,138,4.927253685157205
developing,137,4.919980925828125
occlusion,137,4.919980925828125
childhood,137,4.919980925828125
controlled,136,4.912654885736052
potentially,135,4.90527477843843
damage,135,4.90527477843843
reduction,135,4.90527477843843
benefit,135,4.90527477843843
acid,135,4.90527477843843
essential,134,4.897839799950911
rapidly,134,4.897839799950911
experience,134,4.897839799950911
frequent,134,4.897839799950911
vascular,134,4.897839799950911
according,134,4.897839799950911
Introduction,134,4.897839799950911
occur,134,4.897839799950911
although,133,4.890349128221754
determined,133,4.890349128221754
estimated,133,4.890349128221754
pain,133,4.890349128221754
setting,132,4.882801922586371
For,132,4.882801922586371
11,132,4.882801922586371
genes,131,4.875197323201151
adverse,131,4.875197323201151
seen,131,4.875197323201151
analyzed,131,4.875197323201151
overall,131,4.875197323201151
An,131,4.875197323201151
whereas,131,4.875197323201151
shock,130,4.867534450455582
frequently,130,4.867534450455582
techniques,130,4.867534450455582
estimate,130,4.867534450455582
wave,130,4.867534450455582
characterized,130,4.867534450455582
lack,129,4.859812404361672
epidemics,129,4.859812404361672
protective,129,4.859812404361672
Thus,129,4.859812404361672
target,129,4.859812404361672
epidemiological,129,4.859812404361672
previously,129,4.859812404361672
dose,128,4.852030263919617
andor,128,4.852030263919617
recommendations,128,4.852030263919617
prior,128,4.852030263919617
least,128,4.852030263919617
attack,127,4.844187086458591
rare,127,4.844187086458591
challenge,127,4.844187086458591
volume,127,4.844187086458591
now,127,4.844187086458591
proportion,127,4.844187086458591
daily,127,4.844187086458591
best,126,4.836281906951478
disorders,126,4.836281906951478
contribute,126,4.836281906951478
workers,126,4.836281906951478
so,126,4.836281906951478
single,126,4.836281906951478
injury,126,4.836281906951478
adult,126,4.836281906951478
neurological,126,4.836281906951478
variants,126,4.836281906951478
five,126,4.836281906951478
Despite,125,4.8283137373023015
local,125,4.8283137373023015
binding,125,4.8283137373023015
After,125,4.8283137373023015
identification,124,4.820281565605037
STEMI,124,4.820281565605037
ischaemic,124,4.820281565605037
symptomatic,124,4.820281565605037
treatments,124,4.820281565605037
past,124,4.820281565605037
relative,123,4.812184355372417
trial,123,4.812184355372417
suggests,123,4.812184355372417
medication,123,4.812184355372417
myocardium,123,4.812184355372417
paper,123,4.812184355372417
measured,123,4.812184355372417
emerging,122,4.804021044733257
inhaled,122,4.804021044733257
indicate,122,4.804021044733257
difficult,122,4.804021044733257
stress,122,4.804021044733257
fraction,122,4.804021044733257
values,122,4.804021044733257
dysfunction,122,4.804021044733257
hypertension,122,4.804021044733257
mechanism,121,4.795790545596741
persistent,121,4.795790545596741
proteins,120,4.787491742782046
efforts,120,4.787491742782046
six,120,4.787491742782046
unit,120,4.787491742782046
angiography,120,4.787491742782046
understand,120,4.787491742782046
percutaneous,119,4.77912349311153
expression,119,4.77912349311153
thrombolytic,119,4.77912349311153
involved,119,4.77912349311153
segment,119,4.77912349311153
predictive,118,4.770684624465665
screening,118,4.770684624465665
followed,118,4.770684624465665
indicated,118,4.770684624465665
ability,118,4.770684624465665
percent,117,4.762173934797756
rehabilitation,117,4.762173934797756
reducing,117,4.762173934797756
16,117,4.762173934797756
relevant,117,4.762173934797756
regions,117,4.762173934797756
published,117,4.762173934797756
8,116,4.7535901911063645
part,116,4.7535901911063645
One,116,4.7535901911063645
particular,116,4.7535901911063645
family,116,4.7535901911063645
costs,116,4.7535901911063645
sample,116,4.7535901911063645
combination,115,4.74493212836325
001,115,4.74493212836325
Since,115,4.74493212836325
reports,114,4.736198448394496
arterial,114,4.736198448394496
then,114,4.736198448394496
recently,114,4.736198448394496
basis,114,4.736198448394496
lesions,114,4.736198448394496
necessary,114,4.736198448394496
flu,114,4.736198448394496
13,114,4.736198448394496
reviewed,113,4.727387818712341
animal,113,4.727387818712341
pediatric,113,4.727387818712341
types,113,4.727387818712341
moderate,113,4.727387818712341
signs,113,4.727387818712341
diabetes,113,4.727387818712341
leads,113,4.727387818712341
40,112,4.718498871295094
contrast,112,4.718498871295094
participants,112,4.718498871295094
Of,112,4.718498871295094
training,112,4.718498871295094
PCR,112,4.718498871295094
Severe,111,4.709530201312334
healthy,111,4.709530201312334
air,111,4.709530201312334
physicians,111,4.709530201312334
conclusion,111,4.709530201312334
receptor,111,4.709530201312334
compare,111,4.709530201312334
With,111,4.709530201312334
ejection,110,4.700480365792417
authors,110,4.700480365792417
sensitive,110,4.700480365792417
challenges,110,4.700480365792417
affect,110,4.700480365792417
inhibitors,110,4.700480365792417
Furthermore,110,4.700480365792417
successful,110,4.700480365792417
Acute,110,4.700480365792417
examine,109,4.6913478822291435
men,109,4.6913478822291435
region,109,4.6913478822291435
isolated,109,4.6913478822291435
independent,109,4.6913478822291435
oral,109,4.6913478822291435
decrease,109,4.6913478822291435
h,109,4.6913478822291435
spike,109,4.6913478822291435
randomized,108,4.68213122712422
commonly,108,4.68213122712422
distribution,108,4.68213122712422
hospitalized,108,4.68213122712422
network,108,4.68213122712422
occurrence,108,4.68213122712422
remain,108,4.68213122712422
occupational,108,4.68213122712422
administration,108,4.68213122712422
died,108,4.68213122712422
correlation,108,4.68213122712422
little,107,4.672828834461906
AF,107,4.672828834461906
suggested,107,4.672828834461906
do,107,4.672828834461906
approximately,107,4.672828834461906
variables,106,4.663439094112067
cohort,106,4.663439094112067
mutations,106,4.663439094112067
times,106,4.663439094112067
medicine,106,4.663439094112067
exacerbations,106,4.663439094112067
versus,106,4.663439094112067
despite,106,4.663439094112067
motor,106,4.663439094112067
Among,106,4.663439094112067
patterns,106,4.663439094112067
chain,106,4.663439094112067
No,105,4.653960350157523
body,105,4.653960350157523
fever,105,4.653960350157523
last,105,4.653960350157523
mainly,105,4.653960350157523
delay,105,4.653960350157523
become,105,4.653960350157523
At,105,4.653960350157523
baseline,105,4.653960350157523
activation,105,4.653960350157523
Most,105,4.653960350157523
suspected,104,4.6443908991413725
national,104,4.6443908991413725
60,104,4.6443908991413725
cardiogenic,104,4.6443908991413725
subsequent,104,4.6443908991413725
focus,104,4.6443908991413725
asthmatics,104,4.6443908991413725
problems,104,4.6443908991413725
good,104,4.6443908991413725
interval,104,4.6443908991413725
usually,103,4.634728988229636
antigenic,103,4.634728988229636
65,103,4.634728988229636
unknown,103,4.634728988229636
attention,103,4.634728988229636
March,103,4.634728988229636
benefits,103,4.634728988229636
mechanical,103,4.634728988229636
pathophysiology,103,4.634728988229636
antigen,102,4.624972813284271
duration,102,4.624972813284271
National,102,4.624972813284271
series,102,4.624972813284271
Coronavirus,102,4.624972813284271
December,102,4.624972813284271
predict,102,4.624972813284271
much,102,4.624972813284271
combined,102,4.624972813284271
measure,102,4.624972813284271
event,102,4.624972813284271
emergence,102,4.624972813284271
resulting,101,4.61512051684126
economic,101,4.61512051684126
regression,101,4.61512051684126
carotid,101,4.61512051684126
highest,101,4.61512051684126
thus,101,4.61512051684126
pandemics,101,4.61512051684126
site,101,4.61512051684126
systematic,101,4.61512051684126
end,101,4.61512051684126
perfusion,100,4.605170185988092
reverse,100,4.605170185988092
examination,100,4.605170185988092
thrombosis,100,4.605170185988092
induced,100,4.605170185988092
alternative,100,4.605170185988092
prognostic,100,4.605170185988092
comparison,99,4.59511985013459
underwent,99,4.59511985013459
9,99,4.59511985013459
access,99,4.59511985013459
wheezing,99,4.59511985013459
New,99,4.59511985013459
On,99,4.59511985013459
confidence,99,4.59511985013459
correlated,99,4.59511985013459
airways,98,4.584967478670572
European,98,4.584967478670572
problem,98,4.584967478670572
preventing,98,4.584967478670572
program,98,4.584967478670572
around,98,4.584967478670572
MRI,98,4.584967478670572
provided,97,4.574710978503383
absence,97,4.574710978503383
US,97,4.574710978503383
reliable,97,4.574710978503383
saliva,97,4.574710978503383
regional,97,4.574710978503383
arteries,97,4.574710978503383
taken,97,4.574710978503383
therefore,97,4.574710978503383
degree,97,4.574710978503383
discharge,97,4.574710978503383
increases,97,4.574710978503383
pregnant,97,4.574710978503383
yet,97,4.574710978503383
via,97,4.574710978503383
tool,97,4.574710978503383
responsible,97,4.574710978503383
routine,97,4.574710978503383
concern,96,4.564348191467836
production,96,4.564348191467836
19,96,4.564348191467836
clinically,96,4.564348191467836
isolation,96,4.564348191467836
epidemiology,96,4.564348191467836
circulation,96,4.564348191467836
led,96,4.564348191467836
specimens,96,4.564348191467836
resistance,96,4.564348191467836
does,95,4.553876891600541
pattern,95,4.553876891600541
play,95,4.553876891600541
posterior,95,4.553876891600541
angina,94,4.543294782270004
needs,94,4.543294782270004
polymerase,94,4.543294782270004
17,94,4.543294782270004
contact,94,4.543294782270004
mice,94,4.543294782270004
proposed,94,4.543294782270004
relatively,94,4.543294782270004
relation,93,4.532599493153256
corticosteroids,93,4.532599493153256
surgical,93,4.532599493153256
old,93,4.532599493153256
comprehensive,93,4.532599493153256
attacks,93,4.532599493153256
cost,93,4.532599493153256
nasopharyngeal,93,4.532599493153256
cognitive,93,4.532599493153256
state,93,4.532599493153256
means,93,4.532599493153256
Purpose,92,4.5217885770490405
active,92,4.5217885770490405
systemic,92,4.5217885770490405
21,91,4.51085950651685
average,91,4.51085950651685
experimental,91,4.51085950651685
majority,91,4.51085950651685
selected,91,4.51085950651685
terms,91,4.51085950651685
emerged,91,4.51085950651685
disability,90,4.499809670330265
005,90,4.499809670330265
international,90,4.499809670330265
ongoing,90,4.499809670330265
long,90,4.499809670330265
tract,90,4.499809670330265
capacity,90,4.499809670330265
placebo,90,4.499809670330265
interest,90,4.499809670330265
controls,90,4.499809670330265
uptake,90,4.499809670330265
stage,90,4.499809670330265
smoking,89,4.48863636973214
remodeling,89,4.48863636973214
serious,89,4.48863636973214
abnormalities,89,4.48863636973214
male,89,4.48863636973214
medications,89,4.48863636973214
resulted,89,4.48863636973214
accuracy,89,4.48863636973214
S,89,4.48863636973214
ST-segment,88,4.477336814478207
application,88,4.477336814478207
intravenous,88,4.477336814478207
echocardiography,88,4.477336814478207
vaccinated,88,4.477336814478207
COPD,88,4.477336814478207
presenting,88,4.477336814478207
structure,88,4.477336814478207
widely,88,4.477336814478207
form,88,4.477336814478207
design,88,4.477336814478207
cancer,88,4.477336814478207
Myocardial,87,4.465908118654584
I,87,4.465908118654584
H3N2,87,4.465908118654584
survey,87,4.465908118654584
settings,87,4.465908118654584
processes,87,4.465908118654584
predictors,87,4.465908118654584
issues,87,4.465908118654584
analyses,87,4.465908118654584
child,87,4.465908118654584
Recent,86,4.454347296253507
week,86,4.454347296253507
unclear,86,4.454347296253507
accurate,86,4.454347296253507
swabs,86,4.454347296253507
transient,86,4.454347296253507
fatal,85,4.442651256490317
extent,85,4.442651256490317
variant,85,4.442651256490317
stenosis,85,4.442651256490317
circulating,85,4.442651256490317
vessel,85,4.442651256490317
Several,85,4.442651256490317
scores,85,4.442651256490317
explore,85,4.442651256490317
manifestations,84,4.430816798843313
achieved,84,4.430816798843313
require,84,4.430816798843313
preventive,84,4.430816798843313
mass,84,4.430816798843313
substantial,84,4.430816798843313
immunization,84,4.430816798843313
cellular,84,4.430816798843313
complication,84,4.430816798843313
central,84,4.430816798843313
implications,84,4.430816798843313
programs,84,4.430816798843313
investigation,84,4.430816798843313
pathways,83,4.418840607796598
median,83,4.418840607796598
animals,83,4.418840607796598
markers,83,4.418840607796598
procedures,83,4.418840607796598
While,83,4.418840607796598
II,83,4.418840607796598
70,83,4.418840607796598
applied,83,4.418840607796598
requires,82,4.406719247264253
evolution,82,4.406719247264253
agent,82,4.406719247264253
real-time,82,4.406719247264253
action,82,4.406719247264253
questionnaire,82,4.406719247264253
T,82,4.406719247264253
oseltamivir,82,4.406719247264253
replication,82,4.406719247264253
technique,82,4.406719247264253
context,82,4.406719247264253
safe,81,4.394449154672439
home,81,4.394449154672439
aspects,81,4.394449154672439
sex,81,4.394449154672439
90,81,4.394449154672439
fully,81,4.394449154672439
third,81,4.394449154672439
carried,81,4.394449154672439
Data,81,4.394449154672439
high-risk,81,4.394449154672439
parents,81,4.394449154672439
appears,81,4.394449154672439
delivery,81,4.394449154672439
younger,80,4.382026634673881
cough,80,4.382026634673881
odds,80,4.382026634673881
recorded,80,4.382026634673881
pregnancy,80,4.382026634673881
receiving,80,4.382026634673881
impairment,80,4.382026634673881
recurrence,80,4.382026634673881
tomography,80,4.382026634673881
threat,80,4.382026634673881
complete,80,4.382026634673881
experienced,80,4.382026634673881
later,80,4.382026634673881
field,80,4.382026634673881
survivors,79,4.3694478524670215
PCI,79,4.3694478524670215
swab,79,4.3694478524670215
natural,79,4.3694478524670215
prospective,79,4.3694478524670215
biological,79,4.3694478524670215
preparedness,79,4.3694478524670215
targets,79,4.3694478524670215
consecutive,79,4.3694478524670215
cerebrovascular,79,4.3694478524670215
ventricle,79,4.3694478524670215
18,79,4.3694478524670215
generally,78,4.356708826689592
quantitative,78,4.356708826689592
World,78,4.356708826689592
plan,78,4.356708826689592
etiology,78,4.356708826689592
Two,78,4.356708826689592
risks,78,4.356708826689592
They,78,4.356708826689592
documented,78,4.356708826689592
recognition,78,4.356708826689592
activities,78,4.356708826689592
intensive,78,4.356708826689592
exacerbation,77,4.343805421853684
components,77,4.343805421853684
Group,77,4.343805421853684
episodes,77,4.343805421853684
whom,77,4.343805421853684
retrospective,77,4.343805421853684
identifying,77,4.343805421853684
country,77,4.343805421853684
variable,77,4.343805421853684
demonstrate,77,4.343805421853684
goal,77,4.343805421853684
sought,77,4.343805421853684
pathogenic,77,4.343805421853684
29,77,4.343805421853684
staff,76,4.330733340286331
80,76,4.330733340286331
existing,76,4.330733340286331
Moreover,76,4.330733340286331
way,76,4.330733340286331
policy,76,4.330733340286331
predicted,76,4.330733340286331
classification,76,4.330733340286331
search,75,4.31748811353631
aims,75,4.31748811353631
scientific,75,4.31748811353631
involvement,75,4.31748811353631
clear,75,4.31748811353631
WHO,75,4.31748811353631
promising,75,4.31748811353631
hypothesis,75,4.31748811353631
presentation,75,4.31748811353631
environment,75,4.31748811353631
professionals,75,4.31748811353631
28,75,4.31748811353631
motion,75,4.31748811353631
focused,74,4.30406509320417
in-hospital,74,4.30406509320417
implemented,74,4.30406509320417
bypass,74,4.30406509320417
treating,74,4.30406509320417
Clinical,74,4.30406509320417
doses,74,4.30406509320417
measurements,74,4.30406509320417
designed,74,4.30406509320417
subtypes,74,4.30406509320417
lesion,74,4.30406509320417
upper,74,4.30406509320417
address,74,4.30406509320417
treat,74,4.30406509320417
oxygen,74,4.30406509320417
advances,73,4.290459441148391
having,73,4.290459441148391
allow,73,4.290459441148391
significance,73,4.290459441148391
simple,73,4.290459441148391
ie,73,4.290459441148391
centers,73,4.290459441148391
far,73,4.290459441148391
resources,73,4.290459441148391
eg,73,4.290459441148391
suggesting,73,4.290459441148391
like,73,4.290459441148391
female,73,4.290459441148391
allergy,73,4.290459441148391
source,73,4.290459441148391
loss,73,4.290459441148391
providing,73,4.290459441148391
interaction,73,4.290459441148391
Using,72,4.276666119016055
point,72,4.276666119016055
stem,72,4.276666119016055
make,72,4.276666119016055
Disease,72,4.276666119016055
location,72,4.276666119016055
implementation,72,4.276666119016055
48,72,4.276666119016055
dynamics,72,4.276666119016055
abnormal,72,4.276666119016055
shows,72,4.276666119016055
alone,72,4.276666119016055
almost,72,4.276666119016055
annual,72,4.276666119016055
directly,71,4.2626798770413155
date,71,4.2626798770413155
produced,71,4.2626798770413155
administered,71,4.2626798770413155
tools,71,4.2626798770413155
coverage,71,4.2626798770413155
26,71,4.2626798770413155
mRNA,71,4.2626798770413155
what,71,4.2626798770413155
together,71,4.2626798770413155
computed,71,4.2626798770413155
certain,71,4.2626798770413155
75,71,4.2626798770413155
options,71,4.2626798770413155
strong,71,4.2626798770413155
behavior,70,4.248495242049359
rats,70,4.248495242049359
consequences,70,4.248495242049359
describes,70,4.248495242049359
conventional,70,4.248495242049359
beneficial,70,4.248495242049359
variability,70,4.248495242049359
expiratory,70,4.248495242049359
practices,70,4.248495242049359
seasons,70,4.248495242049359
elevated,70,4.248495242049359
airflow,70,4.248495242049359
throughout,70,4.248495242049359
N,70,4.248495242049359
April,70,4.248495242049359
Because,70,4.248495242049359
great,70,4.248495242049359
Wuhan,70,4.248495242049359
occurs,70,4.248495242049359
man,70,4.248495242049359
crucial,70,4.248495242049359
services,70,4.248495242049359
questions,69,4.23410650459726
already,69,4.23410650459726
enzyme,69,4.23410650459726
hemodynamic,69,4.23410650459726
Hospital,69,4.23410650459726
occurring,69,4.23410650459726
approved,69,4.23410650459726
affecting,69,4.23410650459726
reference,69,4.23410650459726
along,69,4.23410650459726
necrosis,69,4.23410650459726
hand,69,4.23410650459726
By,69,4.23410650459726
Results,69,4.23410650459726
improving,68,4.219507705176107
complicated,68,4.219507705176107
nature,68,4.219507705176107
receive,68,4.219507705176107
revascularization,68,4.219507705176107
infarctions,68,4.219507705176107
seems,68,4.219507705176107
close,68,4.219507705176107
LV,68,4.219507705176107
recognized,68,4.219507705176107
influenza-like,67,4.204692619390966
AH1N1,67,4.204692619390966
FEV1,67,4.204692619390966
magnetic,67,4.204692619390966
consistent,67,4.204692619390966
variation,67,4.204692619390966
hyperresponsiveness,67,4.204692619390966
waves,67,4.204692619390966
Overall,67,4.204692619390966
causing,67,4.204692619390966
minutes,67,4.204692619390966
phenotypes,67,4.204692619390966
Both,67,4.204692619390966
31,67,4.204692619390966
immediate,67,4.204692619390966
South,67,4.204692619390966
22,67,4.204692619390966
cytokine,67,4.204692619390966
prophylaxis,67,4.204692619390966
structural,67,4.204692619390966
peripheral,66,4.189654742026425
Respiratory,66,4.189654742026425
adherence,66,4.189654742026425
origin,66,4.189654742026425
allergen,66,4.189654742026425
students,66,4.189654742026425
nursing,66,4.189654742026425
clinicians,66,4.189654742026425
35,66,4.189654742026425
targeted,66,4.189654742026425
progression,66,4.189654742026425
Many,66,4.189654742026425
45,66,4.189654742026425
department,66,4.189654742026425
sites,66,4.189654742026425
estimates,66,4.189654742026425
timing,66,4.189654742026425
sudden,65,4.174387269895637
psychological,65,4.174387269895637
Europe,65,4.174387269895637
expected,65,4.174387269895637
unique,65,4.174387269895637
obstructive,65,4.174387269895637
modified,65,4.174387269895637
coronaviruses,65,4.174387269895637
When,65,4.174387269895637
Coronary,65,4.174387269895637
includes,65,4.174387269895637
timely,65,4.174387269895637
1918,65,4.174387269895637
resonance,65,4.174387269895637
QRS,65,4.174387269895637
convalescent,64,4.1588830833596715
largely,64,4.1588830833596715
genome,64,4.1588830833596715
±,64,4.1588830833596715
reviews,64,4.1588830833596715
min,64,4.1588830833596715
ACE2,64,4.1588830833596715
surface,64,4.1588830833596715
36,64,4.1588830833596715
points,64,4.1588830833596715
ILI,64,4.1588830833596715
load,64,4.1588830833596715
UK,64,4.1588830833596715
decisions,64,4.1588830833596715
perioperative,63,4.143134726391533
stable,63,4.143134726391533
susceptible,63,4.143134726391533
variety,63,4.143134726391533
electrocardiographic,63,4.143134726391533
half,63,4.143134726391533
understood,63,4.143134726391533
wide,63,4.143134726391533
septal,63,4.143134726391533
scale,63,4.143134726391533
infarcts,63,4.143134726391533
planning,63,4.143134726391533
maximum,63,4.143134726391533
temperature,63,4.143134726391533
Control,62,4.127134385045092
set,62,4.127134385045092
progress,62,4.127134385045092
limitations,62,4.127134385045092
longer,62,4.127134385045092
urgent,62,4.127134385045092
stenting,62,4.127134385045092
every,62,4.127134385045092
assessing,62,4.127134385045092
neuraminidase,62,4.127134385045092
selection,62,4.127134385045092
facilitate,62,4.127134385045092
stages,62,4.127134385045092
probably,62,4.127134385045092
efficient,62,4.127134385045092
thrombus,62,4.127134385045092
ventilation,62,4.127134385045092
indicates,62,4.127134385045092
rather,62,4.127134385045092
biomarkers,62,4.127134385045092
account,62,4.127134385045092
hemorrhagic,62,4.127134385045092
January,62,4.127134385045092
D,61,4.110873864173311
thrombectomy,61,4.110873864173311
concentrations,61,4.110873864173311
primarily,61,4.110873864173311
towards,61,4.110873864173311
short,61,4.110873864173311
candidates,61,4.110873864173311
Further,61,4.110873864173311
comparable,61,4.110873864173311
entry,61,4.110873864173311
facilities,61,4.110873864173311
short-term,61,4.110873864173311
vitamin,61,4.110873864173311
27,61,4.110873864173311
appear,61,4.110873864173311
adolescents,61,4.110873864173311
23,61,4.110873864173311
C,60,4.0943445622221
protocol,60,4.0943445622221
newly,60,4.0943445622221
percentage,60,4.0943445622221
month,60,4.0943445622221
swine,60,4.0943445622221
successfully,60,4.0943445622221
side,60,4.0943445622221
increasingly,60,4.0943445622221
thoracic,60,4.0943445622221
species,60,4.0943445622221
clinic,60,4.0943445622221
considerable,60,4.0943445622221
May,60,4.0943445622221
limit,60,4.0943445622221
extensive,60,4.0943445622221
interactions,59,4.07753744390572
targeting,59,4.07753744390572
toward,59,4.07753744390572
summarize,59,4.07753744390572
vitro,59,4.07753744390572
deficits,59,4.07753744390572
February,59,4.07753744390572
neutralizing,59,4.07753744390572
RBD,59,4.07753744390572
whole,59,4.07753744390572
SARS-CoV,59,4.07753744390572
undergoing,59,4.07753744390572
consider,59,4.07753744390572
decision,59,4.07753744390572
noted,59,4.07753744390572
availability,59,4.07753744390572
others,59,4.07753744390572
calculated,59,4.07753744390572
HA,59,4.07753744390572
PTCA,59,4.07753744390572
monitor,59,4.07753744390572
muscle,59,4.07753744390572
trends,58,4.060443010546419
susceptibility,58,4.060443010546419
able,58,4.060443010546419
42,58,4.060443010546419
whose,58,4.060443010546419
detailed,58,4.060443010546419
seven,58,4.060443010546419
sequence,58,4.060443010546419
statistical,58,4.060443010546419
eight,57,4.04305126783455
38,57,4.04305126783455
statistically,57,4.04305126783455
disorder,57,4.04305126783455
divided,57,4.04305126783455
represents,57,4.04305126783455
Medical,57,4.04305126783455
infarcted,57,4.04305126783455
Q,57,4.04305126783455
schools,57,4.04305126783455
continued,57,4.04305126783455
embolism,57,4.04305126783455
effectively,57,4.04305126783455
establish,56,4.02535169073515
behavioral,56,4.02535169073515
members,56,4.02535169073515
varied,56,4.02535169073515
poultry,56,4.02535169073515
consumption,56,4.02535169073515
nucleic,56,4.02535169073515
adjusted,56,4.02535169073515
states,56,4.02535169073515
networks,56,4.02535169073515
derived,56,4.02535169073515
achieve,56,4.02535169073515
concerns,56,4.02535169073515
isolates,56,4.02535169073515
conclude,56,4.02535169073515
poorly,56,4.02535169073515
Early,56,4.02535169073515
procedure,56,4.02535169073515
variations,56,4.02535169073515
rest,56,4.02535169073515
vivo,56,4.02535169073515
affects,56,4.02535169073515
cent,56,4.02535169073515
done,56,4.02535169073515
arrhythmias,56,4.02535169073515
From,56,4.02535169073515
Organization,56,4.02535169073515
success,56,4.02535169073515
making,56,4.02535169073515
allergens,56,4.02535169073515
gender,55,4.007333185232471
possibility,55,4.007333185232471
differ,55,4.007333185232471
strongly,55,4.007333185232471
intracranial,55,4.007333185232471
block,55,4.007333185232471
finding,55,4.007333185232471
distress,55,4.007333185232471
widespread,55,4.007333185232471
Study,55,4.007333185232471
June,55,4.007333185232471
formation,55,4.007333185232471
visits,55,4.007333185232471
pathology,55,4.007333185232471
validated,55,4.007333185232471
cytokines,55,4.007333185232471
transcription,55,4.007333185232471
term,55,4.007333185232471
mutation,55,4.007333185232471
presents,55,4.007333185232471
plays,55,4.007333185232471
adequate,55,4.007333185232471
females,55,4.007333185232471
forms,55,4.007333185232471
atherosclerosis,55,4.007333185232471
DNA,54,3.9889840465642745
nasal,54,3.9889840465642745
delayed,54,3.9889840465642745
choice,54,3.9889840465642745
2021,54,3.9889840465642745
reporting,54,3.9889840465642745
basic,54,3.9889840465642745
remained,54,3.9889840465642745
degrees,54,3.9889840465642745
urban,54,3.9889840465642745
live,54,3.9889840465642745
concentration,54,3.9889840465642745
rupture,54,3.9889840465642745
component,54,3.9889840465642745
classified,54,3.9889840465642745
measurement,54,3.9889840465642745
If,54,3.9889840465642745
objectives,54,3.9889840465642745
propose,54,3.9889840465642745
concluded,54,3.9889840465642745
diagnostics,53,3.970291913552122
records,53,3.970291913552122
reduces,53,3.970291913552122
his,53,3.970291913552122
growth,53,3.970291913552122
electrocardiogram,53,3.970291913552122
VE,53,3.970291913552122
sequences,53,3.970291913552122
residents,53,3.970291913552122
functions,53,3.970291913552122
find,53,3.970291913552122
2019-nCoV,53,3.970291913552122
bleeding,53,3.970291913552122
subtype,53,3.970291913552122
explain,53,3.970291913552122
represent,53,3.970291913552122
providers,53,3.970291913552122
males,53,3.970291913552122
analyze,53,3.970291913552122
prevalent,53,3.970291913552122
vulnerable,53,3.970291913552122
periods,53,3.970291913552122
angiographic,53,3.970291913552122
continues,53,3.970291913552122
segments,53,3.970291913552122
summarizes,53,3.970291913552122
awareness,53,3.970291913552122
American,53,3.970291913552122
fact,53,3.970291913552122
completed,52,3.9512437185814275
collection,52,3.9512437185814275
invasive,52,3.9512437185814275
plasminogen,52,3.9512437185814275
view,52,3.9512437185814275
highlight,52,3.9512437185814275
linked,52,3.9512437185814275
physician,52,3.9512437185814275
families,52,3.9512437185814275
plans,52,3.9512437185814275
marked,52,3.9512437185814275
agreement,52,3.9512437185814275
predicting,52,3.9512437185814275
Japan,52,3.9512437185814275
offer,52,3.9512437185814275
investigations,52,3.9512437185814275
concerning,52,3.9512437185814275
Chinese,52,3.9512437185814275
contacts,52,3.9512437185814275
influenced,52,3.9512437185814275
profile,52,3.9512437185814275
device,52,3.9512437185814275
RT-qPCR,52,3.9512437185814275
define,52,3.9512437185814275
living,52,3.9512437185814275
explored,52,3.9512437185814275
protocols,52,3.9512437185814275
situation,52,3.9512437185814275
involving,52,3.9512437185814275
sampling,52,3.9512437185814275
Three,51,3.9318256327243257
34,51,3.9318256327243257
expressed,51,3.9318256327243257
specifically,51,3.9318256327243257
recanalization,51,3.9318256327243257
earlier,51,3.9318256327243257
Africa,51,3.9318256327243257
insights,51,3.9318256327243257
cannot,51,3.9318256327243257
place,51,3.9318256327243257
discharged,51,3.9318256327243257
prediction,51,3.9318256327243257
balloon,51,3.9318256327243257
Finally,51,3.9318256327243257
AH3N2,51,3.9318256327243257
upon,51,3.9318256327243257
communication,51,3.9318256327243257
NA,51,3.9318256327243257
indicating,51,3.9318256327243257
activator,51,3.9318256327243257
inhibition,51,3.9318256327243257
hospitalizations,51,3.9318256327243257
discusses,50,3.912023005428146
inhalation,50,3.912023005428146
skin,50,3.912023005428146
traditional,50,3.912023005428146
inpatient,50,3.912023005428146
indirect,50,3.912023005428146
ill,50,3.912023005428146
inform,50,3.912023005428146
admissions,50,3.912023005428146
anti-inflammatory,50,3.912023005428146
post-stroke,50,3.912023005428146
communities,50,3.912023005428146
comparing,50,3.912023005428146
Italy,50,3.912023005428146
2010,50,3.912023005428146
suitable,50,3.912023005428146
until,50,3.912023005428146
ED,50,3.912023005428146
cavity,50,3.912023005428146
laboratories,50,3.912023005428146
titers,50,3.912023005428146
another,50,3.912023005428146
Prevention,50,3.912023005428146
Some,50,3.912023005428146
suffering,49,3.8918202981106265
introduction,49,3.8918202981106265
inactivated,49,3.8918202981106265
trend,49,3.8918202981106265
real,49,3.8918202981106265
maternal,49,3.8918202981106265
step,49,3.8918202981106265
mg,49,3.8918202981106265
resistant,49,3.8918202981106265
Scale,49,3.8918202981106265
regular,49,3.8918202981106265
reactions,49,3.8918202981106265
domain,49,3.8918202981106265
beginning,49,3.8918202981106265
numbers,49,3.8918202981106265
Based,49,3.8918202981106265
special,49,3.8918202981106265
detecting,49,3.8918202981106265
roles,49,3.8918202981106265
marker,49,3.8918202981106265
growing,49,3.8918202981106265
definition,49,3.8918202981106265
determining,49,3.8918202981106265
release,49,3.8918202981106265
August,49,3.8918202981106265
41,48,3.871201010907891
internal,48,3.871201010907891
recovered,48,3.871201010907891
FeNO,48,3.871201010907891
serological,48,3.871201010907891
personal,48,3.871201010907891
descending,48,3.871201010907891
visual,48,3.871201010907891
globally,48,3.871201010907891
infants,48,3.871201010907891
55,48,3.871201010907891
initiation,48,3.871201010907891
distancing,48,3.871201010907891
residual,48,3.871201010907891
Current,48,3.871201010907891
induce,48,3.871201010907891
subgroups,48,3.871201010907891
dynamic,48,3.871201010907891
controlling,48,3.871201010907891
middle,48,3.871201010907891
infarct-related,48,3.871201010907891
ranged,48,3.871201010907891
failed,48,3.871201010907891
CDC,48,3.871201010907891
mm,48,3.871201010907891
above,48,3.871201010907891
33,48,3.871201010907891
anticoagulation,48,3.871201010907891
culture,48,3.871201010907891
substantially,48,3.871201010907891
comorbidities,48,3.871201010907891
lateral,47,3.8501476017100584
vessels,47,3.8501476017100584
pathological,47,3.8501476017100584
continue,47,3.8501476017100584
pathogens,47,3.8501476017100584
regard,47,3.8501476017100584
October,47,3.8501476017100584
issue,47,3.8501476017100584
overview,47,3.8501476017100584
TIA,47,3.8501476017100584
Treatment,47,3.8501476017100584
prolonged,47,3.8501476017100584
steroids,47,3.8501476017100584
hemorrhage,47,3.8501476017100584
repair,47,3.8501476017100584
advanced,47,3.8501476017100584
follow,47,3.8501476017100584
here,47,3.8501476017100584
showing,47,3.8501476017100584
antigens,47,3.8501476017100584
SARS,46,3.828641396489095
exposures,46,3.828641396489095
cross-sectional,46,3.828641396489095
contribution,46,3.828641396489095
membrane,46,3.828641396489095
innate,46,3.828641396489095
Aim,46,3.828641396489095
transport,46,3.828641396489095
Only,46,3.828641396489095
fatality,46,3.828641396489095
oxide,46,3.828641396489095
depends,46,3.828641396489095
decades,46,3.828641396489095
More,46,3.828641396489095
us,46,3.828641396489095
spontaneous,46,3.828641396489095
manage,46,3.828641396489095
associations,46,3.828641396489095
technology,46,3.828641396489095
differential,46,3.828641396489095
guide,46,3.828641396489095
repeated,46,3.828641396489095
perception,46,3.828641396489095
compounds,46,3.828641396489095
clearly,46,3.828641396489095
32,46,3.828641396489095
sera,46,3.828641396489095
next,46,3.828641396489095
framework,46,3.828641396489095
typical,46,3.828641396489095
medium,46,3.828641396489095
vital,46,3.828641396489095
immediately,45,3.8066624897703196
atopic,45,3.8066624897703196
improves,45,3.8066624897703196
46,45,3.8066624897703196
rural,45,3.8066624897703196
units,45,3.8066624897703196
hygiene,45,3.8066624897703196
enhance,45,3.8066624897703196
heterogeneous,45,3.8066624897703196
IAV,45,3.8066624897703196
transplantation,45,3.8066624897703196
logistic,45,3.8066624897703196
physiological,45,3.8066624897703196
density,45,3.8066624897703196
reversible,45,3.8066624897703196
free,45,3.8066624897703196
reasons,45,3.8066624897703196
nine,45,3.8066624897703196
rhythm,45,3.8066624897703196
scan,45,3.8066624897703196
nitric,45,3.8066624897703196
pharmacological,45,3.8066624897703196
concept,45,3.8066624897703196
worse,45,3.8066624897703196
collateral,44,3.784189633918261
take,44,3.784189633918261
century,44,3.784189633918261
prehospital,44,3.784189633918261
self-management,44,3.784189633918261
Emergency,44,3.784189633918261
coronavirus-2,44,3.784189633918261
guidance,44,3.784189633918261
November,44,3.784189633918261
defect,44,3.784189633918261
heterogeneity,44,3.784189633918261
rarely,44,3.784189633918261
analysed,44,3.784189633918261
aortic,44,3.784189633918261
enhanced,44,3.784189633918261
systolic,44,3.784189633918261
venous,44,3.784189633918261
working,44,3.784189633918261
larger,44,3.784189633918261
H7N9,44,3.784189633918261
initially,44,3.784189633918261
impaired,44,3.784189633918261
barriers,44,3.784189633918261
CK,44,3.784189633918261
Studies,44,3.784189633918261
proved,44,3.784189633918261
enrolled,44,3.784189633918261
ensure,44,3.784189633918261
ages,44,3.784189633918261
intensity,43,3.7612001156935624
images,43,3.7612001156935624
illnesses,43,3.7612001156935624
proximal,43,3.7612001156935624
rise,43,3.7612001156935624
cycle,43,3.7612001156935624
evaluating,43,3.7612001156935624
corresponding,43,3.7612001156935624
assist,43,3.7612001156935624
stent,43,3.7612001156935624
proven,43,3.7612001156935624
Asia,43,3.7612001156935624
question,43,3.7612001156935624
remaining,43,3.7612001156935624
stay,43,3.7612001156935624
room,43,3.7612001156935624
IgE,43,3.7612001156935624
easily,43,3.7612001156935624
0,43,3.7612001156935624
compliance,43,3.7612001156935624
length,43,3.7612001156935624
branch,43,3.7612001156935624
effort,43,3.7612001156935624
Such,43,3.7612001156935624
Recently,43,3.7612001156935624
protect,43,3.7612001156935624
curve,43,3.7612001156935624
nurses,43,3.7612001156935624
taking,43,3.7612001156935624
always,43,3.7612001156935624
highlights,43,3.7612001156935624
sources,42,3.7376696182833684
organs,42,3.7376696182833684
According,42,3.7376696182833684
consideration,42,3.7376696182833684
priority,42,3.7376696182833684
mellitus,42,3.7376696182833684
exist,42,3.7376696182833684
transmural,42,3.7376696182833684
laboratory-confirmed,42,3.7376696182833684
dissection,42,3.7376696182833684
lungs,42,3.7376696182833684
emotional,42,3.7376696182833684
exposed,42,3.7376696182833684
utility,42,3.7376696182833684
completely,42,3.7376696182833684
evidence-based,42,3.7376696182833684
serve,42,3.7376696182833684
articles,42,3.7376696182833684
deep,42,3.7376696182833684
inhibitor,42,3.7376696182833684
SD,42,3.7376696182833684
injection,42,3.7376696182833684
anxiety,42,3.7376696182833684
practitioners,42,3.7376696182833684
containing,42,3.7376696182833684
250,42,3.7376696182833684
center,42,3.7376696182833684
database,42,3.7376696182833684
steroid,42,3.7376696182833684
corticosteroid,42,3.7376696182833684
liver,42,3.7376696182833684
reinfarction,42,3.7376696182833684
Currently,42,3.7376696182833684
service,42,3.7376696182833684
Children,42,3.7376696182833684
recommend,42,3.7376696182833684
72,42,3.7376696182833684
respect,42,3.7376696182833684
demographic,41,3.713572066704308
mediators,41,3.713572066704308
attenuated,41,3.713572066704308
sleep,41,3.713572066704308
multivariate,41,3.713572066704308
stimulation,41,3.713572066704308
bacterial,41,3.713572066704308
post,41,3.713572066704308
NIHSS,41,3.713572066704308
greatest,41,3.713572066704308
uncontrolled,41,3.713572066704308
consensus,41,3.713572066704308
rhinitis,41,3.713572066704308
applications,41,3.713572066704308
signaling,41,3.713572066704308
subject,41,3.713572066704308
determination,41,3.713572066704308
promote,41,3.713572066704308
Compared,41,3.713572066704308
predictor,41,3.713572066704308
maximal,41,3.713572066704308
limitation,41,3.713572066704308
confirm,41,3.713572066704308
class,41,3.713572066704308
PEF,41,3.713572066704308
induction,41,3.713572066704308
distinct,41,3.713572066704308
emphasis,41,3.713572066704308
ST-elevation,41,3.713572066704308
mostly,41,3.713572066704308
excess,41,3.713572066704308
meta-analysis,41,3.713572066704308
challenging,41,3.713572066704308
epidemiologic,41,3.713572066704308
standardized,40,3.6888794541139363
receptors,40,3.6888794541139363
decade,40,3.6888794541139363
52,40,3.6888794541139363
Given,40,3.6888794541139363
observational,40,3.6888794541139363
equal,40,3.6888794541139363
closely,40,3.6888794541139363
sequencing,40,3.6888794541139363
serial,40,3.6888794541139363
cumulative,40,3.6888794541139363
respond,40,3.6888794541139363
ranging,40,3.6888794541139363
noninvasive,40,3.6888794541139363
candidate,40,3.6888794541139363
July,40,3.6888794541139363
sustained,40,3.6888794541139363
amount,40,3.6888794541139363
cluster,40,3.6888794541139363
plaque,40,3.6888794541139363
beliefs,40,3.6888794541139363
creatine,40,3.6888794541139363
devastating,40,3.6888794541139363
personnel,40,3.6888794541139363
aerosol,40,3.6888794541139363
thought,40,3.6888794541139363
dominant,40,3.6888794541139363
IV,40,3.6888794541139363
minor,40,3.6888794541139363
predominant,40,3.6888794541139363
outpatient,40,3.6888794541139363
operation,40,3.6888794541139363
spectrum,40,3.6888794541139363
requiring,40,3.6888794541139363
gold,40,3.6888794541139363
determinants,40,3.6888794541139363
winter,40,3.6888794541139363
obesity,40,3.6888794541139363
endovascular,40,3.6888794541139363
biology,40,3.6888794541139363
appeared,40,3.6888794541139363
exhaled,39,3.6635616461296463
weight,39,3.6635616461296463
technologies,39,3.6635616461296463
phenomenon,39,3.6635616461296463
goals,39,3.6635616461296463
depending,39,3.6635616461296463
improvements,39,3.6635616461296463
Over,39,3.6635616461296463
anti-SARS-CoV-2,39,3.6635616461296463
diverse,39,3.6635616461296463
International,39,3.6635616461296463
line,39,3.6635616461296463
superior,39,3.6635616461296463
media,39,3.6635616461296463
attitudes,39,3.6635616461296463
discovery,39,3.6635616461296463
dependent,39,3.6635616461296463
characterize,39,3.6635616461296463
crisis,39,3.6635616461296463
proper,39,3.6635616461296463
transmitted,39,3.6635616461296463
intervals,39,3.6635616461296463
fall,39,3.6635616461296463
III,39,3.6635616461296463
epithelial,39,3.6635616461296463
offers,39,3.6635616461296463
triggers,39,3.6635616461296463
antivirals,39,3.6635616461296463
indicators,39,3.6635616461296463
antithrombotic,39,3.6635616461296463
silent,39,3.6635616461296463
opportunity,39,3.6635616461296463
aggressive,39,3.6635616461296463
potent,39,3.6635616461296463
95CI,39,3.6635616461296463
open,39,3.6635616461296463
large-scale,39,3.6635616461296463
tissues,39,3.6635616461296463
ARDS,39,3.6635616461296463
count,39,3.6635616461296463
contributing,39,3.6635616461296463
diagnoses,39,3.6635616461296463
longitudinal,39,3.6635616461296463
raised,39,3.6635616461296463
ones,39,3.6635616461296463
minority,39,3.6635616461296463
lacunar,38,3.6375861597263857
allows,38,3.6375861597263857
perceptions,38,3.6375861597263857
phenotype,38,3.6375861597263857
observations,38,3.6375861597263857
1997,38,3.6375861597263857
structures,38,3.6375861597263857
molecules,38,3.6375861597263857
final,38,3.6375861597263857
MR,38,3.6375861597263857
experiences,38,3.6375861597263857
ICH,38,3.6375861597263857
44,38,3.6375861597263857
picture,38,3.6375861597263857
valuable,38,3.6375861597263857
Vaccination,38,3.6375861597263857
acceptance,38,3.6375861597263857
addressed,38,3.6375861597263857
37,38,3.6375861597263857
warfarin,38,3.6375861597263857
behaviors,38,3.6375861597263857
Australia,38,3.6375861597263857
involves,38,3.6375861597263857
independently,38,3.6375861597263857
generated,38,3.6375861597263857
manner,38,3.6375861597263857
properties,38,3.6375861597263857
possibly,38,3.6375861597263857
Also,38,3.6375861597263857
clusters,38,3.6375861597263857
et,38,3.6375861597263857
AT,38,3.6375861597263857
r,38,3.6375861597263857
mental,38,3.6375861597263857
renal,38,3.6375861597263857
nervous,38,3.6375861597263857
therapeutics,38,3.6375861597263857
signal,38,3.6375861597263857
millions,38,3.6375861597263857
light,38,3.6375861597263857
atopy,37,3.6109179126442243
Department,37,3.6109179126442243
syndromes,37,3.6109179126442243
health-care,37,3.6109179126442243
transmissibility,37,3.6109179126442243
resolution,37,3.6109179126442243
initiated,37,3.6109179126442243
generation,37,3.6109179126442243
spreading,37,3.6109179126442243
platforms,37,3.6109179126442243
vector,37,3.6109179126442243
influences,37,3.6109179126442243
hyperreactivity,37,3.6109179126442243
platelet,37,3.6109179126442243
2013,37,3.6109179126442243
ELISA,37,3.6109179126442243
Other,37,3.6109179126442243
researchers,37,3.6109179126442243
regulation,37,3.6109179126442243
miRNAs,37,3.6109179126442243
perform,37,3.6109179126442243
modalities,37,3.6109179126442243
water,37,3.6109179126442243
clearance,37,3.6109179126442243
subgroup,37,3.6109179126442243
aneurysm,37,3.6109179126442243
IS,37,3.6109179126442243
E,37,3.6109179126442243
Additionally,37,3.6109179126442243
immunogenicity,37,3.6109179126442243
correlations,37,3.6109179126442243
prophylactic,37,3.6109179126442243
continuous,37,3.6109179126442243
face,37,3.6109179126442243
quickly,37,3.6109179126442243
lives,37,3.6109179126442243
became,37,3.6109179126442243
ways,37,3.6109179126442243
2003,37,3.6109179126442243
donors,37,3.6109179126442243
sputum,37,3.6109179126442243
AH1N1pdm09,37,3.6109179126442243
Infarction,37,3.6109179126442243
itself,36,3.58351893845611
distal,36,3.58351893845611
anticoagulants,36,3.58351893845611
supply,36,3.58351893845611
efficiency,36,3.58351893845611
causative,36,3.58351893845611
markedly,36,3.58351893845611
al,36,3.58351893845611
algorithm,36,3.58351893845611
England,36,3.58351893845611
obtain,36,3.58351893845611
probability,36,3.58351893845611
started,36,3.58351893845611
reflect,36,3.58351893845611
recombinant,36,3.58351893845611
Nevertheless,36,3.58351893845611
authorities,36,3.58351893845611
equipment,36,3.58351893845611
HCWs,36,3.58351893845611
monitored,36,3.58351893845611
employed,36,3.58351893845611
University,36,3.58351893845611
spatial,36,3.58351893845611
Rapid,36,3.58351893845611
devices,36,3.58351893845611
example,36,3.58351893845611
adaptive,36,3.58351893845611
68,36,3.58351893845611
Global,36,3.58351893845611
diastolic,36,3.58351893845611
53,36,3.58351893845611
responsiveness,36,3.58351893845611
America,36,3.58351893845611
background,36,3.58351893845611
poststroke,36,3.58351893845611
amino,36,3.58351893845611
adopted,36,3.58351893845611
avoid,36,3.58351893845611
tracing,36,3.58351893845611
qualitative,36,3.58351893845611
zone,35,3.5553480614894135
neurologic,35,3.5553480614894135
speed,35,3.5553480614894135
programme,35,3.5553480614894135
thereby,35,3.5553480614894135
progressive,35,3.5553480614894135
her,35,3.5553480614894135
clinics,35,3.5553480614894135
preferred,35,3.5553480614894135
North,35,3.5553480614894135
airborne,35,3.5553480614894135
Germany,35,3.5553480614894135
Cardiac,35,3.5553480614894135
robust,35,3.5553480614894135
smooth,35,3.5553480614894135
near,35,3.5553480614894135
numerous,35,3.5553480614894135
inclusion,35,3.5553480614894135
chemical,35,3.5553480614894135
managed,35,3.5553480614894135
validity,35,3.5553480614894135
Research,35,3.5553480614894135
prompt,35,3.5553480614894135
Future,35,3.5553480614894135
inadequate,35,3.5553480614894135
kinase,35,3.5553480614894135
amplification,35,3.5553480614894135
pathway,35,3.5553480614894135
non-invasive,35,3.5553480614894135
43,35,3.5553480614894135
practical,35,3.5553480614894135
lineage,35,3.5553480614894135
produce,35,3.5553480614894135
none,35,3.5553480614894135
commercial,35,3.5553480614894135
applying,34,3.5263605246161616
lowest,34,3.5263605246161616
own,34,3.5263605246161616
amantadine,34,3.5263605246161616
69,34,3.5263605246161616
team,34,3.5263605246161616
breath,34,3.5263605246161616
referred,34,3.5263605246161616
CNS,34,3.5263605246161616
beta,34,3.5263605246161616
extremely,34,3.5263605246161616
utilization,34,3.5263605246161616
forced,34,3.5263605246161616
focuses,34,3.5263605246161616
anticoagulant,34,3.5263605246161616
threshold,34,3.5263605246161616
kidney,34,3.5263605246161616
transfer,34,3.5263605246161616
sufficient,34,3.5263605246161616
shift,34,3.5263605246161616
population-based,34,3.5263605246161616
humidity,34,3.5263605246161616
critically,34,3.5263605246161616
CABG,34,3.5263605246161616
learning,34,3.5263605246161616
predominantly,34,3.5263605246161616
drift,34,3.5263605246161616
life-threatening,34,3.5263605246161616
multiplex,34,3.5263605246161616
tachycardia,34,3.5263605246161616
Canada,34,3.5263605246161616
preclinical,34,3.5263605246161616
unprecedented,34,3.5263605246161616
Due,34,3.5263605246161616
BP,34,3.5263605246161616
edema,34,3.5263605246161616
deterioration,34,3.5263605246161616
extraction,34,3.5263605246161616
directed,33,3.4965075614664802
potentials,33,3.4965075614664802
diagnose,33,3.4965075614664802
white,33,3.4965075614664802
intracoronary,33,3.4965075614664802
He,33,3.4965075614664802
perspective,33,3.4965075614664802
wheeze,33,3.4965075614664802
perceived,33,3.4965075614664802
diagnosing,33,3.4965075614664802
considerations,33,3.4965075614664802
likelihood,33,3.4965075614664802
uses,33,3.4965075614664802
dogs,33,3.4965075614664802
discovered,33,3.4965075614664802
EF,33,3.4965075614664802
September,33,3.4965075614664802
impacts,33,3.4965075614664802
consisted,33,3.4965075614664802
policies,33,3.4965075614664802
characteristic,33,3.4965075614664802
option,33,3.4965075614664802
embolic,33,3.4965075614664802
accompanied,33,3.4965075614664802
socioeconomic,33,3.4965075614664802
antiplatelet,33,3.4965075614664802
city,33,3.4965075614664802
metabolic,33,3.4965075614664802
seem,33,3.4965075614664802
nocturnal,33,3.4965075614664802
soon,33,3.4965075614664802
fluid,33,3.4965075614664802
readily,33,3.4965075614664802
platform,33,3.4965075614664802
profiles,33,3.4965075614664802
positivity,33,3.4965075614664802
helpful,33,3.4965075614664802
decline,33,3.4965075614664802
85,33,3.4965075614664802
prospectively,33,3.4965075614664802
databases,33,3.4965075614664802
recipients,33,3.4965075614664802
intention,33,3.4965075614664802
interpretation,33,3.4965075614664802
matched,33,3.4965075614664802
genomic,33,3.4965075614664802
Western,33,3.4965075614664802
NSTEMI,33,3.4965075614664802
vertical,33,3.4965075614664802
sensitization,33,3.4965075614664802
manifestation,33,3.4965075614664802
histamine,33,3.4965075614664802
lines,33,3.4965075614664802
implement,33,3.4965075614664802
undertaken,32,3.4657359027997265
broad,32,3.4657359027997265
elucidate,32,3.4657359027997265
Care,32,3.4657359027997265
hemisphere,32,3.4657359027997265
organ,32,3.4657359027997265
unstable,32,3.4657359027997265
aid,32,3.4657359027997265
63,32,3.4657359027997265
64,32,3.4657359027997265
cold,32,3.4657359027997265
47,32,3.4657359027997265
viable,32,3.4657359027997265
focusing,32,3.4657359027997265
arrival,32,3.4657359027997265
summary,32,3.4657359027997265
RR,32,3.4657359027997265
fast,32,3.4657359027997265
excellent,32,3.4657359027997265
declared,32,3.4657359027997265
Institute,32,3.4657359027997265
Centers,32,3.4657359027997265
strength,32,3.4657359027997265
geographic,32,3.4657359027997265
observation,32,3.4657359027997265
products,32,3.4657359027997265
Kong,32,3.4657359027997265
atherosclerotic,32,3.4657359027997265
antagonists,32,3.4657359027997265
acquired,32,3.4657359027997265
stratification,32,3.4657359027997265
TIMI,32,3.4657359027997265
relevance,32,3.4657359027997265
Covid-19,32,3.4657359027997265
PFO,32,3.4657359027997265
controversial,32,3.4657359027997265
Aims,32,3.4657359027997265
Korea,31,3.4339872044851463
58,31,3.4339872044851463
changed,31,3.4339872044851463
infectivity,31,3.4339872044851463
TRUNCATED,31,3.4339872044851463
mixed,31,3.4339872044851463
dental,31,3.4339872044851463
Within,31,3.4339872044851463
cardioembolic,31,3.4339872044851463
71,31,3.4339872044851463
psychosocial,31,3.4339872044851463
hundred,31,3.4339872044851463
reached,31,3.4339872044851463
Hong,31,3.4339872044851463
exhibited,31,3.4339872044851463
WORDS,31,3.4339872044851463
biochemical,31,3.4339872044851463
worsening,31,3.4339872044851463
mobile,31,3.4339872044851463
changing,31,3.4339872044851463
subsequently,31,3.4339872044851463
suffered,31,3.4339872044851463
genomes,31,3.4339872044851463
universal,31,3.4339872044851463
integrated,31,3.4339872044851463
eligible,31,3.4339872044851463
correlates,31,3.4339872044851463
avoidance,31,3.4339872044851463
parallel,31,3.4339872044851463
USA,31,3.4339872044851463
Heart,31,3.4339872044851463
latter,31,3.4339872044851463
dust,31,3.4339872044851463
glucose,31,3.4339872044851463
selective,31,3.4339872044851463
epitopes,31,3.4339872044851463
seizures,31,3.4339872044851463
ACE,31,3.4339872044851463
Previous,31,3.4339872044851463
Mexico,31,3.4339872044851463
pooled,31,3.4339872044851463
catheterization,31,3.4339872044851463
causal,31,3.4339872044851463
autopsy,31,3.4339872044851463
Syndrome,31,3.4339872044851463
virulence,31,3.4339872044851463
disparities,31,3.4339872044851463
lacking,31,3.4339872044851463
travel,31,3.4339872044851463
immunological,31,3.4339872044851463
East,31,3.4339872044851463
serology,31,3.4339872044851463
postoperative,31,3.4339872044851463
remote,31,3.4339872044851463
endothelial,30,3.4011973816621555
African,30,3.4011973816621555
LAD,30,3.4011973816621555
severely,30,3.4011973816621555
HR,30,3.4011973816621555
breathing,30,3.4011973816621555
precise,30,3.4011973816621555
94,30,3.4011973816621555
neural,30,3.4011973816621555
meet,30,3.4011973816621555
trigger,30,3.4011973816621555
twice,30,3.4011973816621555
campaign,30,3.4011973816621555
false,30,3.4011973816621555
concomitant,30,3.4011973816621555
examines,30,3.4011973816621555
participated,30,3.4011973816621555
favorable,30,3.4011973816621555
feature,30,3.4011973816621555
hour,30,3.4011973816621555
54,30,3.4011973816621555
closure,30,3.4011973816621555
actual,30,3.4011973816621555
globe,30,3.4011973816621555
uncommon,30,3.4011973816621555
matter,30,3.4011973816621555
altered,30,3.4011973816621555
74,30,3.4011973816621555
analytical,30,3.4011973816621555
she,30,3.4011973816621555
uncertain,30,3.4011973816621555
provocation,30,3.4011973816621555
peptides,30,3.4011973816621555
sickle,30,3.4011973816621555
base,30,3.4011973816621555
intermittent,30,3.4011973816621555
distinguish,30,3.4011973816621555
accelerated,30,3.4011973816621555
approval,30,3.4011973816621555
educational,30,3.4011973816621555
methacholine,30,3.4011973816621555
modelling,30,3.4011973816621555
transluminal,30,3.4011973816621555
mediated,30,3.4011973816621555
homes,30,3.4011973816621555
accepted,30,3.4011973816621555
typically,29,3.367295829986474
hemagglutinin,29,3.367295829986474
pathophysiological,29,3.367295829986474
health-related,29,3.367295829986474
he,29,3.367295829986474
specimen,29,3.367295829986474
reason,29,3.367295829986474
simultaneous,29,3.367295829986474
0005,29,3.367295829986474
Ischemic,29,3.367295829986474
contributes,29,3.367295829986474
called,29,3.367295829986474
EIA,29,3.367295829986474
limits,29,3.367295829986474
NS,29,3.367295829986474
accurately,29,3.367295829986474
indices,29,3.367295829986474
outside,29,3.367295829986474
advantages,29,3.367295829986474
household,29,3.367295829986474
fewer,29,3.367295829986474
introduced,29,3.367295829986474
transplant,29,3.367295829986474
randomly,29,3.367295829986474
temporal,29,3.367295829986474
magnitude,29,3.367295829986474
regimens,29,3.367295829986474
estimation,29,3.367295829986474
ICU,29,3.367295829986474
decreases,29,3.367295829986474
difficulty,29,3.367295829986474
containment,29,3.367295829986474
true,29,3.367295829986474
steps,29,3.367295829986474
categories,29,3.367295829986474
highlighted,29,3.367295829986474
2011,29,3.367295829986474
functioning,29,3.367295829986474
B117,29,3.367295829986474
triggered,29,3.367295829986474
woman,29,3.367295829986474
Use,29,3.367295829986474
Administration,29,3.367295829986474
except,29,3.367295829986474
recognize,29,3.367295829986474
birth,29,3.367295829986474
feasible,29,3.367295829986474
doctors,29,3.367295829986474
dementia,29,3.367295829986474
1000,29,3.367295829986474
combat,29,3.367295829986474
trauma,29,3.367295829986474
congestive,29,3.367295829986474
methodology,29,3.367295829986474
30-day,29,3.367295829986474
demonstrates,29,3.367295829986474
sinus,29,3.367295829986474
feasibility,29,3.367295829986474
actions,29,3.367295829986474
sometimes,29,3.367295829986474
Human,29,3.367295829986474
fatigue,29,3.367295829986474
met,29,3.367295829986474
usual,28,3.332204510175204
200,28,3.332204510175204
characterization,28,3.332204510175204
lethal,28,3.332204510175204
brief,28,3.332204510175204
evolving,28,3.332204510175204
hypothesized,28,3.332204510175204
nurse,28,3.332204510175204
cholesterol,28,3.332204510175204
government,28,3.332204510175204
language,28,3.332204510175204
biomarker,28,3.332204510175204
movement,28,3.332204510175204
Methods,28,3.332204510175204
behaviour,28,3.332204510175204
thrombotic,28,3.332204510175204
neonatal,28,3.332204510175204
cryptogenic,28,3.332204510175204
distributed,28,3.332204510175204
though,28,3.332204510175204
Four,28,3.332204510175204
2006,28,3.332204510175204
scarce,28,3.332204510175204
Test,28,3.332204510175204
remission,28,3.332204510175204
considering,28,3.332204510175204
starting,28,3.332204510175204
clarify,28,3.332204510175204
discussion,28,3.332204510175204
force,28,3.332204510175204
consequence,28,3.332204510175204
hazard,28,3.332204510175204
weekly,28,3.332204510175204
Drug,28,3.332204510175204
Management,28,3.332204510175204
Type,28,3.332204510175204
bronchodilators,28,3.332204510175204
reveal,28,3.332204510175204
57,28,3.332204510175204
uncomplicated,28,3.332204510175204
route,28,3.332204510175204
attributed,28,3.332204510175204
entire,28,3.332204510175204
slightly,28,3.332204510175204
correct,28,3.332204510175204
neuroprotective,28,3.332204510175204
indoor,28,3.332204510175204
electronic,28,3.332204510175204
infusion,28,3.332204510175204
demand,28,3.332204510175204
subset,28,3.332204510175204
project,28,3.332204510175204
defects,28,3.332204510175204
patency,28,3.332204510175204
protease,28,3.332204510175204
product,28,3.332204510175204
peptide,28,3.332204510175204
document,28,3.332204510175204
retrospectively,28,3.332204510175204
echocardiographic,28,3.332204510175204
comparisons,28,3.332204510175204
89,28,3.332204510175204
unusual,28,3.332204510175204
streptokinase,28,3.332204510175204
give,28,3.332204510175204
acceptable,28,3.332204510175204
allowing,28,3.332204510175204
utilized,28,3.332204510175204
39,28,3.332204510175204
alterations,28,3.332204510175204
grade,28,3.332204510175204
elements,28,3.332204510175204
massive,28,3.332204510175204
pH1N1,28,3.332204510175204
77,28,3.332204510175204
Understanding,28,3.332204510175204
share,28,3.332204510175204
62,28,3.332204510175204
full,27,3.295836866004329
lifestyle,27,3.295836866004329
nucleocapsid,27,3.295836866004329
regardless,27,3.295836866004329
mucosal,27,3.295836866004329
smaller,27,3.295836866004329
exercise-induced,27,3.295836866004329
gas,27,3.295836866004329
radionuclide,27,3.295836866004329
fibrosis,27,3.295836866004329
83,27,3.295836866004329
diabetic,27,3.295836866004329
subacute,27,3.295836866004329
aspirin,27,3.295836866004329
CAM,27,3.295836866004329
≥,27,3.295836866004329
minimal,27,3.295836866004329
enable,27,3.295836866004329
AIS,27,3.295836866004329
departments,27,3.295836866004329
updated,27,3.295836866004329
link,27,3.295836866004329
themselves,27,3.295836866004329
88,27,3.295836866004329
intrinsic,27,3.295836866004329
2004,27,3.295836866004329
axis,27,3.295836866004329
arrest,27,3.295836866004329
questionnaires,27,3.295836866004329
MERS-CoV,27,3.295836866004329
Vaccine,27,3.295836866004329
adjustment,27,3.295836866004329
Primary,27,3.295836866004329
separate,27,3.295836866004329
solution,27,3.295836866004329
59,27,3.295836866004329
usefulness,27,3.295836866004329
nearly,27,3.295836866004329
shedding,27,3.295836866004329
core,27,3.295836866004329
participation,27,3.295836866004329
stratified,27,3.295836866004329
Spanish,27,3.295836866004329
Evidence,27,3.295836866004329
scoring,27,3.295836866004329
birds,27,3.295836866004329
former,27,3.295836866004329
humoral,27,3.295836866004329
73,27,3.295836866004329
supports,27,3.295836866004329
act,27,3.295836866004329
get,27,3.295836866004329
quantify,27,3.295836866004329
pharmacologic,27,3.295836866004329
partial,27,3.295836866004329
particles,27,3.295836866004329
principal,27,3.295836866004329
beyond,27,3.295836866004329
decision-making,27,3.295836866004329
salvage,27,3.295836866004329
absolute,27,3.295836866004329
reach,27,3.295836866004329
cities,27,3.295836866004329
implantation,27,3.295836866004329
requirements,27,3.295836866004329
Risk,27,3.295836866004329
97,27,3.295836866004329
indications,26,3.258096538021482
immunoglobulin,26,3.258096538021482
routinely,26,3.258096538021482
EVT,26,3.258096538021482
presentations,26,3.258096538021482
excluded,26,3.258096538021482
quarantine,26,3.258096538021482
Viral,26,3.258096538021482
why,26,3.258096538021482
apparent,26,3.258096538021482
comparative,26,3.258096538021482
overcome,26,3.258096538021482
aware,26,3.258096538021482
consistently,26,3.258096538021482
summarized,26,3.258096538021482
insufficient,26,3.258096538021482
neuroimaging,26,3.258096538021482
simulation,26,3.258096538021482
apply,26,3.258096538021482
cats,26,3.258096538021482
CoV,26,3.258096538021482
Association,26,3.258096538021482
Its,26,3.258096538021482
79,26,3.258096538021482
trivalent,26,3.258096538021482
measuring,26,3.258096538021482
microvascular,26,3.258096538021482
delays,26,3.258096538021482
advice,26,3.258096538021482
managing,26,3.258096538021482
2015,26,3.258096538021482
developments,26,3.258096538021482
varying,26,3.258096538021482
bilateral,26,3.258096538021482
detail,26,3.258096538021482
matrix,26,3.258096538021482
makes,26,3.258096538021482
expansion,26,3.258096538021482
automated,26,3.258096538021482
pollution,26,3.258096538021482
assigned,26,3.258096538021482
optimize,26,3.258096538021482
disturbances,26,3.258096538021482
99,26,3.258096538021482
surrogate,26,3.258096538021482
focal,26,3.258096538021482
appearance,26,3.258096538021482
resource,26,3.258096538021482
shared,26,3.258096538021482
ferrets,26,3.258096538021482
cohorts,26,3.258096538021482
relationships,26,3.258096538021482
accounted,26,3.258096538021482
representative,26,3.258096538021482
incident,26,3.258096538021482
storm,26,3.258096538021482
careful,26,3.258096538021482
debate,26,3.258096538021482
insufficiency,26,3.258096538021482
coding,26,3.258096538021482
decreasing,26,3.258096538021482
phases,26,3.258096538021482
fundamental,26,3.258096538021482
subjective,26,3.258096538021482
point-of-care,25,3.2188758248682006
49,25,3.2188758248682006
wastewater,25,3.2188758248682006
vein,25,3.2188758248682006
reliability,25,3.2188758248682006
spirometry,25,3.2188758248682006
oxidative,25,3.2188758248682006
know,25,3.2188758248682006
fixed,25,3.2188758248682006
attributable,25,3.2188758248682006
fetal,25,3.2188758248682006
Delta,25,3.2188758248682006
surfaces,25,3.2188758248682006
300,25,3.2188758248682006
antibiotic,25,3.2188758248682006
parental,25,3.2188758248682006
Even,25,3.2188758248682006
systematically,25,3.2188758248682006
velocity,25,3.2188758248682006
Herein,25,3.2188758248682006
bronchitis,25,3.2188758248682006
maintenance,25,3.2188758248682006
lost,25,3.2188758248682006
plus,25,3.2188758248682006
diversity,25,3.2188758248682006
content,25,3.2188758248682006
adaptation,25,3.2188758248682006
thromboembolic,25,3.2188758248682006
fusion,25,3.2188758248682006
explained,25,3.2188758248682006
border,25,3.2188758248682006
51,25,3.2188758248682006
61,25,3.2188758248682006
teams,25,3.2188758248682006
persistence,25,3.2188758248682006
Little,25,3.2188758248682006
Spain,25,3.2188758248682006
PubMed,25,3.2188758248682006
volumes,25,3.2188758248682006
geographical,25,3.2188758248682006
details,25,3.2188758248682006
lowering,25,3.2188758248682006
performing,25,3.2188758248682006
complexity,25,3.2188758248682006
pathologic,25,3.2188758248682006
bronchodilator,25,3.2188758248682006
conjunction,25,3.2188758248682006
postinfarction,25,3.2188758248682006
pharmaceutical,25,3.2188758248682006
stability,25,3.2188758248682006
began,25,3.2188758248682006
bundle,25,3.2188758248682006
ventriculography,25,3.2188758248682006
organizations,25,3.2188758248682006
82,25,3.2188758248682006
throat,25,3.2188758248682006
implementing,25,3.2188758248682006
India,25,3.2188758248682006
terminal,25,3.2188758248682006
inhibit,25,3.2188758248682006
Bronchial,25,3.2188758248682006
era,25,3.2188758248682006
Following,24,3.1780538303479458
VOC,24,3.1780538303479458
Institutes,24,3.1780538303479458
power,24,3.1780538303479458
position,24,3.1780538303479458
person,24,3.1780538303479458
Approximately,24,3.1780538303479458
just,24,3.1780538303479458
eosinophils,24,3.1780538303479458
etc,24,3.1780538303479458
eosinophilic,24,3.1780538303479458
easy,24,3.1780538303479458
pathogen,24,3.1780538303479458
material,24,3.1780538303479458
Thrombolysis,24,3.1780538303479458
91,24,3.1780538303479458
barrier,24,3.1780538303479458
05,24,3.1780538303479458
possibilities,24,3.1780538303479458
CHD,24,3.1780538303479458
reactive,24,3.1780538303479458
locations,24,3.1780538303479458
respondents,24,3.1780538303479458
technical,24,3.1780538303479458
gained,24,3.1780538303479458
What,24,3.1780538303479458
at-risk,24,3.1780538303479458
topic,24,3.1780538303479458
wild,24,3.1780538303479458
seroprevalence,24,3.1780538303479458
infect,24,3.1780538303479458
cardiopulmonary,24,3.1780538303479458
window,24,3.1780538303479458
ultrasound,24,3.1780538303479458
IgM,24,3.1780538303479458
BNT162b2,24,3.1780538303479458
apoptosis,24,3.1780538303479458
named,24,3.1780538303479458
ratios,24,3.1780538303479458
preparation,24,3.1780538303479458
Each,24,3.1780538303479458
enables,24,3.1780538303479458
modern,24,3.1780538303479458
kits,24,3.1780538303479458
2008,24,3.1780538303479458
namely,24,3.1780538303479458
released,24,3.1780538303479458
vary,24,3.1780538303479458
2000,24,3.1780538303479458
online,24,3.1780538303479458
Doppler,24,3.1780538303479458
2012,24,3.1780538303479458
aerosols,24,3.1780538303479458
Zealand,24,3.1780538303479458
emergent,24,3.1780538303479458
briefly,24,3.1780538303479458
once,24,3.1780538303479458
identifies,24,3.1780538303479458
declined,24,3.1780538303479458
Rankin,24,3.1780538303479458
HI,24,3.1780538303479458
Six,24,3.1780538303479458
immunotherapy,23,3.1354942159291497
pigs,23,3.1354942159291497
concepts,23,3.1354942159291497
tumor,23,3.1354942159291497
Pandemic,23,3.1354942159291497
processing,23,3.1354942159291497
syncytial,23,3.1354942159291497
yielded,23,3.1354942159291497
parts,23,3.1354942159291497
minimize,23,3.1354942159291497
How,23,3.1354942159291497
random,23,3.1354942159291497
sentinel,23,3.1354942159291497
teaching,23,3.1354942159291497
bone,23,3.1354942159291497
poses,23,3.1354942159291497
neutralization,23,3.1354942159291497
deviation,23,3.1354942159291497
CS,23,3.1354942159291497
ten,23,3.1354942159291497
gastrointestinal,23,3.1354942159291497
SPECT,23,3.1354942159291497
lymphocytes,23,3.1354942159291497
Italian,23,3.1354942159291497
campaigns,23,3.1354942159291497
deficit,23,3.1354942159291497
Trial,23,3.1354942159291497
reproduction,23,3.1354942159291497
enhancement,23,3.1354942159291497
extracted,23,3.1354942159291497
atypical,23,3.1354942159291497
Middle,23,3.1354942159291497
arrhythmia,23,3.1354942159291497
industry,23,3.1354942159291497
implicated,23,3.1354942159291497
definite,23,3.1354942159291497
continuing,23,3.1354942159291497
RT-LAMP,23,3.1354942159291497
Ct,23,3.1354942159291497
reproductive,23,3.1354942159291497
unvaccinated,23,3.1354942159291497
b,23,3.1354942159291497
Diagnosis,23,3.1354942159291497
maintaining,23,3.1354942159291497
maintain,23,3.1354942159291497
similarities,23,3.1354942159291497
grafting,23,3.1354942159291497
RSV,23,3.1354942159291497
principles,23,3.1354942159291497
regulatory,23,3.1354942159291497
algorithms,23,3.1354942159291497
statins,23,3.1354942159291497
Analysis,23,3.1354942159291497
gain,23,3.1354942159291497
heparin,23,3.1354942159291497
direction,23,3.1354942159291497
morphology,23,3.1354942159291497
contain,23,3.1354942159291497
resuscitation,23,3.1354942159291497
HCP,23,3.1354942159291497
France,23,3.1354942159291497
81,23,3.1354942159291497
Mortality,23,3.1354942159291497
nor,23,3.1354942159291497
relating,23,3.1354942159291497
receptor-binding,23,3.1354942159291497
125,23,3.1354942159291497
counts,23,3.1354942159291497
ECMO,23,3.1354942159291497
generate,23,3.1354942159291497
pump,23,3.1354942159291497
linear,23,3.1354942159291497
Asian,23,3.1354942159291497
passive,23,3.1354942159291497
AH5N1,23,3.1354942159291497
supporting,23,3.1354942159291497
contagious,23,3.1354942159291497
cord,23,3.1354942159291497
prevented,23,3.1354942159291497
patent,23,3.1354942159291497
science,23,3.1354942159291497
pollutants,23,3.1354942159291497
representing,22,3.091042453358316
2016,22,3.091042453358316
nucleotide,22,3.091042453358316
race,22,3.091042453358316
suffer,22,3.091042453358316
2014,22,3.091042453358316
76,22,3.091042453358316
Multiple,22,3.091042453358316
coagulation,22,3.091042453358316
Northern,22,3.091042453358316
institutions,22,3.091042453358316
Information,22,3.091042453358316
explanation,22,3.091042453358316
situations,22,3.091042453358316
003,22,3.091042453358316
case-control,22,3.091042453358316
t-PA,22,3.091042453358316
scans,22,3.091042453358316
immunocompromised,22,3.091042453358316
immunized,22,3.091042453358316
PPCI,22,3.091042453358316
aspiration,22,3.091042453358316
ms,22,3.091042453358316
combinations,22,3.091042453358316
effusion,22,3.091042453358316
reactivity,22,3.091042453358316
pleural,22,3.091042453358316
Poland,22,3.091042453358316
expensive,22,3.091042453358316
warning,22,3.091042453358316
remodelling,22,3.091042453358316
Network,22,3.091042453358316
relaxation,22,3.091042453358316
epithelium,22,3.091042453358316
influencing,22,3.091042453358316
list,22,3.091042453358316
contributed,22,3.091042453358316
describing,22,3.091042453358316
First,22,3.091042453358316
searched,22,3.091042453358316
varies,22,3.091042453358316
definitions,22,3.091042453358316
hypertensive,22,3.091042453358316
AH7N9,22,3.091042453358316
greatly,22,3.091042453358316
2007,22,3.091042453358316
hosts,22,3.091042453358316
facility,22,3.091042453358316
added,22,3.091042453358316
Left,22,3.091042453358316
refractory,22,3.091042453358316
complementary,22,3.091042453358316
rational,22,3.091042453358316
zoonotic,22,3.091042453358316
100000,22,3.091042453358316
volunteers,22,3.091042453358316
curves,22,3.091042453358316
uncertainty,22,3.091042453358316
bronchospasm,22,3.091042453358316
follows,22,3.091042453358316
vaccinations,22,3.091042453358316
ICS,22,3.091042453358316
H1N1pdm,22,3.091042453358316
radiological,22,3.091042453358316
valve,22,3.091042453358316
scales,22,3.091042453358316
defining,22,3.091042453358316
depend,22,3.091042453358316
circumstances,22,3.091042453358316
dyspnea,22,3.091042453358316
becomes,22,3.091042453358316
PEFR,22,3.091042453358316
advance,22,3.091042453358316
below,22,3.091042453358316
bronchoconstriction,22,3.091042453358316
ward,22,3.091042453358316
self-reported,22,3.091042453358316
usage,22,3.091042453358316
end-diastolic,22,3.091042453358316
registry,22,3.091042453358316
Importantly,22,3.091042453358316
preliminary,22,3.091042453358316
back,22,3.091042453358316
multidisciplinary,22,3.091042453358316
workplace,22,3.091042453358316
High,22,3.091042453358316
positively,22,3.091042453358316
difficulties,22,3.091042453358316
newer,22,3.091042453358316
solutions,22,3.091042453358316
Whether,22,3.091042453358316
FDA,22,3.091042453358316
simultaneously,22,3.091042453358316
coefficient,22,3.091042453358316
ligation,22,3.091042453358316
start,22,3.091042453358316
oxygenation,22,3.091042453358316
York,22,3.091042453358316
diffusion,22,3.091042453358316
84,22,3.091042453358316
Unit,22,3.091042453358316
encephalopathy,22,3.091042453358316
created,22,3.091042453358316
imperative,22,3.091042453358316
programmes,22,3.091042453358316
00001,22,3.091042453358316
Brazil,22,3.091042453358316
persist,22,3.091042453358316
validate,22,3.091042453358316
teachers,22,3.091042453358316
MB,22,3.091042453358316
caregivers,22,3.091042453358316
metabolism,21,3.044522437723423
Accordingly,21,3.044522437723423
56,21,3.044522437723423
never,21,3.044522437723423
comorbid,21,3.044522437723423
tolerance,21,3.044522437723423
experts,21,3.044522437723423
overlap,21,3.044522437723423
Hg,21,3.044522437723423
conduct,21,3.044522437723423
existence,21,3.044522437723423
quantified,21,3.044522437723423
mask,21,3.044522437723423
titres,21,3.044522437723423
lipid,21,3.044522437723423
adjusting,21,3.044522437723423
deficiency,21,3.044522437723423
translation,21,3.044522437723423
nitroglycerin,21,3.044522437723423
lessons,21,3.044522437723423
67,21,3.044522437723423
accumulation,21,3.044522437723423
behavioural,21,3.044522437723423
all-cause,21,3.044522437723423
stronger,21,3.044522437723423
scar,21,3.044522437723423
nonspecific,21,3.044522437723423
evolved,21,3.044522437723423
latest,21,3.044522437723423
mothers,21,3.044522437723423
haemorrhagic,21,3.044522437723423
2005,21,3.044522437723423
reflects,21,3.044522437723423
78,21,3.044522437723423
double,21,3.044522437723423
aphasia,21,3.044522437723423
believe,21,3.044522437723423
K,21,3.044522437723423
SARS-CoV‑2,21,3.044522437723423
bias,21,3.044522437723423
environments,21,3.044522437723423
extended,21,3.044522437723423
involve,21,3.044522437723423
quick,21,3.044522437723423
transmissible,21,3.044522437723423
modeling,21,3.044522437723423
congenital,21,3.044522437723423
pericardial,21,3.044522437723423
contemporary,21,3.044522437723423
exclusion,21,3.044522437723423
City,21,3.044522437723423
remdesivir,21,3.044522437723423
correlate,21,3.044522437723423
seroconversion,21,3.044522437723423
encountered,21,3.044522437723423
malignant,21,3.044522437723423
restricted,21,3.044522437723423
food,21,3.044522437723423
prepared,21,3.044522437723423
fitness,21,3.044522437723423
exists,21,3.044522437723423
induces,21,3.044522437723423
missing,21,3.044522437723423
FG,21,3.044522437723423
sets,21,3.044522437723423
childrens,21,3.044522437723423
nationwide,21,3.044522437723423
provision,21,3.044522437723423
irreversible,21,3.044522437723423
copies,21,3.044522437723423
experiencing,21,3.044522437723423
two-dimensional,21,3.044522437723423
Food,21,3.044522437723423
code,21,3.044522437723423
agencies,21,3.044522437723423
R,21,3.044522437723423
p0001,21,3.044522437723423
limiting,21,3.044522437723423
Central,21,3.044522437723423
eosinophil,21,3.044522437723423
integral,21,3.044522437723423
replacement,21,3.044522437723423
thrombi,21,3.044522437723423
alert,21,3.044522437723423
regarded,21,3.044522437723423
polymorphisms,21,3.044522437723423
energy,21,3.044522437723423
AI,21,3.044522437723423
ECR,21,3.044522437723423
allowed,21,3.044522437723423
mandatory,21,3.044522437723423
autonomic,21,3.044522437723423
angiotensin-converting,21,3.044522437723423
localization,21,3.044522437723423
pathogenicity,21,3.044522437723423
enzymes,21,3.044522437723423
conservative,21,3.044522437723423
delivered,21,3.044522437723423
insight,21,3.044522437723423
polymorphism,21,3.044522437723423
OAC,21,3.044522437723423
come,20,2.995732273553991
socio-economic,20,2.995732273553991
panel,20,2.995732273553991
reperfused,20,2.995732273553991
evolutionary,20,2.995732273553991
prescribed,20,2.995732273553991
slow,20,2.995732273553991
bird,20,2.995732273553991
Chronic,20,2.995732273553991
postmortem,20,2.995732273553991
predischarge,20,2.995732273553991
skills,20,2.995732273553991
territory,20,2.995732273553991
101,20,2.995732273553991
immunoassay,20,2.995732273553991
CMR,20,2.995732273553991
activated,20,2.995732273553991
66,20,2.995732273553991
attitude,20,2.995732273553991
toxicity,20,2.995732273553991
calcium,20,2.995732273553991
historical,20,2.995732273553991
None,20,2.995732273553991
optimization,20,2.995732273553991
B1351,20,2.995732273553991
collaboration,20,2.995732273553991
put,20,2.995732273553991
thalamic,20,2.995732273553991
87,20,2.995732273553991
Mean,20,2.995732273553991
attempt,20,2.995732273553991
subjected,20,2.995732273553991
Various,20,2.995732273553991
carefully,20,2.995732273553991
hypotension,20,2.995732273553991
LVEF,20,2.995732273553991
96,20,2.995732273553991
promise,20,2.995732273553991
scanning,20,2.995732273553991
Unfortunately,20,2.995732273553991
circadian,20,2.995732273553991
pre-existing,20,2.995732273553991
screened,20,2.995732273553991
forward,20,2.995732273553991
high-throughput,20,2.995732273553991
gaps,20,2.995732273553991
contained,20,2.995732273553991
aneurysms,20,2.995732273553991
partly,20,2.995732273553991
domestic,20,2.995732273553991
coming,20,2.995732273553991
reversibility,20,2.995732273553991
specialists,20,2.995732273553991
acutely,20,2.995732273553991
survived,20,2.995732273553991
nosocomial,20,2.995732273553991
smoke,20,2.995732273553991
validation,20,2.995732273553991
annually,20,2.995732273553991
composition,20,2.995732273553991
cutoff,20,2.995732273553991
elicited,20,2.995732273553991
confirmation,20,2.995732273553991
Airway,20,2.995732273553991
scenario,20,2.995732273553991
achieving,20,2.995732273553991
echo,20,2.995732273553991
myocarditis,20,2.995732273553991
scenarios,20,2.995732273553991
NP,20,2.995732273553991
driving,20,2.995732273553991
promptly,20,2.995732273553991
guideline,20,2.995732273553991
theory,20,2.995732273553991
supported,20,2.995732273553991
H1N1pdm09,20,2.995732273553991
investigating,20,2.995732273553991
D614G,20,2.995732273553991
86,20,2.995732273553991
mitral,20,2.995732273553991
suggestive,20,2.995732273553991
92,20,2.995732273553991
Center,20,2.995732273553991
complement,20,2.995732273553991
instruments,20,2.995732273553991
broadly,20,2.995732273553991
3rd,20,2.995732273553991
efficiently,20,2.995732273553991
occluded,20,2.995732273553991
subsets,20,2.995732273553991
display,20,2.995732273553991
proliferation,20,2.995732273553991
hesitancy,20,2.995732273553991
lockdown,20,2.995732273553991
M,20,2.995732273553991
advantage,20,2.995732273553991
head,20,2.995732273553991
evaluations,20,2.995732273553991
basal,20,2.995732273553991
cortical,20,2.995732273553991
output,20,2.995732273553991
opinion,20,2.995732273553991
mapping,20,2.995732273553991
original,20,2.995732273553991
encouraging,20,2.995732273553991
examinations,20,2.995732273553991
Atrial,20,2.995732273553991
specialist,20,2.995732273553991
institution,20,2.995732273553991
organization,20,2.995732273553991
cost-effectiveness,20,2.995732273553991
northern,20,2.995732273553991
endarterectomy,20,2.995732273553991
Between,20,2.995732273553991
anatomy,20,2.995732273553991
intake,19,2.9444389791664403
childs,19,2.9444389791664403
influenza-related,19,2.9444389791664403
operating,19,2.9444389791664403
smokers,19,2.9444389791664403
sequelae,19,2.9444389791664403
reservoir,19,2.9444389791664403
d,19,2.9444389791664403
intra-arterial,19,2.9444389791664403
D-dimer,19,2.9444389791664403
well-being,19,2.9444389791664403
warranted,19,2.9444389791664403
households,19,2.9444389791664403
licensed,19,2.9444389791664403
mitigation,19,2.9444389791664403
participate,19,2.9444389791664403
external,19,2.9444389791664403
transfusion,19,2.9444389791664403
mathematical,19,2.9444389791664403
rescue,19,2.9444389791664403
minimum,19,2.9444389791664403
presumed,19,2.9444389791664403
statin,19,2.9444389791664403
400,19,2.9444389791664403
broad-spectrum,19,2.9444389791664403
stimuli,19,2.9444389791664403
category,19,2.9444389791664403
Infection,19,2.9444389791664403
Surveillance,19,2.9444389791664403
surrounding,19,2.9444389791664403
thousands,19,2.9444389791664403
anesthesia,19,2.9444389791664403
valid,19,2.9444389791664403
pathophysiologic,19,2.9444389791664403
anatomic,19,2.9444389791664403
neuronal,19,2.9444389791664403
professional,19,2.9444389791664403
diffuse,19,2.9444389791664403
imported,19,2.9444389791664403
attending,19,2.9444389791664403
seeking,19,2.9444389791664403
aetiology,19,2.9444389791664403
human-to-human,19,2.9444389791664403
feedback,19,2.9444389791664403
suspicion,19,2.9444389791664403
regimen,19,2.9444389791664403
originated,19,2.9444389791664403
isolate,19,2.9444389791664403
parameter,19,2.9444389791664403
recruited,19,2.9444389791664403
house,19,2.9444389791664403
intermediate,19,2.9444389791664403
intracerebral,19,2.9444389791664403
permanent,19,2.9444389791664403
capable,19,2.9444389791664403
Science,19,2.9444389791664403
helps,19,2.9444389791664403
respective,19,2.9444389791664403
encourage,19,2.9444389791664403
conserved,19,2.9444389791664403
structured,19,2.9444389791664403
agonists,19,2.9444389791664403
efficacious,19,2.9444389791664403
mimic,19,2.9444389791664403
description,19,2.9444389791664403
introduce,19,2.9444389791664403
disease-2019,19,2.9444389791664403
alter,19,2.9444389791664403
space,19,2.9444389791664403
pool,19,2.9444389791664403
tobacco,19,2.9444389791664403
Patient,19,2.9444389791664403
etiological,19,2.9444389791664403
categorized,19,2.9444389791664403
Community,19,2.9444389791664403
summer,19,2.9444389791664403
bind,19,2.9444389791664403
01,19,2.9444389791664403
antibiotics,19,2.9444389791664403
return,19,2.9444389791664403
registered,19,2.9444389791664403
episode,19,2.9444389791664403
foramen,19,2.9444389791664403
Few,19,2.9444389791664403
coinfection,19,2.9444389791664403
call,19,2.9444389791664403
viability,19,2.9444389791664403
mouse,19,2.9444389791664403
largest,19,2.9444389791664403
differentiation,19,2.9444389791664403
immunologic,19,2.9444389791664403
negatively,19,2.9444389791664403
SBP,19,2.9444389791664403
aspect,19,2.9444389791664403
fight,19,2.9444389791664403
genotype,19,2.9444389791664403
mother,19,2.9444389791664403
clinician,19,2.9444389791664403
topics,19,2.9444389791664403
portion,19,2.9444389791664403
distance,19,2.9444389791664403
poorer,19,2.9444389791664403
alcohol,19,2.9444389791664403
unilateral,19,2.9444389791664403
interview,19,2.9444389791664403
exact,19,2.9444389791664403
lineages,19,2.9444389791664403
paucity,19,2.9444389791664403
Australian,19,2.9444389791664403
anatomical,19,2.9444389791664403
pose,19,2.9444389791664403
intact,18,2.8903717578961645
adoption,18,2.8903717578961645
reflux,18,2.8903717578961645
dissemination,18,2.8903717578961645
pectoris,18,2.8903717578961645
informed,18,2.8903717578961645
record,18,2.8903717578961645
ineffective,18,2.8903717578961645
develops,18,2.8903717578961645
102,18,2.8903717578961645
OA,18,2.8903717578961645
centres,18,2.8903717578961645
cessation,18,2.8903717578961645
angiotensin,18,2.8903717578961645
classic,18,2.8903717578961645
Increased,18,2.8903717578961645
perhaps,18,2.8903717578961645
otherwise,18,2.8903717578961645
narrowing,18,2.8903717578961645
Assessment,18,2.8903717578961645
digital,18,2.8903717578961645
postural,18,2.8903717578961645
trained,18,2.8903717578961645
surveys,18,2.8903717578961645
hope,18,2.8903717578961645
Phase,18,2.8903717578961645
impairments,18,2.8903717578961645
pressures,18,2.8903717578961645
modality,18,2.8903717578961645
tended,18,2.8903717578961645
diet,18,2.8903717578961645
pairs,18,2.8903717578961645
toll,18,2.8903717578961645
detectable,18,2.8903717578961645
Five,18,2.8903717578961645
p005,18,2.8903717578961645
evident,18,2.8903717578961645
herd,18,2.8903717578961645
mode,18,2.8903717578961645
centre,18,2.8903717578961645
select,18,2.8903717578961645
contraction,18,2.8903717578961645
definitive,18,2.8903717578961645
relies,18,2.8903717578961645
infiltration,18,2.8903717578961645
emerge,18,2.8903717578961645
mitigate,18,2.8903717578961645
territories,18,2.8903717578961645
placed,18,2.8903717578961645
lavage,18,2.8903717578961645
surveyed,18,2.8903717578961645
Survey,18,2.8903717578961645
damaged,18,2.8903717578961645
paediatric,18,2.8903717578961645
×,18,2.8903717578961645
Taiwan,18,2.8903717578961645
classical,18,2.8903717578961645
mobility,18,2.8903717578961645
conclusions,18,2.8903717578961645
stored,18,2.8903717578961645
Medicine,18,2.8903717578961645
preceding,18,2.8903717578961645
entity,18,2.8903717578961645
billion,18,2.8903717578961645
indication,18,2.8903717578961645
image,18,2.8903717578961645
climate,18,2.8903717578961645
carry,18,2.8903717578961645
X-ray,18,2.8903717578961645
sign,18,2.8903717578961645
infant,18,2.8903717578961645
rt-PA,18,2.8903717578961645
haemorrhage,18,2.8903717578961645
instability,18,2.8903717578961645
missed,18,2.8903717578961645
transportation,18,2.8903717578961645
intended,18,2.8903717578961645
hence,18,2.8903717578961645
Diseases,18,2.8903717578961645
Abbott,18,2.8903717578961645
off,18,2.8903717578961645
ACT,18,2.8903717578961645
planned,18,2.8903717578961645
brainstem,18,2.8903717578961645
interact,18,2.8903717578961645
rRT-PCR,18,2.8903717578961645
gradually,18,2.8903717578961645
Hypertension,18,2.8903717578961645
directions,18,2.8903717578961645
reinfection,18,2.8903717578961645
cigarette,18,2.8903717578961645
offspring,18,2.8903717578961645
killed,18,2.8903717578961645
hospitalisation,18,2.8903717578961645
multifactorial,18,2.8903717578961645
consultations,18,2.8903717578961645
lymphatic,18,2.8903717578961645
injuries,18,2.8903717578961645
maps,18,2.8903717578961645
manifested,18,2.8903717578961645
tPA,18,2.8903717578961645
2018,18,2.8903717578961645
scintigraphy,18,2.8903717578961645
Cox,18,2.8903717578961645
droplets,18,2.8903717578961645
theoretical,18,2.8903717578961645
repurposing,18,2.8903717578961645
monoclonal,18,2.8903717578961645
U,18,2.8903717578961645
spite,18,2.8903717578961645
domains,18,2.8903717578961645
waste,18,2.8903717578961645
acids,18,2.8903717578961645
mite,18,2.8903717578961645
assessments,18,2.8903717578961645
adapted,18,2.8903717578961645
ovale,18,2.8903717578961645
statistics,18,2.8903717578961645
exhibit,18,2.8903717578961645
hr,18,2.8903717578961645
prominent,18,2.8903717578961645
extension,18,2.8903717578961645
disproportionately,17,2.833213344056216
displayed,17,2.833213344056216
culprit,17,2.833213344056216
middle-aged,17,2.833213344056216
autoimmune,17,2.833213344056216
satisfactory,17,2.833213344056216
hypoxia,17,2.833213344056216
fibrinolysis,17,2.833213344056216
create,17,2.833213344056216
vaccinees,17,2.833213344056216
reagents,17,2.833213344056216
CFR,17,2.833213344056216
posed,17,2.833213344056216
Subjects,17,2.833213344056216
DWI,17,2.833213344056216
System,17,2.833213344056216
localized,17,2.833213344056216
broader,17,2.833213344056216
0002,17,2.833213344056216
TCM,17,2.833213344056216
optimizing,17,2.833213344056216
enough,17,2.833213344056216
recording,17,2.833213344056216
psychiatric,17,2.833213344056216
septum,17,2.833213344056216
QoL,17,2.833213344056216
biologic,17,2.833213344056216
intense,17,2.833213344056216
ascertain,17,2.833213344056216
arise,17,2.833213344056216
purposes,17,2.833213344056216
schoolchildren,17,2.833213344056216
attempted,17,2.833213344056216
intubation,17,2.833213344056216
glycoprotein,17,2.833213344056216
PSD,17,2.833213344056216
quantification,17,2.833213344056216
located,17,2.833213344056216
untreated,17,2.833213344056216
extracorporeal,17,2.833213344056216
real-world,17,2.833213344056216
Lung,17,2.833213344056216
Infarct,17,2.833213344056216
Factors,17,2.833213344056216
morning,17,2.833213344056216
002,17,2.833213344056216
generalized,17,2.833213344056216
moderately,17,2.833213344056216
sodium,17,2.833213344056216
mediastinum,17,2.833213344056216
spontaneously,17,2.833213344056216
non-specific,17,2.833213344056216
Those,17,2.833213344056216
correctly,17,2.833213344056216
differed,17,2.833213344056216
pretreatment,17,2.833213344056216
myoglobin,17,2.833213344056216
unlikely,17,2.833213344056216
CoV-2,17,2.833213344056216
precision,17,2.833213344056216
complicating,17,2.833213344056216
attended,17,2.833213344056216
cleavage,17,2.833213344056216
gap,17,2.833213344056216
Canadian,17,2.833213344056216
restrictions,17,2.833213344056216
COVID,17,2.833213344056216
kinetics,17,2.833213344056216
horses,17,2.833213344056216
masks,17,2.833213344056216
eosinophilia,17,2.833213344056216
weighted,17,2.833213344056216
examples,17,2.833213344056216
escape,17,2.833213344056216
classes,17,2.833213344056216
troponin,17,2.833213344056216
Registry,17,2.833213344056216
Allergy,17,2.833213344056216
interesting,17,2.833213344056216
mediastinal,17,2.833213344056216
106,17,2.833213344056216
Their,17,2.833213344056216
ethical,17,2.833213344056216
military,17,2.833213344056216
synthetic,17,2.833213344056216
descriptive,17,2.833213344056216
biopsy,17,2.833213344056216
antioxidant,17,2.833213344056216
appropriately,17,2.833213344056216
deal,17,2.833213344056216
1918-1919,17,2.833213344056216
ambulatory,17,2.833213344056216
participating,17,2.833213344056216
intercostal,17,2.833213344056216
angiogenesis,17,2.833213344056216
cross-reactivity,17,2.833213344056216
Switzerland,17,2.833213344056216
Infectious,17,2.833213344056216
standards,17,2.833213344056216
differentiate,17,2.833213344056216
inconsistent,17,2.833213344056216
French,17,2.833213344056216
allergies,17,2.833213344056216
persisted,17,2.833213344056216
attempts,17,2.833213344056216
vectors,17,2.833213344056216
specialized,17,2.833213344056216
abnormality,17,2.833213344056216
cerebellar,17,2.833213344056216
Education,17,2.833213344056216
interferon,17,2.833213344056216
powerful,17,2.833213344056216
turn,17,2.833213344056216
TDI,17,2.833213344056216
indicator,17,2.833213344056216
continuously,17,2.833213344056216
opportunities,17,2.833213344056216
clot,17,2.833213344056216
fields,17,2.833213344056216
Guidelines,17,2.833213344056216
getting,17,2.833213344056216
feeding,17,2.833213344056216
de,17,2.833213344056216
brought,17,2.833213344056216
excessive,17,2.833213344056216
private,17,2.833213344056216
false-negative,17,2.833213344056216
first-ever,17,2.833213344056216
neither,17,2.833213344056216
S1,17,2.833213344056216
province,17,2.833213344056216
district,17,2.833213344056216
recommendation,17,2.833213344056216
remarkable,17,2.833213344056216
foreign,17,2.833213344056216
cortex,17,2.833213344056216
expert,17,2.833213344056216
Kingdom,17,2.833213344056216
behind,17,2.833213344056216
contractility,17,2.833213344056216
macrophages,17,2.833213344056216
perinatal,17,2.833213344056216
precordial,17,2.833213344056216
secretion,17,2.833213344056216
IL-6,17,2.833213344056216
compromise,17,2.833213344056216
bridging,17,2.833213344056216
provinces,17,2.833213344056216
L,17,2.833213344056216
rule,17,2.833213344056216
market,16,2.772588722239781
004,16,2.772588722239781
safely,16,2.772588722239781
1978,16,2.772588722239781
Epidemiological,16,2.772588722239781
illustrate,16,2.772588722239781
hydroxychloroquine,16,2.772588722239781
regeneration,16,2.772588722239781
IL-10,16,2.772588722239781
aorta,16,2.772588722239781
hypertrophy,16,2.772588722239781
dry,16,2.772588722239781
Society,16,2.772588722239781
incorporate,16,2.772588722239781
accessible,16,2.772588722239781
posterolateral,16,2.772588722239781
electrocardiography,16,2.772588722239781
endocarditis,16,2.772588722239781
clustering,16,2.772588722239781
CL,16,2.772588722239781
absenteeism,16,2.772588722239781
shortness,16,2.772588722239781
prone,16,2.772588722239781
substitution,16,2.772588722239781
Conclusions,16,2.772588722239781
modification,16,2.772588722239781
confirms,16,2.772588722239781
hemagglutination,16,2.772588722239781
Immunization,16,2.772588722239781
emission,16,2.772588722239781
healing,16,2.772588722239781
inhibited,16,2.772588722239781
OCS,16,2.772588722239781
Strokes,16,2.772588722239781
12-lead,16,2.772588722239781
residence,16,2.772588722239781
affinity,16,2.772588722239781
NPS,16,2.772588722239781
Committee,16,2.772588722239781
task,16,2.772588722239781
equally,16,2.772588722239781
identical,16,2.772588722239781
MSCs,16,2.772588722239781
haemodynamic,16,2.772588722239781
OSA,16,2.772588722239781
threats,16,2.772588722239781
short-,16,2.772588722239781
athletes,16,2.772588722239781
ocular,16,2.772588722239781
MT,16,2.772588722239781
biosensors,16,2.772588722239781
addresses,16,2.772588722239781
reductions,16,2.772588722239781
updates,16,2.772588722239781
epicardial,16,2.772588722239781
cell-based,16,2.772588722239781
contains,16,2.772588722239781
urgently,16,2.772588722239781
acquisition,16,2.772588722239781
commentary,16,2.772588722239781
predisposing,16,2.772588722239781
Right,16,2.772588722239781
match,16,2.772588722239781
She,16,2.772588722239781
transcription-polymerase,16,2.772588722239781
nontransmural,16,2.772588722239781
yr,16,2.772588722239781
community-based,16,2.772588722239781
Eight,16,2.772588722239781
low-income,16,2.772588722239781
suppression,16,2.772588722239781
advent,16,2.772588722239781
proteases,16,2.772588722239781
circumflex,16,2.772588722239781
headache,16,2.772588722239781
intentions,16,2.772588722239781
red,16,2.772588722239781
1983,16,2.772588722239781
thromboembolism,16,2.772588722239781
accounting,16,2.772588722239781
RIDT,16,2.772588722239781
handling,16,2.772588722239781
2002,16,2.772588722239781
pharmacotherapy,16,2.772588722239781
rely,16,2.772588722239781
endemic,16,2.772588722239781
physiologic,16,2.772588722239781
Total,16,2.772588722239781
coordination,16,2.772588722239781
bacteria,16,2.772588722239781
one-third,16,2.772588722239781
PC20,16,2.772588722239781
producing,16,2.772588722239781
immunisation,16,2.772588722239781
rose,16,2.772588722239781
academic,16,2.772588722239781
Healthcare,16,2.772588722239781
confounding,16,2.772588722239781
down,16,2.772588722239781
paradigm,16,2.772588722239781
Real-time,16,2.772588722239781
visited,16,2.772588722239781
constitute,16,2.772588722239781
haemagglutinin,16,2.772588722239781
electrical,16,2.772588722239781
SARS-CoV2,16,2.772588722239781
connected,16,2.772588722239781
dialysis,16,2.772588722239781
believed,16,2.772588722239781
migration,16,2.772588722239781
Laboratory,16,2.772588722239781
documentation,16,2.772588722239781
immunoassays,16,2.772588722239781
again,16,2.772588722239781
becoming,16,2.772588722239781
determinant,16,2.772588722239781
multicenter,16,2.772588722239781
irrespective,16,2.772588722239781
deadly,16,2.772588722239781
double-blind,16,2.772588722239781
spring,16,2.772588722239781
PET,16,2.772588722239781
tertiary,16,2.772588722239781
incorporating,16,2.772588722239781
circulatory,16,2.772588722239781
routes,16,2.772588722239781
depressive,16,2.772588722239781
bedside,16,2.772588722239781
contractile,16,2.772588722239781
empirical,16,2.772588722239781
ICD-9,16,2.772588722239781
titer,16,2.772588722239781
IgA,16,2.772588722239781
undergo,16,2.772588722239781
consistency,16,2.772588722239781
VSR,16,2.772588722239781
asthma-like,16,2.772588722239781
highlighting,16,2.772588722239781
facilitated,16,2.772588722239781
BAL,16,2.772588722239781
demonstrating,16,2.772588722239781
Turkey,16,2.772588722239781
eye,16,2.772588722239781
infective,16,2.772588722239781
innovative,16,2.772588722239781
P1,16,2.772588722239781
narrative,16,2.772588722239781
owing,16,2.772588722239781
challenged,16,2.772588722239781
mmHg,16,2.772588722239781
storage,16,2.772588722239781
Percutaneous,16,2.772588722239781
synthesis,16,2.772588722239781
112,16,2.772588722239781
examining,16,2.772588722239781
anti-influenza,16,2.772588722239781
computer,16,2.772588722239781
Evaluation,16,2.772588722239781
society,16,2.772588722239781
reliably,16,2.772588722239781
see,16,2.772588722239781
Journal,16,2.772588722239781
104,16,2.772588722239781
subclinical,16,2.772588722239781
movements,16,2.772588722239781
Significant,16,2.772588722239781
mismatch,16,2.772588722239781
CHF,16,2.772588722239781
screen,16,2.772588722239781
virological,16,2.772588722239781
map,16,2.772588722239781
partially,16,2.772588722239781
disruption,16,2.772588722239781
Clinically,15,2.70805020110221
RV,15,2.70805020110221
explores,15,2.70805020110221
economy,15,2.70805020110221
enormous,15,2.70805020110221
LAR,15,2.70805020110221
theophylline,15,2.70805020110221
Diabetes,15,2.70805020110221
stents,15,2.70805020110221
febrile,15,2.70805020110221
impacted,15,2.70805020110221
helped,15,2.70805020110221
cultural,15,2.70805020110221
lymphocyte,15,2.70805020110221
expand,15,2.70805020110221
residues,15,2.70805020110221
stroke-related,15,2.70805020110221
ideal,15,2.70805020110221
weakness,15,2.70805020110221
mammalian,15,2.70805020110221
dataset,15,2.70805020110221
Bayesian,15,2.70805020110221
comprised,15,2.70805020110221
wearing,15,2.70805020110221
ischaemia,15,2.70805020110221
mast,15,2.70805020110221
designated,15,2.70805020110221
fluorescence,15,2.70805020110221
run,15,2.70805020110221
boys,15,2.70805020110221
Carotid,15,2.70805020110221
update,15,2.70805020110221
born,15,2.70805020110221
injected,15,2.70805020110221
emphasize,15,2.70805020110221
enhancing,15,2.70805020110221
HWs,15,2.70805020110221
finally,15,2.70805020110221
proportional,15,2.70805020110221
04,15,2.70805020110221
materials,15,2.70805020110221
weather,15,2.70805020110221
facing,15,2.70805020110221
portable,15,2.70805020110221
collagen,15,2.70805020110221
neck,15,2.70805020110221
placebo-controlled,15,2.70805020110221
survive,15,2.70805020110221
hospitalised,15,2.70805020110221
promoting,15,2.70805020110221
Israel,15,2.70805020110221
000,15,2.70805020110221
assistance,15,2.70805020110221
pronounced,15,2.70805020110221
intracellular,15,2.70805020110221
interviews,15,2.70805020110221
consciousness,15,2.70805020110221
separately,15,2.70805020110221
codes,15,2.70805020110221
Similarly,15,2.70805020110221
segmental,15,2.70805020110221
pyrophosphate,15,2.70805020110221
establishing,15,2.70805020110221
relief,15,2.70805020110221
instead,15,2.70805020110221
But,15,2.70805020110221
Apart,15,2.70805020110221
166,15,2.70805020110221
mixing,15,2.70805020110221
shed,15,2.70805020110221
British,15,2.70805020110221
removal,15,2.70805020110221
allocation,15,2.70805020110221
Twenty,15,2.70805020110221
visualization,15,2.70805020110221
pro-inflammatory,15,2.70805020110221
People,15,2.70805020110221
interpreted,15,2.70805020110221
generating,15,2.70805020110221
hypotheses,15,2.70805020110221
nonatopic,15,2.70805020110221
confined,15,2.70805020110221
enabled,15,2.70805020110221
designing,15,2.70805020110221
graft,15,2.70805020110221
93,15,2.70805020110221
makers,15,2.70805020110221
T-wave,15,2.70805020110221
loads,15,2.70805020110221
youth,15,2.70805020110221
optimized,15,2.70805020110221
mV,15,2.70805020110221
phylogenetic,15,2.70805020110221
endogenous,15,2.70805020110221
chance,15,2.70805020110221
obese,15,2.70805020110221
termed,15,2.70805020110221
dobutamine,15,2.70805020110221
appendage,15,2.70805020110221
zanamivir,15,2.70805020110221
studying,15,2.70805020110221
CD8,15,2.70805020110221
HRV,15,2.70805020110221
conference,15,2.70805020110221
105,15,2.70805020110221
memory,15,2.70805020110221
herein,15,2.70805020110221
109,15,2.70805020110221
1994,15,2.70805020110221
IFA,15,2.70805020110221
Wales,15,2.70805020110221
gave,15,2.70805020110221
revised,15,2.70805020110221
i,15,2.70805020110221
1-year,15,2.70805020110221
amongst,15,2.70805020110221
maintained,15,2.70805020110221
So,15,2.70805020110221
unchanged,15,2.70805020110221
1998,15,2.70805020110221
faster,15,2.70805020110221
School,15,2.70805020110221
donor,15,2.70805020110221
apnea,15,2.70805020110221
Japanese,15,2.70805020110221
conducting,15,2.70805020110221
premature,15,2.70805020110221
ambulance,15,2.70805020110221
organic,15,2.70805020110221
filling,15,2.70805020110221
angiogram,15,2.70805020110221
investigators,15,2.70805020110221
elective,15,2.70805020110221
raise,15,2.70805020110221
ideas,15,2.70805020110221
Classification,15,2.70805020110221
absent,15,2.70805020110221
answer,15,2.70805020110221
103,15,2.70805020110221
hemiparesis,15,2.70805020110221
asked,15,2.70805020110221
inspiratory,15,2.70805020110221
referral,15,2.70805020110221
post-MI,15,2.70805020110221
tendency,15,2.70805020110221
experiments,15,2.70805020110221
consisting,15,2.70805020110221
Quality,15,2.70805020110221
shortly,15,2.70805020110221
prepare,15,2.70805020110221
Vaccines,15,2.70805020110221
counterpulsation,15,2.70805020110221
CEA,15,2.70805020110221
DM,15,2.70805020110221
dangerous,15,2.70805020110221
modules,15,2.70805020110221
tree,15,2.70805020110221
Province,15,2.70805020110221
Initiative,15,2.70805020110221
peaked,15,2.70805020110221
manuscript,15,2.70805020110221
sexual,15,2.70805020110221
adequately,15,2.70805020110221
dyspnoea,15,2.70805020110221
sharing,15,2.70805020110221
Thailand,15,2.70805020110221
IT,15,2.70805020110221
stenoses,15,2.70805020110221
pathologies,15,2.70805020110221
aging,14,2.6390573296152584
Intravenous,14,2.6390573296152584
ever,14,2.6390573296152584
fibrinolytic,14,2.6390573296152584
returned,14,2.6390573296152584
Netherlands,14,2.6390573296152584
inducing,14,2.6390573296152584
CXR,14,2.6390573296152584
equine,14,2.6390573296152584
Numerous,14,2.6390573296152584
emphasized,14,2.6390573296152584
02,14,2.6390573296152584
extensively,14,2.6390573296152584
College,14,2.6390573296152584
Increasing,14,2.6390573296152584
PB2,14,2.6390573296152584
inappropriate,14,2.6390573296152584
relations,14,2.6390573296152584
CVA,14,2.6390573296152584
sensors,14,2.6390573296152584
papers,14,2.6390573296152584
places,14,2.6390573296152584
London,14,2.6390573296152584
error,14,2.6390573296152584
ipsilesional,14,2.6390573296152584
transcranial,14,2.6390573296152584
procedural,14,2.6390573296152584
transition,14,2.6390573296152584
sensory,14,2.6390573296152584
die,14,2.6390573296152584
societal,14,2.6390573296152584
Specific,14,2.6390573296152584
oropharyngeal,14,2.6390573296152584
medically,14,2.6390573296152584
raising,14,2.6390573296152584
criterion,14,2.6390573296152584
regularly,14,2.6390573296152584
creating,14,2.6390573296152584
hemispheric,14,2.6390573296152584
RNAs,14,2.6390573296152584
formed,14,2.6390573296152584
preexisting,14,2.6390573296152584
modifications,14,2.6390573296152584
translational,14,2.6390573296152584
encounters,14,2.6390573296152584
Diagnostic,14,2.6390573296152584
neutrophil,14,2.6390573296152584
vestibular,14,2.6390573296152584
Vietnam,14,2.6390573296152584
mucosa,14,2.6390573296152584
treadmill,14,2.6390573296152584
Public,14,2.6390573296152584
Exercise,14,2.6390573296152584
correction,14,2.6390573296152584
mucus,14,2.6390573296152584
workup,14,2.6390573296152584
interviewed,14,2.6390573296152584
occlusive,14,2.6390573296152584
drawn,14,2.6390573296152584
1981,14,2.6390573296152584
Hemisphere,14,2.6390573296152584
victims,14,2.6390573296152584
diameter,14,2.6390573296152584
unrecognized,14,2.6390573296152584
pulse,14,2.6390573296152584
contraindications,14,2.6390573296152584
pertinent,14,2.6390573296152584
multivariable,14,2.6390573296152584
instance,14,2.6390573296152584
asynergy,14,2.6390573296152584
covered,14,2.6390573296152584
Interestingly,14,2.6390573296152584
consultation,14,2.6390573296152584
solid,14,2.6390573296152584
racial,14,2.6390573296152584
regulated,14,2.6390573296152584
suboptimal,14,2.6390573296152584
combining,14,2.6390573296152584
antiinflammatory,14,2.6390573296152584
preoperative,14,2.6390573296152584
spasm,14,2.6390573296152584
T-cell,14,2.6390573296152584
catheter,14,2.6390573296152584
pre-,14,2.6390573296152584
dramatic,14,2.6390573296152584
familial,14,2.6390573296152584
computational,14,2.6390573296152584
1999,14,2.6390573296152584
Questionnaire,14,2.6390573296152584
distributions,14,2.6390573296152584
Sensitivity,14,2.6390573296152584
spectral,14,2.6390573296152584
controversy,14,2.6390573296152584
experimentally,14,2.6390573296152584
vast,14,2.6390573296152584
Secondary,14,2.6390573296152584
interplay,14,2.6390573296152584
Regional,14,2.6390573296152584
statement,14,2.6390573296152584
concordance,14,2.6390573296152584
subcortical,14,2.6390573296152584
covariates,14,2.6390573296152584
publications,14,2.6390573296152584
autophagy,14,2.6390573296152584
delta,14,2.6390573296152584
111,14,2.6390573296152584
fail,14,2.6390573296152584
adapt,14,2.6390573296152584
predictions,14,2.6390573296152584
mixture,14,2.6390573296152584
Development,14,2.6390573296152584
silico,14,2.6390573296152584
98,14,2.6390573296152584
antihypertensive,14,2.6390573296152584
antagonist,14,2.6390573296152584
shorter,14,2.6390573296152584
outpatients,14,2.6390573296152584
Allergic,14,2.6390573296152584
emboli,14,2.6390573296152584
135,14,2.6390573296152584
blockers,14,2.6390573296152584
extreme,14,2.6390573296152584
RVMI,14,2.6390573296152584
BHR,14,2.6390573296152584
encouraged,14,2.6390573296152584
hospital-based,14,2.6390573296152584
ARI,14,2.6390573296152584
T1,14,2.6390573296152584
reassortment,14,2.6390573296152584
unfavorable,14,2.6390573296152584
apparently,14,2.6390573296152584
entered,14,2.6390573296152584
enzymatic,14,2.6390573296152584
eventually,14,2.6390573296152584
ferret,14,2.6390573296152584
insurance,14,2.6390573296152584
accelerate,14,2.6390573296152584
sick,14,2.6390573296152584
Indian,14,2.6390573296152584
J,14,2.6390573296152584
necessarily,14,2.6390573296152584
x,14,2.6390573296152584
fit,14,2.6390573296152584
adenovirus,14,2.6390573296152584
continents,14,2.6390573296152584
exclusively,14,2.6390573296152584
hundreds,14,2.6390573296152584
utilizing,14,2.6390573296152584
gives,14,2.6390573296152584
cervical,14,2.6390573296152584
avoided,14,2.6390573296152584
morphological,14,2.6390573296152584
AHR,14,2.6390573296152584
concurrent,14,2.6390573296152584
practitioner,14,2.6390573296152584
Annual,14,2.6390573296152584
thorough,14,2.6390573296152584
collect,14,2.6390573296152584
Indeed,14,2.6390573296152584
learned,14,2.6390573296152584
neurovascular,14,2.6390573296152584
thallium-201,14,2.6390573296152584
seek,14,2.6390573296152584
writing,14,2.6390573296152584
offered,14,2.6390573296152584
first-line,14,2.6390573296152584
protecting,14,2.6390573296152584
isothermal,14,2.6390573296152584
Direct,14,2.6390573296152584
resolved,14,2.6390573296152584
repeat,14,2.6390573296152584
Review,14,2.6390573296152584
magnesium,14,2.6390573296152584
Novel,14,2.6390573296152584
aiming,14,2.6390573296152584
serologic,14,2.6390573296152584
agreed,14,2.6390573296152584
primer,14,2.6390573296152584
intra-aortic,14,2.6390573296152584
kept,14,2.6390573296152584
droplet,14,2.6390573296152584
AHong,14,2.6390573296152584
fear,14,2.6390573296152584
cultures,14,2.6390573296152584
too,14,2.6390573296152584
Low,14,2.6390573296152584
strict,14,2.6390573296152584
calls,14,2.6390573296152584
P2,14,2.6390573296152584
ultimately,13,2.5649493574615367
assumed,13,2.5649493574615367
nighttime,13,2.5649493574615367
Conclusion,13,2.5649493574615367
prove,13,2.5649493574615367
bat,13,2.5649493574615367
track,13,2.5649493574615367
LOS,13,2.5649493574615367
bronchoalveolar,13,2.5649493574615367
inside,13,2.5649493574615367
readmission,13,2.5649493574615367
Pediatric,13,2.5649493574615367
prescription,13,2.5649493574615367
leukotriene,13,2.5649493574615367
reading,13,2.5649493574615367
designs,13,2.5649493574615367
coded,13,2.5649493574615367
intravascular,13,2.5649493574615367
heavy,13,2.5649493574615367
inhabitants,13,2.5649493574615367
items,13,2.5649493574615367
heavily,13,2.5649493574615367
mood,13,2.5649493574615367
weak,13,2.5649493574615367
endotypes,13,2.5649493574615367
SNPs,13,2.5649493574615367
tailored,13,2.5649493574615367
stakeholders,13,2.5649493574615367
interventional,13,2.5649493574615367
proteomics,13,2.5649493574615367
R0,13,2.5649493574615367
physiology,13,2.5649493574615367
sensitivities,13,2.5649493574615367
Large,13,2.5649493574615367
probe,13,2.5649493574615367
alpha,13,2.5649493574615367
chosen,13,2.5649493574615367
AKI,13,2.5649493574615367
sufficiently,13,2.5649493574615367
text,13,2.5649493574615367
disciplines,13,2.5649493574615367
ribavirin,13,2.5649493574615367
exam,13,2.5649493574615367
Preliminary,13,2.5649493574615367
exchange,13,2.5649493574615367
necessity,13,2.5649493574615367
comorbidity,13,2.5649493574615367
entities,13,2.5649493574615367
paroxysmal,13,2.5649493574615367
SARS-COV-2,13,2.5649493574615367
soluble,13,2.5649493574615367
TLRs,13,2.5649493574615367
translate,13,2.5649493574615367
propagation,13,2.5649493574615367
dilation,13,2.5649493574615367
hyperventilation,13,2.5649493574615367
ii,13,2.5649493574615367
top,13,2.5649493574615367
CSOE,13,2.5649493574615367
adolescent,13,2.5649493574615367
regulate,13,2.5649493574615367
excluding,13,2.5649493574615367
corrected,13,2.5649493574615367
SARS-CoV-2-specific,13,2.5649493574615367
ensuring,13,2.5649493574615367
CD4,13,2.5649493574615367
AB,13,2.5649493574615367
outlined,13,2.5649493574615367
wards,13,2.5649493574615367
Cardiogenic,13,2.5649493574615367
Cancer,13,2.5649493574615367
false-positive,13,2.5649493574615367
facilitating,13,2.5649493574615367
West,13,2.5649493574615367
substances,13,2.5649493574615367
Practices,13,2.5649493574615367
pharyngeal,13,2.5649493574615367
progressively,13,2.5649493574615367
NCP,13,2.5649493574615367
excursion,13,2.5649493574615367
cut,13,2.5649493574615367
visit,13,2.5649493574615367
modify,13,2.5649493574615367
ECP,13,2.5649493574615367
mgml,13,2.5649493574615367
genetically,13,2.5649493574615367
turnaround,13,2.5649493574615367
speech,13,2.5649493574615367
themes,13,2.5649493574615367
microcirculation,13,2.5649493574615367
500,13,2.5649493574615367
overlapping,13,2.5649493574615367
doctor,13,2.5649493574615367
safer,13,2.5649493574615367
western,13,2.5649493574615367
deposition,13,2.5649493574615367
neutrophils,13,2.5649493574615367
closed,13,2.5649493574615367
reflected,13,2.5649493574615367
asthma-related,13,2.5649493574615367
fashion,13,2.5649493574615367
cardiomyopathy,13,2.5649493574615367
tracking,13,2.5649493574615367
enabling,13,2.5649493574615367
Through,13,2.5649493574615367
non,13,2.5649493574615367
randomised,13,2.5649493574615367
obvious,13,2.5649493574615367
C-reactive,13,2.5649493574615367
Different,13,2.5649493574615367
beats,13,2.5649493574615367
establishment,13,2.5649493574615367
cost-effective,13,2.5649493574615367
vaccinate,13,2.5649493574615367
PA,13,2.5649493574615367
CHADS2,13,2.5649493574615367
dual,13,2.5649493574615367
coughing,13,2.5649493574615367
genotypes,13,2.5649493574615367
2001,13,2.5649493574615367
Avian,13,2.5649493574615367
SS,13,2.5649493574615367
version,13,2.5649493574615367
responsive,13,2.5649493574615367
Roche,13,2.5649493574615367
tone,13,2.5649493574615367
progenitor,13,2.5649493574615367
played,13,2.5649493574615367
adjunct,13,2.5649493574615367
pooling,13,2.5649493574615367
constant,13,2.5649493574615367
sparse,13,2.5649493574615367
companies,13,2.5649493574615367
Environmental,13,2.5649493574615367
primers,13,2.5649493574615367
SARS-CoV-1,13,2.5649493574615367
Multivariate,13,2.5649493574615367
Changes,13,2.5649493574615367
spectrometry,13,2.5649493574615367
Blood,13,2.5649493574615367
Additional,13,2.5649493574615367
unexplained,13,2.5649493574615367
meteorological,13,2.5649493574615367
operations,13,2.5649493574615367
observe,13,2.5649493574615367
judged,13,2.5649493574615367
employees,13,2.5649493574615367
revision,13,2.5649493574615367
girl,13,2.5649493574615367
modest,13,2.5649493574615367
equivalent,13,2.5649493574615367
running,13,2.5649493574615367
blockade,13,2.5649493574615367
test-negative,13,2.5649493574615367
115,13,2.5649493574615367
minimizing,13,2.5649493574615367
connection,13,2.5649493574615367
organized,13,2.5649493574615367
outline,13,2.5649493574615367
assumptions,13,2.5649493574615367
endpoint,13,2.5649493574615367
Ten,13,2.5649493574615367
willingness,13,2.5649493574615367
unable,13,2.5649493574615367
140,13,2.5649493574615367
justify,13,2.5649493574615367
CR,13,2.5649493574615367
depressed,13,2.5649493574615367
tube,13,2.5649493574615367
remarkably,13,2.5649493574615367
Another,13,2.5649493574615367
spinal,13,2.5649493574615367
utilize,13,2.5649493574615367
valvular,13,2.5649493574615367
huge,13,2.5649493574615367
resting,13,2.5649493574615367
tomographic,13,2.5649493574615367
Seasonal,13,2.5649493574615367
quite,13,2.5649493574615367
applicable,13,2.5649493574615367
wider,13,2.5649493574615367
Program,13,2.5649493574615367
actively,13,2.5649493574615367
restoration,13,2.5649493574615367
inversely,13,2.5649493574615367
origins,13,2.5649493574615367
tend,13,2.5649493574615367
minute,13,2.5649493574615367
provider,13,2.5649493574615367
complexes,13,2.5649493574615367
tremendous,13,2.5649493574615367
confounders,13,2.5649493574615367
combating,13,2.5649493574615367
2009-2010,13,2.5649493574615367
influenzae,13,2.5649493574615367
Advisory,13,2.5649493574615367
etiologies,13,2.5649493574615367
AC,13,2.5649493574615367
dilatation,13,2.5649493574615367
Singapore,13,2.5649493574615367
analyse,13,2.5649493574615367
relapse,13,2.5649493574615367
fractions,13,2.5649493574615367
scientists,13,2.5649493574615367
mlm2,13,2.5649493574615367
Long-term,13,2.5649493574615367
Flu,13,2.5649493574615367
SA,13,2.5649493574615367
add,13,2.5649493574615367
diarrhea,12,2.4849066497880004
complaints,12,2.4849066497880004
ethnic,12,2.4849066497880004
inhaler,12,2.4849066497880004
Hubei,12,2.4849066497880004
signature,12,2.4849066497880004
Web,12,2.4849066497880004
198,12,2.4849066497880004
university,12,2.4849066497880004
Clinicians,12,2.4849066497880004
mind,12,2.4849066497880004
instrumental,12,2.4849066497880004
TMPRSS2,12,2.4849066497880004
recover,12,2.4849066497880004
mgkg,12,2.4849066497880004
aggregation,12,2.4849066497880004
Late,12,2.4849066497880004
CCP,12,2.4849066497880004
contracting,12,2.4849066497880004
Case,12,2.4849066497880004
keep,12,2.4849066497880004
conjunctivitis,12,2.4849066497880004
Iran,12,2.4849066497880004
2010-11,12,2.4849066497880004
asthmaticus,12,2.4849066497880004
ID,12,2.4849066497880004
naturally,12,2.4849066497880004
sigma,12,2.4849066497880004
predicts,12,2.4849066497880004
breathlessness,12,2.4849066497880004
allele,12,2.4849066497880004
Eastern,12,2.4849066497880004
mRS,12,2.4849066497880004
1996,12,2.4849066497880004
Council,12,2.4849066497880004
datasets,12,2.4849066497880004
solely,12,2.4849066497880004
arteriography,12,2.4849066497880004
node,12,2.4849066497880004
LGE,12,2.4849066497880004
HDAC1,12,2.4849066497880004
so-called,12,2.4849066497880004
comes,12,2.4849066497880004
differentiated,12,2.4849066497880004
visible,12,2.4849066497880004
p00001,12,2.4849066497880004
lab,12,2.4849066497880004
kit,12,2.4849066497880004
authorized,12,2.4849066497880004
regulating,12,2.4849066497880004
federal,12,2.4849066497880004
modulate,12,2.4849066497880004
methylation,12,2.4849066497880004
methodologies,12,2.4849066497880004
PAI-1,12,2.4849066497880004
meeting,12,2.4849066497880004
Time,12,2.4849066497880004
meta-analyses,12,2.4849066497880004
Americans,12,2.4849066497880004
ago,12,2.4849066497880004
nitrate,12,2.4849066497880004
invasion,12,2.4849066497880004
Yet,12,2.4849066497880004
optical,12,2.4849066497880004
interference,12,2.4849066497880004
107,12,2.4849066497880004
preschool,12,2.4849066497880004
permits,12,2.4849066497880004
undiagnosed,12,2.4849066497880004
immunosorbent,12,2.4849066497880004
school-based,12,2.4849066497880004
MCE,12,2.4849066497880004
Indonesia,12,2.4849066497880004
personalized,12,2.4849066497880004
balance,12,2.4849066497880004
miRNA,12,2.4849066497880004
depth,12,2.4849066497880004
salivary,12,2.4849066497880004
views,12,2.4849066497880004
abdominal,12,2.4849066497880004
similarly,12,2.4849066497880004
SE,12,2.4849066497880004
ARD,12,2.4849066497880004
post-myocardial,12,2.4849066497880004
Cognitive,12,2.4849066497880004
epilepsy,12,2.4849066497880004
elimination,12,2.4849066497880004
elicit,12,2.4849066497880004
pneumoniae,12,2.4849066497880004
pre-hospital,12,2.4849066497880004
IVT,12,2.4849066497880004
yearly,12,2.4849066497880004
About,12,2.4849066497880004
S-T,12,2.4849066497880004
driven,12,2.4849066497880004
upregulated,12,2.4849066497880004
digestive,12,2.4849066497880004
sST2,12,2.4849066497880004
dosage,12,2.4849066497880004
geometric,12,2.4849066497880004
saline,12,2.4849066497880004
potency,12,2.4849066497880004
claims,12,2.4849066497880004
ECGs,12,2.4849066497880004
normalized,12,2.4849066497880004
nonvalvular,12,2.4849066497880004
Context,12,2.4849066497880004
sampled,12,2.4849066497880004
Cerebral,12,2.4849066497880004
artificial,12,2.4849066497880004
responded,12,2.4849066497880004
fourth,12,2.4849066497880004
108,12,2.4849066497880004
transformation,12,2.4849066497880004
staining,12,2.4849066497880004
Veterans,12,2.4849066497880004
natriuretic,12,2.4849066497880004
exploration,12,2.4849066497880004
2017,12,2.4849066497880004
LA,12,2.4849066497880004
fetus,12,2.4849066497880004
progressing,12,2.4849066497880004
scope,12,2.4849066497880004
held,12,2.4849066497880004
self,12,2.4849066497880004
CPK,12,2.4849066497880004
EMS,12,2.4849066497880004
CP,12,2.4849066497880004
thallium,12,2.4849066497880004
medicines,12,2.4849066497880004
Expert,12,2.4849066497880004
ethnicity,12,2.4849066497880004
users,12,2.4849066497880004
labs,12,2.4849066497880004
PFR,12,2.4849066497880004
reflecting,12,2.4849066497880004
modulation,12,2.4849066497880004
stimulate,12,2.4849066497880004
faced,12,2.4849066497880004
sequenced,12,2.4849066497880004
lasting,12,2.4849066497880004
Female,12,2.4849066497880004
LAA,12,2.4849066497880004
prick,12,2.4849066497880004
BA,12,2.4849066497880004
took,12,2.4849066497880004
wood,12,2.4849066497880004
black,12,2.4849066497880004
marrow,12,2.4849066497880004
high-dose,12,2.4849066497880004
scalable,12,2.4849066497880004
registers,12,2.4849066497880004
thresholds,12,2.4849066497880004
instances,12,2.4849066497880004
pilot,12,2.4849066497880004
SNP,12,2.4849066497880004
expertise,12,2.4849066497880004
astrocytes,12,2.4849066497880004
covering,12,2.4849066497880004
thickening,12,2.4849066497880004
neuropsychological,12,2.4849066497880004
pericarditis,12,2.4849066497880004
lethality,12,2.4849066497880004
UEMI,12,2.4849066497880004
SF-36,12,2.4849066497880004
pneumothorax,12,2.4849066497880004
simulations,12,2.4849066497880004
180,12,2.4849066497880004
modifiable,12,2.4849066497880004
built,12,2.4849066497880004
drive,12,2.4849066497880004
c,12,2.4849066497880004
Chest,12,2.4849066497880004
1993,12,2.4849066497880004
leukocytes,12,2.4849066497880004
served,12,2.4849066497880004
biosensor,12,2.4849066497880004
composed,12,2.4849066497880004
initiating,12,2.4849066497880004
formulated,12,2.4849066497880004
color,12,2.4849066497880004
antiarrhythmic,12,2.4849066497880004
Blacks,12,2.4849066497880004
go,12,2.4849066497880004
reverse-transcription,12,2.4849066497880004
inpatients,12,2.4849066497880004
inconclusive,12,2.4849066497880004
County,12,2.4849066497880004
recruitment,12,2.4849066497880004
non-Q,12,2.4849066497880004
incubation,12,2.4849066497880004
documents,12,2.4849066497880004
multivessel,12,2.4849066497880004
vomiting,12,2.4849066497880004
initiate,12,2.4849066497880004
rationale,12,2.4849066497880004
southern,12,2.4849066497880004
Ag,12,2.4849066497880004
dengue,12,2.4849066497880004
Follow-up,12,2.4849066497880004
intraaortic,12,2.4849066497880004
Once,12,2.4849066497880004
elevations,12,2.4849066497880004
prompted,12,2.4849066497880004
rising,12,2.4849066497880004
relieve,12,2.4849066497880004
addressing,12,2.4849066497880004
HIV,12,2.4849066497880004
cardiology,12,2.4849066497880004
Consequently,12,2.4849066497880004
075,12,2.4849066497880004
unsuccessful,12,2.4849066497880004
Mb,12,2.4849066497880004
adding,12,2.4849066497880004
Cochrane,12,2.4849066497880004
122,12,2.4849066497880004
shortage,12,2.4849066497880004
prescribing,12,2.4849066497880004
ease,12,2.4849066497880004
albumin,12,2.4849066497880004
molecule,12,2.4849066497880004
co-morbidities,12,2.4849066497880004
MIs,12,2.4849066497880004
116,12,2.4849066497880004
genetics,12,2.4849066497880004
computerized,12,2.4849066497880004
removed,12,2.4849066497880004
requirement,12,2.4849066497880004
case-patients,12,2.4849066497880004
Improved,12,2.4849066497880004
mainstay,12,2.4849066497880004
Neurological,12,2.4849066497880004
infrastructure,12,2.4849066497880004
interventricular,12,2.4849066497880004
V,12,2.4849066497880004
mimics,12,2.4849066497880004
virtual,12,2.4849066497880004
giving,12,2.4849066497880004
G,12,2.4849066497880004
reviewing,12,2.4849066497880004
inversion,12,2.4849066497880004
dedicated,12,2.4849066497880004
protected,12,2.4849066497880004
In-hospital,12,2.4849066497880004
Hispanic,12,2.4849066497880004
phenotypic,12,2.4849066497880004
generic,12,2.4849066497880004
infancy,12,2.4849066497880004
Testing,12,2.4849066497880004
time-consuming,12,2.4849066497880004
Nine,12,2.4849066497880004
tasks,12,2.4849066497880004
undetermined,12,2.4849066497880004
histories,12,2.4849066497880004
perspectives,12,2.4849066497880004
Findings,12,2.4849066497880004
seropositive,11,2.3978952727983707
vertebral,11,2.3978952727983707
puberty,11,2.3978952727983707
manual,11,2.3978952727983707
informative,11,2.3978952727983707
conceptual,11,2.3978952727983707
permeability,11,2.3978952727983707
recordings,11,2.3978952727983707
s,11,2.3978952727983707
throughput,11,2.3978952727983707
importantly,11,2.3978952727983707
cocaine,11,2.3978952727983707
detrimental,11,2.3978952727983707
hyperglycemia,11,2.3978952727983707
recognizing,11,2.3978952727983707
learn,11,2.3978952727983707
threatening,11,2.3978952727983707
dead,11,2.3978952727983707
mites,11,2.3978952727983707
Thrombolytic,11,2.3978952727983707
CAD,11,2.3978952727983707
210,11,2.3978952727983707
antiplatelets,11,2.3978952727983707
Peak,11,2.3978952727983707
mutant,11,2.3978952727983707
community-acquired,11,2.3978952727983707
end-systolic,11,2.3978952727983707
gathered,11,2.3978952727983707
pumping,11,2.3978952727983707
colleagues,11,2.3978952727983707
AH1N1v,11,2.3978952727983707
Antibody,11,2.3978952727983707
Nigeria,11,2.3978952727983707
recovering,11,2.3978952727983707
one-step,11,2.3978952727983707
occlusions,11,2.3978952727983707
Prior,11,2.3978952727983707
metoprolol,11,2.3978952727983707
21st,11,2.3978952727983707
Under,11,2.3978952727983707
long-acting,11,2.3978952727983707
0003,11,2.3978952727983707
acquiring,11,2.3978952727983707
MIF,11,2.3978952727983707
PC,11,2.3978952727983707
English,11,2.3978952727983707
yield,11,2.3978952727983707
upcoming,11,2.3978952727983707
repetitive,11,2.3978952727983707
Limited,11,2.3978952727983707
accomplished,11,2.3978952727983707
accounts,11,2.3978952727983707
Imaging,11,2.3978952727983707
pollen,11,2.3978952727983707
arising,11,2.3978952727983707
accident,11,2.3978952727983707
postdischarge,11,2.3978952727983707
cure,11,2.3978952727983707
nations,11,2.3978952727983707
IFN-γ,11,2.3978952727983707
Cases,11,2.3978952727983707
operational,11,2.3978952727983707
kind,11,2.3978952727983707
progressed,11,2.3978952727983707
self-efficacy,11,2.3978952727983707
impending,11,2.3978952727983707
blue,11,2.3978952727983707
courses,11,2.3978952727983707
vision,11,2.3978952727983707
neurologists,11,2.3978952727983707
endothelium,11,2.3978952727983707
antigenically,11,2.3978952727983707
Age,11,2.3978952727983707
considerably,11,2.3978952727983707
TEE,11,2.3978952727983707
Ontario,11,2.3978952727983707
adhesion,11,2.3978952727983707
vulnerability,11,2.3978952727983707
methodological,11,2.3978952727983707
Toronto,11,2.3978952727983707
exacerbated,11,2.3978952727983707
Moderna,11,2.3978952727983707
qualified,11,2.3978952727983707
ganglia,11,2.3978952727983707
suddenly,11,2.3978952727983707
breast,11,2.3978952727983707
adjuvant,11,2.3978952727983707
substrate,11,2.3978952727983707
130,11,2.3978952727983707
commercially,11,2.3978952727983707
ascertained,11,2.3978952727983707
CBT,11,2.3978952727983707
triage,11,2.3978952727983707
Oral,11,2.3978952727983707
falls,11,2.3978952727983707
fold,11,2.3978952727983707
sialic,11,2.3978952727983707
walking,11,2.3978952727983707
General,11,2.3978952727983707
sense,11,2.3978952727983707
coupled,11,2.3978952727983707
131,11,2.3978952727983707
non-asthmatic,11,2.3978952727983707
interfere,11,2.3978952727983707
ET,11,2.3978952727983707
Molecular,11,2.3978952727983707
compound,11,2.3978952727983707
arch,11,2.3978952727983707
hemoglobin,11,2.3978952727983707
MERS,11,2.3978952727983707
necrotic,11,2.3978952727983707
selecting,11,2.3978952727983707
dysregulation,11,2.3978952727983707
arm,11,2.3978952727983707
conformation,11,2.3978952727983707
explains,11,2.3978952727983707
dexamethasone,11,2.3978952727983707
everyday,11,2.3978952727983707
hemodynamics,11,2.3978952727983707
in-person,11,2.3978952727983707
applicability,11,2.3978952727983707
strengthening,11,2.3978952727983707
alive,11,2.3978952727983707
CST,11,2.3978952727983707
ETT,11,2.3978952727983707
alternatives,11,2.3978952727983707
African-American,11,2.3978952727983707
Cerebrovascular,11,2.3978952727983707
preference,11,2.3978952727983707
VF,11,2.3978952727983707
exclude,11,2.3978952727983707
monovalent,11,2.3978952727983707
beta-blockers,11,2.3978952727983707
Killip,11,2.3978952727983707
favourable,11,2.3978952727983707
MCAO,11,2.3978952727983707
boy,11,2.3978952727983707
non-Q-wave,11,2.3978952727983707
analyzing,11,2.3978952727983707
Black,11,2.3978952727983707
operated,11,2.3978952727983707
neurons,11,2.3978952727983707
kinds,11,2.3978952727983707
tried,11,2.3978952727983707
today,11,2.3978952727983707
MIS,11,2.3978952727983707
CoVs,11,2.3978952727983707
contexts,11,2.3978952727983707
visualized,11,2.3978952727983707
hormonal,11,2.3978952727983707
worked,11,2.3978952727983707
virulent,11,2.3978952727983707
COVID‐19,11,2.3978952727983707
platelets,11,2.3978952727983707
closures,11,2.3978952727983707
engaged,11,2.3978952727983707
cope,11,2.3978952727983707
201112,11,2.3978952727983707
Every,11,2.3978952727983707
partnership,11,2.3978952727983707
beds,11,2.3978952727983707
MCA,11,2.3978952727983707
BT,11,2.3978952727983707
officials,11,2.3978952727983707
conflicting,11,2.3978952727983707
Inhaled,11,2.3978952727983707
PCR-confirmed,11,2.3978952727983707
femoral,11,2.3978952727983707
sinusitis,11,2.3978952727983707
evolve,11,2.3978952727983707
resolve,11,2.3978952727983707
Hz,11,2.3978952727983707
mutants,11,2.3978952727983707
128,11,2.3978952727983707
confusion,11,2.3978952727983707
electrocardiograms,11,2.3978952727983707
thickness,11,2.3978952727983707
incremental,11,2.3978952727983707
avoiding,11,2.3978952727983707
120,11,2.3978952727983707
anti-viral,11,2.3978952727983707
H,11,2.3978952727983707
5-year,11,2.3978952727983707
time-dependent,11,2.3978952727983707
1988,11,2.3978952727983707
symptomatology,11,2.3978952727983707
gamma,11,2.3978952727983707
alveolar,11,2.3978952727983707
tocilizumab,11,2.3978952727983707
GER,11,2.3978952727983707
pivotal,11,2.3978952727983707
SCD,11,2.3978952727983707
lobe,11,2.3978952727983707
sexes,11,2.3978952727983707
1-2,11,2.3978952727983707
Thirty,11,2.3978952727983707
Higher,11,2.3978952727983707
sore,11,2.3978952727983707
Mathematical,11,2.3978952727983707
work-up,11,2.3978952727983707
machine,11,2.3978952727983707
properly,11,2.3978952727983707
extrinsic,11,2.3978952727983707
parainfluenza,11,2.3978952727983707
2D,11,2.3978952727983707
seropositivity,11,2.3978952727983707
mammals,11,2.3978952727983707
initiatives,11,2.3978952727983707
3D,11,2.3978952727983707
Pacific,11,2.3978952727983707
fatty,11,2.3978952727983707
grouped,11,2.3978952727983707
suppress,11,2.3978952727983707
Protection,11,2.3978952727983707
constriction,11,2.3978952727983707
joint,11,2.3978952727983707
bats,11,2.3978952727983707
capillaries,11,2.3978952727983707
echocardiogram,11,2.3978952727983707
occasional,11,2.3978952727983707
hazards,11,2.3978952727983707
downstream,11,2.3978952727983707
elucidated,11,2.3978952727983707
instituted,11,2.3978952727983707
1st,11,2.3978952727983707
jurisdictions,11,2.3978952727983707
funding,11,2.3978952727983707
Serum,11,2.3978952727983707
observers,11,2.3978952727983707
ASM,11,2.3978952727983707
guiding,11,2.3978952727983707
away,11,2.3978952727983707
breastfeeding,11,2.3978952727983707
dying,11,2.3978952727983707
thereafter,11,2.3978952727983707
Occupational,11,2.3978952727983707
enzyme-linked,11,2.3978952727983707
Coronaviruses,11,2.3978952727983707
sympathetic,11,2.3978952727983707
Out,11,2.3978952727983707
industrial,11,2.3978952727983707
VTM,11,2.3978952727983707
adolescence,11,2.3978952727983707
creatinine,11,2.3978952727983707
collaborative,11,2.3978952727983707
I2,11,2.3978952727983707
Cardiovascular,11,2.3978952727983707
spreads,11,2.3978952727983707
prescriptions,11,2.3978952727983707
reveals,11,2.3978952727983707
Accurate,11,2.3978952727983707
zero,11,2.3978952727983707
similarity,11,2.3978952727983707
disparity,11,2.3978952727983707
univariate,11,2.3978952727983707
aeroallergens,11,2.3978952727983707
sociodemographic,11,2.3978952727983707
immunofluorescence,11,2.3978952727983707
supplement,11,2.3978952727983707
entering,11,2.3978952727983707
Echocardiography,11,2.3978952727983707
121,11,2.3978952727983707
LAMP,11,2.3978952727983707
reasonable,11,2.3978952727983707
underway,11,2.3978952727983707
HDM,11,2.3978952727983707
stimulated,10,2.302585092994046
treatable,10,2.302585092994046
pranlukast,10,2.302585092994046
administrative,10,2.302585092994046
authorization,10,2.302585092994046
Nurses,10,2.302585092994046
NSSTTAs,10,2.302585092994046
meter,10,2.302585092994046
ST-T,10,2.302585092994046
takes,10,2.302585092994046
miRs,10,2.302585092994046
milder,10,2.302585092994046
fracture,10,2.302585092994046
sole,10,2.302585092994046
relate,10,2.302585092994046
msec,10,2.302585092994046
in-depth,10,2.302585092994046
suppressing,10,2.302585092994046
NAEPP,10,2.302585092994046
encounter,10,2.302585092994046
receipt,10,2.302585092994046
stunning,10,2.302585092994046
Medline,10,2.302585092994046
Republic,10,2.302585092994046
Participants,10,2.302585092994046
Southern,10,2.302585092994046
look,10,2.302585092994046
P0001,10,2.302585092994046
metrics,10,2.302585092994046
stepwise,10,2.302585092994046
inhibitory,10,2.302585092994046
probable,10,2.302585092994046
radiation,10,2.302585092994046
abilities,10,2.302585092994046
capillary,10,2.302585092994046
Google,10,2.302585092994046
contralesional,10,2.302585092994046
Up,10,2.302585092994046
verify,10,2.302585092994046
Experimental,10,2.302585092994046
infrequent,10,2.302585092994046
Any,10,2.302585092994046
extraordinary,10,2.302585092994046
sensitized,10,2.302585092994046
Purpose-,10,2.302585092994046
Polish,10,2.302585092994046
Methods-,10,2.302585092994046
occasionally,10,2.302585092994046
murine,10,2.302585092994046
microscopic,10,2.302585092994046
degradation,10,2.302585092994046
imbalance,10,2.302585092994046
ACP,10,2.302585092994046
crude,10,2.302585092994046
cerebrospinal,10,2.302585092994046
heightened,10,2.302585092994046
fibrous,10,2.302585092994046
author,10,2.302585092994046
exert,10,2.302585092994046
preventable,10,2.302585092994046
waning,10,2.302585092994046
Life,10,2.302585092994046
hearts,10,2.302585092994046
unexpected,10,2.302585092994046
sent,10,2.302585092994046
incomplete,10,2.302585092994046
Phylogenetic,10,2.302585092994046
20th,10,2.302585092994046
paid,10,2.302585092994046
save,10,2.302585092994046
particle,10,2.302585092994046
parenchymal,10,2.302585092994046
profound,10,2.302585092994046
Project,10,2.302585092994046
RD,10,2.302585092994046
1977,10,2.302585092994046
SRA,10,2.302585092994046
expanding,10,2.302585092994046
predominated,10,2.302585092994046
Agency,10,2.302585092994046
metropolitan,10,2.302585092994046
extract,10,2.302585092994046
sporadic,10,2.302585092994046
worker,10,2.302585092994046
supplies,10,2.302585092994046
HRQoL,10,2.302585092994046
adjunctive,10,2.302585092994046
Women,10,2.302585092994046
toxic,10,2.302585092994046
disturbance,10,2.302585092994046
BMI,10,2.302585092994046
wild-type,10,2.302585092994046
hemorrhages,10,2.302585092994046
Conclusions-,10,2.302585092994046
distinguishing,10,2.302585092994046
analogue,10,2.302585092994046
AstraZeneca,10,2.302585092994046
chances,10,2.302585092994046
proinflammatory,10,2.302585092994046
monthly,10,2.302585092994046
outlines,10,2.302585092994046
RI,10,2.302585092994046
mentioned,10,2.302585092994046
construct,10,2.302585092994046
wk,10,2.302585092994046
sport,10,2.302585092994046
160,10,2.302585092994046
Outcome,10,2.302585092994046
belief,10,2.302585092994046
characterizing,10,2.302585092994046
AND,10,2.302585092994046
debated,10,2.302585092994046
Results-,10,2.302585092994046
build,10,2.302585092994046
dosing,10,2.302585092994046
ambient,10,2.302585092994046
drop,10,2.302585092994046
undergone,10,2.302585092994046
colorimetric,10,2.302585092994046
Similar,10,2.302585092994046
assesses,10,2.302585092994046
Exposure,10,2.302585092994046
register,10,2.302585092994046
ACIP,10,2.302585092994046
Protein,10,2.302585092994046
transthoracic,10,2.302585092994046
zip,10,2.302585092994046
preserved,10,2.302585092994046
comprising,10,2.302585092994046
RVI,10,2.302585092994046
Second,10,2.302585092994046
unless,10,2.302585092994046
HIT,10,2.302585092994046
differentiating,10,2.302585092994046
cornerstone,10,2.302585092994046
adult-onset,10,2.302585092994046
Computed,10,2.302585092994046
124,10,2.302585092994046
NO,10,2.302585092994046
came,10,2.302585092994046
persists,10,2.302585092994046
landscape,10,2.302585092994046
expressing,10,2.302585092994046
anticipated,10,2.302585092994046
underestimated,10,2.302585092994046
unanswered,10,2.302585092994046
hold,10,2.302585092994046
helping,10,2.302585092994046
Considering,10,2.302585092994046
triggering,10,2.302585092994046
transferred,10,2.302585092994046
considers,10,2.302585092994046
evidenced,10,2.302585092994046
passengers,10,2.302585092994046
PPV,10,2.302585092994046
Authorization,10,2.302585092994046
Plasma,10,2.302585092994046
angiographically,10,2.302585092994046
helper,10,2.302585092994046
manifest,10,2.302585092994046
short-acting,10,2.302585092994046
Though,10,2.302585092994046
deemed,10,2.302585092994046
unpredictable,10,2.302585092994046
paired,10,2.302585092994046
choices,10,2.302585092994046
summarise,10,2.302585092994046
age-specific,10,2.302585092994046
collapse,10,2.302585092994046
cytotoxic,10,2.302585092994046
lived,10,2.302585092994046
problematic,10,2.302585092994046
H3N2v,10,2.302585092994046
calculate,10,2.302585092994046
fell,10,2.302585092994046
1987,10,2.302585092994046
binds,10,2.302585092994046
worlds,10,2.302585092994046
counterparts,10,2.302585092994046
fibrinogen,10,2.302585092994046
facilitates,10,2.302585092994046
whites,10,2.302585092994046
variance,10,2.302585092994046
income,10,2.302585092994046
encoding,10,2.302585092994046
thrombocytopenia,10,2.302585092994046
neuroprotection,10,2.302585092994046
RH,10,2.302585092994046
serves,10,2.302585092994046
Rehabilitation,10,2.302585092994046
saturation,10,2.302585092994046
Virus,10,2.302585092994046
errors,10,2.302585092994046
DSE,10,2.302585092994046
127,10,2.302585092994046
resection,10,2.302585092994046
H5,10,2.302585092994046
worsen,10,2.302585092994046
suspect,10,2.302585092994046
RdRp,10,2.302585092994046
Physicians,10,2.302585092994046
preparations,10,2.302585092994046
HF,10,2.302585092994046
AUC,10,2.302585092994046
sequential,10,2.302585092994046
estimating,10,2.302585092994046
influenza-associated,10,2.302585092994046
transcriptase,10,2.302585092994046
Whereas,10,2.302585092994046
Hence,10,2.302585092994046
demonstration,10,2.302585092994046
policymakers,10,2.302585092994046
damages,10,2.302585092994046
Auckland,10,2.302585092994046
differs,10,2.302585092994046
5-10,10,2.302585092994046
extend,10,2.302585092994046
narrow,10,2.302585092994046
real-life,10,2.302585092994046
fifth,10,2.302585092994046
county,10,2.302585092994046
dramatically,10,2.302585092994046
withdrawal,10,2.302585092994046
oseltamivir-resistant,10,2.302585092994046
ICA,10,2.302585092994046
subunit,10,2.302585092994046
retrieved,10,2.302585092994046
weaknesses,10,2.302585092994046
convenient,10,2.302585092994046
instrument,10,2.302585092994046
diffusion-weighted,10,2.302585092994046
shares,10,2.302585092994046
compensatory,10,2.302585092994046
reproducible,10,2.302585092994046
difficult-to-treat,10,2.302585092994046
monocyte,10,2.302585092994046
reproducibility,10,2.302585092994046
coping,10,2.302585092994046
oncology,10,2.302585092994046
maximize,10,2.302585092994046
dependence,10,2.302585092994046
1990,10,2.302585092994046
raises,10,2.302585092994046
Individuals,10,2.302585092994046
winters,10,2.302585092994046
tracer,10,2.302585092994046
Register,10,2.302585092994046
panels,10,2.302585092994046
caring,10,2.302585092994046
one-year,10,2.302585092994046
CK-MB,10,2.302585092994046
injections,10,2.302585092994046
high-quality,10,2.302585092994046
Randomized,10,2.302585092994046
GPX-1,10,2.302585092994046
recall,10,2.302585092994046
adjacent,10,2.302585092994046
10000,10,2.302585092994046
acting,10,2.302585092994046
hazardous,10,2.302585092994046
Until,10,2.302585092994046
corona,10,2.302585092994046
electron,10,2.302585092994046
Seven,10,2.302585092994046
branches,10,2.302585092994046
214,10,2.302585092994046
frequencies,10,2.302585092994046
Ab,10,2.302585092994046
naïve,10,2.302585092994046
receiver,10,2.302585092994046
coexisting,10,2.302585092994046
discomfort,10,2.302585092994046
nanoparticles,10,2.302585092994046
RCTs,10,2.302585092994046
VOCs,10,2.302585092994046
expanded,10,2.302585092994046
governments,10,2.302585092994046
PSF,10,2.302585092994046
Identifying,10,2.302585092994046
zones,10,2.302585092994046
dyslipidemia,10,2.302585092994046
vasculature,10,2.302585092994046
S-OIV,10,2.302585092994046
modes,10,2.302585092994046
manufacturers,10,2.302585092994046
injured,10,2.302585092994046
aspergillosis,10,2.302585092994046
MoCA,10,2.302585092994046
hematoma,10,2.302585092994046
Childhood,10,2.302585092994046
croup,10,2.302585092994046
middle-income,10,2.302585092994046
peaks,10,2.302585092994046
restriction,10,2.302585092994046
inhibiting,10,2.302585092994046
plasticity,10,2.302585092994046
puncture,10,2.302585092994046
alteration,10,2.302585092994046
PD,10,2.302585092994046
Before,10,2.302585092994046
exhibits,10,2.302585092994046
deceased,10,2.302585092994046
accidents,10,2.302585092994046
114,10,2.302585092994046
Sweden,10,2.302585092994046
sublingual,10,2.302585092994046
indirectly,10,2.302585092994046
figures,10,2.302585092994046
biosafety,10,2.302585092994046
ecological,10,2.302585092994046
compromised,10,2.302585092994046
ventricles,10,2.302585092994046
QOL,10,2.302585092994046
aetiological,10,2.302585092994046
post-acute,10,2.302585092994046
high-frequency,10,2.302585092994046
represented,10,2.302585092994046
trajectories,10,2.302585092994046
explanations,10,2.302585092994046
embolization,10,2.302585092994046
vaccine-related,10,2.302585092994046
Now,10,2.302585092994046
TIV,10,2.302585092994046
132,10,2.302585092994046
sound,10,2.302585092994046
vectorcardiography,10,2.302585092994046
pregnancies,10,2.302585092994046
preventative,10,2.302585092994046
Key,10,2.302585092994046
modulating,9,2.1972245773362196
purified,9,2.1972245773362196
CPAP,9,2.1972245773362196
ectopic,9,2.1972245773362196
carries,9,2.1972245773362196
Childrens,9,2.1972245773362196
integrins,9,2.1972245773362196
Recognition,9,2.1972245773362196
luminal,9,2.1972245773362196
VT,9,2.1972245773362196
APN,9,2.1972245773362196
viewed,9,2.1972245773362196
nifedipine,9,2.1972245773362196
BBB,9,2.1972245773362196
Preventive,9,2.1972245773362196
aerobic,9,2.1972245773362196
Egypt,9,2.1972245773362196
priorities,9,2.1972245773362196
delivering,9,2.1972245773362196
phenomena,9,2.1972245773362196
existed,9,2.1972245773362196
Latino,9,2.1972245773362196
personalised,9,2.1972245773362196
indicative,9,2.1972245773362196
disinfection,9,2.1972245773362196
Not,9,2.1972245773362196
cardioplegic,9,2.1972245773362196
interpret,9,2.1972245773362196
contraindicated,9,2.1972245773362196
integrity,9,2.1972245773362196
extracranial,9,2.1972245773362196
150,9,2.1972245773362196
fluids,9,2.1972245773362196
159,9,2.1972245773362196
tolerated,9,2.1972245773362196
evaluates,9,2.1972245773362196
Part,9,2.1972245773362196
mechanistic,9,2.1972245773362196
individually,9,2.1972245773362196
HCoVs,9,2.1972245773362196
beings,9,2.1972245773362196
additive,9,2.1972245773362196
Animal,9,2.1972245773362196
official,9,2.1972245773362196
savings,9,2.1972245773362196
fungi,9,2.1972245773362196
probes,9,2.1972245773362196
malaise,9,2.1972245773362196
attendance,9,2.1972245773362196
pursued,9,2.1972245773362196
microscopy,9,2.1972245773362196
091,9,2.1972245773362196
NK,9,2.1972245773362196
obstacles,9,2.1972245773362196
Endovascular,9,2.1972245773362196
EX,9,2.1972245773362196
RBBB,9,2.1972245773362196
Eighteen,9,2.1972245773362196
German,9,2.1972245773362196
endoscopy,9,2.1972245773362196
incorporated,9,2.1972245773362196
check,9,2.1972245773362196
GI,9,2.1972245773362196
congestion,9,2.1972245773362196
Region,9,2.1972245773362196
DD,9,2.1972245773362196
explaining,9,2.1972245773362196
mitigating,9,2.1972245773362196
radiologic,9,2.1972245773362196
SaO2,9,2.1972245773362196
supplements,9,2.1972245773362196
222,9,2.1972245773362196
transported,9,2.1972245773362196
Positive,9,2.1972245773362196
contralateral,9,2.1972245773362196
1986,9,2.1972245773362196
demographics,9,2.1972245773362196
histopathological,9,2.1972245773362196
feline,9,2.1972245773362196
forcing,9,2.1972245773362196
Successful,9,2.1972245773362196
formulations,9,2.1972245773362196
Pfizer-BioNTech,9,2.1972245773362196
ascending,9,2.1972245773362196
inoculated,9,2.1972245773362196
DC,9,2.1972245773362196
trachea,9,2.1972245773362196
motivation,9,2.1972245773362196
stockpile,9,2.1972245773362196
Report,9,2.1972245773362196
333,9,2.1972245773362196
inoculation,9,2.1972245773362196
economical,9,2.1972245773362196
Physical,9,2.1972245773362196
character,9,2.1972245773362196
width,9,2.1972245773362196
illustrated,9,2.1972245773362196
ventilatory,9,2.1972245773362196
Prehospital,9,2.1972245773362196
state-of-the-art,9,2.1972245773362196
produces,9,2.1972245773362196
oil,9,2.1972245773362196
boost,9,2.1972245773362196
integrating,9,2.1972245773362196
signals,9,2.1972245773362196
messenger,9,2.1972245773362196
6-month,9,2.1972245773362196
transcatheter,9,2.1972245773362196
introducing,9,2.1972245773362196
Conversely,9,2.1972245773362196
depletion,9,2.1972245773362196
Almost,9,2.1972245773362196
adversely,9,2.1972245773362196
Impella,9,2.1972245773362196
hemispheres,9,2.1972245773362196
composite,9,2.1972245773362196
antiphospholipid,9,2.1972245773362196
1992,9,2.1972245773362196
tea,9,2.1972245773362196
curative,9,2.1972245773362196
desirable,9,2.1972245773362196
sustain,9,2.1972245773362196
forecast,9,2.1972245773362196
162,9,2.1972245773362196
LVAD,9,2.1972245773362196
post-infarction,9,2.1972245773362196
underscore,9,2.1972245773362196
big,9,2.1972245773362196
well-known,9,2.1972245773362196
Besides,9,2.1972245773362196
inner-city,9,2.1972245773362196
reaches,9,2.1972245773362196
dispensing,9,2.1972245773362196
saved,9,2.1972245773362196
undertreatment,9,2.1972245773362196
carbon,9,2.1972245773362196
dioxide,9,2.1972245773362196
apical,9,2.1972245773362196
regurgitation,9,2.1972245773362196
Regarding,9,2.1972245773362196
vaccinating,9,2.1972245773362196
extracellular,9,2.1972245773362196
contributions,9,2.1972245773362196
metabolites,9,2.1972245773362196
theories,9,2.1972245773362196
societies,9,2.1972245773362196
AIV,9,2.1972245773362196
tropical,9,2.1972245773362196
bridge,9,2.1972245773362196
drawing,9,2.1972245773362196
Specifically,9,2.1972245773362196
wedge,9,2.1972245773362196
rTMS,9,2.1972245773362196
151,9,2.1972245773362196
PI,9,2.1972245773362196
dose-response,9,2.1972245773362196
proportions,9,2.1972245773362196
histological,9,2.1972245773362196
212,9,2.1972245773362196
qualitatively,9,2.1972245773362196
characterised,9,2.1972245773362196
misdiagnosed,9,2.1972245773362196
stressed,9,2.1972245773362196
consequently,9,2.1972245773362196
converting,9,2.1972245773362196
X,9,2.1972245773362196
references,9,2.1972245773362196
Hispanics,9,2.1972245773362196
trajectory,9,2.1972245773362196
N-terminal,9,2.1972245773362196
Serological,9,2.1972245773362196
MACE,9,2.1972245773362196
06,9,2.1972245773362196
margin,9,2.1972245773362196
Unlike,9,2.1972245773362196
inexpensive,9,2.1972245773362196
member,9,2.1972245773362196
notably,9,2.1972245773362196
altitude,9,2.1972245773362196
atherothrombotic,9,2.1972245773362196
inevitable,9,2.1972245773362196
opposed,9,2.1972245773362196
door-to-balloon,9,2.1972245773362196
seasonality,9,2.1972245773362196
infecting,9,2.1972245773362196
Intensive,9,2.1972245773362196
answers,9,2.1972245773362196
appearing,9,2.1972245773362196
Greece,9,2.1972245773362196
NS1,9,2.1972245773362196
NGS,9,2.1972245773362196
BNP,9,2.1972245773362196
rhinovirus,9,2.1972245773362196
promoted,9,2.1972245773362196
°C,9,2.1972245773362196
rating,9,2.1972245773362196
unrelated,9,2.1972245773362196
AP,9,2.1972245773362196
cooperation,9,2.1972245773362196
begun,9,2.1972245773362196
blunt,9,2.1972245773362196
registries,9,2.1972245773362196
Bangladesh,9,2.1972245773362196
Centre,9,2.1972245773362196
certainly,9,2.1972245773362196
electrochemical,9,2.1972245773362196
anomaly,9,2.1972245773362196
H275Y,9,2.1972245773362196
proteomic,9,2.1972245773362196
0004,9,2.1972245773362196
stigma,9,2.1972245773362196
strengthen,9,2.1972245773362196
intra-hospital,9,2.1972245773362196
hospitalisations,9,2.1972245773362196
neonates,9,2.1972245773362196
presently,9,2.1972245773362196
actually,9,2.1972245773362196
subarachnoid,9,2.1972245773362196
precautions,9,2.1972245773362196
Much,9,2.1972245773362196
Anticoagulation,9,2.1972245773362196
exploring,9,2.1972245773362196
fatalities,9,2.1972245773362196
Services,9,2.1972245773362196
deliver,9,2.1972245773362196
whole-genome,9,2.1972245773362196
disadvantages,9,2.1972245773362196
agonist,9,2.1972245773362196
T2,9,2.1972245773362196
Rationale,9,2.1972245773362196
neuroplasticity,9,2.1972245773362196
CSF,9,2.1972245773362196
225,9,2.1972245773362196
strongest,9,2.1972245773362196
Tomography,9,2.1972245773362196
argue,9,2.1972245773362196
co-infection,9,2.1972245773362196
inducible,9,2.1972245773362196
overt,9,2.1972245773362196
09,9,2.1972245773362196
Complications,9,2.1972245773362196
Thoracic,9,2.1972245773362196
immunology,9,2.1972245773362196
urinary,9,2.1972245773362196
cross,9,2.1972245773362196
instruction,9,2.1972245773362196
QS,9,2.1972245773362196
whilst,9,2.1972245773362196
carrying,9,2.1972245773362196
NOACs,9,2.1972245773362196
strengths,9,2.1972245773362196
marginal,9,2.1972245773362196
milk,9,2.1972245773362196
adjust,9,2.1972245773362196
turned,9,2.1972245773362196
emphasizing,9,2.1972245773362196
COVID‑19,9,2.1972245773362196
steady,9,2.1972245773362196
distinguished,9,2.1972245773362196
right-sided,9,2.1972245773362196
assumption,9,2.1972245773362196
ml,9,2.1972245773362196
revealing,9,2.1972245773362196
moment,9,2.1972245773362196
virology,9,2.1972245773362196
photon,9,2.1972245773362196
districts,9,2.1972245773362196
interface,9,2.1972245773362196
defense,9,2.1972245773362196
render,9,2.1972245773362196
connectivity,9,2.1972245773362196
vasospasm,9,2.1972245773362196
engineered,9,2.1972245773362196
regards,9,2.1972245773362196
parenteral,9,2.1972245773362196
237,9,2.1972245773362196
resultant,9,2.1972245773362196
GP,9,2.1972245773362196
CAP,9,2.1972245773362196
228,9,2.1972245773362196
consolidation,9,2.1972245773362196
distinction,9,2.1972245773362196
His,9,2.1972245773362196
written,9,2.1972245773362196
concerned,9,2.1972245773362196
allocated,9,2.1972245773362196
Oseltamivir,9,2.1972245773362196
neurosurgical,9,2.1972245773362196
entirely,9,2.1972245773362196
operators,9,2.1972245773362196
bring,9,2.1972245773362196
RT,9,2.1972245773362196
comprise,9,2.1972245773362196
Researchers,9,2.1972245773362196
RCA,9,2.1972245773362196
productivity,9,2.1972245773362196
unlike,9,2.1972245773362196
monocytes,9,2.1972245773362196
osteoporosis,9,2.1972245773362196
preferences,9,2.1972245773362196
rat,9,2.1972245773362196
consists,9,2.1972245773362196
controller,9,2.1972245773362196
seriously,9,2.1972245773362196
Silent,9,2.1972245773362196
165,9,2.1972245773362196
shortening,9,2.1972245773362196
ORF1ab,9,2.1972245773362196
246,9,2.1972245773362196
urgency,9,2.1972245773362196
subcutaneous,9,2.1972245773362196
FENO,9,2.1972245773362196
costly,9,2.1972245773362196
gastroesophageal,9,2.1972245773362196
module,9,2.1972245773362196
interfering,9,2.1972245773362196
anteroseptal,9,2.1972245773362196
Quantitative,9,2.1972245773362196
Tl-201,9,2.1972245773362196
ultrasonography,9,2.1972245773362196
suppressed,9,2.1972245773362196
tracheal,9,2.1972245773362196
emphysema,9,2.1972245773362196
favor,9,2.1972245773362196
deployment,9,2.1972245773362196
frontline,9,2.1972245773362196
cysteine,9,2.1972245773362196
veterinary,9,2.1972245773362196
aptamer,9,2.1972245773362196
immunosuppressive,9,2.1972245773362196
achievement,9,2.1972245773362196
issued,9,2.1972245773362196
inference,9,2.1972245773362196
pneumococcal,9,2.1972245773362196
yogurt,9,2.1972245773362196
Optimal,9,2.1972245773362196
cut-off,9,2.1972245773362196
shorten,9,2.1972245773362196
promotes,9,2.1972245773362196
immunogenic,9,2.1972245773362196
contraceptives,9,2.1972245773362196
developmental,9,2.1972245773362196
mediating,9,2.1972245773362196
financial,9,2.1972245773362196
nerve,9,2.1972245773362196
Depression,9,2.1972245773362196
lipids,9,2.1972245773362196
cardiomyocytes,9,2.1972245773362196
mesenchymal,9,2.1972245773362196
spray,9,2.1972245773362196
NI,9,2.1972245773362196
telephone,9,2.1972245773362196
disease-19,9,2.1972245773362196
independence,9,2.1972245773362196
mutated,9,2.1972245773362196
glucocorticoids,9,2.1972245773362196
insulin,9,2.1972245773362196
faces,9,2.1972245773362196
219,9,2.1972245773362196
Knowledge,9,2.1972245773362196
compelling,9,2.1972245773362196
extends,9,2.1972245773362196
transcriptase-polymerase,9,2.1972245773362196
performances,9,2.1972245773362196
Lack,9,2.1972245773362196
Q-wave,9,2.1972245773362196
119,9,2.1972245773362196
autologous,9,2.1972245773362196
paramount,9,2.1972245773362196
Spontaneous,9,2.1972245773362196
Antigen,9,2.1972245773362196
GMT,9,2.1972245773362196
hip,9,2.1972245773362196
infectiousness,9,2.1972245773362196
2010-2011,9,2.1972245773362196
Strategies,9,2.1972245773362196
replaced,9,2.1972245773362196
masking,8,2.0794415416798357
war,8,2.0794415416798357
imply,8,2.0794415416798357
RNAi,8,2.0794415416798357
PPE,8,2.0794415416798357
Prompt,8,2.0794415416798357
Less,8,2.0794415416798357
digoxin,8,2.0794415416798357
NF,8,2.0794415416798357
isoenzyme,8,2.0794415416798357
telestroke,8,2.0794415416798357
modeled,8,2.0794415416798357
Measure,8,2.0794415416798357
claudication,8,2.0794415416798357
newborns,8,2.0794415416798357
preceded,8,2.0794415416798357
imagery,8,2.0794415416798357
mgdl,8,2.0794415416798357
reocclusion,8,2.0794415416798357
quantifying,8,2.0794415416798357
projections,8,2.0794415416798357
Ventricular,8,2.0794415416798357
operative,8,2.0794415416798357
parenchyma,8,2.0794415416798357
excretion,8,2.0794415416798357
thoroughly,8,2.0794415416798357
SCA,8,2.0794415416798357
residue,8,2.0794415416798357
anticipate,8,2.0794415416798357
H9N2,8,2.0794415416798357
qRT-PCR,8,2.0794415416798357
defines,8,2.0794415416798357
Meanwhile,8,2.0794415416798357
dye,8,2.0794415416798357
operate,8,2.0794415416798357
serine,8,2.0794415416798357
womens,8,2.0794415416798357
interleukin,8,2.0794415416798357
dehydrogenase,8,2.0794415416798357
Europeans,8,2.0794415416798357
Cerebrolysin,8,2.0794415416798357
088,8,2.0794415416798357
predispose,8,2.0794415416798357
regenerative,8,2.0794415416798357
medicinal,8,2.0794415416798357
prerequisite,8,2.0794415416798357
interstitial,8,2.0794415416798357
copiesmL,8,2.0794415416798357
durability,8,2.0794415416798357
RNA-dependent,8,2.0794415416798357
tuberculosis,8,2.0794415416798357
identifiable,8,2.0794415416798357
fMRI,8,2.0794415416798357
Southeast,8,2.0794415416798357
Agreement,8,2.0794415416798357
A2,8,2.0794415416798357
hMPV,8,2.0794415416798357
repeatedly,8,2.0794415416798357
shortcomings,8,2.0794415416798357
apart,8,2.0794415416798357
Sera,8,2.0794415416798357
worsened,8,2.0794415416798357
building,8,2.0794415416798357
deletion,8,2.0794415416798357
dinitrate,8,2.0794415416798357
Pulmonary,8,2.0794415416798357
normally,8,2.0794415416798357
clarified,8,2.0794415416798357
Model,8,2.0794415416798357
B-cell,8,2.0794415416798357
predominance,8,2.0794415416798357
A549,8,2.0794415416798357
triple,8,2.0794415416798357
NSP6,8,2.0794415416798357
amenable,8,2.0794415416798357
methylene,8,2.0794415416798357
compression,8,2.0794415416798357
1975,8,2.0794415416798357
codon,8,2.0794415416798357
well-established,8,2.0794415416798357
integration,8,2.0794415416798357
201,8,2.0794415416798357
listed,8,2.0794415416798357
tends,8,2.0794415416798357
sum,8,2.0794415416798357
Score,8,2.0794415416798357
IFNγ,8,2.0794415416798357
thinking,8,2.0794415416798357
ultimate,8,2.0794415416798357
advocated,8,2.0794415416798357
nutritional,8,2.0794415416798357
PCR-based,8,2.0794415416798357
capacities,8,2.0794415416798357
205,8,2.0794415416798357
tumors,8,2.0794415416798357
WUS,8,2.0794415416798357
Improvements,8,2.0794415416798357
Scholar,8,2.0794415416798357
temporally,8,2.0794415416798357
array,8,2.0794415416798357
uncertainties,8,2.0794415416798357
zinc,8,2.0794415416798357
harmful,8,2.0794415416798357
emotions,8,2.0794415416798357
differently,8,2.0794415416798357
LVO,8,2.0794415416798357
inhalers,8,2.0794415416798357
VWF,8,2.0794415416798357
single-dose,8,2.0794415416798357
modifying,8,2.0794415416798357
ICCI,8,2.0794415416798357
stimulating,8,2.0794415416798357
heat,8,2.0794415416798357
202,8,2.0794415416798357
BB536,8,2.0794415416798357
pre-stroke,8,2.0794415416798357
flexible,8,2.0794415416798357
parent,8,2.0794415416798357
negatives,8,2.0794415416798357
NAbs,8,2.0794415416798357
substitutions,8,2.0794415416798357
execution,8,2.0794415416798357
proposes,8,2.0794415416798357
fluorescent,8,2.0794415416798357
verified,8,2.0794415416798357
vertigo,8,2.0794415416798357
N501Y,8,2.0794415416798357
element,8,2.0794415416798357
concentrated,8,2.0794415416798357
employing,8,2.0794415416798357
P005,8,2.0794415416798357
homologous,8,2.0794415416798357
PSA,8,2.0794415416798357
Monitoring,8,2.0794415416798357
estrogen,8,2.0794415416798357
age-adjusted,8,2.0794415416798357
experiment,8,2.0794415416798357
grafts,8,2.0794415416798357
Young,8,2.0794415416798357
leg,8,2.0794415416798357
N1,8,2.0794415416798357
subdivided,8,2.0794415416798357
organisms,8,2.0794415416798357
0000,8,2.0794415416798357
distortion,8,2.0794415416798357
thyroid,8,2.0794415416798357
118,8,2.0794415416798357
traditionally,8,2.0794415416798357
successive,8,2.0794415416798357
reversal,8,2.0794415416798357
233,8,2.0794415416798357
chemoprophylaxis,8,2.0794415416798357
Adherence,8,2.0794415416798357
connections,8,2.0794415416798357
201213,8,2.0794415416798357
1957,8,2.0794415416798357
preservation,8,2.0794415416798357
formal,8,2.0794415416798357
overweight,8,2.0794415416798357
134,8,2.0794415416798357
ranges,8,2.0794415416798357
manually,8,2.0794415416798357
fiber,8,2.0794415416798357
IVIG,8,2.0794415416798357
heterologous,8,2.0794415416798357
contributors,8,2.0794415416798357
implication,8,2.0794415416798357
underused,8,2.0794415416798357
belonging,8,2.0794415416798357
besides,8,2.0794415416798357
extending,8,2.0794415416798357
discussing,8,2.0794415416798357
Better,8,2.0794415416798357
Single,8,2.0794415416798357
BALF,8,2.0794415416798357
bronchi,8,2.0794415416798357
low-risk,8,2.0794415416798357
industrialized,8,2.0794415416798357
lies,8,2.0794415416798357
GPs,8,2.0794415416798357
socio-demographic,8,2.0794415416798357
Angioplasty,8,2.0794415416798357
convalescents,8,2.0794415416798357
capture,8,2.0794415416798357
realistic,8,2.0794415416798357
scheme,8,2.0794415416798357
reconstruction,8,2.0794415416798357
frontal,8,2.0794415416798357
constantly,8,2.0794415416798357
clade,8,2.0794415416798357
tracts,8,2.0794415416798357
poverty,8,2.0794415416798357
ELISAs,8,2.0794415416798357
Ohio,8,2.0794415416798357
placement,8,2.0794415416798357
simplicity,8,2.0794415416798357
behaviours,8,2.0794415416798357
CKD,8,2.0794415416798357
deterministic,8,2.0794415416798357
contamination,8,2.0794415416798357
eliminate,8,2.0794415416798357
IEI,8,2.0794415416798357
surprising,8,2.0794415416798357
assume,8,2.0794415416798357
Baseline,8,2.0794415416798357
conduction,8,2.0794415416798357
ingestion,8,2.0794415416798357
links,8,2.0794415416798357
facial,8,2.0794415416798357
Together,8,2.0794415416798357
NPIs,8,2.0794415416798357
idea,8,2.0794415416798357
restore,8,2.0794415416798357
arguments,8,2.0794415416798357
yrs,8,2.0794415416798357
Family,8,2.0794415416798357
wheezers,8,2.0794415416798357
DA,8,2.0794415416798357
simulated,8,2.0794415416798357
guided,8,2.0794415416798357
chapter,8,2.0794415416798357
skill,8,2.0794415416798357
258,8,2.0794415416798357
146,8,2.0794415416798357
emergencies,8,2.0794415416798357
Swedish,8,2.0794415416798357
POCT,8,2.0794415416798357
ash,8,2.0794415416798357
Nepal,8,2.0794415416798357
non-ST-segment,8,2.0794415416798357
conferred,8,2.0794415416798357
supplied,8,2.0794415416798357
hit,8,2.0794415416798357
POC,8,2.0794415416798357
commonest,8,2.0794415416798357
episodic,8,2.0794415416798357
secretions,8,2.0794415416798357
whenever,8,2.0794415416798357
high-resolution,8,2.0794415416798357
inferoposterior,8,2.0794415416798357
7th,8,2.0794415416798357
submitted,8,2.0794415416798357
Standard,8,2.0794415416798357
non-fatal,8,2.0794415416798357
combines,8,2.0794415416798357
demanding,8,2.0794415416798357
plaques,8,2.0794415416798357
Amongst,8,2.0794415416798357
EUA,8,2.0794415416798357
phosphate,8,2.0794415416798357
utmost,8,2.0794415416798357
Common,8,2.0794415416798357
substrates,8,2.0794415416798357
proof,8,2.0794415416798357
forecasts,8,2.0794415416798357
precipitate,8,2.0794415416798357
comprises,8,2.0794415416798357
minimally,8,2.0794415416798357
extinction,8,2.0794415416798357
COVID-19-related,8,2.0794415416798357
Nineteen,8,2.0794415416798357
X-rays,8,2.0794415416798357
Rwanda,8,2.0794415416798357
fungal,8,2.0794415416798357
Beijing,8,2.0794415416798357
Efforts,8,2.0794415416798357
stopped,8,2.0794415416798357
creation,8,2.0794415416798357
begin,8,2.0794415416798357
extra,8,2.0794415416798357
activate,8,2.0794415416798357
personality,8,2.0794415416798357
stop,8,2.0794415416798357
reservoirs,8,2.0794415416798357
nodes,8,2.0794415416798357
Morbidity,8,2.0794415416798357
transmit,8,2.0794415416798357
KO,8,2.0794415416798357
Brain,8,2.0794415416798357
PR,8,2.0794415416798357
consent,8,2.0794415416798357
intestinal,8,2.0794415416798357
Lombardy,8,2.0794415416798357
atheromatous,8,2.0794415416798357
alongside,8,2.0794415416798357
cross-reactive,8,2.0794415416798357
beta-blocker,8,2.0794415416798357
analyzes,8,2.0794415416798357
CFAF,8,2.0794415416798357
plant,8,2.0794415416798357
literacy,8,2.0794415416798357
fibers,8,2.0794415416798357
deleterious,8,2.0794415416798357
IRA,8,2.0794415416798357
Symptoms,8,2.0794415416798357
investigates,8,2.0794415416798357
intravenously,8,2.0794415416798357
CVD,8,2.0794415416798357
no-reflow,8,2.0794415416798357
hormone,8,2.0794415416798357
precisely,8,2.0794415416798357
endocardial,8,2.0794415416798357
leave,8,2.0794415416798357
traumatic,8,2.0794415416798357
theme,8,2.0794415416798357
PCM,8,2.0794415416798357
seizure,8,2.0794415416798357
surgically,8,2.0794415416798357
telocytes,8,2.0794415416798357
pathogenetic,8,2.0794415416798357
noncardiac,8,2.0794415416798357
fighting,8,2.0794415416798357
herald,8,2.0794415416798357
donation,8,2.0794415416798357
restenosis,8,2.0794415416798357
hierarchical,8,2.0794415416798357
curb,8,2.0794415416798357
gradual,8,2.0794415416798357
pace,8,2.0794415416798357
235,8,2.0794415416798357
humanity,8,2.0794415416798357
limbs,8,2.0794415416798357
epigenetic,8,2.0794415416798357
constraints,8,2.0794415416798357
Traditional,8,2.0794415416798357
in-house,8,2.0794415416798357
contributor,8,2.0794415416798357
Index,8,2.0794415416798357
corresponded,8,2.0794415416798357
117,8,2.0794415416798357
vaccine-induced,8,2.0794415416798357
WMSI,8,2.0794415416798357
126,8,2.0794415416798357
formulation,8,2.0794415416798357
entropy,8,2.0794415416798357
inverse,8,2.0794415416798357
monotherapy,8,2.0794415416798357
radiographs,8,2.0794415416798357
EIAs,8,2.0794415416798357
CHA2DS2-VASc,8,2.0794415416798357
dealing,8,2.0794415416798357
reserve,8,2.0794415416798357
inner,8,2.0794415416798357
195,8,2.0794415416798357
183,8,2.0794415416798357
specificities,8,2.0794415416798357
vasoconstriction,8,2.0794415416798357
m,8,2.0794415416798357
begins,8,2.0794415416798357
War,8,2.0794415416798357
vials,8,2.0794415416798357
Virginia,8,2.0794415416798357
truly,8,2.0794415416798357
unmet,8,2.0794415416798357
markets,8,2.0794415416798357
Academy,8,2.0794415416798357
replicate,8,2.0794415416798357
nAbs,8,2.0794415416798357
separated,8,2.0794415416798357
Effective,8,2.0794415416798357
website,8,2.0794415416798357
habits,8,2.0794415416798357
midbrain,8,2.0794415416798357
lesser,8,2.0794415416798357
classifications,8,2.0794415416798357
section,8,2.0794415416798357
placenta,8,2.0794415416798357
hemiblock,8,2.0794415416798357
satisfaction,8,2.0794415416798357
hematopoietic,8,2.0794415416798357
mainland,8,2.0794415416798357
tilt,8,2.0794415416798357
quantities,8,2.0794415416798357
publicly,8,2.0794415416798357
224,8,2.0794415416798357
anomalies,8,2.0794415416798357
H1,8,2.0794415416798357
flu-like,8,2.0794415416798357
shot,8,2.0794415416798357
Fifteen,8,2.0794415416798357
longevity,8,2.0794415416798357
effector,8,2.0794415416798357
student,8,2.0794415416798357
477,8,2.0794415416798357
person-to-person,8,2.0794415416798357
White,8,2.0794415416798357
NAAT,8,2.0794415416798357
Nonetheless,8,2.0794415416798357
low-cost,8,2.0794415416798357
acceptability,8,2.0794415416798357
microorganisms,8,2.0794415416798357
stated,8,2.0794415416798357
renin-angiotensin,8,2.0794415416798357
NIH,8,2.0794415416798357
favour,8,2.0794415416798357
note,8,2.0794415416798357
seldom,8,2.0794415416798357
Taken,8,2.0794415416798357
Trials,8,2.0794415416798357
aeroallergen,8,2.0794415416798357
Panel,8,2.0794415416798357
011,8,2.0794415416798357
SM,8,2.0794415416798357
drinking,8,2.0794415416798357
ostium,8,2.0794415416798357
Sciences,8,2.0794415416798357
clopidogrel,8,2.0794415416798357
375,8,2.0794415416798357
QP2,8,2.0794415416798357
adulthood,8,2.0794415416798357
dietary,8,2.0794415416798357
HSAP-NP,8,2.0794415416798357
shape,8,2.0794415416798357
constructed,8,2.0794415416798357
remainder,8,2.0794415416798357
doubt,8,2.0794415416798357
undoubtedly,8,2.0794415416798357
1995,8,2.0794415416798357
late-onset,8,2.0794415416798357
occasions,8,2.0794415416798357
unfavourable,8,2.0794415416798357
Antiviral,8,2.0794415416798357
99mTc-sestamibi,8,2.0794415416798357
1980,8,2.0794415416798357
contagion,8,2.0794415416798357
mannitol,8,2.0794415416798357
rooms,8,2.0794415416798357
141,8,2.0794415416798357
243,8,2.0794415416798357
switch,8,2.0794415416798357
conjunctival,8,2.0794415416798357
ablation,8,2.0794415416798357
granzyme,8,2.0794415416798357
overlay,8,2.0794415416798357
T2-weighted,8,2.0794415416798357
myalgia,8,2.0794415416798357
provocative,8,2.0794415416798357
prolongation,8,2.0794415416798357
CCC,8,2.0794415416798357
warrants,7,1.9459101490553132
redistribution,7,1.9459101490553132
explicit,7,1.9459101490553132
measles,7,1.9459101490553132
certification,7,1.9459101490553132
misdiagnosis,7,1.9459101490553132
borders,7,1.9459101490553132
said,7,1.9459101490553132
concludes,7,1.9459101490553132
Melbourne,7,1.9459101490553132
determines,7,1.9459101490553132
152,7,1.9459101490553132
GINA,7,1.9459101490553132
Important,7,1.9459101490553132
loop-mediated,7,1.9459101490553132
shifts,7,1.9459101490553132
Korean,7,1.9459101490553132
differing,7,1.9459101490553132
intricate,7,1.9459101490553132
institutional,7,1.9459101490553132
papillary,7,1.9459101490553132
standardization,7,1.9459101490553132
apo,7,1.9459101490553132
radial,7,1.9459101490553132
normalization,7,1.9459101490553132
serologically,7,1.9459101490553132
deteriorated,7,1.9459101490553132
island,7,1.9459101490553132
postpartum,7,1.9459101490553132
asthma-COPD,7,1.9459101490553132
pets,7,1.9459101490553132
recognised,7,1.9459101490553132
passage,7,1.9459101490553132
circuits,7,1.9459101490553132
single-stranded,7,1.9459101490553132
night,7,1.9459101490553132
stresses,7,1.9459101490553132
C-ACT,7,1.9459101490553132
conditioning,7,1.9459101490553132
graded,7,1.9459101490553132
Particularly,7,1.9459101490553132
correspond,7,1.9459101490553132
neutrophilic,7,1.9459101490553132
rigorous,7,1.9459101490553132
tissue-type,7,1.9459101490553132
discriminate,7,1.9459101490553132
IZ,7,1.9459101490553132
adrenal,7,1.9459101490553132
declines,7,1.9459101490553132
expressions,7,1.9459101490553132
STAT3,7,1.9459101490553132
overlooked,7,1.9459101490553132
148,7,1.9459101490553132
amounted,7,1.9459101490553132
disseminated,7,1.9459101490553132
segmentations,7,1.9459101490553132
hypoxic,7,1.9459101490553132
carriers,7,1.9459101490553132
technological,7,1.9459101490553132
distances,7,1.9459101490553132
returning,7,1.9459101490553132
alters,7,1.9459101490553132
exploiting,7,1.9459101490553132
NQMI,7,1.9459101490553132
CDT,7,1.9459101490553132
column,7,1.9459101490553132
guinea,7,1.9459101490553132
edition,7,1.9459101490553132
multi-organ,7,1.9459101490553132
EDVI,7,1.9459101490553132
keywords,7,1.9459101490553132
Failure,7,1.9459101490553132
non-valvular,7,1.9459101490553132
Prevalence,7,1.9459101490553132
commuting,7,1.9459101490553132
129,7,1.9459101490553132
ACCP,7,1.9459101490553132
low-dose,7,1.9459101490553132
playing,7,1.9459101490553132
2012-2013,7,1.9459101490553132
174,7,1.9459101490553132
augmented,7,1.9459101490553132
NSM,7,1.9459101490553132
tubes,7,1.9459101490553132
nutrition,7,1.9459101490553132
manufacturing,7,1.9459101490553132
quinapril,7,1.9459101490553132
delaying,7,1.9459101490553132
universally,7,1.9459101490553132
Lacunar,7,1.9459101490553132
pts,7,1.9459101490553132
autonomy,7,1.9459101490553132
ground-glass,7,1.9459101490553132
paracrine,7,1.9459101490553132
logistical,7,1.9459101490553132
equitable,7,1.9459101490553132
nitrite,7,1.9459101490553132
unaffected,7,1.9459101490553132
averted,7,1.9459101490553132
saving,7,1.9459101490553132
Brazilian,7,1.9459101490553132
144,7,1.9459101490553132
Having,7,1.9459101490553132
retrieval,7,1.9459101490553132
labelled,7,1.9459101490553132
universities,7,1.9459101490553132
hepatitis,7,1.9459101490553132
peoples,7,1.9459101490553132
microbleeds,7,1.9459101490553132
positions,7,1.9459101490553132
inability,7,1.9459101490553132
epileptic,7,1.9459101490553132
leaders,7,1.9459101490553132
VA,7,1.9459101490553132
moving,7,1.9459101490553132
Cambodia,7,1.9459101490553132
vectorcardiographic,7,1.9459101490553132
healed,7,1.9459101490553132
gaining,7,1.9459101490553132
tackle,7,1.9459101490553132
inotropic,7,1.9459101490553132
esophageal,7,1.9459101490553132
unusually,7,1.9459101490553132
161,7,1.9459101490553132
ventral,7,1.9459101490553132
thalamus,7,1.9459101490553132
Statistical,7,1.9459101490553132
preserve,7,1.9459101490553132
hypokinesia,7,1.9459101490553132
0025,7,1.9459101490553132
virtually,7,1.9459101490553132
non-ST,7,1.9459101490553132
bioactive,7,1.9459101490553132
budget,7,1.9459101490553132
anaphylaxis,7,1.9459101490553132
SVS,7,1.9459101490553132
SDIA,7,1.9459101490553132
stabilized,7,1.9459101490553132
mTOR,7,1.9459101490553132
forming,7,1.9459101490553132
sugar,7,1.9459101490553132
mRNA-based,7,1.9459101490553132
CIs,7,1.9459101490553132
docking,7,1.9459101490553132
Covid,7,1.9459101490553132
Zika,7,1.9459101490553132
overexpression,7,1.9459101490553132
Symptom,7,1.9459101490553132
spaces,7,1.9459101490553132
administer,7,1.9459101490553132
2nd,7,1.9459101490553132
beta2-agonist,7,1.9459101490553132
responders,7,1.9459101490553132
uniquely,7,1.9459101490553132
Texas,7,1.9459101490553132
declining,7,1.9459101490553132
averaged,7,1.9459101490553132
microRNAs,7,1.9459101490553132
homocysteine,7,1.9459101490553132
blocking,7,1.9459101490553132
climatic,7,1.9459101490553132
portal,7,1.9459101490553132
MRA,7,1.9459101490553132
hypersecretion,7,1.9459101490553132
continent,7,1.9459101490553132
orders,7,1.9459101490553132
technetium,7,1.9459101490553132
MHC,7,1.9459101490553132
acts,7,1.9459101490553132
overseas,7,1.9459101490553132
084,7,1.9459101490553132
RAS,7,1.9459101490553132
Complementary,7,1.9459101490553132
PPARgamma,7,1.9459101490553132
favipiravir,7,1.9459101490553132
nuclear,7,1.9459101490553132
Rt,7,1.9459101490553132
lactate,7,1.9459101490553132
immunodeficiency,7,1.9459101490553132
pair,7,1.9459101490553132
automatic,7,1.9459101490553132
teens,7,1.9459101490553132
communicate,7,1.9459101490553132
Zn,7,1.9459101490553132
HPA,7,1.9459101490553132
Medicare,7,1.9459101490553132
cystic,7,1.9459101490553132
colds,7,1.9459101490553132
Statistics,7,1.9459101490553132
multidimensional,7,1.9459101490553132
ACO,7,1.9459101490553132
full-length,7,1.9459101490553132
MVO,7,1.9459101490553132
Figure,7,1.9459101490553132
medial,7,1.9459101490553132
Poor,7,1.9459101490553132
PTCR,7,1.9459101490553132
sex-specific,7,1.9459101490553132
flows,7,1.9459101490553132
cedar,7,1.9459101490553132
RPD,7,1.9459101490553132
Eleven,7,1.9459101490553132
Inc,7,1.9459101490553132
CCIS,7,1.9459101490553132
7-10,7,1.9459101490553132
347,7,1.9459101490553132
prodromal,7,1.9459101490553132
Improvement,7,1.9459101490553132
Year,7,1.9459101490553132
antimicrobial,7,1.9459101490553132
simply,7,1.9459101490553132
citicoline,7,1.9459101490553132
278,7,1.9459101490553132
elementary,7,1.9459101490553132
attractive,7,1.9459101490553132
254,7,1.9459101490553132
consequent,7,1.9459101490553132
depended,7,1.9459101490553132
transesophageal,7,1.9459101490553132
pipeline,7,1.9459101490553132
HADS,7,1.9459101490553132
velocities,7,1.9459101490553132
CBF,7,1.9459101490553132
overnight,7,1.9459101490553132
H7N7,7,1.9459101490553132
manufacture,7,1.9459101490553132
relatives,7,1.9459101490553132
wound,7,1.9459101490553132
template,7,1.9459101490553132
Special,7,1.9459101490553132
cascade,7,1.9459101490553132
leukotrienes,7,1.9459101490553132
olfactory,7,1.9459101490553132
quarter,7,1.9459101490553132
circuit,7,1.9459101490553132
political,7,1.9459101490553132
Motor,7,1.9459101490553132
situ,7,1.9459101490553132
senescence,7,1.9459101490553132
electric,7,1.9459101490553132
123,7,1.9459101490553132
ChAdOx1,7,1.9459101490553132
192,7,1.9459101490553132
accompanying,7,1.9459101490553132
paraplegia,7,1.9459101490553132
confer,7,1.9459101490553132
case-fatality,7,1.9459101490553132
felt,7,1.9459101490553132
reaching,7,1.9459101490553132
Mgl,7,1.9459101490553132
atrioventricular,7,1.9459101490553132
GLS,7,1.9459101490553132
intent,7,1.9459101490553132
Short-term,7,1.9459101490553132
90-day,7,1.9459101490553132
peers,7,1.9459101490553132
sparing,7,1.9459101490553132
penumbra,7,1.9459101490553132
enrollment,7,1.9459101490553132
neuropsychiatric,7,1.9459101490553132
scheduled,7,1.9459101490553132
VO2,7,1.9459101490553132
additionally,7,1.9459101490553132
DTEC,7,1.9459101490553132
182,7,1.9459101490553132
completion,7,1.9459101490553132
radiographic,7,1.9459101490553132
arrhythmic,7,1.9459101490553132
Surgical,7,1.9459101490553132
resident,7,1.9459101490553132
partners,7,1.9459101490553132
preferable,7,1.9459101490553132
seroprotection,7,1.9459101490553132
meaningful,7,1.9459101490553132
antibacterial,7,1.9459101490553132
anesthetic,7,1.9459101490553132
dispersion,7,1.9459101490553132
competition,7,1.9459101490553132
M1,7,1.9459101490553132
H3,7,1.9459101490553132
Kawasaki,7,1.9459101490553132
urokinase,7,1.9459101490553132
controllers,7,1.9459101490553132
obstructed,7,1.9459101490553132
virus-specific,7,1.9459101490553132
arrived,7,1.9459101490553132
03,7,1.9459101490553132
microbial,7,1.9459101490553132
well-defined,7,1.9459101490553132
skilled,7,1.9459101490553132
Existing,7,1.9459101490553132
ruled,7,1.9459101490553132
Emergent,7,1.9459101490553132
ESUS,7,1.9459101490553132
buffer,7,1.9459101490553132
177,7,1.9459101490553132
dilated,7,1.9459101490553132
Combined,7,1.9459101490553132
neurodegenerative,7,1.9459101490553132
anemia,7,1.9459101490553132
IWMI,7,1.9459101490553132
4-year,7,1.9459101490553132
MEDLINE,7,1.9459101490553132
504,7,1.9459101490553132
renewed,7,1.9459101490553132
justified,7,1.9459101490553132
interdisciplinary,7,1.9459101490553132
consecutively,7,1.9459101490553132
surgeons,7,1.9459101490553132
g,7,1.9459101490553132
allergenic,7,1.9459101490553132
hemodialysis,7,1.9459101490553132
nitrates,7,1.9459101490553132
170,7,1.9459101490553132
temperatures,7,1.9459101490553132
PM,7,1.9459101490553132
individualized,7,1.9459101490553132
Therapeutic,7,1.9459101490553132
Asthmatic,7,1.9459101490553132
Neuraminidase,7,1.9459101490553132
hypothetical,7,1.9459101490553132
indium-111,7,1.9459101490553132
new-onset,7,1.9459101490553132
disabilities,7,1.9459101490553132
comparatively,7,1.9459101490553132
daytime,7,1.9459101490553132
pharmacies,7,1.9459101490553132
FHMI,7,1.9459101490553132
incidences,7,1.9459101490553132
fistula,7,1.9459101490553132
endurance,7,1.9459101490553132
consults,7,1.9459101490553132
218,7,1.9459101490553132
Major,7,1.9459101490553132
person-years,7,1.9459101490553132
Reverse,7,1.9459101490553132
physician-diagnosed,7,1.9459101490553132
progresses,7,1.9459101490553132
274,7,1.9459101490553132
265,7,1.9459101490553132
forensic,7,1.9459101490553132
surviving,7,1.9459101490553132
round,7,1.9459101490553132
narratives,7,1.9459101490553132
fractures,7,1.9459101490553132
kinase-MB,7,1.9459101490553132
transit,7,1.9459101490553132
Recurrent,7,1.9459101490553132
C1,7,1.9459101490553132
left-ventricular,7,1.9459101490553132
Swine,7,1.9459101490553132
assembly,7,1.9459101490553132
carrier,7,1.9459101490553132
genome-wide,7,1.9459101490553132
155,7,1.9459101490553132
EC50,7,1.9459101490553132
Asymptomatic,7,1.9459101490553132
209,7,1.9459101490553132
optimum,7,1.9459101490553132
hrs,7,1.9459101490553132
limb,7,1.9459101490553132
compensation,7,1.9459101490553132
cover,7,1.9459101490553132
inactivation,7,1.9459101490553132
S2,7,1.9459101490553132
out-of-hospital,7,1.9459101490553132
misinformation,7,1.9459101490553132
sneezing,7,1.9459101490553132
CdM,7,1.9459101490553132
exception,7,1.9459101490553132
discrete,7,1.9459101490553132
mmoll,7,1.9459101490553132
chemokines,7,1.9459101490553132
subtle,7,1.9459101490553132
hypothermia,7,1.9459101490553132
pericardium,7,1.9459101490553132
durations,7,1.9459101490553132
C4,7,1.9459101490553132
Xpress,7,1.9459101490553132
interquartile,7,1.9459101490553132
in-patient,7,1.9459101490553132
synergistic,7,1.9459101490553132
lipoprotein,7,1.9459101490553132
Th2,7,1.9459101490553132
up-to-date,7,1.9459101490553132
pertaining,7,1.9459101490553132
temperate,7,1.9459101490553132
mapped,7,1.9459101490553132
trust,7,1.9459101490553132
recommends,7,1.9459101490553132
avenues,7,1.9459101490553132
histologic,7,1.9459101490553132
enter,7,1.9459101490553132
306,7,1.9459101490553132
growers,7,1.9459101490553132
Embase,7,1.9459101490553132
HRQL,7,1.9459101490553132
thorax,7,1.9459101490553132
rhinosinusitis,7,1.9459101490553132
anti-RBD,7,1.9459101490553132
Systematic,7,1.9459101490553132
biomedical,7,1.9459101490553132
08,7,1.9459101490553132
240,7,1.9459101490553132
prospects,7,1.9459101490553132
linking,7,1.9459101490553132
Holter,7,1.9459101490553132
principle,7,1.9459101490553132
non-smokers,7,1.9459101490553132
lot,7,1.9459101490553132
nonasthmatic,7,1.9459101490553132
IL-18,7,1.9459101490553132
qPCR,7,1.9459101490553132
timeliness,7,1.9459101490553132
074,7,1.9459101490553132
kidneys,7,1.9459101490553132
Median,7,1.9459101490553132
aligned,7,1.9459101490553132
security,7,1.9459101490553132
N-acetyl,7,1.9459101490553132
functionality,7,1.9459101490553132
syringe,7,1.9459101490553132
Action,7,1.9459101490553132
typing,7,1.9459101490553132
demands,7,1.9459101490553132
087,7,1.9459101490553132
purification,7,1.9459101490553132
indeed,7,1.9459101490553132
mimicking,7,1.9459101490553132
Fourteen,7,1.9459101490553132
creates,7,1.9459101490553132
malnutrition,7,1.9459101490553132
1984,7,1.9459101490553132
perfect,7,1.9459101490553132
mediate,7,1.9459101490553132
messages,7,1.9459101490553132
speaking,7,1.9459101490553132
hyper-responsiveness,7,1.9459101490553132
school-aged,7,1.9459101490553132
Tokyo,7,1.9459101490553132
submaximal,7,1.9459101490553132
circulated,7,1.9459101490553132
benign,7,1.9459101490553132
filtration,7,1.9459101490553132
scintigraphic,7,1.9459101490553132
Aspergillus,7,1.9459101490553132
iii,7,1.9459101490553132
anomalous,7,1.9459101490553132
primates,7,1.9459101490553132
obtaining,7,1.9459101490553132
V4R,7,1.9459101490553132
message,7,1.9459101490553132
FVC,7,1.9459101490553132
hoped,7,1.9459101490553132
Basic,7,1.9459101490553132
CRP,7,1.9459101490553132
lipoproteina,7,1.9459101490553132
Recommendations,7,1.9459101490553132
advancing,7,1.9459101490553132
discoveries,7,1.9459101490553132
tears,7,1.9459101490553132
stratify,7,1.9459101490553132
HRQOL,7,1.9459101490553132
serially,7,1.9459101490553132
clues,7,1.9459101490553132
hypokinetic,7,1.9459101490553132
189,7,1.9459101490553132
travelers,7,1.9459101490553132
AV,7,1.9459101490553132
sensing,7,1.9459101490553132
prevents,7,1.9459101490553132
complexities,7,1.9459101490553132
derivatives,7,1.9459101490553132
conversion,7,1.9459101490553132
biosolids,7,1.9459101490553132
multifaceted,7,1.9459101490553132
GISSI,7,1.9459101490553132
Adverse,7,1.9459101490553132
Air,7,1.9459101490553132
microglia,7,1.9459101490553132
paradoxical,7,1.9459101490553132
291,7,1.9459101490553132
18F-FDG,7,1.9459101490553132
DM2,7,1.9459101490553132
capability,7,1.9459101490553132
long-standing,7,1.9459101490553132
hyperacute,7,1.9459101490553132
notable,7,1.9459101490553132
frame,7,1.9459101490553132
unnecessary,7,1.9459101490553132
prostate,7,1.9459101490553132
encephalitis,7,1.9459101490553132
bodies,7,1.9459101490553132
aspergillus,7,1.9459101490553132
envelope,7,1.9459101490553132
Colorado,7,1.9459101490553132
dependency,7,1.9459101490553132
eligibility,7,1.9459101490553132
conservatively,7,1.9459101490553132
population-level,7,1.9459101490553132
acquire,7,1.9459101490553132
educate,7,1.9459101490553132
cycles,7,1.9459101490553132
psychologic,7,1.9459101490553132
easier,7,1.9459101490553132
holds,7,1.9459101490553132
virion,7,1.9459101490553132
AEFI,7,1.9459101490553132
rank,7,1.9459101490553132
TAT,7,1.9459101490553132
mediates,7,1.9459101490553132
abuse,7,1.9459101490553132
session,7,1.9459101490553132
Aspirin,7,1.9459101490553132
persisting,7,1.9459101490553132
age-related,7,1.9459101490553132
contusion,7,1.9459101490553132
pacing,7,1.9459101490553132
stressors,7,1.9459101490553132
IQR,7,1.9459101490553132
OD,7,1.9459101490553132
confers,7,1.9459101490553132
Samples,7,1.9459101490553132
133,7,1.9459101490553132
capabilities,7,1.9459101490553132
30th,7,1.9459101490553132
167,7,1.9459101490553132
N2,7,1.9459101490553132
transcripts,7,1.9459101490553132
MV,7,1.9459101490553132
office,7,1.9459101490553132
AH,7,1.9459101490553132
forefront,7,1.9459101490553132
aggravated,7,1.9459101490553132
complicate,7,1.9459101490553132
leak,7,1.9459101490553132
Cepheid,7,1.9459101490553132
sclerosis,7,1.9459101490553132
discussions,7,1.9459101490553132
FTN,7,1.9459101490553132
culturally,7,1.9459101490553132
CADASIL,7,1.9459101490553132
P001,7,1.9459101490553132
LVD,7,1.9459101490553132
PAM,7,1.9459101490553132
Service,7,1.9459101490553132
cranial,7,1.9459101490553132
hypersensitivity,7,1.9459101490553132
intrathoracic,7,1.9459101490553132
potassium,7,1.9459101490553132
perforator,7,1.9459101490553132
Hospitals,7,1.9459101490553132
bundle-branch,7,1.9459101490553132
non-cardiac,7,1.9459101490553132
137,7,1.9459101490553132
preterm,7,1.9459101490553132
blood-brain,7,1.9459101490553132
cardiological,7,1.9459101490553132
anterolateral,7,1.9459101490553132
quantitatively,7,1.9459101490553132
summarises,7,1.9459101490553132
Abs,7,1.9459101490553132
coordinated,7,1.9459101490553132
aggravation,6,1.791759469228055
transmissions,6,1.791759469228055
apoptotic,6,1.791759469228055
fossa,6,1.791759469228055
266,6,1.791759469228055
homogeneous,6,1.791759469228055
accordance,6,1.791759469228055
intensities,6,1.791759469228055
agricultural,6,1.791759469228055
neighborhoods,6,1.791759469228055
haemagglutination,6,1.791759469228055
312,6,1.791759469228055
putting,6,1.791759469228055
MHz,6,1.791759469228055
junction,6,1.791759469228055
necessitating,6,1.791759469228055
transmitral,6,1.791759469228055
notified,6,1.791759469228055
Progress,6,1.791759469228055
outweigh,6,1.791759469228055
SCAD,6,1.791759469228055
separation,6,1.791759469228055
Thirty-one,6,1.791759469228055
economies,6,1.791759469228055
readiness,6,1.791759469228055
grounds,6,1.791759469228055
mutate,6,1.791759469228055
biventricular,6,1.791759469228055
workshop,6,1.791759469228055
SCT,6,1.791759469228055
exceeded,6,1.791759469228055
anamnestic,6,1.791759469228055
extremity,6,1.791759469228055
conferring,6,1.791759469228055
eNOS,6,1.791759469228055
Extensive,6,1.791759469228055
SARS‐CoV‐2,6,1.791759469228055
eyes,6,1.791759469228055
1979,6,1.791759469228055
Notch3,6,1.791759469228055
doubled,6,1.791759469228055
needle,6,1.791759469228055
chemiluminescence,6,1.791759469228055
high-income,6,1.791759469228055
neglect,6,1.791759469228055
Without,6,1.791759469228055
economics,6,1.791759469228055
yen,6,1.791759469228055
Detection,6,1.791759469228055
rated,6,1.791759469228055
biomaterials,6,1.791759469228055
physically,6,1.791759469228055
DBP,6,1.791759469228055
convulsion,6,1.791759469228055
expenditure,6,1.791759469228055
caution,6,1.791759469228055
journals,6,1.791759469228055
sizes,6,1.791759469228055
condensate,6,1.791759469228055
Death,6,1.791759469228055
antisera,6,1.791759469228055
compiled,6,1.791759469228055
BECH,6,1.791759469228055
cognition,6,1.791759469228055
hydrogel,6,1.791759469228055
audit,6,1.791759469228055
realized,6,1.791759469228055
PSO,6,1.791759469228055
emphasizes,6,1.791759469228055
evidences,6,1.791759469228055
incorrect,6,1.791759469228055
post-pandemic,6,1.791759469228055
temporary,6,1.791759469228055
choose,6,1.791759469228055
P50,6,1.791759469228055
teach,6,1.791759469228055
irritants,6,1.791759469228055
nonfatal,6,1.791759469228055
electrophysiological,6,1.791759469228055
competitive,6,1.791759469228055
ahead,6,1.791759469228055
176,6,1.791759469228055
superiority,6,1.791759469228055
genomics,6,1.791759469228055
contaminated,6,1.791759469228055
non-EVT,6,1.791759469228055
complained,6,1.791759469228055
hemiplegia,6,1.791759469228055
interrupt,6,1.791759469228055
angiograms,6,1.791759469228055
eliminated,6,1.791759469228055
260,6,1.791759469228055
neurogenesis,6,1.791759469228055
skeletal,6,1.791759469228055
nut,6,1.791759469228055
stays,6,1.791759469228055
stockpiled,6,1.791759469228055
leukocytosis,6,1.791759469228055
evacuation,6,1.791759469228055
indispensable,6,1.791759469228055
MDCK,6,1.791759469228055
539,6,1.791759469228055
bidirectional,6,1.791759469228055
BHong,6,1.791759469228055
Consensus,6,1.791759469228055
predictability,6,1.791759469228055
deployed,6,1.791759469228055
pure,6,1.791759469228055
answering,6,1.791759469228055
E484K,6,1.791759469228055
add-on,6,1.791759469228055
cell-cell,6,1.791759469228055
Assay,6,1.791759469228055
layers,6,1.791759469228055
peripartum,6,1.791759469228055
country-specific,6,1.791759469228055
restricting,6,1.791759469228055
charges,6,1.791759469228055
007,6,1.791759469228055
checked,6,1.791759469228055
ameliorate,6,1.791759469228055
newborn,6,1.791759469228055
intranasal,6,1.791759469228055
Greater,6,1.791759469228055
B16172,6,1.791759469228055
voluntary,6,1.791759469228055
breadth,6,1.791759469228055
multifocal,6,1.791759469228055
interacting,6,1.791759469228055
attentional,6,1.791759469228055
Repeated,6,1.791759469228055
presymptomatic,6,1.791759469228055
deletions,6,1.791759469228055
Next,6,1.791759469228055
interpreting,6,1.791759469228055
drainage,6,1.791759469228055
Treating,6,1.791759469228055
lymphoid,6,1.791759469228055
187,6,1.791759469228055
virus-induced,6,1.791759469228055
Victoria,6,1.791759469228055
Swiss,6,1.791759469228055
drivers,6,1.791759469228055
compartments,6,1.791759469228055
destruction,6,1.791759469228055
regenerating,6,1.791759469228055
longer-term,6,1.791759469228055
Method,6,1.791759469228055
shortened,6,1.791759469228055
045,6,1.791759469228055
procurement,6,1.791759469228055
Whilst,6,1.791759469228055
attribution,6,1.791759469228055
Adult,6,1.791759469228055
figure,6,1.791759469228055
Magnetic,6,1.791759469228055
Atopy,6,1.791759469228055
substance,6,1.791759469228055
lowered,6,1.791759469228055
LFA,6,1.791759469228055
histopathology,6,1.791759469228055
Performance,6,1.791759469228055
suited,6,1.791759469228055
refers,6,1.791759469228055
signal-averaged,6,1.791759469228055
log10,6,1.791759469228055
virologically,6,1.791759469228055
neuroinflammation,6,1.791759469228055
Certain,6,1.791759469228055
large-vessel,6,1.791759469228055
RCT,6,1.791759469228055
sub-Saharan,6,1.791759469228055
worst,6,1.791759469228055
4-week,6,1.791759469228055
TAVR,6,1.791759469228055
prescribe,6,1.791759469228055
cardiomyocyte,6,1.791759469228055
Pregnant,6,1.791759469228055
dynamically,6,1.791759469228055
AR,6,1.791759469228055
battery,6,1.791759469228055
GR,6,1.791759469228055
110,6,1.791759469228055
fractional,6,1.791759469228055
swine-origin,6,1.791759469228055
nausea,6,1.791759469228055
Laboratories,6,1.791759469228055
nail,6,1.791759469228055
losses,6,1.791759469228055
impair,6,1.791759469228055
intracardiac,6,1.791759469228055
derive,6,1.791759469228055
2-agonists,6,1.791759469228055
MMP-9,6,1.791759469228055
163,6,1.791759469228055
Very,6,1.791759469228055
St,6,1.791759469228055
Half,6,1.791759469228055
accept,6,1.791759469228055
Haemophilus,6,1.791759469228055
trace,6,1.791759469228055
010,6,1.791759469228055
well-designed,6,1.791759469228055
afforded,6,1.791759469228055
agency,6,1.791759469228055
μM,6,1.791759469228055
ORs,6,1.791759469228055
web,6,1.791759469228055
stasis-dissolving,6,1.791759469228055
Advances,6,1.791759469228055
immunohistochemistry,6,1.791759469228055
LAIV,6,1.791759469228055
That,6,1.791759469228055
opening,6,1.791759469228055
ruptures,6,1.791759469228055
hourly,6,1.791759469228055
relying,6,1.791759469228055
mononuclear,6,1.791759469228055
exploratory,6,1.791759469228055
frictional,6,1.791759469228055
kappa,6,1.791759469228055
lasted,6,1.791759469228055
ICD,6,1.791759469228055
shifted,6,1.791759469228055
082,6,1.791759469228055
precipitating,6,1.791759469228055
TPA,6,1.791759469228055
boarding,6,1.791759469228055
IVS,6,1.791759469228055
questionable,6,1.791759469228055
Oxford,6,1.791759469228055
vitreous,6,1.791759469228055
conscious,6,1.791759469228055
DLV,6,1.791759469228055
Manitoba,6,1.791759469228055
244,6,1.791759469228055
239,6,1.791759469228055
015,6,1.791759469228055
institute,6,1.791759469228055
Seventeen,6,1.791759469228055
Controversy,6,1.791759469228055
Then,6,1.791759469228055
Prospective,6,1.791759469228055
rtPA,6,1.791759469228055
dermatitis,6,1.791759469228055
Immunology,6,1.791759469228055
086,6,1.791759469228055
impossible,6,1.791759469228055
siRNAs,6,1.791759469228055
DRUL,6,1.791759469228055
METHODS,6,1.791759469228055
belongs,6,1.791759469228055
collective,6,1.791759469228055
uniform,6,1.791759469228055
strictly,6,1.791759469228055
196,6,1.791759469228055
rodents,6,1.791759469228055
imposed,6,1.791759469228055
disaster,6,1.791759469228055
Appropriate,6,1.791759469228055
Social,6,1.791759469228055
individualised,6,1.791759469228055
Antiplatelet,6,1.791759469228055
collecting,6,1.791759469228055
single-nucleotide,6,1.791759469228055
compatible,6,1.791759469228055
veins,6,1.791759469228055
emotion,6,1.791759469228055
diagram,6,1.791759469228055
non-adherence,6,1.791759469228055
favorably,6,1.791759469228055
Minnesota,6,1.791759469228055
laser,6,1.791759469228055
well-controlled,6,1.791759469228055
Genetic,6,1.791759469228055
administering,6,1.791759469228055
insensitive,6,1.791759469228055
circulate,6,1.791759469228055
Cardiology,6,1.791759469228055
AHT,6,1.791759469228055
profiling,6,1.791759469228055
theoretically,6,1.791759469228055
875,6,1.791759469228055
Cost,6,1.791759469228055
vocal,6,1.791759469228055
periodically,6,1.791759469228055
FRPs,6,1.791759469228055
097,6,1.791759469228055
elders,6,1.791759469228055
wealth,6,1.791759469228055
publication,6,1.791759469228055
innovation,6,1.791759469228055
hamsters,6,1.791759469228055
easy-to-use,6,1.791759469228055
Emerging,6,1.791759469228055
PLR,6,1.791759469228055
Ongoing,6,1.791759469228055
Main,6,1.791759469228055
CIN,6,1.791759469228055
recipient,6,1.791759469228055
plotted,6,1.791759469228055
affordable,6,1.791759469228055
notion,6,1.791759469228055
simulate,6,1.791759469228055
fitting,6,1.791759469228055
nonhuman,6,1.791759469228055
late-phase,6,1.791759469228055
visualize,6,1.791759469228055
Illness,6,1.791759469228055
specially,6,1.791759469228055
pending,6,1.791759469228055
201Tl-defect,6,1.791759469228055
ORF3a,6,1.791759469228055
Guinea,6,1.791759469228055
immense,6,1.791759469228055
fulminant,6,1.791759469228055
Sprague-Dawley,6,1.791759469228055
CV,6,1.791759469228055
associate,6,1.791759469228055
organizational,6,1.791759469228055
MVD,6,1.791759469228055
influenzaviruses,6,1.791759469228055
SVD,6,1.791759469228055
particulate,6,1.791759469228055
PM25,6,1.791759469228055
endorsed,6,1.791759469228055
influenzavirus,6,1.791759469228055
meta-population,6,1.791759469228055
Importance,6,1.791759469228055
279,6,1.791759469228055
217,6,1.791759469228055
COVID-19-associated,6,1.791759469228055
hormones,6,1.791759469228055
216,6,1.791759469228055
spots,6,1.791759469228055
perennial,6,1.791759469228055
Cell,6,1.791759469228055
isoproterenol,6,1.791759469228055
enters,6,1.791759469228055
gastric,6,1.791759469228055
ISAAC,6,1.791759469228055
etiologic,6,1.791759469228055
prioritized,6,1.791759469228055
necessitates,6,1.791759469228055
cured,6,1.791759469228055
malignancies,6,1.791759469228055
diary,6,1.791759469228055
doing,6,1.791759469228055
boosting,6,1.791759469228055
adjuvants,6,1.791759469228055
reorganization,6,1.791759469228055
TOAST,6,1.791759469228055
Highly,6,1.791759469228055
basilar,6,1.791759469228055
dilution,6,1.791759469228055
Whites,6,1.791759469228055
Cuba,6,1.791759469228055
hyperintensity,6,1.791759469228055
atheroma,6,1.791759469228055
fine,6,1.791759469228055
antithrombotics,6,1.791759469228055
Complex,6,1.791759469228055
acupuncture,6,1.791759469228055
RRT,6,1.791759469228055
Sputum,6,1.791759469228055
absolutely,6,1.791759469228055
tension,6,1.791759469228055
centralized,6,1.791759469228055
symptom-free,6,1.791759469228055
infiltrates,6,1.791759469228055
QIV,6,1.791759469228055
Smoking,6,1.791759469228055
294,6,1.791759469228055
Nursing,6,1.791759469228055
History,6,1.791759469228055
sports,6,1.791759469228055
AAR,6,1.791759469228055
suitability,6,1.791759469228055
faecal-oral,6,1.791759469228055
156,6,1.791759469228055
IAV-infected,6,1.791759469228055
property,6,1.791759469228055
H7,6,1.791759469228055
wear,6,1.791759469228055
adenoviral,6,1.791759469228055
EL,6,1.791759469228055
OSAS,6,1.791759469228055
spent,6,1.791759469228055
mobilization,6,1.791759469228055
isosorbide,6,1.791759469228055
OMI,6,1.791759469228055
officially,6,1.791759469228055
pig,6,1.791759469228055
Daily,6,1.791759469228055
Viruses,6,1.791759469228055
PMM,6,1.791759469228055
sepsis,6,1.791759469228055
07,6,1.791759469228055
catastrophic,6,1.791759469228055
MC,6,1.791759469228055
frail,6,1.791759469228055
confirmatory,6,1.791759469228055
inequities,6,1.791759469228055
Hemodynamic,6,1.791759469228055
MESs,6,1.791759469228055
preinfarction,6,1.791759469228055
engage,6,1.791759469228055
ISAR,6,1.791759469228055
characterise,6,1.791759469228055
going,6,1.791759469228055
subtraction,6,1.791759469228055
exaggerated,6,1.791759469228055
waiting,6,1.791759469228055
regulators,6,1.791759469228055
recurring,6,1.791759469228055
hyperlipidemia,6,1.791759469228055
IABC,6,1.791759469228055
Identification,6,1.791759469228055
stabilization,6,1.791759469228055
378,6,1.791759469228055
Mx1,6,1.791759469228055
acuteness,6,1.791759469228055
integrate,6,1.791759469228055
accelerating,6,1.791759469228055
KD,6,1.791759469228055
supplementary,6,1.791759469228055
interleukin-6,6,1.791759469228055
cm,6,1.791759469228055
SARS-Cov-2,6,1.791759469228055
pediatricians,6,1.791759469228055
reciprocal,6,1.791759469228055
Differences,6,1.791759469228055
serotonin,6,1.791759469228055
ERM,6,1.791759469228055
relieved,6,1.791759469228055
aggregated,6,1.791759469228055
MMD,6,1.791759469228055
reacted,6,1.791759469228055
ACS,6,1.791759469228055
prime,6,1.791759469228055
SC75741,6,1.791759469228055
strategic,6,1.791759469228055
Across,6,1.791759469228055
Screening,6,1.791759469228055
Union,6,1.791759469228055
admitting,6,1.791759469228055
expectancy,6,1.791759469228055
933,6,1.791759469228055
ground,6,1.791759469228055
Denmark,6,1.791759469228055
Chicago,6,1.791759469228055
dominance,6,1.791759469228055
ngml,6,1.791759469228055
Serial,6,1.791759469228055
laryngeal,6,1.791759469228055
meters,6,1.791759469228055
RdRP,6,1.791759469228055
HU,6,1.791759469228055
preparing,6,1.791759469228055
disturbed,6,1.791759469228055
District,6,1.791759469228055
Subsequently,6,1.791759469228055
hyperplasia,6,1.791759469228055
captured,6,1.791759469228055
Vitamin,6,1.791759469228055
anaerobic,6,1.791759469228055
invaluable,6,1.791759469228055
20-HETE,6,1.791759469228055
Negative,6,1.791759469228055
intelligence,6,1.791759469228055
reagent,6,1.791759469228055
seemingly,6,1.791759469228055
ipsilateral,6,1.791759469228055
nonstructural,6,1.791759469228055
PP,6,1.791759469228055
2-4,6,1.791759469228055
beta-2,6,1.791759469228055
editorial,6,1.791759469228055
penetration,6,1.791759469228055
biosecurity,6,1.791759469228055
equivocal,6,1.791759469228055
vagal,6,1.791759469228055
Mac1,6,1.791759469228055
neurodevelopmental,6,1.791759469228055
hard,6,1.791759469228055
incorporates,6,1.791759469228055
extrapolated,6,1.791759469228055
gadolinium,6,1.791759469228055
Infections,6,1.791759469228055
handgrip,6,1.791759469228055
longitudinally,6,1.791759469228055
Affairs,6,1.791759469228055
delineated,6,1.791759469228055
diminish,6,1.791759469228055
bed,6,1.791759469228055
pocket,6,1.791759469228055
analysing,6,1.791759469228055
tight,6,1.791759469228055
Internal,6,1.791759469228055
UDA,6,1.791759469228055
underline,6,1.791759469228055
Anterior,6,1.791759469228055
bound,6,1.791759469228055
possess,6,1.791759469228055
layer,6,1.791759469228055
circle,6,1.791759469228055
recurrences,6,1.791759469228055
Staphylococcus,6,1.791759469228055
enhances,6,1.791759469228055
regulates,6,1.791759469228055
cAMP,6,1.791759469228055
posts,6,1.791759469228055
chronically,6,1.791759469228055
hybridization,6,1.791759469228055
wake-up,6,1.791759469228055
aureus,6,1.791759469228055
counter,6,1.791759469228055
traffic,6,1.791759469228055
till,6,1.791759469228055
vigilant,6,1.791759469228055
novo,6,1.791759469228055
replace,6,1.791759469228055
feelings,6,1.791759469228055
reasoning,6,1.791759469228055
gross,6,1.791759469228055
interferons,6,1.791759469228055
holistic,6,1.791759469228055
virions,6,1.791759469228055
cardioembolism,6,1.791759469228055
aerosolized,6,1.791759469228055
SR,6,1.791759469228055
seeks,6,1.791759469228055
immunomodulation,6,1.791759469228055
Tfh,6,1.791759469228055
civilian,6,1.791759469228055
crowded,6,1.791759469228055
backgrounds,6,1.791759469228055
constitutes,6,1.791759469228055
Respondents,6,1.791759469228055
classify,6,1.791759469228055
cell-mediated,6,1.791759469228055
migraine,6,1.791759469228055
forest,6,1.791759469228055
detects,6,1.791759469228055
antiasthmatic,6,1.791759469228055
card,6,1.791759469228055
sensor,6,1.791759469228055
plasmonic,6,1.791759469228055
principally,6,1.791759469228055
sec,6,1.791759469228055
formulate,6,1.791759469228055
contrary,6,1.791759469228055
Vero-CCL81,6,1.791759469228055
094,6,1.791759469228055
onset-to-balloon,6,1.791759469228055
THC-MIST,6,1.791759469228055
Notably,6,1.791759469228055
observer,6,1.791759469228055
URTI,6,1.791759469228055
syndromic,6,1.791759469228055
format,6,1.791759469228055
014,6,1.791759469228055
discriminant,6,1.791759469228055
reporter,6,1.791759469228055
1990s,6,1.791759469228055
subpopulation,6,1.791759469228055
announced,6,1.791759469228055
Surprisingly,6,1.791759469228055
dalteparin,6,1.791759469228055
continually,6,1.791759469228055
175,6,1.791759469228055
GISAID,6,1.791759469228055
221,6,1.791759469228055
searches,6,1.791759469228055
shelters,6,1.791759469228055
refer,6,1.791759469228055
Comparison,6,1.791759469228055
comprehensively,6,1.791759469228055
stroke-induced,6,1.791759469228055
leukoaraiosis,6,1.791759469228055
hyperinflation,6,1.791759469228055
striking,6,1.791759469228055
glands,6,1.791759469228055
CDCs,6,1.791759469228055
Asian-Indian,6,1.791759469228055
overwhelming,6,1.791759469228055
inception,6,1.791759469228055
031,6,1.791759469228055
Reperfusion,6,1.791759469228055
325,6,1.791759469228055
030,6,1.791759469228055
sub-strains,6,1.791759469228055
planar,6,1.791759469228055
mgday,6,1.791759469228055
553,6,1.791759469228055
covers,6,1.791759469228055
protects,6,1.791759469228055
motif,6,1.791759469228055
contacted,6,1.791759469228055
Kaplan-Meier,6,1.791759469228055
swallowing,6,1.791759469228055
evoked,6,1.791759469228055
Virocult,6,1.791759469228055
lacks,6,1.791759469228055
Reported,6,1.791759469228055
hereditary,6,1.791759469228055
Neovastat,6,1.791759469228055
SERS,6,1.791759469228055
leakage,6,1.791759469228055
BMD,6,1.791759469228055
201011,6,1.791759469228055
201415,6,1.791759469228055
modelled,6,1.791759469228055
visiting,6,1.791759469228055
lessen,6,1.791759469228055
occipital,6,1.791759469228055
CLD,6,1.791759469228055
Alternative,6,1.791759469228055
bolus,6,1.791759469228055
interpandemic,6,1.791759469228055
ratings,6,1.791759469228055
atmospheric,6,1.791759469228055
anti-ischemic,6,1.791759469228055
bicycle,6,1.791759469228055
autumn,6,1.791759469228055
discrepancies,6,1.791759469228055
252,6,1.791759469228055
eastern,6,1.791759469228055
Independent,6,1.791759469228055
143,6,1.791759469228055
miR‑125a,6,1.791759469228055
conception,6,1.791759469228055
epitope,6,1.791759469228055
bACE2-Rm,6,1.791759469228055
distinctive,6,1.791759469228055
coincided,6,1.791759469228055
camps,6,1.791759469228055
resilience,6,1.791759469228055
ICSs,6,1.791759469228055
bowel,6,1.791759469228055
coffee,6,1.791759469228055
initiative,6,1.791759469228055
249,6,1.791759469228055
PMCT,6,1.791759469228055
9th,6,1.791759469228055
Surveys,6,1.791759469228055
answered,6,1.791759469228055
PRISMA,6,1.791759469228055
mRNAs,6,1.791759469228055
advocate,6,1.791759469228055
Epidemiology,6,1.791759469228055
Portugal,6,1.791759469228055
gains,6,1.791759469228055
deeper,6,1.791759469228055
communications,6,1.791759469228055
nonpharmaceutical,6,1.791759469228055
amplify,6,1.791759469228055
hallmark,6,1.791759469228055
activating,6,1.791759469228055
cromolyn,6,1.791759469228055
arises,6,1.791759469228055
destabilization,6,1.791759469228055
lncRNAs,6,1.791759469228055
immunizations,6,1.791759469228055
evade,6,1.791759469228055
Caucasian,6,1.791759469228055
stochastic,6,1.791759469228055
Elecsys,6,1.791759469228055
Commission,6,1.791759469228055
Day,6,1.791759469228055
outreach,6,1.791759469228055
Scopus,6,1.791759469228055
Postmortem,6,1.791759469228055
aOR,6,1.791759469228055
retinopathy,6,1.791759469228055
Ischaemic,6,1.791759469228055
fat,6,1.791759469228055
rheumatic,6,1.791759469228055
loci,6,1.791759469228055
197,6,1.791759469228055
decide,6,1.791759469228055
gatherings,6,1.791759469228055
Initial,6,1.791759469228055
storms,6,1.791759469228055
green,6,1.791759469228055
impede,6,1.791759469228055
•,6,1.791759469228055
registration,6,1.791759469228055
dominated,6,1.791759469228055
Learning,6,1.791759469228055
repolarization,6,1.791759469228055
specified,6,1.791759469228055
rotation,6,1.791759469228055
sVNT,6,1.791759469228055
2016-2017,6,1.791759469228055
IIV,6,1.791759469228055
technicians,6,1.791759469228055
β,6,1.791759469228055
palliative,6,1.791759469228055
antecedent,6,1.791759469228055
cat,6,1.791759469228055
Isolated,6,1.791759469228055
CysLT1,6,1.791759469228055
words,6,1.791759469228055
popular,6,1.791759469228055
TTE,6,1.791759469228055
sales,6,1.791759469228055
propensity,6,1.791759469228055
IR,6,1.791759469228055
Argentina,6,1.791759469228055
NRP-1,6,1.791759469228055
farms,6,1.791759469228055
522,6,1.791759469228055
plants,6,1.791759469228055
inherent,6,1.791759469228055
Database,6,1.791759469228055
nucleoprotein,6,1.791759469228055
embolisation,6,1.791759469228055
wash,6,1.791759469228055
Reviews,6,1.791759469228055
RAAS,6,1.791759469228055
CA,6,1.791759469228055
deficient,6,1.791759469228055
prosocial,6,1.791759469228055
software,6,1.791759469228055
PB1,6,1.791759469228055
438,6,1.791759469228055
2003-2004,6,1.791759469228055
Twelve,6,1.791759469228055
pneumonias,6,1.791759469228055
post-vaccination,6,1.791759469228055
rhinoviruses,6,1.791759469228055
comparator,6,1.791759469228055
Lmin,6,1.791759469228055
Associations,6,1.791759469228055
45-6h,6,1.791759469228055
haloperidol,6,1.791759469228055
Elderly,6,1.791759469228055
080,6,1.791759469228055
IM,6,1.791759469228055
MA,6,1.791759469228055
State,6,1.791759469228055
diaphragm,6,1.791759469228055
conservation,6,1.791759469228055
HLA,6,1.791759469228055
sector,6,1.791759469228055
proxy,6,1.791759469228055
confirming,6,1.791759469228055
Class,6,1.791759469228055
asynergic,6,1.791759469228055
unified,6,1.791759469228055
Olomouc,6,1.791759469228055
precursors,6,1.791759469228055
≥65,6,1.791759469228055
Autophagy,6,1.791759469228055
causality,6,1.791759469228055
proximity,6,1.791759469228055
cromoglycate,6,1.791759469228055
pilgrims,6,1.791759469228055
afferent,6,1.791759469228055
dysgraphia,6,1.791759469228055
orientation,6,1.791759469228055
171,6,1.791759469228055
Majority,6,1.791759469228055
Like,6,1.791759469228055
exercises,6,1.791759469228055
Safety,6,1.791759469228055
fragments,6,1.791759469228055
enrichment,6,1.791759469228055
MTHFR,6,1.791759469228055
Globally,6,1.791759469228055
home-based,6,1.791759469228055
expect,6,1.791759469228055
Is,6,1.791759469228055
Potential,6,1.791759469228055
suggestions,6,1.791759469228055
H2N2,6,1.791759469228055
1968,6,1.791759469228055
insertion,6,1.791759469228055
works,6,1.791759469228055
diurnal,6,1.791759469228055
STRE,6,1.791759469228055
outdoor,6,1.791759469228055
inferred,6,1.791759469228055
IIbIIIa,6,1.791759469228055
exactly,6,1.791759469228055
PV,6,1.791759469228055
repurposed,6,1.791759469228055
shaped,6,1.791759469228055
RIPerC,6,1.791759469228055
inserted,6,1.791759469228055
139,6,1.791759469228055
impression,6,1.791759469228055
pointed,6,1.791759469228055
Examination,6,1.791759469228055
radical,6,1.791759469228055
nanoparticle,5,1.6094379124341003
threatened,5,1.6094379124341003
CONCLUSIONS,5,1.6094379124341003
Mg,5,1.6094379124341003
342,5,1.6094379124341003
town,5,1.6094379124341003
JMI,5,1.6094379124341003
Nearly,5,1.6094379124341003
thirds,5,1.6094379124341003
diminished,5,1.6094379124341003
IVE,5,1.6094379124341003
advancement,5,1.6094379124341003
Britain,5,1.6094379124341003
thrombophilia,5,1.6094379124341003
isotope,5,1.6094379124341003
physiologically,5,1.6094379124341003
supplemental,5,1.6094379124341003
mediator,5,1.6094379124341003
slices,5,1.6094379124341003
gated,5,1.6094379124341003
credit,5,1.6094379124341003
competence,5,1.6094379124341003
VN,5,1.6094379124341003
Measurement,5,1.6094379124341003
ascorbic,5,1.6094379124341003
user-friendly,5,1.6094379124341003
STRA,5,1.6094379124341003
max,5,1.6094379124341003
side-effects,5,1.6094379124341003
009,5,1.6094379124341003
covid-19,5,1.6094379124341003
tandem,5,1.6094379124341003
Wheezing,5,1.6094379124341003
MCP-1,5,1.6094379124341003
microcatheter,5,1.6094379124341003
framed,5,1.6094379124341003
Grade,5,1.6094379124341003
Responses,5,1.6094379124341003
Published,5,1.6094379124341003
segmentation,5,1.6094379124341003
incurred,5,1.6094379124341003
ophthalmology,5,1.6094379124341003
isocyanate,5,1.6094379124341003
competing,5,1.6094379124341003
RNEF,5,1.6094379124341003
FAK,5,1.6094379124341003
refute,5,1.6094379124341003
continuation,5,1.6094379124341003
hypothesize,5,1.6094379124341003
RESULTS,5,1.6094379124341003
matching,5,1.6094379124341003
untranslated,5,1.6094379124341003
non-structural,5,1.6094379124341003
10th,5,1.6094379124341003
Ml,5,1.6094379124341003
000001,5,1.6094379124341003
pupils,5,1.6094379124341003
6th,5,1.6094379124341003
disappointing,5,1.6094379124341003
226,5,1.6094379124341003
FLU,5,1.6094379124341003
wait,5,1.6094379124341003
centuries,5,1.6094379124341003
dipole,5,1.6094379124341003
reactivation,5,1.6094379124341003
IC,5,1.6094379124341003
Flow,5,1.6094379124341003
Sigma,5,1.6094379124341003
062,5,1.6094379124341003
anti-NP,5,1.6094379124341003
Siemens,5,1.6094379124341003
Peoples,5,1.6094379124341003
R₀,5,1.6094379124341003
PAI-2,5,1.6094379124341003
on-line,5,1.6094379124341003
Proper,5,1.6094379124341003
AZD1222,5,1.6094379124341003
verification,5,1.6094379124341003
filled,5,1.6094379124341003
impairs,5,1.6094379124341003
synchronous,5,1.6094379124341003
greenhouse,5,1.6094379124341003
lymph,5,1.6094379124341003
Moyamoya,5,1.6094379124341003
repositioning,5,1.6094379124341003
executive,5,1.6094379124341003
mL-1,5,1.6094379124341003
cohorting,5,1.6094379124341003
502,5,1.6094379124341003
ostial,5,1.6094379124341003
unsatisfactory,5,1.6094379124341003
dPCR,5,1.6094379124341003
audience,5,1.6094379124341003
SMASH-U,5,1.6094379124341003
Maoris,5,1.6094379124341003
dreams,5,1.6094379124341003
drug-resistant,5,1.6094379124341003
periprocedural,5,1.6094379124341003
nonpregnant,5,1.6094379124341003
O,5,1.6094379124341003
Government,5,1.6094379124341003
titre,5,1.6094379124341003
336,5,1.6094379124341003
Tl-ECT,5,1.6094379124341003
ABO,5,1.6094379124341003
nights,5,1.6094379124341003
stopping,5,1.6094379124341003
decisive,5,1.6094379124341003
functionally,5,1.6094379124341003
RPA-LF,5,1.6094379124341003
contents,5,1.6094379124341003
attenuation,5,1.6094379124341003
restored,5,1.6094379124341003
geriatric,5,1.6094379124341003
strokeTIA,5,1.6094379124341003
aptamer-nucleoprotein,5,1.6094379124341003
gene-environment,5,1.6094379124341003
chambers,5,1.6094379124341003
heme,5,1.6094379124341003
040,5,1.6094379124341003
proteome,5,1.6094379124341003
exposing,5,1.6094379124341003
ROI,5,1.6094379124341003
plasmapheresis,5,1.6094379124341003
Authors,5,1.6094379124341003
dream,5,1.6094379124341003
expired,5,1.6094379124341003
833,5,1.6094379124341003
malignancy,5,1.6094379124341003
raw,5,1.6094379124341003
cryo-EM,5,1.6094379124341003
worry,5,1.6094379124341003
camera,5,1.6094379124341003
Capilia,5,1.6094379124341003
eighth,5,1.6094379124341003
Abstract,5,1.6094379124341003
synonymous,5,1.6094379124341003
school-age,5,1.6094379124341003
foundation,5,1.6094379124341003
149,5,1.6094379124341003
lay,5,1.6094379124341003
188,5,1.6094379124341003
occlude,5,1.6094379124341003
neurocognitive,5,1.6094379124341003
deciding,5,1.6094379124341003
DP,5,1.6094379124341003
Great,5,1.6094379124341003
attribute,5,1.6094379124341003
eliciting,5,1.6094379124341003
Being,5,1.6094379124341003
near-fatal,5,1.6094379124341003
dissociation,5,1.6094379124341003
epidemiologists,5,1.6094379124341003
rales,5,1.6094379124341003
umbrella,5,1.6094379124341003
specialised,5,1.6094379124341003
reinforce,5,1.6094379124341003
needing,5,1.6094379124341003
anginal,5,1.6094379124341003
Toll-like,5,1.6094379124341003
lumen,5,1.6094379124341003
981,5,1.6094379124341003
983,5,1.6094379124341003
thrombocythemia,5,1.6094379124341003
153,5,1.6094379124341003
tilts,5,1.6094379124341003
diltiazem,5,1.6094379124341003
profession,5,1.6094379124341003
swimmers,5,1.6094379124341003
swimming,5,1.6094379124341003
I-MOVE,5,1.6094379124341003
IMD,5,1.6094379124341003
RGD,5,1.6094379124341003
haemodynamics,5,1.6094379124341003
bronchoprovocation,5,1.6094379124341003
rises,5,1.6094379124341003
dichotomized,5,1.6094379124341003
Kaunas,5,1.6094379124341003
disrupt,5,1.6094379124341003
ready,5,1.6094379124341003
compares,5,1.6094379124341003
thrombin,5,1.6094379124341003
equipped,5,1.6094379124341003
blood-based,5,1.6094379124341003
backward,5,1.6094379124341003
QTcd,5,1.6094379124341003
low-,5,1.6094379124341003
pre-pandemic,5,1.6094379124341003
NYHA,5,1.6094379124341003
arteriopathy,5,1.6094379124341003
alignment,5,1.6094379124341003
underlie,5,1.6094379124341003
immunologically,5,1.6094379124341003
anaesthesia,5,1.6094379124341003
selectivity,5,1.6094379124341003
Collectively,5,1.6094379124341003
originating,5,1.6094379124341003
CAC,5,1.6094379124341003
tear,5,1.6094379124341003
responding,5,1.6094379124341003
Available,5,1.6094379124341003
spectra,5,1.6094379124341003
stations,5,1.6094379124341003
Fortunately,5,1.6094379124341003
H9,5,1.6094379124341003
carbohydrate,5,1.6094379124341003
expenses,5,1.6094379124341003
notification,5,1.6094379124341003
totally,5,1.6094379124341003
antispike,5,1.6094379124341003
attributes,5,1.6094379124341003
Red,5,1.6094379124341003
Force,5,1.6094379124341003
busy,5,1.6094379124341003
DDSP,5,1.6094379124341003
AUml,5,1.6094379124341003
valves,5,1.6094379124341003
integrative,5,1.6094379124341003
transduction,5,1.6094379124341003
rehabilitants,5,1.6094379124341003
E-selectin,5,1.6094379124341003
DO2,5,1.6094379124341003
subtyping,5,1.6094379124341003
well-documented,5,1.6094379124341003
SES,5,1.6094379124341003
mRNA-1273,5,1.6094379124341003
forecasting,5,1.6094379124341003
schizophrenia,5,1.6094379124341003
LVT,5,1.6094379124341003
IgMIgG,5,1.6094379124341003
weekdays,5,1.6094379124341003
dysfunctional,5,1.6094379124341003
Avoidance,5,1.6094379124341003
durable,5,1.6094379124341003
trunk,5,1.6094379124341003
Hospitalized,5,1.6094379124341003
haptic,5,1.6094379124341003
RAD,5,1.6094379124341003
motivational,5,1.6094379124341003
2-3,5,1.6094379124341003
231,5,1.6094379124341003
830,5,1.6094379124341003
dimensions,5,1.6094379124341003
SCID,5,1.6094379124341003
Arterial,5,1.6094379124341003
chart,5,1.6094379124341003
WBE,5,1.6094379124341003
table,5,1.6094379124341003
provoke,5,1.6094379124341003
208,5,1.6094379124341003
ideally,5,1.6094379124341003
betacoronavirus,5,1.6094379124341003
resumption,5,1.6094379124341003
450,5,1.6094379124341003
Insurance,5,1.6094379124341003
Average,5,1.6094379124341003
AHAASA,5,1.6094379124341003
electively,5,1.6094379124341003
unremitting,5,1.6094379124341003
nCoV-19,5,1.6094379124341003
two-dose,5,1.6094379124341003
Perth,5,1.6094379124341003
Outbreaks,5,1.6094379124341003
hydrochloride,5,1.6094379124341003
objectively,5,1.6094379124341003
Nasal,5,1.6094379124341003
fragment,5,1.6094379124341003
representation,5,1.6094379124341003
Selected,5,1.6094379124341003
Alpha,5,1.6094379124341003
FSM,5,1.6094379124341003
Reference,5,1.6094379124341003
co-occurrence,5,1.6094379124341003
251,5,1.6094379124341003
rash,5,1.6094379124341003
cruise,5,1.6094379124341003
confused,5,1.6094379124341003
aiding,5,1.6094379124341003
tropism,5,1.6094379124341003
employment,5,1.6094379124341003
ACOS,5,1.6094379124341003
pushing,5,1.6094379124341003
Biomarkers,5,1.6094379124341003
telemedicine,5,1.6094379124341003
await,5,1.6094379124341003
rollout,5,1.6094379124341003
Biotech,5,1.6094379124341003
CAO,5,1.6094379124341003
outperformed,5,1.6094379124341003
TAb,5,1.6094379124341003
SNAb,5,1.6094379124341003
cutaneous,5,1.6094379124341003
employ,5,1.6094379124341003
devise,5,1.6094379124341003
HCPs,5,1.6094379124341003
empiric,5,1.6094379124341003
OVA,5,1.6094379124341003
miniaturized,5,1.6094379124341003
small-vessel,5,1.6094379124341003
unexposed,5,1.6094379124341003
heaves,5,1.6094379124341003
arthritis,5,1.6094379124341003
covert,5,1.6094379124341003
SARI,5,1.6094379124341003
radicals,5,1.6094379124341003
radiologist,5,1.6094379124341003
142,5,1.6094379124341003
Amr,5,1.6094379124341003
ingredients,5,1.6094379124341003
800,5,1.6094379124341003
worth,5,1.6094379124341003
Mutations,5,1.6094379124341003
nationally,5,1.6094379124341003
Hygiene,5,1.6094379124341003
077,5,1.6094379124341003
steadily,5,1.6094379124341003
contraindication,5,1.6094379124341003
Alaska,5,1.6094379124341003
Alternaria,5,1.6094379124341003
V1,5,1.6094379124341003
destructive,5,1.6094379124341003
37-year-old,5,1.6094379124341003
⩾,5,1.6094379124341003
Surgery,5,1.6094379124341003
cholinergic,5,1.6094379124341003
expiration,5,1.6094379124341003
inhibits,5,1.6094379124341003
priming,5,1.6094379124341003
exosomes,5,1.6094379124341003
wives,5,1.6094379124341003
Scientific,5,1.6094379124341003
surge,5,1.6094379124341003
TNFA,5,1.6094379124341003
ESA,5,1.6094379124341003
data-driven,5,1.6094379124341003
NOS,5,1.6094379124341003
siblings,5,1.6094379124341003
evasion,5,1.6094379124341003
disposition,5,1.6094379124341003
blinded,5,1.6094379124341003
GA,5,1.6094379124341003
eggs,5,1.6094379124341003
Attack,5,1.6094379124341003
herpes,5,1.6094379124341003
biologics,5,1.6094379124341003
Statins,5,1.6094379124341003
154,5,1.6094379124341003
assuming,5,1.6094379124341003
perforating,5,1.6094379124341003
PG,5,1.6094379124341003
AS,5,1.6094379124341003
Neutralizing,5,1.6094379124341003
implantable,5,1.6094379124341003
IABP,5,1.6094379124341003
constituted,5,1.6094379124341003
UPE,5,1.6094379124341003
discrepant,5,1.6094379124341003
concordant,5,1.6094379124341003
aforementioned,5,1.6094379124341003
LLEx,5,1.6094379124341003
sections,5,1.6094379124341003
autoregulation,5,1.6094379124341003
echocardiograms,5,1.6094379124341003
179,5,1.6094379124341003
salbutamol,5,1.6094379124341003
self-administered,5,1.6094379124341003
PFV,5,1.6094379124341003
probabilities,5,1.6094379124341003
orthognathic,5,1.6094379124341003
restrictive,5,1.6094379124341003
AGPs,5,1.6094379124341003
RAGE,5,1.6094379124341003
mistaken,5,1.6094379124341003
constructs,5,1.6094379124341003
ADAMTS13,5,1.6094379124341003
mfEMT,5,1.6094379124341003
rationing,5,1.6094379124341003
albeit,5,1.6094379124341003
283,5,1.6094379124341003
haplotypes,5,1.6094379124341003
LPL,5,1.6094379124341003
engineering,5,1.6094379124341003
230,5,1.6094379124341003
higher-risk,5,1.6094379124341003
decided,5,1.6094379124341003
self-report,5,1.6094379124341003
alleviating,5,1.6094379124341003
Investigation,5,1.6094379124341003
herbal,5,1.6094379124341003
exercising,5,1.6094379124341003
Older,5,1.6094379124341003
collaterals,5,1.6094379124341003
meant,5,1.6094379124341003
yields,5,1.6094379124341003
agenda,5,1.6094379124341003
Protocol,5,1.6094379124341003
urine,5,1.6094379124341003
stakeholder,5,1.6094379124341003
kindergarten,5,1.6094379124341003
extracurricular,5,1.6094379124341003
branching,5,1.6094379124341003
posing,5,1.6094379124341003
arrhythmogenic,5,1.6094379124341003
193,5,1.6094379124341003
slowly,5,1.6094379124341003
drawback,5,1.6094379124341003
keeping,5,1.6094379124341003
259,5,1.6094379124341003
Paulo,5,1.6094379124341003
cleared,5,1.6094379124341003
Thirty-five,5,1.6094379124341003
SEM,5,1.6094379124341003
processed,5,1.6094379124341003
requested,5,1.6094379124341003
favored,5,1.6094379124341003
public-health,5,1.6094379124341003
decompressive,5,1.6094379124341003
trait,5,1.6094379124341003
4°C,5,1.6094379124341003
Reliable,5,1.6094379124341003
non-pharmaceutical,5,1.6094379124341003
reversing,5,1.6094379124341003
Promising,5,1.6094379124341003
advancements,5,1.6094379124341003
thunderstorm,5,1.6094379124341003
Zhejiang,5,1.6094379124341003
Comprehensive,5,1.6094379124341003
MI-NCA,5,1.6094379124341003
plot,5,1.6094379124341003
distrust,5,1.6094379124341003
1980s,5,1.6094379124341003
lacked,5,1.6094379124341003
025,5,1.6094379124341003
descriptions,5,1.6094379124341003
convenience,5,1.6094379124341003
excreted,5,1.6094379124341003
CIB,5,1.6094379124341003
4-weekly,5,1.6094379124341003
intra-,5,1.6094379124341003
subjectively,5,1.6094379124341003
MMR,5,1.6094379124341003
reactogenicity,5,1.6094379124341003
yellow,5,1.6094379124341003
SLE,5,1.6094379124341003
adds,5,1.6094379124341003
summed,5,1.6094379124341003
501YV2,5,1.6094379124341003
automatically,5,1.6094379124341003
hospital-acquired,5,1.6094379124341003
NTD,5,1.6094379124341003
killer,5,1.6094379124341003
eliminating,5,1.6094379124341003
Dutch,5,1.6094379124341003
grading,5,1.6094379124341003
shelter,5,1.6094379124341003
SNFs,5,1.6094379124341003
269,5,1.6094379124341003
341,5,1.6094379124341003
oedema,5,1.6094379124341003
Pfizer,5,1.6094379124341003
fill,5,1.6094379124341003
Maternal,5,1.6094379124341003
permit,5,1.6094379124341003
SLI,5,1.6094379124341003
centered,5,1.6094379124341003
radiography,5,1.6094379124341003
phosphokinase,5,1.6094379124341003
inaccurate,5,1.6094379124341003
river,5,1.6094379124341003
Intracerebral,5,1.6094379124341003
dealt,5,1.6094379124341003
Markov,5,1.6094379124341003
attachment,5,1.6094379124341003
shunt,5,1.6094379124341003
nuclei,5,1.6094379124341003
996,5,1.6094379124341003
Anxiety,5,1.6094379124341003
tachyarrhythmia,5,1.6094379124341003
Cough,5,1.6094379124341003
postponed,5,1.6094379124341003
radiograph,5,1.6094379124341003
countermeasure,5,1.6094379124341003
CTP,5,1.6094379124341003
high-sensitivity,5,1.6094379124341003
nAb,5,1.6094379124341003
todays,5,1.6094379124341003
286,5,1.6094379124341003
TE,5,1.6094379124341003
arrive,5,1.6094379124341003
PS,5,1.6094379124341003
pdm09,5,1.6094379124341003
cycling,5,1.6094379124341003
hyperkinetic,5,1.6094379124341003
puzzling,5,1.6094379124341003
Survival,5,1.6094379124341003
infratentorial,5,1.6094379124341003
supratentorial,5,1.6094379124341003
mL,5,1.6094379124341003
883,5,1.6094379124341003
Small,5,1.6094379124341003
Male,5,1.6094379124341003
pools,5,1.6094379124341003
nanoagent,5,1.6094379124341003
spatio-temporal,5,1.6094379124341003
LRE,5,1.6094379124341003
Euroimmun,5,1.6094379124341003
Two-dimensional,5,1.6094379124341003
Delaware,5,1.6094379124341003
aggressively,5,1.6094379124341003
remedies,5,1.6094379124341003
24-hour,5,1.6094379124341003
Educational,5,1.6094379124341003
fixed-axis,5,1.6094379124341003
pave,5,1.6094379124341003
ascertainment,5,1.6094379124341003
trimester,5,1.6094379124341003
balanced,5,1.6094379124341003
youngest,5,1.6094379124341003
tertile,5,1.6094379124341003
204,5,1.6094379124341003
transformed,5,1.6094379124341003
transcriptomic,5,1.6094379124341003
regulator,5,1.6094379124341003
Hsp90,5,1.6094379124341003
diaphragmatic,5,1.6094379124341003
mistrust,5,1.6094379124341003
thrombolytics,5,1.6094379124341003
dorsal,5,1.6094379124341003
SMC,5,1.6094379124341003
LTCFs,5,1.6094379124341003
brittle,5,1.6094379124341003
Response,5,1.6094379124341003
or65,5,1.6094379124341003
Comparisons,5,1.6094379124341003
three-dimensional,5,1.6094379124341003
entails,5,1.6094379124341003
venue,5,1.6094379124341003
drawbacks,5,1.6094379124341003
CKmax,5,1.6094379124341003
136,5,1.6094379124341003
Covasim,5,1.6094379124341003
099,5,1.6094379124341003
signatures,5,1.6094379124341003
VC,5,1.6094379124341003
genotyping,5,1.6094379124341003
accordingly,5,1.6094379124341003
Area,5,1.6094379124341003
evacuees,5,1.6094379124341003
reelevation,5,1.6094379124341003
combine,5,1.6094379124341003
ligands,5,1.6094379124341003
whereby,5,1.6094379124341003
Guangzhou,5,1.6094379124341003
fate,5,1.6094379124341003
housing,5,1.6094379124341003
p-values,5,1.6094379124341003
coagulopathy,5,1.6094379124341003
beta-agonists,5,1.6094379124341003
perforation,5,1.6094379124341003
alternate,5,1.6094379124341003
capital,5,1.6094379124341003
BR,5,1.6094379124341003
breakthrough,5,1.6094379124341003
reconstructed,5,1.6094379124341003
Norway,5,1.6094379124341003
islands,5,1.6094379124341003
antiepileptic,5,1.6094379124341003
nevertheless,5,1.6094379124341003
IgMIgA,5,1.6094379124341003
chemicals,5,1.6094379124341003
bearing,5,1.6094379124341003
residential,5,1.6094379124341003
neutralized,5,1.6094379124341003
TISMO,5,1.6094379124341003
evening,5,1.6094379124341003
blocks,5,1.6094379124341003
227,5,1.6094379124341003
interested,5,1.6094379124341003
underdiagnosis,5,1.6094379124341003
Federation,5,1.6094379124341003
California,5,1.6094379124341003
next-generation,5,1.6094379124341003
3CLpro,5,1.6094379124341003
labor,5,1.6094379124341003
Lastly,5,1.6094379124341003
specify,5,1.6094379124341003
cross-immunity,5,1.6094379124341003
unavailable,5,1.6094379124341003
stunned,5,1.6094379124341003
danger,5,1.6094379124341003
amounts,5,1.6094379124341003
post-influenza,5,1.6094379124341003
displaying,5,1.6094379124341003
Saliva,5,1.6094379124341003
enrolling,5,1.6094379124341003
sustainable,5,1.6094379124341003
Tamiflu,5,1.6094379124341003
deposited,5,1.6094379124341003
elsewhere,5,1.6094379124341003
immunomodulatory,5,1.6094379124341003
reversed,5,1.6094379124341003
loading,5,1.6094379124341003
inferolateral,5,1.6094379124341003
WM,5,1.6094379124341003
CoVdb,5,1.6094379124341003
underpinning,5,1.6094379124341003
door,5,1.6094379124341003
cleaved,5,1.6094379124341003
APS,5,1.6094379124341003
ischemia-reperfusion,5,1.6094379124341003
IDNOW,5,1.6094379124341003
constrained,5,1.6094379124341003
unloading,5,1.6094379124341003
generates,5,1.6094379124341003
MVO2,5,1.6094379124341003
anti-asthma,5,1.6094379124341003
memo,5,1.6094379124341003
Reducing,5,1.6094379124341003
remove,5,1.6094379124341003
prototypes,5,1.6094379124341003
exertion,5,1.6094379124341003
capturing,5,1.6094379124341003
post-operative,5,1.6094379124341003
anastomoses,5,1.6094379124341003
microfluidic,5,1.6094379124341003
unidentified,5,1.6094379124341003
proposals,5,1.6094379124341003
076,5,1.6094379124341003
857,5,1.6094379124341003
Georgia,5,1.6094379124341003
396,5,1.6094379124341003
nRIC,5,1.6094379124341003
sharp,5,1.6094379124341003
SHOCK,5,1.6094379124341003
reflection,5,1.6094379124341003
plastic,5,1.6094379124341003
dysarthria,5,1.6094379124341003
hACE2,5,1.6094379124341003
exceeds,5,1.6094379124341003
CovTI,5,1.6094379124341003
uncover,5,1.6094379124341003
ensures,5,1.6094379124341003
sophisticated,5,1.6094379124341003
1919,5,1.6094379124341003
chromatography,5,1.6094379124341003
SHR-A3,5,1.6094379124341003
Poisson,5,1.6094379124341003
axial,5,1.6094379124341003
SUVmax,5,1.6094379124341003
12th,5,1.6094379124341003
video,5,1.6094379124341003
Sequencing,5,1.6094379124341003
reuteri,5,1.6094379124341003
Atherosclerosis,5,1.6094379124341003
looking,5,1.6094379124341003
203,5,1.6094379124341003
translated,5,1.6094379124341003
Vero,5,1.6094379124341003
blood-pressure,5,1.6094379124341003
deserves,5,1.6094379124341003
mo,5,1.6094379124341003
conditioned,5,1.6094379124341003
toco,5,1.6094379124341003
undertreated,5,1.6094379124341003
categorical,5,1.6094379124341003
εs,5,1.6094379124341003
medullary,5,1.6094379124341003
Act,5,1.6094379124341003
Universal,5,1.6094379124341003
subsided,5,1.6094379124341003
grams,5,1.6094379124341003
advocates,5,1.6094379124341003
gradient,5,1.6094379124341003
necrotizing,5,1.6094379124341003
non-influenza,5,1.6094379124341003
supportive,5,1.6094379124341003
alteplase,5,1.6094379124341003
on-site,5,1.6094379124341003
peer-reviewed,5,1.6094379124341003
Logistic,5,1.6094379124341003
nSTEMI,5,1.6094379124341003
027,5,1.6094379124341003
expedite,5,1.6094379124341003
documenting,5,1.6094379124341003
downregulated,5,1.6094379124341003
propagate,5,1.6094379124341003
493,5,1.6094379124341003
diaries,5,1.6094379124341003
forces,5,1.6094379124341003
endothelin-1,5,1.6094379124341003
Differential,5,1.6094379124341003
FFO,5,1.6094379124341003
bronchodilation,5,1.6094379124341003
1985,5,1.6094379124341003
Odds,5,1.6094379124341003
Statement,5,1.6094379124341003
precursor,5,1.6094379124341003
deficiencies,5,1.6094379124341003
424,5,1.6094379124341003
otitis,5,1.6094379124341003
underdiagnosed,5,1.6094379124341003
downregulation,5,1.6094379124341003
illustrates,5,1.6094379124341003
alternatively,5,1.6094379124341003
front,5,1.6094379124341003
productive,5,1.6094379124341003
worthwhile,5,1.6094379124341003
latent,5,1.6094379124341003
credible,5,1.6094379124341003
bronchiectasis,5,1.6094379124341003
reasonably,5,1.6094379124341003
stabilize,5,1.6094379124341003
Xpert,5,1.6094379124341003
contiguous,5,1.6094379124341003
tobacco-related,5,1.6094379124341003
move,5,1.6094379124341003
non-ST-elevation,5,1.6094379124341003
am,5,1.6094379124341003
OC43,5,1.6094379124341003
revolutionized,5,1.6094379124341003
crossover,5,1.6094379124341003
plausible,5,1.6094379124341003
ROIs,5,1.6094379124341003
nonobstructive,5,1.6094379124341003
SARS-CoV-2-infected,5,1.6094379124341003
Osaka,5,1.6094379124341003
transfusions,5,1.6094379124341003
desensitization,5,1.6094379124341003
post-infection,5,1.6094379124341003
275,5,1.6094379124341003
HCoV-OC43,5,1.6094379124341003
Xpert®,5,1.6094379124341003
carcinoma,5,1.6094379124341003
somewhat,5,1.6094379124341003
distribute,5,1.6094379124341003
burdens,5,1.6094379124341003
peroxidation,5,1.6094379124341003
pressing,5,1.6094379124341003
NMDs,5,1.6094379124341003
reality,5,1.6094379124341003
closest,5,1.6094379124341003
readers,5,1.6094379124341003
revascularisation,5,1.6094379124341003
thin,5,1.6094379124341003
postmenopausal,5,1.6094379124341003
furin,5,1.6094379124341003
Asians,5,1.6094379124341003
Presently,5,1.6094379124341003
Especially,5,1.6094379124341003
retinal,5,1.6094379124341003
suture,5,1.6094379124341003
biopsies,5,1.6094379124341003
resource-limited,5,1.6094379124341003
wildlife,5,1.6094379124341003
IBD,5,1.6094379124341003
beclomethasone,5,1.6094379124341003
Kong68,5,1.6094379124341003
clades,5,1.6094379124341003
Personal,5,1.6094379124341003
BEpCs,5,1.6094379124341003
sectors,5,1.6094379124341003
atlas,5,1.6094379124341003
gut,5,1.6094379124341003
Rats,5,1.6094379124341003
ARIC,5,1.6094379124341003
Paediatric,5,1.6094379124341003
Effectiveness,5,1.6094379124341003
putative,5,1.6094379124341003
cyanosis,5,1.6094379124341003
omics,5,1.6094379124341003
DS,5,1.6094379124341003
Disability,5,1.6094379124341003
basement,5,1.6094379124341003
establishes,5,1.6094379124341003
conspiracy,5,1.6094379124341003
MZ,5,1.6094379124341003
Repeat,5,1.6094379124341003
GAP,5,1.6094379124341003
Antigenic,5,1.6094379124341003
Materials,5,1.6094379124341003
pH,5,1.6094379124341003
self-collected,5,1.6094379124341003
disadvantaged,5,1.6094379124341003
1951,5,1.6094379124341003
tailoring,5,1.6094379124341003
Fever,5,1.6094379124341003
Scotland,5,1.6094379124341003
272,5,1.6094379124341003
desired,5,1.6094379124341003
English-language,5,1.6094379124341003
Spike,5,1.6094379124341003
AC-EIA,5,1.6094379124341003
evolves,5,1.6094379124341003
multiplication,5,1.6094379124341003
friends,5,1.6094379124341003
provoked,5,1.6094379124341003
clue,5,1.6094379124341003
ataxia,5,1.6094379124341003
endpoints,5,1.6094379124341003
NPV,5,1.6094379124341003
labeled,5,1.6094379124341003
HS,5,1.6094379124341003
syndrome-related,5,1.6094379124341003
MSC,5,1.6094379124341003
flipping,5,1.6094379124341003
histology,5,1.6094379124341003
cigarettes,5,1.6094379124341003
forthcoming,5,1.6094379124341003
1976,5,1.6094379124341003
AEs,5,1.6094379124341003
prognoses,5,1.6094379124341003
ozone,5,1.6094379124341003
fibrotic,5,1.6094379124341003
foci,5,1.6094379124341003
320,5,1.6094379124341003
band,5,1.6094379124341003
bypassing,5,1.6094379124341003
infiltrate,5,1.6094379124341003
accumulated,5,1.6094379124341003
dynamical,5,1.6094379124341003
068,5,1.6094379124341003
nebulized,5,1.6094379124341003
389,5,1.6094379124341003
occupying,5,1.6094379124341003
172,5,1.6094379124341003
superimposed,5,1.6094379124341003
308,5,1.6094379124341003
Third,5,1.6094379124341003
draw,5,1.6094379124341003
disrupted,5,1.6094379124341003
34-year-old,5,1.6094379124341003
IVUS-VH,5,1.6094379124341003
Outcomes,5,1.6094379124341003
players,5,1.6094379124341003
doubling,5,1.6094379124341003
monkeys,5,1.6094379124341003
onto,5,1.6094379124341003
199,5,1.6094379124341003
Planning,5,1.6094379124341003
CC,5,1.6094379124341003
AOP,5,1.6094379124341003
disabled,5,1.6094379124341003
postmyocardial,5,1.6094379124341003
164,5,1.6094379124341003
discontinued,5,1.6094379124341003
Congress,5,1.6094379124341003
anticholinergics,5,1.6094379124341003
769,5,1.6094379124341003
215,5,1.6094379124341003
605,5,1.6094379124341003
ESD,5,1.6094379124341003
427,5,1.6094379124341003
tracks,5,1.6094379124341003
OPHL,5,1.6094379124341003
acetylcholine,5,1.6094379124341003
157,5,1.6094379124341003
A-S-C-O,5,1.6094379124341003
charts,5,1.6094379124341003
patient-reported,5,1.6094379124341003
ethically,5,1.6094379124341003
journal,5,1.6094379124341003
implanted,5,1.6094379124341003
prioritize,5,1.6094379124341003
PCG,5,1.6094379124341003
von,5,1.6094379124341003
aVL,5,1.6094379124341003
ADs,5,1.6094379124341003
066,5,1.6094379124341003
3-4,5,1.6094379124341003
Inpatient,5,1.6094379124341003
girls,5,1.6094379124341003
naive,5,1.6094379124341003
oldest,5,1.6094379124341003
coinfections,5,1.6094379124341003
H1N12009,5,1.6094379124341003
TKA,5,1.6094379124341003
neutralize,5,1.6094379124341003
Large-scale,5,1.6094379124341003
58-year-old,5,1.6094379124341003
enriched,5,1.6094379124341003
292,5,1.6094379124341003
327,5,1.6094379124341003
BALBc,5,1.6094379124341003
relieving,5,1.6094379124341003
cardiologists,5,1.6094379124341003
virus-infected,5,1.6094379124341003
sensitizers,5,1.6094379124341003
neighboring,5,1.6094379124341003
MAQLQ-M,5,1.6094379124341003
Y,5,1.6094379124341003
siRNA,5,1.6094379124341003
dentist,5,1.6094379124341003
modulated,5,1.6094379124341003
RS,5,1.6094379124341003
Systems,5,1.6094379124341003
linearity,5,1.6094379124341003
Persons,5,1.6094379124341003
dyssynergy,5,1.6094379124341003
dimension,5,1.6094379124341003
yoga,5,1.6094379124341003
234,5,1.6094379124341003
neurology,5,1.6094379124341003
conformational,5,1.6094379124341003
Survivors,5,1.6094379124341003
perforators,5,1.6094379124341003
3-month,5,1.6094379124341003
Comparing,5,1.6094379124341003
293,5,1.6094379124341003
crises,5,1.6094379124341003
inactivity,5,1.6094379124341003
institutes,5,1.6094379124341003
hidden,5,1.6094379124341003
menopause,5,1.6094379124341003
TDC,5,1.6094379124341003
amplified,5,1.6094379124341003
WT,5,1.6094379124341003
macrophage,5,1.6094379124341003
endocrine,5,1.6094379124341003
standardised,5,1.6094379124341003
consuming,5,1.6094379124341003
disappeared,5,1.6094379124341003
anti-platelet,5,1.6094379124341003
mHla-RBD,5,1.6094379124341003
EMBASE,5,1.6094379124341003
Islanders,5,1.6094379124341003
certainty,5,1.6094379124341003
atrium,5,1.6094379124341003
handle,5,1.6094379124341003
CAFO,5,1.6094379124341003
Frequent,5,1.6094379124341003
library,5,1.6094379124341003
biologicals,5,1.6094379124341003
223,5,1.6094379124341003
mineral,5,1.6094379124341003
abstinence,5,1.6094379124341003
063,5,1.6094379124341003
ovarian,5,1.6094379124341003
fulfilled,5,1.6094379124341003
locally,5,1.6094379124341003
insults,5,1.6094379124341003
12-month,5,1.6094379124341003
11th,5,1.6094379124341003
happen,5,1.6094379124341003
RIDTs,5,1.6094379124341003
expose,5,1.6094379124341003
unspecific,5,1.6094379124341003
FDA-approved,5,1.6094379124341003
projects,5,1.6094379124341003
promotion,5,1.6094379124341003
transitory,5,1.6094379124341003
cardioprotective,5,1.6094379124341003
glycan-based,5,1.6094379124341003
Sensitization,5,1.6094379124341003
Timely,5,1.6094379124341003
Owing,5,1.6094379124341003
infrequently,5,1.6094379124341003
graph,5,1.6094379124341003
DW,5,1.6094379124341003
socially,5,1.6094379124341003
stimulates,5,1.6094379124341003
co-morbidity,5,1.6094379124341003
powder,5,1.6094379124341003
non-coding,5,1.6094379124341003
modulates,5,1.6094379124341003
impacting,5,1.6094379124341003
capsules,5,1.6094379124341003
Conventional,5,1.6094379124341003
Practice,5,1.6094379124341003
undertook,5,1.6094379124341003
iv,5,1.6094379124341003
responsibility,5,1.6094379124341003
Persistent,5,1.6094379124341003
938,5,1.6094379124341003
microenvironment,5,1.6094379124341003
CMIRLV,5,1.6094379124341003
Injury,5,1.6094379124341003
virus-host,5,1.6094379124341003
Dox,5,1.6094379124341003
earthquake,5,1.6094379124341003
LAIV4,5,1.6094379124341003
284,5,1.6094379124341003
C2,5,1.6094379124341003
bases,5,1.6094379124341003
specialty,5,1.6094379124341003
high-altitude,5,1.6094379124341003
stroke-like,5,1.6094379124341003
SARS‑CoV‑2,4,1.3862943611198906
ICUS,4,1.3862943611198906
updating,4,1.3862943611198906
altering,4,1.3862943611198906
-308,4,1.3862943611198906
contextual,4,1.3862943611198906
pay,4,1.3862943611198906
petroleum,4,1.3862943611198906
end-stage,4,1.3862943611198906
Calu-3,4,1.3862943611198906
wind,4,1.3862943611198906
846,4,1.3862943611198906
Office,4,1.3862943611198906
SAH,4,1.3862943611198906
situated,4,1.3862943611198906
invalid,4,1.3862943611198906
neglected,4,1.3862943611198906
precipitation,4,1.3862943611198906
charge,4,1.3862943611198906
seemed,4,1.3862943611198906
case-patient,4,1.3862943611198906
partner,4,1.3862943611198906
swift,4,1.3862943611198906
shunting,4,1.3862943611198906
hoc,4,1.3862943611198906
cautiously,4,1.3862943611198906
five-year,4,1.3862943611198906
pet,4,1.3862943611198906
watching,4,1.3862943611198906
upright,4,1.3862943611198906
attenuate,4,1.3862943611198906
applies,4,1.3862943611198906
EI,4,1.3862943611198906
hypoxemia,4,1.3862943611198906
intractable,4,1.3862943611198906
explanatory,4,1.3862943611198906
reviewers,4,1.3862943611198906
CMILRV,4,1.3862943611198906
Sixteen,4,1.3862943611198906
Organisation,4,1.3862943611198906
A-20,4,1.3862943611198906
Nasopharyngeal,4,1.3862943611198906
Telestroke,4,1.3862943611198906
facilitators,4,1.3862943611198906
cost-benefit,4,1.3862943611198906
specifications,4,1.3862943611198906
haplotype,4,1.3862943611198906
delivers,4,1.3862943611198906
RWM,4,1.3862943611198906
Predictors,4,1.3862943611198906
Jiangsu,4,1.3862943611198906
288,4,1.3862943611198906
Royal,4,1.3862943611198906
HM3,4,1.3862943611198906
HVAD,4,1.3862943611198906
380,4,1.3862943611198906
insular,4,1.3862943611198906
pharmacy,4,1.3862943611198906
IST-3,4,1.3862943611198906
metapneumovirus,4,1.3862943611198906
158,4,1.3862943611198906
breaks,4,1.3862943611198906
κ,4,1.3862943611198906
anaesthetic,4,1.3862943611198906
arithmetic,4,1.3862943611198906
precedes,4,1.3862943611198906
olds,4,1.3862943611198906
LQC,4,1.3862943611198906
statistic,4,1.3862943611198906
hyperactivity,4,1.3862943611198906
CRS,4,1.3862943611198906
disadvantage,4,1.3862943611198906
190,4,1.3862943611198906
attack-rates,4,1.3862943611198906
prosody,4,1.3862943611198906
deficiency，,4,1.3862943611198906
acoustic,4,1.3862943611198906
oblique,4,1.3862943611198906
4th,4,1.3862943611198906
445,4,1.3862943611198906
inspection,4,1.3862943611198906
cava,4,1.3862943611198906
GFR,4,1.3862943611198906
WBC,4,1.3862943611198906
Convalescent,4,1.3862943611198906
subepithelial,4,1.3862943611198906
TH2,4,1.3862943611198906
planetary,4,1.3862943611198906
chromosome,4,1.3862943611198906
legal,4,1.3862943611198906
myofibroblast,4,1.3862943611198906
Croatia,4,1.3862943611198906
nedocromil,4,1.3862943611198906
Cape,4,1.3862943611198906
H10,4,1.3862943611198906
displacement,4,1.3862943611198906
V4,4,1.3862943611198906
Aboriginal,4,1.3862943611198906
dilemmas,4,1.3862943611198906
electrocardiographically,4,1.3862943611198906
nose,4,1.3862943611198906
Saint,4,1.3862943611198906
ER,4,1.3862943611198906
uneventful,4,1.3862943611198906
parasympathetic,4,1.3862943611198906
mandate,4,1.3862943611198906
discover,4,1.3862943611198906
IgE-mediated,4,1.3862943611198906
excitement,4,1.3862943611198906
timeline,4,1.3862943611198906
clean,4,1.3862943611198906
sanitation,4,1.3862943611198906
suppresses,4,1.3862943611198906
elaboration,4,1.3862943611198906
sp-A,4,1.3862943611198906
Patent,4,1.3862943611198906
biggest,4,1.3862943611198906
healers,4,1.3862943611198906
coherence,4,1.3862943611198906
burning,4,1.3862943611198906
NVAF,4,1.3862943611198906
Town,4,1.3862943611198906
enveloped,4,1.3862943611198906
devastated,4,1.3862943611198906
inaccuracy,4,1.3862943611198906
scaled,4,1.3862943611198906
avoidable,4,1.3862943611198906
assurance,4,1.3862943611198906
Long,4,1.3862943611198906
Hb,4,1.3862943611198906
staffing,4,1.3862943611198906
amplicons,4,1.3862943611198906
peaking,4,1.3862943611198906
pial,4,1.3862943611198906
alarming,4,1.3862943611198906
pharmacology,4,1.3862943611198906
teasoda,4,1.3862943611198906
subtropical,4,1.3862943611198906
discordant,4,1.3862943611198906
self-limited,4,1.3862943611198906
fairs,4,1.3862943611198906
worsens,4,1.3862943611198906
Alinity,4,1.3862943611198906
305,4,1.3862943611198906
4-6,4,1.3862943611198906
mink,4,1.3862943611198906
569,4,1.3862943611198906
CICU,4,1.3862943611198906
AII,4,1.3862943611198906
catecholamines,4,1.3862943611198906
irregular,4,1.3862943611198906
Adelaide,4,1.3862943611198906
raceethnicity,4,1.3862943611198906
650,4,1.3862943611198906
MBCS,4,1.3862943611198906
strip,4,1.3862943611198906
continuum,4,1.3862943611198906
earthquakes,4,1.3862943611198906
Olympic,4,1.3862943611198906
Olympics,4,1.3862943611198906
civil,4,1.3862943611198906
uncovered,4,1.3862943611198906
latitude,4,1.3862943611198906
verticality,4,1.3862943611198906
lateropulsion,4,1.3862943611198906
HCoV-229E,4,1.3862943611198906
H6,4,1.3862943611198906
fermentation,4,1.3862943611198906
hydrogen,4,1.3862943611198906
hypokinesis,4,1.3862943611198906
P00001,4,1.3862943611198906
180-day,4,1.3862943611198906
slice,4,1.3862943611198906
138,4,1.3862943611198906
neutralising,4,1.3862943611198906
normalisation,4,1.3862943611198906
channels,4,1.3862943611198906
Forty-three,4,1.3862943611198906
Plaque,4,1.3862943611198906
313,4,1.3862943611198906
Demographic,4,1.3862943611198906
Eighty,4,1.3862943611198906
200910,4,1.3862943611198906
Advanced,4,1.3862943611198906
elusive,4,1.3862943611198906
Genes,4,1.3862943611198906
FLAIR,4,1.3862943611198906
depicted,4,1.3862943611198906
lncRNA,4,1.3862943611198906
plague,4,1.3862943611198906
p-value,4,1.3862943611198906
LVS,4,1.3862943611198906
lymphoma,4,1.3862943611198906
Genome,4,1.3862943611198906
LTB4,4,1.3862943611198906
linkage,4,1.3862943611198906
1982,4,1.3862943611198906
RBD219-N1C1,4,1.3862943611198906
labetalol,4,1.3862943611198906
grow,4,1.3862943611198906
non-synonymous,4,1.3862943611198906
AcHERV-VLP,4,1.3862943611198906
Host,4,1.3862943611198906
627,4,1.3862943611198906
first-time,4,1.3862943611198906
Diltiazem,4,1.3862943611198906
synergism,4,1.3862943611198906
GRADE,4,1.3862943611198906
seriousness,4,1.3862943611198906
amplicon,4,1.3862943611198906
sham,4,1.3862943611198906
film,4,1.3862943611198906
schedule,4,1.3862943611198906
Src,4,1.3862943611198906
AdC68-19S,4,1.3862943611198906
derivative,4,1.3862943611198906
Mexican,4,1.3862943611198906
Barthel,4,1.3862943611198906
EBC,4,1.3862943611198906
ADMA,4,1.3862943611198906
SVC,4,1.3862943611198906
pituitary,4,1.3862943611198906
Coronaviridae,4,1.3862943611198906
rabbits,4,1.3862943611198906
nonsurvivors,4,1.3862943611198906
low-molecular-weight,4,1.3862943611198906
AZ,4,1.3862943611198906
HCoV,4,1.3862943611198906
SVT,4,1.3862943611198906
sinovenous,4,1.3862943611198906
leukemia,4,1.3862943611198906
Hgsec,4,1.3862943611198906
non-approved,4,1.3862943611198906
biosurfactants,4,1.3862943611198906
schemes,4,1.3862943611198906
your,4,1.3862943611198906
911,4,1.3862943611198906
AMIs,4,1.3862943611198906
seroconverted,4,1.3862943611198906
yielding,4,1.3862943611198906
1900,4,1.3862943611198906
opinions,4,1.3862943611198906
exceeding,4,1.3862943611198906
EVT-access,4,1.3862943611198906
amiodarone,4,1.3862943611198906
435,4,1.3862943611198906
296,4,1.3862943611198906
MSI,4,1.3862943611198906
looks,4,1.3862943611198906
seed,4,1.3862943611198906
NOx,4,1.3862943611198906
373,4,1.3862943611198906
eczema,4,1.3862943611198906
Island,4,1.3862943611198906
One-Pot,4,1.3862943611198906
adhere,4,1.3862943611198906
073,4,1.3862943611198906
countrys,4,1.3862943611198906
517,4,1.3862943611198906
SGs,4,1.3862943611198906
ultraviolet,4,1.3862943611198906
antipsychotic,4,1.3862943611198906
reminders,4,1.3862943611198906
influenza-infected,4,1.3862943611198906
post-PET,4,1.3862943611198906
Anti-SARS-CoV-2,4,1.3862943611198906
169,4,1.3862943611198906
cheaper,4,1.3862943611198906
postinfection,4,1.3862943611198906
enlargement,4,1.3862943611198906
commented,4,1.3862943611198906
Stockholm,4,1.3862943611198906
therapeutically,4,1.3862943611198906
locomotor,4,1.3862943611198906
multiorgan,4,1.3862943611198906
18-49,4,1.3862943611198906
2004-2005,4,1.3862943611198906
207,4,1.3862943611198906
hs-CRP,4,1.3862943611198906
inactivate,4,1.3862943611198906
cardiothoracic,4,1.3862943611198906
supervised,4,1.3862943611198906
337,4,1.3862943611198906
polymeric,4,1.3862943611198906
hematological,4,1.3862943611198906
lag,4,1.3862943611198906
house-dust,4,1.3862943611198906
Vascular,4,1.3862943611198906
paretic,4,1.3862943611198906
PTF,4,1.3862943611198906
reserved,4,1.3862943611198906
Treatments,4,1.3862943611198906
vertebrobasilar,4,1.3862943611198906
Med,4,1.3862943611198906
fibroblast,4,1.3862943611198906
conducts,4,1.3862943611198906
cardinal,4,1.3862943611198906
CZ-MD,4,1.3862943611198906
insufficiently,4,1.3862943611198906
crossing,4,1.3862943611198906
walls,4,1.3862943611198906
nm,4,1.3862943611198906
inactivating,4,1.3862943611198906
sporadically,4,1.3862943611198906
FC-SBL,4,1.3862943611198906
corresponds,4,1.3862943611198906
catheterized,4,1.3862943611198906
leukosis,4,1.3862943611198906
vasculitis,4,1.3862943611198906
four-fold,4,1.3862943611198906
HSAP,4,1.3862943611198906
1-3,4,1.3862943611198906
antibody-based,4,1.3862943611198906
Board,4,1.3862943611198906
cited,4,1.3862943611198906
Sequential,4,1.3862943611198906
sanitary,4,1.3862943611198906
setup,4,1.3862943611198906
early-stage,4,1.3862943611198906
killing,4,1.3862943611198906
IL-4,4,1.3862943611198906
elapsed,4,1.3862943611198906
acknowledged,4,1.3862943611198906
coronarosclerosis,4,1.3862943611198906
endomyocardial,4,1.3862943611198906
fabricated,4,1.3862943611198906
patch,4,1.3862943611198906
Uncontrolled,4,1.3862943611198906
Reporting,4,1.3862943611198906
intrauterine,4,1.3862943611198906
spatiotemporal,4,1.3862943611198906
OCD,4,1.3862943611198906
BACKGROUND,4,1.3862943611198906
simpler,4,1.3862943611198906
sociocultural,4,1.3862943611198906
Exhaled,4,1.3862943611198906
Excess,4,1.3862943611198906
Conference,4,1.3862943611198906
rimantadine,4,1.3862943611198906
Papua,4,1.3862943611198906
prioritizing,4,1.3862943611198906
Regulation,4,1.3862943611198906
Reinfarction,4,1.3862943611198906
post-mortem,4,1.3862943611198906
meetings,4,1.3862943611198906
horizontal,4,1.3862943611198906
battle,4,1.3862943611198906
Beyond,4,1.3862943611198906
PVCs,4,1.3862943611198906
PVC,4,1.3862943611198906
risk-benefit,4,1.3862943611198906
equity,4,1.3862943611198906
encompass,4,1.3862943611198906
meets,4,1.3862943611198906
far-reaching,4,1.3862943611198906
isocyanates,4,1.3862943611198906
industries,4,1.3862943611198906
nsp1,4,1.3862943611198906
Longitudinal,4,1.3862943611198906
BinaxNOW,4,1.3862943611198906
inorganic,4,1.3862943611198906
word,4,1.3862943611198906
Finding,4,1.3862943611198906
Prophylactic,4,1.3862943611198906
continuity,4,1.3862943611198906
Biology,4,1.3862943611198906
km,4,1.3862943611198906
Ebola,4,1.3862943611198906
SP,4,1.3862943611198906
opacities,4,1.3862943611198906
Caribbean,4,1.3862943611198906
2005-2006,4,1.3862943611198906
290,4,1.3862943611198906
waterfowl,4,1.3862943611198906
replicated,4,1.3862943611198906
ducks,4,1.3862943611198906
toroidal,4,1.3862943611198906
case-finding,4,1.3862943611198906
terminology,4,1.3862943611198906
persistently,4,1.3862943611198906
rCBV,4,1.3862943611198906
multisystem,4,1.3862943611198906
practically,4,1.3862943611198906
genesis,4,1.3862943611198906
calculating,4,1.3862943611198906
tailor,4,1.3862943611198906
remissions,4,1.3862943611198906
probabilistic,4,1.3862943611198906
renin-angiotensin-aldosterone,4,1.3862943611198906
AH3,4,1.3862943611198906
constituting,4,1.3862943611198906
MTT,4,1.3862943611198906
visually,4,1.3862943611198906
rCBF,4,1.3862943611198906
optimally,4,1.3862943611198906
exacerbating,4,1.3862943611198906
chloride,4,1.3862943611198906
Upper,4,1.3862943611198906
Experts,4,1.3862943611198906
inevitably,4,1.3862943611198906
3-5,4,1.3862943611198906
Impact,4,1.3862943611198906
≥1,4,1.3862943611198906
HCW,4,1.3862943611198906
postulated,4,1.3862943611198906
elucidating,4,1.3862943611198906
DL,4,1.3862943611198906
anticholinergic,4,1.3862943611198906
PSCI,4,1.3862943611198906
937,4,1.3862943611198906
pre-clinical,4,1.3862943611198906
tricuspid,4,1.3862943611198906
297,4,1.3862943611198906
electrographic,4,1.3862943611198906
sensorimotor,4,1.3862943611198906
invited,4,1.3862943611198906
paraclinical,4,1.3862943611198906
intradermal,4,1.3862943611198906
flowers,4,1.3862943611198906
dysphagia,4,1.3862943611198906
molds,4,1.3862943611198906
glucocorticoid,4,1.3862943611198906
Cadm2,4,1.3862943611198906
misuse,4,1.3862943611198906
SI,4,1.3862943611198906
substitute,4,1.3862943611198906
tumours,4,1.3862943611198906
cues,4,1.3862943611198906
EEG,4,1.3862943611198906
cannabis,4,1.3862943611198906
PECAM-1,4,1.3862943611198906
FPA,4,1.3862943611198906
Immune,4,1.3862943611198906
acidosis,4,1.3862943611198906
evoke,4,1.3862943611198906
QTd,4,1.3862943611198906
my,4,1.3862943611198906
1890,4,1.3862943611198906
310,4,1.3862943611198906
claimed,4,1.3862943611198906
602,4,1.3862943611198906
690,4,1.3862943611198906
hypercholesterolaemia,4,1.3862943611198906
consist,4,1.3862943611198906
citizens,4,1.3862943611198906
self-care,4,1.3862943611198906
M40,4,1.3862943611198906
Compliant,4,1.3862943611198906
Antibodies,4,1.3862943611198906
face-to-face,4,1.3862943611198906
village,4,1.3862943611198906
argument,4,1.3862943611198906
confusing,4,1.3862943611198906
questioned,4,1.3862943611198906
CNN,4,1.3862943611198906
deeply,4,1.3862943611198906
jugular,4,1.3862943611198906
standardize,4,1.3862943611198906
migratory,4,1.3862943611198906
phosphatidylserine,4,1.3862943611198906
HeLa,4,1.3862943611198906
398,4,1.3862943611198906
536,4,1.3862943611198906
gain-of-function,4,1.3862943611198906
deteriorating,4,1.3862943611198906
321,4,1.3862943611198906
SRD,4,1.3862943611198906
Thereafter,4,1.3862943611198906
familiar,4,1.3862943611198906
aids,4,1.3862943611198906
noncompliance,4,1.3862943611198906
409,4,1.3862943611198906
WTP,4,1.3862943611198906
synopsis,4,1.3862943611198906
visitors,4,1.3862943611198906
bioanalytical,4,1.3862943611198906
distant,4,1.3862943611198906
completeness,4,1.3862943611198906
pre-epidemic,4,1.3862943611198906
Significantly,4,1.3862943611198906
reflex,4,1.3862943611198906
ICHD,4,1.3862943611198906
jobs,4,1.3862943611198906
proteolytic,4,1.3862943611198906
bioaerosols,4,1.3862943611198906
phenotyping,4,1.3862943611198906
cathepsin,4,1.3862943611198906
co-circulating,4,1.3862943611198906
hesitant,4,1.3862943611198906
aura,4,1.3862943611198906
lists,4,1.3862943611198906
lymphadenopathy,4,1.3862943611198906
unbiased,4,1.3862943611198906
Dr,4,1.3862943611198906
bailout,4,1.3862943611198906
cleaning,4,1.3862943611198906
idiopathic,4,1.3862943611198906
Consideration,4,1.3862943611198906
solve,4,1.3862943611198906
Intracoronary,4,1.3862943611198906
scant,4,1.3862943611198906
wake,4,1.3862943611198906
afterload,4,1.3862943611198906
preconditioning,4,1.3862943611198906
SESs,4,1.3862943611198906
PESs,4,1.3862943611198906
syndrome-coronavirus-2,4,1.3862943611198906
dipyridamole,4,1.3862943611198906
stringent,4,1.3862943611198906
GFT,4,1.3862943611198906
S1S2,4,1.3862943611198906
Sharing,4,1.3862943611198906
268,4,1.3862943611198906
PMNs,4,1.3862943611198906
exciting,4,1.3862943611198906
Tl,4,1.3862943611198906
struggle,4,1.3862943611198906
232,4,1.3862943611198906
bars,4,1.3862943611198906
AW,4,1.3862943611198906
bar,4,1.3862943611198906
umbilical,4,1.3862943611198906
pathobiology,4,1.3862943611198906
VTE,4,1.3862943611198906
ambiguous,4,1.3862943611198906
trade,4,1.3862943611198906
Routine,4,1.3862943611198906
singing,4,1.3862943611198906
BMCs,4,1.3862943611198906
TPB,4,1.3862943611198906
343,4,1.3862943611198906
reassortants,4,1.3862943611198906
C-acetate,4,1.3862943611198906
Amantadine,4,1.3862943611198906
witnessed,4,1.3862943611198906
sH1N1,4,1.3862943611198906
Belt,4,1.3862943611198906
piglets,4,1.3862943611198906
norm,4,1.3862943611198906
Predicting,4,1.3862943611198906
neonate,4,1.3862943611198906
dentists,4,1.3862943611198906
drops,4,1.3862943611198906
searching,4,1.3862943611198906
Twenty-nine,4,1.3862943611198906
planners,4,1.3862943611198906
wherein,4,1.3862943611198906
cytometry,4,1.3862943611198906
T0,4,1.3862943611198906
ethics,4,1.3862943611198906
prudent,4,1.3862943611198906
285,4,1.3862943611198906
farm,4,1.3862943611198906
quantity,4,1.3862943611198906
seconds,4,1.3862943611198906
fluctuation,4,1.3862943611198906
Rates,4,1.3862943611198906
ovalbumin,4,1.3862943611198906
rejection,4,1.3862943611198906
stemprogenitor,4,1.3862943611198906
septic,4,1.3862943611198906
porcine,4,1.3862943611198906
Willebrand,4,1.3862943611198906
vWF,4,1.3862943611198906
Correlation,4,1.3862943611198906
arms,4,1.3862943611198906
Chain,4,1.3862943611198906
shoulder,4,1.3862943611198906
plasmid,4,1.3862943611198906
explicitly,4,1.3862943611198906
blacks,4,1.3862943611198906
opens,4,1.3862943611198906
proactive,4,1.3862943611198906
AuNPs,4,1.3862943611198906
Functioning,4,1.3862943611198906
seeding,4,1.3862943611198906
negligible,4,1.3862943611198906
LS,4,1.3862943611198906
solved,4,1.3862943611198906
SCPS,4,1.3862943611198906
pseudoaneurysms,4,1.3862943611198906
ERPs,4,1.3862943611198906
Digital,4,1.3862943611198906
Precision,4,1.3862943611198906
Biomeme,4,1.3862943611198906
multi-center,4,1.3862943611198906
refined,4,1.3862943611198906
Streptococcus,4,1.3862943611198906
CRTH2,4,1.3862943611198906
long-range,4,1.3862943611198906
fomite,4,1.3862943611198906
least-squares,4,1.3862943611198906
slowed,4,1.3862943611198906
optimism,4,1.3862943611198906
0011,4,1.3862943611198906
sedimentation,4,1.3862943611198906
rigid,4,1.3862943611198906
lowers,4,1.3862943611198906
Younger,4,1.3862943611198906
obscure,4,1.3862943611198906
intolerance,4,1.3862943611198906
lopinavirritonavir,4,1.3862943611198906
Decreased,4,1.3862943611198906
NAFLD,4,1.3862943611198906
RAT,4,1.3862943611198906
boundaries,4,1.3862943611198906
governance,4,1.3862943611198906
Chile,4,1.3862943611198906
airports,4,1.3862943611198906
rendering,4,1.3862943611198906
micro,4,1.3862943611198906
0006,4,1.3862943611198906
pass,4,1.3862943611198906
AGT,4,1.3862943611198906
serotonergic,4,1.3862943611198906
inactive,4,1.3862943611198906
exponential,4,1.3862943611198906
watershed,4,1.3862943611198906
prospect,4,1.3862943611198906
pneumomediastinum,4,1.3862943611198906
012,4,1.3862943611198906
slight,4,1.3862943611198906
web-based,4,1.3862943611198906
additives,4,1.3862943611198906
retained,4,1.3862943611198906
engraftment,4,1.3862943611198906
12000,4,1.3862943611198906
sixth,4,1.3862943611198906
sequentially,4,1.3862943611198906
448,4,1.3862943611198906
normothermic,4,1.3862943611198906
BYamagata,4,1.3862943611198906
intensified,4,1.3862943611198906
Nifedipine,4,1.3862943611198906
coordinating,4,1.3862943611198906
Yamagata,4,1.3862943611198906
illegal,4,1.3862943611198906
practiced,4,1.3862943611198906
projected,4,1.3862943611198906
microangiopathy,4,1.3862943611198906
assisted,4,1.3862943611198906
TW,4,1.3862943611198906
Reasons,4,1.3862943611198906
amplitude,4,1.3862943611198906
perceptual,4,1.3862943611198906
rationally,4,1.3862943611198906
LoD,4,1.3862943611198906
dendritic,4,1.3862943611198906
basics,4,1.3862943611198906
SARP,4,1.3862943611198906
mutagenesis,4,1.3862943611198906
dabigatran,4,1.3862943611198906
Units,4,1.3862943611198906
6h,4,1.3862943611198906
consumed,4,1.3862943611198906
necropsy,4,1.3862943611198906
input,4,1.3862943611198906
Abnormal,4,1.3862943611198906
HLP,4,1.3862943611198906
seals,4,1.3862943611198906
nonculprit,4,1.3862943611198906
post-symptom,4,1.3862943611198906
Mechanical,4,1.3862943611198906
miR-101,4,1.3862943611198906
sulphite,4,1.3862943611198906
predisposition,4,1.3862943611198906
Immediate,4,1.3862943611198906
sulphites,4,1.3862943611198906
Cardioembolic,4,1.3862943611198906
hamper,4,1.3862943611198906
404,4,1.3862943611198906
unresolved,4,1.3862943611198906
retardation,4,1.3862943611198906
impulse,4,1.3862943611198906
microneutralisation,4,1.3862943611198906
ISTIA,4,1.3862943611198906
Nitroglycerin,4,1.3862943611198906
tactics,4,1.3862943611198906
amyloid,4,1.3862943611198906
secretory,4,1.3862943611198906
minimise,4,1.3862943611198906
pneumococci,4,1.3862943611198906
straightforward,4,1.3862943611198906
CMN,4,1.3862943611198906
toddlers,4,1.3862943611198906
tens,4,1.3862943611198906
akinetic,4,1.3862943611198906
1-4,4,1.3862943611198906
re-infection,4,1.3862943611198906
diseased,4,1.3862943611198906
flying,4,1.3862943611198906
442,4,1.3862943611198906
flight,4,1.3862943611198906
reassortant,4,1.3862943611198906
chemokine,4,1.3862943611198906
selectively,4,1.3862943611198906
panic,4,1.3862943611198906
CD4CD8,4,1.3862943611198906
blood-activating,4,1.3862943611198906
alike,4,1.3862943611198906
Arteries,4,1.3862943611198906
Occluded,4,1.3862943611198906
≤,4,1.3862943611198906
HIV-infected,4,1.3862943611198906
GK-7,4,1.3862943611198906
passed,4,1.3862943611198906
Shanghai,4,1.3862943611198906
AMICS,4,1.3862943611198906
Think,4,1.3862943611198906
Dpt,4,1.3862943611198906
autopsies,4,1.3862943611198906
reproduce,4,1.3862943611198906
notifications,4,1.3862943611198906
computer-based,4,1.3862943611198906
SEIR,4,1.3862943611198906
2-dimensional,4,1.3862943611198906
beneficiaries,4,1.3862943611198906
orchestrate,4,1.3862943611198906
tonsils,4,1.3862943611198906
thousand,4,1.3862943611198906
H3N2-like,4,1.3862943611198906
NAT,4,1.3862943611198906
voltage,4,1.3862943611198906
immunosuppression,4,1.3862943611198906
0007,4,1.3862943611198906
synthase,4,1.3862943611198906
LTRAs,4,1.3862943611198906
satisfy,4,1.3862943611198906
copiesμL,4,1.3862943611198906
sessions,4,1.3862943611198906
1960s,4,1.3862943611198906
representatives,4,1.3862943611198906
Cellular,4,1.3862943611198906
influenza-specific,4,1.3862943611198906
BVictoria,4,1.3862943611198906
hypothalamic,4,1.3862943611198906
microarray,4,1.3862943611198906
reliance,4,1.3862943611198906
dizziness,4,1.3862943611198906
3WJ,4,1.3862943611198906
employee,4,1.3862943611198906
RKI,4,1.3862943611198906
resistive,4,1.3862943611198906
NIBS,4,1.3862943611198906
assets,4,1.3862943611198906
Microbiology,4,1.3862943611198906
nasopharynx,4,1.3862943611198906
normal-weight,4,1.3862943611198906
thromboprophylaxis,4,1.3862943611198906
Investigations,4,1.3862943611198906
fourteen,4,1.3862943611198906
2-D,4,1.3862943611198906
retrievers,4,1.3862943611198906
FEV1FVC,4,1.3862943611198906
informing,4,1.3862943611198906
identity,4,1.3862943611198906
531,4,1.3862943611198906
preclude,4,1.3862943611198906
pathologically,4,1.3862943611198906
preferential,4,1.3862943611198906
toucans,4,1.3862943611198906
1969,4,1.3862943611198906
scanner,4,1.3862943611198906
DBS,4,1.3862943611198906
Noninvasive,4,1.3862943611198906
fluctuating,4,1.3862943611198906
BMJ,4,1.3862943611198906
Air-MSU,4,1.3862943611198906
conventionally,4,1.3862943611198906
00002,4,1.3862943611198906
ensuing,4,1.3862943611198906
native,4,1.3862943611198906
cautious,4,1.3862943611198906
2015-2016,4,1.3862943611198906
Telemedicine,4,1.3862943611198906
synd4,4,1.3862943611198906
Complete,4,1.3862943611198906
expectations,4,1.3862943611198906
followed-up,4,1.3862943611198906
differentially,4,1.3862943611198906
309,4,1.3862943611198906
transcription-PCR,4,1.3862943611198906
≥12,4,1.3862943611198906
antidepressant,4,1.3862943611198906
FlOPs,4,1.3862943611198906
036,4,1.3862943611198906
External,4,1.3862943611198906
IMT,4,1.3862943611198906
roadmap,4,1.3862943611198906
geometry,4,1.3862943611198906
reinforced,4,1.3862943611198906
modulator,4,1.3862943611198906
Ad-synd4,4,1.3862943611198906
skewed,4,1.3862943611198906
expressive,4,1.3862943611198906
e,4,1.3862943611198906
MEF50,4,1.3862943611198906
O-deacylated,4,1.3862943611198906
dangers,4,1.3862943611198906
catheterisation,4,1.3862943611198906
prioritization,4,1.3862943611198906
POEMS,4,1.3862943611198906
smoker,4,1.3862943611198906
mAbs,4,1.3862943611198906
ill-defined,4,1.3862943611198906
mutational,4,1.3862943611198906
asymmetrical,4,1.3862943611198906
Open,4,1.3862943611198906
VL,4,1.3862943611198906
Post-stroke,4,1.3862943611198906
EpiRank,4,1.3862943611198906
ELVs,4,1.3862943611198906
583,4,1.3862943611198906
083,4,1.3862943611198906
neurohumoral,4,1.3862943611198906
Either,4,1.3862943611198906
prednisolone,4,1.3862943611198906
Twenty-seven,4,1.3862943611198906
curcumin,4,1.3862943611198906
Pattern,4,1.3862943611198906
900,4,1.3862943611198906
equations,4,1.3862943611198906
SK,4,1.3862943611198906
well-recognized,4,1.3862943611198906
hydrochlorothiazide,4,1.3862943611198906
align,4,1.3862943611198906
mgdL,4,1.3862943611198906
MCD,4,1.3862943611198906
LIS,4,1.3862943611198906
037,4,1.3862943611198906
roughly,4,1.3862943611198906
032,4,1.3862943611198906
VKA,4,1.3862943611198906
difficult-to-manage,4,1.3862943611198906
ordered,4,1.3862943611198906
BPL,4,1.3862943611198906
IFN-λ2,4,1.3862943611198906
IFN-λ3,4,1.3862943611198906
moyamoya,4,1.3862943611198906
lymphocytic,4,1.3862943611198906
BPV,4,1.3862943611198906
infects,4,1.3862943611198906
concurrently,4,1.3862943611198906
LCMV,4,1.3862943611198906
eucapnic,4,1.3862943611198906
wild-silk,4,1.3862943611198906
influenza-attributable,4,1.3862943611198906
317,4,1.3862943611198906
ICF,4,1.3862943611198906
KIV-2,4,1.3862943611198906
CAS,4,1.3862943611198906
caliber,4,1.3862943611198906
trying,4,1.3862943611198906
rendered,4,1.3862943611198906
cytology,4,1.3862943611198906
pre-COVID-19,4,1.3862943611198906
CAPA,4,1.3862943611198906
incidentally,4,1.3862943611198906
Sex,4,1.3862943611198906
channel,4,1.3862943611198906
Utah,4,1.3862943611198906
K627E,4,1.3862943611198906
Multiplex,4,1.3862943611198906
Epidemiologic,4,1.3862943611198906
withholding,4,1.3862943611198906
Hopkins,4,1.3862943611198906
Nowadays,4,1.3862943611198906
OLL1073R-1,4,1.3862943611198906
456,4,1.3862943611198906
skiers,4,1.3862943611198906
substudy,4,1.3862943611198906
gait,4,1.3862943611198906
two-step,4,1.3862943611198906
Quadrivalent,4,1.3862943611198906
immunopathology,4,1.3862943611198906
topology,4,1.3862943611198906
psychophysiological,4,1.3862943611198906
Incidence,4,1.3862943611198906
Forty,4,1.3862943611198906
Monday,4,1.3862943611198906
Roosevelt,4,1.3862943611198906
1991,4,1.3862943611198906
immunotherapeutics,4,1.3862943611198906
displays,4,1.3862943611198906
Jersey,4,1.3862943611198906
Criteria,4,1.3862943611198906
Atypical,4,1.3862943611198906
essay,4,1.3862943611198906
Prefecture,4,1.3862943611198906
disposal,4,1.3862943611198906
sporting,4,1.3862943611198906
Vienna,4,1.3862943611198906
practicing,4,1.3862943611198906
helpers,4,1.3862943611198906
adopt,4,1.3862943611198906
Selvester,4,1.3862943611198906
cheap,4,1.3862943611198906
single-cell,4,1.3862943611198906
528,4,1.3862943611198906
infusions,4,1.3862943611198906
confront,4,1.3862943611198906
twelve,4,1.3862943611198906
LPA,4,1.3862943611198906
mediastinitis,4,1.3862943611198906
assisting,4,1.3862943611198906
secondary-treated,4,1.3862943611198906
750,4,1.3862943611198906
devised,4,1.3862943611198906
0-1,4,1.3862943611198906
devoted,4,1.3862943611198906
discarded,4,1.3862943611198906
tortuosity,4,1.3862943611198906
F₂-isoP,4,1.3862943611198906
ngmL,4,1.3862943611198906
awake,4,1.3862943611198906
085,4,1.3862943611198906
isoprostanes,4,1.3862943611198906
investigational,4,1.3862943611198906
Today,4,1.3862943611198906
self-monitoring,4,1.3862943611198906
characterisation,4,1.3862943611198906
alternating,4,1.3862943611198906
occasion,4,1.3862943611198906
outer,4,1.3862943611198906
encourages,4,1.3862943611198906
145,4,1.3862943611198906
antihistamines,4,1.3862943611198906
hay,4,1.3862943611198906
customized,4,1.3862943611198906
enteral,4,1.3862943611198906
Brittle,4,1.3862943611198906
68Ga-NODAGA-RGD,4,1.3862943611198906
Asia-Pacific,4,1.3862943611198906
Mycoplasma,4,1.3862943611198906
postoperatively,4,1.3862943611198906
recreational,4,1.3862943611198906
mid,4,1.3862943611198906
geographically,4,1.3862943611198906
Cohort,4,1.3862943611198906
extracting,4,1.3862943611198906
Johnson,4,1.3862943611198906
ineligible,4,1.3862943611198906
1977-1978,4,1.3862943611198906
angular,4,1.3862943611198906
immunoglobulins,4,1.3862943611198906
020,4,1.3862943611198906
GOF,4,1.3862943611198906
dPdt,4,1.3862943611198906
preferentially,4,1.3862943611198906
lying,4,1.3862943611198906
permitted,4,1.3862943611198906
respiration,4,1.3862943611198906
Sydney,4,1.3862943611198906
practising,4,1.3862943611198906
pontine,4,1.3862943611198906
pPCI,4,1.3862943611198906
triad,4,1.3862943611198906
workplaces,4,1.3862943611198906
behalf,4,1.3862943611198906
starts,4,1.3862943611198906
alertness,4,1.3862943611198906
093,4,1.3862943611198906
Calcium,4,1.3862943611198906
orthodontic,4,1.3862943611198906
suspended,4,1.3862943611198906
Tozinameran,4,1.3862943611198906
6-8,4,1.3862943611198906
CHA,4,1.3862943611198906
biobanks,4,1.3862943611198906
countermeasures,4,1.3862943611198906
178,4,1.3862943611198906
subphenotypes,4,1.3862943611198906
35°C,4,1.3862943611198906
freeze-thawing,4,1.3862943611198906
ITZs,4,1.3862943611198906
Interventions,4,1.3862943611198906
thinning,4,1.3862943611198906
S3,4,1.3862943611198906
Vaxzevria,4,1.3862943611198906
syndrome-coronavirus,4,1.3862943611198906
dot,4,1.3862943611198906
laboratory-based,4,1.3862943611198906
accessibility,4,1.3862943611198906
you,4,1.3862943611198906
resumed,4,1.3862943611198906
Relative,4,1.3862943611198906
prevailing,4,1.3862943611198906
upward,4,1.3862943611198906
Novosibirsk,4,1.3862943611198906
Taiwanese,4,1.3862943611198906
disappearance,4,1.3862943611198906
affection,4,1.3862943611198906
Indians,4,1.3862943611198906
year-old,4,1.3862943611198906
biased,4,1.3862943611198906
two-thirds,4,1.3862943611198906
withdrawn,4,1.3862943611198906
worried,4,1.3862943611198906
PHI,4,1.3862943611198906
anxious,4,1.3862943611198906
chemistry,4,1.3862943611198906
willing,4,1.3862943611198906
maximizing,4,1.3862943611198906
localize,4,1.3862943611198906
single-photon,4,1.3862943611198906
postprocedural,4,1.3862943611198906
religious,4,1.3862943611198906
Subsequent,4,1.3862943611198906
220,4,1.3862943611198906
conjugate,4,1.3862943611198906
computerised,4,1.3862943611198906
fifty,4,1.3862943611198906
Performing,4,1.3862943611198906
Sentinel,4,1.3862943611198906
939,4,1.3862943611198906
TWN,4,1.3862943611198906
distinctly,4,1.3862943611198906
stimulus,4,1.3862943611198906
counseling,4,1.3862943611198906
≥160,4,1.3862943611198906
slower,4,1.3862943611198906
presumptive,4,1.3862943611198906
HCs,4,1.3862943611198906
TNG,4,1.3862943611198906
090,4,1.3862943611198906
hands,4,1.3862943611198906
Univariate,4,1.3862943611198906
mouth,4,1.3862943611198906
nonsynonymous,4,1.3862943611198906
basigin,4,1.3862943611198906
edge,4,1.3862943611198906
ABCD2,4,1.3862943611198906
respirators,4,1.3862943611198906
Coalition,4,1.3862943611198906
Regular,4,1.3862943611198906
precede,4,1.3862943611198906
Functional,4,1.3862943611198906
penetrating,4,1.3862943611198906
Fast,4,1.3862943611198906
polar,4,1.3862943611198906
ADP-ribose,4,1.3862943611198906
DREP,4,1.3862943611198906
styles,4,1.3862943611198906
resurgence,4,1.3862943611198906
360,4,1.3862943611198906
reopening,4,1.3862943611198906
remembered,4,1.3862943611198906
gestation,4,1.3862943611198906
Cross,4,1.3862943611198906
sustaining,4,1.3862943611198906
035,4,1.3862943611198906
incompletely,4,1.3862943611198906
Z,4,1.3862943611198906
exhaustion,4,1.3862943611198906
Obesity,4,1.3862943611198906
career,4,1.3862943611198906
muscular,4,1.3862943611198906
influenzal,4,1.3862943611198906
p001,4,1.3862943611198906
Long-acting,4,1.3862943611198906
Emergence,4,1.3862943611198906
Critical,4,1.3862943611198906
Groups,4,1.3862943611198906
year-round,4,1.3862943611198906
stressful,4,1.3862943611198906
escalating,4,1.3862943611198906
4G4G,4,1.3862943611198906
Alberta,4,1.3862943611198906
modestly,4,1.3862943611198906
PF4,4,1.3862943611198906
smoked,4,1.3862943611198906
Taking,4,1.3862943611198906
readmissions,4,1.3862943611198906
day-to-day,4,1.3862943611198906
065,4,1.3862943611198906
625,4,1.3862943611198906
ruptured,4,1.3862943611198906
transmembrane,4,1.3862943611198906
COVID-19-positive,4,1.3862943611198906
opposite,4,1.3862943611198906
PE,4,1.3862943611198906
height,4,1.3862943611198906
junior,4,1.3862943611198906
30-40,4,1.3862943611198906
Concerns,4,1.3862943611198906
gravity,4,1.3862943611198906
indexes,4,1.3862943611198906
contractions,4,1.3862943611198906
743,4,1.3862943611198906
5000,4,1.3862943611198906
exerted,4,1.3862943611198906
M2,4,1.3862943611198906
Multivariable,4,1.3862943611198906
notes,4,1.3862943611198906
lateralization,4,1.3862943611198906
fairly,4,1.3862943611198906
null,4,1.3862943611198906
malaria,4,1.3862943611198906
rs1800896,4,1.3862943611198906
Angiotensin-converting,4,1.3862943611198906
offering,4,1.3862943611198906
azithromycin,4,1.3862943611198906
dose-dependent,4,1.3862943611198906
213,4,1.3862943611198906
progenitors,4,1.3862943611198906
claim,4,1.3862943611198906
SARS-CoV-2-positive,4,1.3862943611198906
prototype,4,1.3862943611198906
kinases,4,1.3862943611198906
reinfarctions,4,1.3862943611198906
Florida,4,1.3862943611198906
angiopathy,4,1.3862943611198906
press,4,1.3862943611198906
doubts,4,1.3862943611198906
delineate,4,1.3862943611198906
gustatory,4,1.3862943611198906
appreciated,4,1.3862943611198906
Sample,4,1.3862943611198906
successes,4,1.3862943611198906
age-appropriate,4,1.3862943611198906
populated,4,1.3862943611198906
liquid,4,1.3862943611198906
acceleration,4,1.3862943611198906
express,4,1.3862943611198906
181,4,1.3862943611198906
guardians,4,1.3862943611198906
modifiers,4,1.3862943611198906
mildmoderate,4,1.3862943611198906
ACOV,4,1.3862943611198906
root,4,1.3862943611198906
hinder,4,1.3862943611198906
facilitys,4,1.3862943611198906
calculation,4,1.3862943611198906
008,4,1.3862943611198906
unextracted,4,1.3862943611198906
population-scale,4,1.3862943611198906
incriminated,4,1.3862943611198906
opportunistic,4,1.3862943611198906
Beta,4,1.3862943611198906
machines,4,1.3862943611198906
homeostasis,4,1.3862943611198906
intramuscular,4,1.3862943611198906
IAV-induced,4,1.3862943611198906
clots,4,1.3862943611198906
BH,4,1.3862943611198906
Turkish,4,1.3862943611198906
VS,4,1.3862943611198906
dense,4,1.3862943611198906
PPAR-γ,4,1.3862943611198906
outlook,4,1.3862943611198906
co-circulation,4,1.3862943611198906
Gamma,4,1.3862943611198906
naso-pharyngeal,4,1.3862943611198906
surprised,4,1.3862943611198906
recycling,4,1.3862943611198906
pseudovirus,4,1.3862943611198906
feces,4,1.3862943611198906
364,4,1.3862943611198906
581,4,1.3862943611198906
sludge,4,1.3862943611198906
358,4,1.3862943611198906
judicious,4,1.3862943611198906
analytic,4,1.3862943611198906
non-medical,4,1.3862943611198906
147,4,1.3862943611198906
nonatherosclerotic,4,1.3862943611198906
parsimonious,4,1.3862943611198906
LDL-cholesterol,4,1.3862943611198906
humor,4,1.3862943611198906
plausibility,4,1.3862943611198906
aqueous,4,1.3862943611198906
30-50,4,1.3862943611198906
10-fold,4,1.3862943611198906
calendar,4,1.3862943611198906
fits,4,1.3862943611198906
V2,4,1.3862943611198906
Montreal,4,1.3862943611198906
Standardized,4,1.3862943611198906
marmosets,4,1.3862943611198906
bedding,4,1.3862943611198906
419,4,1.3862943611198906
N3,4,1.3862943611198906
Autopsy,4,1.3862943611198906
bench,4,1.3862943611198906
stool,4,1.3862943611198906
break,4,1.3862943611198906
fQRS,4,1.3862943611198906
Serology,4,1.3862943611198906
15-30,4,1.3862943611198906
spending,4,1.3862943611198906
021,4,1.3862943611198906
962,4,1.3862943611198906
rectal,4,1.3862943611198906
Therapy,4,1.3862943611198906
glycemia,4,1.3862943611198906
intraocular,4,1.3862943611198906
damaging,4,1.3862943611198906
diuretics,4,1.3862943611198906
circumference,4,1.3862943611198906
Gastroesophageal,4,1.3862943611198906
workflow,4,1.3862943611198906
asymmetric,4,1.3862943611198906
Tissue,4,1.3862943611198906
prompting,4,1.3862943611198906
facts,4,1.3862943611198906
FSMs,4,1.3862943611198906
vial,4,1.3862943611198906
occult,4,1.3862943611198906
awakening,4,1.3862943611198906
NYC,4,1.3862943611198906
HPAI,4,1.3862943611198906
motivated,4,1.3862943611198906
compact,4,1.3862943611198906
benchmark,4,1.3862943611198906
Possible,4,1.3862943611198906
neoplasms,4,1.3862943611198906
pitfalls,4,1.3862943611198906
nebulizers,4,1.3862943611198906
047,4,1.3862943611198906
cytoplasmic,4,1.3862943611198906
chains,4,1.3862943611198906
census,4,1.3862943611198906
Pooled,4,1.3862943611198906
Experience,4,1.3862943611198906
IMI,4,1.3862943611198906
mark,4,1.3862943611198906
Islands,4,1.3862943611198906
readout,4,1.3862943611198906
915,4,1.3862943611198906
cardiomegaly,4,1.3862943611198906
cross-protective,4,1.3862943611198906
switching,4,1.3862943611198906
Controls,4,1.3862943611198906
parishes,4,1.3862943611198906
Hopefully,4,1.3862943611198906
Stent,4,1.3862943611198906
organised,4,1.3862943611198906
educating,4,1.3862943611198906
4-5,4,1.3862943611198906
ranked,4,1.3862943611198906
RT-ddPCR,4,1.3862943611198906
warrant,4,1.3862943611198906
presumably,4,1.3862943611198906
tightness,4,1.3862943611198906
10-year,4,1.3862943611198906
epilepsies,4,1.3862943611198906
filter,4,1.3862943611198906
two-year,4,1.3862943611198906
flutter,4,1.3862943611198906
morphologic,4,1.3862943611198906
net,4,1.3862943611198906
overestimate,4,1.3862943611198906
proxies,4,1.3862943611198906
threaten,4,1.3862943611198906
translating,4,1.3862943611198906
Literature,4,1.3862943611198906
Ireland,4,1.3862943611198906
978,4,1.3862943611198906
non-pharmacological,4,1.3862943611198906
counties,4,1.3862943611198906
latency,4,1.3862943611198906
lengths,4,1.3862943611198906
synthesized,4,1.3862943611198906
VOI,4,1.3862943611198906
contrasted,4,1.3862943611198906
thoracotomy,4,1.3862943611198906
Czech,4,1.3862943611198906
vague,4,1.3862943611198906
Syrian,4,1.3862943611198906
escalation,4,1.3862943611198906
workload,4,1.3862943611198906
IF,4,1.3862943611198906
relapsed,4,1.3862943611198906
definitely,4,1.3862943611198906
completing,4,1.3862943611198906
speculated,4,1.3862943611198906
Instead,4,1.3862943611198906
borderline,4,1.3862943611198906
three-vessel,4,1.3862943611198906
Thirty-six,4,1.3862943611198906
unparalleled,4,1.3862943611198906
taught,4,1.3862943611198906
implies,4,1.3862943611198906
southeastern,4,1.3862943611198906
rheumatoid,4,1.3862943611198906
interim,4,1.3862943611198906
importations,4,1.3862943611198906
cytotoxicity,4,1.3862943611198906
anosmia,4,1.3862943611198906
subpopulations,4,1.3862943611198906
underestimate,4,1.3862943611198906
binomial,4,1.3862943611198906
antioxidants,4,1.3862943611198906
adenosine,4,1.3862943611198906
atmosphere,4,1.3862943611198906
affective,4,1.3862943611198906
1974,4,1.3862943611198906
freely,4,1.3862943611198906
overcoming,4,1.3862943611198906
Psychological,4,1.3862943611198906
redesign,4,1.3862943611198906
invading,4,1.3862943611198906
925,4,1.3862943611198906
mildly,4,1.3862943611198906
peer,4,1.3862943611198906
procoagulant,4,1.3862943611198906
labored,4,1.3862943611198906
fibrin,4,1.3862943611198906
licorice,4,1.3862943611198906
CRRT,4,1.3862943611198906
masses,4,1.3862943611198906
201516,4,1.3862943611198906
logistics,4,1.3862943611198906
Improving,4,1.3862943611198906
latex,4,1.3862943611198906
optimise,4,1.3862943611198906
019,4,1.3862943611198906
ultrasonic,4,1.3862943611198906
dysregulated,4,1.3862943611198906
Population,4,1.3862943611198906
Quick,4,1.3862943611198906
noteworthy,4,1.3862943611198906
manipulated,4,1.3862943611198906
iron,4,1.3862943611198906
stroke-specific,4,1.3862943611198906
launched,4,1.3862943611198906
influx,4,1.3862943611198906
Dermatophagoides,4,1.3862943611198906
myxoma,4,1.3862943611198906
hypercoagulable,4,1.3862943611198906
Maori,4,1.3862943611198906
appreciably,4,1.3862943611198906
money,4,1.3862943611198906
Echocardiographic,4,1.3862943611198906
IVA,4,1.3862943611198906
replacing,4,1.3862943611198906
Sixty-seven,4,1.3862943611198906
knowledgeable,4,1.3862943611198906
years-old,4,1.3862943611198906
giant,4,1.3862943611198906
113,4,1.3862943611198906
post-exposure,4,1.3862943611198906
HLH,4,1.3862943611198906
Fifty-three,4,1.3862943611198906
NF-κB,4,1.3862943611198906
RBD-conjugated,4,1.3862943611198906
dog,4,1.3862943611198906
swelling,4,1.3862943611198906
cough-variant,4,1.3862943611198906
MBTE,4,1.3862943611198906
chemotherapy,4,1.3862943611198906
399,4,1.3862943611198906
gestational,4,1.3862943611198906
hyperglycaemia,4,1.3862943611198906
robustness,4,1.3862943611198906
pseudoviral,4,1.3862943611198906
lysis,4,1.3862943611198906
immunocompetence,4,1.3862943611198906
TIAs,4,1.3862943611198906
reductase,4,1.3862943611198906
Resistance,4,1.3862943611198906
323,4,1.3862943611198906
half-maximal,4,1.3862943611198906
Arab,4,1.3862943611198906
microm,4,1.3862943611198906
exogenous,4,1.3862943611198906
possesses,4,1.3862943611198906
certificates,4,1.3862943611198906
fasting,4,1.3862943611198906
ROC,4,1.3862943611198906
rich,4,1.3862943611198906
racing,4,1.3862943611198906
FDG,4,1.3862943611198906
asystole,4,1.3862943611198906
DALYs,4,1.3862943611198906
age-matched,4,1.3862943611198906
Invasive,4,1.3862943611198906
nonetheless,4,1.3862943611198906
NPs,4,1.3862943611198906
Saudi,4,1.3862943611198906
neighborhood,4,1.3862943611198906
Transient,4,1.3862943611198906
CPR,4,1.3862943611198906
discrepancy,4,1.3862943611198906
multimodal,4,1.3862943611198906
patient-centered,4,1.3862943611198906
complicates,4,1.3862943611198906
184,4,1.3862943611198906
loop,4,1.3862943611198906
dysplasia,4,1.3862943611198906
Adults,4,1.3862943611198906
phospholipase,4,1.3862943611198906
MH,4,1.3862943611198906
deacetylase,4,1.3862943611198906
lifesaving,4,1.3862943611198906
heating,4,1.3862943611198906
COVID-19-recovered,4,1.3862943611198906
Transesophageal,4,1.3862943611198906
Allplex,4,1.3862943611198906
phynoptin,4,1.3862943611198906
vehicle,4,1.3862943611198906
41071,4,1.3862943611198906
42-year-old,4,1.3862943611198906
non-responders,4,1.3862943611198906
cold-adapted,4,1.3862943611198906
physiotherapy,4,1.3862943611198906
078,4,1.3862943611198906
percentages,4,1.3862943611198906
30-minute,4,1.3862943611198906
positron,4,1.3862943611198906
295,4,1.3862943611198906
epizootic,4,1.3862943611198906
Interview,4,1.3862943611198906
397,4,1.3862943611198906
mechanics,4,1.3862943611198906
elaborate,4,1.3862943611198906
recombination,4,1.3862943611198906
Inadequate,4,1.3862943611198906
SPSN,4,1.3862943611198906
trialled,4,1.3862943611198906
invade,4,1.3862943611198906
antihypertensives,4,1.3862943611198906
transducer,4,1.3862943611198906
ventilator,4,1.3862943611198906
706,4,1.3862943611198906
Mental,4,1.3862943611198906
Heterogeneity,4,1.3862943611198906
try,4,1.3862943611198906
PICU,4,1.3862943611198906
three-year,4,1.3862943611198906
W,4,1.3862943611198906
Tertiary,4,1.3862943611198906
Emotional,4,1.3862943611198906
twenty,4,1.3862943611198906
tremendously,4,1.3862943611198906
quadrivalent,4,1.3862943611198906
histopathologic,4,1.3862943611198906
PBMCs,4,1.3862943611198906
Framingham,4,1.3862943611198906
intranasally,4,1.3862943611198906
glycosylation,4,1.3862943611198906
8-12,4,1.3862943611198906
Factor,4,1.3862943611198906
Making,4,1.3862943611198906
Arabia,4,1.3862943611198906
ruling,4,1.3862943611198906
AHMPPI,4,1.3862943611198906
job,4,1.3862943611198906
Plan,4,1.3862943611198906
low-density,4,1.3862943611198906
headaches,4,1.3862943611198906
071,4,1.3862943611198906
Indoor,4,1.3862943611198906
numerical,4,1.3862943611198906
sex-related,4,1.3862943611198906
failures,4,1.3862943611198906
Inconsistent,4,1.3862943611198906
imaging-based,4,1.3862943611198906
tolerability,4,1.3862943611198906
Diabetic,4,1.3862943611198906
HeO2,4,1.3862943611198906
risen,4,1.3862943611198906
canine,4,1.3862943611198906
Finland,4,1.3862943611198906
aggravate,4,1.3862943611198906
undetectable,4,1.3862943611198906
School-based,4,1.3862943611198906
peramivir,4,1.3862943611198906
leaving,4,1.3862943611198906
exacerbate,3,1.0986122886681098
Countries,3,1.0986122886681098
n10,3,1.0986122886681098
computer-aided,3,1.0986122886681098
cortisol,3,1.0986122886681098
autonomous,3,1.0986122886681098
mesothelial,3,1.0986122886681098
PD35SGaw,3,1.0986122886681098
Stem,3,1.0986122886681098
drastically,3,1.0986122886681098
Sacks,3,1.0986122886681098
breastmilk,3,1.0986122886681098
posthospital,3,1.0986122886681098
WeChat,3,1.0986122886681098
brings,3,1.0986122886681098
fails,3,1.0986122886681098
Subclinical,3,1.0986122886681098
longterm,3,1.0986122886681098
non-allergic,3,1.0986122886681098
incapable,3,1.0986122886681098
beneficially,3,1.0986122886681098
pro-,3,1.0986122886681098
nephrotic,3,1.0986122886681098
cathepsins,3,1.0986122886681098
adequacy,3,1.0986122886681098
perceive,3,1.0986122886681098
granulocytes,3,1.0986122886681098
low-resource,3,1.0986122886681098
seroepidemiological,3,1.0986122886681098
50-year-old,3,1.0986122886681098
V-lineage,3,1.0986122886681098
stringency,3,1.0986122886681098
left-side,3,1.0986122886681098
Stress,3,1.0986122886681098
attenuating,3,1.0986122886681098
reprogramming,3,1.0986122886681098
tracheas,3,1.0986122886681098
Antithrombotic,3,1.0986122886681098
summarised,3,1.0986122886681098
plethora,3,1.0986122886681098
secreted,3,1.0986122886681098
27-year-old,3,1.0986122886681098
Dublin,3,1.0986122886681098
columns,3,1.0986122886681098
NSP3,3,1.0986122886681098
ORF1a,3,1.0986122886681098
Disparities,3,1.0986122886681098
Broad,3,1.0986122886681098
timesday,3,1.0986122886681098
protein-protein,3,1.0986122886681098
polyprotein,3,1.0986122886681098
Likewise,3,1.0986122886681098
synergistically,3,1.0986122886681098
597,3,1.0986122886681098
holidays,3,1.0986122886681098
abroad,3,1.0986122886681098
rationales,3,1.0986122886681098
breastfeed,3,1.0986122886681098
importation,3,1.0986122886681098
meaning,3,1.0986122886681098
AM,3,1.0986122886681098
FOV,3,1.0986122886681098
exceptional,3,1.0986122886681098
nonmedical,3,1.0986122886681098
coli,3,1.0986122886681098
Reduced,3,1.0986122886681098
responsivness,3,1.0986122886681098
Doctors,3,1.0986122886681098
prognostically,3,1.0986122886681098
immunised,3,1.0986122886681098
967,3,1.0986122886681098
finger,3,1.0986122886681098
cPass,3,1.0986122886681098
SPETT,3,1.0986122886681098
erythrocytes,3,1.0986122886681098
electroencephalogram,3,1.0986122886681098
NSW,3,1.0986122886681098
defenses,3,1.0986122886681098
coreceptor,3,1.0986122886681098
Basigin,3,1.0986122886681098
refine,3,1.0986122886681098
antidysrhythmic,3,1.0986122886681098
LBBB,3,1.0986122886681098
inferences,3,1.0986122886681098
968,3,1.0986122886681098
10172,3,1.0986122886681098
Ethiopia,3,1.0986122886681098
cup,3,1.0986122886681098
prostanoid,3,1.0986122886681098
antispastic,3,1.0986122886681098
PHAC,3,1.0986122886681098
262,3,1.0986122886681098
1979-1980,3,1.0986122886681098
Kong168,3,1.0986122886681098
abbreviated,3,1.0986122886681098
Cx,3,1.0986122886681098
constituents,3,1.0986122886681098
Community-acquired,3,1.0986122886681098
CHC,3,1.0986122886681098
pteronyssinus,3,1.0986122886681098
IPC,3,1.0986122886681098
RVEF,3,1.0986122886681098
cared,3,1.0986122886681098
VAS,3,1.0986122886681098
Inclusion,3,1.0986122886681098
Handgrip,3,1.0986122886681098
Consistent,3,1.0986122886681098
contemporaneous,3,1.0986122886681098
MEF,3,1.0986122886681098
interepidemic,3,1.0986122886681098
661,3,1.0986122886681098
Barcelona,3,1.0986122886681098
754,3,1.0986122886681098
essentially,3,1.0986122886681098
arteriographic,3,1.0986122886681098
TripleLock,3,1.0986122886681098
Biomonitoring,3,1.0986122886681098
autophagic,3,1.0986122886681098
live-attenuated,3,1.0986122886681098
adjuvanted,3,1.0986122886681098
elastic,3,1.0986122886681098
heredity,3,1.0986122886681098
drug-delivery,3,1.0986122886681098
cMCAO,3,1.0986122886681098
fermented,3,1.0986122886681098
calcification,3,1.0986122886681098
Pseudomonas,3,1.0986122886681098
kg,3,1.0986122886681098
TVs,3,1.0986122886681098
coffeegreen,3,1.0986122886681098
hs-cTnI,3,1.0986122886681098
dextromethorphan,3,1.0986122886681098
microbiology,3,1.0986122886681098
Elevated,3,1.0986122886681098
524,3,1.0986122886681098
TAVI,3,1.0986122886681098
Symptomatic,3,1.0986122886681098
LPVr,3,1.0986122886681098
2500,3,1.0986122886681098
2-dose,3,1.0986122886681098
sub-haplotypes,3,1.0986122886681098
stroketransient,3,1.0986122886681098
hot,3,1.0986122886681098
proliferative,3,1.0986122886681098
USSR,3,1.0986122886681098
ORF8,3,1.0986122886681098
COV,3,1.0986122886681098
illuminate,3,1.0986122886681098
660,3,1.0986122886681098
se,3,1.0986122886681098
humid,3,1.0986122886681098
P0003,3,1.0986122886681098
564,3,1.0986122886681098
analyzers,3,1.0986122886681098
359,3,1.0986122886681098
metered,3,1.0986122886681098
polypeptide,3,1.0986122886681098
Geneva,3,1.0986122886681098
006,3,1.0986122886681098
converted,3,1.0986122886681098
975,3,1.0986122886681098
Concerning,3,1.0986122886681098
gel,3,1.0986122886681098
orofacial,3,1.0986122886681098
protein-ligand,3,1.0986122886681098
download,3,1.0986122886681098
commonalities,3,1.0986122886681098
Siberia,3,1.0986122886681098
MgSO4,3,1.0986122886681098
Delay,3,1.0986122886681098
H2,3,1.0986122886681098
histone,3,1.0986122886681098
hyperimmune,3,1.0986122886681098
DPSO,3,1.0986122886681098
SVO,3,1.0986122886681098
upstream,3,1.0986122886681098
Developed,3,1.0986122886681098
OTV-resistant,3,1.0986122886681098
HTN,3,1.0986122886681098
sciences,3,1.0986122886681098
histologically,3,1.0986122886681098
r-TPA,3,1.0986122886681098
CTA,3,1.0986122886681098
024,3,1.0986122886681098
NCIT,3,1.0986122886681098
OS,3,1.0986122886681098
lifestyles,3,1.0986122886681098
Dubai,3,1.0986122886681098
exerts,3,1.0986122886681098
Strong,3,1.0986122886681098
precautionary,3,1.0986122886681098
061,3,1.0986122886681098
029,3,1.0986122886681098
QR,3,1.0986122886681098
communicators,3,1.0986122886681098
abundance,3,1.0986122886681098
insecticides,3,1.0986122886681098
neurosurgery,3,1.0986122886681098
time-efficient,3,1.0986122886681098
Age-specific,3,1.0986122886681098
hindered,3,1.0986122886681098
re-infarction,3,1.0986122886681098
catchment,3,1.0986122886681098
campus,3,1.0986122886681098
ISDs,3,1.0986122886681098
small-molecule,3,1.0986122886681098
Theoretically,3,1.0986122886681098
Qualitative,3,1.0986122886681098
RM,3,1.0986122886681098
mention,3,1.0986122886681098
428,3,1.0986122886681098
unremarkable,3,1.0986122886681098
0018,3,1.0986122886681098
manipulation,3,1.0986122886681098
EtOH,3,1.0986122886681098
toluene,3,1.0986122886681098
defective,3,1.0986122886681098
otolith,3,1.0986122886681098
three-month,3,1.0986122886681098
Ultimately,3,1.0986122886681098
bibliometric,3,1.0986122886681098
internet-based,3,1.0986122886681098
activates,3,1.0986122886681098
Soon,3,1.0986122886681098
Robust,3,1.0986122886681098
Tecumseh,3,1.0986122886681098
charged,3,1.0986122886681098
ischemiareperfusion,3,1.0986122886681098
cockroach,3,1.0986122886681098
Michigan,3,1.0986122886681098
isometric,3,1.0986122886681098
phylodynamic,3,1.0986122886681098
pharmacokinetics,3,1.0986122886681098
relates,3,1.0986122886681098
surprisingly,3,1.0986122886681098
macroscopic,3,1.0986122886681098
Milan,3,1.0986122886681098
Frankfurt,3,1.0986122886681098
convincingly,3,1.0986122886681098
beta-blockade,3,1.0986122886681098
chemiluminescent,3,1.0986122886681098
Contact,3,1.0986122886681098
ISIS,3,1.0986122886681098
cytokine-mediated,3,1.0986122886681098
Cincinnati,3,1.0986122886681098
glial,3,1.0986122886681098
meaningfully,3,1.0986122886681098
nonselective,3,1.0986122886681098
polarimetry,3,1.0986122886681098
bringing,3,1.0986122886681098
midst,3,1.0986122886681098
Binfluenza,3,1.0986122886681098
anecdotal,3,1.0986122886681098
acute-onset,3,1.0986122886681098
Targeting,3,1.0986122886681098
KEY,3,1.0986122886681098
contrast-enhanced,3,1.0986122886681098
colder,3,1.0986122886681098
surface-enhanced,3,1.0986122886681098
shifting,3,1.0986122886681098
606,3,1.0986122886681098
Disorders,3,1.0986122886681098
autosomal,3,1.0986122886681098
mucolytic,3,1.0986122886681098
treatment-subgroup,3,1.0986122886681098
irradiation,3,1.0986122886681098
KTA,3,1.0986122886681098
radiofrequency,3,1.0986122886681098
multicentre,3,1.0986122886681098
therapeutical,3,1.0986122886681098
influenza-like-illness,3,1.0986122886681098
São,3,1.0986122886681098
gathering,3,1.0986122886681098
single-vessel,3,1.0986122886681098
evenly,3,1.0986122886681098
dispersed,3,1.0986122886681098
Montelukast,3,1.0986122886681098
vehicles,3,1.0986122886681098
benzoyl,3,1.0986122886681098
halogenated,3,1.0986122886681098
FNMI,3,1.0986122886681098
editing,3,1.0986122886681098
OF,3,1.0986122886681098
TV,3,1.0986122886681098
lesson,3,1.0986122886681098
Thirty-eight,3,1.0986122886681098
20-40,3,1.0986122886681098
mediation,3,1.0986122886681098
infero-posterior,3,1.0986122886681098
antero-septal,3,1.0986122886681098
non-linear,3,1.0986122886681098
onwards,3,1.0986122886681098
P05,3,1.0986122886681098
attracting,3,1.0986122886681098
alleviate,3,1.0986122886681098
featured,3,1.0986122886681098
YHPG,3,1.0986122886681098
severities,3,1.0986122886681098
Local,3,1.0986122886681098
TI,3,1.0986122886681098
post-training,3,1.0986122886681098
voivodeship,3,1.0986122886681098
devising,3,1.0986122886681098
bodys,3,1.0986122886681098
omalizumab,3,1.0986122886681098
mild-to-moderate,3,1.0986122886681098
nonallergic,3,1.0986122886681098
506,3,1.0986122886681098
exhibiting,3,1.0986122886681098
one-way,3,1.0986122886681098
oblongata,3,1.0986122886681098
421,3,1.0986122886681098
ImpellaCP,3,1.0986122886681098
nucleoside,3,1.0986122886681098
occurrences,3,1.0986122886681098
spinothalamic,3,1.0986122886681098
catecholamine,3,1.0986122886681098
apathy,3,1.0986122886681098
elicits,3,1.0986122886681098
hyper-reactivity,3,1.0986122886681098
classifying,3,1.0986122886681098
Limitations,3,1.0986122886681098
myocytes,3,1.0986122886681098
Capoten,3,1.0986122886681098
counselling,3,1.0986122886681098
1920s,3,1.0986122886681098
encompasses,3,1.0986122886681098
neurohormonal,3,1.0986122886681098
relied,3,1.0986122886681098
Recanalization,3,1.0986122886681098
semi-quantitative,3,1.0986122886681098
alleles,3,1.0986122886681098
incontinence,3,1.0986122886681098
072,3,1.0986122886681098
laninamivir,3,1.0986122886681098
someone,3,1.0986122886681098
urge,3,1.0986122886681098
cancerous,3,1.0986122886681098
suggestion,3,1.0986122886681098
Latinos,3,1.0986122886681098
Foundation,3,1.0986122886681098
Opinion,3,1.0986122886681098
Tests,3,1.0986122886681098
Favipiravir,3,1.0986122886681098
356,3,1.0986122886681098
remind,3,1.0986122886681098
noticed,3,1.0986122886681098
MMWR,3,1.0986122886681098
CHQ,3,1.0986122886681098
jaw,3,1.0986122886681098
feeling,3,1.0986122886681098
RBC,3,1.0986122886681098
practolol,3,1.0986122886681098
millennium,3,1.0986122886681098
bands,3,1.0986122886681098
Indiana,3,1.0986122886681098
cytological,3,1.0986122886681098
long-lasting,3,1.0986122886681098
compromises,3,1.0986122886681098
H5N1-negative,3,1.0986122886681098
H5N1-positive,3,1.0986122886681098
30-year-old,3,1.0986122886681098
2030,3,1.0986122886681098
Achieving,3,1.0986122886681098
burials,3,1.0986122886681098
mechanically,3,1.0986122886681098
arrangements,3,1.0986122886681098
TPE-TR,3,1.0986122886681098
Spirometric,3,1.0986122886681098
Pediatrics,3,1.0986122886681098
preferably,3,1.0986122886681098
head-to-head,3,1.0986122886681098
argues,3,1.0986122886681098
12-15,3,1.0986122886681098
Mediterranean,3,1.0986122886681098
foods,3,1.0986122886681098
DWI-FLAIR,3,1.0986122886681098
Takotsubo,3,1.0986122886681098
Virtual,3,1.0986122886681098
Spirometry,3,1.0986122886681098
conditional,3,1.0986122886681098
lithium,3,1.0986122886681098
destination,3,1.0986122886681098
STAIR,3,1.0986122886681098
deduced,3,1.0986122886681098
recanalized,3,1.0986122886681098
Cairo,3,1.0986122886681098
implicates,3,1.0986122886681098
kill,3,1.0986122886681098
spanning,3,1.0986122886681098
Chief,3,1.0986122886681098
underutilized,3,1.0986122886681098
misclassification,3,1.0986122886681098
templates,3,1.0986122886681098
CCU,3,1.0986122886681098
minorities,3,1.0986122886681098
Simultaneous,3,1.0986122886681098
montelukast,3,1.0986122886681098
Training,3,1.0986122886681098
533,3,1.0986122886681098
reinfected,3,1.0986122886681098
tHcy,3,1.0986122886681098
nomogram,3,1.0986122886681098
rules,3,1.0986122886681098
860,3,1.0986122886681098
flowmetry,3,1.0986122886681098
off-pump,3,1.0986122886681098
Clinic,3,1.0986122886681098
nutrients,3,1.0986122886681098
Historical,3,1.0986122886681098
sE-selectin,3,1.0986122886681098
incur,3,1.0986122886681098
Inflammation,3,1.0986122886681098
antenatal,3,1.0986122886681098
user,3,1.0986122886681098
hinders,3,1.0986122886681098
splanchnic,3,1.0986122886681098
parkinsonism,3,1.0986122886681098
counterpart,3,1.0986122886681098
257,3,1.0986122886681098
pink,3,1.0986122886681098
nonsteroidal,3,1.0986122886681098
adjudication,3,1.0986122886681098
positives,3,1.0986122886681098
Gy,3,1.0986122886681098
erythrocyte,3,1.0986122886681098
topical,3,1.0986122886681098
PGD2,3,1.0986122886681098
radiosurgery,3,1.0986122886681098
undertaking,3,1.0986122886681098
1970s,3,1.0986122886681098
Meteorological,3,1.0986122886681098
ingredient,3,1.0986122886681098
communicating,3,1.0986122886681098
grades,3,1.0986122886681098
URI,3,1.0986122886681098
20-year,3,1.0986122886681098
TOP,3,1.0986122886681098
12-18,3,1.0986122886681098
copper,3,1.0986122886681098
urticariaangioedema,3,1.0986122886681098
NFA,3,1.0986122886681098
instructions,3,1.0986122886681098
ORF,3,1.0986122886681098
2011-2012,3,1.0986122886681098
violence,3,1.0986122886681098
Enhanced,3,1.0986122886681098
tracked,3,1.0986122886681098
Suspected,3,1.0986122886681098
alerts,3,1.0986122886681098
LMICs,3,1.0986122886681098
clustered,3,1.0986122886681098
430,3,1.0986122886681098
Strategy,3,1.0986122886681098
emphasised,3,1.0986122886681098
disturbing,3,1.0986122886681098
EPA,3,1.0986122886681098
CT17,3,1.0986122886681098
CT6,3,1.0986122886681098
Moscow,3,1.0986122886681098
retriever,3,1.0986122886681098
name,3,1.0986122886681098
lymphopenia,3,1.0986122886681098
diminution,3,1.0986122886681098
epizootics,3,1.0986122886681098
asthma-predictive,3,1.0986122886681098
62-year-old,3,1.0986122886681098
Biosensor,3,1.0986122886681098
ethanol,3,1.0986122886681098
encompassing,3,1.0986122886681098
aeruginosa,3,1.0986122886681098
Iranian,3,1.0986122886681098
NJ,3,1.0986122886681098
supine,3,1.0986122886681098
rescued,3,1.0986122886681098
preserving,3,1.0986122886681098
Fifty-seven,3,1.0986122886681098
316,3,1.0986122886681098
appreciation,3,1.0986122886681098
MAC,3,1.0986122886681098
reader,3,1.0986122886681098
GFAP,3,1.0986122886681098
1128,3,1.0986122886681098
formula,3,1.0986122886681098
galactose,3,1.0986122886681098
IAT,3,1.0986122886681098
advantageous,3,1.0986122886681098
Synthetic,3,1.0986122886681098
GRACE,3,1.0986122886681098
7500,3,1.0986122886681098
Latin,3,1.0986122886681098
Notch,3,1.0986122886681098
Serious,3,1.0986122886681098
resuscitated,3,1.0986122886681098
MHV,3,1.0986122886681098
corticospinal,3,1.0986122886681098
Organizations,3,1.0986122886681098
nonadherence,3,1.0986122886681098
imminent,3,1.0986122886681098
PRAMI,3,1.0986122886681098
smell,3,1.0986122886681098
permission,3,1.0986122886681098
attached,3,1.0986122886681098
port,3,1.0986122886681098
bronchoscopy,3,1.0986122886681098
prophylactically,3,1.0986122886681098
pH1N1-related,3,1.0986122886681098
occupations,3,1.0986122886681098
Schools,3,1.0986122886681098
insult,3,1.0986122886681098
Normal,3,1.0986122886681098
confronted,3,1.0986122886681098
morbid,3,1.0986122886681098
497,3,1.0986122886681098
noninfarct,3,1.0986122886681098
plates,3,1.0986122886681098
low-level,3,1.0986122886681098
snoring,3,1.0986122886681098
2019-2020,3,1.0986122886681098
GOT,3,1.0986122886681098
LDH,3,1.0986122886681098
00005,3,1.0986122886681098
LDT,3,1.0986122886681098
shell,3,1.0986122886681098
352,3,1.0986122886681098
firstly,3,1.0986122886681098
bipartite,3,1.0986122886681098
Twenty-four,3,1.0986122886681098
utilizes,3,1.0986122886681098
RdRPE,3,1.0986122886681098
quarantined,3,1.0986122886681098
system-wide,3,1.0986122886681098
low-frequency,3,1.0986122886681098
bradykinin,3,1.0986122886681098
atrophy,3,1.0986122886681098
hsa-miR-1307-3p,3,1.0986122886681098
Continuous,3,1.0986122886681098
474,3,1.0986122886681098
readings,3,1.0986122886681098
IU,3,1.0986122886681098
Mobile,3,1.0986122886681098
bronchiolitis,3,1.0986122886681098
pulsed,3,1.0986122886681098
r-LVR,3,1.0986122886681098
TCD,3,1.0986122886681098
hHIT,3,1.0986122886681098
Excessive,3,1.0986122886681098
antimicrobials,3,1.0986122886681098
anticipation,3,1.0986122886681098
mg100,3,1.0986122886681098
818,3,1.0986122886681098
AVS,3,1.0986122886681098
rs1800871,3,1.0986122886681098
BSL-2,3,1.0986122886681098
dreadful,3,1.0986122886681098
t-peak,3,1.0986122886681098
leptinergic,3,1.0986122886681098
forth,3,1.0986122886681098
INSIGHT,3,1.0986122886681098
1899,3,1.0986122886681098
Australians,3,1.0986122886681098
LOD,3,1.0986122886681098
transforming,3,1.0986122886681098
hemagglutinins,3,1.0986122886681098
glycan,3,1.0986122886681098
NICU,3,1.0986122886681098
2DE,3,1.0986122886681098
atomic,3,1.0986122886681098
strengthened,3,1.0986122886681098
glycans,3,1.0986122886681098
myofibroblasts,3,1.0986122886681098
PIRA,3,1.0986122886681098
amp,3,1.0986122886681098
stocks,3,1.0986122886681098
ions,3,1.0986122886681098
ESO,3,1.0986122886681098
poly,3,1.0986122886681098
heterosexual,3,1.0986122886681098
vegetation,3,1.0986122886681098
horizon,3,1.0986122886681098
Russian,3,1.0986122886681098
east,3,1.0986122886681098
1889,3,1.0986122886681098
remember,3,1.0986122886681098
early-warning,3,1.0986122886681098
intensively,3,1.0986122886681098
encodes,3,1.0986122886681098
sample-specific,3,1.0986122886681098
insertions,3,1.0986122886681098
discovering,3,1.0986122886681098
alarm,3,1.0986122886681098
decentralized,3,1.0986122886681098
cDNA,3,1.0986122886681098
Tongji,3,1.0986122886681098
interacts,3,1.0986122886681098
BCI,3,1.0986122886681098
LUS,3,1.0986122886681098
PAQLQ,3,1.0986122886681098
culmination,3,1.0986122886681098
Dox-,3,1.0986122886681098
noticeable,3,1.0986122886681098
consumables,3,1.0986122886681098
sleepiness,3,1.0986122886681098
supplemented,3,1.0986122886681098
oligosaccharide,3,1.0986122886681098
bad,3,1.0986122886681098
rescinding,3,1.0986122886681098
pandemia,3,1.0986122886681098
interobserver,3,1.0986122886681098
carers,3,1.0986122886681098
hsTn,3,1.0986122886681098
causation,3,1.0986122886681098
macaques,3,1.0986122886681098
rhesus,3,1.0986122886681098
sparsely,3,1.0986122886681098
RAO,3,1.0986122886681098
2008-2009,3,1.0986122886681098
aerosol-generating,3,1.0986122886681098
demyelination,3,1.0986122886681098
sternum,3,1.0986122886681098
work-exacerbated,3,1.0986122886681098
washing,3,1.0986122886681098
eGLIA,3,1.0986122886681098
cavities,3,1.0986122886681098
Cohens,3,1.0986122886681098
Triage,3,1.0986122886681098
Intervention,3,1.0986122886681098
vesicles,3,1.0986122886681098
Ribavirin,3,1.0986122886681098
mirror,3,1.0986122886681098
collaborating,3,1.0986122886681098
densely,3,1.0986122886681098
QTc,3,1.0986122886681098
inter-assay,3,1.0986122886681098
thromboses,3,1.0986122886681098
concentrate,3,1.0986122886681098
underscoring,3,1.0986122886681098
infantile,3,1.0986122886681098
Evans,3,1.0986122886681098
Lower,3,1.0986122886681098
actin,3,1.0986122886681098
weights,3,1.0986122886681098
strata,3,1.0986122886681098
succumbed,3,1.0986122886681098
technically,3,1.0986122886681098
learnt,3,1.0986122886681098
dusts,3,1.0986122886681098
usefully,3,1.0986122886681098
plicatic,3,1.0986122886681098
LEAD,3,1.0986122886681098
Twenty-eight,3,1.0986122886681098
adrenergic,3,1.0986122886681098
lability,3,1.0986122886681098
slopes,3,1.0986122886681098
sawmill,3,1.0986122886681098
accompany,3,1.0986122886681098
grouping,3,1.0986122886681098
low-molecular,3,1.0986122886681098
Cluster,3,1.0986122886681098
non-ST-segment-elevation,3,1.0986122886681098
metasensors,3,1.0986122886681098
metasurface,3,1.0986122886681098
1-5,3,1.0986122886681098
expense,3,1.0986122886681098
afford,3,1.0986122886681098
S-group,3,1.0986122886681098
FDP,3,1.0986122886681098
authority,3,1.0986122886681098
blunted,3,1.0986122886681098
EDP,3,1.0986122886681098
563,3,1.0986122886681098
exceed,3,1.0986122886681098
grows,3,1.0986122886681098
early-onset,3,1.0986122886681098
simvastatin,3,1.0986122886681098
atherothrombosis,3,1.0986122886681098
discount,3,1.0986122886681098
NAIS,3,1.0986122886681098
Georges,3,1.0986122886681098
Salt,3,1.0986122886681098
judgment,3,1.0986122886681098
intraoperative,3,1.0986122886681098
costing,3,1.0986122886681098
epigenome,3,1.0986122886681098
MBBA,3,1.0986122886681098
IL,3,1.0986122886681098
brains,3,1.0986122886681098
associating,3,1.0986122886681098
functionalized,3,1.0986122886681098
aetiologies,3,1.0986122886681098
telemetry,3,1.0986122886681098
vehicle-treated,3,1.0986122886681098
Army,3,1.0986122886681098
consolidated,3,1.0986122886681098
urban-rural,3,1.0986122886681098
PRNT90,3,1.0986122886681098
dearth,3,1.0986122886681098
PCTs,3,1.0986122886681098
MMF-treated,3,1.0986122886681098
bioinformatics,3,1.0986122886681098
568,3,1.0986122886681098
synergy,3,1.0986122886681098
bACE2,3,1.0986122886681098
And,3,1.0986122886681098
MMF,3,1.0986122886681098
935,3,1.0986122886681098
R2,3,1.0986122886681098
Estimates,3,1.0986122886681098
transcriptomics,3,1.0986122886681098
TMGW,3,1.0986122886681098
713,3,1.0986122886681098
suspicious,3,1.0986122886681098
blind,3,1.0986122886681098
nonresponders,3,1.0986122886681098
sinuses,3,1.0986122886681098
amelioration,3,1.0986122886681098
catheter-based,3,1.0986122886681098
10-15,3,1.0986122886681098
lifespan,3,1.0986122886681098
relaxin,3,1.0986122886681098
2002-2003,3,1.0986122886681098
Programme,3,1.0986122886681098
discourse,3,1.0986122886681098
LTC4,3,1.0986122886681098
precipitated,3,1.0986122886681098
creative,3,1.0986122886681098
≥70,3,1.0986122886681098
Worldwide,3,1.0986122886681098
615,3,1.0986122886681098
drug-eluting,3,1.0986122886681098
imperfect,3,1.0986122886681098
nonischemic,3,1.0986122886681098
30-min,3,1.0986122886681098
iso,3,1.0986122886681098
tyrosine,3,1.0986122886681098
DIT,3,1.0986122886681098
-omics,3,1.0986122886681098
560,3,1.0986122886681098
internationally,3,1.0986122886681098
prenatal,3,1.0986122886681098
paralleled,3,1.0986122886681098
Re,3,1.0986122886681098
postnatal,3,1.0986122886681098
druggable,3,1.0986122886681098
calculations,3,1.0986122886681098
T-group,3,1.0986122886681098
Oasys,3,1.0986122886681098
traits,3,1.0986122886681098
preload,3,1.0986122886681098
211,3,1.0986122886681098
House,3,1.0986122886681098
dyskinesis,3,1.0986122886681098
researches,3,1.0986122886681098
Areas,3,1.0986122886681098
organism,3,1.0986122886681098
ventriculographic,3,1.0986122886681098
matrices,3,1.0986122886681098
Rome,3,1.0986122886681098
underserved,3,1.0986122886681098
front-line,3,1.0986122886681098
ordinary,3,1.0986122886681098
QuickVue,3,1.0986122886681098
2006-2007,3,1.0986122886681098
non-occupational,3,1.0986122886681098
mutual,3,1.0986122886681098
INR,3,1.0986122886681098
resembled,3,1.0986122886681098
Real,3,1.0986122886681098
SPSS,3,1.0986122886681098
karyotype,3,1.0986122886681098
correcting,3,1.0986122886681098
beat,3,1.0986122886681098
stores,3,1.0986122886681098
vasodilator,3,1.0986122886681098
neurilemmoma,3,1.0986122886681098
Asthmatics,3,1.0986122886681098
non-high-risk,3,1.0986122886681098
individualize,3,1.0986122886681098
TLR,3,1.0986122886681098
PWI,3,1.0986122886681098
Bronchoconstriction,3,1.0986122886681098
influenzas,3,1.0986122886681098
bee,3,1.0986122886681098
Hospitalization,3,1.0986122886681098
128x,3,1.0986122886681098
vaccine-preventable,3,1.0986122886681098
prothrombotic,3,1.0986122886681098
immunocompetent,3,1.0986122886681098
mitotic,3,1.0986122886681098
reevaluated,3,1.0986122886681098
RCM,3,1.0986122886681098
versions,3,1.0986122886681098
Acupuncture,3,1.0986122886681098
600,3,1.0986122886681098
Individual,3,1.0986122886681098
atlases,3,1.0986122886681098
post-AMI,3,1.0986122886681098
colleges,3,1.0986122886681098
subscale,3,1.0986122886681098
0035,3,1.0986122886681098
512,3,1.0986122886681098
objects,3,1.0986122886681098
myeloproliferative,3,1.0986122886681098
Bank,3,1.0986122886681098
Field,3,1.0986122886681098
20000,3,1.0986122886681098
prefusion,3,1.0986122886681098
40000,3,1.0986122886681098
attempting,3,1.0986122886681098
IBAE,3,1.0986122886681098
IFNs,3,1.0986122886681098
peer-led,3,1.0986122886681098
Chlamydia,3,1.0986122886681098
extensions,3,1.0986122886681098
vitamins,3,1.0986122886681098
Later,3,1.0986122886681098
bullous,3,1.0986122886681098
spike-specific,3,1.0986122886681098
venepuncture,3,1.0986122886681098
miss,3,1.0986122886681098
biosensing,3,1.0986122886681098
PFT,3,1.0986122886681098
0008,3,1.0986122886681098
adenoma,3,1.0986122886681098
spot,3,1.0986122886681098
mutism,3,1.0986122886681098
psychometric,3,1.0986122886681098
proposal,3,1.0986122886681098
span,3,1.0986122886681098
Malays,3,1.0986122886681098
shaping,3,1.0986122886681098
admittance,3,1.0986122886681098
correspondence,3,1.0986122886681098
979,3,1.0986122886681098
eleven,3,1.0986122886681098
sure,3,1.0986122886681098
embedded,3,1.0986122886681098
684,3,1.0986122886681098
interactive,3,1.0986122886681098
tumour,3,1.0986122886681098
7-year,3,1.0986122886681098
Afterwards,3,1.0986122886681098
Th1,3,1.0986122886681098
unwitnessed,3,1.0986122886681098
T2-type,3,1.0986122886681098
obliged,3,1.0986122886681098
endoscopic,3,1.0986122886681098
XeCT,3,1.0986122886681098
accreditation,3,1.0986122886681098
virus-associated,3,1.0986122886681098
non-invasively,3,1.0986122886681098
Tanzania,3,1.0986122886681098
seronegative,3,1.0986122886681098
sitting,3,1.0986122886681098
divergent,3,1.0986122886681098
epinephrine,3,1.0986122886681098
placing,3,1.0986122886681098
NSA,3,1.0986122886681098
Gene,3,1.0986122886681098
arisen,3,1.0986122886681098
virome,3,1.0986122886681098
referent,3,1.0986122886681098
HL,3,1.0986122886681098
extention,3,1.0986122886681098
HAI,3,1.0986122886681098
SAD,3,1.0986122886681098
Cross-sectional,3,1.0986122886681098
SSA,3,1.0986122886681098
twenty-nine,3,1.0986122886681098
Measurements,3,1.0986122886681098
552,3,1.0986122886681098
positioning,3,1.0986122886681098
betacoronaviruses,3,1.0986122886681098
retain,3,1.0986122886681098
ivermectin,3,1.0986122886681098
953,3,1.0986122886681098
Deaths,3,1.0986122886681098
electronically,3,1.0986122886681098
Danish,3,1.0986122886681098
cleaned,3,1.0986122886681098
day-care,3,1.0986122886681098
hypothesised,3,1.0986122886681098
transcribed,3,1.0986122886681098
nCoV,3,1.0986122886681098
entries,3,1.0986122886681098
Grippovak,3,1.0986122886681098
ataxic,3,1.0986122886681098
sub-types,3,1.0986122886681098
ignored,3,1.0986122886681098
degeneration,3,1.0986122886681098
staffs,3,1.0986122886681098
attractor,3,1.0986122886681098
lipoproteins,3,1.0986122886681098
Resonance,3,1.0986122886681098
ICTG,3,1.0986122886681098
cooperative,3,1.0986122886681098
Core,3,1.0986122886681098
purchased,3,1.0986122886681098
convincing,3,1.0986122886681098
purchase,3,1.0986122886681098
segmented,3,1.0986122886681098
commenced,3,1.0986122886681098
Archive,3,1.0986122886681098
Preparedness,3,1.0986122886681098
WMH,3,1.0986122886681098
transferring,3,1.0986122886681098
BoNTA,3,1.0986122886681098
teenagers,3,1.0986122886681098
oncologist,3,1.0986122886681098
MACEs,3,1.0986122886681098
Energy,3,1.0986122886681098
windows,3,1.0986122886681098
disability-adjusted,3,1.0986122886681098
spend,3,1.0986122886681098
equilibrium,3,1.0986122886681098
Accumulating,3,1.0986122886681098
outperform,3,1.0986122886681098
Fractional,3,1.0986122886681098
nearby,3,1.0986122886681098
pharmacists,3,1.0986122886681098
unravel,3,1.0986122886681098
6800,3,1.0986122886681098
cobas,3,1.0986122886681098
premenopausal,3,1.0986122886681098
analyzer,3,1.0986122886681098
termination,3,1.0986122886681098
185,3,1.0986122886681098
epi-aortic,3,1.0986122886681098
Borg,3,1.0986122886681098
058,3,1.0986122886681098
Essential,3,1.0986122886681098
programming,3,1.0986122886681098
501,3,1.0986122886681098
4-11,3,1.0986122886681098
tertiary-care,3,1.0986122886681098
Communities,3,1.0986122886681098
proceeded,3,1.0986122886681098
CVST,3,1.0986122886681098
HP,3,1.0986122886681098
Clusters,3,1.0986122886681098
glyceryl,3,1.0986122886681098
trinitrate,3,1.0986122886681098
452,3,1.0986122886681098
suppressant,3,1.0986122886681098
ictus,3,1.0986122886681098
roots,3,1.0986122886681098
tackling,3,1.0986122886681098
Present,3,1.0986122886681098
cerebellum,3,1.0986122886681098
isolating,3,1.0986122886681098
CPSS,3,1.0986122886681098
perturbance,3,1.0986122886681098
self-perceived,3,1.0986122886681098
Clopidogrel,3,1.0986122886681098
open-label,3,1.0986122886681098
endocytosis,3,1.0986122886681098
n16,3,1.0986122886681098
globulin,3,1.0986122886681098
Country,3,1.0986122886681098
looming,3,1.0986122886681098
derangements,3,1.0986122886681098
serotype,3,1.0986122886681098
FCFA,3,1.0986122886681098
races,3,1.0986122886681098
regressions,3,1.0986122886681098
perturbations,3,1.0986122886681098
EUROS,3,1.0986122886681098
767,3,1.0986122886681098
NT-proBNP,3,1.0986122886681098
Racial,3,1.0986122886681098
metformin,3,1.0986122886681098
aldosterone,3,1.0986122886681098
childcare,3,1.0986122886681098
reverse-transcriptase,3,1.0986122886681098
Ad-null,3,1.0986122886681098
armamentarium,3,1.0986122886681098
genus,3,1.0986122886681098
H7N2,3,1.0986122886681098
antibody-dependent,3,1.0986122886681098
egg,3,1.0986122886681098
photodynamic,3,1.0986122886681098
914,3,1.0986122886681098
EIATS,3,1.0986122886681098
Methylene,3,1.0986122886681098
neurogenic,3,1.0986122886681098
ACE-2,3,1.0986122886681098
Mixed,3,1.0986122886681098
hydrochloric,3,1.0986122886681098
tiredness,3,1.0986122886681098
two-component,3,1.0986122886681098
supplementation,3,1.0986122886681098
NMR,3,1.0986122886681098
anti-S,3,1.0986122886681098
PROGRESS,3,1.0986122886681098
neurotropic,3,1.0986122886681098
aggravating,3,1.0986122886681098
filtered,3,1.0986122886681098
TRA,3,1.0986122886681098
TFA,3,1.0986122886681098
on-road,3,1.0986122886681098
switched,3,1.0986122886681098
zoster,3,1.0986122886681098
Bleeding,3,1.0986122886681098
promises,3,1.0986122886681098
think,3,1.0986122886681098
microarrays,3,1.0986122886681098
Whole,3,1.0986122886681098
displaced,3,1.0986122886681098
PCS,3,1.0986122886681098
unconcentrated,3,1.0986122886681098
maximally,3,1.0986122886681098
periodontal,3,1.0986122886681098
J-point,3,1.0986122886681098
fibrofatty,3,1.0986122886681098
8-14,3,1.0986122886681098
hypercholesterolemia,3,1.0986122886681098
exemplify,3,1.0986122886681098
informal,3,1.0986122886681098
subfertile,3,1.0986122886681098
1084,3,1.0986122886681098
echocardiographically,3,1.0986122886681098
GPIbalpha,3,1.0986122886681098
810,3,1.0986122886681098
clarification,3,1.0986122886681098
Selective,3,1.0986122886681098
two-period,3,1.0986122886681098
550,3,1.0986122886681098
Good,3,1.0986122886681098
neovascularization,3,1.0986122886681098
up-regulated,3,1.0986122886681098
4-year-old,3,1.0986122886681098
chromatographic,3,1.0986122886681098
meditation,3,1.0986122886681098
RNase,3,1.0986122886681098
348,3,1.0986122886681098
couples,3,1.0986122886681098
houses,3,1.0986122886681098
Exercise-induced,3,1.0986122886681098
Wake-Up,3,1.0986122886681098
089,3,1.0986122886681098
453,3,1.0986122886681098
Ad26COV2S,3,1.0986122886681098
ray,3,1.0986122886681098
lasts,3,1.0986122886681098
short-lived,3,1.0986122886681098
Effect,3,1.0986122886681098
outlining,3,1.0986122886681098
1918-19,3,1.0986122886681098
urogenital,3,1.0986122886681098
AT2,3,1.0986122886681098
syndrome，,3,1.0986122886681098
tMCAO,3,1.0986122886681098
ARBs,3,1.0986122886681098
standing,3,1.0986122886681098
misleading,3,1.0986122886681098
microgramsmin,3,1.0986122886681098
unstudied,3,1.0986122886681098
professions,3,1.0986122886681098
Vircell,3,1.0986122886681098
uninsured,3,1.0986122886681098
self-assessment,3,1.0986122886681098
Reaction,3,1.0986122886681098
non-SARS-CoV-2,3,1.0986122886681098
ETS,3,1.0986122886681098
485,3,1.0986122886681098
Pennsylvania,3,1.0986122886681098
patchy,3,1.0986122886681098
adipose,3,1.0986122886681098
over-the-counter,3,1.0986122886681098
2-7,3,1.0986122886681098
premenstrual,3,1.0986122886681098
generalizable,3,1.0986122886681098
symptom-to-door,3,1.0986122886681098
crew,3,1.0986122886681098
2017-2018,3,1.0986122886681098
382,3,1.0986122886681098
min-1,3,1.0986122886681098
MIP,3,1.0986122886681098
non-Hispanic,3,1.0986122886681098
south,3,1.0986122886681098
TX,3,1.0986122886681098
SHR,3,1.0986122886681098
rigor,3,1.0986122886681098
southwestern,3,1.0986122886681098
self-expanding,3,1.0986122886681098
CoVID-19,3,1.0986122886681098
irritability,3,1.0986122886681098
mucous,3,1.0986122886681098
irritation,3,1.0986122886681098
committee,3,1.0986122886681098
STE,3,1.0986122886681098
kUL,3,1.0986122886681098
RHD,3,1.0986122886681098
fulfill,3,1.0986122886681098
minimized,3,1.0986122886681098
packaging,3,1.0986122886681098
stockpiling,3,1.0986122886681098
April-June,3,1.0986122886681098
ns,3,1.0986122886681098
714,3,1.0986122886681098
unselected,3,1.0986122886681098
swabbing,3,1.0986122886681098
IBM-Bonner,3,1.0986122886681098
IA,3,1.0986122886681098
endothelin,3,1.0986122886681098
ESVI,3,1.0986122886681098
Simultaneously,3,1.0986122886681098
unsuppressed,3,1.0986122886681098
pulmonologists,3,1.0986122886681098
multiplicity,3,1.0986122886681098
MFEIT,3,1.0986122886681098
soldiers,3,1.0986122886681098
Midwestern,3,1.0986122886681098
age-,3,1.0986122886681098
EC90,3,1.0986122886681098
computationally,3,1.0986122886681098
antidepressants,3,1.0986122886681098
CP®,3,1.0986122886681098
clearer,3,1.0986122886681098
Past,3,1.0986122886681098
waned,3,1.0986122886681098
metalloproteinase,3,1.0986122886681098
clarifying,3,1.0986122886681098
IAE,3,1.0986122886681098
archives,3,1.0986122886681098
nucleotides,3,1.0986122886681098
provoking,3,1.0986122886681098
esophagectomy,3,1.0986122886681098
steroid-dependent,3,1.0986122886681098
hyperkalemia,3,1.0986122886681098
AH1N1pdm,3,1.0986122886681098
Matrix,3,1.0986122886681098
demanded,3,1.0986122886681098
spatially,3,1.0986122886681098
read,3,1.0986122886681098
680,3,1.0986122886681098
competent,3,1.0986122886681098
ticlopidine,3,1.0986122886681098
mutates,3,1.0986122886681098
Raman,3,1.0986122886681098
0125,3,1.0986122886681098
414,3,1.0986122886681098
Colombia,3,1.0986122886681098
Reduction,3,1.0986122886681098
TIS,3,1.0986122886681098
Closure,3,1.0986122886681098
Last,3,1.0986122886681098
mural,3,1.0986122886681098
hematologic,3,1.0986122886681098
viremia,3,1.0986122886681098
dialogue,3,1.0986122886681098
succeeded,3,1.0986122886681098
irritant,3,1.0986122886681098
Ninety-eight,3,1.0986122886681098
Multicenter,3,1.0986122886681098
everything,3,1.0986122886681098
Close,3,1.0986122886681098
GWAS,3,1.0986122886681098
coinciding,3,1.0986122886681098
DhsLLL,3,1.0986122886681098
indistinguishable,3,1.0986122886681098
subtotal,3,1.0986122886681098
cusp,3,1.0986122886681098
coldflu,3,1.0986122886681098
bilaterally,3,1.0986122886681098
Cobas,3,1.0986122886681098
snakebite,3,1.0986122886681098
discrimination,3,1.0986122886681098
095,3,1.0986122886681098
PMT,3,1.0986122886681098
promoter,3,1.0986122886681098
seamlessly,3,1.0986122886681098
multipurpose,3,1.0986122886681098
FURIN,3,1.0986122886681098
TLR4,3,1.0986122886681098
Prognostic,3,1.0986122886681098
JTotal,3,1.0986122886681098
extremities,3,1.0986122886681098
Events,3,1.0986122886681098
subsamples,3,1.0986122886681098
cationic,3,1.0986122886681098
safeguard,3,1.0986122886681098
neurotoxin,3,1.0986122886681098
cell-specific,3,1.0986122886681098
gold-standard,3,1.0986122886681098
analgesic,3,1.0986122886681098
RMZ,3,1.0986122886681098
hub-and-spoke,3,1.0986122886681098
TNF,3,1.0986122886681098
truncated,3,1.0986122886681098
contracted,3,1.0986122886681098
reconstruct,3,1.0986122886681098
merit,3,1.0986122886681098
originally,3,1.0986122886681098
shear,3,1.0986122886681098
abundant,3,1.0986122886681098
Valsalva,3,1.0986122886681098
ICUs,3,1.0986122886681098
boosted,3,1.0986122886681098
423,3,1.0986122886681098
hub,3,1.0986122886681098
MAPCs,3,1.0986122886681098
MicroRNAs,3,1.0986122886681098
alternation,3,1.0986122886681098
virtue,3,1.0986122886681098
1788,3,1.0986122886681098
north,3,1.0986122886681098
Urgent,3,1.0986122886681098
struggling,3,1.0986122886681098
culminated,3,1.0986122886681098
Including,3,1.0986122886681098
HSCT,3,1.0986122886681098
gets,3,1.0986122886681098
vasoactive,3,1.0986122886681098
earliest,3,1.0986122886681098
IVNC,3,1.0986122886681098
IL-22,3,1.0986122886681098
transcriptome,3,1.0986122886681098
MCS,3,1.0986122886681098
abstract,3,1.0986122886681098
bimodal,3,1.0986122886681098
frameworks,3,1.0986122886681098
054,3,1.0986122886681098
entrance,3,1.0986122886681098
confound,3,1.0986122886681098
RNA-seq,3,1.0986122886681098
credibility,3,1.0986122886681098
funded,3,1.0986122886681098
palate,3,1.0986122886681098
medulla,3,1.0986122886681098
repeatability,3,1.0986122886681098
non-experimental,3,1.0986122886681098
flux,3,1.0986122886681098
periodic,3,1.0986122886681098
N-methyl-D-aspartate,3,1.0986122886681098
polyphenols,3,1.0986122886681098
placental,3,1.0986122886681098
secure,3,1.0986122886681098
clot-busting,3,1.0986122886681098
1232,3,1.0986122886681098
large-artery,3,1.0986122886681098
Initially,3,1.0986122886681098
cohesion,3,1.0986122886681098
365,3,1.0986122886681098
Exacerbations,3,1.0986122886681098
swept,3,1.0986122886681098
Neuroprotection,3,1.0986122886681098
Sarbecoviruses,3,1.0986122886681098
256,3,1.0986122886681098
elderberry,3,1.0986122886681098
POMS,3,1.0986122886681098
Tulsa,3,1.0986122886681098
A1,3,1.0986122886681098
Permanent,3,1.0986122886681098
1010,3,1.0986122886681098
μm,3,1.0986122886681098
Seegene,3,1.0986122886681098
Houston,3,1.0986122886681098
six-month,3,1.0986122886681098
098,3,1.0986122886681098
Sixty,3,1.0986122886681098
GSPECT,3,1.0986122886681098
14-day,3,1.0986122886681098
microscopes,3,1.0986122886681098
traced,3,1.0986122886681098
dysphasia,3,1.0986122886681098
predominately,3,1.0986122886681098
second-generation,3,1.0986122886681098
entitled,3,1.0986122886681098
Immunotherapy,3,1.0986122886681098
proof-of-concept,3,1.0986122886681098
622,3,1.0986122886681098
Diagnostics,3,1.0986122886681098
Symposium,3,1.0986122886681098
preeclampsia,3,1.0986122886681098
news,3,1.0986122886681098
thrombocytopaenia,3,1.0986122886681098
Admission,3,1.0986122886681098
354,3,1.0986122886681098
twenty-eight,3,1.0986122886681098
autoinflammatory,3,1.0986122886681098
upregulating,3,1.0986122886681098
serving,3,1.0986122886681098
three-fold,3,1.0986122886681098
seventy,3,1.0986122886681098
unspecified,3,1.0986122886681098
STANDARD,3,1.0986122886681098
mortem,3,1.0986122886681098
benidipine,3,1.0986122886681098
BMC,3,1.0986122886681098
topographic,3,1.0986122886681098
Seoul,3,1.0986122886681098
immunochromatography,3,1.0986122886681098
redefinition,3,1.0986122886681098
erythrocytic,3,1.0986122886681098
ILK-MSCs,3,1.0986122886681098
allogeneic,3,1.0986122886681098
cell-surface,3,1.0986122886681098
lifetime,3,1.0986122886681098
Repetitive,3,1.0986122886681098
Co,3,1.0986122886681098
EBV,3,1.0986122886681098
weaker,3,1.0986122886681098
parietal,3,1.0986122886681098
pneumocytes,3,1.0986122886681098
HCT,3,1.0986122886681098
ST-segment-elevation,3,1.0986122886681098
fulfilling,3,1.0986122886681098
arenavirus,3,1.0986122886681098
MBs,3,1.0986122886681098
hypoparathyroidism,3,1.0986122886681098
1958,3,1.0986122886681098
contradictory,3,1.0986122886681098
intimate,3,1.0986122886681098
palpable,3,1.0986122886681098
peroxidase,3,1.0986122886681098
semaphorin3E,3,1.0986122886681098
Theory,3,1.0986122886681098
guarantee,3,1.0986122886681098
578,3,1.0986122886681098
sentiment,3,1.0986122886681098
averting,3,1.0986122886681098
campers,3,1.0986122886681098
986,3,1.0986122886681098
plateau,3,1.0986122886681098
granules,3,1.0986122886681098
229,3,1.0986122886681098
IL-13,3,1.0986122886681098
wish,3,1.0986122886681098
penetrate,3,1.0986122886681098
pristimerin,3,1.0986122886681098
cytoplasm,3,1.0986122886681098
achievements,3,1.0986122886681098
Yalta,3,1.0986122886681098
grains,3,1.0986122886681098
Bangladeshi,3,1.0986122886681098
Bay,3,1.0986122886681098
coordinate,3,1.0986122886681098
201TI,3,1.0986122886681098
405,3,1.0986122886681098
community-wide,3,1.0986122886681098
transventricular,3,1.0986122886681098
anOPCAB,3,1.0986122886681098
304,3,1.0986122886681098
383,3,1.0986122886681098
OPCAB,3,1.0986122886681098
necessitate,3,1.0986122886681098
intubated,3,1.0986122886681098
248,3,1.0986122886681098
Uganda,3,1.0986122886681098
transcriptional,3,1.0986122886681098
PPH,3,1.0986122886681098
goblet,3,1.0986122886681098
hyperinflammatory,3,1.0986122886681098
99mTc-glucarate,3,1.0986122886681098
debilitating,3,1.0986122886681098
prolong,3,1.0986122886681098
Forty-four,3,1.0986122886681098
relax,3,1.0986122886681098
760,3,1.0986122886681098
Preventions,3,1.0986122886681098
biotechnology,3,1.0986122886681098
817,3,1.0986122886681098
schema,3,1.0986122886681098
Notice,3,1.0986122886681098
POPs,3,1.0986122886681098
Medicines,3,1.0986122886681098
stretching,3,1.0986122886681098
Specificity,3,1.0986122886681098
twofold,3,1.0986122886681098
want,3,1.0986122886681098
Adjusted,3,1.0986122886681098
Interleukin,3,1.0986122886681098
roll-out,3,1.0986122886681098
Catalonia,3,1.0986122886681098
joints,3,1.0986122886681098
replicates,3,1.0986122886681098
acidification,3,1.0986122886681098
Electrical,3,1.0986122886681098
CTs,3,1.0986122886681098
fulfil,3,1.0986122886681098
24-h,3,1.0986122886681098
cross-over,3,1.0986122886681098
visceral,3,1.0986122886681098
ICAS,3,1.0986122886681098
stepped-wedge,3,1.0986122886681098
unaware,3,1.0986122886681098
prestroke,3,1.0986122886681098
SPME,3,1.0986122886681098
VMX,3,1.0986122886681098
cardiomyoplasty,3,1.0986122886681098
DNB,3,1.0986122886681098
systole,3,1.0986122886681098
spared,3,1.0986122886681098
collaborations,3,1.0986122886681098
predisease,3,1.0986122886681098
passing,3,1.0986122886681098
popularity,3,1.0986122886681098
territorial,3,1.0986122886681098
art,3,1.0986122886681098
triglyceride,3,1.0986122886681098
mmolL,3,1.0986122886681098
portions,3,1.0986122886681098
hypertensives,3,1.0986122886681098
99mTc-PPi,3,1.0986122886681098
ferritin,3,1.0986122886681098
colors,3,1.0986122886681098
LAVs,3,1.0986122886681098
nation-wide,3,1.0986122886681098
gL,3,1.0986122886681098
Reinfection,3,1.0986122886681098
Cooperative,3,1.0986122886681098
favors,3,1.0986122886681098
IL-1,3,1.0986122886681098
pursuit,3,1.0986122886681098
Innate,3,1.0986122886681098
excised,3,1.0986122886681098
drives,3,1.0986122886681098
GTNN,3,1.0986122886681098
IL-17,3,1.0986122886681098
070,3,1.0986122886681098
circumferential,3,1.0986122886681098
14000,3,1.0986122886681098
advised,3,1.0986122886681098
anamnesis,3,1.0986122886681098
scintigrams,3,1.0986122886681098
NGNN,3,1.0986122886681098
disseminating,3,1.0986122886681098
misconceptions,3,1.0986122886681098
favoured,3,1.0986122886681098
Authorities,3,1.0986122886681098
influent,3,1.0986122886681098
Neuroimaging,3,1.0986122886681098
Sixty-nine,3,1.0986122886681098
copiesL,3,1.0986122886681098
indigenous,3,1.0986122886681098
EMV,3,1.0986122886681098
occured,3,1.0986122886681098
fixation,3,1.0986122886681098
telehealth,3,1.0986122886681098
Bedside,3,1.0986122886681098
Frequency,3,1.0986122886681098
endotracheal,3,1.0986122886681098
duplex,3,1.0986122886681098
wet,3,1.0986122886681098
Forty-six,3,1.0986122886681098
Observational,3,1.0986122886681098
Dhaka,3,1.0986122886681098
contributory,3,1.0986122886681098
residuals,3,1.0986122886681098
24-year-old,3,1.0986122886681098
Pandemics,3,1.0986122886681098
consulted,3,1.0986122886681098
489,3,1.0986122886681098
HES,3,1.0986122886681098
Assuming,3,1.0986122886681098
Retrospective,3,1.0986122886681098
obviously,3,1.0986122886681098
enzymatically,3,1.0986122886681098
payment,3,1.0986122886681098
LHI,3,1.0986122886681098
Inventory,3,1.0986122886681098
localisation,3,1.0986122886681098
stenosed,3,1.0986122886681098
hyperglycemic,3,1.0986122886681098
Loefflers,3,1.0986122886681098
mitogen,3,1.0986122886681098
protein-based,3,1.0986122886681098
managers,3,1.0986122886681098
time-lags,3,1.0986122886681098
imprecise,3,1.0986122886681098
rotational,3,1.0986122886681098
feel,3,1.0986122886681098
bodyweight,3,1.0986122886681098
soft,3,1.0986122886681098
staged,3,1.0986122886681098
mediastinoscopy,3,1.0986122886681098
glomangiosarcoma,3,1.0986122886681098
opacity,3,1.0986122886681098
falling,3,1.0986122886681098
nascent,3,1.0986122886681098
bradycardia,3,1.0986122886681098
depict,3,1.0986122886681098
subcostal,3,1.0986122886681098
descent,3,1.0986122886681098
Paul,3,1.0986122886681098
chiefly,3,1.0986122886681098
bp,3,1.0986122886681098
298,3,1.0986122886681098
seventh,3,1.0986122886681098
publics,3,1.0986122886681098
Peripheral,3,1.0986122886681098
post-MCAo,3,1.0986122886681098
thiobarbituric,3,1.0986122886681098
permanently,3,1.0986122886681098
aVF,3,1.0986122886681098
Implementation,3,1.0986122886681098
companion,3,1.0986122886681098
housed,3,1.0986122886681098
relievers,3,1.0986122886681098
Support,3,1.0986122886681098
failing,3,1.0986122886681098
screens,3,1.0986122886681098
advisable,3,1.0986122886681098
Psychosocial,3,1.0986122886681098
ancestor,3,1.0986122886681098
034,3,1.0986122886681098
neurologically,3,1.0986122886681098
cadavers,3,1.0986122886681098
intramyocardially,3,1.0986122886681098
Congenital,3,1.0986122886681098
RNAi-based,3,1.0986122886681098
DB,3,1.0986122886681098
Immediately,3,1.0986122886681098
Shortening,3,1.0986122886681098
angiogenic,3,1.0986122886681098
mandates,3,1.0986122886681098
Allergies,3,1.0986122886681098
co-circulated,3,1.0986122886681098
judge,3,1.0986122886681098
ligand,3,1.0986122886681098
EQA,3,1.0986122886681098
makeup,3,1.0986122886681098
conductive,3,1.0986122886681098
formulating,3,1.0986122886681098
Madagascar,3,1.0986122886681098
Insufficient,3,1.0986122886681098
Comparative,3,1.0986122886681098
lipodystrophy,3,1.0986122886681098
integrin,3,1.0986122886681098
prosthesis,3,1.0986122886681098
Knowing,3,1.0986122886681098
appreciate,3,1.0986122886681098
Berardinelli-Seip,3,1.0986122886681098
Intra-arterial,3,1.0986122886681098
world-wide,3,1.0986122886681098
785,3,1.0986122886681098
enquiry,3,1.0986122886681098
divergence,3,1.0986122886681098
age-group,3,1.0986122886681098
neurologist,3,1.0986122886681098
614,3,1.0986122886681098
HC,3,1.0986122886681098
intuitive,3,1.0986122886681098
investment,3,1.0986122886681098
anger,3,1.0986122886681098
beta2-agonists,3,1.0986122886681098
Referral,3,1.0986122886681098
Nature,3,1.0986122886681098
sensitizing,3,1.0986122886681098
innovations,3,1.0986122886681098
oppression,3,1.0986122886681098
BPT,3,1.0986122886681098
discordance,3,1.0986122886681098
difficult-to-control,3,1.0986122886681098
9-1-1,3,1.0986122886681098
harsh,3,1.0986122886681098
constructing,3,1.0986122886681098
multifunctional,3,1.0986122886681098
computation,3,1.0986122886681098
Division,3,1.0986122886681098
Upon,3,1.0986122886681098
expCFR,3,1.0986122886681098
within-,3,1.0986122886681098
paths,3,1.0986122886681098
undernutrition,3,1.0986122886681098
919,3,1.0986122886681098
Virological,3,1.0986122886681098
0043,3,1.0986122886681098
electrodes,3,1.0986122886681098
supervision,3,1.0986122886681098
resuming,3,1.0986122886681098
Brugada,3,1.0986122886681098
accepting,3,1.0986122886681098
Discharge,3,1.0986122886681098
hyperinflammation,3,1.0986122886681098
Reversible,3,1.0986122886681098
Alternate,3,1.0986122886681098
R95,3,1.0986122886681098
incidents,3,1.0986122886681098
Detecting,3,1.0986122886681098
Fluzone,3,1.0986122886681098
PRMT,3,1.0986122886681098
struck,3,1.0986122886681098
alveoli,3,1.0986122886681098
biofeedback,3,1.0986122886681098
obstetric,3,1.0986122886681098
arginine,3,1.0986122886681098
methylated,3,1.0986122886681098
acetaminophen,3,1.0986122886681098
MS023,3,1.0986122886681098
shortages,3,1.0986122886681098
multilevel,3,1.0986122886681098
064,3,1.0986122886681098
hypercoagulability,3,1.0986122886681098
infer,3,1.0986122886681098
EUROSTROKE,3,1.0986122886681098
caregiver,3,1.0986122886681098
©,3,1.0986122886681098
REM,3,1.0986122886681098
Thirty-day,3,1.0986122886681098
Tea,3,1.0986122886681098
unavoidable,3,1.0986122886681098
predominate,3,1.0986122886681098
Santa,3,1.0986122886681098
Computational,3,1.0986122886681098
200000,3,1.0986122886681098
Ideally,3,1.0986122886681098
315,3,1.0986122886681098
multimodality,3,1.0986122886681098
Romed,3,1.0986122886681098
ultraorthodox,3,1.0986122886681098
norepinephrine,3,1.0986122886681098
well-developed,3,1.0986122886681098
dopamine,3,1.0986122886681098
reevaluation,3,1.0986122886681098
Minority,3,1.0986122886681098
antigenicity,3,1.0986122886681098
AMI-CS,3,1.0986122886681098
believing,3,1.0986122886681098
thanks,3,1.0986122886681098
0020,3,1.0986122886681098
awakened,3,1.0986122886681098
occupationally,3,1.0986122886681098
merely,3,1.0986122886681098
unambiguous,3,1.0986122886681098
Sixty-two,3,1.0986122886681098
overload,3,1.0986122886681098
103-122,3,1.0986122886681098
ex,3,1.0986122886681098
box,3,1.0986122886681098
troponin-I,3,1.0986122886681098
Karachi,3,1.0986122886681098
Pakistan,3,1.0986122886681098
totaling,3,1.0986122886681098
ref,3,1.0986122886681098
386,3,1.0986122886681098
quality-adjusted,3,1.0986122886681098
healthier,3,1.0986122886681098
ancestral,3,1.0986122886681098
194,3,1.0986122886681098
046,3,1.0986122886681098
leaves,3,1.0986122886681098
mining,3,1.0986122886681098
classrooms,3,1.0986122886681098
bead,3,1.0986122886681098
Cochran,3,1.0986122886681098
Caco-2,3,1.0986122886681098
viz,3,1.0986122886681098
dismutase,3,1.0986122886681098
third-party,3,1.0986122886681098
2009-10,3,1.0986122886681098
noncoding,3,1.0986122886681098
detections,3,1.0986122886681098
Altogether,3,1.0986122886681098
endoplasmic,3,1.0986122886681098
freitasi,3,1.0986122886681098
096,3,1.0986122886681098
superoxide,3,1.0986122886681098
Tsp45I,3,1.0986122886681098
labeling,3,1.0986122886681098
scratch,3,1.0986122886681098
921,3,1.0986122886681098
atherogenic,3,1.0986122886681098
floors,3,1.0986122886681098
glomus,3,1.0986122886681098
319,3,1.0986122886681098
mins,3,1.0986122886681098
appeals,3,1.0986122886681098
KNa,3,1.0986122886681098
glycogen,3,1.0986122886681098
dreaming,3,1.0986122886681098
reimbursement,3,1.0986122886681098
launch,3,1.0986122886681098
Yazd,3,1.0986122886681098
age-dependent,3,1.0986122886681098
Biosafety,3,1.0986122886681098
conversations,3,1.0986122886681098
fountains,3,1.0986122886681098
postal,3,1.0986122886681098
sterilization,3,1.0986122886681098
unadjusted,3,1.0986122886681098
non-human,3,1.0986122886681098
modulators,3,1.0986122886681098
frailty,3,1.0986122886681098
staying,3,1.0986122886681098
Seeking,3,1.0986122886681098
accommodation,3,1.0986122886681098
intervene,3,1.0986122886681098
unfractionated,3,1.0986122886681098
engagement,3,1.0986122886681098
057,3,1.0986122886681098
subendocardial,3,1.0986122886681098
participatory,3,1.0986122886681098
Warsaw,3,1.0986122886681098
0048,3,1.0986122886681098
accommodated,3,1.0986122886681098
Perhaps,3,1.0986122886681098
700,3,1.0986122886681098
retraining,3,1.0986122886681098
neurorestorative,3,1.0986122886681098
Perioperative,3,1.0986122886681098
Library,3,1.0986122886681098
Implications,3,1.0986122886681098
accidentally,3,1.0986122886681098
potentiate,3,1.0986122886681098
anti-flu,3,1.0986122886681098
629,3,1.0986122886681098
argued,3,1.0986122886681098
ventriculograms,3,1.0986122886681098
migrating,3,1.0986122886681098
Lab,3,1.0986122886681098
event-free,3,1.0986122886681098
unsuccessfully,3,1.0986122886681098
Cath,3,1.0986122886681098
229E,3,1.0986122886681098
arteriosclerotic,3,1.0986122886681098
transplanted,3,1.0986122886681098
firmly,3,1.0986122886681098
4-fold,3,1.0986122886681098
460,3,1.0986122886681098
confabulation,3,1.0986122886681098
captopril,3,1.0986122886681098
≥15,3,1.0986122886681098
Infected,3,1.0986122886681098
15-20,3,1.0986122886681098
Content,3,1.0986122886681098
liposomes,3,1.0986122886681098
phagocytosis,3,1.0986122886681098
dysfunctions,3,1.0986122886681098
999,3,1.0986122886681098
Questionnaires,3,1.0986122886681098
orthogonal,3,1.0986122886681098
AOntario12522007,3,1.0986122886681098
cause-specific,3,1.0986122886681098
ammonia,3,1.0986122886681098
Wseg,3,1.0986122886681098
868,3,1.0986122886681098
satisfactorily,3,1.0986122886681098
perfusion-weighted,3,1.0986122886681098
079,3,1.0986122886681098
infarctionABSTRACT,3,1.0986122886681098
multicentric,3,1.0986122886681098
991,3,1.0986122886681098
viewpoint,3,1.0986122886681098
streamlined,3,1.0986122886681098
SalivaAll,3,1.0986122886681098
N-13,3,1.0986122886681098
meta-regression,3,1.0986122886681098
instructed,3,1.0986122886681098
AQLQ,3,1.0986122886681098
Nutrition,3,1.0986122886681098
coaching,3,1.0986122886681098
Establishing,3,1.0986122886681098
unsuitable,3,1.0986122886681098
Achievement,3,1.0986122886681098
salvageable,3,1.0986122886681098
preprocedural,3,1.0986122886681098
ARC,3,1.0986122886681098
conjugated,3,1.0986122886681098
primed,3,1.0986122886681098
arachidonic,3,1.0986122886681098
041,3,1.0986122886681098
inconsistently,3,1.0986122886681098
rESV,3,1.0986122886681098
RRs,3,1.0986122886681098
humankind,3,1.0986122886681098
gadolinium-DTPA,3,1.0986122886681098
short-axis,3,1.0986122886681098
hAOs,3,1.0986122886681098
projection,3,1.0986122886681098
streams,3,1.0986122886681098
augment,3,1.0986122886681098
Neurology,3,1.0986122886681098
RBCs,3,1.0986122886681098
ergometer,3,1.0986122886681098
Consecutive,3,1.0986122886681098
hurdles,3,1.0986122886681098
Studying,3,1.0986122886681098
B6-CH1-RBD,3,1.0986122886681098
Streptokinase,3,1.0986122886681098
unacceptable,3,1.0986122886681098
TA,3,1.0986122886681098
562,3,1.0986122886681098
intramural,3,1.0986122886681098
840,3,1.0986122886681098
construction,3,1.0986122886681098
post-infarct,3,1.0986122886681098
uniformly,3,1.0986122886681098
postulates,3,1.0986122886681098
broadband,3,1.0986122886681098
PolyVD,3,1.0986122886681098
PAD,3,1.0986122886681098
equivalents,3,1.0986122886681098
Histological,3,1.0986122886681098
step-up,3,1.0986122886681098
Airborne,3,1.0986122886681098
Hospital-based,3,1.0986122886681098
homing,3,1.0986122886681098
beta-agonist,3,1.0986122886681098
intermediate-term,3,1.0986122886681098
y,3,1.0986122886681098
unavailability,3,1.0986122886681098
transmittable,3,1.0986122886681098
hemodynamically,3,1.0986122886681098
spirit,3,1.0986122886681098
PERC6,3,1.0986122886681098
rotating,3,1.0986122886681098
graphical,3,1.0986122886681098
sub-group,3,1.0986122886681098
Examples,3,1.0986122886681098
intuitively,3,1.0986122886681098
Bcl-2,3,1.0986122886681098
Bax,3,1.0986122886681098
Parental,3,1.0986122886681098
salient,3,1.0986122886681098
exported,3,1.0986122886681098
NOD2,3,1.0986122886681098
payer,3,1.0986122886681098
S-myoglobin,3,1.0986122886681098
leverage,3,1.0986122886681098
CIIS,3,1.0986122886681098
straight,3,1.0986122886681098
menstruation,3,1.0986122886681098
aortocoronary,3,1.0986122886681098
ASD,3,1.0986122886681098
life-saving,3,1.0986122886681098
ended,3,1.0986122886681098
scarcity,3,1.0986122886681098
mentoring,3,1.0986122886681098
Ang,3,1.0986122886681098
retention,3,1.0986122886681098
non-paretic,3,1.0986122886681098
knee,3,1.0986122886681098
Lake,3,1.0986122886681098
inconsistency,3,1.0986122886681098
Visual,3,1.0986122886681098
Aortic,3,1.0986122886681098
exercised,3,1.0986122886681098
factor-alpha,3,1.0986122886681098
life-style,3,1.0986122886681098
nonalcoholic,3,1.0986122886681098
ACalifornia72009,3,1.0986122886681098
TND-IVE,3,1.0986122886681098
stiffness,3,1.0986122886681098
Ltd,3,1.0986122886681098
esophagus,3,1.0986122886681098
coefficients,3,1.0986122886681098
Summary,3,1.0986122886681098
rarity,3,1.0986122886681098
ambivalence,3,1.0986122886681098
Electronic,3,1.0986122886681098
shortest,3,1.0986122886681098
hierarchy,3,1.0986122886681098
bereavement,3,1.0986122886681098
somatic,3,1.0986122886681098
consult,3,1.0986122886681098
676,3,1.0986122886681098
marrow-derived,3,1.0986122886681098
interviewing,3,1.0986122886681098
reluctant,3,1.0986122886681098
ear,3,1.0986122886681098
marital,3,1.0986122886681098
Influenza-like,3,1.0986122886681098
ultrafast,3,1.0986122886681098
puerperium,3,1.0986122886681098
Nocturnal,3,1.0986122886681098
choroidal,3,1.0986122886681098
methodologically,3,1.0986122886681098
Tianjin,3,1.0986122886681098
intriguing,3,1.0986122886681098
PCA,3,1.0986122886681098
912,3,1.0986122886681098
widened,3,1.0986122886681098
Delays,3,1.0986122886681098
oximetry,3,1.0986122886681098
CRISPR-augmented,3,1.0986122886681098
immunosuppressed,3,1.0986122886681098
collector,3,1.0986122886681098
anticoagulated,3,1.0986122886681098
multiplexing,3,1.0986122886681098
ciliary,3,1.0986122886681098
bout,3,1.0986122886681098
049,3,1.0986122886681098
digitalis,3,1.0986122886681098
Ejection,3,1.0986122886681098
spiked,3,1.0986122886681098
chemically,3,1.0986122886681098
cultured,3,1.0986122886681098
entailing,3,1.0986122886681098
muscles,3,1.0986122886681098
beta-adrenergic,3,1.0986122886681098
moderate-severe,3,1.0986122886681098
SNAP1,3,1.0986122886681098
proliferate,3,1.0986122886681098
LTA,3,1.0986122886681098
MCVs,3,1.0986122886681098
Oncology,3,1.0986122886681098
Child,3,1.0986122886681098
tetrazolium,3,1.0986122886681098
dates,3,1.0986122886681098
403,3,1.0986122886681098
Cromolyn,3,1.0986122886681098
non-governmental,3,1.0986122886681098
unscheduled,3,1.0986122886681098
A57,3,1.0986122886681098
governmental,3,1.0986122886681098
PFUmL,3,1.0986122886681098
cattle,3,1.0986122886681098
1349,3,1.0986122886681098
Sinus,3,1.0986122886681098
invariably,3,1.0986122886681098
pictorial,3,1.0986122886681098
farmers,3,1.0986122886681098
conclusively,3,1.0986122886681098
Penh,3,1.0986122886681098
terns,3,1.0986122886681098
618,3,1.0986122886681098
vison,3,1.0986122886681098
PFTs,3,1.0986122886681098
273,3,1.0986122886681098
architecture,3,1.0986122886681098
DFSA,3,1.0986122886681098
structure-function,3,1.0986122886681098
asthmas,3,1.0986122886681098
886,3,1.0986122886681098
high-use,3,1.0986122886681098
1989,3,1.0986122886681098
QT,3,1.0986122886681098
hydroxyl,3,1.0986122886681098
genotypephenotype,3,1.0986122886681098
train,3,1.0986122886681098
convolutional,3,1.0986122886681098
regionally,3,1.0986122886681098
infarct-avid,3,1.0986122886681098
accelerates,3,1.0986122886681098
fecal-oral,3,1.0986122886681098
preserves,3,1.0986122886681098
fifteen,3,1.0986122886681098
667,3,1.0986122886681098
isocyanate-induced,3,1.0986122886681098
monogenic,3,1.0986122886681098
griffithsin,3,1.0986122886681098
lifelong,3,1.0986122886681098
Canadians,3,1.0986122886681098
470,3,1.0986122886681098
Pre-hospital,3,1.0986122886681098
acted,3,1.0986122886681098
facets,3,1.0986122886681098
airline,3,1.0986122886681098
1971,3,1.0986122886681098
hamming,3,1.0986122886681098
nothing,3,1.0986122886681098
non-stroke,3,1.0986122886681098
polygenic,3,1.0986122886681098
LTs,3,1.0986122886681098
Sixty-three,3,1.0986122886681098
hypotensive,3,1.0986122886681098
pheochromocytoma,3,1.0986122886681098
AA,3,1.0986122886681098
bloodstream,3,1.0986122886681098
betablocker,3,1.0986122886681098
restoring,3,1.0986122886681098
Protective,3,1.0986122886681098
sacs,3,1.0986122886681098
viscosity,3,1.0986122886681098
Utilization,3,1.0986122886681098
CysLTs,3,1.0986122886681098
casualty,3,1.0986122886681098
glycemic,3,1.0986122886681098
ranking,3,1.0986122886681098
introduces,3,1.0986122886681098
hemicraniectomy,3,1.0986122886681098
case-based,3,1.0986122886681098
generations,3,1.0986122886681098
unacceptably,3,1.0986122886681098
non-communicable,3,1.0986122886681098
WHOs,3,1.0986122886681098
homology,3,1.0986122886681098
eighteen,3,1.0986122886681098
homogeneity,3,1.0986122886681098
funds,3,1.0986122886681098
LP,3,1.0986122886681098
SLIT,3,1.0986122886681098
authentic,3,1.0986122886681098
instrumentation,3,1.0986122886681098
checking,3,1.0986122886681098
SHEP,3,1.0986122886681098
configurations,3,1.0986122886681098
decompensation,3,1.0986122886681098
necessitated,3,1.0986122886681098
readmitted,3,1.0986122886681098
hotspots,3,1.0986122886681098
formazan,3,1.0986122886681098
researcher,3,1.0986122886681098
JNC,3,1.0986122886681098
VI,3,1.0986122886681098
Preferred,3,1.0986122886681098
nation,3,1.0986122886681098
viruss,3,1.0986122886681098
Items,3,1.0986122886681098
abscess,3,1.0986122886681098
hand-washing,3,1.0986122886681098
281,3,1.0986122886681098
blocker,3,1.0986122886681098
pneumologists,3,1.0986122886681098
CIND,3,1.0986122886681098
547,3,1.0986122886681098
disclosed,3,1.0986122886681098
mailed,3,1.0986122886681098
thermostable,3,1.0986122886681098
centrifugal,3,1.0986122886681098
quality-of-life,3,1.0986122886681098
sweating,3,1.0986122886681098
vena,3,1.0986122886681098
palmitoleic,3,1.0986122886681098
Pathologic,3,1.0986122886681098
weekends,3,1.0986122886681098
cadets,3,1.0986122886681098
Applied,3,1.0986122886681098
971,3,1.0986122886681098
795,3,1.0986122886681098
791,3,1.0986122886681098
asphyxia,3,1.0986122886681098
548,3,1.0986122886681098
coupling,3,1.0986122886681098
Angina,3,1.0986122886681098
SIA,3,1.0986122886681098
multistage,3,1.0986122886681098
Inflammatory,3,1.0986122886681098
13-14,3,1.0986122886681098
resolves,3,1.0986122886681098
RPS3,3,1.0986122886681098
AcHERV-HA,3,1.0986122886681098
Pathway,3,1.0986122886681098
valuation,3,1.0986122886681098
disabling,3,1.0986122886681098
proceed,3,1.0986122886681098
underscores,3,1.0986122886681098
EDCs,3,1.0986122886681098
εa,3,1.0986122886681098
merits,3,1.0986122886681098
-0009,3,1.0986122886681098
Sleep,3,1.0986122886681098
nonepidemic,3,1.0986122886681098
stridor,3,1.0986122886681098
CH,3,1.0986122886681098
heat-inactivated,3,1.0986122886681098
L194P,3,1.0986122886681098
990,3,1.0986122886681098
anaphylactic,3,1.0986122886681098
predisposed,3,1.0986122886681098
item,3,1.0986122886681098
Mucosal,3,1.0986122886681098
laboratory-developed,3,1.0986122886681098
PARG,3,1.0986122886681098
Perfusion,3,1.0986122886681098
skin-prick,3,1.0986122886681098
redox,3,1.0986122886681098
high-priority,3,1.0986122886681098
COVID-2019,3,1.0986122886681098
MCAS,3,1.0986122886681098
incorporation,3,1.0986122886681098
μ,3,1.0986122886681098
counter-pulsation,3,1.0986122886681098
restructuring,3,1.0986122886681098
followup,3,1.0986122886681098
transcendental,3,1.0986122886681098
TRPM2,3,1.0986122886681098
theatre,3,1.0986122886681098
JMB2002,3,1.0986122886681098
vasculopathy,3,1.0986122886681098
compulsory,3,1.0986122886681098
shall,3,1.0986122886681098
realizing,3,1.0986122886681098
Tmprss2--,3,1.0986122886681098
cut-offs,3,1.0986122886681098
314,3,1.0986122886681098
Abstracts,3,1.0986122886681098
bivariate,3,1.0986122886681098
radiologists,3,1.0986122886681098
Stalin,3,1.0986122886681098
Kong3302001-like,3,1.0986122886681098
PMN,3,1.0986122886681098
disproportionate,3,1.0986122886681098
outweighs,3,1.0986122886681098
endotoxin,3,1.0986122886681098
Navarre,3,1.0986122886681098
cynomolgus,3,1.0986122886681098
formerly,3,1.0986122886681098
056,3,1.0986122886681098
transfection,3,1.0986122886681098
ends,3,1.0986122886681098
≥3,3,1.0986122886681098
Paired,3,1.0986122886681098
elite,3,1.0986122886681098
MRI-FT,3,1.0986122886681098
LoS,3,1.0986122886681098
predefined,3,1.0986122886681098
insolation,3,1.0986122886681098
solar,3,1.0986122886681098
Conservative,3,1.0986122886681098
OM,3,1.0986122886681098
posttraumatic,3,1.0986122886681098
flexibility,3,1.0986122886681098
RBB,3,1.0986122886681098
sedentary,3,1.0986122886681098
L452R,3,1.0986122886681098
connective,3,1.0986122886681098
thunderstorms,3,1.0986122886681098
simplify,3,1.0986122886681098
Twenty-one,3,1.0986122886681098
Birmingham,3,1.0986122886681098
implicating,3,1.0986122886681098
092,3,1.0986122886681098
038,3,1.0986122886681098
pollutant,3,1.0986122886681098
Sandy,3,1.0986122886681098
submit,3,1.0986122886681098
ES,3,1.0986122886681098
speak,3,1.0986122886681098
dysbiosis,3,1.0986122886681098
colitis,3,1.0986122886681098
ergometry,3,1.0986122886681098
fair,3,1.0986122886681098
042,3,1.0986122886681098
Prolonged,3,1.0986122886681098
exhibitors,3,1.0986122886681098
Eurasian,3,1.0986122886681098
correlational,3,1.0986122886681098
first-onset,3,1.0986122886681098
t,3,1.0986122886681098
staging,3,1.0986122886681098
overstated,3,1.0986122886681098
εe,3,1.0986122886681098
revise,3,1.0986122886681098
Uncertainty,3,1.0986122886681098
augmentation,3,1.0986122886681098
OSEs,3,1.0986122886681098
hopefully,3,1.0986122886681098
Hurricane,3,1.0986122886681098
arrangement,3,1.0986122886681098
emerges,3,1.0986122886681098
hygiene-related,3,1.0986122886681098
cms,3,1.0986122886681098
cytoprotective,3,1.0986122886681098
heritable,3,1.0986122886681098
dehydration,3,1.0986122886681098
silencing,3,1.0986122886681098
non-significant,3,1.0986122886681098
injectable,3,1.0986122886681098
TATs,3,1.0986122886681098
bedroom,3,1.0986122886681098
sensation,3,1.0986122886681098
mankind,3,1.0986122886681098
somatosensory,3,1.0986122886681098
friend,3,1.0986122886681098
cardiorespiratory,3,1.0986122886681098
embolus,3,1.0986122886681098
insensitivity,3,1.0986122886681098
in-vitro,3,1.0986122886681098
977,3,1.0986122886681098
1950s,3,1.0986122886681098
173,3,1.0986122886681098
COVID-19s,3,1.0986122886681098
high-grade,3,1.0986122886681098
bacillus,3,1.0986122886681098
periphery,3,1.0986122886681098
20102011,3,1.0986122886681098
Economic,3,1.0986122886681098
decision-makers,3,1.0986122886681098
FVH,3,1.0986122886681098
asymptomatics,3,1.0986122886681098
cp,3,1.0986122886681098
V5,3,1.0986122886681098
V6,3,1.0986122886681098
transmodal,3,1.0986122886681098
A-H3N2,3,1.0986122886681098
46-year-old,3,1.0986122886681098
Wide,3,1.0986122886681098
Continued,3,1.0986122886681098
Neurologic,3,1.0986122886681098
bacteriology,3,1.0986122886681098
Gastrointestinal,3,1.0986122886681098
phased,3,1.0986122886681098
Sixty-five,3,1.0986122886681098
fomites,3,1.0986122886681098
microbiota,3,1.0986122886681098
949,3,1.0986122886681098
unplanned,3,1.0986122886681098
lockdowns,3,1.0986122886681098
static,3,1.0986122886681098
VO2max,3,1.0986122886681098
crossed,3,1.0986122886681098
intra-arrest,3,1.0986122886681098
ml-1,3,1.0986122886681098
rhetorics,3,1.0986122886681098
transitional,3,1.0986122886681098
bridges,3,1.0986122886681098
calling,3,1.0986122886681098
Perceived,3,1.0986122886681098
congregate,3,1.0986122886681098
legs,3,1.0986122886681098
slow-flow,3,1.0986122886681098
Collaborating,3,1.0986122886681098
1918-20,3,1.0986122886681098
sulfate,3,1.0986122886681098
horizons,3,1.0986122886681098
AMCAS,3,1.0986122886681098
mitochondrial,3,1.0986122886681098
Recovery,3,1.0986122886681098
ownership,3,1.0986122886681098
nonclinical,3,1.0986122886681098
3-6,3,1.0986122886681098
Native,3,1.0986122886681098
college,3,1.0986122886681098
Variation,3,1.0986122886681098
depolarization,3,1.0986122886681098
recur,3,1.0986122886681098
Caspian,3,1.0986122886681098
attained,3,1.0986122886681098
cardioversion,3,1.0986122886681098
scored,3,1.0986122886681098
transitioning,3,1.0986122886681098
night-time,3,1.0986122886681098
Gloucestershire,3,1.0986122886681098
two-part,2,0.6931471805599453
cardio-respiratory,2,0.6931471805599453
ECRHS,2,0.6931471805599453
adapting,2,0.6931471805599453
Louisiana,2,0.6931471805599453
1809,2,0.6931471805599453
stoke,2,0.6931471805599453
impersistence,2,0.6931471805599453
Laos,2,0.6931471805599453
swabbed,2,0.6931471805599453
dysfunctioning,2,0.6931471805599453
tracheomalacia,2,0.6931471805599453
OverCOVID,2,0.6931471805599453
721,2,0.6931471805599453
299,2,0.6931471805599453
low-passage,2,0.6931471805599453
parasternal,2,0.6931471805599453
proteinuria,2,0.6931471805599453
pages,2,0.6931471805599453
EPR2,2,0.6931471805599453
HPB,2,0.6931471805599453
murmur,2,0.6931471805599453
kills,2,0.6931471805599453
webservers,2,0.6931471805599453
gather,2,0.6931471805599453
common-cold,2,0.6931471805599453
Opinions,2,0.6931471805599453
authorizations,2,0.6931471805599453
Slovenian,2,0.6931471805599453
weight-adjusted,2,0.6931471805599453
sport-specific,2,0.6931471805599453
BMT,2,0.6931471805599453
IUkg,2,0.6931471805599453
prepublications,2,0.6931471805599453
by-pass,2,0.6931471805599453
backyard,2,0.6931471805599453
Internet-based,2,0.6931471805599453
omnipresent,2,0.6931471805599453
club,2,0.6931471805599453
chloroquine,2,0.6931471805599453
inhalant,2,0.6931471805599453
predisposes,2,0.6931471805599453
Nation,2,0.6931471805599453
quarters,2,0.6931471805599453
severevery,2,0.6931471805599453
Slovenia,2,0.6931471805599453
high-volume,2,0.6931471805599453
coordinator,2,0.6931471805599453
non-atherosclerotic,2,0.6931471805599453
observable,2,0.6931471805599453
collaborated,2,0.6931471805599453
November-December,2,0.6931471805599453
resected,2,0.6931471805599453
farming,2,0.6931471805599453
ordinarily,2,0.6931471805599453
vRNA,2,0.6931471805599453
stemming,2,0.6931471805599453
Eskimo,2,0.6931471805599453
permitting,2,0.6931471805599453
subcutaneously,2,0.6931471805599453
leukocyte,2,0.6931471805599453
passaging,2,0.6931471805599453
Preventable,2,0.6931471805599453
on-going,2,0.6931471805599453
coma,2,0.6931471805599453
happening,2,0.6931471805599453
essence,2,0.6931471805599453
alphacoronavirus,2,0.6931471805599453
darkness,2,0.6931471805599453
full-growns,2,0.6931471805599453
Dengue,2,0.6931471805599453
flap,2,0.6931471805599453
side‑effects,2,0.6931471805599453
retirement,2,0.6931471805599453
topological,2,0.6931471805599453
A23403G,2,0.6931471805599453
Th2-type,2,0.6931471805599453
sequestering,2,0.6931471805599453
serous,2,0.6931471805599453
MDA,2,0.6931471805599453
premise,2,0.6931471805599453
impose,2,0.6931471805599453
hyposensitization,2,0.6931471805599453
polysomnography,2,0.6931471805599453
antibody-avidity,2,0.6931471805599453
informational,2,0.6931471805599453
33-year-old,2,0.6931471805599453
Onset,2,0.6931471805599453
Senegal,2,0.6931471805599453
tennis,2,0.6931471805599453
Barriers,2,0.6931471805599453
hide,2,0.6931471805599453
cross-education,2,0.6931471805599453
Fann,2,0.6931471805599453
pre-infarction,2,0.6931471805599453
Nonadherence,2,0.6931471805599453
gray,2,0.6931471805599453
FS,2,0.6931471805599453
gm3,2,0.6931471805599453
non-IHD,2,0.6931471805599453
Design,2,0.6931471805599453
recorder,2,0.6931471805599453
heard,2,0.6931471805599453
133xenon,2,0.6931471805599453
orchestrating,2,0.6931471805599453
891,2,0.6931471805599453
20-30,2,0.6931471805599453
CD,2,0.6931471805599453
Spearman,2,0.6931471805599453
-4,2,0.6931471805599453
hemispatial,2,0.6931471805599453
≥6,2,0.6931471805599453
yearsThe,2,0.6931471805599453
Epidemiol,2,0.6931471805599453
ft,2,0.6931471805599453
0-14,2,0.6931471805599453
Wise,2,0.6931471805599453
laparoscopic,2,0.6931471805599453
examiners,2,0.6931471805599453
Correcting,2,0.6931471805599453
quantum,2,0.6931471805599453
attracted,2,0.6931471805599453
cardiac-related,2,0.6931471805599453
telemedically,2,0.6931471805599453
Postinfarction,2,0.6931471805599453
urges,2,0.6931471805599453
NeuroAiD,2,0.6931471805599453
50-60,2,0.6931471805599453
moesin,2,0.6931471805599453
debridement,2,0.6931471805599453
Hemorrhagic,2,0.6931471805599453
misattributions,2,0.6931471805599453
empyema,2,0.6931471805599453
licensing,2,0.6931471805599453
kmono,2,0.6931471805599453
quest,2,0.6931471805599453
63-year-old,2,0.6931471805599453
Fig,2,0.6931471805599453
lesion-symptom,2,0.6931471805599453
evidenced-based,2,0.6931471805599453
accrued,2,0.6931471805599453
undertake,2,0.6931471805599453
luciferase,2,0.6931471805599453
hint,2,0.6931471805599453
poisoning,2,0.6931471805599453
DAD,2,0.6931471805599453
Be,2,0.6931471805599453
scientifically,2,0.6931471805599453
long-axis,2,0.6931471805599453
MID,2,0.6931471805599453
kinetic,2,0.6931471805599453
Romania,2,0.6931471805599453
suicidal,2,0.6931471805599453
micro-,2,0.6931471805599453
excessively,2,0.6931471805599453
monoform,2,0.6931471805599453
191,2,0.6931471805599453
Eighty-five,2,0.6931471805599453
thirteen,2,0.6931471805599453
Teaching,2,0.6931471805599453
738,2,0.6931471805599453
isolate-specific,2,0.6931471805599453
videofluoroscopic,2,0.6931471805599453
appointments,2,0.6931471805599453
ezrin,2,0.6931471805599453
six-week,2,0.6931471805599453
cancelled,2,0.6931471805599453
categorization,2,0.6931471805599453
systematize,2,0.6931471805599453
Depending,2,0.6931471805599453
disseminate,2,0.6931471805599453
PCW,2,0.6931471805599453
IHD,2,0.6931471805599453
Woolhouse,2,0.6931471805599453
T85I,2,0.6931471805599453
7-day,2,0.6931471805599453
LSG-based,2,0.6931471805599453
drug-induced,2,0.6931471805599453
custom,2,0.6931471805599453
NCAG,2,0.6931471805599453
Q57H,2,0.6931471805599453
influenza-positive,2,0.6931471805599453
speculate,2,0.6931471805599453
gastroenteritis,2,0.6931471805599453
downregulate,2,0.6931471805599453
Backgroundpurpose,2,0.6931471805599453
Whenever,2,0.6931471805599453
Dendritic,2,0.6931471805599453
MS2,2,0.6931471805599453
eight-year,2,0.6931471805599453
1932,2,0.6931471805599453
single-tube,2,0.6931471805599453
1-sec,2,0.6931471805599453
galvanic,2,0.6931471805599453
677,2,0.6931471805599453
aquatic,2,0.6931471805599453
allergologic,2,0.6931471805599453
insignificant,2,0.6931471805599453
booster,2,0.6931471805599453
EIB,2,0.6931471805599453
cadet,2,0.6931471805599453
exit,2,0.6931471805599453
cardioverted,2,0.6931471805599453
misdiagnose,2,0.6931471805599453
simplex,2,0.6931471805599453
MarchApril,2,0.6931471805599453
Max,2,0.6931471805599453
wastewater-based,2,0.6931471805599453
H10-HA,2,0.6931471805599453
patinets,2,0.6931471805599453
125min,2,0.6931471805599453
Provocative,2,0.6931471805599453
Diffuse,2,0.6931471805599453
nineteen,2,0.6931471805599453
biobanking,2,0.6931471805599453
Classical,2,0.6931471805599453
889,2,0.6931471805599453
immunosensor,2,0.6931471805599453
Magnesium,2,0.6931471805599453
t-tests,2,0.6931471805599453
1075,2,0.6931471805599453
RIC,2,0.6931471805599453
Seventy-four,2,0.6931471805599453
repository,2,0.6931471805599453
intentionally,2,0.6931471805599453
Dental,2,0.6931471805599453
kDa,2,0.6931471805599453
gauge,2,0.6931471805599453
notoriously,2,0.6931471805599453
CHQ-PF50,2,0.6931471805599453
Still,2,0.6931471805599453
LIMS,2,0.6931471805599453
BioNTechPfizer,2,0.6931471805599453
Excluding,2,0.6931471805599453
LFAs,2,0.6931471805599453
monomer,2,0.6931471805599453
765,2,0.6931471805599453
etiopathogenetic,2,0.6931471805599453
label-free,2,0.6931471805599453
Angiography,2,0.6931471805599453
blush,2,0.6931471805599453
hyaline,2,0.6931471805599453
820,2,0.6931471805599453
RBD-specific,2,0.6931471805599453
vasomotor,2,0.6931471805599453
extrapleural,2,0.6931471805599453
newspapers,2,0.6931471805599453
shadow,2,0.6931471805599453
infarct-healing,2,0.6931471805599453
monkey,2,0.6931471805599453
cholecystectomy,2,0.6931471805599453
Pediatricians,2,0.6931471805599453
cg05575921,2,0.6931471805599453
hypomethylation,2,0.6931471805599453
anti-LCMV,2,0.6931471805599453
cirrhosis,2,0.6931471805599453
anemic,2,0.6931471805599453
AHRR,2,0.6931471805599453
apatinib,2,0.6931471805599453
BioNTech,2,0.6931471805599453
Pardi,2,0.6931471805599453
deploy,2,0.6931471805599453
dabrafenib,2,0.6931471805599453
clofazimine,2,0.6931471805599453
mycophenolic,2,0.6931471805599453
sub-haplotype,2,0.6931471805599453
propelled,2,0.6931471805599453
Wegeners,2,0.6931471805599453
arguably,2,0.6931471805599453
granulomatosis,2,0.6931471805599453
meanwhile,2,0.6931471805599453
network-based,2,0.6931471805599453
fevers,2,0.6931471805599453
PPI,2,0.6931471805599453
Household,2,0.6931471805599453
suppurative,2,0.6931471805599453
favourably,2,0.6931471805599453
HMW,2,0.6931471805599453
Serologic,2,0.6931471805599453
fenestration,2,0.6931471805599453
Corona,2,0.6931471805599453
1972–1973,2,0.6931471805599453
Suzuki,2,0.6931471805599453
harbor,2,0.6931471805599453
Min,2,0.6931471805599453
p65,2,0.6931471805599453
Confirmation,2,0.6931471805599453
U-wave,2,0.6931471805599453
multiple-organ,2,0.6931471805599453
predominating,2,0.6931471805599453
fundamentally,2,0.6931471805599453
P0024,2,0.6931471805599453
Ninety-nine,2,0.6931471805599453
nCOV-19,2,0.6931471805599453
AEngland,2,0.6931471805599453
kd,2,0.6931471805599453
IEDB,2,0.6931471805599453
NL63,2,0.6931471805599453
HKU1,2,0.6931471805599453
phone,2,0.6931471805599453
v,2,0.6931471805599453
PhT,2,0.6931471805599453
homonymous,2,0.6931471805599453
BE,2,0.6931471805599453
bleed,2,0.6931471805599453
longstanding,2,0.6931471805599453
1020,2,0.6931471805599453
rubber,2,0.6931471805599453
run-in,2,0.6931471805599453
Thai-Myanmar,2,0.6931471805599453
aneurysmal,2,0.6931471805599453
convergent,2,0.6931471805599453
converge,2,0.6931471805599453
colonies,2,0.6931471805599453
vertebra,2,0.6931471805599453
Immunisation,2,0.6931471805599453
Attitudes,2,0.6931471805599453
inundated,2,0.6931471805599453
Stepwise,2,0.6931471805599453
planes,2,0.6931471805599453
endeavour,2,0.6931471805599453
logarithmically,2,0.6931471805599453
occupied,2,0.6931471805599453
melting,2,0.6931471805599453
subsidence,2,0.6931471805599453
Setting,2,0.6931471805599453
1964,2,0.6931471805599453
tablet,2,0.6931471805599453
dark,2,0.6931471805599453
624,2,0.6931471805599453
2019-nCov,2,0.6931471805599453
8064,2,0.6931471805599453
nephropathy,2,0.6931471805599453
Investigational,2,0.6931471805599453
5719,2,0.6931471805599453
elderlies,2,0.6931471805599453
bronchiale,2,0.6931471805599453
doubles,2,0.6931471805599453
300000,2,0.6931471805599453
patient-level,2,0.6931471805599453
11-,2,0.6931471805599453
attainment,2,0.6931471805599453
non-infarct-related,2,0.6931471805599453
anxieties,2,0.6931471805599453
514,2,0.6931471805599453
ships,2,0.6931471805599453
foundational,2,0.6931471805599453
unequivocally,2,0.6931471805599453
Files,2,0.6931471805599453
criticized,2,0.6931471805599453
MMI,2,0.6931471805599453
NAs,2,0.6931471805599453
Number,2,0.6931471805599453
Bivariate,2,0.6931471805599453
discontinuance,2,0.6931471805599453
874,2,0.6931471805599453
proceedings,2,0.6931471805599453
Years,2,0.6931471805599453
Robert,2,0.6931471805599453
Koch,2,0.6931471805599453
underuse,2,0.6931471805599453
Pune,2,0.6931471805599453
1917,2,0.6931471805599453
ALL,2,0.6931471805599453
Burden,2,0.6931471805599453
CD68,2,0.6931471805599453
non-CIN,2,0.6931471805599453
reticulum-associated,2,0.6931471805599453
syrinx,2,0.6931471805599453
cocaine-associated,2,0.6931471805599453
pair-wise,2,0.6931471805599453
hypoperfusion,2,0.6931471805599453
dysregulates,2,0.6931471805599453
convergence,2,0.6931471805599453
coryza,2,0.6931471805599453
reconcile,2,0.6931471805599453
agitation,2,0.6931471805599453
physiopathologic,2,0.6931471805599453
vaccine-resistant,2,0.6931471805599453
differentials,2,0.6931471805599453
Orange,2,0.6931471805599453
638,2,0.6931471805599453
falsely,2,0.6931471805599453
ICR,2,0.6931471805599453
batches,2,0.6931471805599453
non-traditional,2,0.6931471805599453
campuses,2,0.6931471805599453
IC50,2,0.6931471805599453
eradicate,2,0.6931471805599453
refractoriness,2,0.6931471805599453
Volunteers,2,0.6931471805599453
β-coronavirus,2,0.6931471805599453
varieties,2,0.6931471805599453
31172,2,0.6931471805599453
Prevent,2,0.6931471805599453
Pharmacologic,2,0.6931471805599453
Nitrite,2,0.6931471805599453
platelet-activating,2,0.6931471805599453
victim,2,0.6931471805599453
CardiologyAmerican,2,0.6931471805599453
glomerular,2,0.6931471805599453
19181919,2,0.6931471805599453
restraint,2,0.6931471805599453
coelomic,2,0.6931471805599453
neurodegeneration,2,0.6931471805599453
≥090,2,0.6931471805599453
springboard,2,0.6931471805599453
dysregulate,2,0.6931471805599453
616,2,0.6931471805599453
right-handed,2,0.6931471805599453
neuroinvasion,2,0.6931471805599453
cross-protection,2,0.6931471805599453
Alzheimer,2,0.6931471805599453
steno-occlusive,2,0.6931471805599453
hypothalamus,2,0.6931471805599453
1976-1981,2,0.6931471805599453
1976-1977,2,0.6931471805599453
jointly,2,0.6931471805599453
PNS,2,0.6931471805599453
1980-1981,2,0.6931471805599453
excludes,2,0.6931471805599453
652,2,0.6931471805599453
Range,2,0.6931471805599453
5-14,2,0.6931471805599453
factorial,2,0.6931471805599453
SVR,2,0.6931471805599453
hypothyroidism,2,0.6931471805599453
pluripotent,2,0.6931471805599453
equipoise,2,0.6931471805599453
Usually,2,0.6931471805599453
plethysmography,2,0.6931471805599453
gases,2,0.6931471805599453
caffeine,2,0.6931471805599453
Oxygen,2,0.6931471805599453
ASCO,2,0.6931471805599453
PFC,2,0.6931471805599453
repression,2,0.6931471805599453
Org,2,0.6931471805599453
opacification,2,0.6931471805599453
miR,2,0.6931471805599453
deregulation,2,0.6931471805599453
pairing,2,0.6931471805599453
CVT,2,0.6931471805599453
familiarity,2,0.6931471805599453
suffers,2,0.6931471805599453
expectoration,2,0.6931471805599453
non-SDIA,2,0.6931471805599453
Parallel,2,0.6931471805599453
GUSTO,2,0.6931471805599453
Fe,2,0.6931471805599453
PAMI,2,0.6931471805599453
rolling,2,0.6931471805599453
Going,2,0.6931471805599453
Or,2,0.6931471805599453
RP,2,0.6931471805599453
selenium,2,0.6931471805599453
aptamers,2,0.6931471805599453
3500,2,0.6931471805599453
antiseizure,2,0.6931471805599453
2300,2,0.6931471805599453
anorexia,2,0.6931471805599453
hardship,2,0.6931471805599453
Twenty-two,2,0.6931471805599453
ABPA,2,0.6931471805599453
Live,2,0.6931471805599453
Carolina,2,0.6931471805599453
Myocarditis,2,0.6931471805599453
heparins,2,0.6931471805599453
Measuring,2,0.6931471805599453
lethargy,2,0.6931471805599453
598,2,0.6931471805599453
0017,2,0.6931471805599453
055,2,0.6931471805599453
immunofluorescent,2,0.6931471805599453
anesthesiologists,2,0.6931471805599453
484,2,0.6931471805599453
Thallium,2,0.6931471805599453
CRTx,2,0.6931471805599453
peridural,2,0.6931471805599453
fumigatus,2,0.6931471805599453
impaction,2,0.6931471805599453
HAM,2,0.6931471805599453
Esophageal,2,0.6931471805599453
neuroradiological,2,0.6931471805599453
thermodilution,2,0.6931471805599453
virulence-conferring,2,0.6931471805599453
obstetricians,2,0.6931471805599453
Are,2,0.6931471805599453
18-64,2,0.6931471805599453
afterwards,2,0.6931471805599453
smart,2,0.6931471805599453
SirRH,2,0.6931471805599453
ΔsirR,2,0.6931471805599453
manifold,2,0.6931471805599453
Treated,2,0.6931471805599453
non-corticosteroid,2,0.6931471805599453
NSBH,2,0.6931471805599453
1996-1997,2,0.6931471805599453
telephoning,2,0.6931471805599453
spin,2,0.6931471805599453
chaperone,2,0.6931471805599453
TH2-type,2,0.6931471805599453
transporter,2,0.6931471805599453
Keywords,2,0.6931471805599453
87-lead,2,0.6931471805599453
573,2,0.6931471805599453
Corticosteroid,2,0.6931471805599453
IO-PDT,2,0.6931471805599453
midlife,2,0.6931471805599453
handheld,2,0.6931471805599453
irradiance,2,0.6931471805599453
time-resolved,2,0.6931471805599453
intersection,2,0.6931471805599453
Well-Integrated,2,0.6931471805599453
12-month-old,2,0.6931471805599453
touches,2,0.6931471805599453
N1N2N3,2,0.6931471805599453
cubic,2,0.6931471805599453
PCPS,2,0.6931471805599453
soil,2,0.6931471805599453
480,2,0.6931471805599453
ensue,2,0.6931471805599453
700000,2,0.6931471805599453
mVmsec,2,0.6931471805599453
intolerable,2,0.6931471805599453
VTM-3840,2,0.6931471805599453
professor,2,0.6931471805599453
circulates,2,0.6931471805599453
Co-infections,2,0.6931471805599453
nested,2,0.6931471805599453
maxima,2,0.6931471805599453
Coverdell,2,0.6931471805599453
knowing,2,0.6931471805599453
RMS,2,0.6931471805599453
anastomotic,2,0.6931471805599453
squirrels,2,0.6931471805599453
irregularity,2,0.6931471805599453
multiethnic,2,0.6931471805599453
CRISPR-Cas,2,0.6931471805599453
Ischaemia,2,0.6931471805599453
HRVs,2,0.6931471805599453
Propofol,2,0.6931471805599453
post-discharge,2,0.6931471805599453
MMSE,2,0.6931471805599453
19971998,2,0.6931471805599453
seventy-two,2,0.6931471805599453
CAA,2,0.6931471805599453
Widespread,2,0.6931471805599453
dual-gene,2,0.6931471805599453
Loss,2,0.6931471805599453
low-middle,2,0.6931471805599453
accountable,2,0.6931471805599453
waking,2,0.6931471805599453
CFD,2,0.6931471805599453
cobas®,2,0.6931471805599453
RAP,2,0.6931471805599453
PAEDP,2,0.6931471805599453
adventitia,2,0.6931471805599453
hypothermic,2,0.6931471805599453
triglycerides,2,0.6931471805599453
1106,2,0.6931471805599453
troponins,2,0.6931471805599453
Isoproterenol,2,0.6931471805599453
pretreated,2,0.6931471805599453
officers,2,0.6931471805599453
fiscal,2,0.6931471805599453
EISS,2,0.6931471805599453
veritable,2,0.6931471805599453
culture-based,2,0.6931471805599453
Samsun,2,0.6931471805599453
PDM09,2,0.6931471805599453
constricted,2,0.6931471805599453
glycomics,2,0.6931471805599453
Embolism,2,0.6931471805599453
enroll,2,0.6931471805599453
R-R,2,0.6931471805599453
Elderberry,2,0.6931471805599453
folk,2,0.6931471805599453
Lightmix®,2,0.6931471805599453
melanoma,2,0.6931471805599453
30-339,2,0.6931471805599453
conceive,2,0.6931471805599453
clearing,2,0.6931471805599453
cysts,2,0.6931471805599453
homotypic,2,0.6931471805599453
aortal,2,0.6931471805599453
angle,2,0.6931471805599453
vegetations,2,0.6931471805599453
non-gated,2,0.6931471805599453
spike-based,2,0.6931471805599453
23403AG,2,0.6931471805599453
interrogate,2,0.6931471805599453
supraventricular,2,0.6931471805599453
Dramatic,2,0.6931471805599453
abolished,2,0.6931471805599453
samplers,2,0.6931471805599453
Discordance,2,0.6931471805599453
referenced,2,0.6931471805599453
Histopathological,2,0.6931471805599453
SARS-Cov,2,0.6931471805599453
Pretreatment,2,0.6931471805599453
depressions,2,0.6931471805599453
sampler,2,0.6931471805599453
RPP,2,0.6931471805599453
strained,2,0.6931471805599453
runny,2,0.6931471805599453
48-year-old,2,0.6931471805599453
logs,2,0.6931471805599453
concrete,2,0.6931471805599453
molecular-based,2,0.6931471805599453
DF,2,0.6931471805599453
habit,2,0.6931471805599453
Taiwans,2,0.6931471805599453
depleted,2,0.6931471805599453
biannual,2,0.6931471805599453
occupation,2,0.6931471805599453
moreover,2,0.6931471805599453
Drawings,2,0.6931471805599453
viperin,2,0.6931471805599453
jumping,2,0.6931471805599453
Practitioners,2,0.6931471805599453
bladeupper,2,0.6931471805599453
15-44,2,0.6931471805599453
8-11,2,0.6931471805599453
micronutrients,2,0.6931471805599453
T-,2,0.6931471805599453
Intraoperative,2,0.6931471805599453
eating,2,0.6931471805599453
exotic,2,0.6931471805599453
glioma,2,0.6931471805599453
multi-dimensional,2,0.6931471805599453
dried,2,0.6931471805599453
seeded,2,0.6931471805599453
labour-intensive,2,0.6931471805599453
contigs,2,0.6931471805599453
fearing,2,0.6931471805599453
East-Southeast,2,0.6931471805599453
baby,2,0.6931471805599453
went,2,0.6931471805599453
T-and,2,0.6931471805599453
hopes,2,0.6931471805599453
hindering,2,0.6931471805599453
spleen,2,0.6931471805599453
joining,2,0.6931471805599453
unpredictability,2,0.6931471805599453
ablate,2,0.6931471805599453
syrup,2,0.6931471805599453
fees,2,0.6931471805599453
realize,2,0.6931471805599453
academia,2,0.6931471805599453
Indications,2,0.6931471805599453
H1v,2,0.6931471805599453
Humidity,2,0.6931471805599453
defensive,2,0.6931471805599453
colon,2,0.6931471805599453
Denver,2,0.6931471805599453
BSWH,2,0.6931471805599453
168,2,0.6931471805599453
decompression,2,0.6931471805599453
hemostasis,2,0.6931471805599453
biosynthesis,2,0.6931471805599453
sulfites,2,0.6931471805599453
anesthetists,2,0.6931471805599453
polyunsaturated,2,0.6931471805599453
condition-specific,2,0.6931471805599453
gastro-esophageal,2,0.6931471805599453
intermittently,2,0.6931471805599453
insure,2,0.6931471805599453
board,2,0.6931471805599453
BM1918,2,0.6931471805599453
mathematically,2,0.6931471805599453
probiotics,2,0.6931471805599453
23-SL,2,0.6931471805599453
disorientation,2,0.6931471805599453
exhaustive,2,0.6931471805599453
cardiologic,2,0.6931471805599453
externalities,2,0.6931471805599453
Previously,2,0.6931471805599453
LAIVs,2,0.6931471805599453
Warfarin,2,0.6931471805599453
adipose-derived,2,0.6931471805599453
mainstays,2,0.6931471805599453
flower,2,0.6931471805599453
ornamental,2,0.6931471805599453
crops,2,0.6931471805599453
hemithorax,2,0.6931471805599453
Dyspnea,2,0.6931471805599453
contaminants,2,0.6931471805599453
77-year-old,2,0.6931471805599453
tracheobronchial,2,0.6931471805599453
positional,2,0.6931471805599453
erythropoietin,2,0.6931471805599453
microbiome,2,0.6931471805599453
dissecting,2,0.6931471805599453
Oxidative,2,0.6931471805599453
Tl201,2,0.6931471805599453
radioactivity,2,0.6931471805599453
MPS,2,0.6931471805599453
epicardium,2,0.6931471805599453
weapons,2,0.6931471805599453
Excellent,2,0.6931471805599453
underassessed,2,0.6931471805599453
post-treatment,2,0.6931471805599453
HPV,2,0.6931471805599453
atelectasis,2,0.6931471805599453
cell-derived,2,0.6931471805599453
High-risk,2,0.6931471805599453
EAR,2,0.6931471805599453
early-phase,2,0.6931471805599453
large-focal,2,0.6931471805599453
introducer,2,0.6931471805599453
excavatum,2,0.6931471805599453
OSE,2,0.6931471805599453
oxidation,2,0.6931471805599453
steroid-resistant,2,0.6931471805599453
Rican,2,0.6931471805599453
postulate,2,0.6931471805599453
libraries,2,0.6931471805599453
Sickle,2,0.6931471805599453
828,2,0.6931471805599453
GMTs,2,0.6931471805599453
twentieth,2,0.6931471805599453
inanimate,2,0.6931471805599453
sounds,2,0.6931471805599453
burial,2,0.6931471805599453
symptomless,2,0.6931471805599453
March-June,2,0.6931471805599453
leveraging,2,0.6931471805599453
agree,2,0.6931471805599453
succumb,2,0.6931471805599453
day-time,2,0.6931471805599453
relaxed,2,0.6931471805599453
RaTG13,2,0.6931471805599453
immunodominant,2,0.6931471805599453
MTA,2,0.6931471805599453
6-23,2,0.6931471805599453
Lessons,2,0.6931471805599453
endobronchial,2,0.6931471805599453
preoperatively,2,0.6931471805599453
E611,2,0.6931471805599453
room-visiting,2,0.6931471805599453
mid-term,2,0.6931471805599453
obliteration,2,0.6931471805599453
B-type,2,0.6931471805599453
neurite,2,0.6931471805599453
20-44,2,0.6931471805599453
AH1pdm09,2,0.6931471805599453
G186V,2,0.6931471805599453
room-based,2,0.6931471805599453
SC2InflAInflB-UCT,2,0.6931471805599453
n19,2,0.6931471805599453
crying,2,0.6931471805599453
laughing,2,0.6931471805599453
Analytical,2,0.6931471805599453
799,2,0.6931471805599453
Belief,2,0.6931471805599453
coastal,2,0.6931471805599453
predetermined,2,0.6931471805599453
bizarre,2,0.6931471805599453
DRG,2,0.6931471805599453
Wagga,2,0.6931471805599453
amphetamine,2,0.6931471805599453
dupilumab,2,0.6931471805599453
remit,2,0.6931471805599453
acid-challenged,2,0.6931471805599453
ISRO,2,0.6931471805599453
43-year-old,2,0.6931471805599453
transcriptomes,2,0.6931471805599453
fibrolipoma,2,0.6931471805599453
nerves,2,0.6931471805599453
Doubled,2,0.6931471805599453
Head,2,0.6931471805599453
ears,2,0.6931471805599453
Malignant,2,0.6931471805599453
intrahospital,2,0.6931471805599453
15-year-old,2,0.6931471805599453
biochemistry,2,0.6931471805599453
underrepresented,2,0.6931471805599453
innocuous,2,0.6931471805599453
psychogenic,2,0.6931471805599453
abutting,2,0.6931471805599453
lobar,2,0.6931471805599453
QUEST,2,0.6931471805599453
1902,2,0.6931471805599453
Practitioner,2,0.6931471805599453
hadnt,2,0.6931471805599453
CS-dependent,2,0.6931471805599453
Predominant,2,0.6931471805599453
immunize,2,0.6931471805599453
Simple,2,0.6931471805599453
city-level,2,0.6931471805599453
Hawaii,2,0.6931471805599453
16-segment,2,0.6931471805599453
microgkg,2,0.6931471805599453
Dobutamine,2,0.6931471805599453
disregarded,2,0.6931471805599453
Worse,2,0.6931471805599453
thermoplasty,2,0.6931471805599453
thermal,2,0.6931471805599453
47-year-old,2,0.6931471805599453
Antarctica,2,0.6931471805599453
analyser,2,0.6931471805599453
NIOX,2,0.6931471805599453
Spanish-speaking,2,0.6931471805599453
really,2,0.6931471805599453
Determining,2,0.6931471805599453
ICHs,2,0.6931471805599453
abolishing,2,0.6931471805599453
spectrometer,2,0.6931471805599453
compensated,2,0.6931471805599453
acetate,2,0.6931471805599453
peribronchial,2,0.6931471805599453
granted,2,0.6931471805599453
refinement,2,0.6931471805599453
594,2,0.6931471805599453
excitability,2,0.6931471805599453
debris,2,0.6931471805599453
BMC-derived,2,0.6931471805599453
AML,2,0.6931471805599453
treatment-related,2,0.6931471805599453
cannula,2,0.6931471805599453
clamping,2,0.6931471805599453
neutropenia,2,0.6931471805599453
Daylight,2,0.6931471805599453
AEDT,2,0.6931471805599453
VPB,2,0.6931471805599453
ECGraphic,2,0.6931471805599453
paucimicronic,2,0.6931471805599453
LPs,2,0.6931471805599453
Epstein-Barr,2,0.6931471805599453
oil-in-water,2,0.6931471805599453
Deployment,2,0.6931471805599453
Hearts,2,0.6931471805599453
myeloid,2,0.6931471805599453
109L,2,0.6931471805599453
edges,2,0.6931471805599453
biofluid,2,0.6931471805599453
LSTM,2,0.6931471805599453
LAV,2,0.6931471805599453
mitigates,2,0.6931471805599453
Corresponding,2,0.6931471805599453
microg,2,0.6931471805599453
Subjective,2,0.6931471805599453
postexposure,2,0.6931471805599453
bibliographic,2,0.6931471805599453
undergraduate,2,0.6931471805599453
nitrogen,2,0.6931471805599453
Structural,2,0.6931471805599453
NO2,2,0.6931471805599453
mucociliary,2,0.6931471805599453
longest,2,0.6931471805599453
016,2,0.6931471805599453
cross-reacted,2,0.6931471805599453
pre-discharge,2,0.6931471805599453
LCX,2,0.6931471805599453
influenzalike,2,0.6931471805599453
1995-1996,2,0.6931471805599453
post-bronchodilator,2,0.6931471805599453
immunodiagnostic,2,0.6931471805599453
shearwaters,2,0.6931471805599453
Puffinus,2,0.6931471805599453
nonhospitalized,2,0.6931471805599453
nanopopcorn,2,0.6931471805599453
Au,2,0.6931471805599453
scattering,2,0.6931471805599453
confounder,2,0.6931471805599453
2344,2,0.6931471805599453
partitioning,2,0.6931471805599453
dozens,2,0.6931471805599453
H5N6,2,0.6931471805599453
H5N8,2,0.6931471805599453
nesting,2,0.6931471805599453
north-east,2,0.6931471805599453
neuraminidases,2,0.6931471805599453
NOAC,2,0.6931471805599453
labour,2,0.6931471805599453
Non-vitamin,2,0.6931471805599453
purely,2,0.6931471805599453
auditory,2,0.6931471805599453
MS,2,0.6931471805599453
mumps,2,0.6931471805599453
VEMPs,2,0.6931471805599453
Resources,2,0.6931471805599453
Again,2,0.6931471805599453
DAO,2,0.6931471805599453
ROM,2,0.6931471805599453
992,2,0.6931471805599453
nasalnasopharyngeal,2,0.6931471805599453
NHPs,2,0.6931471805599453
sensitively,2,0.6931471805599453
microcomputer,2,0.6931471805599453
Apache,2,0.6931471805599453
SAPS,2,0.6931471805599453
singleplex,2,0.6931471805599453
station,2,0.6931471805599453
seminar,2,0.6931471805599453
passes,2,0.6931471805599453
αVβ3,2,0.6931471805599453
typesubtype-specific,2,0.6931471805599453
brown,2,0.6931471805599453
individual-level,2,0.6931471805599453
anti-H5N1,2,0.6931471805599453
eustachian,2,0.6931471805599453
athletic,2,0.6931471805599453
self-esteem,2,0.6931471805599453
non-Emiratis,2,0.6931471805599453
glutathione,2,0.6931471805599453
Staff,2,0.6931471805599453
SARSr-CoVs,2,0.6931471805599453
hematologic-metabolic,2,0.6931471805599453
7-9,2,0.6931471805599453
702,2,0.6931471805599453
hematocrit,2,0.6931471805599453
corpuscular,2,0.6931471805599453
Sixty-four,2,0.6931471805599453
empirically,2,0.6931471805599453
503,2,0.6931471805599453
sIgG4,2,0.6931471805599453
peptide-based,2,0.6931471805599453
histochemical,2,0.6931471805599453
granule,2,0.6931471805599453
Antibiotic,2,0.6931471805599453
Obstructive,2,0.6931471805599453
mists,2,0.6931471805599453
predecessors,2,0.6931471805599453
PM10,2,0.6931471805599453
nonrheumatic,2,0.6931471805599453
two-vessel,2,0.6931471805599453
direct-acting,2,0.6931471805599453
Fifty-two,2,0.6931471805599453
possessing,2,0.6931471805599453
banks,2,0.6931471805599453
nowadays,2,0.6931471805599453
corneas,2,0.6931471805599453
minimising,2,0.6931471805599453
amoxicillin,2,0.6931471805599453
elaborated,2,0.6931471805599453
Chemical,2,0.6931471805599453
DDDs,2,0.6931471805599453
40-50,2,0.6931471805599453
introductions,2,0.6931471805599453
paramyxoviruses,2,0.6931471805599453
31-year-old,2,0.6931471805599453
microgramsl,2,0.6931471805599453
LLC,2,0.6931471805599453
pharma,2,0.6931471805599453
acquisitions,2,0.6931471805599453
Monoclonal,2,0.6931471805599453
restrict,2,0.6931471805599453
APOE,2,0.6931471805599453
steadier,2,0.6931471805599453
syncopal,2,0.6931471805599453
972,2,0.6931471805599453
Contrary,2,0.6931471805599453
expectation,2,0.6931471805599453
Prima,2,0.6931471805599453
apolipoprotein,2,0.6931471805599453
Regardless,2,0.6931471805599453
FLU-A,2,0.6931471805599453
Directigen,2,0.6931471805599453
PDCA,2,0.6931471805599453
fishbone,2,0.6931471805599453
coronaviral,2,0.6931471805599453
EMR,2,0.6931471805599453
MVC,2,0.6931471805599453
memory-guided,2,0.6931471805599453
primigravida,2,0.6931471805599453
432,2,0.6931471805599453
misclassifications,2,0.6931471805599453
overlapped,2,0.6931471805599453
probit,2,0.6931471805599453
Angiographic,2,0.6931471805599453
RIA,2,0.6931471805599453
mortalities,2,0.6931471805599453
Larger,2,0.6931471805599453
languages,2,0.6931471805599453
aerodynamic,2,0.6931471805599453
Unadjusted,2,0.6931471805599453
sponsored,2,0.6931471805599453
Neuroplasticity,2,0.6931471805599453
antimyosin,2,0.6931471805599453
sub-phenotypes,2,0.6931471805599453
neoplasm,2,0.6931471805599453
quantitated,2,0.6931471805599453
Suppression,2,0.6931471805599453
coronal,2,0.6931471805599453
GlaxoSmithKline,2,0.6931471805599453
peritoneal,2,0.6931471805599453
phagocytosed,2,0.6931471805599453
noncore,2,0.6931471805599453
Supplement,2,0.6931471805599453
grandparents,2,0.6931471805599453
disentangle,2,0.6931471805599453
gender-specific,2,0.6931471805599453
generalised,2,0.6931471805599453
daughter,2,0.6931471805599453
constitution,2,0.6931471805599453
chickens,2,0.6931471805599453
medicolegal,2,0.6931471805599453
LCSC,2,0.6931471805599453
Columbia,2,0.6931471805599453
month-to-month,2,0.6931471805599453
inspire,2,0.6931471805599453
policymaking,2,0.6931471805599453
EDC,2,0.6931471805599453
Sequence,2,0.6931471805599453
998,2,0.6931471805599453
Jaccard,2,0.6931471805599453
chronological,2,0.6931471805599453
booth,2,0.6931471805599453
generalize,2,0.6931471805599453
co-workers,2,0.6931471805599453
1260,2,0.6931471805599453
022,2,0.6931471805599453
PAF,2,0.6931471805599453
antagonism,2,0.6931471805599453
neuritis,2,0.6931471805599453
fortnightly,2,0.6931471805599453
robotic,2,0.6931471805599453
727,2,0.6931471805599453
amply,2,0.6931471805599453
Impulsive,2,0.6931471805599453
Sensation,2,0.6931471805599453
475,2,0.6931471805599453
coverings,2,0.6931471805599453
sub-populations,2,0.6931471805599453
IADL,2,0.6931471805599453
sub-population,2,0.6931471805599453
465,2,0.6931471805599453
inaugural,2,0.6931471805599453
redirected,2,0.6931471805599453
convex,2,0.6931471805599453
FRAST,2,0.6931471805599453
663,2,0.6931471805599453
dyssynergic,2,0.6931471805599453
floating-axis,2,0.6931471805599453
Earlier,2,0.6931471805599453
Floating-axis,2,0.6931471805599453
perfused,2,0.6931471805599453
CTACTP,2,0.6931471805599453
dating,2,0.6931471805599453
CIDS,2,0.6931471805599453
injury-induced,2,0.6931471805599453
Self-reported,2,0.6931471805599453
prematurity,2,0.6931471805599453
convey,2,0.6931471805599453
upregulation,2,0.6931471805599453
dead-volume,2,0.6931471805599453
997,2,0.6931471805599453
premotor,2,0.6931471805599453
867,2,0.6931471805599453
withdrawing,2,0.6931471805599453
Rapidly,2,0.6931471805599453
EEG-fMRI,2,0.6931471805599453
Drugs,2,0.6931471805599453
aspirate,2,0.6931471805599453
Collateral,2,0.6931471805599453
says,2,0.6931471805599453
Connections,2,0.6931471805599453
bronchoconstrictors,2,0.6931471805599453
Crisis,2,0.6931471805599453
Leukotriene,2,0.6931471805599453
interrupted,2,0.6931471805599453
responder,2,0.6931471805599453
anti-IgE,2,0.6931471805599453
Anhui,2,0.6931471805599453
not-well,2,0.6931471805599453
genuine,2,0.6931471805599453
IIa,2,0.6931471805599453
secular,2,0.6931471805599453
protracted,2,0.6931471805599453
Targets,2,0.6931471805599453
pollens,2,0.6931471805599453
safest,2,0.6931471805599453
Analyzing,2,0.6931471805599453
Sansure,2,0.6931471805599453
anastomosing,2,0.6931471805599453
TaqPathTM,2,0.6931471805599453
accumulate,2,0.6931471805599453
Preoperative,2,0.6931471805599453
Zagreb,2,0.6931471805599453
epidemiologically,2,0.6931471805599453
330,2,0.6931471805599453
intelligent,2,0.6931471805599453
internally,2,0.6931471805599453
Environment,2,0.6931471805599453
accidental,2,0.6931471805599453
10hour,2,0.6931471805599453
Level,2,0.6931471805599453
prerequisites,2,0.6931471805599453
20192020,2,0.6931471805599453
ignores,2,0.6931471805599453
Nagasaki,2,0.6931471805599453
363,2,0.6931471805599453
2015-16,2,0.6931471805599453
2014-15,2,0.6931471805599453
Updated,2,0.6931471805599453
foresee,2,0.6931471805599453
informatics,2,0.6931471805599453
wanted,2,0.6931471805599453
RHC,2,0.6931471805599453
332,2,0.6931471805599453
post-intervention,2,0.6931471805599453
3702,2,0.6931471805599453
unidirectional,2,0.6931471805599453
six-year,2,0.6931471805599453
Days,2,0.6931471805599453
Newer,2,0.6931471805599453
Qiagen,2,0.6931471805599453
adjuncts,2,0.6931471805599453
Manual,2,0.6931471805599453
Rural,2,0.6931471805599453
Wiley,2,0.6931471805599453
preservative,2,0.6931471805599453
14-yr-old,2,0.6931471805599453
maternity,2,0.6931471805599453
MATERIAL,2,0.6931471805599453
838,2,0.6931471805599453
antigenantibody,2,0.6931471805599453
NPOP,2,0.6931471805599453
82-year-old,2,0.6931471805599453
13-,2,0.6931471805599453
Johns,2,0.6931471805599453
Leukotrienes,2,0.6931471805599453
hypoplastic,2,0.6931471805599453
transoesophageal,2,0.6931471805599453
exercise-related,2,0.6931471805599453
270,2,0.6931471805599453
DTI,2,0.6931471805599453
unpartnered,2,0.6931471805599453
neuropathology,2,0.6931471805599453
Brisbane,2,0.6931471805599453
ventilated,2,0.6931471805599453
Transmission,2,0.6931471805599453
extrapolate,2,0.6931471805599453
487,2,0.6931471805599453
draws,2,0.6931471805599453
locomotion,2,0.6931471805599453
speeds,2,0.6931471805599453
BCoM,2,0.6931471805599453
Work-related,2,0.6931471805599453
pleurodesis,2,0.6931471805599453
irritant-induced,2,0.6931471805599453
pleurectomy,2,0.6931471805599453
mixed-methods,2,0.6931471805599453
N-linked,2,0.6931471805599453
73·8,2,0.6931471805599453
hyperresponsive,2,0.6931471805599453
Associated,2,0.6931471805599453
63·3,2,0.6931471805599453
25°C,2,0.6931471805599453
preexercise,2,0.6931471805599453
catheters,2,0.6931471805599453
cooling,2,0.6931471805599453
disparate,2,0.6931471805599453
pemphigoid,2,0.6931471805599453
Priorities,2,0.6931471805599453
drinks,2,0.6931471805599453
style,2,0.6931471805599453
salmeterol,2,0.6931471805599453
slurry,2,0.6931471805599453
Probiotics,2,0.6931471805599453
alveolar-arterial,2,0.6931471805599453
0·0001,2,0.6931471805599453
sufferers,2,0.6931471805599453
retaining,2,0.6931471805599453
headteachers,2,0.6931471805599453
289,2,0.6931471805599453
confident,2,0.6931471805599453
collections,2,0.6931471805599453
workdays,2,0.6931471805599453
unit-level,2,0.6931471805599453
pillar,2,0.6931471805599453
Premier,2,0.6931471805599453
chi2-test,2,0.6931471805599453
goodness-of-fit,2,0.6931471805599453
Prime,2,0.6931471805599453
landfall,2,0.6931471805599453
effluents,2,0.6931471805599453
fresh,2,0.6931471805599453
erosion,2,0.6931471805599453
polymers,2,0.6931471805599453
Minister,2,0.6931471805599453
virucidal,2,0.6931471805599453
Churchill,2,0.6931471805599453
radionuclides,2,0.6931471805599453
behaves,2,0.6931471805599453
eventual,2,0.6931471805599453
biomarker-driven,2,0.6931471805599453
Integrated,2,0.6931471805599453
stasis,2,0.6931471805599453
culling,2,0.6931471805599453
Soviet,2,0.6931471805599453
prolongs,2,0.6931471805599453
206,2,0.6931471805599453
QIVs,2,0.6931471805599453
Developing,2,0.6931471805599453
stroke-unit,2,0.6931471805599453
Stingray™,2,0.6931471805599453
catamenial,2,0.6931471805599453
place-based,2,0.6931471805599453
centrally,2,0.6931471805599453
Natural,2,0.6931471805599453
20152016,2,0.6931471805599453
FluNet,2,0.6931471805599453
weekend,2,0.6931471805599453
IFN-I,2,0.6931471805599453
type-1,2,0.6931471805599453
tropics,2,0.6931471805599453
Immunogenicity,2,0.6931471805599453
pharmacogenomics,2,0.6931471805599453
DOAC,2,0.6931471805599453
nonoccupational,2,0.6931471805599453
President,2,0.6931471805599453
CPLNI,2,0.6931471805599453
instigating,2,0.6931471805599453
extrapolation,2,0.6931471805599453
1880,2,0.6931471805599453
telediastolic,2,0.6931471805599453
immortalized,2,0.6931471805599453
upper-limb,2,0.6931471805599453
goggles,2,0.6931471805599453
ninety-seven,2,0.6931471805599453
in-stent,2,0.6931471805599453
FRET,2,0.6931471805599453
Methodological,2,0.6931471805599453
sub-divided,2,0.6931471805599453
fluorogenic,2,0.6931471805599453
replacements,2,0.6931471805599453
Pontryagins,2,0.6931471805599453
C-,2,0.6931471805599453
IFVB,2,0.6931471805599453
IFVA,2,0.6931471805599453
beads,2,0.6931471805599453
senile,2,0.6931471805599453
Throughout,2,0.6931471805599453
bond,2,0.6931471805599453
lessens,2,0.6931471805599453
formally,2,0.6931471805599453
028,2,0.6931471805599453
ascribed,2,0.6931471805599453
942,2,0.6931471805599453
Procedural,2,0.6931471805599453
saw,2,0.6931471805599453
disagreed,2,0.6931471805599453
gymnasium,2,0.6931471805599453
BDNF,2,0.6931471805599453
underestimation,2,0.6931471805599453
Angiotensin-converting-enzyme,2,0.6931471805599453
onward,2,0.6931471805599453
affluent,2,0.6931471805599453
Box,2,0.6931471805599453
Block,2,0.6931471805599453
disasters,2,0.6931471805599453
practicable,2,0.6931471805599453
Arm,2,0.6931471805599453
390,2,0.6931471805599453
resemble,2,0.6931471805599453
Slovakia,2,0.6931471805599453
mercury,2,0.6931471805599453
Ward,2,0.6931471805599453
hall,2,0.6931471805599453
Qinhuangdao,2,0.6931471805599453
calibration,2,0.6931471805599453
ushered,2,0.6931471805599453
SUA,2,0.6931471805599453
feet,2,0.6931471805599453
clouds,2,0.6931471805599453
singleton,2,0.6931471805599453
academy,2,0.6931471805599453
334,2,0.6931471805599453
T-cells,2,0.6931471805599453
supposed,2,0.6931471805599453
long-time,2,0.6931471805599453
characteristically,2,0.6931471805599453
metadata,2,0.6931471805599453
CTSL,2,0.6931471805599453
birthweight,2,0.6931471805599453
refuse,2,0.6931471805599453
GICA,2,0.6931471805599453
malformations,2,0.6931471805599453
invisible,2,0.6931471805599453
3h,2,0.6931471805599453
moral,2,0.6931471805599453
pectoral,2,0.6931471805599453
experimentation,2,0.6931471805599453
recessive,2,0.6931471805599453
compositions,2,0.6931471805599453
Fugl-Meyer,2,0.6931471805599453
-015,2,0.6931471805599453
Betacoronaviruses,2,0.6931471805599453
Graphical,2,0.6931471805599453
Wolf,2,0.6931471805599453
Function,2,0.6931471805599453
diagonal,2,0.6931471805599453
lambda-like,2,0.6931471805599453
T2-gradient,2,0.6931471805599453
veloergometry,2,0.6931471805599453
362,2,0.6931471805599453
Croatian,2,0.6931471805599453
Issue,2,0.6931471805599453
in-center,2,0.6931471805599453
Ischemia,2,0.6931471805599453
513,2,0.6931471805599453
contentious,2,0.6931471805599453
Thirteen,2,0.6931471805599453
mFIM,2,0.6931471805599453
N95,2,0.6931471805599453
mere,2,0.6931471805599453
duck,2,0.6931471805599453
Hemagglutinin,2,0.6931471805599453
non-vaccine-controlled,2,0.6931471805599453
vaccine-controlled,2,0.6931471805599453
polio,2,0.6931471805599453
diphtheria,2,0.6931471805599453
tetanus,2,0.6931471805599453
2-20,2,0.6931471805599453
files,2,0.6931471805599453
laughter,2,0.6931471805599453
HArS,2,0.6931471805599453
POS,2,0.6931471805599453
0047,2,0.6931471805599453
miscarriage,2,0.6931471805599453
Compliance,2,0.6931471805599453
as-needed,2,0.6931471805599453
≥14,2,0.6931471805599453
Health-care,2,0.6931471805599453
head-velocity,2,0.6931471805599453
trail,2,0.6931471805599453
endeavors,2,0.6931471805599453
CD3,2,0.6931471805599453
fetuses,2,0.6931471805599453
cocaine-related,2,0.6931471805599453
Cocaine,2,0.6931471805599453
6-7,2,0.6931471805599453
birthplace,2,0.6931471805599453
353,2,0.6931471805599453
cerebrum,2,0.6931471805599453
V1-V6,2,0.6931471805599453
nongovernmental,2,0.6931471805599453
contend,2,0.6931471805599453
cesarean,2,0.6931471805599453
46-fold,2,0.6931471805599453
pair-approximation,2,0.6931471805599453
αvβ3,2,0.6931471805599453
diastole,2,0.6931471805599453
hypobiotic,2,0.6931471805599453
host-gene,2,0.6931471805599453
CiC,2,0.6931471805599453
SBI,2,0.6931471805599453
seaweed,2,0.6931471805599453
adsorption-direct,2,0.6931471805599453
perceptible,2,0.6931471805599453
multi-faceted,2,0.6931471805599453
Yamanashi,2,0.6931471805599453
two-fold,2,0.6931471805599453
graphs,2,0.6931471805599453
virus-neutralizing,2,0.6931471805599453
1344,2,0.6931471805599453
VNT,2,0.6931471805599453
200958No,2,0.6931471805599453
Highlights,2,0.6931471805599453
supersite,2,0.6931471805599453
anti-NTD,2,0.6931471805599453
242-244Δ,2,0.6931471805599453
K417N,2,0.6931471805599453
BBrisbane602008-like,2,0.6931471805599453
music-supported,2,0.6931471805599453
RBD-subunit,2,0.6931471805599453
ZF2001,2,0.6931471805599453
CoronaVac,2,0.6931471805599453
CD3CD1656,2,0.6931471805599453
temporarily,2,0.6931471805599453
HRs,2,0.6931471805599453
GIK,2,0.6931471805599453
Scoring,2,0.6931471805599453
ACSS,2,0.6931471805599453
Hemorrhage,2,0.6931471805599453
Wastewater-based,2,0.6931471805599453
rostral,2,0.6931471805599453
Historically,2,0.6931471805599453
tegmentum,2,0.6931471805599453
caudal,2,0.6931471805599453
ketamine,2,0.6931471805599453
Neurosurgery,2,0.6931471805599453
GOS,2,0.6931471805599453
texts,2,0.6931471805599453
Systemic,2,0.6931471805599453
biofeedback-assisted,2,0.6931471805599453
rough,2,0.6931471805599453
Neutralization,2,0.6931471805599453
non-CIB,2,0.6931471805599453
descend,2,0.6931471805599453
throws,2,0.6931471805599453
three-quarters,2,0.6931471805599453
tackled,2,0.6931471805599453
0019,2,0.6931471805599453
sIgE,2,0.6931471805599453
spaced,2,0.6931471805599453
oesophageal,2,0.6931471805599453
ASA,2,0.6931471805599453
HCRU,2,0.6931471805599453
deciphering,2,0.6931471805599453
encoded,2,0.6931471805599453
Process,2,0.6931471805599453
Hungarian,2,0.6931471805599453
exiting,2,0.6931471805599453
aPL-,2,0.6931471805599453
aPL,2,0.6931471805599453
verbal,2,0.6931471805599453
GCS,2,0.6931471805599453
Glasgow,2,0.6931471805599453
cerebroprotection,2,0.6931471805599453
quarantining,2,0.6931471805599453
inflation,2,0.6931471805599453
re-randomized,2,0.6931471805599453
reinforcement,2,0.6931471805599453
graduated,2,0.6931471805599453
Léa,2,0.6931471805599453
ramipril,2,0.6931471805599453
deals,2,0.6931471805599453
hypoglycemia,2,0.6931471805599453
Israeli,2,0.6931471805599453
immature,2,0.6931471805599453
preadmission,2,0.6931471805599453
Transfer,2,0.6931471805599453
OAT,2,0.6931471805599453
interrelation,2,0.6931471805599453
cicatrices,2,0.6931471805599453
nondippers,2,0.6931471805599453
stricter,2,0.6931471805599453
leptin,2,0.6931471805599453
EIATS-WV,2,0.6931471805599453
EIATS-GP,2,0.6931471805599453
constrictor,2,0.6931471805599453
nonpathogenic,2,0.6931471805599453
reflexes,2,0.6931471805599453
subtypical,2,0.6931471805599453
diminishing,2,0.6931471805599453
severity-of-asthma,2,0.6931471805599453
post-,2,0.6931471805599453
Brown,2,0.6931471805599453
over-expression,2,0.6931471805599453
scoping,2,0.6931471805599453
attaching,2,0.6931471805599453
Hokkaido,2,0.6931471805599453
filed,2,0.6931471805599453
neutralisation,2,0.6931471805599453
acidic,2,0.6931471805599453
impedimetric,2,0.6931471805599453
ultrasensitive,2,0.6931471805599453
Comirnaty,2,0.6931471805599453
nonrespiratory,2,0.6931471805599453
SM1,2,0.6931471805599453
bihemispheric,2,0.6931471805599453
divides,2,0.6931471805599453
inlet,2,0.6931471805599453
PCR-positive,2,0.6931471805599453
perfectly,2,0.6931471805599453
transmitting,2,0.6931471805599453
antibody-positive,2,0.6931471805599453
road,2,0.6931471805599453
lifting,2,0.6931471805599453
Castlemans,2,0.6931471805599453
Sometimes,2,0.6931471805599453
lectin,2,0.6931471805599453
aM,2,0.6931471805599453
μl,2,0.6931471805599453
PSP,2,0.6931471805599453
assembled,2,0.6931471805599453
time-series,2,0.6931471805599453
analytes,2,0.6931471805599453
high-dimensional,2,0.6931471805599453
iNOS,2,0.6931471805599453
Statistically,2,0.6931471805599453
anticancer,2,0.6931471805599453
Topical,2,0.6931471805599453
dipropionate,2,0.6931471805599453
magnitudes,2,0.6931471805599453
inherited,2,0.6931471805599453
counteracting,2,0.6931471805599453
transcript,2,0.6931471805599453
performs,2,0.6931471805599453
transfected,2,0.6931471805599453
hpi,2,0.6931471805599453
mono,2,0.6931471805599453
attract,2,0.6931471805599453
epilepticus,2,0.6931471805599453
vicious,2,0.6931471805599453
Copenhagen,2,0.6931471805599453
Ninety-day,2,0.6931471805599453
24-48,2,0.6931471805599453
479,2,0.6931471805599453
succeeding,2,0.6931471805599453
Identical,2,0.6931471805599453
842,2,0.6931471805599453
deploying,2,0.6931471805599453
DSP,2,0.6931471805599453
Chi-square,2,0.6931471805599453
Tabriz,2,0.6931471805599453
reminder,2,0.6931471805599453
cardiologist,2,0.6931471805599453
Subunit,2,0.6931471805599453
allocating,2,0.6931471805599453
CPs,2,0.6931471805599453
See,2,0.6931471805599453
realization,2,0.6931471805599453
Polymerase,2,0.6931471805599453
Transcription,2,0.6931471805599453
Multimodal,2,0.6931471805599453
Charlson,2,0.6931471805599453
Comorbidity,2,0.6931471805599453
clotting,2,0.6931471805599453
MB-CPK,2,0.6931471805599453
Wilcoxon,2,0.6931471805599453
Accuracy,2,0.6931471805599453
unpaired,2,0.6931471805599453
adrenalectomy,2,0.6931471805599453
neuron,2,0.6931471805599453
Pearson,2,0.6931471805599453
chromaffin,2,0.6931471805599453
caretakers,2,0.6931471805599453
crosses,2,0.6931471805599453
norms,2,0.6931471805599453
Around,2,0.6931471805599453
likes,2,0.6931471805599453
Develop,2,0.6931471805599453
Cryptogenic,2,0.6931471805599453
Population-based,2,0.6931471805599453
1972,2,0.6931471805599453
444,2,0.6931471805599453
prostatectomy,2,0.6931471805599453
conflicts,2,0.6931471805599453
V1-3QS,2,0.6931471805599453
V1-4QS,2,0.6931471805599453
VAT,2,0.6931471805599453
199697,2,0.6931471805599453
cross-validation,2,0.6931471805599453
moved,2,0.6931471805599453
comprehension,2,0.6931471805599453
contradictions,2,0.6931471805599453
t-test,2,0.6931471805599453
attend,2,0.6931471805599453
Caregivers,2,0.6931471805599453
unseen,2,0.6931471805599453
Macao,2,0.6931471805599453
anastomosis,2,0.6931471805599453
subclavian,2,0.6931471805599453
elected,2,0.6931471805599453
974,2,0.6931471805599453
MDD,2,0.6931471805599453
neurotrophic,2,0.6931471805599453
tied,2,0.6931471805599453
Neurologists,2,0.6931471805599453
signify,2,0.6931471805599453
apneas,2,0.6931471805599453
overwhelmingly,2,0.6931471805599453
fluency,2,0.6931471805599453
diuretic,2,0.6931471805599453
iterative,2,0.6931471805599453
periodicity,2,0.6931471805599453
V1-5QS,2,0.6931471805599453
filter-based,2,0.6931471805599453
Circulating,2,0.6931471805599453
Walker,2,0.6931471805599453
fed,2,0.6931471805599453
orthopaedic,2,0.6931471805599453
disease-related,2,0.6931471805599453
paradoxic,2,0.6931471805599453
Brocas,2,0.6931471805599453
estimations,2,0.6931471805599453
factor-α,2,0.6931471805599453
trees,2,0.6931471805599453
Candida,2,0.6931471805599453
standpoint,2,0.6931471805599453
maximise,2,0.6931471805599453
refusal,2,0.6931471805599453
classifiers,2,0.6931471805599453
psychology,2,0.6931471805599453
Lipid,2,0.6931471805599453
referents,2,0.6931471805599453
Sigma-Virocult,2,0.6931471805599453
sub,2,0.6931471805599453
educator,2,0.6931471805599453
Levels,2,0.6931471805599453
Myoglobin,2,0.6931471805599453
hypovolemia,2,0.6931471805599453
versa,2,0.6931471805599453
vice,2,0.6931471805599453
--,2,0.6931471805599453
CDPH,2,0.6931471805599453
spurred,2,0.6931471805599453
sociological,2,0.6931471805599453
636,2,0.6931471805599453
nanocages,2,0.6931471805599453
mosaic,2,0.6931471805599453
407,2,0.6931471805599453
bottlenecks,2,0.6931471805599453
WGS,2,0.6931471805599453
exemplar,2,0.6931471805599453
boards,2,0.6931471805599453
EMEM,2,0.6931471805599453
freezing,2,0.6931471805599453
raceethnic,2,0.6931471805599453
Concurrent,2,0.6931471805599453
9385,2,0.6931471805599453
Chimeric,2,0.6931471805599453
Short-Form,2,0.6931471805599453
36-Item,2,0.6931471805599453
Oasys-2,2,0.6931471805599453
LVADs,2,0.6931471805599453
Descriptive,2,0.6931471805599453
DNT,2,0.6931471805599453
U-BIOPRED,2,0.6931471805599453
personalize,2,0.6931471805599453
door-to-imaging,2,0.6931471805599453
pediatrics,2,0.6931471805599453
metabolomics,2,0.6931471805599453
CB1,2,0.6931471805599453
CB2,2,0.6931471805599453
chemoreflex,2,0.6931471805599453
1175,2,0.6931471805599453
semen,2,0.6931471805599453
supratherapeutic,2,0.6931471805599453
grossly,2,0.6931471805599453
untrained,2,0.6931471805599453
drafting,2,0.6931471805599453
Joint,2,0.6931471805599453
attenuates,2,0.6931471805599453
Y41,2,0.6931471805599453
pseudotyped,2,0.6931471805599453
Euroimmun-IgA,2,0.6931471805599453
SARS-CoV-2-related,2,0.6931471805599453
rights,2,0.6931471805599453
NFZ,2,0.6931471805599453
obscured,2,0.6931471805599453
incompetence,2,0.6931471805599453
ICD-10,2,0.6931471805599453
lupus,2,0.6931471805599453
mgkgday,2,0.6931471805599453
absorption,2,0.6931471805599453
within-host,2,0.6931471805599453
trimetazidine,2,0.6931471805599453
salicylate,2,0.6931471805599453
416,2,0.6931471805599453
RAST,2,0.6931471805599453
cycEVA,2,0.6931471805599453
Vircell-IgG,2,0.6931471805599453
impeding,2,0.6931471805599453
Euroimmun-IgG,2,0.6931471805599453
standalone,2,0.6931471805599453
vasodilatory,2,0.6931471805599453
balancing,2,0.6931471805599453
Gram,2,0.6931471805599453
Working,2,0.6931471805599453
radioimmunoassay,2,0.6931471805599453
paradox,2,0.6931471805599453
pred,2,0.6931471805599453
visit-to-visit,2,0.6931471805599453
spirometers,2,0.6931471805599453
Twenty-three,2,0.6931471805599453
unconventional,2,0.6931471805599453
transplants,2,0.6931471805599453
899,2,0.6931471805599453
fortunately,2,0.6931471805599453
906,2,0.6931471805599453
fires,2,0.6931471805599453
transparency,2,0.6931471805599453
metric,2,0.6931471805599453
NOMAS,2,0.6931471805599453
isopotential,2,0.6931471805599453
Image,2,0.6931471805599453
Strengthening,2,0.6931471805599453
ion,2,0.6931471805599453
HBV,2,0.6931471805599453
Cooperation,2,0.6931471805599453
oligosaccharides,2,0.6931471805599453
GHD,2,0.6931471805599453
MISs,2,0.6931471805599453
Bt-CoV,2,0.6931471805599453
actors,2,0.6931471805599453
3D-STE,2,0.6931471805599453
leaks,2,0.6931471805599453
nationalist,2,0.6931471805599453
appetite,2,0.6931471805599453
Kentucky,2,0.6931471805599453
lobectomy,2,0.6931471805599453
Words,2,0.6931471805599453
048,2,0.6931471805599453
Size,2,0.6931471805599453
462,2,0.6931471805599453
644,2,0.6931471805599453
hydrolysis,2,0.6931471805599453
proves,2,0.6931471805599453
akinesis,2,0.6931471805599453
partnerships,2,0.6931471805599453
moiety,2,0.6931471805599453
FEF25-75,2,0.6931471805599453
hs,2,0.6931471805599453
affliction,2,0.6931471805599453
believes,2,0.6931471805599453
Mr,2,0.6931471805599453
fitted,2,0.6931471805599453
neurotherapeutic,2,0.6931471805599453
glutamate,2,0.6931471805599453
astrocyte,2,0.6931471805599453
Damage,2,0.6931471805599453
T1-weighted,2,0.6931471805599453
structurally,2,0.6931471805599453
KDO,2,0.6931471805599453
opened,2,0.6931471805599453
Sensory,2,0.6931471805599453
telocyte,2,0.6931471805599453
expands,2,0.6931471805599453
geopolitical,2,0.6931471805599453
Matching,2,0.6931471805599453
posttransplant,2,0.6931471805599453
cytomegalovirus,2,0.6931471805599453
happened,2,0.6931471805599453
Movement,2,0.6931471805599453
ovariectomized,2,0.6931471805599453
Nucleocapsid,2,0.6931471805599453
diverge,2,0.6931471805599453
married,2,0.6931471805599453
non-diabetic,2,0.6931471805599453
out-patients,2,0.6931471805599453
RdRPN,2,0.6931471805599453
stripe,2,0.6931471805599453
esophageal-pleural,2,0.6931471805599453
macrofocal,2,0.6931471805599453
EN,2,0.6931471805599453
tunnel,2,0.6931471805599453
Azygos,2,0.6931471805599453
infrastructures,2,0.6931471805599453
Allplex™,2,0.6931471805599453
PowerChek™,2,0.6931471805599453
≤40,2,0.6931471805599453
WIV-1,2,0.6931471805599453
63±2,2,0.6931471805599453
asymmetry,2,0.6931471805599453
n8,2,0.6931471805599453
APC-PCI,2,0.6931471805599453
gram-negative,2,0.6931471805599453
301,2,0.6931471805599453
017,2,0.6931471805599453
executed,2,0.6931471805599453
obliterans,2,0.6931471805599453
immunodeficiencies,2,0.6931471805599453
disagreement,2,0.6931471805599453
V1-V2,2,0.6931471805599453
Mixing,2,0.6931471805599453
intra-assay,2,0.6931471805599453
coating,2,0.6931471805599453
inferoapical,2,0.6931471805599453
domain-binding,2,0.6931471805599453
apnoea,2,0.6931471805599453
n9,2,0.6931471805599453
terminated,2,0.6931471805599453
n11,2,0.6931471805599453
RealTime,2,0.6931471805599453
82A6,2,0.6931471805599453
1140,2,0.6931471805599453
washings,2,0.6931471805599453
Rwandas,2,0.6931471805599453
mHealth,2,0.6931471805599453
non-PCM,2,0.6931471805599453
Controlled,2,0.6931471805599453
ancillary,2,0.6931471805599453
effectors,2,0.6931471805599453
Contributors,2,0.6931471805599453
electronics,2,0.6931471805599453
NADPH,2,0.6931471805599453
wearable,2,0.6931471805599453
haematopoietic,2,0.6931471805599453
Perspective,2,0.6931471805599453
Industry,2,0.6931471805599453
Academic,2,0.6931471805599453
H5N1-induced,2,0.6931471805599453
Arguments,2,0.6931471805599453
implicate,2,0.6931471805599453
Hyper,2,0.6931471805599453
colored,2,0.6931471805599453
Aq,2,0.6931471805599453
untreatable,2,0.6931471805599453
accessed,2,0.6931471805599453
unfolding,2,0.6931471805599453
neuropsychiatry,2,0.6931471805599453
Korczyński,2,0.6931471805599453
progeny,2,0.6931471805599453
CYP4A11,2,0.6931471805599453
CYP4F2,2,0.6931471805599453
potentiating,2,0.6931471805599453
denominator,2,0.6931471805599453
Władysław,2,0.6931471805599453
Józef,2,0.6931471805599453
nt,2,0.6931471805599453
872,2,0.6931471805599453
AMoscow1099,2,0.6931471805599453
deliveries,2,0.6931471805599453
Cybulski,2,0.6931471805599453
ideation,2,0.6931471805599453
H1N1-like,2,0.6931471805599453
delirium,2,0.6931471805599453
Strains,2,0.6931471805599453
recalls,2,0.6931471805599453
anosognosia,2,0.6931471805599453
divisive,2,0.6931471805599453
Defect,2,0.6931471805599453
fabrication,2,0.6931471805599453
uremia,2,0.6931471805599453
posture,2,0.6931471805599453
substantiated,2,0.6931471805599453
Olten,2,0.6931471805599453
organisations,2,0.6931471805599453
Expanding,2,0.6931471805599453
arteriovenous,2,0.6931471805599453
mock,2,0.6931471805599453
probing,2,0.6931471805599453
valued,2,0.6931471805599453
388,2,0.6931471805599453
Undoubtedly,2,0.6931471805599453
579,2,0.6931471805599453
inhalative,2,0.6931471805599453
471,2,0.6931471805599453
mildest,2,0.6931471805599453
orderly,2,0.6931471805599453
Journals,2,0.6931471805599453
MD,2,0.6931471805599453
Adalja,2,0.6931471805599453
debates,2,0.6931471805599453
Postural,2,0.6931471805599453
Vancouver,2,0.6931471805599453
FGF-23,2,0.6931471805599453
understated,2,0.6931471805599453
Acquired,2,0.6931471805599453
deoxyribonucleic,2,0.6931471805599453
nitrogenous,2,0.6931471805599453
THD,2,0.6931471805599453
Na3Ct,2,0.6931471805599453
citrate,2,0.6931471805599453
HAuCl4,2,0.6931471805599453
faecium,2,0.6931471805599453
prednisone,2,0.6931471805599453
proximate,2,0.6931471805599453
507,2,0.6931471805599453
virgin,2,0.6931471805599453
41-year-old,2,0.6931471805599453
extubated,2,0.6931471805599453
Edward,2,0.6931471805599453
Causes,2,0.6931471805599453
emphasises,2,0.6931471805599453
conclusive,2,0.6931471805599453
DAOS,2,0.6931471805599453
editor,2,0.6931471805599453
nM,2,0.6931471805599453
sequel,2,0.6931471805599453
resume,2,0.6931471805599453
lobes,2,0.6931471805599453
Antivirals,2,0.6931471805599453
profoundly,2,0.6931471805599453
fungus,2,0.6931471805599453
SPS3,2,0.6931471805599453
SPRINT,2,0.6931471805599453
Lesions,2,0.6931471805599453
CpGs,2,0.6931471805599453
2-year,2,0.6931471805599453
impairing,2,0.6931471805599453
psychogenias,2,0.6931471805599453
False,2,0.6931471805599453
masked,2,0.6931471805599453
immunosenescence,2,0.6931471805599453
neurotic,2,0.6931471805599453
interrelated,2,0.6931471805599453
marine,2,0.6931471805599453
0-7,2,0.6931471805599453
tetravalent,2,0.6931471805599453
suboptimally,2,0.6931471805599453
Memorial,2,0.6931471805599453
revising,2,0.6931471805599453
economically,2,0.6931471805599453
infectious-related,2,0.6931471805599453
anonymous,2,0.6931471805599453
Lithuanian,2,0.6931471805599453
UD,2,0.6931471805599453
Aphasia,2,0.6931471805599453
late-stage,2,0.6931471805599453
525,2,0.6931471805599453
tongue,2,0.6931471805599453
lips,2,0.6931471805599453
palsy,2,0.6931471805599453
307,2,0.6931471805599453
Below,2,0.6931471805599453
23-71,2,0.6931471805599453
accumulating,2,0.6931471805599453
bulk,2,0.6931471805599453
Luminex,2,0.6931471805599453
UKs,2,0.6931471805599453
Stenting,2,0.6931471805599453
artificially,2,0.6931471805599453
OHCA,2,0.6931471805599453
pinnipeds,2,0.6931471805599453
carriage,2,0.6931471805599453
Passengers,2,0.6931471805599453
collaboratively,2,0.6931471805599453
leukopenia,2,0.6931471805599453
Thirty-seven,2,0.6931471805599453
auxiliary,2,0.6931471805599453
gaseous,2,0.6931471805599453
trigeminal,2,0.6931471805599453
SDs,2,0.6931471805599453
coronarography,2,0.6931471805599453
Useful,2,0.6931471805599453
Inactivated,2,0.6931471805599453
ADRs,2,0.6931471805599453
seeing,2,0.6931471805599453
651,2,0.6931471805599453
metabolite,2,0.6931471805599453
phagocytes,2,0.6931471805599453
interpretations,2,0.6931471805599453
maintains,2,0.6931471805599453
VDR,2,0.6931471805599453
DEPs,2,0.6931471805599453
Munich,2,0.6931471805599453
northeastern,2,0.6931471805599453
deferring,2,0.6931471805599453
approximate,2,0.6931471805599453
enjoy,2,0.6931471805599453
timed,2,0.6931471805599453
extended-care,2,0.6931471805599453
naked-eye,2,0.6931471805599453
absorbance,2,0.6931471805599453
17-fold,2,0.6931471805599453
utilisation,2,0.6931471805599453
9-11,2,0.6931471805599453
thalamotomy,2,0.6931471805599453
post-conditioning,2,0.6931471805599453
Presented,2,0.6931471805599453
Serine128Arginine,2,0.6931471805599453
ASPIRE,2,0.6931471805599453
Delayed,2,0.6931471805599453
secreting,2,0.6931471805599453
ASC,2,0.6931471805599453
Amesh,2,0.6931471805599453
Readers,2,0.6931471805599453
resided,2,0.6931471805599453
population-wide,2,0.6931471805599453
silk,2,0.6931471805599453
atypia,2,0.6931471805599453
rug,2,0.6931471805599453
seasonally,2,0.6931471805599453
Regimen,2,0.6931471805599453
disappear,2,0.6931471805599453
Pakistani,2,0.6931471805599453
reappraisal,2,0.6931471805599453
Junta,2,0.6931471805599453
shoulders,2,0.6931471805599453
hisher,2,0.6931471805599453
bipolar,2,0.6931471805599453
horse,2,0.6931471805599453
Socorros,2,0.6931471805599453
Thirty-two,2,0.6931471805599453
posttreatment,2,0.6931471805599453
sacrifice,2,0.6931471805599453
hepatic,2,0.6931471805599453
IFN,2,0.6931471805599453
EUA-approved,2,0.6931471805599453
reperfusion-induced,2,0.6931471805599453
signal-to-noise,2,0.6931471805599453
sympathomimetic,2,0.6931471805599453
LC,2,0.6931471805599453
Radiomics,2,0.6931471805599453
non-alcoholic,2,0.6931471805599453
LVED,2,0.6931471805599453
pneumonia-causing,2,0.6931471805599453
effusions,2,0.6931471805599453
guides,2,0.6931471805599453
serum-based,2,0.6931471805599453
BIOSYNEX®,2,0.6931471805599453
BSS,2,0.6931471805599453
bovine,2,0.6931471805599453
Wright,2,0.6931471805599453
cows,2,0.6931471805599453
lactating,2,0.6931471805599453
tocolytic,2,0.6931471805599453
seal,2,0.6931471805599453
reassuring,2,0.6931471805599453
Consider,2,0.6931471805599453
CMEAnswers,2,0.6931471805599453
nonlinear,2,0.6931471805599453
Neuro-occupation,2,0.6931471805599453
D2BT,2,0.6931471805599453
conserving,2,0.6931471805599453
moulds,2,0.6931471805599453
EDTA,2,0.6931471805599453
massively,2,0.6931471805599453
monoxide,2,0.6931471805599453
en,2,0.6931471805599453
submucosal,2,0.6931471805599453
Interferons,2,0.6931471805599453
QuantStudio,2,0.6931471805599453
CPT,2,0.6931471805599453
one-half,2,0.6931471805599453
592,2,0.6931471805599453
DESs,2,0.6931471805599453
324,2,0.6931471805599453
transfusing,2,0.6931471805599453
SU,2,0.6931471805599453
Innovative,2,0.6931471805599453
Willis,2,0.6931471805599453
efficacies,2,0.6931471805599453
28-year-old,2,0.6931471805599453
OP,2,0.6931471805599453
sparked,2,0.6931471805599453
A549-IFN-λ2,2,0.6931471805599453
Excellence,2,0.6931471805599453
Pool,2,0.6931471805599453
offices,2,0.6931471805599453
UIIP,2,0.6931471805599453
pinpoint,2,0.6931471805599453
disastrous,2,0.6931471805599453
SWCM,2,0.6931471805599453
Underuse,2,0.6931471805599453
Dexamethasone,2,0.6931471805599453
pre-determined,2,0.6931471805599453
APP,2,0.6931471805599453
Polands,2,0.6931471805599453
Swietokrzyskie,2,0.6931471805599453
synthesised,2,0.6931471805599453
realist,2,0.6931471805599453
year-olds,2,0.6931471805599453
lingered,2,0.6931471805599453
653,2,0.6931471805599453
prefer,2,0.6931471805599453
NSCLC,2,0.6931471805599453
therapy-resistant,2,0.6931471805599453
pneumococcus,2,0.6931471805599453
Status,2,0.6931471805599453
conductance,2,0.6931471805599453
SGaw,2,0.6931471805599453
Curcumin,2,0.6931471805599453
OVA-induced,2,0.6931471805599453
NBT,2,0.6931471805599453
atraumatic,2,0.6931471805599453
10-20,2,0.6931471805599453
Inappropriate,2,0.6931471805599453
LRTIs,2,0.6931471805599453
cognate,2,0.6931471805599453
687,2,0.6931471805599453
558,2,0.6931471805599453
Adolescents,2,0.6931471805599453
≥18,2,0.6931471805599453
Presence,2,0.6931471805599453
formations,2,0.6931471805599453
tonsillitis,2,0.6931471805599453
14-year-old,2,0.6931471805599453
abscesses,2,0.6931471805599453
successively,2,0.6931471805599453
hypoxaemia,2,0.6931471805599453
LVES,2,0.6931471805599453
PMI,2,0.6931471805599453
Ipratropium,2,0.6931471805599453
Policymakers,2,0.6931471805599453
AE,2,0.6931471805599453
Accident,2,0.6931471805599453
conserve,2,0.6931471805599453
ST-SD,2,0.6931471805599453
Hetil,2,0.6931471805599453
Orv,2,0.6931471805599453
Hungary,2,0.6931471805599453
cite,2,0.6931471805599453
microbiological,2,0.6931471805599453
AIIRD,2,0.6931471805599453
944,2,0.6931471805599453
ben,2,0.6931471805599453
reappearance,2,0.6931471805599453
rehospitalization,2,0.6931471805599453
pragmatic,2,0.6931471805599453
3T,2,0.6931471805599453
prepaid,2,0.6931471805599453
accessory,2,0.6931471805599453
productions,2,0.6931471805599453
odontogenic,2,0.6931471805599453
BDI,2,0.6931471805599453
accessing,2,0.6931471805599453
residing,2,0.6931471805599453
bulb,2,0.6931471805599453
programmatic,2,0.6931471805599453
99mTc-gated,2,0.6931471805599453
hypogeusia,2,0.6931471805599453
201Tl-scintigraphy,2,0.6931471805599453
HPG,2,0.6931471805599453
colophony,2,0.6931471805599453
TNF-α,2,0.6931471805599453
Lipoprotein-associated,2,0.6931471805599453
Lp-PLA2,2,0.6931471805599453
annotated,2,0.6931471805599453
402,2,0.6931471805599453
FRET-based,2,0.6931471805599453
Teen-caregiver,2,0.6931471805599453
pipelines,2,0.6931471805599453
radiomics,2,0.6931471805599453
teen,2,0.6931471805599453
hemodialyzed,2,0.6931471805599453
Sublingual,2,0.6931471805599453
331,2,0.6931471805599453
ORF10,2,0.6931471805599453
ORF7a,2,0.6931471805599453
immunopathogenesis,2,0.6931471805599453
IBV,2,0.6931471805599453
UTR,2,0.6931471805599453
uniqueness,2,0.6931471805599453
Kit,2,0.6931471805599453
ORF9b,2,0.6931471805599453
ORF7b,2,0.6931471805599453
Franklin,2,0.6931471805599453
326,2,0.6931471805599453
awaiting,2,0.6931471805599453
trafermin,2,0.6931471805599453
matters,2,0.6931471805599453
elevate,2,0.6931471805599453
satisfies,2,0.6931471805599453
Typical,2,0.6931471805599453
PGE2,2,0.6931471805599453
dampen,2,0.6931471805599453
pre-PTCA,2,0.6931471805599453
Earthing,2,0.6931471805599453
dampness,2,0.6931471805599453
Zhu,2,0.6931471805599453
Access,2,0.6931471805599453
pieces,2,0.6931471805599453
Selecting,2,0.6931471805599453
rationalize,2,0.6931471805599453
corporation,2,0.6931471805599453
387,2,0.6931471805599453
662,2,0.6931471805599453
squared,2,0.6931471805599453
urbanization,2,0.6931471805599453
Set,2,0.6931471805599453
receptor-mediated,2,0.6931471805599453
neurorehabilitation,2,0.6931471805599453
Francisco,2,0.6931471805599453
Readiness,2,0.6931471805599453
do-it-yourself,2,0.6931471805599453
blot,2,0.6931471805599453
IL-5,2,0.6931471805599453
441,2,0.6931471805599453
trophic,2,0.6931471805599453
-3,2,0.6931471805599453
tape,2,0.6931471805599453
Arrhythmias,2,0.6931471805599453
peculiar,2,0.6931471805599453
Mice,2,0.6931471805599453
medium-sized,2,0.6931471805599453
logical,2,0.6931471805599453
summarizing,2,0.6931471805599453
serum-free,2,0.6931471805599453
Everest,2,0.6931471805599453
compromising,2,0.6931471805599453
prevailed,2,0.6931471805599453
Cities,2,0.6931471805599453
January-February,2,0.6931471805599453
intrafamilial,2,0.6931471805599453
unwarranted,2,0.6931471805599453
overmortality,2,0.6931471805599453
columnar,2,0.6931471805599453
epidermal,2,0.6931471805599453
Ag-RDTs,2,0.6931471805599453
assayed,2,0.6931471805599453
0032,2,0.6931471805599453
underpin,2,0.6931471805599453
physiopathology,2,0.6931471805599453
648,2,0.6931471805599453
multiplexed,2,0.6931471805599453
near-patient,2,0.6931471805599453
intakes,2,0.6931471805599453
236,2,0.6931471805599453
473,2,0.6931471805599453
242,2,0.6931471805599453
sternotomy,2,0.6931471805599453
peri-infarct,2,0.6931471805599453
Johansen,2,0.6931471805599453
Bagging,2,0.6931471805599453
28th,2,0.6931471805599453
Art,2,0.6931471805599453
198990,2,0.6931471805599453
Gøtzsche,2,0.6931471805599453
factor-beta,2,0.6931471805599453
washout,2,0.6931471805599453
Indigenous,2,0.6931471805599453
631,2,0.6931471805599453
NASBA,2,0.6931471805599453
sequence-based,2,0.6931471805599453
operates,2,0.6931471805599453
FluCAN,2,0.6931471805599453
sequencing-based,2,0.6931471805599453
two-stage,2,0.6931471805599453
mandating,2,0.6931471805599453
Cumulative,2,0.6931471805599453
Ethnopharmacological,2,0.6931471805599453
acid-based,2,0.6931471805599453
analytically,2,0.6931471805599453
Genomic,2,0.6931471805599453
dozen,2,0.6931471805599453
post-ischemic,2,0.6931471805599453
MI-SVO,2,0.6931471805599453
Containment,2,0.6931471805599453
3-terminal,2,0.6931471805599453
bore,2,0.6931471805599453
appreciable,2,0.6931471805599453
Africans,2,0.6931471805599453
psychotherapy,2,0.6931471805599453
HRV-induced,2,0.6931471805599453
Urinary,2,0.6931471805599453
embryonic,2,0.6931471805599453
ESC,2,0.6931471805599453
collects,2,0.6931471805599453
uninfected,2,0.6931471805599453
reassort,2,0.6931471805599453
Communicable,2,0.6931471805599453
PHLS,2,0.6931471805599453
Censuses,2,0.6931471805599453
tetracycline,2,0.6931471805599453
Bed,2,0.6931471805599453
B-cells,2,0.6931471805599453
610,2,0.6931471805599453
wearers,2,0.6931471805599453
work-related,2,0.6931471805599453
inflammometry,2,0.6931471805599453
supposedly,2,0.6931471805599453
Disease-2019,2,0.6931471805599453
067,2,0.6931471805599453
cast,2,0.6931471805599453
duo,2,0.6931471805599453
cochleovestibular,2,0.6931471805599453
non-IgE,2,0.6931471805599453
antigenemiaviremia,2,0.6931471805599453
inorganic-,2,0.6931471805599453
Mass,2,0.6931471805599453
heterozygote,2,0.6931471805599453
disease-specific,2,0.6931471805599453
Subgroup,2,0.6931471805599453
continuous-time,2,0.6931471805599453
metal,2,0.6931471805599453
corroborate,2,0.6931471805599453
prefectures,2,0.6931471805599453
D614,2,0.6931471805599453
BAC,2,0.6931471805599453
dewfrost,2,0.6931471805599453
vector-MSCs,2,0.6931471805599453
classroom,2,0.6931471805599453
Residential,2,0.6931471805599453
Australias,2,0.6931471805599453
Flk-1,2,0.6931471805599453
MMM,2,0.6931471805599453
spectrogram,2,0.6931471805599453
doxycycline,2,0.6931471805599453
G614,2,0.6931471805599453
400000,2,0.6931471805599453
surpassed,2,0.6931471805599453
committees,2,0.6931471805599453
deconditioning,2,0.6931471805599453
convalescence,2,0.6931471805599453
explosive,2,0.6931471805599453
business,2,0.6931471805599453
angiographical,2,0.6931471805599453
Plasmapheresis,2,0.6931471805599453
PLL,2,0.6931471805599453
AHA,2,0.6931471805599453
CBV,2,0.6931471805599453
meningitis,2,0.6931471805599453
pons,2,0.6931471805599453
symmetrical,2,0.6931471805599453
ailments,2,0.6931471805599453
25-75,2,0.6931471805599453
35-year-old,2,0.6931471805599453
boundary,2,0.6931471805599453
Table,2,0.6931471805599453
declaration,2,0.6931471805599453
NeuroIntervent,2,0.6931471805599453
ferumoxytol,2,0.6931471805599453
Surg,2,0.6931471805599453
donated,2,0.6931471805599453
Hunan,2,0.6931471805599453
validating,2,0.6931471805599453
prevail,2,0.6931471805599453
14-44,2,0.6931471805599453
shapes,2,0.6931471805599453
PHIs,2,0.6931471805599453
correlating,2,0.6931471805599453
VISION,2,0.6931471805599453
audible,2,0.6931471805599453
broke,2,0.6931471805599453
walk,2,0.6931471805599453
biopsied,2,0.6931471805599453
COVID19,2,0.6931471805599453
VLP-forming,2,0.6931471805599453
collagenous,2,0.6931471805599453
webs,2,0.6931471805599453
fecal-viral,2,0.6931471805599453
CoviVac,2,0.6931471805599453
regiments,2,0.6931471805599453
NPEs,2,0.6931471805599453
Reports,2,0.6931471805599453
allergists,2,0.6931471805599453
280,2,0.6931471805599453
Motivated,2,0.6931471805599453
superfamily,2,0.6931471805599453
flights,2,0.6931471805599453
Litomosoides,2,0.6931471805599453
Musteloidea,2,0.6931471805599453
Anderson,2,0.6931471805599453
affiliation,2,0.6931471805599453
make-up,2,0.6931471805599453
ACQ,2,0.6931471805599453
Russia,2,0.6931471805599453
remits,2,0.6931471805599453
wholly,2,0.6931471805599453
interactive-critical,2,0.6931471805599453
releasing,2,0.6931471805599453
Observed,2,0.6931471805599453
EIT,2,0.6931471805599453
infodemic,2,0.6931471805599453
syncope,2,0.6931471805599453
foreseen,2,0.6931471805599453
Electrocardiogram,2,0.6931471805599453
Pranayama,2,0.6931471805599453
digestion,2,0.6931471805599453
toxicologic,2,0.6931471805599453
proliferator-activated,2,0.6931471805599453
in-,2,0.6931471805599453
BVF,2,0.6931471805599453
worthy,2,0.6931471805599453
interviewer,2,0.6931471805599453
bamlanivimab,2,0.6931471805599453
gonadotrophin-releasing,2,0.6931471805599453
m-2,2,0.6931471805599453
thermometer,2,0.6931471805599453
para-clinical,2,0.6931471805599453
premenstrually,2,0.6931471805599453
virus-neutralisation,2,0.6931471805599453
GeneScriptcPass,2,0.6931471805599453
electrode,2,0.6931471805599453
operator,2,0.6931471805599453
2-12,2,0.6931471805599453
571,2,0.6931471805599453
rp,2,0.6931471805599453
GAPDH,2,0.6931471805599453
Pearsons,2,0.6931471805599453
multitude,2,0.6931471805599453
urged,2,0.6931471805599453
930,2,0.6931471805599453
635,2,0.6931471805599453
Thirty-three,2,0.6931471805599453
encapsulated,2,0.6931471805599453
Fecal,2,0.6931471805599453
true-positives,2,0.6931471805599453
cingulate,2,0.6931471805599453
marijuana,2,0.6931471805599453
16-year-old,2,0.6931471805599453
P014,2,0.6931471805599453
940,2,0.6931471805599453
milieu,2,0.6931471805599453
Combination,2,0.6931471805599453
376,2,0.6931471805599453
CAL,2,0.6931471805599453
PBI,2,0.6931471805599453
n35,2,0.6931471805599453
RTK,2,0.6931471805599453
n23,2,0.6931471805599453
anorgasmia,2,0.6931471805599453
prescription，,2,0.6931471805599453
systemically,2,0.6931471805599453
hardly,2,0.6931471805599453
unprotected,2,0.6931471805599453
200405,2,0.6931471805599453
pro-ANP,2,0.6931471805599453
progestin,2,0.6931471805599453
manuscripts,2,0.6931471805599453
phlegm，,2,0.6931471805599453
wind，,2,0.6931471805599453
diabetics,2,0.6931471805599453
Yin,2,0.6931471805599453
Qi,2,0.6931471805599453
Pro-ANP,2,0.6931471805599453
1966,2,0.6931471805599453
BOP,2,0.6931471805599453
sensitizations,2,0.6931471805599453
non-dentist,2,0.6931471805599453
ANew,2,0.6931471805599453
pre-Delta,2,0.6931471805599453
Federal,2,0.6931471805599453
Sao,2,0.6931471805599453
Changing,2,0.6931471805599453
Rarely,2,0.6931471805599453
hybrid,2,0.6931471805599453
335,2,0.6931471805599453
36-48,2,0.6931471805599453
nitrate-enhanced,2,0.6931471805599453
visualizing,2,0.6931471805599453
High-frequency,2,0.6931471805599453
895,2,0.6931471805599453
Ninety,2,0.6931471805599453
2125,2,0.6931471805599453
Neither,2,0.6931471805599453
wished,2,0.6931471805599453
Yang，,2,0.6931471805599453
weakly,2,0.6931471805599453
phlegm-reducing,2,0.6931471805599453
revisited,2,0.6931471805599453
IAVs,2,0.6931471805599453
affiliated,2,0.6931471805599453
Finnish,2,0.6931471805599453
threatens,2,0.6931471805599453
Chilean,2,0.6931471805599453
cloacal,2,0.6931471805599453
EIW,2,0.6931471805599453
antiparasitic,2,0.6931471805599453
annular,2,0.6931471805599453
transparent,2,0.6931471805599453
capsule,2,0.6931471805599453
immunopathological,2,0.6931471805599453
diets,2,0.6931471805599453
envision,2,0.6931471805599453
mold,2,0.6931471805599453
inefficient,2,0.6931471805599453
57-year-old,2,0.6931471805599453
drug，,2,0.6931471805599453
liver，,2,0.6931471805599453
marketed,2,0.6931471805599453
spirometer,2,0.6931471805599453
11-19,2,0.6931471805599453
1425,2,0.6931471805599453
pulsus,2,0.6931471805599453
paradoxus,2,0.6931471805599453
Mustela,2,0.6931471805599453
circulation-improving,2,0.6931471805599453
medicineor,2,0.6931471805599453
anti-fibrinogen,2,0.6931471805599453
discriminatory,2,0.6931471805599453
historically,2,0.6931471805599453
egg-based,2,0.6931471805599453
Evidence-based,2,0.6931471805599453
nystagmus,2,0.6931471805599453
bigger,2,0.6931471805599453
Mexican-Americans,2,0.6931471805599453
fibrillationflutter,2,0.6931471805599453
intima-media,2,0.6931471805599453
Get,2,0.6931471805599453
NY,2,0.6931471805599453
Guidelines-Stroke,2,0.6931471805599453
cautioned,2,0.6931471805599453
Medicaid,2,0.6931471805599453
1962,2,0.6931471805599453
islanders,2,0.6931471805599453
Why,2,0.6931471805599453
Cunha,2,0.6931471805599453
Nairobi,2,0.6931471805599453
Muranga,2,0.6931471805599453
603,2,0.6931471805599453
time-of-flight,2,0.6931471805599453
896,2,0.6931471805599453
radiology,2,0.6931471805599453
CrCl,2,0.6931471805599453
nearest,2,0.6931471805599453
Hyperthyroidism,2,0.6931471805599453
Anti-inflammatory,2,0.6931471805599453
bank,2,0.6931471805599453
extra-respiratory,2,0.6931471805599453
hypnotherapy,2,0.6931471805599453
oxygenase,2,0.6931471805599453
Tumor,2,0.6931471805599453
inimitable,2,0.6931471805599453
Nationwide,2,0.6931471805599453
255,2,0.6931471805599453
Bahia,2,0.6931471805599453
455,2,0.6931471805599453
989,2,0.6931471805599453
1941,2,0.6931471805599453
cross-react,2,0.6931471805599453
nucleoproteins,2,0.6931471805599453
geo-centroid,2,0.6931471805599453
hamster,2,0.6931471805599453
genotyped,2,0.6931471805599453
paramedics,2,0.6931471805599453
akinesia,2,0.6931471805599453
eradicating,2,0.6931471805599453
integrates,2,0.6931471805599453
25OHD,2,0.6931471805599453
Malaysia,2,0.6931471805599453
Brewers,2,0.6931471805599453
Antihypertensive,2,0.6931471805599453
nuanced,2,0.6931471805599453
man-made,2,0.6931471805599453
Vietnamese,2,0.6931471805599453
outburst,2,0.6931471805599453
homozonal,2,0.6931471805599453
á-2,2,0.6931471805599453
powered,2,0.6931471805599453
IVSPW,2,0.6931471805599453
excursions,2,0.6931471805599453
RealOpt,2,0.6931471805599453
Hyperglycemia,2,0.6931471805599453
MBBAs,2,0.6931471805599453
TNFi,2,0.6931471805599453
dispatchers,2,0.6931471805599453
IL-1B,2,0.6931471805599453
da,2,0.6931471805599453
Kenya,2,0.6931471805599453
TSH,2,0.6931471805599453
phage,2,0.6931471805599453
Tristan,2,0.6931471805599453
FT4,2,0.6931471805599453
investigative,2,0.6931471805599453
IL-1A,2,0.6931471805599453
species-specific,2,0.6931471805599453
3-45,2,0.6931471805599453
contract,2,0.6931471805599453
hyperthyroidism,2,0.6931471805599453
TO,2,0.6931471805599453
NEED,2,0.6931471805599453
WE,2,0.6931471805599453
WHAT,2,0.6931471805599453
lenvatinibremdesivir,2,0.6931471805599453
Profile,2,0.6931471805599453
one-fifth,2,0.6931471805599453
system-level,2,0.6931471805599453
launching,2,0.6931471805599453
VITT,2,0.6931471805599453
anti-PF4,2,0.6931471805599453
FA,2,0.6931471805599453
DTD,2,0.6931471805599453
interactome,2,0.6931471805599453
react,2,0.6931471805599453
Candidate,2,0.6931471805599453
439,2,0.6931471805599453
helium,2,0.6931471805599453
gait-training,2,0.6931471805599453
FKN,2,0.6931471805599453
Nanyang,2,0.6931471805599453
907,2,0.6931471805599453
frozen,2,0.6931471805599453
cross-neutralization,2,0.6931471805599453
peribronchovascular,2,0.6931471805599453
smear,2,0.6931471805599453
voles,2,0.6931471805599453
loaded,2,0.6931471805599453
noneosinophilic,2,0.6931471805599453
Seventy-five,2,0.6931471805599453
Induced,2,0.6931471805599453
449,2,0.6931471805599453
path,2,0.6931471805599453
Receiving,2,0.6931471805599453
Generalized,2,0.6931471805599453
Microvascular,2,0.6931471805599453
pelleted,2,0.6931471805599453
immigrants,2,0.6931471805599453
20122013,2,0.6931471805599453
ASLR,2,0.6931471805599453
closings,2,0.6931471805599453
hypertrophic,2,0.6931471805599453
382000,2,0.6931471805599453
Decree,2,0.6931471805599453
Naples,2,0.6931471805599453
agreements,2,0.6931471805599453
upto,2,0.6931471805599453
snuff,2,0.6931471805599453
Anesthesia,2,0.6931471805599453
epidural,2,0.6931471805599453
marboxil,2,0.6931471805599453
helium-oxygen,2,0.6931471805599453
≥75,2,0.6931471805599453
988,2,0.6931471805599453
nonvitamin,2,0.6931471805599453
USD,2,0.6931471805599453
nickel,2,0.6931471805599453
LCOS,2,0.6931471805599453
hypnotic,2,0.6931471805599453
fM,2,0.6931471805599453
Generally,2,0.6931471805599453
cockroaches,2,0.6931471805599453
gland,2,0.6931471805599453
drain,2,0.6931471805599453
186,2,0.6931471805599453
ulceration,2,0.6931471805599453
Fibrillation,2,0.6931471805599453
endoluminal,2,0.6931471805599453
abrogated,2,0.6931471805599453
LD-A,2,0.6931471805599453
microgramsdl,2,0.6931471805599453
PTK,2,0.6931471805599453
Co-infection,2,0.6931471805599453
PTKs,2,0.6931471805599453
Vmax,2,0.6931471805599453
tPA-treated,2,0.6931471805599453
categorize,2,0.6931471805599453
Spinal,2,0.6931471805599453
recent-phase,2,0.6931471805599453
Nosocomial,2,0.6931471805599453
intraluminal,2,0.6931471805599453
baloxavir,2,0.6931471805599453
Norwegian,2,0.6931471805599453
dyskinesia,2,0.6931471805599453
bullet,2,0.6931471805599453
over-mortality,2,0.6931471805599453
post-COVID,2,0.6931471805599453
n5,2,0.6931471805599453
kinesis,2,0.6931471805599453
exponentially,2,0.6931471805599453
distinguishes,2,0.6931471805599453
PEGs,2,0.6931471805599453
5th,2,0.6931471805599453
counting,2,0.6931471805599453
TTs,2,0.6931471805599453
Lebanon,2,0.6931471805599453
commencing,2,0.6931471805599453
repercussions,2,0.6931471805599453
vaccinology,2,0.6931471805599453
Machine,2,0.6931471805599453
waviness,2,0.6931471805599453
sixteen,2,0.6931471805599453
FCR,2,0.6931471805599453
wellbeing,2,0.6931471805599453
disinfecting,2,0.6931471805599453
radialis,2,0.6931471805599453
set-up,2,0.6931471805599453
witnessing,2,0.6931471805599453
Alternatively,2,0.6931471805599453
singularly,2,0.6931471805599453
voluntarily,2,0.6931471805599453
intensify,2,0.6931471805599453
orchestrated,2,0.6931471805599453
Yijinjing,2,0.6931471805599453
teenage,2,0.6931471805599453
16-64,2,0.6931471805599453
Centres,2,0.6931471805599453
GC×GC-HRTOF-MS,2,0.6931471805599453
vaccae,2,0.6931471805599453
Fabry,2,0.6931471805599453
nebulization,2,0.6931471805599453
QuickVue®,2,0.6931471805599453
Mini-Log,2,0.6931471805599453
electrostatic,2,0.6931471805599453
carpi,2,0.6931471805599453
Wall,2,0.6931471805599453
Buenos,2,0.6931471805599453
heroic,2,0.6931471805599453
AH1N109,2,0.6931471805599453
microbiologist,2,0.6931471805599453
perindopril,2,0.6931471805599453
liquid-based,2,0.6931471805599453
teamwork,2,0.6931471805599453
contacting,2,0.6931471805599453
Aires,2,0.6931471805599453
RdRpHel,2,0.6931471805599453
rs1800872,2,0.6931471805599453
neuroendovascular,2,0.6931471805599453
Hypercholesterolaemia,2,0.6931471805599453
Blue,2,0.6931471805599453
EC,2,0.6931471805599453
vSP,2,0.6931471805599453
loose,2,0.6931471805599453
BCE,2,0.6931471805599453
detectability,2,0.6931471805599453
pull,2,0.6931471805599453
Defence,2,0.6931471805599453
postinfluenzal,2,0.6931471805599453
781,2,0.6931471805599453
Athens,2,0.6931471805599453
Weighted,2,0.6931471805599453
surely,2,0.6931471805599453
99m,2,0.6931471805599453
contention,2,0.6931471805599453
Rh,2,0.6931471805599453
ERICA,2,0.6931471805599453
MN,2,0.6931471805599453
7-8,2,0.6931471805599453
capitals,2,0.6931471805599453
facility-level,2,0.6931471805599453
AH1,2,0.6931471805599453
200506,2,0.6931471805599453
got,2,0.6931471805599453
comply,2,0.6931471805599453
concomitantly,2,0.6931471805599453
minimally-invasive,2,0.6931471805599453
Context—,2,0.6931471805599453
speaker,2,0.6931471805599453
simulating,2,0.6931471805599453
pre-treatment,2,0.6931471805599453
hydrochlorotiazide,2,0.6931471805599453
fluticasone,2,0.6931471805599453
thoracoscopy,2,0.6931471805599453
discharges,2,0.6931471805599453
P003,2,0.6931471805599453
deadliest,2,0.6931471805599453
olive,2,0.6931471805599453
350,2,0.6931471805599453
NMDA,2,0.6931471805599453
PHC,2,0.6931471805599453
sting,2,0.6931471805599453
advise,2,0.6931471805599453
Affected,2,0.6931471805599453
NCSVT,2,0.6931471805599453
Unacceptable,2,0.6931471805599453
participant,2,0.6931471805599453
or2,2,0.6931471805599453
415,2,0.6931471805599453
drill,2,0.6931471805599453
small-scale,2,0.6931471805599453
intensive-care,2,0.6931471805599453
LVOS,2,0.6931471805599453
SDH,2,0.6931471805599453
5-34,2,0.6931471805599453
Frank,2,0.6931471805599453
standardisation,2,0.6931471805599453
non-infectious,2,0.6931471805599453
1210,2,0.6931471805599453
CES,2,0.6931471805599453
dire,2,0.6931471805599453
unclassified,2,0.6931471805599453
hyperlipidaemia,2,0.6931471805599453
Intense,2,0.6931471805599453
AGTP,2,0.6931471805599453
ensemble,2,0.6931471805599453
frightening,2,0.6931471805599453
histocompatibility,2,0.6931471805599453
Preparation,2,0.6931471805599453
correctable,2,0.6931471805599453
pertain,2,0.6931471805599453
suit,2,0.6931471805599453
standard-of-care,2,0.6931471805599453
homeostatic,2,0.6931471805599453
allergologists,2,0.6931471805599453
interleukin-10,2,0.6931471805599453
immunoregulatory,2,0.6931471805599453
authorisation,2,0.6931471805599453
weaned,2,0.6931471805599453
patient-focused,2,0.6931471805599453
Remission,2,0.6931471805599453
Re-analysis,2,0.6931471805599453
frontier,2,0.6931471805599453
QMI,2,0.6931471805599453
atlas-assisted,2,0.6931471805599453
myeloperoxidase,2,0.6931471805599453
21-22,2,0.6931471805599453
13-15,2,0.6931471805599453
346,2,0.6931471805599453
776,2,0.6931471805599453
microbes,2,0.6931471805599453
constituent,2,0.6931471805599453
cytogenetic,2,0.6931471805599453
Ivano-Frankivsk,2,0.6931471805599453
Interstitial,2,0.6931471805599453
re-emergent,2,0.6931471805599453
361,2,0.6931471805599453
neuromuscular,2,0.6931471805599453
chromosomes,2,0.6931471805599453
defer,2,0.6931471805599453
acrocentral,2,0.6931471805599453
DE-MRI,2,0.6931471805599453
left-sided,2,0.6931471805599453
interferon-γ,2,0.6931471805599453
intoxication,2,0.6931471805599453
sharply,2,0.6931471805599453
metastatic,2,0.6931471805599453
Percent,2,0.6931471805599453
733,2,0.6931471805599453
vectorial,2,0.6931471805599453
preprint,2,0.6931471805599453
724,2,0.6931471805599453
2007-2008,2,0.6931471805599453
attracts,2,0.6931471805599453
painless,2,0.6931471805599453
propagated,2,0.6931471805599453
VCG,2,0.6931471805599453
Remdesivir,2,0.6931471805599453
untimely,2,0.6931471805599453
civic,2,0.6931471805599453
businesses,2,0.6931471805599453
revascularized,2,0.6931471805599453
scale-up,2,0.6931471805599453
anaemia,2,0.6931471805599453
pmoll,2,0.6931471805599453
Tailoring,2,0.6931471805599453
smallpox,2,0.6931471805599453
Psoralen,2,0.6931471805599453
ATM,2,0.6931471805599453
PUVA,2,0.6931471805599453
Valid,2,0.6931471805599453
scepticism,2,0.6931471805599453
AMEI,2,0.6931471805599453
neuroendocrine,2,0.6931471805599453
subepicardial,2,0.6931471805599453
Cambodian,2,0.6931471805599453
papilloma,2,0.6931471805599453
ample,2,0.6931471805599453
505,2,0.6931471805599453
coagulative,2,0.6931471805599453
distilled,2,0.6931471805599453
formidable,2,0.6931471805599453
Abundant,2,0.6931471805599453
Disease-19,2,0.6931471805599453
Ray,2,0.6931471805599453
2-adrenergic,2,0.6931471805599453
supernatants,2,0.6931471805599453
Ophthalmol,2,0.6931471805599453
needless,2,0.6931471805599453
IL-1β,2,0.6931471805599453
guano,2,0.6931471805599453
Preclinical,2,0.6931471805599453
high-prevalence,2,0.6931471805599453
one-day,2,0.6931471805599453
repeatable,2,0.6931471805599453
K-dependent,2,0.6931471805599453
Hypothesis,2,0.6931471805599453
ACE-inhibitor,2,0.6931471805599453
Refinement,2,0.6931471805599453
covalent,2,0.6931471805599453
ACE-inhibitors,2,0.6931471805599453
ATG,2,0.6931471805599453
non-receptor,2,0.6931471805599453
8-,2,0.6931471805599453
neuroradiologist,2,0.6931471805599453
blocked,2,0.6931471805599453
TEE-detected,2,0.6931471805599453
Ophthalmology,2,0.6931471805599453
Age-related,2,0.6931471805599453
018,2,0.6931471805599453
EMs,2,0.6931471805599453
junctional,2,0.6931471805599453
Th-2,2,0.6931471805599453
LVI,2,0.6931471805599453
ophthalmological,2,0.6931471805599453
CLOCK,2,0.6931471805599453
centred,2,0.6931471805599453
370,2,0.6931471805599453
SAR-CoV-2,2,0.6931471805599453
post-transcriptional,2,0.6931471805599453
deregulated,2,0.6931471805599453
BMAL1,2,0.6931471805599453
Odate,2,0.6931471805599453
831,2,0.6931471805599453
45h,2,0.6931471805599453
772,2,0.6931471805599453
obturation,2,0.6931471805599453
municipalities,2,0.6931471805599453
sMCAO,2,0.6931471805599453
beta2,2,0.6931471805599453
conferences,2,0.6931471805599453
hypoxic-ischemic,2,0.6931471805599453
Anticoagulants,2,0.6931471805599453
ninth,2,0.6931471805599453
syncytia,2,0.6931471805599453
Philippines,2,0.6931471805599453
sonography,2,0.6931471805599453
eliminates,2,0.6931471805599453
edvs,2,0.6931471805599453
Y-lineage,2,0.6931471805599453
biomolecules,2,0.6931471805599453
redundant,2,0.6931471805599453
abstracted,2,0.6931471805599453
Priming,2,0.6931471805599453
β2,2,0.6931471805599453
polytetrafluoroethylene,2,0.6931471805599453
chronicity,2,0.6931471805599453
amitriptyline,2,0.6931471805599453
RBD-2E8,2,0.6931471805599453
paramagnetic,2,0.6931471805599453
questionnaire-based,2,0.6931471805599453
Leningrad,2,0.6931471805599453
1970,2,0.6931471805599453
radiolabelled,2,0.6931471805599453
concert,2,0.6931471805599453
enormously,2,0.6931471805599453
686,2,0.6931471805599453
spiral,2,0.6931471805599453
892,2,0.6931471805599453
thrombin-antithrombin,2,0.6931471805599453
CTPA,2,0.6931471805599453
CPD,2,0.6931471805599453
mNIHSS,2,0.6931471805599453
hepatocellular,2,0.6931471805599453
four-month,2,0.6931471805599453
Healthy,2,0.6931471805599453
isocapnic,2,0.6931471805599453
component-gene,2,0.6931471805599453
Analyses,2,0.6931471805599453
918,2,0.6931471805599453
jump,2,0.6931471805599453
work-place,2,0.6931471805599453
NAMRU-3,2,0.6931471805599453
Naval,2,0.6931471805599453
decipher,2,0.6931471805599453
liver-related,2,0.6931471805599453
Defense,2,0.6931471805599453
Walking,2,0.6931471805599453
AST,2,0.6931471805599453
NEMSIS,2,0.6931471805599453
distally,2,0.6931471805599453
re-opening,2,0.6931471805599453
sedation,2,0.6931471805599453
LCBI,2,0.6931471805599453
phenotyped,2,0.6931471805599453
LCBIs,2,0.6931471805599453
chromosomal,2,0.6931471805599453
Maine,2,0.6931471805599453
therapists,2,0.6931471805599453
OLT,2,0.6931471805599453
after-care,2,0.6931471805599453
DMP,2,0.6931471805599453
VNS,2,0.6931471805599453
SkMs,2,0.6931471805599453
pipe,2,0.6931471805599453
24-72,2,0.6931471805599453
MMEF,2,0.6931471805599453
webcast,2,0.6931471805599453
accentuated,2,0.6931471805599453
perpetuate,2,0.6931471805599453
Sam,2,0.6931471805599453
Application,2,0.6931471805599453
FMA-UE,2,0.6931471805599453
NFkB,2,0.6931471805599453
serumplasma,2,0.6931471805599453
lambda,2,0.6931471805599453
800000,2,0.6931471805599453
DRR,2,0.6931471805599453
antileukotriene,2,0.6931471805599453
3434,2,0.6931471805599453
369,2,0.6931471805599453
cation,2,0.6931471805599453
San,2,0.6931471805599453
Where,2,0.6931471805599453
bradyarrhythmias,2,0.6931471805599453
Witwatersrand,2,0.6931471805599453
permeation,2,0.6931471805599453
optimisation,2,0.6931471805599453
non-mutagenic,2,0.6931471805599453
sunlight,2,0.6931471805599453
decontamination,2,0.6931471805599453
carcinogenicity,2,0.6931471805599453
carrageenan,2,0.6931471805599453
LD,2,0.6931471805599453
servers,2,0.6931471805599453
non-infarcted,2,0.6931471805599453
Ul,2,0.6931471805599453
warm,2,0.6931471805599453
1322,2,0.6931471805599453
LVOT,2,0.6931471805599453
irrigated,2,0.6931471805599453
regimes,2,0.6931471805599453
55-year-old,2,0.6931471805599453
nonsmoking,2,0.6931471805599453
VBDE,2,0.6931471805599453
SARS-,2,0.6931471805599453
ORMDL3,2,0.6931471805599453
µgmL,2,0.6931471805599453
off-target,2,0.6931471805599453
disequilibrium,2,0.6931471805599453
disinfectants,2,0.6931471805599453
pharmacologically,2,0.6931471805599453
hepatotoxicity,2,0.6931471805599453
recoil,2,0.6931471805599453
SIS,2,0.6931471805599453
Easy,2,0.6931471805599453
apparatus,2,0.6931471805599453
strikingly,2,0.6931471805599453
HA-pseudoviruses,2,0.6931471805599453
Provocation,2,0.6931471805599453
Assessing,2,0.6931471805599453
Ninety-two,2,0.6931471805599453
patient-specific,2,0.6931471805599453
group-specific,2,0.6931471805599453
raced,2,0.6931471805599453
aviators,2,0.6931471805599453
secondly,2,0.6931471805599453
eNO,2,0.6931471805599453
5-7,2,0.6931471805599453
incapacitation,2,0.6931471805599453
aviation,2,0.6931471805599453
-12,2,0.6931471805599453
morbidities,2,0.6931471805599453
POINTS,2,0.6931471805599453
cross-section,2,0.6931471805599453
time-varying,2,0.6931471805599453
CTLs,2,0.6931471805599453
virologists,2,0.6931471805599453
returns,2,0.6931471805599453
stock,2,0.6931471805599453
obstacle,2,0.6931471805599453
yeast,2,0.6931471805599453
Transcatheter,2,0.6931471805599453
CrI,2,0.6931471805599453
OCR,2,0.6931471805599453
spherical,2,0.6931471805599453
646,2,0.6931471805599453
heterogeneities,2,0.6931471805599453
Physiologically,2,0.6931471805599453
Active,2,0.6931471805599453
transform,2,0.6931471805599453
cage,2,0.6931471805599453
leukoencephalopathy,2,0.6931471805599453
degenerative,2,0.6931471805599453
smallest,2,0.6931471805599453
Wild,2,0.6931471805599453
2-5,2,0.6931471805599453
splenium,2,0.6931471805599453
Smaller,2,0.6931471805599453
CDS,2,0.6931471805599453
historic,2,0.6931471805599453
paramedical,2,0.6931471805599453
5-,2,0.6931471805599453
extubation,2,0.6931471805599453
isolations,2,0.6931471805599453
AOSC,2,0.6931471805599453
clinicopathologic,2,0.6931471805599453
411,2,0.6931471805599453
Arizona,2,0.6931471805599453
leadership,2,0.6931471805599453
co-infections,2,0.6931471805599453
droppings,2,0.6931471805599453
VV-ECMO,2,0.6931471805599453
subgenomic,2,0.6931471805599453
sarcoidosis,2,0.6931471805599453
improper,2,0.6931471805599453
AGTs,2,0.6931471805599453
Y15,2,0.6931471805599453
undetected,2,0.6931471805599453
armhand,2,0.6931471805599453
Circadian,2,0.6931471805599453
FAK-KD,2,0.6931471805599453
0992,2,0.6931471805599453
Pheochromocytomas,2,0.6931471805599453
491,2,0.6931471805599453
prognostication,2,0.6931471805599453
Radionuclide,2,0.6931471805599453
deferred,2,0.6931471805599453
English-speaking,2,0.6931471805599453
blood-pool,2,0.6931471805599453
Lifestyle,2,0.6931471805599453
hypercapnia,2,0.6931471805599453
destined,2,0.6931471805599453
coincident,2,0.6931471805599453
ring,2,0.6931471805599453
3991,2,0.6931471805599453
6-year-old,2,0.6931471805599453
3611,2,0.6931471805599453
Loop,2,0.6931471805599453
1342,2,0.6931471805599453
Trail,2,0.6931471805599453
3481,2,0.6931471805599453
4122,2,0.6931471805599453
1356,2,0.6931471805599453
positive-sense,2,0.6931471805599453
intermediates,2,0.6931471805599453
climates,2,0.6931471805599453
neoplastic,2,0.6931471805599453
negative-sense,2,0.6931471805599453
diisocyanate,2,0.6931471805599453
p-interaction,2,0.6931471805599453
chamber,2,0.6931471805599453
UL-VWFM,2,0.6931471805599453
subtended,2,0.6931471805599453
443,2,0.6931471805599453
SCDs,2,0.6931471805599453
callosum,2,0.6931471805599453
corpus,2,0.6931471805599453
post-COVID-19,2,0.6931471805599453
hand-held,2,0.6931471805599453
401,2,0.6931471805599453
Ukg,2,0.6931471805599453
under-recognised,2,0.6931471805599453
under-recognition,2,0.6931471805599453
insurers,2,0.6931471805599453
ERIS,2,0.6931471805599453
subunits,2,0.6931471805599453
culminating,2,0.6931471805599453
366,2,0.6931471805599453
Oslo,2,0.6931471805599453
1071,2,0.6931471805599453
8th,2,0.6931471805599453
1840,2,0.6931471805599453
Deficiencies,2,0.6931471805599453
rituximab,2,0.6931471805599453
Disease-modifying,2,0.6931471805599453
reflective,2,0.6931471805599453
059,2,0.6931471805599453
Rituximab,2,0.6931471805599453
Modification,2,0.6931471805599453
Students,2,0.6931471805599453
enjoyed,2,0.6931471805599453
ASTER,2,0.6931471805599453
open-ended,2,0.6931471805599453
Amazon,2,0.6931471805599453
41-50,2,0.6931471805599453
practise,2,0.6931471805599453
discipline,2,0.6931471805599453
671,2,0.6931471805599453
Artery,2,0.6931471805599453
flour,2,0.6931471805599453
confluent,2,0.6931471805599453
1324,2,0.6931471805599453
pretest,2,0.6931471805599453
tilted,2,0.6931471805599453
SNF-associated,2,0.6931471805599453
immunosuppressants,2,0.6931471805599453
Tocilizumab,2,0.6931471805599453
TAMI-6,2,0.6931471805599453
virologic,2,0.6931471805599453
defend,2,0.6931471805599453
astounding,2,0.6931471805599453
Pulsed,2,0.6931471805599453
Aggressive,2,0.6931471805599453
pharmacotherapies,2,0.6931471805599453
Spike-specific,2,0.6931471805599453
V3,2,0.6931471805599453
bilingual,2,0.6931471805599453
haemoglobin,2,0.6931471805599453
Recipients,2,0.6931471805599453
vectormRNA,2,0.6931471805599453
light-to-moderate,2,0.6931471805599453
exertional,2,0.6931471805599453
quantitate,2,0.6931471805599453
jeopardized,2,0.6931471805599453
HDT,2,0.6931471805599453
CTR,2,0.6931471805599453
fibromuscular,2,0.6931471805599453
complementaryalternative,2,0.6931471805599453
Parents,2,0.6931471805599453
normotensive,2,0.6931471805599453
Fishers,2,0.6931471805599453
302,2,0.6931471805599453
cardioplegia,2,0.6931471805599453
proportionally,2,0.6931471805599453
competency,2,0.6931471805599453
IUC,2,0.6931471805599453
Mild,2,0.6931471805599453
user-generated,2,0.6931471805599453
self-collection,2,0.6931471805599453
anti-vaccine,2,0.6931471805599453
VPW,2,0.6931471805599453
EIC,2,0.6931471805599453
constrictive,2,0.6931471805599453
303,2,0.6931471805599453
Fibromuscular,2,0.6931471805599453
constrictiva,2,0.6931471805599453
politicians,2,0.6931471805599453
monument,2,0.6931471805599453
appealing,2,0.6931471805599453
Scientists,2,0.6931471805599453
stay-at-home,2,0.6931471805599453
65-year-old,2,0.6931471805599453
UE,2,0.6931471805599453
characterizes,2,0.6931471805599453
Types,2,0.6931471805599453
imagined,2,0.6931471805599453
Sustained,2,0.6931471805599453
Mechanisms,2,0.6931471805599453
Questions,2,0.6931471805599453
right-hemisphere,2,0.6931471805599453
60-80,2,0.6931471805599453
Estimated,2,0.6931471805599453
immunostimulants,2,0.6931471805599453
thick,2,0.6931471805599453
suicide,2,0.6931471805599453
accrue,2,0.6931471805599453
DRGs,2,0.6931471805599453
Ninth,2,0.6931471805599453
Revision,2,0.6931471805599453
stepped,2,0.6931471805599453
developers,2,0.6931471805599453
grown,2,0.6931471805599453
cohesive,2,0.6931471805599453
vitamin-D-mediated,2,0.6931471805599453
VEM,2,0.6931471805599453
selectin,2,0.6931471805599453
Characterization,2,0.6931471805599453
licensure,2,0.6931471805599453
Sudden,2,0.6931471805599453
ordinal,2,0.6931471805599453
diagnosis-related,2,0.6931471805599453
Latinx,2,0.6931471805599453
antineoplastic,2,0.6931471805599453
syringes,2,0.6931471805599453
CSVT,2,0.6931471805599453
recalled,2,0.6931471805599453
compounded,2,0.6931471805599453
Euroimmun-anti-S1-IgA,2,0.6931471805599453
stretched,2,0.6931471805599453
physiopathological,2,0.6931471805599453
accomplish,2,0.6931471805599453
usable,2,0.6931471805599453
erroneously,2,0.6931471805599453
dichotomizations,2,0.6931471805599453
nonimmunologic,2,0.6931471805599453
bears,2,0.6931471805599453
Emphasis,2,0.6931471805599453
risk-stratification,2,0.6931471805599453
Roche-anti-N,2,0.6931471805599453
accountability,2,0.6931471805599453
Cessation,2,0.6931471805599453
VAL,2,0.6931471805599453
450000,2,0.6931471805599453
24000,2,0.6931471805599453
classically,2,0.6931471805599453
allele-specific,2,0.6931471805599453
non-reperfusion,2,0.6931471805599453
Humoral,2,0.6931471805599453
1187,2,0.6931471805599453
reassessment,2,0.6931471805599453
organisation,2,0.6931471805599453
PACSI,2,0.6931471805599453
God,2,0.6931471805599453
-25,2,0.6931471805599453
0045,2,0.6931471805599453
audits,2,0.6931471805599453
0046,2,0.6931471805599453
n22,2,0.6931471805599453
0009,2,0.6931471805599453
spells,2,0.6931471805599453
baricitinib,2,0.6931471805599453
Posterior,2,0.6931471805599453
neurobehavioral,2,0.6931471805599453
stacked,2,0.6931471805599453
MDCT,2,0.6931471805599453
multidetector,2,0.6931471805599453
antifibrillatory,2,0.6931471805599453
Seventy,2,0.6931471805599453
complemented,2,0.6931471805599453
overrepresented,2,0.6931471805599453
cross-country,2,0.6931471805599453
dividing,2,0.6931471805599453
re-entry,2,0.6931471805599453
Residents,2,0.6931471805599453
Play,2,0.6931471805599453
mandated,2,0.6931471805599453
Grotta,2,0.6931471805599453
chair,2,0.6931471805599453
MAST-I,2,0.6931471805599453
cerebroprotective,2,0.6931471805599453
prazosin,2,0.6931471805599453
utilised,2,0.6931471805599453
unimmunised,2,0.6931471805599453
CoronaVac®,2,0.6931471805599453
colonization,2,0.6931471805599453
sexuality,2,0.6931471805599453
887,2,0.6931471805599453
nonsignificant,2,0.6931471805599453
curricula,2,0.6931471805599453
time-related,2,0.6931471805599453
001The,2,0.6931471805599453
illuminating,2,0.6931471805599453
biosciences,2,0.6931471805599453
pleural-space-fluid,2,0.6931471805599453
Bland-Altman,2,0.6931471805599453
CD147,2,0.6931471805599453
chi-square,2,0.6931471805599453
HNE,2,0.6931471805599453
basically,2,0.6931471805599453
infection-related,2,0.6931471805599453
200809,2,0.6931471805599453
mLh,2,0.6931471805599453
close-contact,2,0.6931471805599453
trimer,2,0.6931471805599453
pneumophila,2,0.6931471805599453
tail,2,0.6931471805599453
ANOVA,2,0.6931471805599453
climatological,2,0.6931471805599453
mastocytes,2,0.6931471805599453
Der,2,0.6931471805599453
Mann-Whitney,2,0.6931471805599453
tubular,2,0.6931471805599453
Legionella,2,0.6931471805599453
367,2,0.6931471805599453
intensification,2,0.6931471805599453
Point-of-care,2,0.6931471805599453
789,2,0.6931471805599453
SM-IVE,2,0.6931471805599453
traveled,2,0.6931471805599453
Beckman,2,0.6931471805599453
Vitros,2,0.6931471805599453
0015,2,0.6931471805599453
Escherichia,2,0.6931471805599453
CLRD,2,0.6931471805599453
stranded,2,0.6931471805599453
nsp7-10,2,0.6931471805599453
Biochemical,2,0.6931471805599453
replicating,2,0.6931471805599453
workforce,2,0.6931471805599453
plasmon,2,0.6931471805599453
cholesterol-lowering,2,0.6931471805599453
Mpro,2,0.6931471805599453
multi-burden,2,0.6931471805599453
reflectance,2,0.6931471805599453
bioscience,2,0.6931471805599453
Translating,2,0.6931471805599453
altogether,2,0.6931471805599453
IMPORTANCE,2,0.6931471805599453
PRB,2,0.6931471805599453
childhood-onset,2,0.6931471805599453
Cleavage,2,0.6931471805599453
Ia,2,0.6931471805599453
329-473,2,0.6931471805599453
Anti,2,0.6931471805599453
2001-2002,2,0.6931471805599453
pursuing,2,0.6931471805599453
prioritising,2,0.6931471805599453
AZD1222-dependent,2,0.6931471805599453
≥40,2,0.6931471805599453
parasites,2,0.6931471805599453
adultchild,2,0.6931471805599453
Two-hundred,2,0.6931471805599453
909,2,0.6931471805599453
AUCs,2,0.6931471805599453
atresia,2,0.6931471805599453
HRCurrent,2,0.6931471805599453
transdisciplinary,2,0.6931471805599453
Games,2,0.6931471805599453
antiretroviral,2,0.6931471805599453
PWV,2,0.6931471805599453
multiply,2,0.6931471805599453
253,2,0.6931471805599453
repositive,2,0.6931471805599453
Can,2,0.6931471805599453
H4,2,0.6931471805599453
fueled,2,0.6931471805599453
Autonomous,2,0.6931471805599453
Soluble,2,0.6931471805599453
heterogenous,2,0.6931471805599453
motivate,2,0.6931471805599453
reliant,2,0.6931471805599453
conduit,2,0.6931471805599453
BID,2,0.6931471805599453
discounted,2,0.6931471805599453
responsively,2,0.6931471805599453
liberation,2,0.6931471805599453
immunise,2,0.6931471805599453
hotspot,2,0.6931471805599453
non-severe,2,0.6931471805599453
maturation,2,0.6931471805599453
587,2,0.6931471805599453
presenceabsence,2,0.6931471805599453
588,2,0.6931471805599453
locate,2,0.6931471805599453
plateaued,2,0.6931471805599453
fourfold,2,0.6931471805599453
0026,2,0.6931471805599453
hurdle,2,0.6931471805599453
atheroembolic,2,0.6931471805599453
outset,2,0.6931471805599453
374,2,0.6931471805599453
Dysregulation,2,0.6931471805599453
uncomfortable,2,0.6931471805599453
Programs,2,0.6931471805599453
Midwest,2,0.6931471805599453
201314,2,0.6931471805599453
Valencia,2,0.6931471805599453
deviations,2,0.6931471805599453
vagotomized,2,0.6931471805599453
finite,2,0.6931471805599453
pricing,2,0.6931471805599453
Pharmacists,2,0.6931471805599453
R-wave,2,0.6931471805599453
preconditioned,2,0.6931471805599453
adhered,2,0.6931471805599453
packaged,2,0.6931471805599453
untypical,2,0.6931471805599453
margins,2,0.6931471805599453
normalize,2,0.6931471805599453
Q-,2,0.6931471805599453
capsid,2,0.6931471805599453
ignoring,2,0.6931471805599453
VLP-based,2,0.6931471805599453
obviate,2,0.6931471805599453
baculovirus,2,0.6931471805599453
vegetable,2,0.6931471805599453
Fatality,2,0.6931471805599453
Skin,2,0.6931471805599453
insect,2,0.6931471805599453
manipulations,2,0.6931471805599453
Communication,2,0.6931471805599453
allied,2,0.6931471805599453
MobileNet,2,0.6931471805599453
Sakai,2,0.6931471805599453
geography,2,0.6931471805599453
peri-operative,2,0.6931471805599453
deviate,2,0.6931471805599453
invades,2,0.6931471805599453
blockage,2,0.6931471805599453
PANAS,2,0.6931471805599453
Acting,2,0.6931471805599453
Aspergillosis,2,0.6931471805599453
35326,2,0.6931471805599453
radically,2,0.6931471805599453
993,2,0.6931471805599453
chylothorax,2,0.6931471805599453
cytopathology,2,0.6931471805599453
ResNet,2,0.6931471805599453
RCAP,2,0.6931471805599453
mlminm2,2,0.6931471805599453
Cultural,2,0.6931471805599453
revival,2,0.6931471805599453
cocktail,2,0.6931471805599453
polypharmacy,2,0.6931471805599453
End,2,0.6931471805599453
CTS,2,0.6931471805599453
navigate,2,0.6931471805599453
expert-reviewed,2,0.6931471805599453
fathers,2,0.6931471805599453
NSTEMIs,2,0.6931471805599453
AIRS,2,0.6931471805599453
warnings,2,0.6931471805599453
law,2,0.6931471805599453
IRs,2,0.6931471805599453
View,2,0.6931471805599453
inadequately,2,0.6931471805599453
noncardioembolic,2,0.6931471805599453
causally,2,0.6931471805599453
Richard,2,0.6931471805599453
stratifying,2,0.6931471805599453
garnered,2,0.6931471805599453
Twenty-five,2,0.6931471805599453
malformation,2,0.6931471805599453
post-exercise,2,0.6931471805599453
travelling,2,0.6931471805599453
demographically,2,0.6931471805599453
Characteristic,2,0.6931471805599453
sonographic,2,0.6931471805599453
Return,2,0.6931471805599453
Receiver,2,0.6931471805599453
DBM,2,0.6931471805599453
964,2,0.6931471805599453
centerpiece,2,0.6931471805599453
isnt,2,0.6931471805599453
consortium,2,0.6931471805599453
president,2,0.6931471805599453
sibs,2,0.6931471805599453
683,2,0.6931471805599453
hypercontraction,2,0.6931471805599453
personally,2,0.6931471805599453
542,2,0.6931471805599453
glucose-lowering,2,0.6931471805599453
SAPCReN-CPCSSN,2,0.6931471805599453
Correct,2,0.6931471805599453
community-level,2,0.6931471805599453
non-pregnant,2,0.6931471805599453
potentiation,2,0.6931471805599453
Commercial,2,0.6931471805599453
subventricular,2,0.6931471805599453
benefit-risk,2,0.6931471805599453
atlantoaxial,2,0.6931471805599453
hinges,2,0.6931471805599453
Meta-Analyses,2,0.6931471805599453
burdened,2,0.6931471805599453
Discussion,2,0.6931471805599453
receiptnon-receipt,2,0.6931471805599453
551,2,0.6931471805599453
ANE,2,0.6931471805599453
CPCSSN,2,0.6931471805599453
52-year-old,2,0.6931471805599453
INS,2,0.6931471805599453
stented,2,0.6931471805599453
Section,2,0.6931471805599453
precludes,2,0.6931471805599453
disconcerting,2,0.6931471805599453
Exclusion,2,0.6931471805599453
overproduction,2,0.6931471805599453
obtainable,2,0.6931471805599453
stroke-risk-reduction,2,0.6931471805599453
triennium,2,0.6931471805599453
BABM,2,0.6931471805599453
4G,2,0.6931471805599453
Egyptian,2,0.6931471805599453
311,2,0.6931471805599453
MADE-DBM,2,0.6931471805599453
isozymes,2,0.6931471805599453
mitigated,2,0.6931471805599453
handicap,2,0.6931471805599453
Expiratory,2,0.6931471805599453
Pharmaceutical,2,0.6931471805599453
318,2,0.6931471805599453
prearrival,2,0.6931471805599453
tell,2,0.6931471805599453
Jones,2,0.6931471805599453
50-64,2,0.6931471805599453
orally,2,0.6931471805599453
stimulant,2,0.6931471805599453
Preschool,2,0.6931471805599453
June-August,2,0.6931471805599453
sub-optimal,2,0.6931471805599453
67-year-old,2,0.6931471805599453
fare,2,0.6931471805599453
1a,2,0.6931471805599453
Portuguese,2,0.6931471805599453
201T1,2,0.6931471805599453
camp,2,0.6931471805599453
beta2-adrenergic,2,0.6931471805599453
process-of-care,2,0.6931471805599453
747,2,0.6931471805599453
northeast,2,0.6931471805599453
pleiotropic,2,0.6931471805599453
908,2,0.6931471805599453
Just,2,0.6931471805599453
HDLs,2,0.6931471805599453
Multi-Tabs,2,0.6931471805599453
1-6,2,0.6931471805599453
overlying,2,0.6931471805599453
longitude,2,0.6931471805599453
subdural,2,0.6931471805599453
high-density,2,0.6931471805599453
1920,2,0.6931471805599453
Nor,2,0.6931471805599453
774,2,0.6931471805599453
HSAP-NPpHO1,2,0.6931471805599453
inheritance,2,0.6931471805599453
consultant,2,0.6931471805599453
nadir,2,0.6931471805599453
fragmentation,2,0.6931471805599453
DP2k,2,0.6931471805599453
atheromatosis,2,0.6931471805599453
α-SYN,2,0.6931471805599453
remedy,2,0.6931471805599453
exceptionally,2,0.6931471805599453
pHO1,2,0.6931471805599453
plane,2,0.6931471805599453
AIMI,2,0.6931471805599453
AUSSR,2,0.6931471805599453
hypoxia-specific,2,0.6931471805599453
L5,2,0.6931471805599453
Mounting,2,0.6931471805599453
asses,2,0.6931471805599453
RAGE-mediated,2,0.6931471805599453
LVEDP,2,0.6931471805599453
ribs,2,0.6931471805599453
osteopathic,2,0.6931471805599453
stem-cell,2,0.6931471805599453
phylogeny,2,0.6931471805599453
broncho-pleural,2,0.6931471805599453
lymphadenectomy,2,0.6931471805599453
kinship,2,0.6931471805599453
pyothorax,2,0.6931471805599453
Fragile,2,0.6931471805599453
Stanford,2,0.6931471805599453
coil,2,0.6931471805599453
Electrocardiographic,2,0.6931471805599453
fragmented,2,0.6931471805599453
neurofibromatosis,2,0.6931471805599453
2019-nCoV-infected,2,0.6931471805599453
notching,2,0.6931471805599453
manipulative,2,0.6931471805599453
contraception,2,0.6931471805599453
tachyarrhythmias,2,0.6931471805599453
correlative,2,0.6931471805599453
437,2,0.6931471805599453
Adequate,2,0.6931471805599453
coronary-care,2,0.6931471805599453
Men,2,0.6931471805599453
Ca,2,0.6931471805599453
Microalbuminuria,2,0.6931471805599453
swineTaiwan69,2,0.6931471805599453
Electrocardiograms,2,0.6931471805599453
544,2,0.6931471805599453
internalizing,2,0.6931471805599453
conjugates,2,0.6931471805599453
TTETOE,2,0.6931471805599453
sparser,2,0.6931471805599453
cleavable,2,0.6931471805599453
2490,2,0.6931471805599453
oxidized,2,0.6931471805599453
extrasystoles,2,0.6931471805599453
Split,2,0.6931471805599453
19-fold,2,0.6931471805599453
crystallography,2,0.6931471805599453
483,2,0.6931471805599453
274Y,2,0.6931471805599453
conspicuous,2,0.6931471805599453
full-term,2,0.6931471805599453
Portal,2,0.6931471805599453
exhausted,2,0.6931471805599453
belong,2,0.6931471805599453
co-morbid,2,0.6931471805599453
store,2,0.6931471805599453
Neonatal,2,0.6931471805599453
land,2,0.6931471805599453
monitors,2,0.6931471805599453
biomaterial,2,0.6931471805599453
patches,2,0.6931471805599453
united,2,0.6931471805599453
hyaluronic,2,0.6931471805599453
TOE,2,0.6931471805599453
unfortunately,2,0.6931471805599453
hemisensory,2,0.6931471805599453
maze,2,0.6931471805599453
influenza-negative,2,0.6931471805599453
Near-fatal,2,0.6931471805599453
Indirect,2,0.6931471805599453
sex-based,2,0.6931471805599453
plugging,2,0.6931471805599453
Washington,2,0.6931471805599453
Eurasia,2,0.6931471805599453
vitally,2,0.6931471805599453
free-ranging,2,0.6931471805599453
object,2,0.6931471805599453
Arbidol,2,0.6931471805599453
HPAIV,2,0.6931471805599453
grippe,2,0.6931471805599453
Ingavirin,2,0.6931471805599453
illustrative,2,0.6931471805599453
22-month-old,2,0.6931471805599453
repolarisation,2,0.6931471805599453
MeV-based,2,0.6931471805599453
injecting,2,0.6931471805599453
localised,2,0.6931471805599453
Difficult,2,0.6931471805599453
motivates,2,0.6931471805599453
denial,2,0.6931471805599453
tenth,2,0.6931471805599453
Reactive,2,0.6931471805599453
preoccupation,2,0.6931471805599453
TN,2,0.6931471805599453
TCC,2,0.6931471805599453
hampered,2,0.6931471805599453
PLpro,2,0.6931471805599453
inter-pandemic,2,0.6931471805599453
definable,2,0.6931471805599453
1989-90,2,0.6931471805599453
740,2,0.6931471805599453
beatsmin,2,0.6931471805599453
10-4,2,0.6931471805599453
crepitations,2,0.6931471805599453
Clin,2,0.6931471805599453
Activation,2,0.6931471805599453
Neovison,2,0.6931471805599453
minks,2,0.6931471805599453
microneutralization,2,0.6931471805599453
ship,2,0.6931471805599453
Enzyme,2,0.6931471805599453
permissive,2,0.6931471805599453
Decision,2,0.6931471805599453
prepandemic,2,0.6931471805599453
transcriptase-PCR,2,0.6931471805599453
LFIA,2,0.6931471805599453
Informed,2,0.6931471805599453
CLIA-iFlash,2,0.6931471805599453
dysesthesia,2,0.6931471805599453
Immunol,2,0.6931471805599453
myxomas,2,0.6931471805599453
coexist,2,0.6931471805599453
AluI,2,0.6931471805599453
19th,2,0.6931471805599453
random-effects,2,0.6931471805599453
CENTRAL,2,0.6931471805599453
beet,2,0.6931471805599453
rarer,2,0.6931471805599453
Saitama,2,0.6931471805599453
865,2,0.6931471805599453
Pittsburgh,2,0.6931471805599453
co-occur,2,0.6931471805599453
EcoRI,2,0.6931471805599453
ventriculotomy,2,0.6931471805599453
amplifying,2,0.6931471805599453
Totally,2,0.6931471805599453
ACORN,2,0.6931471805599453
chromatin,2,0.6931471805599453
Room,2,0.6931471805599453
tidal,2,0.6931471805599453
hosted,2,0.6931471805599453
XL,2,0.6931471805599453
exudate,2,0.6931471805599453
step-wise,2,0.6931471805599453
PCRs,2,0.6931471805599453
2-agonist,2,0.6931471805599453
6-18,2,0.6931471805599453
Difficulties,2,0.6931471805599453
XFD,2,0.6931471805599453
isoprenaline,2,0.6931471805599453
turmoil,2,0.6931471805599453
harbors,2,0.6931471805599453
OTV,2,0.6931471805599453
739,2,0.6931471805599453
Porto,2,0.6931471805599453
Xinfadi,2,0.6931471805599453
emergently,2,0.6931471805599453
Extracorporeal,2,0.6931471805599453
Ministry,2,0.6931471805599453
beagles,2,0.6931471805599453
WWTP,2,0.6931471805599453
FRISC,2,0.6931471805599453
elicitation,2,0.6931471805599453
Cardiologists,2,0.6931471805599453
localizing,2,0.6931471805599453
RASi,2,0.6931471805599453
electrophoresis,2,0.6931471805599453
Liguria,2,0.6931471805599453
coronavirus-induced,2,0.6931471805599453
vRNPs,2,0.6931471805599453
cutting,2,0.6931471805599453
691,2,0.6931471805599453
843,2,0.6931471805599453
indeterminate,2,0.6931471805599453
ACalifornia072009,2,0.6931471805599453
Markers,2,0.6931471805599453
company,2,0.6931471805599453
685,2,0.6931471805599453
symptom-limited,2,0.6931471805599453
scanners,2,0.6931471805599453
GAIN,2,0.6931471805599453
glycine,2,0.6931471805599453
GV150526,2,0.6931471805599453
Gavestinel,2,0.6931471805599453
Islander,2,0.6931471805599453
Light-to-moderate,2,0.6931471805599453
Urban,2,0.6931471805599453
MI-associated,2,0.6931471805599453
intervillositis,2,0.6931471805599453
villitis,2,0.6931471805599453
PMR,2,0.6931471805599453
PD20,2,0.6931471805599453
VFWR,2,0.6931471805599453
725,2,0.6931471805599453
509,2,0.6931471805599453
053,2,0.6931471805599453
384,2,0.6931471805599453
Nations,2,0.6931471805599453
uptakes,2,0.6931471805599453
recruits,2,0.6931471805599453
periinfarct,2,0.6931471805599453
rhinorrhea,2,0.6931471805599453
door-to-CT,2,0.6931471805599453
Paramedics,2,0.6931471805599453
Minor,2,0.6931471805599453
strike,2,0.6931471805599453
imagings,2,0.6931471805599453
Pap,2,0.6931471805599453
lymphoblastic,2,0.6931471805599453
AIEOP,2,0.6931471805599453
Randomised,2,0.6931471805599453
Inuit,2,0.6931471805599453
Métis,2,0.6931471805599453
coworkers,2,0.6931471805599453
MCs,2,0.6931471805599453
approached,2,0.6931471805599453
greenyellow,2,0.6931471805599453
postinfarct,2,0.6931471805599453
unrestricted,2,0.6931471805599453
ZIKV,2,0.6931471805599453
linguistic,2,0.6931471805599453
canton,2,0.6931471805599453
1911,2,0.6931471805599453
M-mode,2,0.6931471805599453
429,2,0.6931471805599453
royalblue,2,0.6931471805599453
myosin,2,0.6931471805599453
multiplied,2,0.6931471805599453
Evaluations,2,0.6931471805599453
IAP,2,0.6931471805599453
statements,2,0.6931471805599453
implying,2,0.6931471805599453
Distribution,2,0.6931471805599453
trypsin,2,0.6931471805599453
Q-MI,2,0.6931471805599453
AU,2,0.6931471805599453
codons,2,0.6931471805599453
TCID50,2,0.6931471805599453
Louis,2,0.6931471805599453
692,2,0.6931471805599453
9000,2,0.6931471805599453
fears,2,0.6931471805599453
nodosome,2,0.6931471805599453
right-to-left,2,0.6931471805599453
refused,2,0.6931471805599453
malperfusion,2,0.6931471805599453
MDCK-H,2,0.6931471805599453
MDCK-2,2,0.6931471805599453
4428,2,0.6931471805599453
Caucasians,2,0.6931471805599453
subarachnoidal,2,0.6931471805599453
cyclosporin,2,0.6931471805599453
letter,2,0.6931471805599453
100-fold,2,0.6931471805599453
architectural,2,0.6931471805599453
occupant,2,0.6931471805599453
Addressing,2,0.6931471805599453
hindsight,2,0.6931471805599453
1207,2,0.6931471805599453
genotypic,2,0.6931471805599453
micrograms,2,0.6931471805599453
sixty,2,0.6931471805599453
self-isolation,2,0.6931471805599453
abandoned,2,0.6931471805599453
unambiguously,2,0.6931471805599453
non-eosinophilic,2,0.6931471805599453
Issues,2,0.6931471805599453
mid-May,2,0.6931471805599453
cores,2,0.6931471805599453
intraplaque,2,0.6931471805599453
inequalities,2,0.6931471805599453
aspartate,2,0.6931471805599453
exanthem,2,0.6931471805599453
parasitic,2,0.6931471805599453
requesting,2,0.6931471805599453
judgement,2,0.6931471805599453
post-PTCA,2,0.6931471805599453
one-year-beforeone-year-after,2,0.6931471805599453
hits,2,0.6931471805599453
-308GA,2,0.6931471805599453
PsycINFO,2,0.6931471805599453
toolbox,2,0.6931471805599453
701,2,0.6931471805599453
PASC,2,0.6931471805599453
imposing,2,0.6931471805599453
havoc,2,0.6931471805599453
adenine,2,0.6931471805599453
Trialists,2,0.6931471805599453
anti-allergy,2,0.6931471805599453
mouthwashes,2,0.6931471805599453
Way,2,0.6931471805599453
archived,2,0.6931471805599453
flawed,2,0.6931471805599453
VLAs,2,0.6931471805599453
replicative,2,0.6931471805599453
Annually,2,0.6931471805599453
re-vaccination,2,0.6931471805599453
thermophilus,2,0.6931471805599453
Frequently,2,0.6931471805599453
Inhalation,2,0.6931471805599453
European-wide,2,0.6931471805599453
Update,2,0.6931471805599453
thrombolitic,2,0.6931471805599453
publish,2,0.6931471805599453
Influ,2,0.6931471805599453
tempered,2,0.6931471805599453
seroreactivity,2,0.6931471805599453
snapshot,2,0.6931471805599453
resting-state,2,0.6931471805599453
asthma-specific,2,0.6931471805599453
Symphony,2,0.6931471805599453
rewarming,2,0.6931471805599453
struggled,2,0.6931471805599453
Veneto,2,0.6931471805599453
bronchoscopic,2,0.6931471805599453
default,2,0.6931471805599453
fractured,2,0.6931471805599453
intimal,2,0.6931471805599453
OVID,2,0.6931471805599453
reshaping,2,0.6931471805599453
MM4,2,0.6931471805599453
foam,2,0.6931471805599453
AH1N12009,2,0.6931471805599453
cholesterin,2,0.6931471805599453
clefts,2,0.6931471805599453
CPB,2,0.6931471805599453
fronto-temporal,2,0.6931471805599453
USEPA,2,0.6931471805599453
percutaneously,2,0.6931471805599453
aligns,2,0.6931471805599453
saliva-based,2,0.6931471805599453
MHT,2,0.6931471805599453
implied,2,0.6931471805599453
fluorescence-based,2,0.6931471805599453
nonteaching,2,0.6931471805599453
Polymorphism,2,0.6931471805599453
medRxiv,2,0.6931471805599453
toll-like,2,0.6931471805599453
Wanfang,2,0.6931471805599453
CNKI,2,0.6931471805599453
acquaintances,2,0.6931471805599453
signalling,2,0.6931471805599453
conductivity,2,0.6931471805599453
Admissions,2,0.6931471805599453
Sparse,2,0.6931471805599453
cumulated,2,0.6931471805599453
l-isoproterenol,2,0.6931471805599453
laminar,2,0.6931471805599453
homozygous,2,0.6931471805599453
15th,2,0.6931471805599453
neuroscience,2,0.6931471805599453
Swabs,2,0.6931471805599453
actuarial,2,0.6931471805599453
hospital-level,2,0.6931471805599453
Contemporary,2,0.6931471805599453
Kappa,2,0.6931471805599453
Meta-analysis,2,0.6931471805599453
0013,2,0.6931471805599453
burst,2,0.6931471805599453
Aged,2,0.6931471805599453
050,2,0.6931471805599453
bachelor,2,0.6931471805599453
813,2,0.6931471805599453
extinct,2,0.6931471805599453
Binary,2,0.6931471805599453
appearances,2,0.6931471805599453
nanobiosensors,2,0.6931471805599453
10-day,2,0.6931471805599453
bilirubin,2,0.6931471805599453
myocardiac,2,0.6931471805599453
enhancers,2,0.6931471805599453
-7,2,0.6931471805599453
Dynamic,2,0.6931471805599453
OBJECTIVE,2,0.6931471805599453
Binding,2,0.6931471805599453
Post,2,0.6931471805599453
MMP,2,0.6931471805599453
integrin-mediated,2,0.6931471805599453
hypodensity,2,0.6931471805599453
retrieving,2,0.6931471805599453
psychosomatic,2,0.6931471805599453
HDL,2,0.6931471805599453
defences,2,0.6931471805599453
transmits,2,0.6931471805599453
Cathepsin,2,0.6931471805599453
Horners,2,0.6931471805599453
missense,2,0.6931471805599453
topography,2,0.6931471805599453
ecg,2,0.6931471805599453
HA1,2,0.6931471805599453
837,2,0.6931471805599453
proceeding,2,0.6931471805599453
spirometric,2,0.6931471805599453
Cytokines,2,0.6931471805599453
enthusiasm,2,0.6931471805599453
6-year,2,0.6931471805599453
DNAm,2,0.6931471805599453
Corticosteroids,2,0.6931471805599453
chief,2,0.6931471805599453
nonsevere,2,0.6931471805599453
non-surgical,2,0.6931471805599453
microembolic,2,0.6931471805599453
nicotine,2,0.6931471805599453
1016,2,0.6931471805599453
singular,2,0.6931471805599453
Rt-PCR,2,0.6931471805599453
pluralism,2,0.6931471805599453
understandings,2,0.6931471805599453
speckle,2,0.6931471805599453
LSCI,2,0.6931471805599453
losartan,2,0.6931471805599453
pathologists,2,0.6931471805599453
Ligation,2,0.6931471805599453
high-energy,2,0.6931471805599453
copeptin,2,0.6931471805599453
dual-marker,2,0.6931471805599453
TPLSM,2,0.6931471805599453
mature,2,0.6931471805599453
triphosphate,2,0.6931471805599453
Dentists,2,0.6931471805599453
RBD-ACE2,2,0.6931471805599453
advocating,2,0.6931471805599453
enteroviruses,2,0.6931471805599453
Indias,2,0.6931471805599453
901,2,0.6931471805599453
Veritor™,2,0.6931471805599453
Chinas,2,0.6931471805599453
Behavioral,2,0.6931471805599453
mounted,2,0.6931471805599453
electrograms,2,0.6931471805599453
practised,2,0.6931471805599453
carboxyhemoglobin,2,0.6931471805599453
Thematic,2,0.6931471805599453
MCAo,2,0.6931471805599453
superficial,2,0.6931471805599453
Hcy,2,0.6931471805599453
ASDs,2,0.6931471805599453
rinses,2,0.6931471805599453
pancreas,2,0.6931471805599453
vignettes,2,0.6931471805599453
semi-structured,2,0.6931471805599453
nontraining,2,0.6931471805599453
PARP,2,0.6931471805599453
van,2,0.6931471805599453
municipal,2,0.6931471805599453
Zanamivir,2,0.6931471805599453
Experimentally,2,0.6931471805599453
ICIs,2,0.6931471805599453
e-mail,2,0.6931471805599453
left-ventricular-assist,2,0.6931471805599453
30-35,2,0.6931471805599453
COLD,2,0.6931471805599453
8-10,2,0.6931471805599453
1931,2,0.6931471805599453
ventilators,2,0.6931471805599453
closing,2,0.6931471805599453
typified,2,0.6931471805599453
mucoid,2,0.6931471805599453
543,2,0.6931471805599453
rheolytic,2,0.6931471805599453
2020-2021,2,0.6931471805599453
381,2,0.6931471805599453
peroxide,2,0.6931471805599453
exceedingly,2,0.6931471805599453
B-C,2,0.6931471805599453
reinforces,2,0.6931471805599453
Throat,2,0.6931471805599453
vigilance,2,0.6931471805599453
Zambia,2,0.6931471805599453
AD,2,0.6931471805599453
No1-9,2,0.6931471805599453
Schirmers,2,0.6931471805599453
Create,2,0.6931471805599453
Leiden,2,0.6931471805599453
low-intensity,2,0.6931471805599453
Contamination,2,0.6931471805599453
Subacute,2,0.6931471805599453
NIs,2,0.6931471805599453
mPFC,2,0.6931471805599453
letters,2,0.6931471805599453
IHS,2,0.6931471805599453
say,2,0.6931471805599453
LABA,2,0.6931471805599453
sex-ratio,2,0.6931471805599453
PBV,2,0.6931471805599453
discharging,2,0.6931471805599453
valuations,2,0.6931471805599453
annum,2,0.6931471805599453
T-helper,2,0.6931471805599453
unreliable,2,0.6931471805599453
339,2,0.6931471805599453
AWenshan012009,2,0.6931471805599453
p00005,2,0.6931471805599453
referring,2,0.6931471805599453
431,2,0.6931471805599453
gateway,2,0.6931471805599453
schedules,2,0.6931471805599453
legacy,2,0.6931471805599453
495,2,0.6931471805599453
TnI,2,0.6931471805599453
stains,2,0.6931471805599453
helices,2,0.6931471805599453
Gensini,2,0.6931471805599453
Marks,2,0.6931471805599453
chose,2,0.6931471805599453
AQLQ-M,2,0.6931471805599453
neutrophilia,2,0.6931471805599453
large-core,2,0.6931471805599453
Bronchoalveolar,2,0.6931471805599453
attitudinal,2,0.6931471805599453
indexed,2,0.6931471805599453
Bureau,2,0.6931471805599453
END,2,0.6931471805599453
adaptable,2,0.6931471805599453
96-well,2,0.6931471805599453
wedge-shaped,2,0.6931471805599453
Peter,2,0.6931471805599453
facemasks,2,0.6931471805599453
brewing,2,0.6931471805599453
Linkage,2,0.6931471805599453
catching,2,0.6931471805599453
crosstalk,2,0.6931471805599453
vivid,2,0.6931471805599453
Diffusion-weighted,2,0.6931471805599453
10664,2,0.6931471805599453
borne,2,0.6931471805599453
Relevant,2,0.6931471805599453
β-agonists,2,0.6931471805599453
adamantanes,2,0.6931471805599453
RGGRG,2,0.6931471805599453
R177,2,0.6931471805599453
5-years,2,0.6931471805599453
PRMT1,2,0.6931471805599453
preventer,2,0.6931471805599453
normative,2,0.6931471805599453
pokeweed,2,0.6931471805599453
NOEs,2,0.6931471805599453
AWenshan,2,0.6931471805599453
Likert,2,0.6931471805599453
Thrombus,2,0.6931471805599453
plasmablasts,2,0.6931471805599453
CVRF,2,0.6931471805599453
749,2,0.6931471805599453
Week,2,0.6931471805599453
left-to-right,2,0.6931471805599453
DR,2,0.6931471805599453
intertrabecular,2,0.6931471805599453
1422,2,0.6931471805599453
Goal,2,0.6931471805599453
collated,2,0.6931471805599453
aircrews,2,0.6931471805599453
epidrugs,2,0.6931471805599453
Klebsiella,2,0.6931471805599453
sternal,2,0.6931471805599453
cloning,2,0.6931471805599453
Sources,2,0.6931471805599453
aggression,2,0.6931471805599453
Inner-City,2,0.6931471805599453
aORs,2,0.6931471805599453
QALYs,2,0.6931471805599453
discern,2,0.6931471805599453
toxicants,2,0.6931471805599453
Fall,2,0.6931471805599453
recesses,2,0.6931471805599453
10-12,2,0.6931471805599453
remediation,2,0.6931471805599453
meshwork,2,0.6931471805599453
Solitaire,2,0.6931471805599453
oclock,2,0.6931471805599453
UTI,2,0.6931471805599453
hygienic,2,0.6931471805599453
averages,2,0.6931471805599453
radiographically,2,0.6931471805599453
well-matched,2,0.6931471805599453
contrasts,2,0.6931471805599453
discriminative,2,0.6931471805599453
Moderate,2,0.6931471805599453
hyperstimulation-IVFICSI,2,0.6931471805599453
employer,2,0.6931471805599453
biases,2,0.6931471805599453
self-grounding,2,0.6931471805599453
sample-to-result,2,0.6931471805599453
FGF-2,2,0.6931471805599453
linkages,2,0.6931471805599453
051,2,0.6931471805599453
sperm,2,0.6931471805599453
ILVNC,2,0.6931471805599453
Ninety-six,2,0.6931471805599453
stops,2,0.6931471805599453
emptying,2,0.6931471805599453
early-,2,0.6931471805599453
2157,2,0.6931471805599453
hydrophobic,2,0.6931471805599453
perceivers,2,0.6931471805599453
antigen-specific,2,0.6931471805599453
dont,2,0.6931471805599453
intimacy,2,0.6931471805599453
Dipetalonema,2,0.6931471805599453
fulfillment,2,0.6931471805599453
IPA,2,0.6931471805599453
LBMs,2,0.6931471805599453
zymography,2,0.6931471805599453
untoward,2,0.6931471805599453
dictates,2,0.6931471805599453
LBM,2,0.6931471805599453
hsCRP,2,0.6931471805599453
virus-positive,2,0.6931471805599453
assure,2,0.6931471805599453
Challenges,2,0.6931471805599453
gelatin,2,0.6931471805599453
BFMI,2,0.6931471805599453
FFMI,2,0.6931471805599453
uncommonly,2,0.6931471805599453
1968-69,2,0.6931471805599453
team-based,2,0.6931471805599453
cases100,2,0.6931471805599453
waist,2,0.6931471805599453
Workers,2,0.6931471805599453
cross-reaction,2,0.6931471805599453
0-4,2,0.6931471805599453
domain-containing,2,0.6931471805599453
commitment,2,0.6931471805599453
bifascicular,2,0.6931471805599453
intrinsically,2,0.6931471805599453
Institutional,2,0.6931471805599453
haploidentical,2,0.6931471805599453
reflections,2,0.6931471805599453
burnout,2,0.6931471805599453
Problematic,2,0.6931471805599453
Antiarrhythmic,2,0.6931471805599453
recapitulates,2,0.6931471805599453
endo-systolic,2,0.6931471805599453
reperfusionABSTRACT,2,0.6931471805599453
thirty,2,0.6931471805599453
virophagy,2,0.6931471805599453
sickness,2,0.6931471805599453
sooner,2,0.6931471805599453
hypothesis-driven,2,0.6931471805599453
263,2,0.6931471805599453
elude,2,0.6931471805599453
mountain,2,0.6931471805599453
self-sampling,2,0.6931471805599453
consulting,2,0.6931471805599453
EM,2,0.6931471805599453
autophagy-related,2,0.6931471805599453
nucleoside-modified,2,0.6931471805599453
flu-associated,2,0.6931471805599453
417,2,0.6931471805599453
4-10,2,0.6931471805599453
COVID-19-specific,2,0.6931471805599453
gracile,2,0.6931471805599453
Estimating,2,0.6931471805599453
non-inferiority,2,0.6931471805599453
NABL,2,0.6931471805599453
Enzymatic,2,0.6931471805599453
Others,2,0.6931471805599453
monachus,2,0.6931471805599453
playgrounds,2,0.6931471805599453
proteolysis,2,0.6931471805599453
diagrams,2,0.6931471805599453
sex-standardized,2,0.6931471805599453
74-year-old,2,0.6931471805599453
suite,2,0.6931471805599453
nomenclature,2,0.6931471805599453
catalyze,2,0.6931471805599453
Orthopedics,2,0.6931471805599453
haemolysis,2,0.6931471805599453
ecosystem,2,0.6931471805599453
prairie,2,0.6931471805599453
B1128,2,0.6931471805599453
FSRP,2,0.6931471805599453
unmatched,2,0.6931471805599453
linearly,2,0.6931471805599453
neutral,2,0.6931471805599453
385,2,0.6931471805599453
leukocyte-erythrocyte,2,0.6931471805599453
allergist,2,0.6931471805599453
aggregations,2,0.6931471805599453
WMCs,2,0.6931471805599453
bio-safety,2,0.6931471805599453
flare-ups,2,0.6931471805599453
venues,2,0.6931471805599453
high-touch,2,0.6931471805599453
recanalisation,2,0.6931471805599453
pathognomonic,2,0.6931471805599453
Medication,2,0.6931471805599453
UL,2,0.6931471805599453
diagramming,2,0.6931471805599453
touching,2,0.6931471805599453
60-year-old,2,0.6931471805599453
watch,2,0.6931471805599453
immune-mediated,2,0.6931471805599453
inspired,2,0.6931471805599453
worms,2,0.6931471805599453
playground,2,0.6931471805599453
CPE,2,0.6931471805599453
post-inoculation,2,0.6931471805599453
stroke-free,2,0.6931471805599453
Technological,2,0.6931471805599453
decontaminate,2,0.6931471805599453
publishes,2,0.6931471805599453
well-validated,2,0.6931471805599453
mobilize,2,0.6931471805599453
renin,2,0.6931471805599453
Lead,2,0.6931471805599453
Physiologic,2,0.6931471805599453
abrupt,2,0.6931471805599453
pre-school,2,0.6931471805599453
EPM,2,0.6931471805599453
Orf1ab,2,0.6931471805599453
Q677H,2,0.6931471805599453
corroborated,2,0.6931471805599453
H5N1AV,2,0.6931471805599453
label,2,0.6931471805599453
n52,2,0.6931471805599453
IV-rtPA,2,0.6931471805599453
sigma-1,2,0.6931471805599453
removing,2,0.6931471805599453
isoproterenol-induced,2,0.6931471805599453
recovers,2,0.6931471805599453
Equally,2,0.6931471805599453
furosemide,2,0.6931471805599453
11-45,2,0.6931471805599453
excitation,2,0.6931471805599453
immunoblotting,2,0.6931471805599453
venom,2,0.6931471805599453
castrates,2,0.6931471805599453
ranks,2,0.6931471805599453
hitherto,2,0.6931471805599453
TPE,2,0.6931471805599453
underlined,2,0.6931471805599453
P0009,2,0.6931471805599453
457,2,0.6931471805599453
abruptly,2,0.6931471805599453
prodromi,2,0.6931471805599453
constraint,2,0.6931471805599453
orand,2,0.6931471805599453
hottest,2,0.6931471805599453
hesitancyresistance,2,0.6931471805599453
OCT,2,0.6931471805599453
switches,2,0.6931471805599453
Jewish,2,0.6931471805599453
James,2,0.6931471805599453
dragon,2,0.6931471805599453
Alma-Ata,2,0.6931471805599453
CSI,2,0.6931471805599453
observing,2,0.6931471805599453
givers,2,0.6931471805599453
frustrations,2,0.6931471805599453
Adjunctive,2,0.6931471805599453
bioanalysis,2,0.6931471805599453
716,2,0.6931471805599453
analytics,2,0.6931471805599453
inflammation-related,2,0.6931471805599453
non-cardioembolic,2,0.6931471805599453
BIOVASC,2,0.6931471805599453
β2-agonists,2,0.6931471805599453
8-15,2,0.6931471805599453
13685,2,0.6931471805599453
castrated,2,0.6931471805599453
furthermore,2,0.6931471805599453
Living,2,0.6931471805599453
dropped,2,0.6931471805599453
sweeping,2,0.6931471805599453
∼30,2,0.6931471805599453
dissected,2,0.6931471805599453
μL,2,0.6931471805599453
inaccuracies,2,0.6931471805599453
pseudoviruses,2,0.6931471805599453
organelles,2,0.6931471805599453
EPICES,2,0.6931471805599453
IL-2,2,0.6931471805599453
premorbid,2,0.6931471805599453
acute-phase,2,0.6931471805599453
pleura,2,0.6931471805599453
Separate,2,0.6931471805599453
early-differentiated,2,0.6931471805599453
340,2,0.6931471805599453
Drawing,2,0.6931471805599453
historians,2,0.6931471805599453
well-tolerated,2,0.6931471805599453
1973,2,0.6931471805599453
Detailed,2,0.6931471805599453
nonarteriosclerotic,2,0.6931471805599453
Plus,2,0.6931471805599453
artefactual,2,0.6931471805599453
Grading,2,0.6931471805599453
pays,2,0.6931471805599453
neuroprotectants,2,0.6931471805599453
Backgroundobjectives,2,0.6931471805599453
AdC68-19RBDs,2,0.6931471805599453
mid-,2,0.6931471805599453
AdC68-19RBD,2,0.6931471805599453
troublesome,2,0.6931471805599453
homogeneously,2,0.6931471805599453
bronchiolo-alveolar,2,0.6931471805599453
neuroadrenergic,2,0.6931471805599453
certified,2,0.6931471805599453
reintegration,2,0.6931471805599453
methacoline,2,0.6931471805599453
Eosinophilia,2,0.6931471805599453
infectors,2,0.6931471805599453
phase-III,2,0.6931471805599453
certifying,2,0.6931471805599453
rethrombosis,2,0.6931471805599453
Increase,2,0.6931471805599453
Premature,2,0.6931471805599453
Ca2,2,0.6931471805599453
autogenic,2,0.6931471805599453
Eighty-one,2,0.6931471805599453
premier,2,0.6931471805599453
RTR,2,0.6931471805599453
adopting,2,0.6931471805599453
dyspneic,2,0.6931471805599453
moderate-to-severe,2,0.6931471805599453
rhinorrhoea,2,0.6931471805599453
amantadine-treated,2,0.6931471805599453
Eosinophil,2,0.6931471805599453
enzyme-2,2,0.6931471805599453
case-by-case,2,0.6931471805599453
inter-,2,0.6931471805599453
wife,2,0.6931471805599453
sub-strain,2,0.6931471805599453
Intrinsic,2,0.6931471805599453
age-associated,2,0.6931471805599453
bactericidal,2,0.6931471805599453
AVs,2,0.6931471805599453
TTS,2,0.6931471805599453
participates,2,0.6931471805599453
upper-respiratory-tract,2,0.6931471805599453
Combining,2,0.6931471805599453
driver,2,0.6931471805599453
Traditionally,2,0.6931471805599453
S-protein,2,0.6931471805599453
FHMI-by-risk,1,0.0
1485,1,0.0
Airport,1,0.0
towns,1,0.0
source-subpopulation,1,0.0
-16,1,0.0
finger-prick,1,0.0
Populations,1,0.0
2282,1,0.0
quicker,1,0.0
corporations,1,0.0
host-cell,1,0.0
2743,1,0.0
1613,1,0.0
ECG-gated,1,0.0
regenerated,1,0.0
-49,1,0.0
RFA-ablated,1,0.0
048-082,1,0.0
Collecting,1,0.0
case-fatality--which,1,0.0
parish,1,0.0
Schiphol,1,0.0
098-100,1,0.0
079-090,1,0.0
ever-increasing,1,0.0
Prominent,1,0.0
NGO,1,0.0
meta-analytic,1,0.0
expansions,1,0.0
Massachusetts,1,0.0
low-grade,1,0.0
Optical,1,0.0
-70,1,0.0
48-fold,1,0.0
Mimicry,1,0.0
115ABSTRACT,1,0.0
Interval,1,0.0
Credible,1,0.0
753,1,0.0
varicella-zoster,1,0.0
084-149,1,0.0
1114,1,0.0
oro-,1,0.0
26-19,1,0.0
7-fold,1,0.0
scanty,1,0.0
Alkaline,1,0.0
trabeculations,1,0.0
goiters,1,0.0
COVID-19-suspect,1,0.0
precocultured,1,0.0
4-600,1,0.0
Hematology,1,0.0
low-to-moderate,1,0.0
antiwei,1,0.0
SROC,1,0.0
-11,1,0.0
-6,1,0.0
NA-specific,1,0.0
RFA,1,0.0
maoto,1,0.0
SFlu,1,0.0
agglutination,1,0.0
361538,1,0.0
Invest,1,0.0
-18,1,0.0
9633,1,0.0
2009H1N1,1,0.0
dawn,1,0.0
2857,1,0.0
over-aggressive,1,0.0
improverestore,1,0.0
serum-cholesterol,1,0.0
2318,1,0.0
clinicopathogenetic,1,0.0
arrhythmogenesis,1,0.0
6000,1,0.0
Engineered,1,0.0
microstructural,1,0.0
FQHC,1,0.0
2904,1,0.0
scFv,1,0.0
metalloporphyrin,1,0.0
619,1,0.0
aseptic,1,0.0
Indigenous-led,1,0.0
arguing,1,0.0
9-OH,1,0.0
Multi-centre,1,0.0
2b-3,1,0.0
MINOCA,1,0.0
disease-state,1,0.0
LRI,1,0.0
Lausanne,1,0.0
modus,1,0.0
mammalian-derived,1,0.0
non-compaction,1,0.0
Ministers,1,0.0
Federally,1,0.0
undermined,1,0.0
9085,1,0.0
185-187,1,0.0
Multiple-target,1,0.0
Y406,1,0.0
38-year-old,1,0.0
20th-century,1,0.0
DHS,1,0.0
staving,1,0.0
Qualified,1,0.0
053-086,1,0.0
1972-73,1,0.0
-8,1,0.0
racialethnic,1,0.0
villages,1,0.0
haphazard,1,0.0
juxtaposition,1,0.0
Radiofrequency,1,0.0
4867,1,0.0
peri-infarcted,1,0.0
terbutaline,1,0.0
deoxygenated,1,0.0
60-70,1,0.0
thrombo-embolic,1,0.0
last-well,1,0.0
Placebo,1,0.0
923,1,0.0
kgm,1,0.0
575,1,0.0
Dallas,1,0.0
2-family,1,0.0
-50,1,0.0
astma,1,0.0
alkaline,1,0.0
097-099,1,0.0
1960s--may,1,0.0
065-081,1,0.0
Boundary,1,0.0
Apical,1,0.0
requests,1,0.0
palliation,1,0.0
-2019,1,0.0
3C2a,1,0.0
Layer-PBL,1,0.0
RNAish,1,0.0
thrombolyzed,1,0.0
Dose-response,1,0.0
flight-contact,1,0.0
Devon,1,0.0
January-30,1,0.0
freshly,1,0.0
rows,1,0.0
IHC,1,0.0
Cross-reactive,1,0.0
147-901,1,0.0
Stephen,1,0.0
Perugia,1,0.0
hampering,1,0.0
580000,1,0.0
mid-February,1,0.0
tigers,1,0.0
carnosic,1,0.0
isotype-specific,1,0.0
Hemoglobin,1,0.0
Della,1,0.0
Echinacea,1,0.0
paradoxes,1,0.0
Planetary,1,0.0
Misericordia,1,0.0
berries,1,0.0
pro-oxidant,1,0.0
3C3a,1,0.0
frustration,1,0.0
immersive,1,0.0
N-acetylamino-235-trideoxy-23-difluoro-d-erythro-β-l-manno-2-nonulopyranosonic,1,0.0
Diseases-9,1,0.0
25-29,1,0.0
seated,1,0.0
ensues,1,0.0
9753,1,0.0
Cumbria,1,0.0
outflow,1,0.0
115-1046,1,0.0
agglomerated,1,0.0
triamcinolone,1,0.0
Deferral,1,0.0
-291,1,0.0
Ecologic,1,0.0
ginseng,1,0.0
pretraining,1,0.0
Gould,1,0.0
activiation,1,0.0
040050049,1,0.0
time-of-addition,1,0.0
kinematic,1,0.0
owners,1,0.0
hyperdynamic,1,0.0
interrater,1,0.0
Jay,1,0.0
9932,1,0.0
9380,1,0.0
NPA,1,0.0
paraffin-embedded,1,0.0
employers,1,0.0
row,1,0.0
Veloergometry,1,0.0
depot,1,0.0
formalin-fixed,1,0.0
PAO,1,0.0
colloidal,1,0.0
vascular-brain,1,0.0
subjectsABSTRACT,1,0.0
pomegranate,1,0.0
unfractioned,1,0.0
mM,1,0.0
nickle,1,0.0
Shao,1,0.0
Robot-assisted,1,0.0
Bai,1,0.0
2-8,1,0.0
topographically,1,0.0
808,1,0.0
Competitive,1,0.0
Municipal,1,0.0
somewhere,1,0.0
decimated,1,0.0
2167,1,0.0
411e27-e32,1,0.0
thoracoscopic,1,0.0
aetiology-oriented,1,0.0
suburban,1,0.0
sutured,1,0.0
cancer-associated,1,0.0
breakthroughs,1,0.0
LMT,1,0.0
Toxicologists,1,0.0
Af,1,0.0
rNP,1,0.0
1261,1,0.0
RNa,1,0.0
cancer-related,1,0.0
sub-acute,1,0.0
Trauma,1,0.0
37584,1,0.0
enthusiastic,1,0.0
Alinity™,1,0.0
717,1,0.0
WVA,1,0.0
T-V6,1,0.0
attain,1,0.0
polarization,1,0.0
eighteenth,1,0.0
Maria,1,0.0
guava,1,0.0
auto-immune,1,0.0
deranged,1,0.0
latrogenic,1,0.0
9297,1,0.0
assist-as-needed,1,0.0
Anglia,1,0.0
venography,1,0.0
Dyfed,1,0.0
caspase,1,0.0
093-097,1,0.0
tendon,1,0.0
Non-Hispanic,1,0.0
2-mm,1,0.0
weal,1,0.0
45-50th,1,0.0
097-100,1,0.0
inter-epidemic,1,0.0
craniocerebral,1,0.0
Corporation,1,0.0
wave--the,1,0.0
reopenings,1,0.0
1730,1,0.0
siderosis,1,0.0
CIbRIVM,1,0.0
105-574,1,0.0
disease-prone,1,0.0
inhalable,1,0.0
1-103,1,0.0
T-V1,1,0.0
Northumbria,1,0.0
Lomudal,1,0.0
AsianPacific,1,0.0
65-75,1,0.0
abrogate,1,0.0
Primers,1,0.0
seletive,1,0.0
cuts,1,0.0
promisingly,1,0.0
primeval,1,0.0
mesencephalic,1,0.0
misperceptions,1,0.0
homozygotous,1,0.0
poly-L-lysine,1,0.0
treatment-seeking,1,0.0
alpha-thalassemia,1,0.0
cephalalgia,1,0.0
345-bp,1,0.0
42-60,1,0.0
splenocytes,1,0.0
calciﬁcation,1,0.0
Oklahoma,1,0.0
396-bp,1,0.0
isotonic,1,0.0
267,1,0.0
laboratory-proven,1,0.0
vaccinee,1,0.0
ILK,1,0.0
widoweddivorced,1,0.0
29th,1,0.0
RTKs,1,0.0
RdRP-amplified,1,0.0
eco-friendly,1,0.0
Thrombi,1,0.0
3D-printed,1,0.0
speculative,1,0.0
traumatism,1,0.0
stems,1,0.0
MSC-based,1,0.0
ia,1,0.0
protuberance,1,0.0
necrosed,1,0.0
ILK-engineered,1,0.0
sudden-onset,1,0.0
S-N501Y,1,0.0
postero-inferior,1,0.0
undigested,1,0.0
sited,1,0.0
semicircular,1,0.0
15-day,1,0.0
risk-based,1,0.0
digested,1,0.0
meso-diencephalic,1,0.0
infae,1,0.0
polygon,1,0.0
corporate,1,0.0
VLP,1,0.0
canal,1,0.0
STT-wave,1,0.0
≥2690,1,0.0
0036,1,0.0
Islamic,1,0.0
well-cooked,1,0.0
serendipitously,1,0.0
uraemia,1,0.0
2005-08,1,0.0
Opportunities,1,0.0
meat,1,0.0
S-E484K,1,0.0
271,1,0.0
2014-17,1,0.0
≤50,1,0.0
non-bacterial,1,0.0
51-year-old,1,0.0
endured,1,0.0
Human-to-human,1,0.0
onset-to-reperfusion,1,0.0
acquaints,1,0.0
T2-w,1,0.0
herbs,1,0.0
anti-cancer,1,0.0
2005-06,1,0.0
innate-to-adaptive,1,0.0
faulty,1,0.0
time-sensitive,1,0.0
Acculturation,1,0.0
swaying,1,0.0
integrin-linked,1,0.0
Winter,1,0.0
36-item,1,0.0
1440,1,0.0
MSCs-based,1,0.0
STEMI-equivalents,1,0.0
tachyarrthythmias,1,0.0
buried,1,0.0
Lobar,1,0.0
tries,1,0.0
CD16,1,0.0
storm-induced,1,0.0
467,1,0.0
24-756,1,0.0
Lenvatinib,1,0.0
MODS,1,0.0
keys,1,0.0
gradient-echo,1,0.0
tissue-plasminogen,1,0.0
Semnan,1,0.0
CD14,1,0.0
no-touch,1,0.0
PR8,1,0.0
routined,1,0.0
flaccid,1,0.0
man-ifestations,1,0.0
privacy,1,0.0
pseudoaneurysm,1,0.0
AFAS,1,0.0
confidentiality,1,0.0
MAPKs,1,0.0
Worsening,1,0.0
Estonian,1,0.0
unter,1,0.0
self-control,1,0.0
bloodlettings,1,0.0
0-777,1,0.0
localisable,1,0.0
1971-1977,1,0.0
ruinous,1,0.0
empowerment,1,0.0
focussed,1,0.0
operationally,1,0.0
Coupled,1,0.0
countries--the,1,0.0
18449,1,0.0
mean-field,1,0.0
httpswwwcdcgovcoronavirus2019-ncov,1,0.0
catastrophes,1,0.0
recombined,1,0.0
forums,1,0.0
1638,1,0.0
mutation-specific,1,0.0
chick,1,0.0
Pre-admission,1,0.0
Chronical,1,0.0
HIR,1,0.0
preformed,1,0.0
1313,1,0.0
Yokohama,1,0.0
dead-on-arrival,1,0.0
Bokutoh,1,0.0
33-83,1,0.0
dictate,1,0.0
same-day,1,0.0
pazopanib,1,0.0
disease-controlling,1,0.0
DOA,1,0.0
humanistic,1,0.0
non-DOA,1,0.0
embryos,1,0.0
SSR,1,0.0
Prognosis,1,0.0
emetics,1,0.0
paraparesis,1,0.0
cannulation,1,0.0
anaortic,1,0.0
laxatives,1,0.0
mechanism-of-action,1,0.0
deoxynucleotidyl,1,0.0
mutability,1,0.0
renewable,1,0.0
expectorants,1,0.0
transferase-mediated,1,0.0
proteo-genomic,1,0.0
Bodyweight,1,0.0
ACalifornia042009,1,0.0
1×107,1,0.0
FFU,1,0.0
im,1,0.0
oscillation,1,0.0
broadly-acting,1,0.0
Thromboembolic,1,0.0
hemicorporal,1,0.0
fluororadiographs,1,0.0
intrasubgroup,1,0.0
inspiration,1,0.0
acculturation,1,0.0
tangential,1,0.0
Coordination,1,0.0
Oppression,1,0.0
Vertebral,1,0.0
unsteadiness,1,0.0
Adoption,1,0.0
IL-12-mediated,1,0.0
MedlinePubMed,1,0.0
seacoast,1,0.0
Bilbao,1,0.0
sunitinib,1,0.0
1782-1782,1,0.0
HE,1,0.0
baculoviral,1,0.0
cross-clamping,1,0.0
EAACI,1,0.0
host-virus,1,0.0
imposes,1,0.0
virus-like-particle,1,0.0
extragenic,1,0.0
side-biting,1,0.0
retrovirus,1,0.0
thirty-two-year-old,1,0.0
OVA-specific,1,0.0
HERV,1,0.0
envelope-coated,1,0.0
baculovirus-based,1,0.0
lumbar,1,0.0
Pristimerin,1,0.0
hemopneumothorax,1,0.0
Confirming,1,0.0
ethology,1,0.0
Integrins,1,0.0
7days,1,0.0
epsilon2-,1,0.0
Arthralgia,1,0.0
Patient-specific,1,0.0
pre-moistened,1,0.0
acronym,1,0.0
virion-integrin,1,0.0
sinusoidal-cell,1,0.0
microthrombi,1,0.0
S291-carrying,1,0.0
9173,1,0.0
shreds,1,0.0
whole-body,1,0.0
fountain,1,0.0
Technetium-99m,1,0.0
diphosphonate,1,0.0
denoting,1,0.0
McGill,1,0.0
Non-steroidal,1,0.0
Glutathione,1,0.0
Narrative,1,0.0
biopsychosocial,1,0.0
Doubled-Vascular,1,0.0
5years,1,0.0
non-major,1,0.0
volatile,1,0.0
6-months,1,0.0
I2135,1,0.0
dopaminergic,1,0.0
replication-inhibition,1,0.0
124-534,1,0.0
nonparenchymal,1,0.0
microextraction,1,0.0
Sterile,1,0.0
rheumatologic,1,0.0
antipyretic,1,0.0
-10,1,0.0
Parkinsons,1,0.0
epsilon4-carrying,1,0.0
20201201,1,0.0
solid-phase,1,0.0
HRR,1,0.0
VUI,1,0.0
123-1515,1,0.0
147-253,1,0.0
149-260,1,0.0
699,1,0.0
X447-containing,1,0.0
chromatography-high-resolution,1,0.0
receptacle,1,0.0
arginine-glycine-aspartate,1,0.0
Midbrain,1,0.0
Implementing,1,0.0
Ole,1,0.0
triple-reassortant,1,0.0
competitions,1,0.0
afebrile,1,0.0
escalates,1,0.0
thickened,1,0.0
340B,1,0.0
rectification,1,0.0
JUST,1,0.0
traumas,1,0.0
pangolins,1,0.0
qualities,1,0.0
one-on-one,1,0.0
References,1,0.0
Prinzmetal,1,0.0
meta-analytical,1,0.0
Dietary,1,0.0
congressional,1,0.0
15-billion-a-year,1,0.0
intermitting,1,0.0
Awareness,1,0.0
spirituality,1,0.0
single-chain,1,0.0
Definitive,1,0.0
SVS-,1,0.0
vascularity,1,0.0
protease-inhibition,1,0.0
fostered,1,0.0
extra-pulmonary,1,0.0
65-74,1,0.0
3-million,1,0.0
lifes,1,0.0
ordeals,1,0.0
casework,1,0.0
Governments,1,0.0
catarrhal,1,0.0
Ug,1,0.0
sub-epithelial,1,0.0
disseminates,1,0.0
-1,1,0.0
low-socioeconomic,1,0.0
lipase,1,0.0
weeksmonths,1,0.0
Travel,1,0.0
chymotrypsin-like,1,0.0
interindividual,1,0.0
multisystemic,1,0.0
pandemic-variant,1,0.0
DrugBank,1,0.0
comprehensiveness,1,0.0
S447X,1,0.0
0325,1,0.0
Military,1,0.0
benchmarking,1,0.0
end-labeling,1,0.0
Thucydides,1,0.0
king,1,0.0
≤30,1,0.0
08-20,1,0.0
test-elasticity,1,0.0
posterolaterally,1,0.0
Integration,1,0.0
hypercholesterolaemic,1,0.0
1387,1,0.0
historian,1,0.0
noncardiovascular,1,0.0
non-motor,1,0.0
gleaned,1,0.0
concur,1,0.0
synapses,1,0.0
neuropharmacological,1,0.0
Athenian,1,0.0
COVID-19-infected,1,0.0
anti-protozoal,1,0.0
training-induced,1,0.0
B1427429,1,0.0
Benchmarking,1,0.0
Maurice,1,0.0
Hilleman,1,0.0
lymphocytopenia,1,0.0
RTq-PCR,1,0.0
Swaying,1,0.0
Naturally,1,0.0
dUTP-biotin,1,0.0
COVID-19-suspected,1,0.0
lenvatinib,1,0.0
transcriptase-,1,0.0
Feline,1,0.0
pontomedullary,1,0.0
989-100,1,0.0
µM,1,0.0
YouTube,1,0.0
royal,1,0.0
S-H69-V70del,1,0.0
nick,1,0.0
hyperechogenic,1,0.0
S-L450R,1,0.0
V7-V9,1,0.0
dimethylarginine,1,0.0
speaks,1,0.0
679-782,1,0.0
Carraro,1,0.0
decomposed,1,0.0
non-haemorrhagic,1,0.0
neuroinflammatory,1,0.0
compacta,1,0.0
Neuroscience,1,0.0
Blueprint,1,0.0
susceptible-infectious-recovered,1,0.0
I20,1,0.0
1389,1,0.0
SNpc,1,0.0
reorganizing,1,0.0
4000000,1,0.0
polyarthralgia,1,0.0
diclazuril,1,0.0
deuterated,1,0.0
nigrostriatal,1,0.0
pars,1,0.0
250000,1,0.0
childbirth,1,0.0
nigra,1,0.0
Altering,1,0.0
Babies,1,0.0
HDL-,1,0.0
substantia,1,0.0
neuropilin-1,1,0.0
arthropathy,1,0.0
accredited,1,0.0
Guro,1,0.0
Peloponnesian,1,0.0
Confounding,1,0.0
denominators,1,0.0
HMG-CoA,1,0.0
restricts,1,0.0
B15261,1,0.0
MRIs,1,0.0
brain-specific,1,0.0
AssociationAmerican,1,0.0
non-exhaustive,1,0.0
CO-RADS,1,0.0
α-synuclein,1,0.0
TUNEL,1,0.0
ravished,1,0.0
neurodegenerationageing,1,0.0
PFO-mediated,1,0.0
paediatricdevelopmental,1,0.0
walled,1,0.0
mentaladdictive,1,0.0
injurystroke,1,0.0
on-call,1,0.0
intuition,1,0.0
0629,1,0.0
caspases,1,0.0
T-705,1,0.0
IFN-λ2-treated,1,0.0
-57,1,0.0
emphasise,1,0.0
TECARTUS,1,0.0
YESCARTA,1,0.0
RNA-negative,1,0.0
miR-491,1,0.0
IMLYGIC,1,0.0
Phenotype-driven,1,0.0
Phenotypic,1,0.0
endotyping,1,0.0
KYMRIAH,1,0.0
PROVENGE,1,0.0
miR-654,1,0.0
BioNTechamp39s,1,0.0
Th2-expression,1,0.0
Maderno,1,0.0
Individualized,1,0.0
inflammation-predominant,1,0.0
Phenotypes,1,0.0
unravelled,1,0.0
Unbiased,1,0.0
Pathogen,1,0.0
BREYANZI,1,0.0
lyse,1,0.0
beclouded,1,0.0
harvesting,1,0.0
Dozens,1,0.0
settler,1,0.0
hostenvironment,1,0.0
Nicobar,1,0.0
Andaman,1,0.0
missions,1,0.0
2020b,1,0.0
shown2,1,0.0
adapts,1,0.0
Bout,1,0.0
explainable,1,0.0
ampndash,1,0.0
Millions,1,0.0
Artificial,1,0.0
everywhere,1,0.0
exempt,1,0.0
8864,1,0.0
httpswwwgisaidorg,1,0.0
Amisha,1,0.0
ever-intriguing,1,0.0
heliox,1,0.0
anti-human,1,0.0
K-antagonists,1,0.0
countriesregions,1,0.0
outfitted,1,0.0
re-purposing,1,0.0
AHI,1,0.0
24-question,1,0.0
herniation,1,0.0
xenon-enhanced,1,0.0
Discussions,1,0.0
audio-recorded,1,0.0
apnea-hypopnea,1,0.0
racemic,1,0.0
Stigma,1,0.0
arterio-arterial,1,0.0
stent-assisted,1,0.0
insertable,1,0.0
supplying,1,0.0
ICM,1,0.0
prohibitive,1,0.0
logic,1,0.0
feared,1,0.0
TOCC,1,0.0
impact-of-asthma,1,0.0
human-virus,1,0.0
Enteric,1,0.0
barky,1,0.0
free-standing,1,0.0
monocytosis,1,0.0
eosinophil-depleting,1,0.0
LKN,1,0.0
Baylor,1,0.0
Scott,1,0.0
Intriguingly,1,0.0
Temple,1,0.0
1912,1,0.0
1659,1,0.0
EPR3,1,0.0
reperformed,1,0.0
factor-based,1,0.0
departmentinpatients,1,0.0
County-specific,1,0.0
Incidentally,1,0.0
tracings,1,0.0
health-economic,1,0.0
seamless,1,0.0
defuzzification,1,0.0
confusable,1,0.0
cropping,1,0.0
impatient-care,1,0.0
encephalitic,1,0.0
flare,1,0.0
endemicity,1,0.0
coasts,1,0.0
Seattle,1,0.0
mounting,1,0.0
WA,1,0.0
buttress,1,0.0
entertain,1,0.0
2020a,1,0.0
inland,1,0.0
behooves,1,0.0
encountering,1,0.0
hallmarks,1,0.0
anxiety-like,1,0.0
Prefrontal,1,0.0
win-shiftwin-stay,1,0.0
optimistic,1,0.0
AWSN33,1,0.0
post-influenzal,1,0.0
host-pathogen,1,0.0
cause-of-death,1,0.0
Parkinsonism,1,0.0
perturb,1,0.0
opioids,1,0.0
cod,1,0.0
Blair,1,0.0
glycerol,1,0.0
tetrahydrocannabinol,1,0.0
disorderly,1,0.0
cannabidiol,1,0.0
ColdZyme®,1,0.0
oromucosal,1,0.0
Encephalitis,1,0.0
lethargica,1,0.0
Port,1,0.0
1927,1,0.0
guessed,1,0.0
configuration,1,0.0
neuro-psychiatric,1,0.0
unstructured,1,0.0
intelligence-based,1,0.0
supporters,1,0.0
Geynisman,1,0.0
Barnes,1,0.0
Gatti-Mays,1,0.0
thoracoabdominal,1,0.0
field-of-view,1,0.0
2017Other,1,0.0
autofluorescence,1,0.0
idiotype,1,0.0
anti-idiotype,1,0.0
bioimaging,1,0.0
Racotumomab,1,0.0
tribe,1,0.0
Eu-luminescent,1,0.0
Nicobarese,1,0.0
Vaxira,1,0.0
aboriginal,1,0.0
two-photon,1,0.0
thoracoepigastric,1,0.0
FDACancer,1,0.0
May-August,1,0.0
May-September,1,0.0
intra-country,1,0.0
miR-323,1,0.0
submillimeter,1,0.0
light-dark,1,0.0
Mastelic-Gavillet,1,0.0
set-shifting,1,0.0
Bialkowski,1,0.0
Stanton,1,0.0
Disis,1,0.0
Destroy,1,0.0
Tagliamonte,1,0.0
prefrontal,1,0.0
394,1,0.0
apneahypopnea,1,0.0
transcription-quantitative,1,0.0
nanotheranostics,1,0.0
∼32,1,0.0
Whole-Cell,1,0.0
whole-cell,1,0.0
Keenan,1,0.0
Jaffee,1,0.0
sequestration,1,0.0
2012Dendritic,1,0.0
Wang,1,0.0
6753,1,0.0
popularized,1,0.0
202021,1,0.0
H1-H13,1,0.0
repatriation,1,0.0
pyroptosis,1,0.0
re-purposed,1,0.0
lake,1,0.0
year-by-year,1,0.0
83-185,1,0.0
downloaded,1,0.0
perpetuated,1,0.0
1017,1,0.0
NC045512,1,0.0
allergen-induced,1,0.0
purifying,1,0.0
C28144T,1,0.0
C14408T,1,0.0
T8782C,1,0.0
Ecological,1,0.0
C3037T,1,0.0
C1059T,1,0.0
G25563T,1,0.0
spike-ACE2,1,0.0
evacuee,1,0.0
Pneumonia,1,0.0
1534,1,0.0
47-87,1,0.0
chronic-phase,1,0.0
nonsensitizing,1,0.0
jumped,1,0.0
animal-human,1,0.0
FCoV,1,0.0
somehow,1,0.0
peritonitis,1,0.0
FIP,1,0.0
Felids,1,0.0
Cat,1,0.0
alliance,1,0.0
evolutions,1,0.0
ABCD,1,0.0
Atelectasis,1,0.0
human-to-animal,1,0.0
1234,1,0.0
non-domestic,1,0.0
felids,1,0.0
mink-to-human-cat,1,0.0
Haemodynamically,1,0.0
privileged,1,0.0
intervariability,1,0.0
spectrometry-based,1,0.0
PCT,1,0.0
6176,1,0.0
6766,1,0.0
syphilis,1,0.0
exploit,1,0.0
re-assortment,1,0.0
interests,1,0.0
devastate,1,0.0
middle-,1,0.0
notoriety,1,0.0
phage-displayed,1,0.0
streptavidin-coated,1,0.0
pool-testing,1,0.0
biotin-conjugated,1,0.0
biotin-streptavidin,1,0.0
cytometers,1,0.0
Pool-testing,1,0.0
PRAM,1,0.0
reminds,1,0.0
7172,1,0.0
Steps,1,0.0
anatomical-functional,1,0.0
Persistently,1,0.0
groups--Group,1,0.0
subserving,1,0.0
Workforce,1,0.0
Infect,1,0.0
Hosp,1,0.0
2017381361-1363,1,0.0
LTCF,1,0.0
phenotypic-directed,1,0.0
infection-control,1,0.0
AgooseGuangdong196,1,0.0
hepato-pancreato-biliary,1,0.0
Presidents,1,0.0
Trends,1,0.0
Eurotransplant,1,0.0
long-term--care,1,0.0
instigated,1,0.0
Ad,1,0.0
Which,1,0.0
Hoc,1,0.0
first-hand,1,0.0
long-recognized,1,0.0
simplified,1,0.0
defending,1,0.0
glycation,1,0.0
Forest,1,0.0
silica,1,0.0
androgens,1,0.0
sol-gel,1,0.0
SerologicDiagnostic,1,0.0
coatingbonding,1,0.0
appraised,1,0.0
CRISPR,1,0.0
Santiago,1,0.0
hyper-acute,1,0.0
rhythms,1,0.0
HAV,1,0.0
norovirus,1,0.0
virus-bacterial,1,0.0
Río,1,0.0
del,1,0.0
Roberto,1,0.0
scrambling,1,0.0
httpsdoiorg107196SAMJ2021v111i615740,1,0.0
Nanowire,1,0.0
Silicon,1,0.0
Porous,1,0.0
SPM,1,0.0
Re-education,1,0.0
under-reporting,1,0.0
autocorrelation,1,0.0
FluView,1,0.0
justice,1,0.0
Attempts,1,0.0
Microfluidic,1,0.0
rigorously,1,0.0
battling,1,0.0
nested-PCR,1,0.0
APOEε2,1,0.0
fluorescence-Based,1,0.0
adipokines,1,0.0
XII,1,0.0
4D,1,0.0
phosphodiesterase,1,0.0
endproducts,1,0.0
Assays,1,0.0
multiplexer,1,0.0
20211116522-523,1,0.0
wt,1,0.0
clpL,1,0.0
Consumer,1,0.0
Fooks,1,0.0
0966-1000,1,0.0
0986,1,0.0
Van,1,0.0
Poel,1,0.0
949-998,1,0.0
974-1000,1,0.0
Cross-reactivity,1,0.0
Taylor,1,0.0
Latham,1,0.0
CT3412,1,0.0
Primer,1,0.0
lyophilized,1,0.0
ozagrel,1,0.0
argatroban,1,0.0
Gowtage-Sequeria,1,0.0
Fauci,1,0.0
smokelaparoscopic,1,0.0
pneumoperitoneum,1,0.0
storable,1,0.0
Cutler,1,0.0
intimately,1,0.0
74-122,1,0.0
psaB,1,0.0
Mn2,1,0.0
ΔclpL,1,0.0
ΔpsaB,1,0.0
Afr,1,0.0
rhetoric,1,0.0
volunteering,1,0.0
Dial,1,0.0
pneumocyte,1,0.0
senses,1,0.0
Schoub,1,0.0
Coker,1,0.0
bottom-up,1,0.0
Venter,1,0.0
Letter,1,0.0
Cascio,1,0.0
crudeness,1,0.0
top-down,1,0.0
intraarterial,1,0.0
consolidate,1,0.0
nasopharyngolaryngoscopy,1,0.0
co-led,1,0.0
ABangkok179-like,1,0.0
Observation,1,0.0
-ACE2,1,0.0
solvents,1,0.0
Insights,1,0.0
BNP-associated,1,0.0
frustrating,1,0.0
Angiotensin-Converting,1,0.0
time-to-treatment,1,0.0
ischemically,1,0.0
SeLECT,1,0.0
journey,1,0.0
CAVE,1,0.0
epileptogenesis,1,0.0
pharmacodynamics,1,0.0
MCI,1,0.0
substitutes,1,0.0
workarounds,1,0.0
Drug-drug,1,0.0
co-medication,1,0.0
MCIs,1,0.0
top-ranked,1,0.0
DB08248,1,0.0
natriuretric,1,0.0
bottom,1,0.0
CED,1,0.0
586,1,0.0
Authorizations,1,0.0
RIMAS,1,0.0
Asturias,1,0.0
Administration-Emergency,1,0.0
Microbe,1,0.0
DB14826,1,0.0
Lu,1,0.0
single-molecule,1,0.0
transitions,1,0.0
receptor-accessible,1,0.0
on-path,1,0.0
conformations,1,0.0
immunogen,1,0.0
post-cocaine,1,0.0
DB03714,1,0.0
DB02651,1,0.0
tabulated,1,0.0
Disturbances,1,0.0
existential,1,0.0
pregabalin,1,0.0
generalizability,1,0.0
Electromagnetic,1,0.0
1979-1981,1,0.0
multi-frequency,1,0.0
non-radiative,1,0.0
bio-impedance,1,0.0
mentions,1,0.0
ceasing,1,0.0
1-30,1,0.0
spoke,1,0.0
inter-hospital,1,0.0
mirrors,1,0.0
metaplasia,1,0.0
ABangkok179,1,0.0
Remodelling,1,0.0
NSE,1,0.0
Elucidation,1,0.0
ppm,1,0.0
enolase,1,0.0
mgL,1,0.0
neuron-specific,1,0.0
gradiometer,1,0.0
coils,1,0.0
door-to-reperfusion,1,0.0
adjustable,1,0.0
end-of-life,1,0.0
frontoparietal,1,0.0
mesencephalon,1,0.0
futile,1,0.0
anticipatory,1,0.0
five-years,1,0.0
baseline-free,1,0.0
noisy,1,0.0
hemiplegic,1,0.0
sudomotor,1,0.0
skull,1,0.0
SBL,1,0.0
MMV,1,0.0
Bladder,1,0.0
impotence,1,0.0
Vector,1,0.0
Start,1,0.0
Frequency-Constrained,1,0.0
hyperfunction,1,0.0
reoperations,1,0.0
cine-NMR,1,0.0
Tucson,1,0.0
undertakes,1,0.0
N66,1,0.0
non-RCT,1,0.0
N65,1,0.0
744,1,0.0
duplicates,1,0.0
99-166,1,0.0
N197,1,0.0
contagions,1,0.0
EBM,1,0.0
precedent,1,0.0
pubertal,1,0.0
3136,1,0.0
CBF-blood,1,0.0
Post-infarction,1,0.0
abolition,1,0.0
PTSD,1,0.0
EPR,1,0.0
Qinggan,1,0.0
ce,1,0.0
Jinhua,1,0.0
Harvard,1,0.0
N9,1,0.0
mind-body,1,0.0
homeokinetic,1,0.0
lymphotoxin-alpha,1,0.0
physician-confirmed,1,0.0
co-ordinated,1,0.0
Pollution,1,0.0
SAPALDIA,1,0.0
11136,1,0.0
nonparametric,1,0.0
252AG,1,0.0
1970-1989,1,0.0
guanine,1,0.0
6-12,1,0.0
afternoon,1,0.0
Precipitating,1,0.0
upset,1,0.0
polypill,1,0.0
4203,1,0.0
excuse,1,0.0
POD,1,0.0
Europe-wide,1,0.0
Yinqiao,1,0.0
revisions,1,0.0
decoction,1,0.0
possibleThere,1,0.0
avascular,1,0.0
decidual,1,0.0
Build,1,0.0
benzene,1,0.0
Besat,1,0.0
thromboinflammation-mediated,1,0.0
neonateThe,1,0.0
immunodefensive,1,0.0
womenIn,1,0.0
segmentectomy,1,0.0
decortication,1,0.0
syndrome-coronavirus‑2,1,0.0
Fourty,1,0.0
alkalization,1,0.0
Carbon,1,0.0
2489,1,0.0
Switching,1,0.0
postcardiotomy-syndrome,1,0.0
lighted,1,0.0
villi,1,0.0
Hydrocarbon,1,0.0
fast-tracked,1,0.0
primary-care,1,0.0
ischaemi,1,0.0
Shigan,1,0.0
Maxing,1,0.0
ECST,1,0.0
Endarterectomy,1,0.0
Qingwen,1,0.0
Lianhua,1,0.0
Jiedu,1,0.0
NASCET,1,0.0
Shufeng,1,0.0
pan-European,1,0.0
appropriated,1,0.0
budgets,1,0.0
30-69,1,0.0
H7N9--has,1,0.0
influenza--H5N1,1,0.0
ACAS,1,0.0
thrombovasculitis,1,0.0
18500,1,0.0
AAichi268,1,0.0
subsidies,1,0.0
€6956559,1,0.0
inflammation-associated,1,0.0
video-EEG,1,0.0
2633,1,0.0
11120microl,1,0.0
PEG-based,1,0.0
mlmin173,1,0.0
m2,1,0.0
must-have,1,0.0
Cats,1,0.0
virus-,1,0.0
disruptions,1,0.0
airway-invasive,1,0.0
SARS-coronavirus-2,1,0.0
Pathologists,1,0.0
briefing,1,0.0
metaanalysis,1,0.0
mega,1,0.0
verifying,1,0.0
prescriber,1,0.0
intrasubtypic,1,0.0
clinicopathological,1,0.0
angio-invasive,1,0.0
electrostatically,1,0.0
ultrafiltration,1,0.0
well-proven,1,0.0
Analogous,1,0.0
outsized,1,0.0
entirety,1,0.0
renal-related,1,0.0
cardiac-,1,0.0
monotonically,1,0.0
neurological-,1,0.0
Modulating,1,0.0
1100000,1,0.0
39000000,1,0.0
conservatively--560,1,0.0
Seroepidemiological,1,0.0
host-host,1,0.0
Eight-year,1,0.0
life-interfering,1,0.0
perceptibly,1,0.0
ill-suboptimal,1,0.0
Nitric,1,0.0
antiepileptics,1,0.0
non-availability,1,0.0
K-8,1,0.0
K-5,1,0.0
Ventilatory,1,0.0
dispositions,1,0.0
Cesarean,1,0.0
Seventy-six,1,0.0
UAI,1,0.0
hypothetically,1,0.0
pension,1,0.0
Constitution,1,0.0
61-year-old,1,0.0
RASis,1,0.0
contrasting,1,0.0
emergences,1,0.0
Wallenberg,1,0.0
2019-2021,1,0.0
Separated,1,0.0
tingling,1,0.0
shooting,1,0.0
pre-visit,1,0.0
gabapentin,1,0.0
OHNS,1,0.0
Gulf,1,0.0
exercise-running,1,0.0
underusage,1,0.0
swimming-was,1,0.0
2000106S144-52,1,0.0
Radiologic,1,0.0
nebulised,1,0.0
False-positive,1,0.0
certifications,1,0.0
1994-95,1,0.0
1995-96,1,0.0
CFIp,1,0.0
Clinicaltrialsgov,1,0.0
nosocominal,1,0.0
pressure-derived,1,0.0
underpinned,1,0.0
Veracruz,1,0.0
interview-based,1,0.0
child-parent,1,0.0
differIn,1,0.0
equate,1,0.0
Biotelemetric,1,0.0
Habana,1,0.0
player,1,0.0
hydroxychloroquine-a,1,0.0
high-hit,1,0.0
unsolved,1,0.0
minerals,1,0.0
exposome,1,0.0
halting,1,0.0
11-year-old,1,0.0
IVs,1,0.0
Vasoactive,1,0.0
unobserved,1,0.0
DP2kpHO1,1,0.0
HIF-1α-negative,1,0.0
exposure-disease,1,0.0
beginning-were,1,0.0
HIF-1α-positive,1,0.0
factor-1α,1,0.0
hypoxia-inducible,1,0.0
dew,1,0.0
city-specific,1,0.0
2000-2005,1,0.0
-0027,1,0.0
HO1,1,0.0
-00032,1,0.0
5301,1,0.0
hens,1,0.0
ELISA-positive,1,0.0
Ukraine,1,0.0
specialties,1,0.0
scientometric,1,0.0
Sulfonylureas,1,0.0
€13024,1,0.0
Unobserved,1,0.0
€557549,1,0.0
€1044,1,0.0
sulfonylureas,1,0.0
sulfonylurea,1,0.0
Methodology,1,0.0
GISRS,1,0.0
automotive,1,0.0
toe,1,0.0
delicate,1,0.0
hemostimulating,1,0.0
endowed,1,0.0
9266,1,0.0
Used,1,0.0
embryonated,1,0.0
Lipofectamine,1,0.0
polyethylenimine-25k,1,0.0
H1-H15,1,0.0
1875,1,0.0
mid-2005,1,0.0
pharmacology-based,1,0.0
sham-stimulation,1,0.0
concealed,1,0.0
EEG-spectra,1,0.0
concluding,1,0.0
2002-2004,1,0.0
vision-related,1,0.0
disease-associated,1,0.0
hemianopic,1,0.0
REVIS,1,0.0
tDCS,1,0.0
rtACS,1,0.0
transorbital,1,0.0
constellation,1,0.0
30-45,1,0.0
Structured,1,0.0
Occipital,1,0.0
Formulating,1,0.0
toxicmetabolic,1,0.0
Interventional,1,0.0
box-1,1,0.0
diagnostic-therapy-organizational,1,0.0
cleave,1,0.0
RAGE-binding,1,0.0
hemagglutination-inhibition,1,0.0
over-expressed,1,0.0
polyethylenimine-2k,1,0.0
re-assorted,1,0.0
lose,1,0.0
deoxycholate-conjugated,1,0.0
1142,1,0.0
caspica,1,0.0
oxygenase-1,1,0.0
anti-RAGE,1,0.0
Hutterite,1,0.0
self-assembled,1,0.0
personalizing,1,0.0
Adrenergic,1,0.0
Phoca,1,0.0
kindred,1,0.0
condensed,1,0.0
afflicts,1,0.0
concentrates,1,0.0
schematic,1,0.0
chronopharmacology,1,0.0
sustained-action,1,0.0
A895V,1,0.0
CUS3,1,0.0
high-potency,1,0.0
corticosteroid-induced,1,0.0
meal,1,0.0
Uniphyl,1,0.0
Controlled-release,1,0.0
250↔640,1,0.0
197000,1,0.0
Paroxysmal,1,0.0
Appreciation,1,0.0
predilection,1,0.0
Requirement,1,0.0
AHong-KongI68,1,0.0
unload,1,0.0
23--24,1,0.0
ammounted,1,0.0
1971--1972,1,0.0
AHong-Kong,1,0.0
inhospital,1,0.0
A41V,1,0.0
sinusoid-left,1,0.0
sinusoid,1,0.0
synchrony,1,0.0
interhemisphere,1,0.0
HADS-D,1,0.0
Behaviorally,1,0.0
nonmodifiable,1,0.0
imaging-fluid-attenuated,1,0.0
1034,1,0.0
glues,1,0.0
380↔2812,1,0.0
eculizumab,1,0.0
Aggregation,1,0.0
Immunoglobulin,1,0.0
Autoantibodies,1,0.0
Aspiration,1,0.0
Laryngeal,1,0.0
gapless,1,0.0
sinusoid-coronary,1,0.0
protein-disrupting,1,0.0
S813I,1,0.0
hemostatic,1,0.0
scaffolds,1,0.0
drills,1,0.0
eyewear,1,0.0
18-50,1,0.0
drug-caused,1,0.0
123-57,1,0.0
215-138,1,0.0
quickest,1,0.0
IJME,1,0.0
patencyABSTRACT,1,0.0
infarct-free,1,0.0
nonsurgical,1,0.0
Ninety-four,1,0.0
non-industrial,1,0.0
millionyear,1,0.0
134-46,1,0.0
‒,1,0.0
receives,1,0.0
Hua,1,0.0
myelitis,1,0.0
shieldsvisors,1,0.0
Zhong,1,0.0
transverse,1,0.0
n25,1,0.0
subanalyses,1,0.0
n12,1,0.0
mid-expiratory,1,0.0
undeveloped,1,0.0
Mid-April,1,0.0
Concomitant,1,0.0
Faced,1,0.0
complications--most,1,0.0
tyre,1,0.0
dwindling,1,0.0
thombolytic,1,0.0
Nonregular,1,0.0
triaged,1,0.0
Colophony,1,0.0
inappropriately,1,0.0
osteocyte-derived,1,0.0
Misidentification,1,0.0
conveyance,1,0.0
Introductionbackground,1,0.0
pulsatile,1,0.0
Hanoi,1,0.0
Iowa,1,0.0
Aging,1,0.0
reacts,1,0.0
HADS-A,1,0.0
amylnitrate,1,0.0
nonbiomedical,1,0.0
packages,1,0.0
botanical,1,0.0
approvalimplementation,1,0.0
exclusions,1,0.0
unforeseeable,1,0.0
Judging,1,0.0
AN,1,0.0
wax,1,0.0
LVET,1,0.0
Sinovac,1,0.0
Nucleic,1,0.0
real‐time,1,0.0
PEP,1,0.0
preejection,1,0.0
oropharyngealnasal,1,0.0
false‐negative,1,0.0
reexamined,1,0.0
unsatisfied,1,0.0
increasement,1,0.0
dreaded,1,0.0
nonhypotensive,1,0.0
Baye,1,0.0
non-asthmatics,1,0.0
642,1,0.0
2014-April,1,0.0
CSCs,1,0.0
3-17,1,0.0
redirection,1,0.0
Pima,1,0.0
≥10,1,0.0
Sustainable,1,0.0
execute,1,0.0
3419,1,0.0
Manufacturers,1,0.0
IFPMA,1,0.0
Supply,1,0.0
NAATs,1,0.0
Task,1,0.0
Middle-east,1,0.0
Card,1,0.0
Bogota,1,0.0
volume1,1,0.0
Edition,1,0.0
in-utero,1,0.0
high-consequence,1,0.0
9691-,1,0.0
peak-GOT,1,0.0
15T,1,0.0
peak-LDH,1,0.0
-0655,1,0.0
-0713,1,0.0
INF,1,0.0
225-281,1,0.0
Stata,1,0.0
Wallis,1,0.0
Kruskall,1,0.0
STAY,1,0.0
Dia-Pro,1,0.0
ACE2-RBD,1,0.0
771,1,0.0
Centaur®,1,0.0
ADVIA,1,0.0
COV2T®,1,0.0
134±08,1,0.0
1053,1,0.0
peak-CPK,1,0.0
9893,1,0.0
1992-1993,1,0.0
0012,1,0.0
teen-caregiver,1,0.0
in-vitroin-vivo,1,0.0
gene-editing-based,1,0.0
cell-,1,0.0
Inadequacies,1,0.0
unrecognised,1,0.0
patientsOur,1,0.0
mildpersistent,1,0.0
evaluatedNineteen,1,0.0
Mofid,1,0.0
aspergillosisNinety-six,1,0.0
ARTerial,1,0.0
symptom-days,1,0.0
sealing,1,0.0
disease-Magnetic,1,0.0
SMART-MR,1,0.0
Show,1,0.0
0783,1,0.0
ELISA-based,1,0.0
Technology,1,0.0
procalcitonin,1,0.0
carryover,1,0.0
Fr,1,0.0
FOXP2,1,0.0
HLA-B,1,0.0
HLA-DQB2,1,0.0
pressuregeomagnetic,1,0.0
excessing,1,0.0
impactful,1,0.0
Thrombotic,1,0.0
Anadyr,1,0.0
Tynda,1,0.0
RESCUE,1,0.0
（CCS）,1,0.0
Stroke-case,1,0.0
crystals,1,0.0
mycoplasma,1,0.0
Anadyr--348,1,0.0
Tynda--329,1,0.0
HIV-related,1,0.0
Krasnoyarsk--325,1,0.0
1987-1988,1,0.0
west,1,0.0
PPA,1,0.0
pharmaceutics,1,0.0
polycomb-group,1,0.0
hypo-methylated,1,0.0
infarction）,1,0.0
impeded,1,0.0
（including,1,0.0
pharmaceuticals,1,0.0
awake-onset,1,0.0
radiologically,1,0.0
50-74,1,0.0
Strengths,1,0.0
tabletop,1,0.0
immune-relevant,1,0.0
per-site,1,0.0
（SCD）,1,0.0
cis-acting,1,0.0
preclinically,1,0.0
trans-acting,1,0.0
machineries,1,0.0
Host-based,1,0.0
host-based,1,0.0
coordinately,1,0.0
King,1,0.0
Chulalongkorn,1,0.0
Age-standardized,1,0.0
cards,1,0.0
MiRs,1,0.0
DHR,1,0.0
maximization,1,0.0
7143,1,0.0
Studied,1,0.0
x-ray,1,0.0
Postdischarge,1,0.0
worst-case,1,0.0
1671,1,0.0
2643,1,0.0
bronchopneumonia,1,0.0
susceptible-exposed-infectious-recovered,1,0.0
Ag-RDT,1,0.0
haemagglutination-inhibiting,1,0.0
Decades,1,0.0
Metis,1,0.0
-72,1,0.0
-27,1,0.0
rectify,1,0.0
stochasticity,1,0.0
accommodations,1,0.0
espoused,1,0.0
SQ,1,0.0
Bangkok,1,0.0
6952,1,0.0
05-10,1,0.0
MONICA,1,0.0
haematology-oncology,1,0.0
2945,1,0.0
Covid-19-related,1,0.0
4286,1,0.0
quantiles,1,0.0
186-485,1,0.0
cellsmL,1,0.0
8159,1,0.0
statewide,1,0.0
Virologically,1,0.0
quantile,1,0.0
607,1,0.0
PC35Gaw,1,0.0
Alutard,1,0.0
infectives,1,0.0
drug-testing,1,0.0
CCS,1,0.0
aroused,1,0.0
virus-infested,1,0.0
sideways,1,0.0
vaccinators,1,0.0
situate,1,0.0
politics,1,0.0
marginality,1,0.0
evidence-to-practice,1,0.0
unfavorably,1,0.0
Physiological,1,0.0
Tetrahydrofolate,1,0.0
Reductase,1,0.0
Pharmacogenetics,1,0.0
catalyzes,1,0.0
tetrahydrofolate,1,0.0
concertation,1,0.0
abnormally,1,0.0
methylte,1,0.0
trahydrofolate,1,0.0
677th,1,0.0
technietium,1,0.0
MTHFR677TT,1,0.0
redress,1,0.0
historiography,1,0.0
framing,1,0.0
Rosenbergs,1,0.0
cocirculated,1,0.0
thereof,1,0.0
TIVs,1,0.0
comparability,1,0.0
weak-spot,1,0.0
B-lineage,1,0.0
cross-cutting,1,0.0
population-specific,1,0.0
RPE,1,0.0
Sanger,1,0.0
stretch,1,0.0
Ns,1,0.0
Effects,1,0.0
35–59,1,0.0
2–7,1,0.0
1–3,1,0.0
assigns,1,0.0
Protecting,1,0.0
1-week,1,0.0
down-regulated,1,0.0
Haptoglobin,1,0.0
Impaired,1,0.0
Auricle,1,0.0
polygraphic,1,0.0
auricle,1,0.0
KEGG,1,0.0
disconnection,1,0.0
PPIs,1,0.0
callosal,1,0.0
C677T,1,0.0
MAGPIX,1,0.0
high-incidence,1,0.0
n28,1,0.0
331125,1,0.0
2000-years,1,0.0
colourful,1,0.0
n60,1,0.0
Friendship,1,0.0
China-Japan,1,0.0
characters,1,0.0
inter-individual,1,0.0
commissural,1,0.0
n1,1,0.0
n3,1,0.0
Endothelial,1,0.0
diffuselarge,1,0.0
HPT,1,0.0
malnourishment,1,0.0
Classically,1,0.0
Transferrin,1,0.0
TRFE,1,0.0
Factoring,1,0.0
0368,1,0.0
DCW,1,0.0
0680,1,0.0
glycosides,1,0.0
0155,1,0.0
035x1000mL,1,0.0
Kyoto,1,0.0
Encyclopedia,1,0.0
anticipatory-guidance,1,0.0
Genomes,1,0.0
Sapienza,1,0.0
Umberto,1,0.0
Policlinico,1,0.0
926,1,0.0
786,1,0.0
Manifestations,1,0.0
pneumothoraces,1,0.0
scorings,1,0.0
RsSHC014,1,0.0
unchangeduncertain,1,0.0
incontrovertibly,1,0.0
brackets,1,0.0
UI,1,0.0
SPECT-detected,1,0.0
anteroposterior,1,0.0
sub-grouped,1,0.0
0728,1,0.0
warns,1,0.0
posteroanterior,1,0.0
-138,1,0.0
preliminarily,1,0.0
gauged,1,0.0
Foreign,1,0.0
9-year,1,0.0
gone,1,0.0
2849,1,0.0
Prefectures,1,0.0
741808,1,0.0
settling,1,0.0
non-statistically,1,0.0
targetsdrugs,1,0.0
35825,1,0.0
lubuskie,1,0.0
14348,1,0.0
Haddon,1,0.0
15431,1,0.0
mazowieckie,1,0.0
circular,1,0.0
16904,1,0.0
swietokrzyskie,1,0.0
non-contrast,1,0.0
T-tests,1,0.0
Hounsfield,1,0.0
756,1,0.0
Regionally,1,0.0
515,1,0.0
HCoV-specific,1,0.0
vigorously,1,0.0
6604,1,0.0
251815,1,0.0
Hyogo,1,0.0
thrombophilic,1,0.0
114-189,1,0.0
Sarbecovirus,1,0.0
Backgroundaim,1,0.0
mutifactorial,1,0.0
endoscopically,1,0.0
Maximum,1,0.0
total-Ig,1,0.0
p0028,1,0.0
B-cell-,1,0.0
co-operate,1,0.0
T-cell-stimulating,1,0.0
sphenoid,1,0.0
783,1,0.0
non-modifiable,1,0.0
multi-ethnic,1,0.0
non-city,1,0.0
676were,1,0.0
Micro-neutralisation,1,0.0
insulting,1,0.0
Off,1,0.0
herniating,1,0.0
restart,1,0.0
7-14,1,0.0
droop,1,0.0
48-72,1,0.0
donating,1,0.0
semipermeable,1,0.0
pill,1,0.0
Forced,1,0.0
Raynauds,1,0.0
chimeric,1,0.0
prolapse,1,0.0
mcg,1,0.0
MDI,1,0.0
537,1,0.0
uric,1,0.0
Segmental,1,0.0
905,1,0.0
pejorative,1,0.0
extra-hospital,1,0.0
justifies,1,0.0
subgenus,1,0.0
ovreview,1,0.0
knowlegde,1,0.0
Barnett,1,0.0
register-based,1,0.0
points-of-entry,1,0.0
non-invasiveness,1,0.0
grappling,1,0.0
geneticist,1,0.0
mi-AGTP,1,0.0
AdiFLAP,1,0.0
NCT01473433,1,0.0
Low-cost,1,0.0
S-groups,1,0.0
Thousands,1,0.0
Atmospheric,1,0.0
immuno-unbalance,1,0.0
lódzkie,1,0.0
transcription-Polymerase,1,0.0
nephrology,1,0.0
care--the,1,0.0
proficiency,1,0.0
co-factor,1,0.0
objectified,1,0.0
Goals,1,0.0
Spermatozoa,1,0.0
prooxidative,1,0.0
targetted,1,0.0
ScienceDirect,1,0.0
marks,1,0.0
100-year,1,0.0
rampaging,1,0.0
larger-scale,1,0.0
twenty-six,1,0.0
county-level,1,0.0
RealOpt-based,1,0.0
parameterizing,1,0.0
50000,1,0.0
cookers,1,0.0
asthma-variable,1,0.0
countys,1,0.0
obstruction-is,1,0.0
parameterize,1,0.0
withstands,1,0.0
Ambulatory,1,0.0
anthrax,1,0.0
RealOpt-POD-v802,1,0.0
Radiography,1,0.0
reconciliation,1,0.0
anniversary,1,0.0
Essentials,1,0.0
Electrochemical,1,0.0
learner,1,0.0
10-,1,0.0
≥100,1,0.0
≥4,1,0.0
animal-derived,1,0.0
phosphate-buffered,1,0.0
HRRs,1,0.0
poliomyelitis-like,1,0.0
121-332,1,0.0
132-409,1,0.0
infectionABSTRACT,1,0.0
alcoholism,1,0.0
assuring,1,0.0
miniaturization,1,0.0
much-needed,1,0.0
follow-upIn,1,0.0
nonpandemic,1,0.0
perpetual,1,0.0
breaking,1,0.0
imprecision,1,0.0
prematurely,1,0.0
9-year-olds,1,0.0
17-year-olds,1,0.0
polluted,1,0.0
≥11,1,0.0
foster,1,0.0
fg⋅mL-1,1,0.0
CLEIA,1,0.0
predictorThe,1,0.0
nasopharyngealoropharyngeal,1,0.0
reinforcing,1,0.0
SARS-like,1,0.0
forty-one,1,0.0
spikes,1,0.0
objectivized,1,0.0
Qigong,1,0.0
42-58,1,0.0
multiplexed-chimeric,1,0.0
80-99,1,0.0
92-100,1,0.0
18-35,1,0.0
Austrian,1,0.0
deathAnxiety,1,0.0
graders,1,0.0
pre-designed,1,0.0
Technologies,1,0.0
25-50,1,0.0
discounting,1,0.0
land-based,1,0.0
-B,1,0.0
HLA-A,1,0.0
Formula,1,0.0
HLA-identical,1,0.0
Contextual,1,0.0
spill-over,1,0.0
virus-immune,1,0.0
Registry-based,1,0.0
time-period,1,0.0
cross-linking,1,0.0
encapsulate,1,0.0
multi-symptomatic,1,0.0
CEC,1,0.0
overdiagnosing,1,0.0
under-,1,0.0
NHIRD,1,0.0
5414,1,0.0
nonatrial,1,0.0
scholarly,1,0.0
Newborns,1,0.0
Alaskan,1,0.0
tour,1,0.0
iGLS,1,0.0
pepsin-insoluble,1,0.0
hydroxyproline,1,0.0
waveform,1,0.0
anywhere,1,0.0
brand,1,0.0
Galicia,1,0.0
covalently,1,0.0
peptidomimetic,1,0.0
Least,1,0.0
Squares,1,0.0
Yichang,1,0.0
informants,1,0.0
estimators,1,0.0
arrythmias,1,0.0
up-titration,1,0.0
axis-45,1,0.0
Zealand-Sydney,1,0.0
Sydney-New,1,0.0
estimator,1,0.0
0978,1,0.0
0520,1,0.0
ice-hockey,1,0.0
cheat,1,0.0
iPred,1,0.0
case-mix,1,0.0
shortlist,1,0.0
IFN-λ,1,0.0
citys,1,0.0
Audits,1,0.0
Neurodegenerative,1,0.0
Bogotás,1,0.0
second-largest,1,0.0
LVOs,1,0.0
A549-IFN-λ3,1,0.0
P00028,1,0.0
fragility,1,0.0
ETIS,1,0.0
1003,1,0.0
Post-hoc,1,0.0
dander,1,0.0
IFN-λ3-treated,1,0.0
IFN-stimulated,1,0.0
divert,1,0.0
TCR,1,0.0
small-airway,1,0.0
measles-mumps-rubella,1,0.0
oversimplification,1,0.0
18-February-2020,1,0.0
lmin,1,0.0
72000,1,0.0
curated,1,0.0
NetMHCpan,1,0.0
Athletes,1,0.0
HRCs,1,0.0
randomisation,1,0.0
Trial-Italy,1,0.0
Multicentre,1,0.0
cost-containment,1,0.0
Epitope,1,0.0
MMR-vaccinated,1,0.0
871234,1,0.0
contra,1,0.0
9-mer,1,0.0
political-institutional,1,0.0
Receptor,1,0.0
noncollagenouscollagenous,1,0.0
noncollagenous,1,0.0
1992-93,1,0.0
NICUs,1,0.0
3183,1,0.0
Connecticut,1,0.0
Vocal,1,0.0
extremes,1,0.0
305-310,1,0.0
barotrauma,1,0.0
scuba,1,0.0
Chin,1,0.0
diving,1,0.0
eye-nose,1,0.0
intervensions,1,0.0
coronavirus2019-nCoV,1,0.0
ExT,1,0.0
Unrecognized,1,0.0
coryzal,1,0.0
AEM,1,0.0
single-pill,1,0.0
alpha2-adrenergic,1,0.0
firm,1,0.0
SMILE,1,0.0
Diagnosing,1,0.0
beside,1,0.0
Cretan,1,0.0
β-chain,1,0.0
Bioanalytical,1,0.0
conquer,1,0.0
encephalocele,1,0.0
12-14,1,0.0
intend,1,0.0
unblocking,1,0.0
14th,1,0.0
Beta-2-transferrin,1,0.0
5763,1,0.0
1143,1,0.0
1490,1,0.0
5868,1,0.0
dice,1,0.0
1481,1,0.0
Augmenting,1,0.0
Biosensors,1,0.0
Surface,1,0.0
variant-dominant,1,0.0
SPR,1,0.0
zofenopril,1,0.0
acetylsalicylic,1,0.0
glycaemic,1,0.0
centurys,1,0.0
re-presented,1,0.0
C-6,1,0.0
in-flight,1,0.0
D-5,1,0.0
lung-function,1,0.0
pig-to-pig,1,0.0
SwONT97,1,0.0
piglet,1,0.0
perimetric,1,0.0
Arteriosclerosis,1,0.0
350-500000,1,0.0
re-established,1,0.0
end-to-end,1,0.0
gainfully,1,0.0
abciximab,1,0.0
stasus,1,0.0
universe,1,0.0
OLSA,1,0.0
1991-1996,1,0.0
nostril,1,0.0
milestone,1,0.0
daunting,1,0.0
unification,1,0.0
Prinzmetals,1,0.0
subspecialty,1,0.0
Conditions,1,0.0
perindopril-based,1,0.0
GP-based,1,0.0
whole-virion,1,0.0
WV,1,0.0
Against,1,0.0
suspensions,1,0.0
conversions,1,0.0
83-90,1,0.0
Perindopril,1,0.0
non-diseased,1,0.0
14090,1,0.0
modernization,1,0.0
impetus,1,0.0
Cross-detection,1,0.0
A-5,1,0.0
B-6,1,0.0
chest-first,1,0.0
tentative,1,0.0
earthing,1,0.0
147-187,1,0.0
infinite,1,0.0
129-161,1,0.0
small-world,1,0.0
scale-free,1,0.0
non-existent,1,0.0
MicroRNA,1,0.0
97-105,1,0.0
signals--red,1,0.0
Teresina,1,0.0
49-77,1,0.0
things,1,0.0
twitchy,1,0.0
hyperreactive,1,0.0
aggravators,1,0.0
Consequentially,1,0.0
eradication,1,0.0
hubs,1,0.0
stomach,1,0.0
114-134,1,0.0
142-177,1,0.0
hernia,1,0.0
L-CDH,1,0.0
liver-to-thoracic,1,0.0
LiTR,1,0.0
X-linked,1,0.0
lysosomal,1,0.0
alpha-galactosidase,1,0.0
theophylline-sensitive,1,0.0
E-POL,1,0.0
Stage-by-stage,1,0.0
counterbalance,1,0.0
green--pediatricians,1,0.0
82-91,1,0.0
137-160,1,0.0
cavitary,1,0.0
repeatabilty,1,0.0
60-78,1,0.0
Cuiaba,1,0.0
38-59,1,0.0
preemptively,1,0.0
particularities,1,0.0
4053,1,0.0
seat,1,0.0
2295,1,0.0
imitate,1,0.0
2078,1,0.0
caudodorsal,1,0.0
Reversibility,1,0.0
3120,1,0.0
dosimeter,1,0.0
commence,1,0.0
within-subject,1,0.0
Bland,1,0.0
Altman,1,0.0
175-223,1,0.0
hyperrepsonsiveness,1,0.0
Problems,1,0.0
Alegre,1,0.0
Genevas,1,0.0
enhancement-magnetic,1,0.0
normalised,1,0.0
Kids,1,0.0
Los,1,0.0
Angeles,1,0.0
UCLA,1,0.0
127-142,1,0.0
births,1,0.0
non-optimal,1,0.0
co-expression,1,0.0
stroke23,1,0.0
bail-out,1,0.0
punctures,1,0.0
likely--scenario,1,0.0
caveat,1,0.0
intima,1,0.0
consenting,1,0.0
adduce,1,0.0
Transcriptomic,1,0.0
clinicolaboratory,1,0.0
transcutaneous,1,0.0
Radial,1,0.0
patients1,1,0.0
SIR,1,0.0
Healthcare-acquired,1,0.0
republished,1,0.0
Sekhar,1,0.0
LN,1,0.0
Iwai,1,0.0
Bloom,1,0.0
the--very,1,0.0
Vein,1,0.0
Antibacterial,1,0.0
embolectomy,1,0.0
1993334723-727,1,0.0
Surgeons,1,0.0
2009-like,1,0.0
1918-like,1,0.0
Griffin,1,0.0
Looby,1,0.0
2019117647-652,1,0.0
©The,1,0.0
RNA-mediated,1,0.0
suppressor,1,0.0
reoriented,1,0.0
whistling,1,0.0
macro-regions,1,0.0
pneumotachometry,1,0.0
self-filled,1,0.0
Dynamics,1,0.0
bubbling,1,0.0
prevalences,1,0.0
Auscultation,1,0.0
labyrinthine,1,0.0
subfebrile,1,0.0
74589,1,0.0
thigh-focused,1,0.0
unproductive,1,0.0
121-139,1,0.0
Peripartum,1,0.0
representativeness,1,0.0
flowmetric,1,0.0
MEFR25,1,0.0
MEFR50--p,1,0.0
MEFR75--p,1,0.0
4421,1,0.0
slum,1,0.0
dwellers,1,0.0
Risks,1,0.0
gaze-holding,1,0.0
Ψ,1,0.0
skew,1,0.0
mass-vaccination,1,0.0
e1e2,1,0.0
central-type,1,0.0
throughly,1,0.0
neuro-otologists,1,0.0
0038,1,0.0
α-smooth,1,0.0
stained,1,0.0
floral,1,0.0
alpha-amylase,1,0.0
Alpha-amylase,1,0.0
orizae,1,0.0
cutoffs,1,0.0
ρ,1,0.0
Plant,1,0.0
Ficus,1,0.0
atopics,1,0.0
к,1,0.0
Ginseng,1,0.0
Gypsophila,1,0.0
immuno,1,0.0
discarding,1,0.0
More-severe,1,0.0
sesame,1,0.0
flours,1,0.0
cereal,1,0.0
wheat,1,0.0
pyrosequencing,1,0.0
Bakers,1,0.0
manufactures,1,0.0
carpet-making,1,0.0
gums,1,0.0
Friuli,1,0.0
Venezia,1,0.0
Giulia,1,0.0
vegetal,1,0.0
IgE-dependent,1,0.0
unanimous,1,0.0
preferring,1,0.0
coumadin,1,0.0
GenScript,1,0.0
H7N9A,1,0.0
histomorphometry,1,0.0
Niigata,1,0.0
Records,1,0.0
3032,1,0.0
r-020,1,0.0
MIDUS,1,0.0
Midlife,1,0.0
institutionalized,1,0.0
long-term-care,1,0.0
synchronously,1,0.0
p02,1,0.0
scavenging,1,0.0
t12-10-9s,1,0.0
ROS,1,0.0
PD20FEV1,1,0.0
•OH,1,0.0
climbing,1,0.0
stairs,1,0.0
NIHWHO,1,0.0
gamut,1,0.0
1987-97,1,0.0
compensating,1,0.0
immunotherapeutic,1,0.0
china,1,0.0
Hip,1,0.0
patientes,1,0.0
Tracheal,1,0.0
relational,1,0.0
narcosis,1,0.0
near-complete,1,0.0
postintubation,1,0.0
cocirculation,1,0.0
respirator,1,0.0
customisation,1,0.0
noninferiority,1,0.0
mLmin,1,0.0
tallies,1,0.0
Seventy-nine,1,0.0
uremic,1,0.0
hyperparathyroidism,1,0.0
disables,1,0.0
depletes,1,0.0
013,1,0.0
amplifies,1,0.0
conceptualisation,1,0.0
5331,1,0.0
swayed,1,0.0
523194,1,0.0
116771,1,0.0
outright,1,0.0
refuses,1,0.0
99mTc-diphosphonate,1,0.0
biometeorological,1,0.0
involved-is,1,0.0
reanalyzed,1,0.0
NINDS,1,0.0
unclassifiable,1,0.0
designation,1,0.0
investigator-determined,1,0.0
general-embolism,1,0.0
that-for,1,0.0
venopathy,1,0.0
normoglycemia,1,0.0
463,1,0.0
Junipers,1,0.0
cor,1,0.0
pulmonale,1,0.0
rodent,1,0.0
25-hydroxyvitamin,1,0.0
tumultuous,1,0.0
partisan,1,0.0
Geographical,1,0.0
BACKGROUND-,1,0.0
RESULTS-,1,0.0
1028,1,0.0
GWTG-Stroke,1,0.0
stressorssocial,1,0.0
culturallylinguistically,1,0.0
Facilitators,1,0.0
≈5,1,0.0
narratively,1,0.0
synthesise,1,0.0
defensiveness,1,0.0
CONCLUSIONS-,1,0.0
first-grade,1,0.0
Anchorage,1,0.0
GIS,1,0.0
trusted,1,0.0
streets,1,0.0
123651,1,0.0
0056,1,0.0
1374,1,0.0
P-value,1,0.0
exposure-effect,1,0.0
00097,1,0.0
scare,1,0.0
milestones,1,0.0
persuade,1,0.0
SARS-CoV-2COVID-19,1,0.0
Concurrently,1,0.0
unwilling,1,0.0
time-frame,1,0.0
Sarah,1,0.0
gender-neutral,1,0.0
Power,1,0.0
806,1,0.0
recomLine-RBD,1,0.0
GeneScriptcPassTM,1,0.0
Confirmatory,1,0.0
Optimised,1,0.0
Mikrogen-recomLine-RBD,1,0.0
Neutralisation,1,0.0
complementing,1,0.0
998997,1,0.0
Virus-neutralisation,1,0.0
RT-PCR-positivity,1,0.0
3090,1,0.0
-IgG,1,0.0
2-6-a,1,0.0
favoring,1,0.0
Head-to-head,1,0.0
80000,1,0.0
Verona,1,0.0
1515,1,0.0
autumn-winter,1,0.0
1983--first,1,0.0
commissioned,1,0.0
3-7-year-old,1,0.0
colloquially,1,0.0
SE-AZh,1,0.0
short-time,1,0.0
Numerical,1,0.0
SAITR,1,0.0
Recovered,1,0.0
Susceptible,1,0.0
1981-1984,1,0.0
20082009,1,0.0
Illustrative,1,0.0
855886,1,0.0
synergize,1,0.0
true-negatives,1,0.0
presenter,1,0.0
Euroimmun-Anti-SARS-CoV-2-ELISA-IgAIgG,1,0.0
effect-represented,1,0.0
n5374,1,0.0
connecting,1,0.0
n1091,1,0.0
n193,1,0.0
980978,1,0.0
6658,1,0.0
neededWe,1,0.0
seroassays,1,0.0
segments-as,1,0.0
DUS,1,0.0
doppler,1,0.0
discretion,1,0.0
nominal,1,0.0
Hochberg-Holm,1,0.0
Roche-Elecsys-Anti-SARS-CoV-2,1,0.0
Bonferroni,1,0.0
priori,1,0.0
VIRAMED-SARS-CoV-2-ViraChip,1,0.0
Mikrogen-recomLine-SARS-CoV-2-IgG,1,0.0
Prespecifying,1,0.0
optimised,1,0.0
pre-specification,1,0.0
Euroimmun-anti-S1-IgG,1,0.0
formalizing,1,0.0
772798,1,0.0
SWIFT-PRIME,1,0.0
manufacturersoptimised,1,0.0
ESCAPE,1,0.0
harmless,1,0.0
3-35-fold,1,0.0
20072008,1,0.0
Forensic,1,0.0
fibrin-macrophagic,1,0.0
proteinaceous,1,0.0
Mehedinţi,1,0.0
Severin,1,0.0
Turnu,1,0.0
Drobeta,1,0.0
winterly,1,0.0
laboratory-verified,1,0.0
tiny,1,0.0
conglomerate,1,0.0
Medulla,1,0.0
vertebro-basilar,1,0.0
Medullary,1,0.0
GAPs,1,0.0
520,1,0.0
interalveolar,1,0.0
indwelling,1,0.0
CSR,1,0.0
months-17,1,0.0
bladder,1,0.0
noninstitutionalized,1,0.0
Positioning,1,0.0
HeadPoST,1,0.0
disproportional,1,0.0
random-digit-dialed,1,0.0
NHLBI,1,0.0
Strategic,1,0.0
EIPs,1,0.0
Attacks,1,0.0
36000,1,0.0
NOW,1,0.0
1983-1984,1,0.0
policy-makers,1,0.0
Seventy-seven,1,0.0
2-299,1,0.0
JMEI,1,0.0
49-54,1,0.0
AStockholm182011H3N2,1,0.0
ZA,1,0.0
Bashliaeva,1,0.0
Sumarokov,1,0.0
nonrandomized,1,0.0
disagreeing,1,0.0
decoded,1,0.0
controlsABSTRACT,1,0.0
nonreperfused,1,0.0
Subperiod,1,0.0
433-519,1,0.0
527-608,1,0.0
SDcord,1,0.0
httpwwwwhointinfluenzavaccinesplanen,1,0.0
1-July,1,0.0
-044,1,0.0
-054,1,0.0
Th2-driven,1,0.0
Montana,1,0.0
pro-resolving,1,0.0
fetusesnewborns,1,0.0
re-emerging,1,0.0
Dosage,1,0.0
1500,1,0.0
stroke-injured,1,0.0
Too,1,0.0
ascribable,1,0.0
July-August,1,0.0
thromboembolus,1,0.0
lesionbehavioural,1,0.0
reproduced,1,0.0
zoonoses,1,0.0
Darnell,1,0.0
Rockefeller,1,0.0
copyμl,1,0.0
extractions,1,0.0
reverse-vaccinology,1,0.0
legitimate,1,0.0
Alarms,1,0.0
co-collected,1,0.0
ND,1,0.0
aspecific,1,0.0
275x106,1,0.0
PFUml,1,0.0
1218,1,0.0
OAS,1,0.0
abstinent,1,0.0
Maintaining,1,0.0
non-residents,1,0.0
mineralocorticoid,1,0.0
nullomer,1,0.0
deserve,1,0.0
repairs,1,0.0
tasked,1,0.0
Work-exacerbated,1,0.0
vasointestinal,1,0.0
bombesin,1,0.0
teeth,1,0.0
neurotensin,1,0.0
urgencies,1,0.0
phenylephrine,1,0.0
radioisotopes,1,0.0
prolactin,1,0.0
WMA,1,0.0
00325,1,0.0
ceaseless,1,0.0
©2013,1,0.0
8528,1,0.0
Implementations,1,0.0
populationThe,1,0.0
albuminuria,1,0.0
Publishing,1,0.0
ICD-10-coded,1,0.0
201469652-657,1,0.0
1118,1,0.0
Transcervical,1,0.0
Grandhi,1,0.0
High-sensitivity,1,0.0
Ribo,1,0.0
HsTn,1,0.0
Jadkhav,1,0.0
7909,1,0.0
156803,1,0.0
vaccinationData,1,0.0
anonymized,1,0.0
626,1,0.0
1063,1,0.0
Case-based,1,0.0
patientsICD-10-based,1,0.0
diseasesThe,1,0.0
COVIDCareHome,1,0.0
medicine-led,1,0.0
pods,1,0.0
1109,1,0.0
3724,1,0.0
00041,1,0.0
1060,1,0.0
1005,1,0.0
corticotrophin,1,0.0
nitrate-treated,1,0.0
benefitted,1,0.0
redistribute,1,0.0
lectured,1,0.0
lecture,1,0.0
LASS,1,0.0
Lara,1,0.0
UC,1,0.0
ATAQ,1,0.0
reorganize,1,0.0
vasopressin,1,0.0
contemporarily,1,0.0
intensely,1,0.0
gingivitis,1,0.0
non-statistical,1,0.0
calculus,1,0.0
gingival,1,0.0
Pulmonology,1,0.0
EDs,1,0.0
32867,1,0.0
authored,1,0.0
doi,1,0.0
gynecologic,1,0.0
Becks,1,0.0
Mitford,1,0.0
Barisal,1,0.0
httpsdoiorg101016jscitotenv2020138704,1,0.0
spurious,1,0.0
omission,1,0.0
deflated,1,0.0
centers--one,1,0.0
bronchoconstrictor,1,0.0
ASMs,1,0.0
fine-tuned,1,0.0
3395,1,0.0
Fulton,1,0.0
Fowkes,1,0.0
day，,1,0.0
Final,1,0.0
40-60,1,0.0
Nitrates,1,0.0
space-time，,1,0.0
systemHIS,1,0.0
glucagon,1,0.0
commencement,1,0.0
3A,1,0.0
patients，,1,0.0
volume-outcome,1,0.0
heat，,1,0.0
FRSCV,1,0.0
Ferret,1,0.0
furo,1,0.0
hospitalization，,1,0.0
OpenGrey,1,0.0
stasis，,1,0.0
putorius,1,0.0
mustelids,1,0.0
drugs，,1,0.0
phlegm,1,0.0
refreshing,1,0.0
urgent，,1,0.0
research，,1,0.0
space-time,1,0.0
theory，,1,0.0
patient-syndrome-drug-time-effective,1,0.0
dug,1,0.0
out，,1,0.0
LILACS,1,0.0
Fenton,1,0.0
comprehend,1,0.0
undiscovered,1,0.0
1007,1,0.0
immunotolerance,1,0.0
Interferon-gamma,1,0.0
pathomechanisms,1,0.0
-508,1,0.0
t233,1,0.0
829,1,0.0
0346,1,0.0
august,1,0.0
electro-mechanical,1,0.0
0498,1,0.0
BIPQ,1,0.0
2248,1,0.0
outstanding,1,0.0
conjectural,1,0.0
expedient,1,0.0
IFNγ-based,1,0.0
Elements,1,0.0
CDEs,1,0.0
postinfluenza,1,0.0
reclassification,1,0.0
Standardizing,1,0.0
start-up,1,0.0
well-informed,1,0.0
63012,1,0.0
102679,1,0.0
UMCs,1,0.0
REGARDS,1,0.0
Geographic,1,0.0
4-3,1,0.0
NRMI,1,0.0
4-4,1,0.0
6171,1,0.0
SEREMI,1,0.0
hereafter,1,0.0
Online,1,0.0
accumulative,1,0.0
Granger,1,0.0
purulent,1,0.0
odor,1,0.0
25μm,1,0.0
Almeida,1,0.0
RSNA,1,0.0
Chico,1,0.0
Feature,1,0.0
440,1,0.0
1235,1,0.0
NCT01612312,1,0.0
TATORT,1,0.0
NCT00712101,1,0.0
log-linear,1,0.0
integer-valued,1,0.0
GARCH,1,0.0
autoregressive,1,0.0
heteroscedastic,1,0.0
integer-value,1,0.0
lagged,1,0.0
milk-coffee-like,1,0.0
over-dispersion,1,0.0
25-64,1,0.0
films,1,0.0
Taipei,1,0.0
Globalization,1,0.0
Minimizing,1,0.0
Prediction,1,0.0
WHOannounced,1,0.0
13th,1,0.0
5-3,1,0.0
5-4,1,0.0
3111,1,0.0
Marmosets,1,0.0
PREVESE,1,0.0
N2013,1,0.0
Wellbeing,1,0.0
Families,1,0.0
IPV,1,0.0
Deep,1,0.0
post-translational,1,0.0
Adjusting,1,0.0
PARP1,1,0.0
Poly,1,0.0
00017,1,0.0
Preceding,1,0.0
significant--age,1,0.0
prevous,1,0.0
cohabitating,1,0.0
asparagine-to-glycine,1,0.0
dominates,1,0.0
chemistrybiology,1,0.0
lemniscus,1,0.0
thalamic-pain-like,1,0.0
unpleasant,1,0.0
N20,1,0.0
P15,1,0.0
unilaterally,1,0.0
P1314,1,0.0
intracranially,1,0.0
510,1,0.0
Occurrence,1,0.0
human-like,1,0.0
unadapted,1,0.0
mate,1,0.0
sprayed,1,0.0
leveraged,1,0.0
enforced,1,0.0
Stroke-Thrombolytic,1,0.0
105-167,1,0.0
100-162,1,0.0
Multifactorial,1,0.0
stroke-in,1,0.0
dyslipidaemia-will,1,0.0
coders,1,0.0
410x,1,0.0
Hyperglycaemia,1,0.0
regions-for,1,0.0
surrounds,1,0.0
normoglycaemia,1,0.0
Pepitope-a,1,0.0
hypoglycaemia,1,0.0
angioresonance,1,0.0
Predictive,1,0.0
pulp,1,0.0
Instrument,1,0.0
Stroke-TPI,1,0.0
Parameters,1,0.0
programmed,1,0.0
Programmed,1,0.0
inducibility,1,0.0
step-like,1,0.0
preselection,1,0.0
Estimation,1,0.0
influenza--a,1,0.0
11-year-old-girl,1,0.0
Symptomatology,1,0.0
moldy,1,0.0
excision,1,0.0
AIDA,1,0.0
multicomponent,1,0.0
serum-specific,1,0.0
bodily,1,0.0
enterocolic,1,0.0
sensitizer,1,0.0
necroses,1,0.0
dicumarol,1,0.0
Regression,1,0.0
vitality,1,0.0
Northeastern,1,0.0
remembering,1,0.0
shortens,1,0.0
floor,1,0.0
shoes,1,0.0
60s,1,0.0
import,1,0.0
socks,1,0.0
high-molecular-weight,1,0.0
Ninety-seven,1,0.0
2733,1,0.0
70-year,1,0.0
fear-appeal,1,0.0
orthogonally,1,0.0
Extended,1,0.0
threatlow,1,0.0
Cardio,1,0.0
efficacylow,1,0.0
between-subjects,1,0.0
femoro-femoral,1,0.0
dosages,1,0.0
assignment,1,0.0
Dependent,1,0.0
high-efficacy,1,0.0
response-efficacy,1,0.0
echoes,1,0.0
individualistic,1,0.0
camper,1,0.0
lncRNA-mRNAs,1,0.0
SPRTN,1,0.0
KLHL28,1,0.0
Hamidiye,1,0.0
Etfal,1,0.0
RP11-847H182,1,0.0
Cookie,1,0.0
1816,1,0.0
Apparently,1,0.0
lncRNAmRNA,1,0.0
darkred,1,0.0
Theft,1,0.0
lightgreen,1,0.0
tensor,1,0.0
grey60,1,0.0
EPM2AIP1,1,0.0
Phosphate,1,0.0
dihydrate,1,0.0
tests-BD,1,0.0
Binax,1,0.0
NOW®,1,0.0
Influenza-for,1,0.0
2010-2012,1,0.0
Limits,1,0.0
Organised,1,0.0
incident-definite,1,0.0
Resuscitation,1,0.0
Xa-specific,1,0.0
Sisli,1,0.0
pentasaccharide,1,0.0
antithrombin,1,0.0
bivalirudin,1,0.0
CardioWest,1,0.0
expansive,1,0.0
rheumatism,1,0.0
plowing,1,0.0
Espírito,1,0.0
CAST,1,0.0
Wingspan,1,0.0
neuro-interventionist,1,0.0
inadvertently,1,0.0
diminishes,1,0.0
snow,1,0.0
precerebral,1,0.0
stand,1,0.0
hypo-perfusion,1,0.0
fade,1,0.0
groin,1,0.0
end-anastomosing,1,0.0
calibers,1,0.0
Santo,1,0.0
urbanized,1,0.0
naturally-induced,1,0.0
non-pandemic,1,0.0
isolator,1,0.0
pulsation,1,0.0
postarrival,1,0.0
7173,1,0.0
bacilli,1,0.0
podding,1,0.0
years†,1,0.0
Bacteroides,1,0.0
1955,1,0.0
5218,1,0.0
site-specific,1,0.0
protocol-defined,1,0.0
38059,1,0.0
NAHA,1,0.0
three-level,1,0.0
Theophylline,1,0.0
retarded,1,0.0
Embolic,1,0.0
longitidinal,1,0.0
Three-dimensional,1,0.0
RVPER,1,0.0
RVPFR,1,0.0
compliances,1,0.0
ck-levels,1,0.0
stress-redistribution,1,0.0
implanting,1,0.0
bronchodilating,1,0.0
controlMethods,1,0.0
2012-2014,1,0.0
OLIN,1,0.0
1006,1,0.0
SF-8,1,0.0
inhalants,1,0.0
Pharmacological,1,0.0
32-92,1,0.0
studyResults,1,0.0
Daytime,1,0.0
241,1,0.0
0022Conclusions,1,0.0
ligated,1,0.0
one-week,1,0.0
enlarged,1,0.0
arranged,1,0.0
sprouting,1,0.0
theophyllinemia,1,0.0
time-points,1,0.0
A3,1,0.0
jacchus,1,0.0
Affiliated,1,0.0
thromboticfibrinolytic,1,0.0
hypocholesterolemic,1,0.0
precocity,1,0.0
Storage,1,0.0
alimentary,1,0.0
transaminase,1,0.0
transaminases,1,0.0
100-4800,1,0.0
dipyridamole-aspirine,1,0.0
S507C,1,0.0
eprosartan,1,0.0
AC®,1,0.0
children®,1,0.0
Anaferon,1,0.0
gamma-interferon,1,0.0
ultra-low,1,0.0
uninterpretable,1,0.0
intermediary,1,0.0
microfoci,1,0.0
bottle,1,0.0
sanitizer,1,0.0
0738-1000,1,0.0
bestoptimal,1,0.0
RNA-RT-PCR,1,0.0
2057,1,0.0
near-perfect,1,0.0
heparin-treated,1,0.0
µl,1,0.0
self-collect,1,0.0
19-69,1,0.0
postage,1,0.0
SARS-CoV-2-positives,1,0.0
9899,1,0.0
Exon,1,0.0
F506L,1,0.0
nonintensive,1,0.0
Belgium,1,0.0
Nucleotide,1,0.0
onslaught,1,0.0
ischemia--that,1,0.0
adipocyte,1,0.0
insults--such,1,0.0
under-recognized,1,0.0
-71·4,1,0.0
NSP2,1,0.0
20·7,1,0.0
67·1,1,0.0
-40·9,1,0.0
31·9,1,0.0
Crude,1,0.0
Upregulation,1,0.0
Peroxisome,1,0.0
Hamming,1,0.0
SARS-cov,1,0.0
Silhouette,1,0.0
goodness,1,0.0
cov,1,0.0
MERS-,1,0.0
string,1,0.0
immune-induced,1,0.0
immune-related,1,0.0
Tendency,1,0.0
receptor-inhibiting,1,0.0
humanised,1,0.0
visualised,1,0.0
normocholesterolemic,1,0.0
homology-based,1,0.0
R203M,1,0.0
compelled,1,0.0
Capillary,1,0.0
hematology,1,0.0
graver,1,0.0
Illustrated,1,0.0
p0034,1,0.0
Coinciding,1,0.0
fo,1,0.0
underevaluate,1,0.0
damageimpairment,1,0.0
Premonitory,1,0.0
pseudomyocardial,1,0.0
multiparous,1,0.0
tumorigenesis-2,1,0.0
10-68,1,0.0
736,1,0.0
35-65,1,0.0
dynamin-dependent,1,0.0
behavior-modification,1,0.0
conjointly,1,0.0
Electromyography,1,0.0
r034,1,0.0
EMG--a,1,0.0
tension--and,1,0.0
electrodermal,1,0.0
EDR--a,1,0.0
response--biofeedback,1,0.0
nosologically,1,0.0
hypothalamopituitary,1,0.0
hypopituitarism,1,0.0
postresuscitation,1,0.0
p0017,1,0.0
antidiuretic,1,0.0
r037,1,0.0
mch,1,0.0
clathrin-,1,0.0
adenocarcinoma,1,0.0
CNE-2Z,1,0.0
KCDC,1,0.0
hyperkalemia-induced,1,0.0
multisite,1,0.0
Board-approved,1,0.0
1996-1998,1,0.0
pseudoacute,1,0.0
4360,1,0.0
0-002,1,0.0
multiplex-type,1,0.0
relegated,1,0.0
«SEIMC,1,0.0
2016»,1,0.0
Ossong,1,0.0
Microbiologists,1,0.0
Soria,1,0.0
Melguizo,1,0.0
Restoration,1,0.0
Elsevier,1,0.0
España,1,0.0
arrivals,1,0.0
Headquarters,1,0.0
SLU,1,0.0
twins,1,0.0
MerciPenumbra,1,0.0
Sociedad,1,0.0
FR,1,0.0
Española,1,0.0
Enfermedades,1,0.0
Infecciosasy,1,0.0
Microbiología,1,0.0
Clínica,1,0.0
92·6,1,0.0
post-EVT,1,0.0
Callithrix,1,0.0
∼20,1,0.0
TISMO-infused,1,0.0
hippocampal,1,0.0
∼50,1,0.0
SERT,1,0.0
mesotheliomas,1,0.0
P60,1,0.0
mesothelioma,1,0.0
muscarinic,1,0.0
methacholine-induced,1,0.0
non-variant,1,0.0
Campinas,1,0.0
inflammationLabored,1,0.0
onceweek,1,0.0
Labored,1,0.0
ovary,1,0.0
5Htr1a,1,0.0
AJ,1,0.0
corticotropin,1,0.0
Crhr1,1,0.0
P75,1,0.0
fiber-shaped,1,0.0
65-week,1,0.0
experimentally-induced,1,0.0
52-,1,0.0
anxiety-related,1,0.0
Anginal,1,0.0
ST--T,1,0.0
Nontransmural,1,0.0
unjustified,1,0.0
direct-PTCA,1,0.0
Neurons,1,0.0
timesweek,1,0.0
non-selective,1,0.0
Evidently,1,0.0
119V,1,0.0
274Y-containing,1,0.0
treatment-naïve,1,0.0
self-reporting,1,0.0
OTV-treated,1,0.0
bicycling,1,0.0
292K,1,0.0
OTV-resistance,1,0.0
ministers,1,0.0
bled,1,0.0
deadline,1,0.0
distantly,1,0.0
Nonhuman,1,0.0
NHP,1,0.0
productively,1,0.0
Influenzanet,1,0.0
LoE,1,0.0
risk-factor,1,0.0
diabetes-associated,1,0.0
2336,1,0.0
1098,1,0.0
race-ethnic,1,0.0
replies,1,0.0
Severity,1,0.0
neurobiological,1,0.0
anxiety-,1,0.0
doubtfulness,1,0.0
depression-related,1,0.0
BALBcJ,1,0.0
Germanys,1,0.0
7-57,1,0.0
N98,1,0.0
K2O·6TiO2,1,0.0
ophthalmologist,1,0.0
octatitanate,1,0.0
metacholine,1,0.0
Assessement,1,0.0
aer,1,0.0
slope,1,0.0
1758,1,0.0
mint,1,0.0
Tilade,1,0.0
steep,1,0.0
AMIS,1,0.0
hyperresponsivness,1,0.0
Nedocromil,1,0.0
intermediate-risk,1,0.0
infection-naive,1,0.0
•Haloperidol,1,0.0
•These,1,0.0
dose--PD20,1,0.0
CD69,1,0.0
CD66,1,0.0
CD81,1,0.0
possessed,1,0.0
Tab,1,0.0
Ref,1,0.0
PSIs,1,0.0
Tomsk,1,0.0
RAMI,1,0.0
ofpatients,1,0.0
AMIpicture,1,0.0
Perception,1,0.0
QS-wave,1,0.0
Undiagnosed,1,0.0
Diagnosed,1,0.0
healthcare-associated,1,0.0
•Dextromethorphan,1,0.0
•Antipsychotic,1,0.0
•Inhibitors,1,0.0
androgen,1,0.0
cineventriculographic,1,0.0
Thanks,1,0.0
cineangiographically,1,0.0
four-channel,1,0.0
FES,1,0.0
1-December,1,0.0
2006-07,1,0.0
Cepheids,1,0.0
region-wide,1,0.0
easiest,1,0.0
breeder,1,0.0
Free,1,0.0
835,1,0.0
breeders,1,0.0
ameliorative,1,0.0
MESSAGES,1,0.0
Orf9c,1,0.0
sigma-2,1,0.0
adjudicated,1,0.0
Discrepant,1,0.0
benzomorphan,1,0.0
pro-viral,1,0.0
docking-based,1,0.0
protein-drug,1,0.0
ABI,1,0.0
bioMérieux,1,0.0
eMag,1,0.0
NSP6-drug,1,0.0
m2000,1,0.0
energetic,1,0.0
H1N1S-OIV,1,0.0
catheterizations,1,0.0
efferent,1,0.0
automic,1,0.0
COVID-like,1,0.0
PGP,1,0.0
girdle,1,0.0
pelvic,1,0.0
better-understand,1,0.0
≥100°F,1,0.0
2953,1,0.0
aborting,1,0.0
25-37,1,0.0
hypnosis,1,0.0
recourse,1,0.0
ameliorating,1,0.0
Stay-at-Home,1,0.0
1970-73,1,0.0
Indianapolis,1,0.0
iNfection,1,0.0
ASLRPL,1,0.0
patterned,1,0.0
CORonavirus,1,0.0
filarial,1,0.0
Morphometric,1,0.0
basin,1,0.0
River,1,0.0
nonwhite,1,0.0
intertwined,1,0.0
low-SES,1,0.0
segregated,1,0.0
Marginalized,1,0.0
Yavari-Mirin,1,0.0
Pitheciidae,1,0.0
diesel-related,1,0.0
1980-83,1,0.0
15-127,1,0.0
Diuretics,1,0.0
surmise,1,0.0
R2375,1,0.0
allergen-sensitive,1,0.0
357-393,1,0.0
557-637,1,0.0
79-87,1,0.0
inducer,1,0.0
Altered,1,0.0
HMO,1,0.0
detrimentally,1,0.0
guarantees,1,0.0
actine,1,0.0
alpha-smooth,1,0.0
Log,1,0.0
14-months,1,0.0
Overt,1,0.0
STOP,1,0.0
145-153,1,0.0
R1149,1,0.0
agrees,1,0.0
hydroxyurea,1,0.0
unconditional,1,0.0
002-04,1,0.0
identifiability,1,0.0
Canton,1,0.0
illustrating,1,0.0
waist-to-hip,1,0.0
15-11,1,0.0
leisure,1,0.0
01-09,1,0.0
narrowly,1,0.0
15-27,1,0.0
Primates,1,0.0
marginalized,1,0.0
Far,1,0.0
Rudolphi,1,0.0
Bain,1,0.0
PKUPH,1,0.0
Peking,1,0.0
ribavirin-treated,1,0.0
Diagne,1,0.0
Muller,1,0.0
recoverable,1,0.0
recognizes,1,0.0
disguised,1,0.0
1-beta-D-Ribofuranosyl-124-triazole-3-carboxamide,1,0.0
hasten,1,0.0
2x75,1,0.0
free-living,1,0.0
pitheciid,1,0.0
non-nucleic,1,0.0
sorted,1,0.0
closed-loop,1,0.0
Neotropical,1,0.0
etiopathogeny,1,0.0
mediums,1,0.0
1929,1,0.0
genetical,1,0.0
Palmeri,1,0.0
Faust,1,0.0
Morgantown,1,0.0
GAN,1,0.0
5141,1,0.0
Mansonella,1,0.0
1861,1,0.0
Diesing,1,0.0
3069,1,0.0
antiaggregant,1,0.0
Peruvian,1,0.0
Pithecia,1,0.0
mainstone,1,0.0
embedding,1,0.0
psycho-socioeconomic,1,0.0
avian-like,1,0.0
time-limited,1,0.0
fibrillations,1,0.0
Rabdomyolysis,1,0.0
wheezes,1,0.0
adage,1,0.0
forgotten,1,0.0
broncholithiasis,1,0.0
nihilist,1,0.0
EMEA,1,0.0
protocolised,1,0.0
Thomas,1,0.0
intrarterial,1,0.0
É,1,0.0
ucayalii,1,0.0
ethiopathogeny,1,0.0
calvus,1,0.0
jjfoxupmcedu,1,0.0
mimicked,1,0.0
Cacajao,1,0.0
Saint-Hilaire,1,0.0
three-day,1,0.0
392,1,0.0
8040,1,0.0
Geoffroy,1,0.0
Electrocardiography,1,0.0
1-mm,1,0.0
radiogram,1,0.0
coevolution,1,0.0
Symptom-limited,1,0.0
genera,1,0.0
predominated¶,1,0.0
anovel,1,0.0
aglobal,1,0.0
19718030,1,0.0
728013,1,0.0
Time-frequency,1,0.0
21-August,1,0.0
Wigner,1,0.0
variant†,1,0.0
1-May,1,0.0
NHSN§,1,0.0
CMS-certified,1,0.0
nonstationary,1,0.0
Weekly,1,0.0
time-domain,1,0.0
Wadsworth,1,0.0
17407,1,0.0
3862,1,0.0
700-788,1,0.0
33160,1,0.0
11581,1,0.0
10-June,1,0.0
675,1,0.0
Jude,1,0.0
-h,1,0.0
601-735,1,0.0
85593,1,0.0
14917,1,0.0
491-567,1,0.0
NeuMoDx,1,0.0
NeuMoDx™,1,0.0
Mitigation,1,0.0
separable,1,0.0
popularly,1,0.0
dysrhythmias,1,0.0
17-N-allylamino-17-demethoxygeldanamycin,1,0.0
Typically,1,0.0
south-to-north,1,0.0
west-to-east,1,0.0
triphosphatase,1,0.0
WHO-defined,1,0.0
650000,1,0.0
Tasmanian,1,0.0
sialidase,1,0.0
rerouting,1,0.0
17AAG,1,0.0
client,1,0.0
NA-Hsp90,1,0.0
venosus-type,1,0.0
stabilizing,1,0.0
colocalized,1,0.0
Confocal,1,0.0
bordering,1,0.0
extra-European,1,0.0
WHO-developed,1,0.0
between-countries,1,0.0
transmitters,1,0.0
abstracts,1,0.0
transiently,1,0.0
counted,1,0.0
OTC,1,0.0
coimmunoprecipitation,1,0.0
suddenness,1,0.0
two-hybrid,1,0.0
Pre-stroke,1,0.0
protein-heat,1,0.0
Terminal,1,0.0
Structure,1,0.0
disrupts,1,0.0
chemotaxis,1,0.0
0997,1,0.0
polyethylene,1,0.0
25-36,1,0.0
13-24,1,0.0
0-12,1,0.0
2775,1,0.0
regional-specific,1,0.0
06389,1,0.0
Epithelial,1,0.0
-02876,1,0.0
05331,1,0.0
glycol-b-polycaprolactone,1,0.0
-003757,1,0.0
614G,1,0.0
4715L,1,0.0
methoxy,1,0.0
Polymersomes,1,0.0
sulfate-polyacrylamide,1,0.0
dodecyl,1,0.0
nanoparticles-based,1,0.0
purify,1,0.0
serums,1,0.0
0-6,1,0.0
7-15,1,0.0
Beneficial,1,0.0
polymersome,1,0.0
dye-loaded,1,0.0
CKMB,1,0.0
Ischemia-related,1,0.0
auspices,1,0.0
choosing,1,0.0
manipulate,1,0.0
mPEG-b-PCL,1,0.0
diblock,1,0.0
copolymers,1,0.0
Bangkokian,1,0.0
T-lymphocytes,1,0.0
1995-2005,1,0.0
Epithelium,1,0.0
hyperkinesia,1,0.0
Endogenic,1,0.0
04822,1,0.0
J11,1,0.0
J10,1,0.0
Seventy-two,1,0.0
00186,1,0.0
clarithromycin,1,0.0
stain,1,0.0
gram,1,0.0
3-day,1,0.0
Calculated,1,0.0
ORF1abRdRp,1,0.0
S-CK,1,0.0
relapses,1,0.0
uta,1,0.0
09207,1,0.0
0029,1,0.0
91-97,1,0.0
96-98,1,0.0
hoarse,1,0.0
mid-October,1,0.0
92-94,1,0.0
922,1,0.0
mid-November,1,0.0
polymersomes,1,0.0
Coomassie,1,0.0
2072,1,0.0
p0026,1,0.0
steatohepatitis,1,0.0
Trial-1,1,0.0
mmin,1,0.0
Pediatric-specific,1,0.0
100-day-old,1,0.0
lenticulostriate,1,0.0
uncrossed,1,0.0
ACST-1,1,0.0
cortico-hypothalamic,1,0.0
2·3,1,0.0
oculosympathetic,1,0.0
0·039,1,0.0
thrombolytic-treated,1,0.0
50000000,1,0.0
1250000,1,0.0
syndrome-CoV,1,0.0
Donor,1,0.0
Prospects,1,0.0
abdomen,1,0.0
sensitivespecific,1,0.0
incline,1,0.0
dwk,1,0.0
nanoscopic,1,0.0
versatility,1,0.0
Growth,1,0.0
386-421min,1,0.0
Resting,1,0.0
nanobiotechnology,1,0.0
Absent,1,0.0
9263,1,0.0
7448,1,0.0
SAP,1,0.0
Tetanus,1,0.0
Enzymes,1,0.0
0·019,1,0.0
arched,1,0.0
Lyte-A,1,0.0
odontoid,1,0.0
lippalate,1,0.0
cleft,1,0.0
sister,1,0.0
sagittal-cleft,1,0.0
mid-LAD,1,0.0
C7,1,0.0
3·1,1,0.0
transarterial,1,0.0
microsyringe,1,0.0
Animals,1,0.0
hemi-arches,1,0.0
translatable,1,0.0
erythematosus,1,0.0
peg,1,0.0
articular,1,0.0
PTPN11,1,0.0
exons,1,0.0
Yorkshire,1,0.0
Multipotent,1,0.0
dysmorphic,1,0.0
patientprovider,1,0.0
financing,1,0.0
expressivity,1,0.0
periostin,1,0.0
82·1,1,0.0
health-systems,1,0.0
interpersonal,1,0.0
53·5,1,0.0
gloves,1,0.0
Visiting,1,0.0
Diphtheria,1,0.0
acellular,1,0.0
Pertussis,1,0.0
Cutaneous,1,0.0
Anastomotic,1,0.0
surgeon,1,0.0
Baru,1,0.0
Badak,1,0.0
paracetamol,1,0.0
Tested,1,0.0
20012002,1,0.0
TDaP,1,0.0
nursing-home,1,0.0
reimbursing,1,0.0
discouraging,1,0.0
Infu,1,0.0
40-fold,1,0.0
Preexisting,1,0.0
0-30,1,0.0
in-Soult,1,0.0
3-24,1,0.0
276,1,0.0
468,1,0.0
men-with,1,0.0
atrophic,1,0.0
3985,1,0.0
COVID-infected,1,0.0
anti-spike,1,0.0
812,1,0.0
anosmiadysgeusia,1,0.0
Trauma-associated,1,0.0
gripped,1,0.0
dermatology,1,0.0
hockey,1,0.0
ice,1,0.0
anti-cytokine,1,0.0
TSLP,1,0.0
accompanies,1,0.0
Palestinians,1,0.0
angor,1,0.0
angiocardioscintigraphy,1,0.0
Tc-99,1,0.0
620-113,1,0.0
nodosome-targeting,1,0.0
engineers,1,0.0
transformative,1,0.0
virus-deactivating,1,0.0
RIPK2,1,0.0
serinethreonine,1,0.0
receptor-interacting,1,0.0
coatings,1,0.0
alphaviruses,1,0.0
Palestinian,1,0.0
flaviviruses,1,0.0
perturbed,1,0.0
shunts,1,0.0
oligomerization,1,0.0
nucleotide-binding,1,0.0
venous-based,1,0.0
pandemic-like,1,0.0
orientations,1,0.0
negotiation,1,0.0
Cytokine,1,0.0
anti-IL-4,1,0.0
outcompeted,1,0.0
anti-IL-5,1,0.0
Inhibition,1,0.0
positivenegative,1,0.0
nontriaged,1,0.0
surging,1,0.0
carinatum,1,0.0
SABA,1,0.0
Cardioaortic,1,0.0
Contrast,1,0.0
MRI-in,1,0.0
year’s,1,0.0
imaging-transthoracic,1,0.0
redefined,1,0.0
One-quarter,1,0.0
unethical,1,0.0
akin,1,0.0
fibroblasts,1,0.0
personalization,1,0.0
re-hospitalization,1,0.0
microalbuminuria,1,0.0
instigate,1,0.0
precariousness,1,0.0
offending,1,0.0
Salmeterol,1,0.0
chemoreceptor,1,0.0
1979--1980,1,0.0
enterprises,1,0.0
ubiquitous,1,0.0
Immunohistochemical,1,0.0
roubles,1,0.0
apidemiological,1,0.0
above-mentioned,1,0.0
antiepidemic,1,0.0
metastasis,1,0.0
glomangiosarcomas,1,0.0
mobilisation,1,0.0
httpswwwcovid19dataportalorg,1,0.0
pleomorphism,1,0.0
nucleoli,1,0.0
Related,1,0.0
already-existing,1,0.0
coughs,1,0.0
after-effects,1,0.0
certificate,1,0.0
benefited,1,0.0
stuffy,1,0.0
persulphates,1,0.0
NIOSH,1,0.0
13-37,1,0.0
p0019,1,0.0
deprivation,1,0.0
12-63,1,0.0
rooming-in,1,0.0
breast-feeding,1,0.0
nematodes,1,0.0
Onchocercidae,1,0.0
Leiper,1,0.0
life-threating,1,0.0
Thrombocytopenia,1,0.0
overland,1,0.0
vector-vaccinated,1,0.0
1982-1983,1,0.0
etiologically,1,0.0
Kzyl-Orda,1,0.0
Guiana,1,0.0
aluminum,1,0.0
hydroxide,1,0.0
FWI,1,0.0
Indies,1,0.0
DIF,1,0.0
Al-OH,1,0.0
Item,1,0.0
Undernutrition,1,0.0
coxsackievirus,1,0.0
Platform,1,0.0
releases,1,0.0
visualisations,1,0.0
ventriculoatrial,1,0.0
179-435,1,0.0
cooking,1,0.0
paediatricians,1,0.0
fulfils,1,0.0
gaselectricity,1,0.0
rural-town-city,1,0.0
urbanicity,1,0.0
FAIR,1,0.0
bifida,1,0.0
environmentallifestyle,1,0.0
spina,1,0.0
trash,1,0.0
smokeABSTRACT,1,0.0
interplays,1,0.0
160-292,1,0.0
anthropometrics,1,0.0
CG,1,0.0
138-248,1,0.0
Lebanese,1,0.0
171-316,1,0.0
1115,1,0.0
consanguineous,1,0.0
555,1,0.0
stature,1,0.0
5-17,1,0.0
conurbation,1,0.0
microcephaly,1,0.0
spectrographic,1,0.0
ptosis,1,0.0
dysplastic,1,0.0
pectum,1,0.0
psycho-behavioural,1,0.0
first-trimester,1,0.0
cans,1,0.0
US-Mexican,1,0.0
inconspicuous,1,0.0
Findable,1,0.0
Accessible,1,0.0
homogenous,1,0.0
Histologically,1,0.0
intrapulmonary,1,0.0
Interoperable,1,0.0
Reusable,1,0.0
ribonucleoprotein,1,0.0
WWTPs,1,0.0
twenty-one,1,0.0
Fluctuations,1,0.0
wanes,1,0.0
pre-screening,1,0.0
Anatomically,1,0.0
sickbed,1,0.0
semistructured,1,0.0
indigent,1,0.0
hemoptysis,1,0.0
40-year,1,0.0
≈4,1,0.0
supine-standing-supine,1,0.0
002-05,1,0.0
VLF,1,0.0
handrails,1,0.0
002-005,1,0.0
LF,1,0.0
005-015,1,0.0
015-05,1,0.0
orthostatic,1,0.0
NASH,1,0.0
post-IAV,1,0.0
thrombosed,1,0.0
fibrates,1,0.0
Supra-tentorial,1,0.0
up-regulation,1,0.0
serum-expanded,1,0.0
hypertriglyceridemia,1,0.0
antidiabetic,1,0.0
auto,1,0.0
uniformity,1,0.0
non-viral,1,0.0
anti-atherosclerotic,1,0.0
SACAWG,1,0.0
Virologic,1,0.0
speculation,1,0.0
inherit,1,0.0
Campaigns,1,0.0
infarctionNINDS-III,1,0.0
MRIor,1,0.0
3D-CTA,1,0.0
DSA,1,0.0
t-PAPAI-1,1,0.0
Classified,1,0.0
prothromboticantifibrinolytic,1,0.0
junctions,1,0.0
Disclosure,1,0.0
roundtable,1,0.0
2012-13,1,0.0
Viewing,1,0.0
JH,1,0.0
UH,1,0.0
GH,1,0.0
AHK21203,1,0.0
AHK21303,1,0.0
apoplexy,1,0.0
DNA-,1,0.0
928,1,0.0
Frictional,1,0.0
myoblast,1,0.0
Activities,1,0.0
stress-induced,1,0.0
inflamed,1,0.0
SkM,1,0.0
Nm2,1,0.0
Wntβ-catenin,1,0.0
delegates,1,0.0
Wnt1gene,1,0.0
Wnt1,1,0.0
flowing,1,0.0
synthesize,1,0.0
IFR,1,0.0
656,1,0.0
Yoga,1,0.0
PCRTaqMan,1,0.0
optimizes,1,0.0
post-PCR,1,0.0
LiCl,1,0.0
granular,1,0.0
Wnt,1,0.0
fibrillationABSTRACT,1,0.0
7-month,1,0.0
PTFE-covered,1,0.0
IVUS,1,0.0
numberrate,1,0.0
64-year-old,1,0.0
psoralen,1,0.0
c-ACT,1,0.0
morphea,1,0.0
socioeconomical,1,0.0
AHK21203-like,1,0.0
postinfectious,1,0.0
CESI,1,0.0
collaborate,1,0.0
non-STEMI,1,0.0
ailment,1,0.0
embryogenesis,1,0.0
metabolically,1,0.0
Senescent,1,0.0
Senescence,1,0.0
PGD2-related,1,0.0
unveiling,1,0.0
HCl,1,0.0
vasodilation-extravasation,1,0.0
DP-mediated,1,0.0
transendothelial,1,0.0
vasodilatation,1,0.0
PGD2-induced,1,0.0
18-year-old,1,0.0
influenza-mediated,1,0.0
multimers,1,0.0
Backgrounds,1,0.0
microcirculatures,1,0.0
sheds,1,0.0
Luks,1,0.0
Andrew,1,0.0
Colin,1,0.0
age-oriented,1,0.0
unsettling,1,0.0
Grissom,1,0.0
aorto-coronary,1,0.0
Alt,1,0.0
Biol,1,0.0
119-127,1,0.0
suffice,1,0.0
D2,1,0.0
Prostaglandin,1,0.0
endoscopic-related,1,0.0
capitalize,1,0.0
OACs,1,0.0
stablished,1,0.0
Households,1,0.0
cross-disciplinary,1,0.0
multiple-vessel,1,0.0
SKPTCA,1,0.0
unyielding,1,0.0
balloon-dependent,1,0.0
semi-emergent,1,0.0
850,1,0.0
Heartlands,1,0.0
BHH,1,0.0
embrace,1,0.0
extra-corporeal,1,0.0
yearsExpert,1,0.0
jaundice,1,0.0
bibasal,1,0.0
293-2870,1,0.0
appraise,1,0.0
solutionsAreas,1,0.0
actionable,1,0.0
comments,1,0.0
hypotheses-generating,1,0.0
investing,1,0.0
Well-trained,1,0.0
technologists,1,0.0
microbiologists,1,0.0
Big,1,0.0
cholangitis,1,0.0
Immunotyping,1,0.0
caught,1,0.0
2002--2003,1,0.0
tourism,1,0.0
Hospitality,1,0.0
87-97,1,0.0
5-23,1,0.0
1-dose,1,0.0
bronchiolar,1,0.0
2-,1,0.0
underreporting,1,0.0
instructors,1,0.0
bacterium,1,0.0
compensate,1,0.0
hairdressers,1,0.0
queries,1,0.0
aestheticians,1,0.0
semiclosed,1,0.0
mined,1,0.0
urea,1,0.0
≥7,1,0.0
74-87,1,0.0
hematuria,1,0.0
nephrotoxic,1,0.0
ATI,1,0.0
Interim,1,0.0
Bacterial,1,0.0
ceased,1,0.0
wheezed,1,0.0
27-81,1,0.0
600years,1,0.0
4-164,1,0.0
aerated,1,0.0
four-part,1,0.0
DLVpulmonary,1,0.0
PCA-related,1,0.0
AAFP,1,0.0
desquamating,1,0.0
organophosphorous,1,0.0
DABI,1,0.0
Descending,1,0.0
1219,1,0.0
1171,1,0.0
PANS,1,0.0
RIVA,1,0.0
rivaroxaban,1,0.0
9987,1,0.0
platn,1,0.0
9868,1,0.0
Interruption,1,0.0
culminate,1,0.0
Cocaine-induced,1,0.0
5827,1,0.0
mentality,1,0.0
ICP,1,0.0
2774,1,0.0
A2009H1N1,1,0.0
2081,1,0.0
implicitly,1,0.0
2661,1,0.0
random-mixing,1,0.0
inferior-posterior,1,0.0
low-output,1,0.0
Schedule,1,0.0
unresponsive,1,0.0
multigated,1,0.0
LTRs,1,0.0
outpatient-treated,1,0.0
Affect,1,0.0
Uninfected,1,0.0
self-evaluation,1,0.0
p00469,1,0.0
p00161,1,0.0
10-34,1,0.0
Organ,1,0.0
Thammasat,1,0.0
heritability,1,0.0
indiscriminately,1,0.0
meta-analyse,1,0.0
contralesioned,1,0.0
family-centered,1,0.0
245,1,0.0
35-59,1,0.0
2016-17,1,0.0
Post-CVA,1,0.0
Conflicting,1,0.0
sexually,1,0.0
Single-radial-immunodiffusion,1,0.0
ezetimide,1,0.0
focussing,1,0.0
proteome-wide,1,0.0
3C,1,0.0
ever-expanding,1,0.0
infarction-remains,1,0.0
BVictoria287-like,1,0.0
Postpartum,1,0.0
BYamagata1688-like,1,0.0
9624,1,0.0
VISTA,1,0.0
Medications,1,0.0
costliness,1,0.0
questioning,1,0.0
haemagglutination-inhibition,1,0.0
insecticide,1,0.0
cholinesterase,1,0.0
2000--2001,1,0.0
cholesterol-absorption,1,0.0
anterior-posterior,1,0.0
medial-lateral,1,0.0
case-matched,1,0.0
mid-1970s,1,0.0
1979-88,1,0.0
hystero-hypochondriacal,1,0.0
ICD8,1,0.0
Affecting,1,0.0
GASROS,1,0.0
curve60,1,0.0
jurisdiction,1,0.0
blurred,1,0.0
clozapine,1,0.0
still-developing,1,0.0
psychiatrists,1,0.0
dimensionality,1,0.0
collaborators,1,0.0
shadowed,1,0.0
SHARP,1,0.0
semblance,1,0.0
prodigious,1,0.0
concerted,1,0.0
stabilogram,1,0.0
stabilometric,1,0.0
witnesses,1,0.0
dysregulations,1,0.0
Isiskate,1,0.0
omnidirectional,1,0.0
dynamism,1,0.0
US-based,1,0.0
01-05,1,0.0
sinusoidal,1,0.0
Renal,1,0.0
2021-With,1,0.0
rebound,1,0.0
Infarct-like,1,0.0
imaging--MRI,1,0.0
Near,1,0.0
Fatal,1,0.0
410,1,0.0
7589,1,0.0
imaging--DWI,1,0.0
UIl,1,0.0
behaviours-that,1,0.0
non-Stroke,1,0.0
conditions-multilevel,1,0.0
virtuous,1,0.0
readying,1,0.0
58189,1,0.0
stopgap,1,0.0
avian-human,1,0.0
115123,1,0.0
antecedents,1,0.0
7980,1,0.0
P0005,1,0.0
non-survivors,1,0.0
777,1,0.0
Co-pathogens,1,0.0
FEV,1,0.0
426,1,0.0
81245,1,0.0
108226,1,0.0
Acinetobacter,1,0.0
baumannii,1,0.0
flavus,1,0.0
rhinovirusenterovirus,1,0.0
co-infective,1,0.0
189471,1,0.0
Aerosol-generating,1,0.0
DHCPs,1,0.0
numbering,1,0.0
7895,1,0.0
75000,1,0.0
Tomographic,1,0.0
Anderson-Wilkins,1,0.0
northwestern,1,0.0
ninety-five,1,0.0
Pattern-based,1,0.0
corpses,1,0.0
Extension,1,0.0
pmMRI,1,0.0
Vaccinating,1,0.0
encompassed,1,0.0
maxingshigan-yinqiaosan,1,0.0
subcategorization,1,0.0
equivalences,1,0.0
multimedia,1,0.0
affairs,1,0.0
CF,1,0.0
faculty,1,0.0
rests,1,0.0
gamma-angiography,1,0.0
bi-dimensional,1,0.0
ergometric,1,0.0
retains,1,0.0
isotopic,1,0.0
rEDV,1,0.0
corner,1,0.0
stone,1,0.0
bronchoprovocations,1,0.0
exercise-test,1,0.0
neuroscientific,1,0.0
one-vessel,1,0.0
12-31-2014,1,0.0
1-1-2005,1,0.0
unmodified,1,0.0
bisphenol,1,0.0
Computerized,1,0.0
Coincidence,1,0.0
neurophysiological,1,0.0
Poststroke,1,0.0
envenomation,1,0.0
Isoprenaline,1,0.0
diglycidyl,1,0.0
Newly,1,0.0
hymenoptera,1,0.0
Kounis,1,0.0
envenomed,1,0.0
chord,1,0.0
ether,1,0.0
BADGE,1,0.0
Genetical,1,0.0
GSH,1,0.0
SOD,1,0.0
malondialdehyde,1,0.0
infarct-like,1,0.0
isoprenaline-induced,1,0.0
reassortation,1,0.0
17462,1,0.0
5110,1,0.0
alpha-hydroxybutyrate,1,0.0
1396,1,0.0
Bradycardia,1,0.0
II-IV,1,0.0
high-degree,1,0.0
peroxisome,1,0.0
Quarantine,1,0.0
talk,1,0.0
867-66,1,0.0
pre-administered,1,0.0
6-24h,1,0.0
DNA-launched,1,0.0
H8,1,0.0
H11,1,0.0
turkeys,1,0.0
turkey,1,0.0
12-128,1,0.0
20-1152,1,0.0
DREP-Secto,1,0.0
ectodomain,1,0.0
non-exposed,1,0.0
sometime,1,0.0
confinement,1,0.0
DREP-S,1,0.0
self-replicating,1,0.0
constraint-induced,1,0.0
alphavirus-based,1,0.0
mini-review,1,0.0
mCIMT,1,0.0
fastest,1,0.0
THE,1,0.0
THERAPEUTIC,1,0.0
phagocytic,1,0.0
ROLE,1,0.0
cfu,1,0.0
ULTRASOUND,1,0.0
POTENTIAL,1,0.0
MECHANISM,1,0.0
SONOTHROMBOLYSIS,1,0.0
Augmentation,1,0.0
1x1011,1,0.0
microspheres,1,0.0
modernize,1,0.0
AH1AH3B,1,0.0
hypobaric,1,0.0
3-hour,1,0.0
Zimbabweans,1,0.0
Coloured,1,0.0
Parirenyatwa,1,0.0
torr,1,0.0
precarious,1,0.0
transportrequirement,1,0.0
Etiological,1,0.0
654,1,0.0
1--4,1,0.0
Vaxigrip,1,0.0
physicochemical,1,0.0
or1,1,0.0
890-1000,1,0.0
or99,1,0.0
-074,1,0.0
spirals,1,0.0
medicationsamantadine,1,0.0
613,1,0.0
false-positives,1,0.0
false-negatives,1,0.0
hemoglobin-oxygen,1,0.0
18922,1,0.0
Cq,1,0.0
-098,1,0.0
interrelations,1,0.0
thoracolithiasis,1,0.0
-80°C,1,0.0
19535,1,0.0
ROCHE,1,0.0
ABBOTT,1,0.0
4400,1,0.0
Ocrelizumab,1,0.0
861,1,0.0
Nobusawa,1,0.0
fibrinogen-alpha,1,0.0
fibrinogen-gamma,1,0.0
regenerate,1,0.0
inconvenience,1,0.0
therapy--inhaled,1,0.0
fibrinogen-beta,1,0.0
sodium--as,1,0.0
PMA,1,0.0
RRMS,1,0.0
129Cs,1,0.0
Observer,1,0.0
Predicted,1,0.0
diffusely,1,0.0
myocardiun,1,0.0
Fibrinogen,1,0.0
50-kb,1,0.0
brain-based,1,0.0
brain-protective,1,0.0
neurorestoration,1,0.0
choline,1,0.0
doesnt,1,0.0
Therapies,1,0.0
vasotherapeutics,1,0.0
times-to-inactivation,1,0.0
Chengdu,1,0.0
non-contact,1,0.0
infrared,1,0.0
thermometers,1,0.0
collapsibility,1,0.0
air-trapping,1,0.0
72327,1,0.0
PPMS,1,0.0
Calculation,1,0.0
liability,1,0.0
GENERIC,1,0.0
Computer,1,0.0
Does,1,0.0
Interactions,1,0.0
antiaggregants,1,0.0
UV-inactivated,1,0.0
5×105,1,0.0
industrializing,1,0.0
paints,1,0.0
Diurnal,1,0.0
eNOS-induced,1,0.0
Wistar,1,0.0
plastics,1,0.0
HIIT,1,0.0
Isocyanates,1,0.0
bakerss,1,0.0
benzo-diazepines,1,0.0
tranquillisers,1,0.0
Beta-blocking,1,0.0
psychic,1,0.0
ICUCCU,1,0.0
TU,1,0.0
Maharajgunj,1,0.0
Seroprotection,1,0.0
Bir,1,0.0
Kathmandu,1,0.0
allograft,1,0.0
mv,1,0.0
nodal,1,0.0
non-vaccinated,1,0.0
A-V,1,0.0
Wolverhampton,1,0.0
0033,1,0.0
--however,1,0.0
minday,1,0.0
--some,1,0.0
ethnographic,1,0.0
midexpiratory,1,0.0
Minimum,1,0.0
prebronchodilator,1,0.0
once-daily,1,0.0
asynchronism,1,0.0
Marked,1,0.0
Change,1,0.0
first-generation,1,0.0
CTP-based,1,0.0
decongestants,1,0.0
skin-blister,1,0.0
basophils,1,0.0
MA-SM,1,0.0
Migrainous,1,0.0
Tijuana,1,0.0
Rhinomanometry,1,0.0
insects,1,0.0
impoverished,1,0.0
pAMPK,1,0.0
peNOS,1,0.0
non-exercise,1,0.0
stroked,1,0.0
IP,1,0.0
clerks,1,0.0
L-NIO,1,0.0
EBP,1,0.0
p-T172-AMPK,1,0.0
AMPK,1,0.0
p-S1177-eNOS,1,0.0
Exercised,1,0.0
saddlebrown,1,0.0
lexical-semantic,1,0.0
SPD,1,0.0
strain-selection,1,0.0
StrOke,1,0.0
aFter,1,0.0
HYPOTHESIS,1,0.0
AIM,1,0.0
sufficiency,1,0.0
vaccine-selection,1,0.0
interprets,1,0.0
coronary-occlusion,1,0.0
3-factor,1,0.0
176193,1,0.0
158176,1,0.0
128176,1,0.0
noninfarction,1,0.0
staunch,1,0.0
SAFFO,1,0.0
hesitation,1,0.0
four-point,1,0.0
1159,1,0.0
30-49,1,0.0
350-406,1,0.0
undecided,1,0.0
20-37,1,0.0
11-28,1,0.0
Imbalance,1,0.0
electrophysiologic,1,0.0
weakened,1,0.0
Agents,1,0.0
repositories,1,0.0
Matched,1,0.0
anti-N,1,0.0
2424,1,0.0
enzymes--superoxide,1,0.0
walkers,1,0.0
anti-receptor,1,0.0
elaborating,1,0.0
strain-transcending,1,0.0
constancy,1,0.0
foregoing,1,0.0
Methodical,1,0.0
secondard,1,0.0
852,1,0.0
unhelpful,1,0.0
KR,1,0.0
ACO1,1,0.0
consensus-based,1,0.0
GOLD,1,0.0
161176,1,0.0
issue23,1,0.0
COPD1,1,0.0
Building,1,0.0
immune-response,1,0.0
unconstrained,1,0.0
arouses,1,0.0
attact,1,0.0
150176,1,0.0
localising,1,0.0
Phenazine,1,0.0
methosulphate,1,0.0
PMS,1,0.0
incubating,1,0.0
electron-acceptor,1,0.0
circumvent,1,0.0
tetrazolium-reductase,1,0.0
diaphorase,1,0.0
6-minute,1,0.0
6MWT,1,0.0
RT-PCR-confirmed,1,0.0
Temporal,1,0.0
volunteerism,1,0.0
Practical,1,0.0
amplifications,1,0.0
naked,1,0.0
orange,1,0.0
habitual,1,0.0
two-color,1,0.0
transcriptase-loop,1,0.0
1614,1,0.0
microgliosis,1,0.0
methodologic,1,0.0
Unique,1,0.0
embodied,1,0.0
59-year-old,1,0.0
Salient,1,0.0
disutility,1,0.0
accelerometer,1,0.0
onset-to-door,1,0.0
NIEHS,1,0.0
Extramural,1,0.0
extramural,1,0.0
concise,1,0.0
E-selection,1,0.0
reaction-restriction,1,0.0
PCR-RFLP,1,0.0
ex-smoker,1,0.0
P0,1,0.0
Frequencies,1,0.0
westernized,1,0.0
00,1,0.0
128Arg,1,0.0
307-1086,1,0.0
128Arginine,1,0.0
neuroimmunological,1,0.0
astrogliosis,1,0.0
seroconvert,1,0.0
SICAS,1,0.0
ADA,1,0.0
mosquito-borne,1,0.0
allergistimmunologist,1,0.0
Guatemala,1,0.0
PR-interval,1,0.0
NIHNIAID,1,0.0
less-examined,1,0.0
Meeting,1,0.0
timings,1,0.0
Discoveries,1,0.0
nasooropharyngeal,1,0.0
DTS,1,0.0
putamen,1,0.0
Algorithms,1,0.0
toolkits,1,0.0
asthma-friendly,1,0.0
adaptative,1,0.0
psycho-autonomic,1,0.0
disjuncture,1,0.0
adrenomedullary,1,0.0
asthenization,1,0.0
neuro-mental,1,0.0
sphere,1,0.0
conflict,1,0.0
noradrenaline,1,0.0
motivating,1,0.0
Paradoxical,1,0.0
disadaptation,1,0.0
hypochondriacal,1,0.0
Neurorepair,1,0.0
Magdeburg,1,0.0
67176,1,0.0
574,1,0.0
intercontinental,1,0.0
surveying,1,0.0
airtrapping,1,0.0
Trade-offs,1,0.0
Ineffective,1,0.0
Activity,1,0.0
Recommended,1,0.0
1045,1,0.0
insultology,1,0.0
positive-stranded,1,0.0
assimilation,1,0.0
sanogenetic,1,0.0
pontine-cerebellar,1,0.0
saccade,1,0.0
aVOR,1,0.0
Nidovirales,1,0.0
sonothrombosis,1,0.0
heparinoids,1,0.0
drowsy,1,0.0
Inefficient,1,0.0
endotype,1,0.0
unveil,1,0.0
IADLs,1,0.0
evasive,1,0.0
Covaxin,1,0.0
B11282,1,0.0
metereological,1,0.0
Ambient,1,0.0
rainfall,1,0.0
indecision,1,0.0
reproductive-aged,1,0.0
fragile,1,0.0
broach,1,0.0
vestibulo-ocular,1,0.0
unimportant,1,0.0
trip,1,0.0
24-fold,1,0.0
force-matching,1,0.0
vision-guided,1,0.0
regularity,1,0.0
risk-modifying,1,0.0
bereavement-related,1,0.0
bereaved,1,0.0
first-degree,1,0.0
Documentation,1,0.0
case-crossover,1,0.0
Bereavement,1,0.0
Left-sided,1,0.0
menses,1,0.0
Hormonal,1,0.0
restores,1,0.0
torque,1,0.0
5-s,1,0.0
0-3-Hz,1,0.0
chicken,1,0.0
nonparetic,1,0.0
vision-,1,0.0
sensory-motor,1,0.0
NEW,1,0.0
NOTEWORTHY,1,0.0
recalling,1,0.0
aged≥65,1,0.0
HHS,1,0.0
2010-May,1,0.0
replication-mediating,1,0.0
2011-12,1,0.0
plan-do-check-act,1,0.0
Physician,1,0.0
embarrassment,1,0.0
parties,1,0.0
family-provider,1,0.0
58176,1,0.0
72176,1,0.0
administrated,1,0.0
antiangiogenic,1,0.0
antimetastatic,1,0.0
antitumor,1,0.0
inferobasal,1,0.0
straight-line,1,0.0
879,1,0.0
Emiratis,1,0.0
intercepts,1,0.0
handwashing,1,0.0
Nonhospitalized,1,0.0
Handwashing,1,0.0
Lethal,1,0.0
gavage,1,0.0
pause,1,0.0
112176,1,0.0
AgooseGuangdong96-like,1,0.0
GD96,1,0.0
Jan,1,0.0
Sept,1,0.0
litre,1,0.0
89176,1,0.0
101176,1,0.0
862,1,0.0
1-comprised,1,0.0
2-comprised,1,0.0
employable,1,0.0
unused,1,0.0
Traveling,1,0.0
traveling,1,0.0
SOFA,1,0.0
Murrays,1,0.0
PaO2\FiO2,1,0.0
Assoc,1,0.0
macroscopically,1,0.0
SARS-CoV-2virus,1,0.0
httpvirologicalorg,1,0.0
11132,1,0.0
pertains,1,0.0
underutilization,1,0.0
characterizationclassification,1,0.0
7640,1,0.0
model-free,1,0.0
candidate-predictors,1,0.0
Eurosurveillance,1,0.0
465-469,1,0.0
Formosan,1,0.0
Empirical,1,0.0
encouragement,1,0.0
Krasnodar,1,0.0
1123,1,0.0
mass-spectrometry-based,1,0.0
isopropanol,1,0.0
tryptic,1,0.0
sedimented,1,0.0
phosphoprotein,1,0.0
156176,1,0.0
mass-spectrometric,1,0.0
11645,1,0.0
Precious,1,0.0
anti-2019-nCoV,1,0.0
Computational-based,1,0.0
pandemias,1,0.0
2212,1,0.0
22727,1,0.0
Ser128Arg,1,0.0
vectorcardiograms,1,0.0
study--ten,1,0.0
Immunocompromised,1,0.0
Paradoxically,1,0.0
airborne-transmissible,1,0.0
Zoonotic,1,0.0
exacts,1,0.0
antiinfluenza,1,0.0
radiotopography,1,0.0
9509,1,0.0
pathomorphological,1,0.0
cardiotopography,1,0.0
unlicensed,1,0.0
alleviates,1,0.0
reuptake,1,0.0
menopausal,1,0.0
risk-informed,1,0.0
flebography,1,0.0
individuals--eg,1,0.0
Transoesophageal,1,0.0
Hodgkin,1,0.0
BPs,1,0.0
SARS‑CoV,1,0.0
treatment--could,1,0.0
Cameroon,1,0.0
Rapids,1,0.0
AmpliQuick®,1,0.0
nonlinearity,1,0.0
flowmeter,1,0.0
13826,1,0.0
ritodrine,1,0.0
non‑expensive,1,0.0
vaginal,1,0.0
Adult-Onset,1,0.0
Endocrine,1,0.0
gellan,1,0.0
forty,1,0.0
sub-nanomolar,1,0.0
polysaccharide-based,1,0.0
sorting,1,0.0
overdose,1,0.0
mucoadhesive,1,0.0
teicoplanin,1,0.0
Troponin,1,0.0
Multi-Hit,1,0.0
RNV,1,0.0
socio-economically,1,0.0
scintillation,1,0.0
nitroblue-tetrazolium,1,0.0
planimetry,1,0.0
transaxial,1,0.0
packing,1,0.0
Formulation,1,0.0
hydrogen-bonding,1,0.0
disulfide,1,0.0
fixing,1,0.0
co-incubation,1,0.0
passages,1,0.0
Ironically,1,0.0
bFGF,1,0.0
hypothalamic-pituitary-adrenal,1,0.0
Trafermin,1,0.0
corticosteroid-responsive,1,0.0
invested,1,0.0
cortisol-induced,1,0.0
noninfarcts,1,0.0
SMCs,1,0.0
GPCRs,1,0.0
SARS‑coronavirus,1,0.0
Obviously,1,0.0
Zinc,1,0.0
antibiotic-producing,1,0.0
benzylpenicilloyl,1,0.0
allergological,1,0.0
nephroureterotomy,1,0.0
nephrolithiasis,1,0.0
factory,1,0.0
well-trained,1,0.0
clinimetric,1,0.0
foetal,1,0.0
AHSN,1,0.0
Eminase,1,0.0
CG180,1,0.0
well-identified,1,0.0
12-37,1,0.0
Changsha,1,0.0
BPO,1,0.0
hyperventilated,1,0.0
lactose,1,0.0
nontraumatic,1,0.0
ampicillin,1,0.0
definition-based,1,0.0
chloramphenicol,1,0.0
Spinhaler,1,0.0
turboinhaler,1,0.0
pneumonia--cause,1,0.0
immunocomplexes,1,0.0
C1q-binding,1,0.0
anti-BPO-IgG,1,0.0
anti-BPO-IgE,1,0.0
complications--including,1,0.0
rhabdomyolysis,1,0.0
Macrophages,1,0.0
denied,1,0.0
tantamount,1,0.0
emergencycompassionate,1,0.0
EuropeWe,1,0.0
plasmids,1,0.0
RT-qPCR-based,1,0.0
sci-,1,0.0
entific,1,0.0
hu-,1,0.0
proteinase,1,0.0
vi-,1,0.0
rus,1,0.0
patholog-,1,0.0
3C‑like,1,0.0
ical,1,0.0
RNA‑polymerase,1,0.0
epithe-,1,0.0
lial,1,0.0
RNA‑dependent,1,0.0
Phases,1,0.0
non-OCS,1,0.0
±6,1,0.0
≥90,1,0.0
≥450,1,0.0
statusOf,1,0.0
6-9,1,0.0
∼3,1,0.0
13-22,1,0.0
55-75,1,0.0
≥2,1,0.0
effectsOur,1,0.0
TEAM,1,0.0
raging,1,0.0
livelihoods,1,0.0
engineer,1,0.0
aQua,1,0.0
HIVAIDS,1,0.0
Antoni,1,0.0
Napoleon,1,0.0
beginnings,1,0.0
Franke,1,0.0
Marian,1,0.0
beta-adrenoreceptor,1,0.0
Gluziński,1,0.0
Dmochowski,1,0.0
burgeoning,1,0.0
Zdzisław,1,0.0
Risperidone,1,0.0
Pawiński,1,0.0
risperidone,1,0.0
Biegański,1,0.0
anatomopathology,1,0.0
Latkowski,1,0.0
adrenaline,1,0.0
Szymonowicz,1,0.0
nitroglycerine,1,0.0
years--pharmacotherapy,1,0.0
Hypertrophy,1,0.0
Remodeling,1,0.0
Neutralising,1,0.0
Immunodiagnostic,1,0.0
72-hour,1,0.0
A-29,1,0.0
B-35,1,0.0
C-53,1,0.0
Eq,1,0.0
eight-week,1,0.0
31st,1,0.0
thicknesses,1,0.0
treatment-decision,1,0.0
XX,1,0.0
λ-carrageenan,1,0.0
fellowship,1,0.0
miscellaneous,1,0.0
55254,1,0.0
92254,1,0.0
Hubeiin,1,0.0
11280,1,0.0
allergyimmunology,1,0.0
825731,1,0.0
1887,1,0.0
tallied,1,0.0
nanomedicine,1,0.0
Nanotechnology,1,0.0
Epidemiologists,1,0.0
Mymensingh,1,0.0
58871,1,0.0
43254,1,0.0
32254,1,0.0
Will,1,0.0
23254,1,0.0
8254,1,0.0
00023,1,0.0
555-4993,1,0.0
intravital,1,0.0
Adam,1,0.0
Hammer,1,0.0
Binomial,1,0.0
1157,1,0.0
Austria,1,0.0
Pleasure,1,0.0
1878,1,0.0
Krakow,1,0.0
obstructions,1,0.0
8308,1,0.0
10554,1,0.0
1985-1986,1,0.0
inhibiters,1,0.0
704,1,0.0
viscous,1,0.0
non-ischemic,1,0.0
Cantonal,1,0.0
avian-to-human,1,0.0
methotrexate,1,0.0
theophyllines,1,0.0
1962-1972,1,0.0
bata-2,1,0.0
lining,1,0.0
finalizing,1,0.0
Economics,1,0.0
spacers,1,0.0
bronchomalacia,1,0.0
566,1,0.0
pioneers,1,0.0
turns,1,0.0
scale-back,1,0.0
sterically,1,0.0
defeated,1,0.0
geo-data,1,0.0
ultra-cold,1,0.0
Middlesex,1,0.0
408,1,0.0
559,1,0.0
20-minute,1,0.0
ECG-defined,1,0.0
bronchidilators,1,0.0
dissatisfaction,1,0.0
Assurance,1,0.0
entrapment,1,0.0
difficult-to,1,0.0
care-seeking,1,0.0
Bronchoalveolar-lavage,1,0.0
communitySee,1,0.0
Intramyocardial,1,0.0
541,1,0.0
httpwwwbiomedcentralcom1741-701510117,1,0.0
apex,1,0.0
Apicoseptal,1,0.0
inferoseptal,1,0.0
595,1,0.0
703,1,0.0
surgical-treated,1,0.0
stentriever,1,0.0
Colored,1,0.0
CERX-CQ3001,1,0.0
eight-colored,1,0.0
terrestrial,1,0.0
Stroke-prevention,1,0.0
subpleural,1,0.0
Urged,1,0.0
compendium,1,0.0
Briefly,1,0.0
Patterns,1,0.0
nonrandom,1,0.0
migrations,1,0.0
Providing,1,0.0
derivation,1,0.0
Cree,1,0.0
Hudsons,1,0.0
Company,1,0.0
Subarctic,1,0.0
aged≤45,1,0.0
LpPLA2,1,0.0
monocellular,1,0.0
exquisitely,1,0.0
antiplatelet-aggregating,1,0.0
IUliter,1,0.0
USA‒specific,1,0.0
genome-scale,1,0.0
arrayed,1,0.0
Relatively,1,0.0
SDchord,1,0.0
-42,1,0.0
4310,1,0.0
Mulhouse,1,0.0
3477,1,0.0
6550,1,0.0
reperfusion-associated,1,0.0
Perspectives,1,0.0
disease‒related,1,0.0
crossroads,1,0.0
usurped,1,0.0
re-targeted,1,0.0
regains,1,0.0
disclose,1,0.0
monohemispheric,1,0.0
19-channel,1,0.0
electroencephalography,1,0.0
magnetoencephalography,1,0.0
MEG,1,0.0
powers,1,0.0
contra-,1,0.0
CLH,1,0.0
ILH,1,0.0
symmetry,1,0.0
parameterized,1,0.0
susceptible-exposed-infected-recovered,1,0.0
Low-band,1,0.0
Alsace-Lorraine,1,0.0
Haut-Rhin,1,0.0
LysGlu,1,0.0
Davis,1,0.0
J501YV3,1,0.0
ACVA,1,0.0
talked,1,0.0
ACVIs,1,0.0
non-rural,1,0.0
LaSalle,1,0.0
Jefferson,1,0.0
ant,1,0.0
Caldwell,1,0.0
Parish,1,0.0
admit,1,0.0
14401,1,0.0
21398,1,0.0
equivalence,1,0.0
Brescia,1,0.0
1450,1,0.0
SPT,1,0.0
extracts,1,0.0
768,1,0.0
20H501YV2,1,0.0
20I501YV1,1,0.0
eased,1,0.0
scenario-based,1,0.0
prefecture,1,0.0
descriptivecomparative,1,0.0
Needs,1,0.0
March‒June,1,0.0
Means,1,0.0
empowering,1,0.0
Anesthesiologists,1,0.0
acuteischemic,1,0.0
2-6,1,0.0
low-band,1,0.0
ipsi-,1,0.0
slows,1,0.0
RR-10,1,0.0
vaccine---recommendations,1,0.0
RR-8,1,0.0
pillars,1,0.0
unchecked,1,0.0
assuages,1,0.0
tangles,1,0.0
Antioxidants,1,0.0
neurofibrillary,1,0.0
three-fourths,1,0.0
fivefold,1,0.0
three-,1,0.0
autoregulatory,1,0.0
150mmHg,1,0.0
or6,1,0.0
months--8,1,0.0
mobilized,1,0.0
2010--11,1,0.0
APerth162009,1,0.0
High-Dose,1,0.0
standard-dose,1,0.0
Appeared,1,0.0
nephrologists,1,0.0
US-licensed,1,0.0
httpwwwcdcgovflu,1,0.0
announcements,1,0.0
Cytokine-mediated,1,0.0
IL-1-related,1,0.0
J-shaped,1,0.0
fine-tuning,1,0.0
cofactor,1,0.0
1232791,1,0.0
48539872,1,0.0
ARTIs,1,0.0
echogenicity,1,0.0
Diarylheptanoids,1,0.0
regional-level,1,0.0
diphenylheptanoids,1,0.0
α-tocopherol,1,0.0
turmeric,1,0.0
approximations,1,0.0
drug-sensitive,1,0.0
hitchhiking,1,0.0
counterpart--a,1,0.0
panzootic,1,0.0
modellers,1,0.0
FluWeb,1,0.0
Muscular,1,0.0
nonagenarian,1,0.0
inflow,1,0.0
twenty-first,1,0.0
cyst,1,0.0
liquefactive,1,0.0
El,1,0.0
Salvador,1,0.0
co-infected,1,0.0
aVR,1,0.0
Radiology,1,0.0
2010-2015,1,0.0
Crying-induced,1,0.0
xanthines,1,0.0
stimulants,1,0.0
enduring,1,0.0
refuting,1,0.0
Humans,1,0.0
Glu,1,0.0
interferon-β,1,0.0
collateralization,1,0.0
aquaculture--the,1,0.0
synthesisResults,1,0.0
criteriaData,1,0.0
dataStudy,1,0.0
Non-systematically,1,0.0
Person,1,0.0
neurorehabilitationThis,1,0.0
fundament,1,0.0
pendular,1,0.0
adaptations,1,0.0
lift,1,0.0
pushed,1,0.0
Revolution--will,1,0.0
shaft,1,0.0
lower-limb,1,0.0
ubiquitously,1,0.0
saliva-containing,1,0.0
splatter,1,0.0
Antegrade,1,0.0
guidewire,1,0.0
inequity,1,0.0
Uptake,1,0.0
universalize,1,0.0
geostatistical,1,0.0
Valencian,1,0.0
rhinoconjunctivitis,1,0.0
VSN,1,0.0
kringing,1,0.0
allergy-related,1,0.0
concomittant,1,0.0
Summarising,1,0.0
cooperate,1,0.0
Rint,1,0.0
nonventilated,1,0.0
acyclovir,1,0.0
January-March,1,0.0
stationary,1,0.0
1200,1,0.0
Considerable,1,0.0
PGM,1,0.0
Torrent,1,0.0
Ion,1,0.0
latecomer,1,0.0
solving,1,0.0
formoterol,1,0.0
reoccurrence,1,0.0
Ticagrelor,1,0.0
Prasugrel,1,0.0
682,1,0.0
sonothrombolysis,1,0.0
intensifying,1,0.0
6-week,1,0.0
pre-community-outbreak,1,0.0
uphill,1,0.0
P0·001,1,0.0
80·5,1,0.0
P0·025,1,0.0
Provision,1,0.0
unfolds,1,0.0
looked,1,0.0
hPSC,1,0.0
hPSC-derived,1,0.0
Unpartnered,1,0.0
co-location,1,0.0
nurse-coached,1,0.0
validationfeedback,1,0.0
encouragementsupport,1,0.0
relapsing-remitting,1,0.0
affordability,1,0.0
DOACs,1,0.0
bit,1,0.0
extrafine,1,0.0
CovaxinTM,1,0.0
BBV-152,1,0.0
CovishieldTM,1,0.0
ChAdOx1-nCOV,1,0.0
J-curve,1,0.0
SanSure,1,0.0
2-week,1,0.0
0107,1,0.0
GeneFinderTM,1,0.0
Janeiro,1,0.0
Rio,1,0.0
14-October,1,0.0
B1133,1,0.0
3272,1,0.0
electro-cardiographic,1,0.0
35-49,1,0.0
22-34,1,0.0
32-45,1,0.0
post-load,1,0.0
Misclassification,1,0.0
2-high,1,0.0
2-low,1,0.0
non-type,1,0.0
strives,1,0.0
ambiguity,1,0.0
bat-derived,1,0.0
strains-severe,1,0.0
paramivir,1,0.0
ganciclovir,1,0.0
protein-related,1,0.0
Whole-genome,1,0.0
flow-limiting,1,0.0
ulcerated,1,0.0
resign,1,0.0
1945,1,0.0
wean,1,0.0
veno-venous,1,0.0
Joseph,1,0.0
bioprosthesis,1,0.0
valvuloplasty,1,0.0
repaired,1,0.0
veno-arterial,1,0.0
Winston,1,0.0
Crimea,1,0.0
post-World,1,0.0
WWII,1,0.0
Churchills,1,0.0
him,1,0.0
minister,1,0.0
2h,1,0.0
unfolded,1,0.0
resignation,1,0.0
Britains,1,0.0
mismanagement,1,0.0
Suez,1,0.0
ramifications,1,0.0
post-WWII,1,0.0
miscommunication,1,0.0
Union-miscommunication,1,0.0
Cold,1,0.0
Administering,1,0.0
cardiopathy,1,0.0
deducing,1,0.0
1375,1,0.0
Brain-derived,1,0.0
angiotensin-converting-enzyme,1,0.0
survivability,1,0.0
biodistribution,1,0.0
electrically-heated,1,0.0
Infantile,1,0.0
purview,1,0.0
aphasias,1,0.0
phonology,1,0.0
Stroke-associated,1,0.0
polycations,1,0.0
ties,1,0.0
highly-conserved,1,0.0
semantics,1,0.0
sequence-specific,1,0.0
tow-,1,0.0
syntax,1,0.0
semantic,1,0.0
badly,1,0.0
orientated,1,0.0
feather-bedding,1,0.0
soft-toy,1,0.0
countryside,1,0.0
aeration,1,0.0
934,1,0.0
hemiplegias,1,0.0
Haemagglutination,1,0.0
ELISpot,1,0.0
sub-cohort,1,0.0
IL-17F,1,0.0
6769,1,0.0
fulfilment,1,0.0
Ex,1,0.0
617,1,0.0
backbones,1,0.0
single-,1,0.0
-22,1,0.0
Diagnosticat,1,0.0
instillation,1,0.0
knock-out,1,0.0
adipokine,1,0.0
Adiponectin,1,0.0
IL-10-secreting,1,0.0
IL-10-induced,1,0.0
salbutamol-induced,1,0.0
BMC-secreted,1,0.0
MGCBS,1,0.0
OLS,1,0.0
Plastic-adherent,1,0.0
COIVD-19-associated,1,0.0
bacterialallergic,1,0.0
skews,1,0.0
Life-threatening,1,0.0
cytopenias,1,0.0
clinicallaboratory,1,0.0
leukemias,1,0.0
Sloan,1,0.0
Kettering,1,0.0
CLL,1,0.0
p028,1,0.0
patient-related,1,0.0
p047,1,0.0
655,1,0.0
p019,1,0.0
postacute,1,0.0
ith,1,0.0
PWP,1,0.0
increment,1,0.0
nay,1,0.0
STABSTRACT,1,0.0
baculovirus-insect,1,0.0
Luminex-based,1,0.0
suspension,1,0.0
non-hospitalized,1,0.0
Q226I,1,0.0
adamantine,1,0.0
neuramidinase,1,0.0
stigmatization,1,0.0
undue,1,0.0
HIor40,1,0.0
mini-mental,1,0.0
scrutinized,1,0.0
post-immunization,1,0.0
community-living,1,0.0
p0018,1,0.0
A-H1N1,1,0.0
titreor140,1,0.0
single-blind,1,0.0
lowpathogenicity,1,0.0
Person-to-person,1,0.0
AEngland61107,1,0.0
tortuous,1,0.0
PR8-based,1,0.0
calcified,1,0.0
activations,1,0.0
rcso2,1,0.0
CBVI,1,0.0
000067,1,0.0
faithfully,1,0.0
Christchurch485-like,1,0.0
Amazingly,1,0.0
many-sided,1,0.0
Causal,1,0.0
endangered,1,0.0
heated,1,0.0
community-dwelling,1,0.0
EBBx,1,0.0
hundred-six,1,0.0
httpsbitly38JaUmB,1,0.0
16-685,1,0.0
comorbidityExpert,1,0.0
BAUmL,1,0.0
diseaseAreas,1,0.0
mixedChronic,1,0.0
cultivated,1,0.0
Farmers,1,0.0
weeksyear,1,0.0
Thirty-nine,1,0.0
nonsensitized,1,0.0
001-104,1,0.0
one-fourth,1,0.0
cultivate,1,0.0
Tayside,1,0.0
itching,1,0.0
5-month,1,0.0
cascades,1,0.0
E611PR8,1,0.0
mid-201314,1,0.0
n431,1,0.0
n344,1,0.0
-14,1,0.0
-36,1,0.0
clinically-useful,1,0.0
inpatient-based,1,0.0
Inpatient-based,1,0.0
17921000,1,0.0
Weeks,1,0.0
16961000,1,0.0
287,1,0.0
O3,1,0.0
specificityABSTRACT,1,0.0
improvementimmunity,1,0.0
Influenzas,1,0.0
1190,1,0.0
Running,1,0.0
asthmagenic,1,0.0
athmagenic,1,0.0
non-targeted,1,0.0
non-admitted,1,0.0
non-East,1,0.0
drastic,1,0.0
non-infarctive,1,0.0
MCP-1-mediated,1,0.0
CCR2,1,0.0
Targeted,1,0.0
MCP-1CCL2,1,0.0
Chemoattractant,1,0.0
non-transferred,1,0.0
90-180,1,0.0
180-360,1,0.0
pre-exercise,1,0.0
sub-sets,1,0.0
Door-to-balloon,1,0.0
intergenerational,1,0.0
anti-arrhythmic,1,0.0
asthmaA,1,0.0
Pregnancy,1,0.0
revisionsThe,1,0.0
intraventricular,1,0.0
mastery,1,0.0
pre-eclampsia,1,0.0
112-151,1,0.0
dovetailed,1,0.0
pregnancy-induced,1,0.0
Monocyte,1,0.0
pleasantly,1,0.0
Planar,1,0.0
vasodilators,1,0.0
sirolimus-,1,0.0
bare,1,0.0
mistakenly,1,0.0
A5,1,0.0
logically,1,0.0
Comment,1,0.0
dilating,1,0.0
overwhelmed,1,0.0
semi-closed,1,0.0
EU,1,0.0
out-of-danger,1,0.0
Unvaccinated,1,0.0
non-compliance,1,0.0
schooling,1,0.0
paclitaxel-eluting,1,0.0
annexin,1,0.0
9-month,1,0.0
PES,1,0.0
-020,1,0.0
aptitude,1,0.0
obligations,1,0.0
Gd-based,1,0.0
Gd-containing,1,0.0
aura-like,1,0.0
Manganese,1,0.0
precuneus,1,0.0
age-structured,1,0.0
preschool-age,1,0.0
20-39,1,0.0
6-19,1,0.0
Failing,1,0.0
4th-grade,1,0.0
102-133,1,0.0
babies,1,0.0
Vertical,1,0.0
Framing,1,0.0
pregnancyExpert,1,0.0
non-pharmacologic,1,0.0
PUBMEDMEDLINE,1,0.0
Covered,1,0.0
importanceAreas,1,0.0
afflict,1,0.0
3rd-,1,0.0
WhatsApp,1,0.0
smartphones,1,0.0
flourishing,1,0.0
Keeping,1,0.0
remoteruraldistrict,1,0.0
stretches,1,0.0
narrated,1,0.0
ambition,1,0.0
interoperable,1,0.0
co-ordinate,1,0.0
GNNs,1,0.0
GNN,1,0.0
high-intensity,1,0.0
graph-theory-based,1,0.0
neighborhood-based,1,0.0
99mTc-pyrophosphate,1,0.0
IMPACT,1,0.0
20SD,1,0.0
four-view,1,0.0
detector,1,0.0
halves,1,0.0
originate,1,0.0
bichromic,1,0.0
Space,1,0.0
strenghten,1,0.0
2337,1,0.0
sickened,1,0.0
100-131,1,0.0
101-129,1,0.0
3rd-grade,1,0.0
radiopager,1,0.0
105-139,1,0.0
113-133,1,0.0
lifeAsthma,1,0.0
co-variables,1,0.0
38-349,1,0.0
influenzapneumonia,1,0.0
piecewise,1,0.0
three-state,1,0.0
VSS,1,0.0
crucially,1,0.0
ridership,1,0.0
BRL,1,0.0
super-infections,1,0.0
DCP,1,0.0
DRC,1,0.0
infero-lateral,1,0.0
36-year-old,1,0.0
preventingtreating,1,0.0
transbronchial,1,0.0
Supportive,1,0.0
microsimulation,1,0.0
adult-specific,1,0.0
147072,1,0.0
157126,1,0.0
75663,1,0.0
63753,1,0.0
post-infectious,1,0.0
CRB-65,1,0.0
RBM,1,0.0
Rhinitis,1,0.0
localities,1,0.0
aircrafts,1,0.0
centrality,1,0.0
nil,1,0.0
well-managed,1,0.0
Suggestions,1,0.0
β-blockers,1,0.0
Anxieties,1,0.0
clips,1,0.0
stapling,1,0.0
18-39,1,0.0
60-81,1,0.0
voluntarism,1,0.0
self-confidence,1,0.0
Air-Mobile,1,0.0
aircraft,1,0.0
onboard,1,0.0
envisioned,1,0.0
Documents,1,0.0
controlledAreas,1,0.0
Delphi,1,0.0
send,1,0.0
agreedExpert,1,0.0
barely,1,0.0
aided,1,0.0
Resurgences,1,0.0
near-real-time,1,0.0
procured,1,0.0
self-quarantine,1,0.0
Richmond,1,0.0
Boston,1,0.0
grocery,1,0.0
Confirmative,1,0.0
5217,1,0.0
1991-1995,1,0.0
quarter-century-old,1,0.0
TH2-low,1,0.0
endotypes--has,1,0.0
Fourth,1,0.0
2392,1,0.0
1999-2009,1,0.0
vapor,1,0.0
Metropolitan,1,0.0
8696,1,0.0
chills,1,0.0
hijacking,1,0.0
enclosed,1,0.0
coronaviruss,1,0.0
dusty,1,0.0
assertion,1,0.0
Characterised,1,0.0
trading,1,0.0
Samoan,1,0.0
mainstream,1,0.0
sadly,1,0.0
contagionism,1,0.0
TH2-high,1,0.0
monocausalism,1,0.0
inflammation--into,1,0.0
Original,1,0.0
dichotomizing,1,0.0
colonial,1,0.0
00004,1,0.0
editorials,1,0.0
interconnected,1,0.0
Oceania,1,0.0
cryptic,1,0.0
exemplifies,1,0.0
Baltic,1,0.0
vaccinations5,1,0.0
3935,1,0.0
778,1,0.0
Ribosomal,1,0.0
17081000,1,0.0
annually6,1,0.0
care-associated,1,0.0
viruses4,1,0.0
fish,1,0.0
lineage3,1,0.0
BPhuket30732013-like,1,0.0
Kong48012014,1,0.0
H1N1pdm09-like,1,0.0
22711000,1,0.0
Trivalent,1,0.0
40S,1,0.0
1974—The,1,0.0
ribosomal,1,0.0
S3P,1,0.0
DNA-binding,1,0.0
100216–221,1,0.0
Macaca,1,0.0
Am,1,0.0
fascicularis,1,0.0
Kong15697,1,0.0
euthanatized,1,0.0
broncho-interstitial,1,0.0
desquamation,1,0.0
intra-alveolar,1,0.0
splenial,1,0.0
Inaccurate,1,0.0
psychophysical,1,0.0
vaccine2,1,0.0
everyone,1,0.0
AAP,1,0.0
8951000,1,0.0
current-day,1,0.0
subcellular,1,0.0
alignments,1,0.0
httpcovdbpopgeneticsnet,1,0.0
exudation,1,0.0
Antigen-induced,1,0.0
neuropeptides,1,0.0
30-DEM,1,0.0
extravasation,1,0.0
protein-bound,1,0.0
dyes,1,0.0
Non-invasive,1,0.0
probiotic,1,0.0
England4272,1,0.0
midshipman,1,0.0
Along,1,0.0
DSM,1,0.0
17938,1,0.0
1X108CFU,1,0.0
DBPC,1,0.0
6-14,1,0.0
T-2,1,0.0
108CFU,1,0.0
exaled,1,0.0
midshipmen,1,0.0
p0045,1,0.0
CFU,1,0.0
Aeroallergens,1,0.0
flares,1,0.0
naval,1,0.0
6129,1,0.0
9565,1,0.0
Corrado,1,0.0
dAP,1,0.0
bulgaricus,1,0.0
Airways,1,0.0
ssp,1,0.0
delbrueckii,1,0.0
Lactobacillus,1,0.0
Fomite,1,0.0
Endpoint,1,0.0
Zixiao,1,0.0
rate-pressure,1,0.0
≥34,1,0.0
3237,1,0.0
Ct≥34,1,0.0
E-gene,1,0.0
Modular,1,0.0
academies,1,0.0
PRACTALL,1,0.0
nominated,1,0.0
961,1,0.0
Amendments,1,0.0
20-71,1,0.0
482,1,0.0
drink,1,0.0
consume,1,0.0
dairy,1,0.0
Consumption,1,0.0
500000,1,0.0
Depressed,1,0.0
turning,1,0.0
nebulisation,1,0.0
Suzhou,1,0.0
leftventricular,1,0.0
Li,1,0.0
Glycomics,1,0.0
6130,1,0.0
Live-attenuated,1,0.0
cell-depleting,1,0.0
natalizumab,1,0.0
fumarates,1,0.0
teriflunomide,1,0.0
glatiramer,1,0.0
Interferon-beta,1,0.0
anti-anginal,1,0.0
alphabet,1,0.0
increments,1,0.0
negotiate,1,0.0
opted,1,0.0
CRISPRCas9-mediated,1,0.0
lady,1,0.0
84-year-old,1,0.0
ocrelizumab,1,0.0
ofatumumab,1,0.0
alemtuzumab,1,0.0
measurable,1,0.0
cladribine,1,0.0
sphingosine-1-phosphate,1,0.0
Coordinating,1,0.0
photovoice,1,0.0
Mexican-American,1,0.0
Albacete,1,0.0
Galdakao,1,0.0
Huelva,1,0.0
Oviedo,1,0.0
ARIs,1,0.0
dPAP,1,0.0
proofing,1,0.0
habitats,1,0.0
concentrating,1,0.0
Physiotherapy,1,0.0
predicated,1,0.0
agriculture,1,0.0
vs7391,1,0.0
forceps,1,0.0
Chapter,1,0.0
alligator-tooth,1,0.0
bystander-initiated,1,0.0
hood,1,0.0
broken,1,0.0
Histopathologic,1,0.0
queried,1,0.0
technetium-99,1,0.0
pylorus,1,0.0
stannous,1,0.0
neck-chest-abdominal,1,0.0
half-broken,1,0.0
hastens,1,0.0
hopeful,1,0.0
Peri-hematomal,1,0.0
Self-ratings,1,0.0
Couples,1,0.0
3-77,1,0.0
polysensitization,1,0.0
cereals,1,0.0
7742,1,0.0
textiles,1,0.0
5652,1,0.0
arthropod,1,0.0
herbicides,1,0.0
fungicides,1,0.0
antiparasites,1,0.0
dependant,1,0.0
endotoxins,1,0.0
swallowed,1,0.0
Timing,1,0.0
ingested,1,0.0
unforced,1,0.0
beneath,1,0.0
arming,1,0.0
waived,1,0.0
reexposure,1,0.0
antinflammatory,1,0.0
toxics,1,0.0
individual-,1,0.0
neighborhood-level,1,0.0
Rising,1,0.0
criterion-based,1,0.0
audited,1,0.0
five-week,1,0.0
history-taking,1,0.0
one-month,1,0.0
step--elimination,1,0.0
Meta-Analysis,1,0.0
methylxanthines,1,0.0
facilities--these,1,0.0
Loop-mediated,1,0.0
976,1,0.0
bear,1,0.0
Biobanks,1,0.0
biobank,1,0.0
upload,1,0.0
preconfigured,1,0.0
purpose-built,1,0.0
V1-V3,1,0.0
V4-V6,1,0.0
phonocardiography,1,0.0
10144,1,0.0
Mutational,1,0.0
Kolonel,1,0.0
Biochemistry,1,0.0
cytoskeleton,1,0.0
surfactant,1,0.0
peptidome,1,0.0
Hsp70,1,0.0
FKBP4,1,0.0
Alteration,1,0.0
signal-associated,1,0.0
iTRAQ,1,0.0
cortico-subcortical,1,0.0
627K,1,0.0
H10N8,1,0.0
Coxs,1,0.0
tachycardias,1,0.0
multiform,1,0.0
mgHg,1,0.0
shotgun,1,0.0
immunodiagnostics,1,0.0
Accurately,1,0.0
E627K,1,0.0
hyperintensities,1,0.0
punctate,1,0.0
emanating,1,0.0
aside,1,0.0
multiprofessional,1,0.0
non-pulmonary,1,0.0
realigning,1,0.0
co-ordination,1,0.0
clarity,1,0.0
artery-associated,1,0.0
Thailands,1,0.0
Implicit,1,0.0
470000,1,0.0
Saxony-Anhalt,1,0.0
filly,1,0.0
odd,1,0.0
MIDs,1,0.0
peculiarities,1,0.0
showcasing,1,0.0
rabies,1,0.0
spitting,1,0.0
deliberately,1,0.0
multiplying,1,0.0
disregarding,1,0.0
sulfonamide,1,0.0
goal-oriented,1,0.0
RHS,1,0.0
self-confinement,1,0.0
LHS,1,0.0
super-emitters,1,0.0
super-spreaders,1,0.0
intentional,1,0.0
clinical-epidemiological,1,0.0
elution,1,0.0
ascendant,1,0.0
seroepidemiologic,1,0.0
rolled,1,0.0
GFYAQGSR,1,0.0
inhibitorsThe,1,0.0
ADETQALPQR,1,0.0
B-types,1,0.0
elder,1,0.0
nanoLC-MSMS,1,0.0
precedence,1,0.0
timeframe,1,0.0
foal,1,0.0
Hypersensitivity,1,0.0
simili,1,0.0
infestation,1,0.0
Tanzanian,1,0.0
4305,1,0.0
protrusion,1,0.0
myocutaneous,1,0.0
arrives,1,0.0
symposium,1,0.0
tracheostoma,1,0.0
819,1,0.0
LBC,1,0.0
smears,1,0.0
ascaris-endemic,1,0.0
Papanicolaou,1,0.0
reposition,1,0.0
cervix,1,0.0
Gore-Tex,1,0.0
uterine,1,0.0
eluded,1,0.0
dispatches,1,0.0
manubriectomy,1,0.0
brain-saving,1,0.0
hemiclaviculectomy,1,0.0
pharynx,1,0.0
nine-week,1,0.0
anal,1,0.0
n125,1,0.0
7-year-old,1,0.0
shadows,1,0.0
stoma,1,0.0
postradiotherapy,1,0.0
tracheostomy,1,0.0
aides,1,0.0
theater,1,0.0
syntactic,1,0.0
Counterbalancing,1,0.0
colour,1,0.0
software-generated,1,0.0
ACC,1,0.0
heat-resistant,1,0.0
Faecal,1,0.0
weaning,1,0.0
64-91,1,0.0
wealthy,1,0.0
mRNA-COVID-19,1,0.0
19-,1,0.0
585,1,0.0
riskbenefit,1,0.0
Platelet,1,0.0
pharmacoinvasive,1,0.0
transcriptases,1,0.0
polymerases,1,0.0
better-customized,1,0.0
immune-compromised,1,0.0
Moloney,1,0.0
9944,1,0.0
Thermotoga,1,0.0
petrophila,1,0.0
K4,1,0.0
Thermococcus,1,0.0
newest,1,0.0
kodakarensis,1,0.0
KOD1,1,0.0
hobbies,1,0.0
Thermus,1,0.0
uracil-DNA,1,0.0
glycosylase,1,0.0
sewage-based,1,0.0
UNG,1,0.0
biorepositories,1,0.0
irresponsible,1,0.0
directional,1,0.0
MEGA,1,0.0
Breathing,1,0.0
stressing,1,0.0
metabisulphites,1,0.0
metabisulphates,1,0.0
preservatives,1,0.0
Sulfites,1,0.0
ordering,1,0.0
cluster-specific,1,0.0
hydraulic,1,0.0
USAF,1,0.0
depositions,1,0.0
bifurcations,1,0.0
impinged,1,0.0
Constricted,1,0.0
Aerospace,1,0.0
Blouse,1,0.0
Preventative,1,0.0
Searches,1,0.0
STROBE,1,0.0
writing-up,1,0.0
recruiting,1,0.0
D222G,1,0.0
-310,1,0.0
HA-D222N,1,0.0
Optimizing,1,0.0
D222E,1,0.0
PB2-E627K,1,0.0
NS1-T123V,1,0.0
severefatal,1,0.0
quasispecies,1,0.0
Percheron,1,0.0
flatten,1,0.0
Nonsevere,1,0.0
flow-related,1,0.0
mortal,1,0.0
Non-uniform,1,0.0
inactivator,1,0.0
β-propiolactone,1,0.0
whole-virus,1,0.0
NSP13,1,0.0
Neutral,1,0.0
mutating,1,0.0
NSP12b,1,0.0
CT-based,1,0.0
parsimony,1,0.0
ws-SNPsGO,1,0.0
PROVEAN,1,0.0
SIFT,1,0.0
Detective,1,0.0
78236,1,0.0
vv,1,0.0
α-26-linked,1,0.0
lysing,1,0.0
salvaging,1,0.0
AFB,1,0.0
Neuroprotective,1,0.0
Brooks,1,0.0
anti-leucocyte,1,0.0
clomethiazole,1,0.0
nalmefene,1,0.0
Encouragingly,1,0.0
YM,1,0.0
BMS,1,0.0
204352,1,0.0
140690-700e8,1,0.0
archetypes,1,0.0
1-8,1,0.0
reinfect,1,0.0
packed,1,0.0
recognising,1,0.0
germ,1,0.0
long-termed,1,0.0
hospices,1,0.0
gravidas,1,0.0
teen-agers,1,0.0
eruption,1,0.0
syb-type,1,0.0
piggy,1,0.0
CVEs,1,0.0
dose-dependently,1,0.0
mivacurium,1,0.0
atracurium,1,0.0
pancuronium,1,0.0
cisatracurium,1,0.0
rocuronium,1,0.0
post-hoc,1,0.0
hipurgia,1,0.0
compulsory-duty,1,0.0
servicemen,1,0.0
Latent,1,0.0
Accountancy,1,0.0
hyperpyretic,1,0.0
NAVY,1,0.0
HAIVEN,1,0.0
multiyear,1,0.0
breath-omics,1,0.0
aftercare,1,0.0
allergen-specific,1,0.0
Th1-type,1,0.0
allergen-related,1,0.0
Human-severe,1,0.0
outcomes-it,1,0.0
Vecuronium,1,0.0
Sevoflurane,1,0.0
isoflurane,1,0.0
ANOVAs,1,0.0
children5,1,0.0
infection-induced,1,0.0
Age-,1,0.0
Deciding,1,0.0
dies,1,0.0
appeal,1,0.0
Aetiological,1,0.0
explorations,1,0.0
hierarchically,1,0.0
VUM,1,0.0
4272,1,0.0
6971,1,0.0
40-44,1,0.0
Kruskal-Wallis,1,0.0
pairwise,1,0.0
enflurane,1,0.0
state-based,1,0.0
1995-1998,1,0.0
deathmyocardial,1,0.0
infarctionrevascularizationangina,1,0.0
understandable,1,0.0
Anaesthetic,1,0.0
visualizations,1,0.0
Lidocaine,1,0.0
albuterol,1,0.0
minimizes,1,0.0
histamine-induced,1,0.0
etomidate,1,0.0
thiopental,1,0.0
Halothane,1,0.0
triple-line,1,0.0
TL-LFA,1,0.0
Pneumococcus,1,0.0
non-Jewish,1,0.0
Well-standardized,1,0.0
hastened,1,0.0
EUSI,1,0.0
ENS,1,0.0
unremittingly,1,0.0
Societies,1,0.0
1120,1,0.0
harboring,1,0.0
internet,1,0.0
faster-spreading,1,0.0
cytometry-based,1,0.0
14-fold,1,0.0
Cominarty,1,0.0
sixfold,1,0.0
One-fifth,1,0.0
histometric,1,0.0
dystrophic,1,0.0
necrobiotic,1,0.0
intrarenal,1,0.0
Xe133,1,0.0
Estonia,1,0.0
inventory-20,1,0.0
MFI-20,1,0.0
apathetic,1,0.0
avert,1,0.0
imagingdiffusion-weighted,1,0.0
activity-related,1,0.0
municipality,1,0.0
Tubarão,1,0.0
Catarina,1,0.0
creeping,1,0.0
GFP,1,0.0
gargling,1,0.0
exposure-type,1,0.0
Sulphites,1,0.0
TDI-induced,1,0.0
forty-two,1,0.0
diarrhoea,1,0.0
flushing,1,0.0
urticaria,1,0.0
pulmonologist,1,0.0
H1NI,1,0.0
55-64,1,0.0
subtropicaltropical,1,0.0
vapour,1,0.0
2000-2007,1,0.0
Territory,1,0.0
805,1,0.0
Kongs,1,0.0
3-10,1,0.0
sulphite-sensitive,1,0.0
sensibilisation,1,0.0
Hydrometeorological,1,0.0
ppb,1,0.0
isocyanate-related,1,0.0
Station,1,0.0
4038,1,0.0
toluene-diisocyanate,1,0.0
804,1,0.0
isocyanate-sensitive,1,0.0
EFNS,1,0.0
strokes-196,1,0.0
-0016,1,0.0
ARIMA,1,0.0
-0006,1,0.0
-0003,1,0.0
Hypercoagulability,1,0.0
sepsis-induced,1,0.0
decides,1,0.0
reestablished,1,0.0
17187,1,0.0
11712,1,0.0
3539,1,0.0
vectorcardiogram,1,0.0
Techniques,1,0.0
ST-segments,1,0.0
sensitivity-96,1,0.0
optic,1,0.0
clot-specific,1,0.0
plasmin,1,0.0
Glial,1,0.0
inert,1,0.0
dissolve,1,0.0
Urokinase,1,0.0
12490,1,0.0
Inhibitor,1,0.0
subsetting,1,0.0
MIsABSTRACT,1,0.0
CCL81,1,0.0
008-014,1,0.0
2821-2849,1,0.0
contours,1,0.0
marginated,1,0.0
Activated,1,0.0
names,1,0.0
posteriorly,1,0.0
questionnaireEighteen,1,0.0
anteriorly,1,0.0
paratracheal,1,0.0
disappears,1,0.0
strokeA,1,0.0
e-stim,1,0.0
Metoprolol,1,0.0
Fibrillary,1,0.0
httpisaregistriesorg,1,0.0
macular,1,0.0
pucker,1,0.0
fundus,1,0.0
extinguished,1,0.0
non-winter,1,0.0
neurotrophins,1,0.0
S-100β,1,0.0
reinvigorated,1,0.0
incidental,1,0.0
typesOur,1,0.0
revisit,1,0.0
specificity-,1,0.0
RBP4,1,0.0
intraoperability,1,0.0
inclusivityopenness,1,0.0
Acidic,1,0.0
continuance,1,0.0
SARS-CoV-2hepatitis,1,0.0
Procedure-related,1,0.0
Retinol,1,0.0
procedure-related,1,0.0
Distal,1,0.0
sensitivity-,1,0.0
open-cell,1,0.0
specificity-100,1,0.0
friable,1,0.0
adhering,1,0.0
reflow,1,0.0
thromboatherosclerotic,1,0.0
clear-cut,1,0.0
June-September,1,0.0
November-March,1,0.0
para-aortic,1,0.0
mid-January,1,0.0
sides,1,0.0
woken,1,0.0
lmin-1,1,0.0
printed,1,0.0
Consultations,1,0.0
2020433e151-e158,1,0.0
0628-0885,1,0.0
3824,1,0.0
0749,1,0.0
0663-0871,1,0.0
0762,1,0.0
registrations,1,0.0
Xa,1,0.0
2614-5406,1,0.0
helpfulABSTRACT,1,0.0
immobility,1,0.0
adopts,1,0.0
Avant,1,0.0
reciprocally,1,0.0
472,1,0.0
478,1,0.0
Influenza-associated,1,0.0
PTAS,1,0.0
PURPOSE,1,0.0
inconveniences,1,0.0
reliabilities,1,0.0
Self-protection,1,0.0
refusing,1,0.0
warn,1,0.0
Goroka,1,0.0
compartmentalization,1,0.0
enpowerment,1,0.0
2272,1,0.0
mid-way,1,0.0
Medisoft,1,0.0
navigateaccess,1,0.0
Potent,1,0.0
non-cognitive,1,0.0
Aerocrine,1,0.0
chemiluminescence-based,1,0.0
HypAir,1,0.0
electrochemical-based,1,0.0
Personalised,1,0.0
on-and-off,1,0.0
triples,1,0.0
uncharacteristic,1,0.0
Microbiological,1,0.0
mAb,1,0.0
subordinate,1,0.0
captures,1,0.0
5-HL,1,0.0
transsternal,1,0.0
renin-aldosterone-angiotensin-system,1,0.0
activators,1,0.0
transclavicular,1,0.0
urokinase-type,1,0.0
unhealthy,1,0.0
Metabolically,1,0.0
uPA,1,0.0
obesity-associated,1,0.0
Venous,1,0.0
arthroplasty,1,0.0
Humana,1,0.0
153245,1,0.0
implements,1,0.0
TKAs,1,0.0
BA44,1,0.0
≥71,1,0.0
Bydgoszcz,1,0.0
nosological,1,0.0
double-blinded,1,0.0
rupturing,1,0.0
colonized,1,0.0
Charcot-Bouchard,1,0.0
p0049,1,0.0
justifying,1,0.0
self-awareness,1,0.0
Medicum,1,0.0
crystallization,1,0.0
immersion,1,0.0
verbatim,1,0.0
Interpretive,1,0.0
interpretive,1,0.0
pessimism,1,0.0
PATS,1,0.0
CAPPP,1,0.0
HOPE,1,0.0
NORDIL,1,0.0
LIFE,1,0.0
p0004,1,0.0
SCOPE,1,0.0
ANBP2,1,0.0
ALLHAT,1,0.0
devoid,1,0.0
Inside,1,0.0
ARB,1,0.0
communicability,1,0.0
Cold-adapted,1,0.0
Difficult-to-Treat,1,0.0
Bronchiale,1,0.0
Necessarily,1,0.0
Carrying,1,0.0
sustained-handgrip,1,0.0
convalescing,1,0.0
Glucagon,1,0.0
2011-September,1,0.0
Jakarta,1,0.0
18756008,1,0.0
5713811,1,0.0
281010135,1,0.0
VF--primary,1,0.0
recurrent--are,1,0.0
Metabolic,1,0.0
Collegium,1,0.0
acid-base,1,0.0
electrolyte,1,0.0
35-74,1,0.0
reanimation,1,0.0
Carbohydrate,1,0.0
Pathophysiologic,1,0.0
ambulant,1,0.0
endometriosis,1,0.0
cardiotonic,1,0.0
terrain,1,0.0
resp,1,0.0
Greek,1,0.0
rhinorhea,1,0.0
reverse-transcriptase-polymerase-chain-reaction,1,0.0
myocardiosclerosis,1,0.0
tragically,1,0.0
Morris,1,0.0
BTS,1,0.0
shoppong,1,0.0
basket,1,0.0
rucksack,1,0.0
Azygos-pleural,1,0.0
paraspinous,1,0.0
F₂-isoprostanes,1,0.0
027–093,1,0.0
samplespotentially,1,0.0
proportion-positive,1,0.0
acceptanceThe,1,0.0
p031,1,0.0
thresholdCt,1,0.0
refrigeration,1,0.0
95confidence,1,0.0
httpsbitly3gpBC75,1,0.0
LRIs,1,0.0
spheres,1,0.0
constraining,1,0.0
7833,1,0.0
8°C,1,0.0
4°Cfor,1,0.0
non-serious,1,0.0
populationAlmost,1,0.0
1170,1,0.0
1030,1,0.0
clarifies,1,0.0
skepticism,1,0.0
distorts,1,0.0
Agencies,1,0.0
purposefully,1,0.0
less-focused,1,0.0
company-sponsored,1,0.0
thereunder,1,0.0
cost-savings,1,0.0
strokestransitory,1,0.0
TH1-type,1,0.0
alternata,1,0.0
one-size,1,0.0
challengingGuidelines,1,0.0
monitoringcontainment,1,0.0
7-12,1,0.0
blistering,1,0.0
A--55,1,0.0
P002,1,0.0
low-population,1,0.0
southwest,1,0.0
scarcely,1,0.0
subepidermal,1,0.0
Bullous,1,0.0
conceivable,1,0.0
MLC601,1,0.0
reside,1,0.0
CHIMES,1,0.0
devolution,1,0.0
asset-based,1,0.0
noninvasively,1,0.0
B--70,1,0.0
multi-vessel,1,0.0
resource-heavy,1,0.0
experimenting,1,0.0
antianginal,1,0.0
prodromata,1,0.0
golf,1,0.0
claiming,1,0.0
bowling,1,0.0
gateball,1,0.0
jogging,1,0.0
baseball,1,0.0
alarmingly,1,0.0
ball,1,0.0
games,1,0.0
trunks,1,0.0
concordantly,1,0.0
2622,1,0.0
acid-human,1,0.0
PA-HSA,1,0.0
9714,1,0.0
contig,1,0.0
24-hours,1,0.0
UFH,1,0.0
1ab,1,0.0
cell-cultured,1,0.0
LMWHs,1,0.0
price,1,0.0
beforehand,1,0.0
chemoradiotherapy,1,0.0
paying,1,0.0
praise,1,0.0
radiotherapy,1,0.0
disregard,1,0.0
prohibition,1,0.0
enrichment-based,1,0.0
insulo-opercular,1,0.0
BTA,1,0.0
RT-RPA,1,0.0
confidential,1,0.0
halved,1,0.0
Isoprostanes,1,0.0
prostaglandin,1,0.0
PG-like,1,0.0
non-enzymatic,1,0.0
prostane,1,0.0
isoprostane,1,0.0
Generation,1,0.0
F₂-isoprostane,1,0.0
D₂-,1,0.0
E₂-isoprostanes,1,0.0
transcription-recombinase,1,0.0
fractionate,1,0.0
JES,1,0.0
Hashimoto,1,0.0
49-year-old,1,0.0
cursorily,1,0.0
1995-March,1,0.0
arteriosclerosis,1,0.0
vasculitides,1,0.0
coagulopathies,1,0.0
3Ms,1,0.0
hypoglycaemic,1,0.0
berry,1,0.0
asthma-prurigo,1,0.0
carried-out,1,0.0
Eysenck,1,0.0
Personality,1,0.0
sea-side,1,0.0
everybody,1,0.0
counter-shocks,1,0.0
one-to-one,1,0.0
cardiac-assist,1,0.0
microaxial,1,0.0
35Lmin,1,0.0
Pre-infarction,1,0.0
intravenous-inter-arterial,1,0.0
IV-IA,1,0.0
full-dose,1,0.0
realtime,1,0.0
kringle,1,0.0
PVD,1,0.0
Intermediate,1,0.0
malefemale,1,0.0
factorssubtypes,1,0.0
stroke-affected,1,0.0
Enjoyment,1,0.0
near-infrared-fluorescence,1,0.0
whereof,1,0.0
Sputnik,1,0.0
Length,1,0.0
chemoprophylactic,1,0.0
MEP,1,0.0
Rather,1,0.0
PWIDWI,1,0.0
appropriateness,1,0.0
Gamaleyas,1,0.0
cardiocirculatory,1,0.0
AstraZenecas,1,0.0
Modernas,1,0.0
PfizerBioNTechs,1,0.0
tessutal,1,0.0
vasopressor,1,0.0
volemic,1,0.0
HEK,1,0.0
roentgenography,1,0.0
Intermittent,1,0.0
subgrouped,1,0.0
Fam,1,0.0
25-32,1,0.0
32-38,1,0.0
flow-cytometric,1,0.0
somnolence,1,0.0
psittaci,1,0.0
paresthesias,1,0.0
hearing,1,0.0
963,1,0.0
Bronx,1,0.0
epicenters,1,0.0
Fifty-five,1,0.0
848,1,0.0
plain,1,0.0
biorhythmic,1,0.0
50-500,1,0.0
Multivariable-adjusted,1,0.0
91000,1,0.0
misreporting,1,0.0
101000,1,0.0
131000,1,0.0
69±10,1,0.0
3298,1,0.0
14±7,1,0.0
breath-ing,1,0.0
Manhattan,1,0.0
phosphorylated,1,0.0
settingsTo,1,0.0
realities,1,0.0
prepares,1,0.0
vanished,1,0.0
biorhythm,1,0.0
sociodemographics,1,0.0
113-202,1,0.0
agesex-adjusted,1,0.0
113-193,1,0.0
socieoeconomic,1,0.0
33-day,1,0.0
085-162,1,0.0
endocannabinoid,1,0.0
cannabinoid,1,0.0
photothrombotic,1,0.0
sympathoexcitation,1,0.0
28-,1,0.0
23-,1,0.0
acute-stage,1,0.0
130000,1,0.0
Biorhythm,1,0.0
post-diagnosis,1,0.0
Inter,1,0.0
Quartile,1,0.0
incompleteAimsThis,1,0.0
entertainment,1,0.0
absences,1,0.0
201617,1,0.0
011-093,1,0.0
analysisResultsThe,1,0.0
oseltamivirMethodsParticipants,1,0.0
BackgroundEvidence,1,0.0
31-58,1,0.0
Dominican,1,0.0
trombolytic,1,0.0
unadvisable,1,0.0
titrate,1,0.0
one-time,1,0.0
calcium-antagonists--the,1,0.0
influenzaConclusionsOseltamivir,1,0.0
NICE,1,0.0
IDSA,1,0.0
antibody-maturation,1,0.0
complying,1,0.0
Laser-scribed,1,0.0
COVID-19-negative,1,0.0
graphene,1,0.0
holding,1,0.0
nanostructures,1,0.0
photoelectron,1,0.0
spectroscopy,1,0.0
avidities,1,0.0
nanostructured,1,0.0
XPS,1,0.0
characterizations,1,0.0
smartphone,1,0.0
nitrodrivatives,1,0.0
therapies--ie,1,0.0
fast-paced,1,0.0
infuse,1,0.0
Vircell-IgMIgA,1,0.0
allografts,1,0.0
deceased-donor,1,0.0
interleukine-6,1,0.0
neglecting,1,0.0
cross-regionally,1,0.0
Fund,1,0.0
I63,1,0.0
Vircell-IgMA,1,0.0
well-organised,1,0.0
Dermatology,1,0.0
hyposensitation,1,0.0
MVA,1,0.0
81-year-old,1,0.0
interatomic,1,0.0
TNFα,1,0.0
inequitable,1,0.0
scattered,1,0.0
discretely,1,0.0
httpbiszjueducnovercovid,1,0.0
page,1,0.0
scientist,1,0.0
PF14,1,0.0
NF55,1,0.0
scheduling,1,0.0
transfect,1,0.0
lung-targeted,1,0.0
cargos,1,0.0
pDNA,1,0.0
shRNA,1,0.0
1969-78,1,0.0
ionized,1,0.0
intrapsychic,1,0.0
spasticity,1,0.0
symptom-monitoring,1,0.0
deaths1,1,0.0
countries2,1,0.0
20113,1,0.0
requisite,1,0.0
incurring,1,0.0
possession,1,0.0
terrible,1,0.0
pandemic-fighting,1,0.0
inflammation-prone,1,0.0
bronchus-associated,1,0.0
iBALTs,1,0.0
CCL19,1,0.0
CXCL13,1,0.0
patented,1,0.0
anti-proinflammatory,1,0.0
employs,1,0.0
Atlas-to-scan,1,0.0
application-dependent,1,0.0
handles,1,0.0
atlas-defined,1,0.0
atlas-quantified,1,0.0
atlas-guided,1,0.0
scan-derived,1,0.0
quantifies,1,0.0
immunosuppressiveimmunomodulating,1,0.0
Topic,1,0.0
diseasesauthors,1,0.0
vasculatures,1,0.0
interlinked,1,0.0
plethysmograph,1,0.0
POSSIBLE,1,0.0
DEFINITE,1,0.0
28-day,1,0.0
faciliate,1,0.0
BK,1,0.0
test-based,1,0.0
Basketball,1,0.0
rapid-turnaround,1,0.0
cortically,1,0.0
MI-based,1,0.0
brain-machine,1,0.0
wrist,1,0.0
extensor,1,0.0
flexor,1,0.0
conditioning-test,1,0.0
interstimulus,1,0.0
cytokinemia,1,0.0
injury-causing,1,0.0
6600000,1,0.0
390000,1,0.0
animate,1,0.0
unanimate,1,0.0
infectuousness,1,0.0
equipments,1,0.0
authories,1,0.0
reexamine,1,0.0
Augsburg,1,0.0
Event,1,0.0
330000,1,0.0
25-74,1,0.0
1012,1,0.0
1021,1,0.0
over-production,1,0.0
anti-infectious,1,0.0
Model-B,1,0.0
IL1A,1,0.0
confluence,1,0.0
THAWS,1,0.0
Unclear-Onset,1,0.0
Alteplase,1,0.0
KNOW,1,0.0
TLCO,1,0.0
DO,1,0.0
Conduct,1,0.0
Interleukin-1A,1,0.0
Interleukin-1B,1,0.0
rs1304037,1,0.0
rs16347,1,0.0
rs17561,1,0.0
rs2071373,1,0.0
rs1143623,1,0.0
accrual,1,0.0
rs3917345,1,0.0
rs1143627,1,0.0
IL1B,1,0.0
matrix-assisted,1,0.0
desorptionionization,1,0.0
MALDI-TOF,1,0.0
stroke-treating,1,0.0
geo-mapping,1,0.0
EVT-center,1,0.0
trauma-models,1,0.0
15-,1,0.0
state-level,1,0.0
Model-A,1,0.0
greedy,1,0.0
cardiogram,1,0.0
entrenching,1,0.0
30-70,1,0.0
recalcitrant,1,0.0
Reflecting,1,0.0
envenomated,1,0.0
normality,1,0.0
heart-disease,1,0.0
100--109,1,0.0
FDPS,1,0.0
104--110,1,0.0
Health-related,1,0.0
judgments,1,0.0
Acceptable,1,0.0
Acceptability,1,0.0
rho,1,0.0
-065,1,0.0
Institut,1,0.0
Veille,1,0.0
Sanitaire,1,0.0
AH3N2-related,1,0.0
36-55,1,0.0
8th-10th,1,0.0
monophasic,1,0.0
polyphasic,1,0.0
evaluable,1,0.0
Increasingly,1,0.0
regionallyABSTRACT,1,0.0
814,1,0.0
792,1,0.0
469,1,0.0
p0036,1,0.0
underutilize,1,0.0
prelude,1,0.0
courseABSTRACT,1,0.0
8000,1,0.0
674,1,0.0
midregional,1,0.0
proatrial,1,0.0
MR-proANP,1,0.0
Twenty-six,1,0.0
257000,1,0.0
481000,1,0.0
047-088,1,0.0
166-277,1,0.0
prefecture-level,1,0.0
demographers,1,0.0
197-202,1,0.0
362-371,1,0.0
puzzle,1,0.0
Informal,1,0.0
scintigraphically,1,0.0
hyperuricaemia,1,0.0
99Tcm,1,0.0
PyP,1,0.0
unremittent,1,0.0
instrumentation-based,1,0.0
Chemistry,1,0.0
IFCC,1,0.0
Taskforce,1,0.0
pre-analytical,1,0.0
ampliconread,1,0.0
length-based,1,0.0
Nanopore,1,0.0
MinIONGridION,1,0.0
Amplicons,1,0.0
RSLAs,1,0.0
0860,1,0.0
0870,1,0.0
0798,1,0.0
0786,1,0.0
sp,1,0.0
carinii,1,0.0
amphids,1,0.0
dorsally,1,0.0
buccal,1,0.0
glandular,1,0.0
aperture,1,0.0
protruded,1,0.0
microfilaria,1,0.0
sheathed,1,0.0
petteri,1,0.0
parasite,1,0.0
marsupials,1,0.0
host-switching,1,0.0
diversification,1,0.0
Kigali,1,0.0
countrywide,1,0.0
tamponade,1,0.0
re-evaluated,1,0.0
or--if,1,0.0
indicated--pulmonary,1,0.0
coexistence,1,0.0
whichever,1,0.0
Atherosclerosis-small,1,0.0
disease-cardiac,1,0.0
source-other,1,0.0
categorizes,1,0.0
inter-rater,1,0.0
Inter-rater,1,0.0
formulas,1,0.0
Alert,1,0.0
minus,1,0.0
astograph,1,0.0
Spotter,1,0.0
Schemes,1,0.0
RCGP,1,0.0
Officers,1,0.0
MOSA,1,0.0
OPCS,1,0.0
CDSC,1,0.0
CDR,1,0.0
particle-like,1,0.0
60-140,1,0.0
nanomaterials,1,0.0
metal-conjugates,1,0.0
Metal,1,0.0
complexes-,1,0.0
bismuth,1,0.0
duplex-unwinding,1,0.0
helicase,1,0.0
Q-RT-PCR,1,0.0
radioassay,1,0.0
Metal-conjugates,1,0.0
3Clike,1,0.0
intercurrent,1,0.0
chemotherapeutic,1,0.0
clinico-epidemiological,1,0.0
unequivocal,1,0.0
next-of-kin,1,0.0
years--2,1,0.0
daily--3,1,0.0
hypertriglyceridaemia,1,0.0
adduction,1,0.0
2009-July,1,0.0
non-elderly,1,0.0
stockpiles,1,0.0
epithelial-mesenchymal,1,0.0
attachments,1,0.0
mediator-generating,1,0.0
Beneath,1,0.0
deposit,1,0.0
collagens,1,0.0
cooperates,1,0.0
practitioner-based,1,0.0
MITI,1,0.0
3750,1,0.0
contingent,1,0.0
enpaneled,1,0.0
Work-Related,1,0.0
“long,1,0.0
COVID”,1,0.0
httpsbitly3y8n0Bt,1,0.0
disaggregate,1,0.0
117276,1,0.0
Modelling,1,0.0
undefined,1,0.0
12-year-old,1,0.0
brother,1,0.0
Xiangtan,1,0.0
radiocardiography,1,0.0
tetrapolar,1,0.0
rheography,1,0.0
eukinetic,1,0.0
after-load,1,0.0
provisions,1,0.0
EVT-centers,1,0.0
drive-time,1,0.0
Flusurvey,1,0.0
2004-2016,1,0.0
manufacturer-independent,1,0.0
2129,1,0.0
987,1,0.0
20922129,1,0.0
976-987,1,0.0
961961,1,0.0
996-100,1,0.0
11311168,1,0.0
957-977,1,0.0
0965,1,0.0
0954-0976,1,0.0
repeatedfurther,1,0.0
8-hour,1,0.0
Examinee,1,0.0
3146,1,0.0
or75,1,0.0
158902,1,0.0
non-asthma,1,0.0
073-093,1,0.0
078-097,1,0.0
soda,1,0.0
066-087,1,0.0
070-090,1,0.0
Drinking,1,0.0
PAIS,1,0.0
ATexas185,1,0.0
100-mg,1,0.0
Wild-type,1,0.0
antiphosholipid,1,0.0
Pharmacotherapy,1,0.0
Branchburg,1,0.0
Plaines,1,0.0
Des,1,0.0
self-rating,1,0.0
knockouts,1,0.0
Mot,1,0.0
commentators,1,0.0
Syncytial,1,0.0
Community-based,1,0.0
mobility-dependent,1,0.0
robotics,1,0.0
ropes,1,0.0
catch,1,0.0
filaments,1,0.0
reactants,1,0.0
Mali,1,0.0
Bamako,1,0.0
Pneumo-phthisiology,1,0.0
CHU,1,0.0
1595,1,0.0
nicotinism,1,0.0
75750,1,0.0
222750,1,0.0
147000,1,0.0
father,1,0.0
servant,1,0.0
2885,1,0.0
2564,1,0.0
22-item,1,0.0
7-point,1,0.0
Cronbachs,1,0.0
Test-retest,1,0.0
Stronger,1,0.0
prasugrel,1,0.0
pre-emptive,1,0.0
stroke-centers,1,0.0
VP,1,0.0
BNT162b2-induced,1,0.0
epitope-specific,1,0.0
effector-memory,1,0.0
002-292,1,0.0
001-028,1,0.0
poly-specific,1,0.0
Etiologic,1,0.0
albino,1,0.0
Remantadin,1,0.0
Poorly,1,0.0
organisational,1,0.0
losing,1,0.0
Paramedian,1,0.0
paramedian,1,0.0
Pcom,1,0.0
18F-fluorodeoxyglucose,1,0.0
Irreversible,1,0.0
pentane,1,0.0
giver,1,0.0
reconsidered,1,0.0
Sufficient,1,0.0
time--at,1,0.0
year--must,1,0.0
endures,1,0.0
reaffirmed,1,0.0
duplicate,1,0.0
therapy-related,1,0.0
childfamily,1,0.0
evaluator,1,0.0
slow-reacting,1,0.0
multimer,1,0.0
peptide-MHC,1,0.0
33-fold,1,0.0
18-55,1,0.0
BiomarkersImaging,1,0.0
Vulnerable,1,0.0
coregistered,1,0.0
PETcomputed,1,0.0
unpublished,1,0.0
individual-patient,1,0.0
nonprocedural,1,0.0
n109,1,0.0
gmL,1,0.0
P0025,1,0.0
11-43,1,0.0
098-55,1,0.0
n196,1,0.0
141-339,1,0.0
15-1396,1,0.0
P0008,1,0.0
quartiles,1,0.0
log-rank,1,0.0
059-078,1,0.0
064-096,1,0.0
antiischemic,1,0.0
fiberoscope,1,0.0
intrabronchial,1,0.0
intra-bronchial,1,0.0
2834,1,0.0
mast-cells,1,0.0
COVID-191,1,0.0
report2,1,0.0
prime-boost,1,0.0
vaccinesantivirals,1,0.0
neutralizationvirological,1,0.0
P1821S,1,0.0
1-75,1,0.0
demographicpre-stroke,1,0.0
Orientation,1,0.0
Reintegration,1,0.0
Deterioration,1,0.0
AdC68,1,0.0
Single-dose,1,0.0
golden,1,0.0
Vaccinated,1,0.0
meriting,1,0.0
surroundings,1,0.0
anti-virals,1,0.0
high-,1,0.0
18-28,1,0.0
2-63,1,0.0
puts,1,0.0
exonuclease,1,0.0
Capsule,1,0.0
Dry,1,0.0
Syrup,1,0.0
cross-correlation,1,0.0
Kanagawa,1,0.0
876,1,0.0
Facebook,1,0.0
advertisement,1,0.0
Sexual,1,0.0
Regulators,1,0.0
admirable,1,0.0
brain-computer,1,0.0
down-regulating,1,0.0
paresis,1,0.0
Clock,1,0.0
allergistsimmunologists,1,0.0
familiarize,1,0.0
Eosinophilic,1,0.0
15-minute,1,0.0
Flipping,1,0.0
EVT-capable,1,0.0
Bypassing,1,0.0
Optimization,1,0.0
Isocapnic,1,0.0
ATRIA,1,0.0
categorizing,1,0.0
nontreated,1,0.0
lavendustin,1,0.0
heretofore,1,0.0
Alterations,1,0.0
downstroke,1,0.0
Prolonging,1,0.0
680000,1,0.0
Vasculitis,1,0.0
Severely,1,0.0
Gene-disease,1,0.0
interactors,1,0.0
MI-related,1,0.0
drug-target-disease,1,0.0
non-MI,1,0.0
contrifugation,1,0.0
SVCs,1,0.0
complements,1,0.0
lentiviral-based,1,0.0
shrews,1,0.0
attends,1,0.0
potentialities,1,0.0
antibody-discovery,1,0.0
arduous,1,0.0
antibody-secreting,1,0.0
Non-SARS-CoV-2,1,0.0
blending,1,0.0
symptom-to-reperfusion,1,0.0
Contrast-enhanced,1,0.0
Bari,1,0.0
symptom-to-balloon,1,0.0
Accomplishment,1,0.0
Basel,1,0.0
manipulating,1,0.0
macroautophagyautophagy,1,0.0
reprocess,1,0.0
Abbreviations,1,0.0
CoVCoVs,1,0.0
coronaviruscoronaviruses,1,0.0
Sub-Saharan,1,0.0
task-shifting,1,0.0
avenue,1,0.0
nurse-led,1,0.0
worker-years,1,0.0
pens,1,0.0
foodwater,1,0.0
containers,1,0.0
HO,1,0.0
8003,1,0.0
8004,1,0.0
Pfuml,1,0.0
CPE-based,1,0.0
TCID50ml,1,0.0
nsp3,1,0.0
A1812D,1,0.0
past-COVID-19,1,0.0
thirty-seven,1,0.0
Oxford-AstraZeneca,1,0.0
LIAISON,1,0.0
singletons,1,0.0
hyperstimulation,1,0.0
IVFintracytoplasmic,1,0.0
ICSI,1,0.0
IVFICSI,1,0.0
100-384,1,0.0
subfertility,1,0.0
unify,1,0.0
Self-management,1,0.0
preventers,1,0.0
Appointment,1,0.0
Simplification,1,0.0
appointment,1,0.0
immunoglobin,1,0.0
dysgeusia,1,0.0
1970-1995,1,0.0
8-102,1,0.0
AH1N1B,1,0.0
conveniently,1,0.0
Highland,1,0.0
AScotland74,1,0.0
AVictoria75,1,0.0
speedily,1,0.0
alphahydroxybutyrate,1,0.0
04p0006,1,0.0
alphahydroxybutytrate,1,0.0
Investigating,1,0.0
introspective,1,0.0
EUROIMMUN,1,0.0
odilae,1,0.0
Misiones,1,0.0
rainforest,1,0.0
pulsing,1,0.0
50-fold,1,0.0
6799,1,0.0
0300,1,0.0
1217-1436,1,0.0
1100,1,0.0
1001-1146,1,0.0
0081,1,0.0
lend,1,0.0
immunoenzymometric,1,0.0
catalytic,1,0.0
Thirty-four,1,0.0
harmonic,1,0.0
Optison,1,0.0
offline,1,0.0
Plateau,1,0.0
frustrate,1,0.0
subtending,1,0.0
329,1,0.0
receiver-operator,1,0.0
15-50,1,0.0
explicate,1,0.0
opercular,1,0.0
Foix-Chavany-Marie,1,0.0
lingual,1,0.0
mastication,1,0.0
opercula,1,0.0
well-localized,1,0.0
patients--48,1,0.0
patients--24,1,0.0
cent--were,1,0.0
melt,1,0.0
GISSI-Avoidable,1,0.0
httpssars3dcom,1,0.0
allosteric,1,0.0
61-90,1,0.0
IgM-IgG,1,0.0
Check™,1,0.0
Check,1,0.0
incompatible,1,0.0
Firstly,1,0.0
asthmogenic,1,0.0
unfamiliar,1,0.0
ganglion,1,0.0
abulia,1,0.0
AH1N1v-associated,1,0.0
8-9,1,0.0
Nontraumatic,1,0.0
∼18-50,1,0.0
∼5,1,0.0
DNA-centric,1,0.0
PAIMS,1,0.0
connectedness,1,0.0
INFR,1,0.0
3-chymotrypsin-like,1,0.0
mutagenicity,1,0.0
cardiotoxicity,1,0.0
categorised,1,0.0
526,1,0.0
non-hERG,1,0.0
target-based,1,0.0
Models,1,0.0
protomers,1,0.0
oligomers,1,0.0
patients--24--were,1,0.0
rest--10--between,1,0.0
semideciduous,1,0.0
subsystems,1,0.0
Corrected,1,0.0
grew,1,0.0
81-97,1,0.0
well-performing,1,0.0
RT-PCR-positive,1,0.0
automaticity,1,0.0
midpoint,1,0.0
461,1,0.0
538,1,0.0
2092,1,0.0
1846,1,0.0
GRs,1,0.0
unidimensional,1,0.0
physics,1,0.0
Month,1,0.0
febrility,1,0.0
Recognizing,1,0.0
lightheaded,1,0.0
faint,1,0.0
741,1,0.0
HPAI-related,1,0.0
KAPs,1,0.0
-057,1,0.0
Histamine,1,0.0
oxidant,1,0.0
18th,1,0.0
Immunisations,1,0.0
First-ever,1,0.0
1721,1,0.0
328,1,0.0
ATGs,1,0.0
Sensitivities,1,0.0
NDFOS,1,0.0
VivaChek,1,0.0
pains,1,0.0
pleuritis,1,0.0
tnine,1,0.0
syndrome--two,1,0.0
six--with,1,0.0
accentuate,1,0.0
Cysteiny,1,0.0
zafirlukast,1,0.0
rashes,1,0.0
angioedema,1,0.0
arthralgia,1,0.0
viral-induced,1,0.0
12514,1,0.0
12023,1,0.0
11402,1,0.0
112-241,1,0.0
133-362,1,0.0
071-191,1,0.0
0539,1,0.0
040-055,1,0.0
062-194,1,0.0
0763,1,0.0
inverted,1,0.0
weighting,1,0.0
1141,1,0.0
CV-1,1,0.0
JOYSBIO,1,0.0
Assure,1,0.0
Tech,1,0.0
31-60,1,0.0
timepoints,1,0.0
nitinol,1,0.0
parotitis,1,0.0
Age-adjusted,1,0.0
22–39,1,0.0
58–63,1,0.0
imputing,1,0.0
overestimating,1,0.0
trade-offs,1,0.0
2013-2014,1,0.0
37015,1,0.0
4326,1,0.0
120-158,1,0.0
Former,1,0.0
073-118,1,0.0
108-185,1,0.0
196-514,1,0.0
859,1,0.0
membrane-,1,0.0
Romanian,1,0.0
Sjögren,1,0.0
sadderdepressive,1,0.0
agitatedanxious,1,0.0
myalgias,1,0.0
Acutely,1,0.0
glia,1,0.0
Intracellular,1,0.0
mitogen-activated,1,0.0
Nut,1,0.0
Pertinent,1,0.0
476181,1,0.0
083-098,1,0.0
Stratifying,1,0.0
TND,1,0.0
pro-B-type,1,0.0
redirecting,1,0.0
biopharmaceuticals,1,0.0
thesis,1,0.0
Virology,1,0.0
postwar,1,0.0
school-building,1,0.0
chinine,1,0.0
polypragmasy,1,0.0
archaeology,1,0.0
reductionism,1,0.0
re-construct,1,0.0
postlytic,1,0.0
postthrombolytic,1,0.0
saphenous,1,0.0
retrograde,1,0.0
tepid,1,0.0
prayers,1,0.0
rubs,1,0.0
massage,1,0.0
PRIMVAC,1,0.0
Proyecto,1,0.0
Registro,1,0.0
Infarto,1,0.0
agudo,1,0.0
Miocardio,1,0.0
Alicante,1,0.0
Castellón,1,0.0
Fibrous,1,0.0
0954,1,0.0
Virus-like,1,0.0
VLPs,1,0.0
078-098,1,0.0
069-106,1,0.0
under-diagnosed,1,0.0
craniectomy,1,0.0
broncholytic,1,0.0
venovenous,1,0.0
double-lumen,1,0.0
low-flow,1,0.0
CO₂,1,0.0
waterbodies,1,0.0
soiled,1,0.0
Aimed,1,0.0
echo-cardiography,1,0.0
3725,1,0.0
4720,1,0.0
1441,1,0.0
5957,1,0.0
3876,1,0.0
1209,1,0.0
4327,1,0.0
1777,1,0.0
Lowns,1,0.0
weapon,1,0.0
DCs,1,0.0
drains,1,0.0
diet--primarily,1,0.0
salt--was,1,0.0
27000,1,0.0
Göteborg,1,0.0
MIAMI,1,0.0
atenolol,1,0.0
Pooling,1,0.0
PLAATO,1,0.0
supra-,1,0.0
1-10,1,0.0
Hospital-acquired,1,0.0
-038,1,0.0
March‒October,1,0.0
10848,1,0.0
line‒associated,1,0.0
COVID-19‒positive,1,0.0
Reinforcement,1,0.0
inferiority,1,0.0
Inspired,1,0.0
end-tidal,1,0.0
test-and-travel,1,0.0
passenger,1,0.0
astonishing,1,0.0
axilla,1,0.0
lump,1,0.0
supraclavicular,1,0.0
axillary,1,0.0
Virchow,1,0.0
low-neck,1,0.0
sinister,1,0.0
print,1,0.0
162020,1,0.0
Guangxi,1,0.0
Zhuang,1,0.0
inquiring,1,0.0
conjunctivitis-related,1,0.0
1667±929,1,0.0
2019Chin,1,0.0
433-437,1,0.0
20-75,1,0.0
1-18,1,0.0
QI,1,0.0
DoD,1,0.0
64E,1,0.0
hereof,1,0.0
heath,1,0.0
record-based,1,0.0
2004-14,1,0.0
violent,1,0.0
sandstorm,1,0.0
eighty-six,1,0.0
Lea,1,0.0
Xga,1,0.0
G6PD,1,0.0
hyper-homocysteinemia,1,0.0
scene,1,0.0
XXI,1,0.0
opinionated,1,0.0
decelerating,1,0.0
biosensing-related,1,0.0
modified-Rankin,1,0.0
cardiac-embolic,1,0.0
syndromeinfarct,1,0.0
desaturation,1,0.0
Counterpulsation,1,0.0
myocarial,1,0.0
in-situ,1,0.0
In-situ,1,0.0
embolisms,1,0.0
temporo-occipital,1,0.0
sit,1,0.0
gene-expression,1,0.0
oligonucleotide,1,0.0
Interferon-regulated,1,0.0
interferon-induced,1,0.0
Patient-clinician,1,0.0
31-40,1,0.0
51-64,1,0.0
BYamagata1688,1,0.0
486,1,0.0
2-13,1,0.0
138-1159,1,0.0
128-1003,1,0.0
035-091,1,0.0
MOSES,1,0.0
120-14080-90,1,0.0
J-,1,0.0
U-shaped,1,0.0
non-dipping,1,0.0
investigatedCurrently,1,0.0
hyperthyroid,1,0.0
os,1,0.0
radioactive,1,0.0
iodine,1,0.0
euthyroid,1,0.0
dysprosody,1,0.0
stutter,1,0.0
reverting,1,0.0
rampantly,1,0.0
mini,1,0.0
Towards,1,0.0
RBD-binding,1,0.0
non-neutralizing,1,0.0
Pericarditis,1,0.0
NIC,1,0.0
199091,1,0.0
H3-AShanghai1688,1,0.0
H1-ATaiwan186,1,0.0
tetratricopeptide,1,0.0
repeats,1,0.0
IFIT2,1,0.0
Organiza,1,0.0
P004,1,0.0
hyperosmolar,1,0.0
drying,1,0.0
Dinkihaler,1,0.0
PD15,1,0.0
hyperpnea,1,0.0
office-based,1,0.0
microbiologic,1,0.0
suicidesuicide,1,0.0
-T1702A,1,0.0
-C1562T,1,0.0
R279Q,1,0.0
C6T,1,0.0
Insight,1,0.0
telephone-based,1,0.0
internists,1,0.0
Asthma-related,1,0.0
allergistspulmonologists,1,0.0
countered,1,0.0
paper-and-pencil,1,0.0
Perceptions,1,0.0
record-breaking,1,0.0
roll-outs,1,0.0
frustratingly,1,0.0
Tatum,1,0.0
Oligoryzomys,1,0.0
nigripes,1,0.0
Rodentia,1,0.0
Muridae,1,0.0
leucopoenia,1,0.0
demic,1,0.0
vipirin,1,0.0
Diarrhoea,1,0.0
ontology,1,0.0
Gene-expression,1,0.0
Hindu,1,0.0
twice--4,1,0.0
karma,1,0.0
intercorrelated,1,0.0
Attribution,1,0.0
773,1,0.0
6-17,1,0.0
30-62,1,0.0
32-70,1,0.0
Watch,1,0.0
Discover,1,0.0
educators,1,0.0
Chlorine,1,0.0
Existence,1,0.0
hypochlorite,1,0.0
manuals,1,0.0
impinge,1,0.0
Nueces,1,0.0
Premenstrual,1,0.0
40-100,1,0.0
perimenstrually,1,0.0
32-yr,1,0.0
gonadotrophin,1,0.0
dips,1,0.0
hormone-analogue,1,0.0
2019-2019-nCoV,1,0.0
3-12,1,0.0
1134,1,0.0
Demographics,1,0.0
veterinarian,1,0.0
replicationtranscription,1,0.0
P0012,1,0.0
score21,1,0.0
Z-9190,1,0.0
3266,1,0.0
2220,1,0.0
χ249614,1,0.0
χ224267,1,0.0
Plzen,1,0.0
prehospitalization,1,0.0
three-years,1,0.0
141--16081--100,1,0.0
61--80min,1,0.0
Krichel,1,0.0
coauthors,1,0.0
nsp,1,0.0
18-45,1,0.0
post-immunisation,1,0.0
17-120,1,0.0
months-old,1,0.0
20-59,1,0.0
sero-susceptibility,1,0.0
swH3N2,1,0.0
ASydney51997,1,0.0
pre-immunisation,1,0.0
Titres,1,0.0
Fewer,1,0.0
single-target,1,0.0
orf,1,0.0
ab,1,0.0
transcription-insulated,1,0.0
χ26267,1,0.0
2348,1,0.0
χ28616,1,0.0
2531,1,0.0
Armed,1,0.0
Forces,1,0.0
reformulated,1,0.0
Highly-pathogenic,1,0.0
veterinarians,1,0.0
polyDL-lactide-co-glycolide,1,0.0
PLGA-based,1,0.0
biodegradable,1,0.0
60-69,1,0.0
Equine,1,0.0
low-airborne,1,0.0
short-termed,1,0.0
posttransplantation,1,0.0
vascularisation,1,0.0
re-consideration,1,0.0
cross-talk,1,0.0
bloodserum,1,0.0
third-level,1,0.0
Tibet,1,0.0
levelaccording,1,0.0
6603,1,0.0
3213,1,0.0
2773,1,0.0
823,1,0.0
7613,1,0.0
score20,1,0.0
Z-3928,1,0.0
P0001and,1,0.0
2992,1,0.0
RT-iiPCR,1,0.0
905-100,1,0.0
931-100,1,0.0
hostile,1,0.0
X-Ray,1,0.0
generalisability,1,0.0
vanishing,1,0.0
Tuberculosis,1,0.0
non-COVID-19,1,0.0
five-category,1,0.0
architectures,1,0.0
COVID-Net,1,0.0
COVIDNet-CT,1,0.0
preschool-aged,1,0.0
6-20,1,0.0
gkg,1,0.0
IVIG-treated,1,0.0
monthsABSTRACT,1,0.0
∼2789,1,0.0
105558,1,0.0
£187682,1,0.0
Caution,1,0.0
foremost,1,0.0
post-coronary,1,0.0
Epi-aortic,1,0.0
Monetarised,1,0.0
visualisation,1,0.0
Plans,1,0.0
storing,1,0.0
replenishing,1,0.0
tumorigenicity,1,0.0
quartile,1,0.0
102-1630,1,0.0
Preconditioning,1,0.0
repairing,1,0.0
dyssynchrony,1,0.0
conundrums,1,0.0
RT-3DE,1,0.0
hemiparetic,1,0.0
epileptiform,1,0.0
Epileptic,1,0.0
anticonvulsant,1,0.0
Hunter,1,0.0
866000,1,0.0
pH1N1-associated,1,0.0
ORF1,1,0.0
2707,1,0.0
2562,1,0.0
2852,1,0.0
2824,1,0.0
2662,1,0.0
2985,1,0.0
2014-2015,1,0.0
drifted,1,0.0
Transplanted,1,0.0
spawning,1,0.0
CABP,1,0.0
Reviewed,1,0.0
0-40,1,0.0
NOW™,1,0.0
trimeric,1,0.0
S-mediated,1,0.0
high-profile,1,0.0
irritative,1,0.0
assigning,1,0.0
phenotype-specific,1,0.0
misses,1,0.0
health-seeking,1,0.0
microvasculature,1,0.0
2732,1,0.0
Advice,1,0.0
virus-appeared,1,0.0
antipandemic,1,0.0
interferon-gamma,1,0.0
IGRA,1,0.0
timepoint,1,0.0
694,1,0.0
2036,1,0.0
556,1,0.0
3829-7167,1,0.0
SARS-CoV-2-IgG,1,0.0
3236,1,0.0
7300-9638,1,0.0
anti-SARS-CoV-2-IgG,1,0.0
8437,1,0.0
arteriogram,1,0.0
6646-9410,1,0.0
3336,1,0.0
9167,1,0.0
7641-9782,1,0.0
5938,1,0.0
4079-7578,1,0.0
2131,1,0.0
4853-8268,1,0.0
4244,1,0.0
7649-9884,1,0.0
morbidly,1,0.0
month-long,1,0.0
Mongolia,1,0.0
Pathological,1,0.0
worries,1,0.0
empower,1,0.0
Pre-school,1,0.0
cross-infection,1,0.0
1162,1,0.0
1432,1,0.0
1205-1816,1,0.0
multi-wave,1,0.0
illustration,1,0.0
calibrate,1,0.0
two-wave,1,0.0
Scandinavian,1,0.0
left-handed,1,0.0
M-shape,1,0.0
counterproductive,1,0.0
1978-1979,1,0.0
fall-off,1,0.0
5-19,1,0.0
Pathogenicity,1,0.0
1713,1,0.0
1253,1,0.0
264,1,0.0
dynes,1,0.0
cm-5,1,0.0
mortalityABSTRACT,1,0.0
primate,1,0.0
recognise,1,0.0
Refractoriness,1,0.0
soap,1,0.0
steel,1,0.0
silver,1,0.0
return-visits,1,0.0
shutdown,1,0.0
re-assessment,1,0.0
plexectomy,1,0.0
screen-negative,1,0.0
trapping,1,0.0
Intrathoracic,1,0.0
coelom,1,0.0
cardiophrenic,1,0.0
pleuropericardial,1,0.0
age-by-sex,1,0.0
hormone-dependent,1,0.0
Clarifying,1,0.0
male-female,1,0.0
aftermath,1,0.0
disrupting,1,0.0
PTFE,1,0.0
filters,1,0.0
filers,1,0.0
cyclones,1,0.0
SARS-Co,1,0.0
demostrated,1,0.0
MERS-Cov,1,0.0
undercontrolled,1,0.0
TOPCAB,1,0.0
bright,1,0.0
13500,1,0.0
Scheme,1,0.0
Coordinated,1,0.0
cardioverterdefibrillator,1,0.0
Defibrillator,1,0.0
DINAMIT,1,0.0
parallel-group,1,0.0
normal-to-normal,1,0.0
intent-to-treat,1,0.0
pre-admission,1,0.0
drug-gene,1,0.0
DGIDb,1,0.0
miRWalk,1,0.0
pre-post,1,0.0
vasospastic,1,0.0
fusiform,1,0.0
transected,1,0.0
Dacron,1,0.0
disarrayed,1,0.0
portend,1,0.0
floaters,1,0.0
ChADOx1,1,0.0
bloods,1,0.0
venogram,1,0.0
liasing,1,0.0
haematologist,1,0.0
hemianopia,1,0.0
idarucizumab,1,0.0
craniotomy,1,0.0
unsurvivable,1,0.0
Laparoscopic,1,0.0
Lately,1,0.0
live-bird,1,0.0
low-pathogenic,1,0.0
strain-specific,1,0.0
neuraminidase-inhibitors,1,0.0
HAIS,1,0.0
atrial-to-femoral,1,0.0
Erythropoietin,1,0.0
erythropoietic,1,0.0
fresh-blood,1,0.0
insightful,1,0.0
ORG,1,0.0
623,1,0.0
1738,1,0.0
Contrast-induced,1,0.0
ATP,1,0.0
000year,1,0.0
injuryinfarction,1,0.0
time-density,1,0.0
0435,1,0.0
densitytime,1,0.0
TDC-derived,1,0.0
guideline-recommended,1,0.0
extrapolations,1,0.0
Fluid-attenuated,1,0.0
three-part,1,0.0
take-off,1,0.0
ostia,1,0.0
cardioprotection,1,0.0
hind,1,0.0
metered-dose,1,0.0
contrast-induced,1,0.0
perceptiveness,1,0.0
desires,1,0.0
system-integrated,1,0.0
pathogen-monitoring,1,0.0
small-volume,1,0.0
chip-integrated,1,0.0
withinbetween,1,0.0
chip,1,0.0
Device,1,0.0
Inspection,1,0.0
4408,1,0.0
perceives,1,0.0
worrying,1,0.0
Crombachs,1,0.0
infarctioninjury,1,0.0
rejuvenate,1,0.0
2019-coronavirus,1,0.0
overriding,1,0.0
Arenaviruses,1,0.0
negative-strand,1,0.0
FDA-licensed,1,0.0
off-labeled,1,0.0
Old,1,0.0
choriomeningitis,1,0.0
D414,1,0.0
antagonize,1,0.0
Mycophenolic,1,0.0
depleting,1,0.0
GTP,1,0.0
794,1,0.0
self-reactivity,1,0.0
coronavirus-specific,1,0.0
fluctuates,1,0.0
BOSS,1,0.0
Fluctuation,1,0.0
divide,1,0.0
C3,1,0.0
C5,1,0.0
1095,1,0.0
ratioORC2,1,0.0
012-080,1,0.0
ORC4,1,0.0
014-097,1,0.0
neurohormone,1,0.0
apoliopoproteina,1,0.0
multiples,1,0.0
Cerebrospinal-fluid,1,0.0
inter-item,1,0.0
039,1,0.0
rotations,1,0.0
questionnaire-guided,1,0.0
53-298,1,0.0
14-82,1,0.0
11-54,1,0.0
severity-based,1,0.0
control-based,1,0.0
Graham,1,0.0
audit-feedback,1,0.0
contextualize,1,0.0
ILBI,1,0.0
AOF,1,0.0
Goethe,1,0.0
Incorporated,1,0.0
guaranteed,1,0.0
inspections,1,0.0
Monde,1,0.0
Carlo,1,0.0
Thai,1,0.0
boder,1,0.0
Ratchaburi,1,0.0
house-,1,0.0
Karen,1,0.0
uneducated,1,0.0
Income,1,0.0
radio,1,0.0
HRM,1,0.0
reluctance,1,0.0
inductive,1,0.0
overarching,1,0.0
haematologists,1,0.0
856,1,0.0
1-month,1,0.0
sub-scales,1,0.0
1-yr,1,0.0
varianceABSTRACT,1,0.0
Neuroinvasion,1,0.0
intrahypothalamic,1,0.0
finely,1,0.0
tuned,1,0.0
Hypothalamic,1,0.0
helical,1,0.0
Ramphastos,1,0.0
ventrodorsal,1,0.0
2376,1,0.0
2594,1,0.0
4887,1,0.0
honeycomb-like,1,0.0
air-filled,1,0.0
positioned,1,0.0
ventrally,1,0.0
V-shaped,1,0.0
division,1,0.0
ischaemiaABSTRACT,1,0.0
540,1,0.0
redeveloped,1,0.0
Measles,1,0.0
Containing,1,0.0
657,1,0.0
0126,1,0.0
739-939,1,0.0
742-940,1,0.0
under-utilization,1,0.0
follow-ups,1,0.0
373℃,1,0.0
disinfected,1,0.0
anti-hemagglutinin,1,0.0
subtentorial,1,0.0
148-1001,1,0.0
107-809,1,0.0
0037,1,0.0
corticobulbar,1,0.0
Linear,1,0.0
0016,1,0.0
spillage,1,0.0
Fazekas,1,0.0
Muscle,1,0.0
myopathic,1,0.0
ATexas177,1,0.0
Hemiplegia,1,0.0
Intraparenchymal,1,0.0
hematomas,1,0.0
creatinemia,1,0.0
EV,1,0.0
Neuropsychological,1,0.0
HBM,1,0.0
Nigerias,1,0.0
resource-poor,1,0.0
1821,1,0.0
8638,1,0.0
7976,1,0.0
7328,1,0.0
human-animal,1,0.0
illicit,1,0.0
Cannabis,1,0.0
Ann,1,0.0
Arbor,1,0.0
Basing,1,0.0
13-99,1,0.0
108-53,1,0.0
emergency-department,1,0.0
accused,1,0.0
p090,1,0.0
2008-9,1,0.0
asthma-chronic,1,0.0
AO,1,0.0
influenza-virus,1,0.0
justification,1,0.0
self-limiting,1,0.0
underlines,1,0.0
Exacerbation,1,0.0
progesterone,1,0.0
oestrogen,1,0.0
progesterone-only,1,0.0
progestagen,1,0.0
medical-diagnostic,1,0.0
four-,1,0.0
Canonical,1,0.0
interrelationships,1,0.0
canonical,1,0.0
2003-February,1,0.0
respectful,1,0.0
incredible,1,0.0
COVID-19–related,1,0.0
respondents’,1,0.0
dispersal,1,0.0
1154,1,0.0
latitudes,1,0.0
cyclically,1,0.0
mid-latitudes,1,0.0
progress-would,1,0.0
singled,1,0.0
2008-09,1,0.0
periodSurgical,1,0.0
Limit,1,0.0
concisely,1,0.0
congressmen,1,0.0
senators,1,0.0
sturdy,1,0.0
counterarguments,1,0.0
ADE,1,0.0
24-meric,1,0.0
nanobodies,1,0.0
deceive,1,0.0
ferritin-antibody,1,0.0
ferritin-haemagglutinin,1,0.0
Georgian,1,0.0
Collected,1,0.0
IBM,1,0.0
laboratory-instrumental,1,0.0
EUEEA,1,0.0
clinical-pathogenetic,1,0.0
hemoreologic,1,0.0
camouflaged,1,0.0
goes,1,0.0
thebasis,1,0.0
resorting,1,0.0
164-285,1,0.0
rechallenged,1,0.0
1107,1,0.0
mgmL,1,0.0
stagnated,1,0.0
dawning,1,0.0
lipidomics,1,0.0
breathomics,1,0.0
removingrecanalizing,1,0.0
1400,1,0.0
metabolomic,1,0.0
5·3,1,0.0
editions,1,0.0
uninformed,1,0.0
heparine,1,0.0
erythaematosus,1,0.0
Necropsy,1,0.0
arteritis,1,0.0
evades,1,0.0
Rhinolophus,1,0.0
macrotis,1,0.0
E42,1,0.0
Bats,1,0.0
Y41H,1,0.0
equals,1,0.0
guarded,1,0.0
inter-country,1,0.0
Publicly,1,0.0
044,1,0.0
Iceland,1,0.0
913,1,0.0
902,1,0.0
669,1,0.0
610-728,1,0.0
176-419,1,0.0
2931,1,0.0
shingles,1,0.0
mgm3,1,0.0
ex-workers,1,0.0
2-part,1,0.0
Westminster,1,0.0
062-152,1,0.0
n518,1,0.0
n519,1,0.0
Pre-contrast,1,0.0
OC431890,1,0.0
SARS-CoV-12003,1,0.0
MERS-CoV2012,1,0.0
SARS-CoV-22019,1,0.0
selling,1,0.0
travels,1,0.0
exploding,1,0.0
SARS-CoV-3,1,0.0
antiviral-resistant,1,0.0
harm,1,0.0
harmonized,1,0.0
Combating,1,0.0
splitsubunit,1,0.0
Solid,1,0.0
pre-contrast,1,0.0
paients,1,0.0
ABangkokH3N2,1,0.0
anonymously,1,0.0
knew,1,0.0
pre-specified,1,0.0
postexercise,1,0.0
Aside,1,0.0
gateways,1,0.0
pre-selected,1,0.0
tough,1,0.0
whom--and,1,0.0
wavelength,1,0.0
all-encompassing,1,0.0
shuttle,1,0.0
Europes,1,0.0
animal-to-human,1,0.0
HKU5,1,0.0
HKU4,1,0.0
MERS-related,1,0.0
MDT,1,0.0
anti-tumor,1,0.0
Neoadjuvant,1,0.0
NCCN,1,0.0
2rectal,1,0.0
3unresectable,1,0.0
Gastric,1,0.0
esophagogastricjunction,1,0.0
EGJ,1,0.0
Transnasal,1,0.0
intubationpercutaneous,1,0.0
gastrostomy,1,0.0
colorectal,1,0.0
goggle,1,0.0
enterostomy,1,0.0
Thoroughly,1,0.0
post-surgery,1,0.0
infectioninflammation,1,0.0
Single-room,1,0.0
unprecedentedly,1,0.0
win,1,0.0
Wisconsin,1,0.0
Endothelin-1,1,0.0
-071,1,0.0
1894-plague,1,0.0
1918-AH1N1,1,0.0
heralded,1,0.0
civet,1,0.0
SARS-related-CoVs,1,0.0
outbreak--or,1,0.0
hoarding,1,0.0
chaired,1,0.0
Prussian,1,0.0
Paris,1,0.0
Berlin,1,0.0
1889-1890,1,0.0
afflicted,1,0.0
1968-1969,1,0.0
reemerge,1,0.0
AEngland72,1,0.0
ADunedin73,1,0.0
successors,1,0.0
replication-competent,1,0.0
Orf3a,1,0.0
nsp2,1,0.0
Strikingly,1,0.0
Vero-derived,1,0.0
Rare,1,0.0
uncovers,1,0.0
Observers,1,0.0
fellows,1,0.0
Pairs,1,0.0
kappas,1,0.0
mirror-aided,1,0.0
NHs,1,0.0
ML,1,0.0
Hyperuricemia,1,0.0
hyperuricemia,1,0.0
H1N1pdmsH1N1,1,0.0
intra-virion,1,0.0
virus-epithelial,1,0.0
1037,1,0.0
Press,1,0.0
Poznań,1,0.0
Fedson,1,0.0
nineteenth-century,1,0.0
cries,1,0.0
coherent,1,0.0
transradial,1,0.0
transfemoral,1,0.0
Allens,1,0.0
Achilles,1,0.0
heel,1,0.0
guideline-driven,1,0.0
300161,1,0.0
2003-2013,1,0.0
Audit,1,0.0
8922,1,0.0
106-179,1,0.0
092-117,1,0.0
109-130,1,0.0
021-028,1,0.0
024-030,1,0.0
059-162,1,0.0
072-136,1,0.0
047-168,1,0.0
085-128,1,0.0
150300,1,0.0
pathomorphologic,1,0.0
topmost,1,0.0
spilling,1,0.0
ICMR,1,0.0
lacunae,1,0.0
Similarities,1,0.0
applicator,1,0.0
edoxaban,1,0.0
non-VKA,1,0.0
undifferentiated,1,0.0
compassion,1,0.0
Links,1,0.0
websites,1,0.0
inapparent,1,0.0
Globe,1,0.0
inexorable,1,0.0
responds,1,0.0
defence,1,0.0
stroke-miRNA,1,0.0
Rumors,1,0.0
negating,1,0.0
rumors,1,0.0
declaring,1,0.0
4806299,1,0.0
318599,1,0.0
antidote,1,0.0
TNF-A308G,1,0.0
lighten,1,0.0
attest,1,0.0
fittest,1,0.0
freedom,1,0.0
citizen,1,0.0
actualizes,1,0.0
pressured,1,0.0
Emboli,1,0.0
fibrillating,1,0.0
Wausau,1,0.0
corticosteroid-refractory,1,0.0
demonstrable,1,0.0
thirteen-year-old,1,0.0
Viremia,1,0.0
Accuracies,1,0.0
201Tl,1,0.0
20E,1,0.0
20W,1,0.0
malapposition,1,0.0
anginanon-Q,1,0.0
myeloperaxidase,1,0.0
CD401,1,0.0
thermotools,1,0.0
optimalization,1,0.0
Ximelagatran,1,0.0
finished,1,0.0
wishes,1,0.0
tomorrow,1,0.0
Lazio,1,0.0
elderlys,1,0.0
Withholding,1,0.0
diathesis,1,0.0
intra-abdominal,1,0.0
obtuse,1,0.0
Standards,1,0.0
averts,1,0.0
1202,1,0.0
interviewees,1,0.0
spouses,1,0.0
disbelief,1,0.0
Intensified,1,0.0
amidst,1,0.0
tweets,1,0.0
Vectorcardiographic,1,0.0
Franks,1,0.0
20N,1,0.0
80S,1,0.0
TNF-A863C,1,0.0
TNF-A238G,1,0.0
Congestive,1,0.0
Foucaults,1,0.0
anion,1,0.0
directive,1,0.0
Forty-five,1,0.0
conversation,1,0.0
23-101,1,0.0
12-78,1,0.0
≤1,1,0.0
13-64,1,0.0
20-117,1,0.0
Completed,1,0.0
goal-concordant,1,0.0
theorizing,1,0.0
meanings,1,0.0
consensual,1,0.0
Hoffman,1,0.0
IL1B-C511T,1,0.0
Goolishian,1,0.0
distort,1,0.0
co-existence,1,0.0
signssymptoms,1,0.0
Recognising,1,0.0
allopathy,1,0.0
homeopathy,1,0.0
Ayurveda,1,0.0
Solapur,1,0.0
inquiry,1,0.0
Antibiotics,1,0.0
human-to-human-transmitted,1,0.0
2013-2017,1,0.0
pre-trial,1,0.0
antiradical,1,0.0
invitation,1,0.0
Kohn,1,0.0
pores,1,0.0
IL1B-C-31T,1,0.0
IL4-C590T,1,0.0
IL6-C174G,1,0.0
IL10A-1082G,1,0.0
IL10-A592C,1,0.0
Absence,1,0.0
multidirectional,1,0.0
distirbances,1,0.0
Excerpta,1,0.0
Medica,1,0.0
Infrastructure,1,0.0
preprinted,1,0.0
bioRxiv,1,0.0
palsies,1,0.0
pressure-wire-,1,0.0
echocardiography-based,1,0.0
vaccineMethods,1,0.0
acceptanceResults,1,0.0
052,1,0.0
Henan,1,0.0
acceptanceConclusions,1,0.0
Triggering,1,0.0
first-responders,1,0.0
thoughtful,1,0.0
expeditious,1,0.0
assembling,1,0.0
bronchioles,1,0.0
trapped,1,0.0
resorbed,1,0.0
balloon-expandable,1,0.0
unreported,1,0.0
NF1,1,0.0
Bashkortostan,1,0.0
bail,1,0.0
conspecifics,1,0.0
livestock,1,0.0
Cricetidae,1,0.0
fur,1,0.0
Compelling,1,0.0
inextricably,1,0.0
deviance,1,0.0
personalities,1,0.0
deviant,1,0.0
femalemale,1,0.0
Repair,1,0.0
transatrial,1,0.0
syndrome-2,1,0.0
oncologists,1,0.0
osteopaths,1,0.0
unclearWe,1,0.0
fixed-effects,1,0.0
usedSix,1,0.0
69990,1,0.0
Postantithrombotic,1,0.0
059-087,1,0.0
063-086,1,0.0
067-083,1,0.0
085-108,1,0.0
043-123,1,0.0
033-054,1,0.0
trended,1,0.0
typeThe,1,0.0
Ability,1,0.0
proactively,1,0.0
hazard-based,1,0.0
assessors,1,0.0
mixtures,1,0.0
inferior--posterior--left,1,0.0
TT,1,0.0
myocarditis-associated,1,0.0
saturations,1,0.0
FiO2,1,0.0
utero,1,0.0
Neonates,1,0.0
intra-cardiac,1,0.0
Gastroenterology,1,0.0
Hepatology,1,0.0
ESPGHAN,1,0.0
2006-March,1,0.0
6355,1,0.0
Greatest,1,0.0
20092010,1,0.0
drew,1,0.0
Genova,1,0.0
RHA,1,0.0
physicians--syndromic,1,0.0
Uncertainties,1,0.0
modes-of-action,1,0.0
Cleaning,1,0.0
webinar,1,0.0
state-of-science,1,0.0
chemical-induced,1,0.0
toxicological,1,0.0
Validated,1,0.0
irritancy,1,0.0
irritant-based,1,0.0
qualitative-descriptive,1,0.0
conceptualization,1,0.0
EMRs,1,0.0
Whatever,1,0.0
tune,1,0.0
hyperparameters,1,0.0
Memetic,1,0.0
Adaptive,1,0.0
Evolution,1,0.0
MADE,1,0.0
chest-Computed,1,0.0
chest-CT,1,0.0
outperforms,1,0.0
Electrophoresis,1,0.0
CK-MM,1,0.0
CK-BB,1,0.0
isozyme,1,0.0
sisters,1,0.0
S-100B,1,0.0
Polypeptide,1,0.0
sNIHSS-5,1,0.0
gaze,1,0.0
contributive,1,0.0
4-item,1,0.0
sNIHSS-4,1,0.0
omitting,1,0.0
nasaloropharyngeal,1,0.0
arteriolar,1,0.0
host-environment,1,0.0
type-A,1,0.0
greater-than-normal,1,0.0
Tens,1,0.0
Osteopathic,1,0.0
predictably,1,0.0
atopia,1,0.0
17y,1,0.0
parasitosis,1,0.0
2014-December,1,0.0
caseness,1,0.0
8333,1,0.0
6361-9388,1,0.0
9928,1,0.0
9851-9967,1,0.0
7407,1,0.0
5503-8714,1,0.0
9959,1,0.0
9893-9986,1,0.0
420,1,0.0
409-431,1,0.0
OGDs,1,0.0
3-week-old,1,0.0
ip,1,0.0
milligrams,1,0.0
antipyretics,1,0.0
polyvascular,1,0.0
Paper,1,0.0
ankle-brachial,1,0.0
Continuum,1,0.0
Assembly,1,0.0
iteration,1,0.0
protagonists,1,0.0
obliges,1,0.0
attributing,1,0.0
expecting,1,0.0
specifying,1,0.0
addiction,1,0.0
re-evaluation,1,0.0
Phenotyping,1,0.0
inducers,1,0.0
2007-8,1,0.0
peridomestic,1,0.0
deer,1,0.0
bushy-tailed,1,0.0
woodrats,1,0.0
striped,1,0.0
skunks,1,0.0
cottontail,1,0.0
fox,1,0.0
Wyoming,1,0.0
black-tailed,1,0.0
racoons,1,0.0
human-wildlife,1,0.0
2005-6,1,0.0
2006-7,1,0.0
aspirates,1,0.0
d-dimer,1,0.0
2005-2008,1,0.0
0-18,1,0.0
19-60-year-olds,1,0.0
0-18-year-olds,1,0.0
easesTo,1,0.0
stagesphases,1,0.0
research-in-humans,1,0.0
processesExamining,1,0.0
discoverybasic,1,0.0
proportionate,1,0.0
proving,1,0.0
extraordinarily,1,0.0
speeding,1,0.0
posttranscriptional,1,0.0
cautions,1,0.0
0942,1,0.0
0408,1,0.0
0620,1,0.0
coagulation-like,1,0.0
substituted,1,0.0
choroiditis,1,0.0
vaccinationStudy,1,0.0
reportResults,1,0.0
34-year,1,0.0
detachment,1,0.0
macula,1,0.0
detachments,1,0.0
subsequentlyConclusions,1,0.0
Ophthalmologists,1,0.0
uveitis,1,0.0
vignette,1,0.0
macroangiopathy,1,0.0
atherogenesis,1,0.0
Welfare,1,0.0
council,1,0.0
Reunion,1,0.0
well-researched,1,0.0
Pasteur,1,0.0
eighty-nine,1,0.0
mgl,1,0.0
109l,1,0.0
697,1,0.0
Hazard,1,0.0
0698,1,0.0
0512,1,0.0
0951,1,0.0
0023,1,0.0
Mechanistically,1,0.0
cell-type-specific,1,0.0
miR-based,1,0.0
mesentery,1,0.0
Fogartys,1,0.0
Sea,1,0.0
ERCHS,1,0.0
1916,1,0.0
577,1,0.0
years-155,1,0.0
chi2516,1,0.0
Morning,1,0.0
phlegmy,1,0.0
n191,1,0.0
n110,1,0.0
P042,1,0.0
076-092,1,0.0
007-031,1,0.0
95CI076-090,1,0.0
CI046-064,1,0.0
CI057-075,1,0.0
rooted,1,0.0
kinins,1,0.0
ultrastructural,1,0.0
aerohematic,1,0.0
hypercoagulation,1,0.0
atelectases,1,0.0
sludging,1,0.0
sterilizing,1,0.0
nucleocapsid-based,1,0.0
nucleocapsid-specific,1,0.0
warranting,1,0.0
AUSSR9277,1,0.0
545,1,0.0
Locations,1,0.0
counteract,1,0.0
noncerebral,1,0.0
maladaptive,1,0.0
cineangiography,1,0.0
Bland-White-Garland,1,0.0
progeria,1,0.0
Localisation,1,0.0
022-059,1,0.0
033-093,1,0.0
cancel,1,0.0
Inferior,1,0.0
Lumipulse,1,0.0
e-health,1,0.0
Covod-19,1,0.0
Sixty-eight,1,0.0
paindiscomfort,1,0.0
recession,1,0.0
wrong,1,0.0
confrontation,1,0.0
regressed,1,0.0
pro-homeostatic,1,0.0
elovanoids,1,0.0
very-long-chain,1,0.0
VLC-PUFA,1,0.0
n-3,1,0.0
ELV,1,0.0
disease-modifiable,1,0.0
unicentric,1,0.0
fixes,1,0.0
plead,1,0.0
1277,1,0.0
prothrombin,1,0.0
Low-dose,1,0.0
medico-legal,1,0.0
11–80,1,0.0
P0037,1,0.0
58-61,1,0.0
P0771,1,0.0
accomplishment,1,0.0
bronchologic,1,0.0
aso,1,0.0
pharmacodynamic,1,0.0
serological-immunological,1,0.0
ssRNA,1,0.0
equating,1,0.0
biomedicine,1,0.0
152585,1,0.0
mid-season,1,0.0
20–40,1,0.0
1–30,1,0.0
post-Covid-19,1,0.0
23–87,1,0.0
Nephrology,1,0.0
Dialysis,1,0.0
AULSS7,1,0.0
Pedemontana,1,0.0
Vicenza,1,0.0
community-orientated,1,0.0
Delft,1,0.0
prioritised,1,0.0
Employers,1,0.0
unhappy,1,0.0
upscaling,1,0.0
IE1,1,0.0
ASAT,1,0.0
62-41,1,0.0
P0467,1,0.0
P0039,1,0.0
finger-to-nose,1,0.0
macro-,1,0.0
provokes,1,0.0
reproducibly,1,0.0
cobra,1,0.0
Complement,1,0.0
statuses,1,0.0
inaccessibility,1,0.0
contraceptive,1,0.0
hyper-production,1,0.0
reticulum,1,0.0
27th,1,0.0
deciphered,1,0.0
10-100,1,0.0
SLUCVD,1,0.0
-associated,1,0.0
Included,1,0.0
Nihon,1,0.0
MC-ventricular,1,0.0
EuroSCORE,1,0.0
0044Our,1,0.0
Glycine,1,0.0
Antagonist,1,0.0
Americas,1,0.0
gavestinel,1,0.0
assistants,1,0.0
Followup,1,0.0
blame,1,0.0
health-service,1,0.0
disrespectful,1,0.0
Unequal,1,0.0
wreak,1,0.0
sequalae,1,0.0
flow-volume,1,0.0
technologys,1,0.0
IHD-patients,1,0.0
Domestic,1,0.0
CAFOs,1,0.0
amplifiers,1,0.0
15-45,1,0.0
42-86,1,0.0
fewest,1,0.0
prefectural,1,0.0
Sport,1,0.0
cognitions,1,0.0
upfront,1,0.0
Standardization,1,0.0
Well-established,1,0.0
unattended,1,0.0
PAP,1,0.0
bilevel,1,0.0
BiPAP,1,0.0
Suggestive,1,0.0
2010-2019,1,0.0
Forresters,1,0.0
1980-1984,1,0.0
endotheliitis,1,0.0
humeral,1,0.0
superantigen,1,0.0
immune-based,1,0.0
editors,1,0.0
oximeter,1,0.0
respiratory-directed,1,0.0
Radiological,1,0.0
tracheo-esophageal,1,0.0
intra-host,1,0.0
Subglottic,1,0.0
engines,1,0.0
motives,1,0.0
expectancies,1,0.0
asthma-smoking,1,0.0
non-diagnostic,1,0.0
welcomed,1,0.0
overtreatment,1,0.0
SocietyScottish,1,0.0
Intercollegiate,1,0.0
Philadelphia,1,0.0
Gel-filtration,1,0.0
Divided,1,0.0
UV-monitor,1,0.0
Fe2-induced,1,0.0
malonic,1,0.0
dialdehyde,1,0.0
dienes,1,0.0
A4,1,0.0
F,1,0.0
PL,1,0.0
pathochemical,1,0.0
Deeks,1,0.0
JJ,1,0.0
Dinnes,1,0.0
Takwoingi,1,0.0
Syst,1,0.0
Rev,1,0.0
20206CD013652,1,0.0
32584464,1,0.0
189091,1,0.0
Pfeiffer,1,0.0
1918-1920,1,0.0
hypermetabolism,1,0.0
lipohyalinosis,1,0.0
Atheroma,1,0.0
tabulation,1,0.0
ArcGIS,1,0.0
code-level,1,0.0
12577,1,0.0
16623,1,0.0
all-campus,1,0.0
Bates,1,0.0
40-y-old,1,0.0
dyskinesias,1,0.0
PETCT,1,0.0
limbic,1,0.0
extralimbic,1,0.0
hypermetabolic,1,0.0
-of,1,0.0
10-yr-old,1,0.0
Immunosuppressive,1,0.0
re-occlusion,1,0.0
1914,1,0.0
Glostrup,1,0.0
50-,1,0.0
64-year-olds,1,0.0
epicentre,1,0.0
ILIs,1,0.0
leukaemia,1,0.0
membersvisitors,1,0.0
recentclose,1,0.0
anyone,1,0.0
ILIH1N1,1,0.0
overemphasized,1,0.0
Lipohyalinosis,1,0.0
BPTs,1,0.0
long-held,1,0.0
16760,1,0.0
14741,1,0.0
broncho,1,0.0
Mycology,1,0.0
BDT,1,0.0
absorbed,1,0.0
dissipation,1,0.0
non-smoker,1,0.0
interferon-α2a,1,0.0
stuffiness,1,0.0
indicted,1,0.0
didnt,1,0.0
heal,1,0.0
tangible,1,0.0
3-hydroxy-3,1,0.0
methyl,1,0.0
glutaryl-Coenzyme-A,1,0.0
antilipidemic,1,0.0
interventionist,1,0.0
dollars,1,0.0
hospital-related,1,0.0
0-19,1,0.0
Breastfeeding,1,0.0
Starting,1,0.0
advises,1,0.0
check-ups,1,0.0
inquire,1,0.0
Ethiopias,1,0.0
under-diagnosis,1,0.0
rotated,1,0.0
Involvement,1,0.0
modifier,1,0.0
Hospitalisations,1,0.0
polypous,1,0.0
institutionalization,1,0.0
Receipt,1,0.0
arriving,1,0.0
screenings,1,0.0
referrals,1,0.0
Illinois,1,0.0
physical-activity-related,1,0.0
federally,1,0.0
director,1,0.0
dietitian,1,0.0
deepening,1,0.0
Facing,1,0.0
Potentially,1,0.0
599,1,0.0
Evolving,1,0.0
non-progressing,1,0.0
non-progressive,1,0.0
arteriogrpahy,1,0.0
didactic,1,0.0
Teams,1,0.0
Bringing,1,0.0
momentum,1,0.0
spores,1,0.0
Penicillium,1,0.0
propagules,1,0.0
indoors,1,0.0
Modifiable,1,0.0
alleviation,1,0.0
fuel,1,0.0
laryngo-bronchial,1,0.0
rhino-,1,0.0
Modern,1,0.0
endeavor,1,0.0
converging,1,0.0
Proclamation,1,0.0
dementias,1,0.0
pre-operative,1,0.0
operable,1,0.0
medical-surgical,1,0.0
forego,1,0.0
multisectoral,1,0.0
heptamer,1,0.0
protein-aided,1,0.0
alum,1,0.0
mHla,1,0.0
Intraaortic,1,0.0
Windsor,1,0.0
Nova,1,0.0
Scotia,1,0.0
Wave,1,0.0
IWK,1,0.0
astute,1,0.0
1943421452,1,0.0
783180968,1,0.0
≥55,1,0.0
Specimens,1,0.0
same-household,1,0.0
definitively,1,0.0
inferiorlateral,1,0.0
aortography,1,0.0
obstructing,1,0.0
human-transmissible,1,0.0
1910,1,0.0
high-attenuation,1,0.0
High-resolution,1,0.0
swallow,1,0.0
host-mediated,1,0.0
ADP-ribosylation,1,0.0
ADP-ribose-1,1,0.0
ZINC,1,0.0
XP,1,0.0
QPLD,1,0.0
Quantum,1,0.0
allocates,1,0.0
substrate-binding,1,0.0
acceptor,1,0.0
well-adopt,1,0.0
Unlabelled,1,0.0
proof-of-principle,1,0.0
taste,1,0.0
biomechanics,1,0.0
25-year-old,1,0.0
salivation,1,0.0
mealtime,1,0.0
enjoyment,1,0.0
pharyngolaryngeal,1,0.0
deglutition,1,0.0
Pretransplant,1,0.0
Choice,1,0.0
periodontitis,1,0.0
gum,1,0.0
NHIS,1,0.0
24275,1,0.0
131-257,1,0.0
137-277,1,0.0
151-293,1,0.0
ADP-ribosylhydrolase,1,0.0
Nsp3,1,0.0
pinpointing,1,0.0
ultrasound-virtual,1,0.0
attributional,1,0.0
biography,1,0.0
alignment-free,1,0.0
1582,1,0.0
three-base,1,0.0
k-nearest,1,0.0
neighbor,1,0.0
F-measure,1,0.0
Kappa-scores,1,0.0
unbalanced,1,0.0
Random,1,0.0
982,1,0.0
compute,1,0.0
outperforming,1,0.0
CVR,1,0.0
ambivalent,1,0.0
precipitates,1,0.0
Pathogenetic,1,0.0
imperfectly,1,0.0
eso-bronchial,1,0.0
oesofagus,1,0.0
microaspiration,1,0.0
sphincter,1,0.0
esogastroscopy,1,0.0
proton-pump,1,0.0
reintroduction,1,0.0
290000,1,0.0
3486,1,0.0
declare,1,0.0
104-293,1,0.0
043-092,1,0.0
069,1,0.0
radio-allergo-sorbent-test,1,0.0
carency,1,0.0
low-volume,1,0.0
re-emergence,1,0.0
rekindled,1,0.0
confinements,1,0.0
Compounds,1,0.0
optimizations,1,0.0
aerodigestive,1,0.0
WMF,1,0.0
pathogenesistransmission,1,0.0
precipitous,1,0.0
bottleneck,1,0.0
qRT-PCR-based,1,0.0
supply-chain,1,0.0
primersprobe,1,0.0
RP-control,1,0.0
replaces,1,0.0
extractionpurification,1,0.0
heat-inactivation,1,0.0
inoculation-with,1,0.0
concentration-into,1,0.0
master,1,0.0
mixes,1,0.0
primerprobe-set,1,0.0
VTM-3941,1,0.0
VTM-4141,1,0.0
VTM-8181,1,0.0
likewise,1,0.0
contingency,1,0.0
intracutaneous,1,0.0
excretions,1,0.0
048-097,1,0.0
nisoldipine,1,0.0
logistically,1,0.0
door-to-needle,1,0.0
psychodiagnostic,1,0.0
hyperactive,1,0.0
subforms,1,0.0
Hyperactivity,1,0.0
vasoconstrictory,1,0.0
3-hydroxy-3-methylglutaryl,1,0.0
coenzyme,1,0.0
Stroke-prone,1,0.0
end-organ,1,0.0
salt-loaded,1,0.0
immunosuppressant,1,0.0
mycophenolate,1,0.0
mofetil,1,0.0
po,1,0.0
Gross,1,0.0
macrophagemicroglial,1,0.0
albumincreatinine,1,0.0
752,1,0.0
mgmg,1,0.0
tubulointerstitial,1,0.0
stroke-prone,1,0.0
small-molecular,1,0.0
PDB,1,0.0
affinities,1,0.0
antibody-antigen,1,0.0
hibernating,1,0.0
beta-Blocker,1,0.0
damp,1,0.0
caps,1,0.0
0-100,1,0.0
deploys,1,0.0
defects--VSDs,1,0.0
inotropes,1,0.0
VSDs,1,0.0
5-28,1,0.0
39-86,1,0.0
24-49,1,0.0
4-32,1,0.0
adiposity,1,0.0
BROCA,1,0.0
WC,1,0.0
waist-height,1,0.0
WHtR,1,0.0
rearrange,1,0.0
viral-cell,1,0.0
membranes,1,0.0
705,1,0.0
transforms,1,0.0
bilayered,1,0.0
micelles,1,0.0
15N,1,0.0
globular,1,0.0
acyl,1,0.0
phospholipids,1,0.0
nitroxide,1,0.0
displace,1,0.0
Polar,1,0.0
helix,1,0.0
protrudes,1,0.0
bilayer,1,0.0
Favorable,1,0.0
70-year-old,1,0.0
not-withstanding,1,0.0
Himalayas,1,0.0
trekking,1,0.0
SS-OCT,1,0.0
artifacts,1,0.0
EPCs,1,0.0
snake,1,0.0
disruptors,1,0.0
micro-RNAs,1,0.0
phytochemicals,1,0.0
ACE2-S-protein,1,0.0
debatable,1,0.0
patientsA,1,0.0
1339,1,0.0
non-CCC,1,0.0
sub-groups,1,0.0
pro-brain,1,0.0
analyzedCCC,1,0.0
attentions,1,0.0
Consolidated,1,0.0
prethrombolytic,1,0.0
prereperfusion,1,0.0
GISSI-2,1,0.0
unsuitability,1,0.0
nonresolution,1,0.0
baroreflex,1,0.0
alternans,1,0.0
Often,1,0.0
nobody,1,0.0
-blockers,1,0.0
lipid-lowering,1,0.0
4000,1,0.0
Salivary,1,0.0
creatinine-kinase,1,0.0
carotid-plaque,1,0.0
extracardiac,1,0.0
Camp,1,0.0
Humphreys,1,0.0
army,1,0.0
dirty,1,0.0
dishes,1,0.0
flies,1,0.0
crowding,1,0.0
Overcrowding,1,0.0
stood,1,0.0
five-fold,1,0.0
Calculations,1,0.0
overcrowding,1,0.0
transmediastinal,1,0.0
gunshot,1,0.0
standby,1,0.0
3-week,1,0.0
hints,1,0.0
cardiac-penetrating,1,0.0
30100,1,0.0
1981-82,1,0.0
caucasians,1,0.0
Fifty-four,1,0.0
368,1,0.0
458,1,0.0
supply-demand,1,0.0
chronotropic,1,0.0
bradycardic,1,0.0
ivabradine,1,0.0
mechano-chronotropic,1,0.0
oleic,1,0.0
Brewer,1,0.0
outlier,1,0.0
Theranostics,1,0.0
superinfections,1,0.0
alanine,1,0.0
transferase,1,0.0
inotropics,1,0.0
H1N1-infected,1,0.0
RRT-requiring,1,0.0
anticipating,1,0.0
nonambulatory,1,0.0
task-oriented,1,0.0
ambulate,1,0.0
n70,1,0.0
n59,1,0.0
Lymphocyte,1,0.0
morbimortality,1,0.0
transesophagical,1,0.0
HSPC,1,0.0
nonmalignant,1,0.0
Outdoor,1,0.0
long-segment,1,0.0
flap-like,1,0.0
1823,1,0.0
1540,1,0.0
narrowings,1,0.0
regress,1,0.0
theranostics,1,0.0
retinoic,1,0.0
acid-inducible,1,0.0
RIG-I,1,0.0
kappa-light-chain-enhancer,1,0.0
Steroids,1,0.0
swept-source,1,0.0
whole-brain,1,0.0
conducive,1,0.0
influenza-July,1,0.0
Interhospital,1,0.0
transfers,1,0.0
bedsize,1,0.0
362065,1,0.0
081,1,0.0
30-60,1,0.0
assists,1,0.0
crescendo,1,0.0
pressure-lowering,1,0.0
reassessed,1,0.0
archeo-epidemiologic,1,0.0
respiratory-related,1,0.0
1916-1922,1,0.0
Influenza-related,1,0.0
1919-were,1,0.0
contemplating,1,0.0
fallwinter,1,0.0
subnational,1,0.0
hyperdense,1,0.0
Ono,1,0.0
microgramsday,1,0.0
Pranlukast,1,0.0
puffs,1,0.0
Twelve-lead,1,0.0
indefinitely,1,0.0
enacted,1,0.0
Jean,1,0.0
Chrétien,1,0.0
Pledge,1,0.0
license,1,0.0
diasthesis,1,0.0
villagers,1,0.0
piloted,1,0.0
Chemoprophylaxis,1,0.0
small-cell,1,0.0
octreotide,1,0.0
non-professional,1,0.0
bronchospastic,1,0.0
profuse,1,0.0
watery,1,0.0
lacrimation,1,0.0
pine,1,0.0
histamine-PC20,1,0.0
Cockroft,1,0.0
IgE-allergen,1,0.0
themed,1,0.0
Lancet,1,0.0
Claiborne-Johnston,1,0.0
Chalela,1,0.0
unfounded,1,0.0
SITS-MOST,1,0.0
Safe,1,0.0
PROSIT,1,0.0
ABrevig,1,0.0
Mission11918,1,0.0
abort,1,0.0
OSHA,1,0.0
protections,1,0.0
non-enveloped,1,0.0
embroidery,1,0.0
knitting,1,0.0
sewing,1,0.0
ion-channel,1,0.0
Elliott,1,0.0
unwieldy,1,0.0
noting,1,0.0
Sa,1,0.0
ATianjinjinnanSWL412011H1,1,0.0
D239N,1,0.0
ATianjinningheSWL492009H1,1,0.0
oseltamivir-resistance,1,0.0
Amino,1,0.0
host-targeted,1,0.0
dihydroorotate,1,0.0
DHODH,1,0.0
analogues,1,0.0
3C-like,1,0.0
papain-like,1,0.0
Mouse,1,0.0
Relenza,1,0.0
health-promoting,1,0.0
80-85,1,0.0
anxietydepression,1,0.0
temporality,1,0.0
confounds,1,0.0
Biological,1,0.0
self-degradative,1,0.0
degraded,1,0.0
lysosome,1,0.0
renovation,1,0.0
Principal,1,0.0
starvation,1,0.0
immunometabolic,1,0.0
overactive,1,0.0
allergen-driven,1,0.0
autophagy-mediated,1,0.0
ATianjinhedongSWL442011H1,1,0.0
K180T,1,0.0
pledge,1,0.0
S179N,1,0.0
fix,1,0.0
prescribes,1,0.0
bifrontal,1,0.0
mesial,1,0.0
orbitofrontal,1,0.0
rapid-eye-movement,1,0.0
hypometabolism,1,0.0
bow,1,0.0
hunters,1,0.0
happens,1,0.0
subaxial,1,0.0
tri-assortment,1,0.0
Northeast,1,0.0
3068,1,0.0
12089,1,0.0
12693068,1,0.0
1921269,1,0.0
2009-March,1,0.0
9301346,1,0.0
2010-March,1,0.0
220523,1,0.0
infectiondeath,1,0.0
splicing,1,0.0
Identity,1,0.0
ACalifornia072009H1N1,1,0.0
07-26,1,0.0
06-17,1,0.0
0-06,1,0.0
10-3,1,0.0
behavior-not,1,0.0
appears-unlike,1,0.0
intermingled,1,0.0
STAT1,1,0.0
off-site,1,0.0
OSCTC,1,0.0
OSCTCs,1,0.0
Colleges,1,0.0
1451,1,0.0
≤4,1,0.0
≤6,1,0.0
3-fold,1,0.0
6-fold,1,0.0
2-fold,1,0.0
repressor,1,0.0
lately,1,0.0
coactivator,1,0.0
phosphorylation,1,0.0
interferon-stimulated,1,0.0
time-course,1,0.0
IFITM3,1,0.0
ISG15,1,0.0
knockdown,1,0.0
conversely,1,0.0
lidocaine,1,0.0
logarithm,1,0.0
log-cubic,1,0.0
climacteric,1,0.0
4-chamber,1,0.0
closer,1,0.0
asserted,1,0.0
unregistered,1,0.0
story,1,0.0
twenties,1,0.0
Adjustment,1,0.0
Faroe,1,0.0
No-reflow,1,0.0
categorically,1,0.0
self-smoking,1,0.0
PCWP,1,0.0
hypovolemic,1,0.0
-056,1,0.0
-031,1,0.0
-026,1,0.0
NSABSTRACT,1,0.0
fibrocystic,1,0.0
mineralizing,1,0.0
Potency,1,0.0
industry-wide,1,0.0
angiotencin,1,0.0
Renin-Angiotensin-Aldosterone,1,0.0
opposes,1,0.0
1-7,1,0.0
vasodilation,1,0.0
syndrome-induced,1,0.0
leap,1,0.0
forestall,1,0.0
defeat,1,0.0
Mini-Mental,1,0.0
AH1v,1,0.0
AN1v,1,0.0
NVRL,1,0.0
Nose,1,0.0
non-related,1,0.0
disastolic,1,0.0
inoperable,1,0.0
corrective,1,0.0
ageusia,1,0.0
myoglobinemia,1,0.0
65-69,1,0.0
cartridges,1,0.0
nutritive,1,0.0
abundantly,1,0.0
tapped,1,0.0
ambiguities,1,0.0
opportune,1,0.0
prolific,1,0.0
suckling,1,0.0
arrhythmiaThe,1,0.0
developmentHigh-quality,1,0.0
testing-on-a-probe,1,0.0
RBD-coated,1,0.0
quartz,1,0.0
Cy5-Streptavidin-polysacharide,1,0.0
Disposable,1,0.0
pre-dispensed,1,0.0
ng,1,0.0
fluidics,1,0.0
TOP-TAb,1,0.0
FDA-EUA,1,0.0
TOP-SNAb,1,0.0
Proportional,1,0.0
Hazards,1,0.0
frames,1,0.0
digitized,1,0.0
off-line,1,0.0
wall-motion,1,0.0
hyperkinesis,1,0.0
Woven,1,0.0
664,1,0.0
Saturday,1,0.0
enddiastolic,1,0.0
Emission,1,0.0
Photon,1,0.0
Gated,1,0.0
hemolysis,1,0.0
380-53,1,0.0
Wehn,1,0.0
195-47,1,0.0
determinations,1,0.0
41-6,1,0.0
Radioimmunoassay,1,0.0
non-dominant,1,0.0
aged-matched,1,0.0
Left-brain,1,0.0
right-brain,1,0.0
left-brain,1,0.0
two-handed,1,0.0
non-mirror,1,0.0
implementability,1,0.0
Executability,1,0.0
Decidability,1,0.0
Validity,1,0.0
publishing,1,0.0
Modifications,1,0.0
balloon-mounted,1,0.0
navigable,1,0.0
Coinfection,1,0.0
1473,1,0.0
SpO2,1,0.0
30-fold,1,0.0
thrombohemorrhagic,1,0.0
SARS-CoV-2-reactive,1,0.0
Transluminal,1,0.0
carpet,1,0.0
aluminum-framed,1,0.0
ferroconcrete,1,0.0
CC50,1,0.0
package,1,0.0
square,1,0.0
-066,1,0.0
-007,1,0.0
μgg,1,0.0
tendencies,1,0.0
44-94,1,0.0
15-item,1,0.0
abridged,1,0.0
11-item,1,0.0
simplifies,1,0.0
sulfated,1,0.0
non-sulfated,1,0.0
polysaccharides,1,0.0
dose-response-inhibition,1,0.0
apartment,1,0.0
GraphPad,1,0.0
Prism,1,0.0
v902,1,0.0
Diego,1,0.0
CC50EC50,1,0.0
antagonistic,1,0.0
CalcuSyn,1,0.0
v1,1,0.0
Biosoft,1,0.0
Cambridge,1,0.0
Iota,1,0.0
Carrageenan,1,0.0
gRNA,1,0.0
sgRNAs,1,0.0
metafor,1,0.0
mixed-effect,1,0.0
well-discussed,1,0.0
CD001187,1,0.0
over-preferred,1,0.0
GC,1,0.0
4291,1,0.0
584,1,0.0
GC3,1,0.0
3014,1,0.0
693,1,0.0
ancestry,1,0.0
departing,1,0.0
Hajj,1,0.0
coronariography,1,0.0
lineal,1,0.0
z,1,0.0
X1,1,0.0
X2,1,0.0
X3,1,0.0
Polygraphic,1,0.0
recollection,1,0.0
sentences,1,0.0
narrations,1,0.0
conflictual,1,0.0
repressed,1,0.0
Autoimmune,1,0.0
antimetabolites,1,0.0
calcineurin,1,0.0
Necrosis,1,0.0
anti-CD-20,1,0.0
costimulatory,1,0.0
JAK,1,0.0
discontinuous,1,0.0
unassociated,1,0.0
toxiclethal,1,0.0
2312,1,0.0
extraneous,1,0.0
Roys,1,0.0
acarabose,1,0.0
triflusal,1,0.0
Appropriately,1,0.0
post-menopausal,1,0.0
Surrogate,1,0.0
intersect,1,0.0
Secondly,1,0.0
Vmax50,1,0.0
airport,1,0.0
debaters,1,0.0
vested,1,0.0
Myanmar,1,0.0
1654100000,1,0.0
29713100000,1,0.0
40-99,1,0.0
32933,1,0.0
Beside,1,0.0
nonmetropolitan,1,0.0
preregistered,1,0.0
interacted,1,0.0
Moderated,1,0.0
reap,1,0.0
sheets,1,0.0
Relapse,1,0.0
retes,1,0.0
IUml,1,0.0
remitted,1,0.0
dsmCRIPSR,1,0.0
7353,1,0.0
1968-1980,1,0.0
G614D164,1,0.0
1908,1,0.0
1413,1,0.0
1974-1975,1,0.0
Lagos,1,0.0
WvGS,1,0.0
1332,1,0.0
377,1,0.0
Males,1,0.0
COVID-19IMPORTANCE,1,0.0
lock-down,1,0.0
ordinances,1,0.0
hematology-oncology,1,0.0
laceration,1,0.0
casirimabimdevimab,1,0.0
desperately,1,0.0
BioNTechs,1,0.0
1625,1,0.0
1525,1,0.0
Postoperative,1,0.0
incision,1,0.0
reoperation,1,0.0
2325,1,0.0
mismatches,1,0.0
CRISPRCas12a,1,0.0
dsmCRISPR,1,0.0
crRNAs,1,0.0
annealing,1,0.0
crRNA--1,1,0.0
1345,1,0.0
skipped,1,0.0
multi-marker,1,0.0
MM,1,0.0
VANQWISH,1,0.0
-181-152,1,0.0
379-679,1,0.0
348-621,1,0.0
707,1,0.0
513-824,1,0.0
-574-608,1,0.0
single-centre,1,0.0
psychosis,1,0.0
Ablative,1,0.0
neurosurgeries,1,0.0
ablative,1,0.0
Telephone,1,0.0
adhesions,1,0.0
Non-Q-Wave,1,0.0
fared,1,0.0
cullers,1,0.0
construed,1,0.0
substantiation,1,0.0
Marx,1,0.0
Leipzig,1,0.0
DDR,1,0.0
Chair,1,0.0
Pirogov,1,0.0
precoditions,1,0.0
precondition,1,0.0
floating,1,0.0
Musashino,1,0.0
IgGII,1,0.0
Quant,1,0.0
≥50,1,0.0
300-651,1,0.0
3617,1,0.0
3152,1,0.0
4759,1,0.0
travelled,1,0.0
sixteenth,1,0.0
dated,1,0.0
conceptions,1,0.0
sized,1,0.0
-090,1,0.0
Dissections,1,0.0
laterocervical,1,0.0
hemicranial,1,0.0
Horner,1,0.0
migraines,1,0.0
SS-QOL,1,0.0
Rasch,1,0.0
anti-COVID-19,1,0.0
Kunming,1,0.0
locality,1,0.0
PEIPKGRG,1,0.0
R292K,1,0.0
dual-receptor,1,0.0
Swallowing,1,0.0
first-wave,1,0.0
Immunosuppression,1,0.0
embolize,1,0.0
Ventilation,1,0.0
eosinophil-driven,1,0.0
anti-T2,1,0.0
20089,1,0.0
medically-attended,1,0.0
spline,1,0.0
22-75,1,0.0
0-311,1,0.0
0-395,1,0.0
TLR-4,1,0.0
TRL-2,1,0.0
TRL-4,1,0.0
TRL-7,1,0.0
downgrade,1,0.0
Modeling,1,0.0
InfluSim,1,0.0
19500,1,0.0
deteriorates,1,0.0
Wide-spread,1,0.0
NI-resistant,1,0.0
Disruption,1,0.0
Striking,1,0.0
neuroepidemiological,1,0.0
deductive,1,0.0
B-associated,1,0.0
2000-2001,1,0.0
or18,1,0.0
Speech,1,0.0
5939234,1,0.0
367255,1,0.0
case-referent,1,0.0
35-69,1,0.0
neighbourhood,1,0.0
coronary-prone,1,0.0
35-44,1,0.0
cohort-specific,1,0.0
non-normative,1,0.0
35-39,1,0.0
50-54,1,0.0
TLR-7,1,0.0
TLR-2,1,0.0
5291,1,0.0
IL-1βIL-1F2,1,0.0
483-87114,1,0.0
188369,1,0.0
7422-572604,1,0.0
Pregnancy-associated,1,0.0
30100000,1,0.0
pregnancy-associated,1,0.0
10316,1,0.0
strategiesWe,1,0.0
CFRs,1,0.0
CFROverall,1,0.0
Language,1,0.0
Evaluating,1,0.0
ascent,1,0.0
hierarchies,1,0.0
clot-selective,1,0.0
Selection,1,0.0
AIIRDs,1,0.0
polyclinics,1,0.0
High-affinity,1,0.0
follicular,1,0.0
germinal,1,0.0
Tfh-mediated,1,0.0
gastrooesophageal,1,0.0
coincide,1,0.0
Subepithelial-layer,1,0.0
subepithelial-layer,1,0.0
Thickness,1,0.0
arranging,1,0.0
Agrippal,1,0.0
circumstantial,1,0.0
non-familial,1,0.0
cTnI,1,0.0
als,1,0.0
semaphorin3EplexinD1,1,0.0
neurocritical,1,0.0
Features,1,0.0
neurointensivist,1,0.0
neurodiagnostics,1,0.0
sympton-free,1,0.0
Tentacious,1,0.0
exaggerate,1,0.0
maldistribution,1,0.0
O2,1,0.0
sympathomimetics,1,0.0
work-aggravated,1,0.0
possibleto,1,0.0
Workup,1,0.0
o,1,0.0
preponderance,1,0.0
Latex,1,0.0
latex-induced,1,0.0
copy,1,0.0
disproven,1,0.0
postloads,1,0.0
expenditures,1,0.0
Lingering,1,0.0
orthopedic,1,0.0
bouts,1,0.0
p0002,1,0.0
R254,1,0.0
R229,1,0.0
Event-free,1,0.0
whatever,1,0.0
semaphorin,1,0.0
hyperresponsivenss,1,0.0
plexinD1,1,0.0
Ubiquitously,1,0.0
chromogranin,1,0.0
CgA,1,0.0
48h,1,0.0
EPO,1,0.0
44-77,1,0.0
26-73,1,0.0
AH1N1pdm09-positive,1,0.0
belonged,1,0.0
6B1,1,0.0
subclade,1,0.0
S162N,1,0.0
I216T,1,0.0
927,1,0.0
GeneFinder,1,0.0
Elitech,1,0.0
planimetrically,1,0.0
Sobel,1,0.0
T2HIGH,1,0.0
T2LOW,1,0.0
inter-patient,1,0.0
translates,1,0.0
downward,1,0.0
40th,1,0.0
FFP2,1,0.0
508,1,0.0
ramping,1,0.0
abortion,1,0.0
Semaphorins,1,0.0
axonal,1,0.0
T25-100,1,0.0
gerontology,1,0.0
Thung,1,0.0
Balbc,1,0.0
epitope-based,1,0.0
equip,1,0.0
hemophagocytic,1,0.0
lymphohistiocytosis,1,0.0
farmer,1,0.0
pancytopenia,1,0.0
81404,1,0.0
μgL,1,0.0
5013-6083,1,0.0
Hemophagocytosis,1,0.0
etoposide,1,0.0
Signs,1,0.0
aberrantly,1,0.0
immuno-stimulation,1,0.0
Pregnancy-induced,1,0.0
Fc,1,0.0
COVID-positive,1,0.0
rechecked,1,0.0
main-group,1,0.0
10-22,1,0.0
checkups,1,0.0
bicycle-ergometric,1,0.0
riding,1,0.0
rationed,1,0.0
sanatorium,1,0.0
Aas,1,0.0
00007,1,0.0
Cronbach,1,0.0
broncho-obstructive,1,0.0
in-comparison,1,0.0
MHC-II,1,0.0
Song,1,0.0
MHC-I,1,0.0
Sporadic,1,0.0
Continual,1,0.0
Seroprevalence,1,0.0
01-30,1,0.0
PEDro,1,0.0
9-Hole,1,0.0
Peg,1,0.0
-001,1,0.0
Paresis,1,0.0
-004,1,0.0
-024,1,0.0
Berg,1,0.0
Balance,1,0.0
-036,1,0.0
Stride,1,0.0
Gait,1,0.0
Velocity,1,0.0
Frontal,1,0.0
Battery,1,0.0
PRESPERO,1,0.0
CRD42016037106,1,0.0
immunoinformatics,1,0.0
custommune,1,0.0
QTGKIADYNYK,1,0.0
TEIYQASTPCNGVEG,1,0.0
LQSYGFQPT,1,0.0
IRGDEVRQIAPGQTGKIADYNYKLPD,1,0.0
FSQILPDPSKPSKRS,1,0.0
PFAMQMAYRFNG,1,0.0
attendees,1,0.0
Al-Ain,1,0.0
Emirates,1,0.0
03Conclusion,1,0.0
entrusted,1,0.0
Objecive,1,0.0
swabsMethods,1,0.0
No10-35,1,0.0
No10-29,1,0.0
Reverse-transcriptase-polymerase-chain-reaction,1,0.0
performedResults,1,0.0
No1-29,1,0.0
No30-35,1,0.0
no132131,1,0.0
no21,1,0.0
9The,1,0.0
Ct-value,1,0.0
2288,1,0.0
judging,1,0.0
282,1,0.0
pointing,1,0.0
receptor-lipopolysaccharide,1,0.0
TLR-LPS,1,0.0
unifying,1,0.0
Backgroundaims,1,0.0
GLPSS,1,0.0
AFI,1,0.0
H3N2v-associated,1,0.0
barns,1,0.0
hematochemical,1,0.0
exams,1,0.0
abusive,1,0.0
Le,1,0.0
Bonheur,1,0.0
caveats,1,0.0
rule-out,1,0.0
Copeptin,1,0.0
irreplaceable,1,0.0
Between-group,1,0.0
educated,1,0.0
canalization,1,0.0
Ruptured,1,0.0
unblocked,1,0.0
Fibrin,1,0.0
surrounded,1,0.0
Fresh,1,0.0
occluding,1,0.0
supposition,1,0.0
peinfarction,1,0.0
Sixty-seven-year-old,1,0.0
tachycardic,1,0.0
peripherally,1,0.0
Fifty-eight,1,0.0
Adamantane-resistant,1,0.0
adamantane,1,0.0
Resistant,1,0.0
2053,1,0.0
mumol,1,0.0
Polynesians,1,0.0
rRTPCR,1,0.0
De-identified,1,0.0
29713,1,0.0
BRFSS,1,0.0
Virgin,1,0.0
USVI,1,0.0
cardio-embolic,1,0.0
CVE,1,0.0
LBCH,1,0.0
3879,1,0.0
116017,1,0.0
bronchialbronchiolar,1,0.0
1192,1,0.0
p004,1,0.0
structure-activity,1,0.0
activity-based,1,0.0
nanomolar,1,0.0
metalloproteinases,1,0.0
chemotactic,1,0.0
neuroblasts,1,0.0
restorative,1,0.0
self-regulation,1,0.0
Combinations,1,0.0
Promotion,1,0.0
Excitingly,1,0.0
Intranasal,1,0.0
condensation,1,0.0
watershedhypoperfusion,1,0.0
Nick,1,0.0
end-labelling,1,0.0
footballers,1,0.0
immunochromatographic,1,0.0
Technogenetics,1,0.0
Shenzhen,1,0.0
YHLO,1,0.0
CLIA-LIAISON®,1,0.0
DiaSorin,1,0.0
electrochemiluminescence,1,0.0
ECLIA-Elecsys®,1,0.0
Euroimmune,1,0.0
708,1,0.0
476,1,0.0
primo-infection,1,0.0
pyelonephritis,1,0.0
chorioamniotitis,1,0.0
listeriosis,1,0.0
174700,1,0.0
32500,1,0.0
nonstroke,1,0.0
postinjury,1,0.0
subcategory,1,0.0
1b,1,0.0
sequence-independent,1,0.0
single-primer,1,0.0
nanopore,1,0.0
Validation,1,0.0
931,1,0.0
862-972,1,0.0
929-100,1,0.0
multitarget,1,0.0
primersprobes,1,0.0
degrees-120,1,0.0
degrees-60,1,0.0
digitally,1,0.0
La,1,0.0
Poste,1,0.0
Visp,1,0.0
smoothly,1,0.0
sophistication,1,0.0
sizable,1,0.0
defy,1,0.0
interatrial,1,0.0
emboligenic,1,0.0
clinic-based,1,0.0
oseltamivir-based,1,0.0
6329,1,0.0
8822,1,0.0
9652,1,0.0
posted,1,0.0
764,1,0.0
870,1,0.0
Endogenous,1,0.0
inhibitor-1,1,0.0
catherization,1,0.0
arteririography,1,0.0
scintigram,1,0.0
doulbe-radionuclide,1,0.0
still-viable,1,0.0
cold-spot,1,0.0
recently-infarcted,1,0.0
hot-spot,1,0.0
clearinghouse,1,0.0
expert-review,1,0.0
Kalafong,1,0.0
workschool,1,0.0
intern,1,0.0
human-human,1,0.0
Success,1,0.0
currentprevious,1,0.0
SARS-CoV-Spike,1,0.0
C19-S-I-IFA,1,0.0
exogenously,1,0.0
SARS-CoV-2-Spike,1,0.0
Spike-variants,1,0.0
inter-provider,1,0.0
Fort,1,0.0
ATexas,1,0.0
drug-drug,1,0.0
tightly,1,0.0
Performed,1,0.0
1099,1,0.0
ImmunoDiagnostics,1,0.0
EDI,1,0.0
€3047,1,0.0
€43129,1,0.0
Internationally,1,0.0
ICTUSCARE,1,0.0
half-standardized,1,0.0
crescendo-course,1,0.0
approximation,1,0.0
seven-item,1,0.0
overestimated,1,0.0
15-64,1,0.0
coroners,1,0.0
waiver,1,0.0
enlist,1,0.0
bronchopulmonary,1,0.0
1991-92,1,0.0
Random-effects,1,0.0
moderators,1,0.0
22-27,1,0.0
13-18,1,0.0
weaknessnumbness,1,0.0
Stratified,1,0.0
discernible,1,0.0
Non-pharmaceutical,1,0.0
Beijings,1,0.0
biocompatibility,1,0.0
Inspiratory,1,0.0
cmH2O,1,0.0
kilogram,1,0.0
heart-lung,1,0.0
T3,1,0.0
interwoven,1,0.0
informs,1,0.0
Need,1,0.0
US164,1,0.0
earnings,1,0.0
non-taking,1,0.0
ECT,1,0.0
F-18,1,0.0
deoxyglucose,1,0.0
hypoperfused,1,0.0
“Is,1,0.0
COVID‐19”,1,0.0
Carli,1,0.0
al1,1,0.0
VII,1,0.0
Collaborative,1,0.0
SYST-Eur,1,0.0
SYST-China,1,0.0
WHOInternational,1,0.0
ISH,1,0.0
metaregression,1,0.0
thing,1,0.0
thiazide-type,1,0.0
respirologists,1,0.0
peak-flow,1,0.0
2408,1,0.0
2307,1,0.0
021004,1,0.0
024004,1,0.0
040009,1,0.0
1305,1,0.0
1309,1,0.0
US104,1,0.0
1-vessel,1,0.0
Babol,1,0.0
regained,1,0.0
Rate,1,0.0
Medium,1,0.0
simplistic,1,0.0
excitotoxicity,1,0.0
lipoprotein-associated,1,0.0
cause-effect,1,0.0
sMMPi,1,0.0
MMP-1,1,0.0
cold-recombinant,1,0.0
recombining,1,0.0
BAnn,1,0.0
Arbor166,1,0.0
Kong873,1,0.0
unsustainable,1,0.0
Instrumental,1,0.0
trustworthy,1,0.0
auspicious,1,0.0
obviated,1,0.0
optimistically,1,0.0
Relying,1,0.0
wit,1,0.0
cases--that,1,0.0
attacks--were,1,0.0
effected,1,0.0
ligating,1,0.0
Wedge,1,0.0
20Fr,1,0.0
cannulas,1,0.0
litersmin,1,0.0
546,1,0.0
985,1,0.0
IGM,1,0.0
low-amplitude,1,0.0
rythmical,1,0.0
paralyzed,1,0.0
outward,1,0.0
bulging,1,0.0
Evaluate,1,0.0
eletrocardiogram,1,0.0
ABo,1,0.0
Examinations,1,0.0
2760,1,0.0
adsorb,1,0.0
Ph,1,0.0
Spatial,1,0.0
Regions,1,0.0
constitutional,1,0.0
dial,1,0.0
Beck,1,0.0
90000,1,0.0
1973--4,1,0.0
0--4,1,0.0
brunt,1,0.0
Overweight,1,0.0
2415,1,0.0
2126,1,0.0
0285,1,0.0
0224,1,0.0
0331,1,0.0
0163,1,0.0
22-80,1,0.0
ST-depression,1,0.0
Non-smokers,1,0.0
autolysis,1,0.0
well-characterized,1,0.0
burn,1,0.0
Pneumothorax,1,0.0
tension-anxiety,1,0.0
depression-dejection,1,0.0
vigor-activity,1,0.0
CCA,1,0.0
test--cardiopulmonary,1,0.0
possible--before,1,0.0
furnished,1,0.0
thyrotropin,1,0.0
thyroxin,1,0.0
prognosing,1,0.0
DOHMH,1,0.0
or5,1,0.0
Obstetricians,1,0.0
12-hour,1,0.0
Hosmer-Lemeshow,1,0.0
8085,1,0.0
7572,1,0.0
572,1,0.0
Modulation,1,0.0
prostaglandins,1,0.0
newly-developed,1,0.0
tryptase,1,0.0
eosinophil-derived,1,0.0
EDN,1,0.0
reassurance,1,0.0
Ro,1,0.0
journeys,1,0.0
electrocution,1,0.0
burns,1,0.0
Twin,1,0.0
metro,1,0.0
fragmentary,1,0.0
immune-histochemical,1,0.0
C5b-9,1,0.0
deposits,1,0.0
lytic,1,0.0
explode,1,0.0
hemo-vascular,1,0.0
high-efficiency,1,0.0
Nonrandomized,1,0.0
Abciximab,1,0.0
ic,1,0.0
observationally,1,0.0
1298,1,0.0
3235,1,0.0
fecal-viral-excreting,1,0.0
fecal,1,0.0
Dunedin,1,0.0
Specially,1,0.0
manages,1,0.0
Tunisian,1,0.0
Stay†,1,0.0
school-wide,1,0.0
2020-March,1,0.0
59552,1,0.0
1886,1,0.0
Utahs,1,0.0
athletics,1,0.0
events§,1,0.0
Stay,1,0.0
109752,1,0.0
student-days¶,1,0.0
co-localized,1,0.0
complement-mediated,1,0.0
best-practice,1,0.0
Hemo-vascular,1,0.0
Agent-based,1,0.0
Simulator,1,0.0
open-source,1,0.0
intrahost,1,0.0
viral-load-based,1,0.0
loss-to-follow-up,1,0.0
micro-targeting,1,0.0
Implemented,1,0.0
Python,1,0.0
laptop,1,0.0
34670,1,0.0
49-83,1,0.0
Mammography,1,0.0
1998-2008,1,0.0
1680,1,0.0
1310,1,0.0
quintile,1,0.0
AMI-RV,1,0.0
predictable,1,0.0
conveyed,1,0.0
vetting,1,0.0
submission,1,0.0
niche,1,0.0
end-users,1,0.0
evolutionarily,1,0.0
self-damaging,1,0.0
a-specific,1,0.0
Immunological,1,0.0
intermediately,1,0.0
covariance,1,0.0
Spielberger,1,0.0
upperlower,1,0.0
etiopathogenia,1,0.0
early-passage,1,0.0
April-December,1,0.0
S203T,1,0.0
reactors,1,0.0
203T,1,0.0
disulphine,1,0.0
187000,1,0.0
peri-interventional,1,0.0
⩽,1,0.0
1125,1,0.0
728,1,0.0
1725,1,0.0
1528,1,0.0
X24073,1,0.0
72-year-old,1,0.0
Mood,1,0.0
holosystolic,1,0.0
pretibial,1,0.0
Proximal,1,0.0
right-heart,1,0.0
V3R,1,0.0
V6R,1,0.0
arteriolopathies,1,0.0
leucocytes,1,0.0
Cells,1,0.0
brisk,1,0.0
Aldhous,1,0.0
discovers,1,0.0
Saskatchewan,1,0.0
inclusive,1,0.0
mouse-adapted,1,0.0
protein-specific,1,0.0
Th1-biased,1,0.0
MeV,1,0.0
cardiorrhexis,1,0.0
stenosing,1,0.0
ishemic,1,0.0
figuring,1,0.0
anti-hypertrophic,1,0.0
anti-fibrotic,1,0.0
anti-hypertensive,1,0.0
ourselves,1,0.0
tissue-engineering,1,0.0
hydrogels,1,0.0
coadministration,1,0.0
self-adhesive,1,0.0
Fe3-induced,1,0.0
ionic,1,0.0
dopamine-gelatin,1,0.0
GelDA,1,0.0
dopamine-functionalized,1,0.0
polypyrrole,1,0.0
DA-PPy,1,0.0
Schiff,1,0.0
HA-CHO,1,0.0
hydrazided,1,0.0
HHA,1,0.0
single-mode,1,0.0
HA-CHOHHA,1,0.0
painting,1,0.0
GelDADA-PPy,1,0.0
echocardiographical,1,0.0
Insertion,1,0.0
random-digit,1,0.0
dialing,1,0.0
kin,1,0.0
5522,1,0.0
3793,1,0.0
3375-4211,1,0.0
24-31,1,0.0
51-74,1,0.0
30-43,1,0.0
44-68,1,0.0
monetary,1,0.0
10-13,1,0.0
Hashimotos,1,0.0
thyroiditis,1,0.0
immuno-allergological,1,0.0
dose-efficacy,1,0.0
hand-lung,1,0.0
Beclojet,1,0.0
Jet,1,0.0
broncho-pulmonary,1,0.0
down-trend,1,0.0
averaging,1,0.0
misinterpretation,1,0.0
native-born,1,0.0
resettlement,1,0.0
conceivably,1,0.0
recency,1,0.0
immigration,1,0.0
cross-neutralize,1,0.0
3-19,1,0.0
6-11,1,0.0
17-90,1,0.0
Endoluminal,1,0.0
4834-6210,1,0.0
2112-2964,1,0.0
CPRintubation,1,0.0
2538,1,0.0
Mitigating,1,0.0
vulnerabilities,1,0.0
Oak,1,0.0
Ridge,1,0.0
opposition,1,0.0
Goggle,1,0.0
audiences,1,0.0
MBCK,1,0.0
LVG,1,0.0
endo,1,0.0
Endo-diastolic,1,0.0
RMW,1,0.0
accomplishments,1,0.0
practice-based,1,0.0
theory-based,1,0.0
replicable,1,0.0
enrich,1,0.0
parentscaregivers,1,0.0
co-create,1,0.0
derail,1,0.0
23000,1,0.0
influenza-induced,1,0.0
Influenza-attributed,1,0.0
VAs,1,0.0
Managerial,1,0.0
Accounting,1,0.0
Labor,1,0.0
10674,1,0.0
8661-12687,1,0.0
14933,1,0.0
beta2-adrenoceptor,1,0.0
Arabic,1,0.0
phylogenetically,1,0.0
Extraordinary,1,0.0
prioritisation,1,0.0
cytopathologists,1,0.0
hypercontractility,1,0.0
mucoviscidosis,1,0.0
farinae,1,0.0
Euroglyphus,1,0.0
maynei,1,0.0
carpets,1,0.0
upholstered,1,0.0
furniture,1,0.0
HDMs,1,0.0
Sensitized,1,0.0
nonimmunological,1,0.0
G11083T,1,0.0
casting,1,0.0
G26144T,1,0.0
C14805T,1,0.0
rubella,1,0.0
varicella,1,0.0
8-18,1,0.0
Plasmodium,1,0.0
falciparum,1,0.0
reticulocyte,1,0.0
homolog,1,0.0
RH5,1,0.0
RH5-basigin,1,0.0
recombinantly,1,0.0
polyclonal,1,0.0
anti-basigin,1,0.0
information-sharing,1,0.0
overusing,1,0.0
underusing,1,0.0
alerting,1,0.0
Triple,1,0.0
Jordan,1,0.0
Feasibility,1,0.0
adaptability,1,0.0
well-received,1,0.0
Jordanian,1,0.0
Dissection,1,0.0
non-traumatic,1,0.0
non-iatrogenic,1,0.0
noninflammatory,1,0.0
Host-directed,1,0.0
anti-infection,1,0.0
self-protective,1,0.0
Metformin,1,0.0
rationality,1,0.0
elevating,1,0.0
Hib,1,0.0
nonencapsulated,1,0.0
ncHi,1,0.0
recapitulated,1,0.0
G2P2,1,0.0
3200,1,0.0
amniotic,1,0.0
Apgar,1,0.0
weight-dependent,1,0.0
746,1,0.0
maximized,1,0.0
complain,1,0.0
snack,1,0.0
E6,1,0.0
ergometrine,1,0.0
immune-assays,1,0.0
on-pump,1,0.0
Taxonomy,1,0.0
ICTV,1,0.0
Coronavirus-2,1,0.0
ameliorated,1,0.0
immunotherapies,1,0.0
Reddy,1,0.0
actor,1,0.0
q-RTPCR,1,0.0
Monocytes,1,0.0
One-Step,1,0.0
Cosinor,1,0.0
acrophase,1,0.0
bathyphase,1,0.0
death-related,1,0.0
1969-1983,1,0.0
maleate,1,0.0
Immunofluorescence,1,0.0
impressions,1,0.0
parenchymatous,1,0.0
drift-variant,1,0.0
Victoria75,1,0.0
wheezy,1,0.0
sensitisation,1,0.0
antigonists,1,0.0
solvent-accessible,1,0.0
SASA,1,0.0
anchor-locker,1,0.0
Y473-F490,1,0.0
anchor,1,0.0
G496-V503,1,0.0
maturity,1,0.0
1458,1,0.0
interstitium,1,0.0
maneuvers,1,0.0
plasmin-alpha,1,0.0
2-plasmin,1,0.0
SARS-coronavirus,1,0.0
NATURE,1,0.0
Willey,1,0.0
ALPHA,1,0.0
BETA,1,0.0
GAMMA,1,0.0
VOIs,1,0.0
Theta,1,0.0
Kent,1,0.0
20-bed,1,0.0
remedial,1,0.0
bursts,1,0.0
vagus,1,0.0
rehabilitative,1,0.0
generalization,1,0.0
Foster,1,0.0
Nurse,1,0.0
Clot,1,0.0
Tracker,1,0.0
color-coded,1,0.0
trending,1,0.0
83-year-old,1,0.0
hypercontractile,1,0.0
mid-apical,1,0.0
ballooning,1,0.0
Shortly,1,0.0
pulseless,1,0.0
Adolescent,1,0.0
SOC,1,0.0
proxalutamide,1,0.0
Kaplan,1,0.0
doxcycline,1,0.0
tet-notch4,1,0.0
ESCs,1,0.0
Flk1,1,0.0
respecified,1,0.0
reasoned,1,0.0
Tet-notch4,1,0.0
embryoid,1,0.0
uninduced,1,0.0
Dox-cells,1,0.0
Immunohistochemistry,1,0.0
therapy-Adler,1,0.0
Chen,1,0.0
Bystrup,1,0.0
Giovannone,1,0.0
nitazoxanide,1,0.0
Briley-Saebo,1,0.0
Kattman,1,0.0
Mani,1,0.0
Laflamme,1,0.0
W-Z,1,0.0
Fayad,1,0.0
Keller,1,0.0
barcoded,1,0.0
Stage,1,0.0
barcodes,1,0.0
Cerebellar,1,0.0
Cerebellum,1,0.0
AICA,1,0.0
PICA,1,0.0
cardialgia,1,0.0
hypnosuggestive,1,0.0
Mini-Mult,1,0.0
026-070,1,0.0
railed,1,0.0
466,1,0.0
nonimmune,1,0.0
Priority,1,0.0
kinesthetic-,1,0.0
visual-dominant,1,0.0
healthy-controls,1,0.0
visuomotor,1,0.0
cursor,1,0.0
kinesthetic,1,0.0
tailor-made,1,0.0
pre-assessment,1,0.0
only-based,1,0.0
MRI-based,1,0.0
Tian,1,0.0
Nius,1,0.0
Nail,1,0.0
Fold,1,0.0
Microcirculation,1,0.0
microcirculatory,1,0.0
082-097,1,0.0
incongruent,1,0.0
5678,1,0.0
6079,1,0.0
053-082,1,0.0
050-090,1,0.0
049-088,1,0.0
028-072,1,0.0
043,1,0.0
harder,1,0.0
sensibility,1,0.0
topographical,1,0.0
1516,1,0.0
exogenic,1,0.0
extrapulmonary,1,0.0
manometry,1,0.0
duodenography,1,0.0
duodenal,1,0.0
dysbacteriosis,1,0.0
intestines,1,0.0
endogenic,1,0.0
microflora,1,0.0
dose-capacity,1,0.0
wastage,1,0.0
ergonomic,1,0.0
Flutrade,1,0.0
dead-space,1,0.0
10-dose,1,0.0
Extrapolations,1,0.0
platelet-rich,1,0.0
prompts,1,0.0
P-selectin,1,0.0
valinomycin,1,0.0
equal-tailed,1,0.0
CrIs,1,0.0
102950,1,0.0
imatinib,1,0.0
colchicine,1,0.0
granulocyte,1,0.0
colony,1,0.0
tofacitinib,1,0.0
sarilumab,1,0.0
Bauhins,1,0.0
1616,1,0.0
misdiagnoses,1,0.0
2821103,1,0.0
570,1,0.0
practices--yogasanas,1,0.0
kriyas--and,1,0.0
normalcy,1,0.0
cortisone,1,0.0
86-year-old,1,0.0
Wake-up,1,0.0
14-296,1,0.0
cross-referenced,1,0.0
Papers,1,0.0
above-matched,1,0.0
known-onset,1,0.0
MRI-guided,1,0.0
downtown,1,0.0
enumerated,1,0.0
Pulse,1,0.0
TorontoABSTRACT,1,0.0
antifungal,1,0.0
non-photodynamic,1,0.0
non-photoactivated,1,0.0
micromolar,1,0.0
MOI,1,0.0
IHUMI-3,1,0.0
CmaxEC50,1,0.0
CmaxEC90,1,0.0
adept,1,0.0
timescale,1,0.0
thrive,1,0.0
Less-frequent,1,0.0
locks,1,0.0
nonanchoring,1,0.0
long-chain,1,0.0
cleavability,1,0.0
Wouldnt,1,0.0
cardiodiabetic,1,0.0
diabetologists,1,0.0
ECC,1,0.0
system-of-care,1,0.0
benefiting,1,0.0
drowsiness,1,0.0
hydrocephalus,1,0.0
ventriculopleural,1,0.0
Her,1,0.0
loculated,1,0.0
costophrenic,1,0.0
recess,1,0.0
systems-based,1,0.0
cost-,1,0.0
embryo-,1,0.0
manpower-saving,1,0.0
PHASIFY™,1,0.0
bead-based,1,0.0
NucliSENS®,1,0.0
easyMAG®,1,0.0
111120,1,0.0
108120,1,0.0
5360,1,0.0
4960,1,0.0
concoctions,1,0.0
Licorice,1,0.0
Gancao,1,0.0
Pinyin,1,0.0
cuisines,1,0.0
noninsulin-diabetes,1,0.0
EURASPIRE,1,0.0
B1526,1,0.0
B1429,1,0.0
teratogenic,1,0.0
NAb,1,0.0
Robustness,1,0.0
underdeveloped,1,0.0
NPI,1,0.0
Anxious,1,0.0
Paediatricians,1,0.0
caseload,1,0.0
exhibition,1,0.0
husbandry,1,0.0
typesubtype,1,0.0
n420,1,0.0
parainfluenzavirus,1,0.0
DIFA,1,0.0
688,1,0.0
26-45,1,0.0
15-25,1,0.0
0-3,1,0.0
AWyoming32003-like,1,0.0
Caledonia2099-like,1,0.0
BJiangsu102003-like,1,0.0
200304,1,0.0
Costs,1,0.0
intensiv,1,0.0
confines,1,0.0
SENTINEL,1,0.0
4049,1,0.0
1567,1,0.0
B1427,1,0.0
desserts,1,0.0
sweets,1,0.0
socialised,1,0.0
074-100,1,0.0
hypereosinophilic,1,0.0
nonmechanical,1,0.0
ventriculogram,1,0.0
Operation,1,0.0
Life-table,1,0.0
tenets,1,0.0
Association-American,1,0.0
neuro-interventional,1,0.0
post-recanalization,1,0.0
rea-ltime,1,0.0
und,1,0.0
widely-used,1,0.0
methological,1,0.0
analgesia,1,0.0
tracheotomy,1,0.0
SARS-CoV-2-spike-encoding,1,0.0
agile,1,0.0
interruption,1,0.0
plexus,1,0.0
science-based,1,0.0
cocreation-based,1,0.0
competences,1,0.0
TÜBİTAK,1,0.0
coalitions,1,0.0
cocreation,1,0.0
teleconferences,1,0.0
aborted,1,0.0
ajmaline,1,0.0
cardioverter-defibrillator,1,0.0
polyposis,1,0.0
062-089,1,0.0
grapple,1,0.0
Full,1,0.0
Rosen,1,0.0
folklore,1,0.0
originates,1,0.0
sweats,1,0.0
nightmares,1,0.0
disease-a,1,0.0
ischaemia-induced,1,0.0
RA,1,0.0
Delivery,1,0.0
Snakebites,1,0.0
neuromyopathies,1,0.0
intraparenchymal,1,0.0
Bothrops,1,0.0
jararaca,1,0.0
Reconcavo,1,0.0
precocious,1,0.0
Extra-respiratory,1,0.0
lacteal,1,0.0
non-tobacco,1,0.0
10-16,1,0.0
5-day,1,0.0
high-titre,1,0.0
cavernous,1,0.0
20142015,1,0.0
7945,1,0.0
one-,1,0.0
non-vaccination,1,0.0
065-092,1,0.0
075-102,1,0.0
fetotoxicity,1,0.0
acutechronic,1,0.0
β-sheet,1,0.0
≤16,1,0.0
solutes,1,0.0
pericytes,1,0.0
glial-expressed,1,0.0
receptorstargets,1,0.0
Epicardial,1,0.0
halfway,1,0.0
VTs,1,0.0
Stroke-Canadian,1,0.0
Symbol-Digit,1,0.0
Modalities,1,0.0
2530,1,0.0
23-2430,1,0.0
Exploratory,1,0.0
16-year,1,0.0
Sepsis-like,1,0.0
β-propiolactone-inactivated,1,0.0
7-16,1,0.0
convulsions,1,0.0
sepsis-like,1,0.0
Tissue-type,1,0.0
recanalizationreperfusion,1,0.0
counteracted,1,0.0
neurotoxicity,1,0.0
amnesic,1,0.0
amnesia,1,0.0
RBD-Ferritin,1,0.0
24-mer,1,0.0
RBD-mi3,1,0.0
60-mer,1,0.0
RBD-I53-50,1,0.0
transporters,1,0.0
efflux,1,0.0
charcteristics,1,0.0
90-95,1,0.0
N450-F456,1,0.0
kinin,1,0.0
H1N1pdm-vaccinated,1,0.0
001-098,1,0.0
Vertebrobasilar,1,0.0
dolichoectasia,1,0.0
brainstem-,1,0.0
compressive,1,0.0
bromide,1,0.0
LVPW,1,0.0
Color,1,0.0
open-chest,1,0.0
transducers,1,0.0
swabsaliva,1,0.0
Difference,1,0.0
treatment-it,1,0.0
Invalidism,1,0.0
malonylation,1,0.0
succinylation,1,0.0
glutarylation,1,0.0
stressor,1,0.0
heterogenity,1,0.0
cortisolaemia,1,0.0
Aeroallergen,1,0.0
approximates,1,0.0
Ovid,1,0.0
significances,1,0.0
hypersensitive,1,0.0
polyps,1,0.0
120-mer,1,0.0
conjugation,1,0.0
SpyTag-SpyCatcher,1,0.0
builds,1,0.0
weigh,1,0.0
Reflective,1,0.0
listening,1,0.0
well-recognised,1,0.0
disinformation,1,0.0
rhetorical,1,0.0
COVID-denialist,1,0.0
organizes,1,0.0
corrupt,1,0.0
elites,1,0.0
messaging,1,0.0
persuasive,1,0.0
Lymphangio-MRI,1,0.0
contrast-enhancing,1,0.0
3950,1,0.0
48711,1,0.0
Facility-wide,1,0.0
MDH,1,0.0
lapses,1,0.0
12-day,1,0.0
facility-based,1,0.0
practices†,1,0.0
export,1,0.0
B117s,1,0.0
retail,1,0.0
narcotics,1,0.0
dolantine,1,0.0
morphine,1,0.0
upheaval,1,0.0
overlaps,1,0.0
Motivational,1,0.0
AddaVax,1,0.0
Patient-centered,1,0.0
Adjuvant,1,0.0
120-fold,1,0.0
monomeric,1,0.0
corroborating,1,0.0
troubled,1,0.0
Arrays,1,0.0
technology-based,1,0.0
sect,1,0.0
nightclubs,1,0.0
Koreas,1,0.0
6-54,1,0.0
re-employed,1,0.0
legally,1,0.0
documentations,1,0.0
non-participants,1,0.0
DMP-,1,0.0
DMPs,1,0.0
self-isolate,1,0.0
super,1,0.0
pre-clinically,1,0.0
DipHE,1,0.0
n153,1,0.0
placements,1,0.0
n171,1,0.0
n266,1,0.0
midline,1,0.0
articulating,1,0.0
reiterates,1,0.0
postregistration,1,0.0
bronchoscopically,1,0.0
unsurprising,1,0.0
GKV-Modernisierungsgesetz,1,0.0
low-detectible,1,0.0
non-hemorrhagic,1,0.0
reportsseries,1,0.0
Insular,1,0.0
inversions,1,0.0
mcgdL,1,0.0
344,1,0.0
AHamburg0509,1,0.0
AMoscow5012011,1,0.0
AMoscow4502003,1,0.0
AMemphis1496,1,0.0
APR834,1,0.0
HA0--HA1HA2,1,0.0
virus-activating,1,0.0
Comparatively,1,0.0
Multiplication,1,0.0
Storm,1,0.0
cytopathic,1,0.0
recommending,1,0.0
Remote,1,0.0
perconditioning,1,0.0
ACA,1,0.0
Sprague,1,0.0
Dawley,1,0.0
arterioles,1,0.0
150-min,1,0.0
constricting,1,0.0
80-90,1,0.0
diameters,1,0.0
105-110,1,0.0
pre-RIPerC,1,0.0
Neurogenic,1,0.0
investigator,1,0.0
dissimilarities,1,0.0
confounded,1,0.0
F5,1,0.0
F2,1,0.0
FGAFGB,1,0.0
F7,1,0.0
F13A1,1,0.0
F12,1,0.0
SERPINE1,1,0.0
ITGB3ITGA2B,1,0.0
ITGA2,1,0.0
GP1BA,1,0.0
TAFI,1,0.0
THBD,1,0.0
PZ,1,0.0
ANX5,1,0.0
CBS,1,0.0
MTR,1,0.0
CETP,1,0.0
ABCA1,1,0.0
CIII,1,0.0
apoa,1,0.0
PON123,1,0.0
LDLRLOX-1,1,0.0
genegene,1,0.0
antimediator,1,0.0
non-coronary,1,0.0
sided,1,0.0
coved,1,0.0
15750,1,0.0
2007-2010,1,0.0
penumbral,1,0.0
Leeuwen,1,0.0
4382443,1,0.0
hypercube,1,0.0
cross-species,1,0.0
thematic,1,0.0
agro-ecological,1,0.0
BRT,1,0.0
croplands,1,0.0
built-up,1,0.0
One-hundred,1,0.0
fifty-two,1,0.0
arteriograms,1,0.0
Suppressing,1,0.0
Reverse-transcription,1,0.0
low-to-middle-income,1,0.0
groups1-7,1,0.0
test8,1,0.0
rounds,1,0.0
De,1,0.0
subsample,1,0.0
diluted,1,0.0
30-48-fold,1,0.0
dilutions,1,0.0
studies9-11,1,0.0
re-testing,1,0.0
GEIG,1,0.0
Groupement,1,0.0
dExpertise,1,0.0
dInformation,1,0.0
sur,1,0.0
la,1,0.0
Grippe,1,0.0
Expertise,1,0.0
bird-to-human,1,0.0
taper,1,0.0
UNV,1,0.0
MRS4,1,0.0
Lind,1,0.0
Wijngaarden,1,0.0
climatized,1,0.0
allergen-free,1,0.0
785000,1,0.0
infections2,1,0.0
1365,1,0.0
B1154,1,0.0
B1156,1,0.0
African-specific,1,0.0
B1106,1,0.0
KwaZulu-Natal,1,0.0
Ma,1,0.0
Huang,1,0.0
Tang,1,0.0
anti-inflammation,1,0.0
mecanism,1,0.0
Befelatanana,1,0.0
january,1,0.0
december,1,0.0
3650,1,0.0
5541,1,0.0
Predominantly,1,0.0
5154,1,0.0
3612,1,0.0
5022,1,0.0
7753,1,0.0
6784,1,0.0
NIHSS8,1,0.0
haemostasis,1,0.0
penetrates,1,0.0
Ct≤29,1,0.0
Repeats,1,0.0
theobromine,1,0.0
acidophilic,1,0.0
crop,1,0.0
Cu,1,0.0
manganese,1,0.0
Mn,1,0.0
Se,1,0.0
Micronutrients,1,0.0
straining,1,0.0
fabric,1,0.0
Clustered,1,0.0
Regularly-Interspaced,1,0.0
Short,1,0.0
Palindromic,1,0.0
CRISPR-,1,0.0
lavages,1,0.0
CRISPR-associated,1,0.0
Cas,1,0.0
RNA-directed,1,0.0
Applications,1,0.0
CRISPR-Cas-based,1,0.0
postvaccination,1,0.0
Homologous,1,0.0
Commercially,1,0.0
IgA-,1,0.0
IgG-specific,1,0.0
manifolds,1,0.0
granularity,1,0.0
non-neurologic,1,0.0
haunting,1,0.0
alkaloids,1,0.0
TF,1,0.0
theaflavin,1,0.0
EGCG,1,0.0
unblinding,1,0.0
active-controlled,1,0.0
trialsIt,1,0.0
18·1,1,0.0
84·9,1,0.0
84·7,1,0.0
66·5,1,0.0
60·1,1,0.0
58·1,1,0.0
18·4,1,0.0
5·1,1,0.0
1·1,1,0.0
2·9,1,0.0
0·0-6·7,1,0.0
31980,1,0.0
0·02,1,0.0
18-54,1,0.0
1999-2000,1,0.0
misconstrued,1,0.0
Flint,1,0.0
Genomics-led,1,0.0
Docking,1,0.0
Transcriptome,1,0.0
Proposed,1,0.0
Camellia,1,0.0
sinensis,1,0.0
shoots,1,0.0
epigallocatechin,1,0.0
gallate,1,0.0
balances,1,0.0
980,1,0.0
risk-factors,1,0.0
Neutrophils,1,0.0
Latinao,1,0.0
Reopening,1,0.0
2020-January,1,0.0
reopened,1,0.0
670,1,0.0
persons†,1,0.0
Susceptible§,1,0.0
contacts¶,1,0.0
1041,1,0.0
735,1,0.0
school-associated,1,0.0
Mask,1,0.0
seats,1,0.0
isotypes,1,0.0
16PF,1,0.0
Learys,1,0.0
498,1,0.0
self-image,1,0.0
observance,1,0.0
854,1,0.0
-door,1,0.0
Transportation,1,0.0
unfunded,1,0.0
Plasminogen,1,0.0
Activator,1,0.0
GUSTO-IIB,1,0.0
PAMI-I,1,0.0
equaled,1,0.0
gargle,1,0.0
Neutrophil,1,0.0
membrane-derived,1,0.0
approvals,1,0.0
crystalloid,1,0.0
BNT162,1,0.0
PfizerBioNTech,1,0.0
succinct,1,0.0
offsprings,1,0.0
IV-tPA,1,0.0
Catheter-based,1,0.0
IV-tPa,1,0.0
pre-washout,1,0.0
overinfected,1,0.0
aerobiology,1,0.0
pathophysiobiology,1,0.0
Alternaria-induced,1,0.0
investments,1,0.0
vaccine‑induced,1,0.0
690±235,1,0.0
423±276,1,0.0
Females,1,0.0
444±270,1,0.0
±284,1,0.0
P0007,1,0.0
non‑smokers,1,0.0
448±279,1,0.0
380±264,1,0.0
dizzinessweakness,1,0.0
non‑modifiable,1,0.0
immunosurveillance,1,0.0
derangement,1,0.0
Turner-Warwick,1,0.0
Eosinophils,1,0.0
2443,1,0.0
832443,1,0.0
Governor,1,0.0
Endotoxin,1,0.0
494,1,0.0
spasmogens,1,0.0
disintegrin,1,0.0
metalloprotease,1,0.0
ADAM-33,1,0.0
dipeptidyl,1,0.0
peptidase,1,0.0
PHD,1,0.0
DP1,1,0.0
pharmacotherapeutic,1,0.0
RNASE3,1,0.0
q24-q31,1,0.0
electrophysiology,1,0.0
semester,1,0.0
Bacteroicles,1,0.0
HF-rTMS,1,0.0
Proteus,1,0.0
volunteer,1,0.0
biodata,1,0.0
Hyperperceivers,1,0.0
Regimens,1,0.0
ultrasonically,1,0.0
hypertonic,1,0.0
n50,1,0.0
n72,1,0.0
n15,1,0.0
nonasthmatics,1,0.0
Mast,1,0.0
rRt-PCR,1,0.0
httpsbitly3aZUAPB,1,0.0
≤12,1,0.0
2074,1,0.0
preconditions,1,0.0
PACMANS,1,0.0
Asthma-COPD,1,0.0
high-sensitive,1,0.0
amotosalenUVA,1,0.0
Al,1,0.0
unknown--apart,1,0.0
1961--before,1,0.0
ecosystems,1,0.0
exposes,1,0.0
long-distance,1,0.0
Rigorous,1,0.0
reorganized,1,0.0
understatement,1,0.0
nonregistration,1,0.0
vicinity,1,0.0
247-393,1,0.0
Vincent,1,0.0
tools--evidence-based,1,0.0
technology--to,1,0.0
Automated,1,0.0
interpatient,1,0.0
intrapatient,1,0.0
4-quadrant,1,0.0
Medically,1,0.0
Breathlessness,1,0.0
PIE,1,0.0
richer,1,0.0
nondrug,1,0.0
Proteases,1,0.0
hydrolyze,1,0.0
Adamantanes,1,0.0
Hesed,1,0.0
3662218,1,0.0
PAI,1,0.0
interpretability,1,0.0
equated,1,0.0
Alabama,1,0.0
Side,1,0.0
insomnia,1,0.0
2046,1,0.0
Self-reports,1,0.0
well-equipped,1,0.0
transversarium,1,0.0
dura,1,0.0
lends,1,0.0
C1-2,1,0.0
dislocation,1,0.0
Sexuality,1,0.0
border-zone,1,0.0
H-coil,1,0.0
BZ,1,0.0
Postischemic,1,0.0
stimulatory,1,0.0
insulin-like,1,0.0
factor-I,1,0.0
factor-2,1,0.0
noncompaction,1,0.0
compaction,1,0.0
trabecular,1,0.0
AChA,1,0.0
crushing,1,0.0
overstrained,1,0.0
tabs,1,0.0
asymptomaticsymptomatic,1,0.0
scalability,1,0.0
clinical-radiological,1,0.0
non-,1,0.0
underlining,1,0.0
LE,1,0.0
disruptor,1,0.0
manageable,1,0.0
cant,1,0.0
whipped,1,0.0
cursory,1,0.0
nongenomic,1,0.0
Manaus,1,0.0
641,1,0.0
--003,1,0.0
mmsec,1,0.0
age-corrected,1,0.0
Mantel-Haenszel,1,0.0
--30,1,0.0
assures,1,0.0
upgrade,1,0.0
unleashed,1,0.0
Accreditation,1,0.0
Calibration,1,0.0
par,1,0.0
organogram,1,0.0
inventory,1,0.0
laid,1,0.0
Biotechnology,1,0.0
1922,1,0.0
expedited,1,0.0
doctorspecialist,1,0.0
scents,1,0.0
capsaicin,1,0.0
pathogeneses,1,0.0
nonvaccinated,1,0.0
745,1,0.0
breakdown,1,0.0
advising,1,0.0
thrombolysisHighlights,1,0.0
Terminology,1,0.0
haematological,1,0.0
ascertains,1,0.0
neuro-disability,1,0.0
bland,1,0.0
underrecognized,1,0.0
hemoglobinopathy,1,0.0
sort,1,0.0
exploits,1,0.0
spreadsheet,1,0.0
15841,1,0.0
finds,1,0.0
insubsequent,1,0.0
Biontech,1,0.0
glitch,1,0.0
Futhermore,1,0.0
subdue,1,0.0
deteriorate,1,0.0
Principally,1,0.0
mastering,1,0.0
BDA,1,0.0
Replies,1,0.0
pre-retinal,1,0.0
risk-reducing,1,0.0
simple-advice,1,0.0
stroke-risk,1,0.0
refines,1,0.0
achievable,1,0.0
1990-2010,1,0.0
GBD,1,0.0
Injuries,1,0.0
low-fat,1,0.0
71225,1,0.0
Parent,1,0.0
Syndrome-Coronavirus-1,1,0.0
Guangdong,1,0.0
8089,1,0.0
Syndrome-Coronavirus,1,0.0
100000000,1,0.0
2000000,1,0.0
cold-like,1,0.0
-2,1,0.0
Remarkably,1,0.0
offerings,1,0.0
maxillofacial,1,0.0
Spire,1,0.0
plc©,1,0.0
two-week,1,0.0
worn,1,0.0
4259,1,0.0
bimaxillary,1,0.0
1759,1,0.0
917,1,0.0
maxillary,1,0.0
mandibular,1,0.0
genioplasty,1,0.0
Zero,1,0.0
Adopting,1,0.0
detriment,1,0.0
Boards,1,0.0
Statin,1,0.0
injurydisorders,1,0.0
VHA,1,0.0
self-protection,1,0.0
stably,1,0.0
EGFR,1,0.0
normalizing,1,0.0
huEGFRt,1,0.0
T2A,1,0.0
self-cleaving,1,0.0
double-staining,1,0.0
anti-EGFR,1,0.0
CBMSO,1,0.0
Madrid,1,0.0
amrinone,1,0.0
490,1,0.0
24h,1,0.0
kPas,1,0.0
630,1,0.0
non-sinus,1,0.0
nonfailing,1,0.0
monospecific,1,0.0
H0,1,0.0
Heq1,1,0.0
Heq2,1,0.0
Porcine,1,0.0
swineIowa1530,1,0.0
KentUnited,1,0.0
R‑value,1,0.0
etesivimab,1,0.0
B11281,1,0.0
17-26,1,0.0
8-fold,1,0.0
B1617,1,0.0
expresses,1,0.0
Jurkat,1,0.0
Articles,1,0.0
non-adherent,1,0.0
evaluate-via,1,0.0
questionnaire-the,1,0.0
co-existing,1,0.0
vaccinesmass,1,0.0
agencieshealth,1,0.0
Professional,1,0.0
recombine,1,0.0
coronavirus-related,1,0.0
interspecies,1,0.0
European-CDC,1,0.0
USA-CDC,1,0.0
Taiwan-CDC,1,0.0
Claims,1,0.0
validates,1,0.0
aboard,1,0.0
Diamond,1,0.0
Princess,1,0.0
departure,1,0.0
coalescent-based,1,0.0
working-out,1,0.0
athopy,1,0.0
conditionings,1,0.0
anti-asthmatic,1,0.0
leukotriens,1,0.0
tromboxanes,1,0.0
Panic,1,0.0
cognitiveaffective,1,0.0
PAs,1,0.0
cytometer-friendly,1,0.0
maleficence,1,0.0
medicineIn,1,0.0
contended,1,0.0
Envelope,1,0.0
pacemaker,1,0.0
serodiagnostic,1,0.0
serodiagnosis,1,0.0
seraplasma,1,0.0
snored,1,0.0
non-rapid,1,0.0
NREM,1,0.0
cranio-mandibular,1,0.0
cephalometric,1,0.0
Snoring,1,0.0
pharynxes,1,0.0
Müller,1,0.0
manoeuvres,1,0.0
epicenter,1,0.0
RdRPEN,1,0.0
454,1,0.0
RdRPNInternal,1,0.0
RdRPNIC,1,0.0
Kogenebiotech,1,0.0
FAMN,1,0.0
CY5IC,1,0.0
Hex,1,0.0
9462,1,0.0
9692,1,0.0
9231,1,0.0
9538,1,0.0
Heartmate,1,0.0
Heartware,1,0.0
247,1,0.0
EPPY,1,0.0
PLWH,1,0.0
lactosamine,1,0.0
sialylated,1,0.0
sugars,1,0.0
otorhinolaryngology,1,0.0
host-specific,1,0.0
de-escalation,1,0.0
lipooligosaccharides,1,0.0
glycolipids,1,0.0
O-deacylation,1,0.0
anhydrous,1,0.0
hydrazine,1,0.0
electrospray,1,0.0
22778,1,0.0
34164,1,0.0
hexoses,1,0.0
L-glycero-D-manno-heptoses,1,0.0
3-deoxy-D-manno-octulosonic,1,0.0
diphosphorylated,1,0.0
phosphoethanolamine,1,0.0
PEA,1,0.0
N-acetylhexosamine,1,0.0
size-exclusion,1,0.0
12434,1,0.0
22158,1,0.0
heptose,1,0.0
trisaccharide,1,0.0
anhydro-KDO,1,0.0
terminus,1,0.0
artifact,1,0.0
beta-elimination,1,0.0
4-position,1,0.0
N-acetylglucosamine,1,0.0
subtherapeutic,1,0.0
888,1,0.0
academically,1,0.0
90th,1,0.0
higher-order,1,0.0
specialization,1,0.0
lesion-behavior,1,0.0
voxel-based,1,0.0
right-hemispheric,1,0.0
Voxel-based,1,0.0
Lobules,1,0.0
VIIb,1,0.0
VIII,1,0.0
Crus,1,0.0
misattribution,1,0.0
pitch,1,0.0
loudness,1,0.0
sings,1,0.0
hyperfibrinogenemia,1,0.0
hemorrhaghic,1,0.0
1165,1,0.0
IUL,1,0.0
elastase,1,0.0
informativeness,1,0.0
Liptovsky,1,0.0
Mikulas,1,0.0
1996-2002,1,0.0
15512,1,0.0
uropoetic,1,0.0
oncohematological,1,0.0
paraneoplastic,1,0.0
beans,1,0.0
MBT,1,0.0
illnessILI,1,0.0
voices,1,0.0
miscarriages,1,0.0
heterosubtypic,1,0.0
population-age,1,0.0
15-May,1,0.0
722,1,0.0
on-campus,1,0.0
dormitories,1,0.0
undergraduate-aged,1,0.0
B11222,1,0.0
discourage,1,0.0
Party,1,0.0
calculator,1,0.0
pound,1,0.0
variables--age,1,0.0
smoking--for,1,0.0
Tables,1,0.0
multiplicative,1,0.0
Actually,1,0.0
interestingly,1,0.0
invadability,1,0.0
Lianhua-Qingwen,1,0.0
herb,1,0.0
Products,1,0.0
NMPA,1,0.0
HIN1,1,0.0
wind-heat,1,0.0
amygdalitis,1,0.0
infection-acquired,1,0.0
wave-by-wave,1,0.0
sero-epidemiological,1,0.0
influenza-experienced,1,0.0
Best,1,0.0
otorhinolaryngologic,1,0.0
cross-study,1,0.0
CEAs,1,0.0
PageRank,1,0.0
co-treatment,1,0.0
Citicoline,1,0.0
devided,1,0.0
322,1,0.0
182IU,1,0.0
Mechanism,1,0.0
salvaged,1,0.0
Apoptosis,1,0.0
Commuting,1,0.0
bi-directionally,1,0.0
weekday,1,0.0
commutes,1,0.0
PageRank-like,1,0.0
enterovirus,1,0.0
HITS,1,0.0
under-used,1,0.0
Fluorescent,1,0.0
cross-sectionally,1,0.0
EGEA,1,0.0
odds-ratio,1,0.0
132-390,1,0.0
Lazarus,1,0.0
phenomenological,1,0.0
troubling,1,0.0
Degree,1,0.0
therapyself-care,1,0.0
workphysical,1,0.0
interpersonalfamily,1,0.0
PSG,1,0.0
Cheyne-Stokes,1,0.0
secured,1,0.0
Treadmill,1,0.0
099-112,1,0.0
143-182,1,0.0
nasopharyngeal-,1,0.0
anal-swabs,1,0.0
Oropharyngeal,1,0.0
millilitres,1,0.0
spun,1,0.0
QIAamp,1,0.0
Mini,1,0.0
BGI,1,0.0
OPNP,1,0.0
GMW,1,0.0
mini-Wright,1,0.0
5-9,1,0.0
signed,1,0.0
Friedman,1,0.0
ERMs,1,0.0
inter-subject,1,0.0
transcribing,1,0.0
recognizable,1,0.0
Pathologically,1,0.0
obligatory,1,0.0
582,1,0.0
Offspring,1,0.0
5533,1,0.0
8678,1,0.0
1430,1,0.0
1950,1,0.0
1566,1,0.0
104-118,1,0.0
155-197,1,0.0
OSA-induced,1,0.0
noon,1,0.0
20-fold,1,0.0
Westcott,1,0.0
CoronaVirus,1,0.0
9206,1,0.0
RBDs,1,0.0
Utilizing,1,0.0
multi-scale,1,0.0
stabilities,1,0.0
Electrostatic,1,0.0
dominantly,1,0.0
folding,1,0.0
redone,1,0.0
CT-alternative,1,0.0
httpsqapecdceuropaeupublicextensionsCOVID-19COVID-19html,1,0.0
marginally,1,0.0
1888,1,0.0
erythematous,1,0.0
urticarial,1,0.0
chickenpox‐like,1,0.0
Trunk,1,0.0
Itching,1,0.0
pseudochilblain,1,0.0
APhilippines,1,0.0
1156-bed,1,0.0
polyneuropathy,1,0.0
organomegaly,1,0.0
endocrinopathy,1,0.0
gammopathy,1,0.0
lymphoproliferative,1,0.0
vasculopathic,1,0.0
Queens,1,0.0
natu-ral,1,0.0
α-SMA,1,0.0
polysomnogram,1,0.0
CD45,1,0.0
RT-PCR-negative,1,0.0
2008-2013,1,0.0
10138,1,0.0
4226,1,0.0
5912,1,0.0
19-39,1,0.0
041-091,1,0.0
119-402,1,0.0
Nicotine,1,0.0
alpha7-nicotinic,1,0.0
HBEpC,1,0.0
httpsbitly3eJ5b35,1,0.0
Sero-conversion,1,0.0
manufacturer,1,0.0
Mx1-,1,0.0
BALB,1,0.0
·,1,0.0
A2G-Mx1,1,0.0
Mx-,1,0.0
changingcleaning,1,0.0
acaricides,1,0.0
Quebec,1,0.0
Syndecan-4,1,0.0
heparan,1,0.0
proteoglycan,1,0.0
synd4-deficient,1,0.0
Adenovirus,1,0.0
myocyte,1,0.0
arteriogenesis,1,0.0
Laboratory-confirmed,1,0.0
-73,1,0.0
culture-proven,1,0.0
multi-country,1,0.0
2460092,1,0.0
2040611,1,0.0
2280247,1,0.0
criticisms,1,0.0
10LV,1,0.0
6LV,1,0.0
8LV,1,0.0
5LV,1,0.0
AARs,1,0.0
Amid,1,0.0
second-dose,1,0.0
deferral,1,0.0
first-vaccine-dose,1,0.0
patient-preference-sensitive,1,0.0
damping,1,0.0
immunopathogenic,1,0.0
non-atheromatic,1,0.0
NZiS,1,0.0
IMAC,1,0.0
convened,1,0.0
paradigms,1,0.0
Exosomes,1,0.0
intercellular,1,0.0
unveiled,1,0.0
Southwestern,1,0.0
150-cavity,1,0.0
group-1,1,0.0
precampaign,1,0.0
Debre,1,0.0
Berhan,1,0.0
metabolome,1,0.0
pHCWs,1,0.0
SARS-CoV-2-antibody,1,0.0
CASOD,1,0.0
laboratory-controlled,1,0.0
unsafe,1,0.0
dominate,1,0.0
faeces,1,0.0
wastewaters,1,0.0
Shell,1,0.0
cooked,1,0.0
vegetatble,1,0.0
salads,1,0.0
aquaculture,1,0.0
vector-mediated,1,0.0
faecal,1,0.0
street,1,0.0
vending,1,0.0
unhygienic,1,0.0
rudimentary,1,0.0
funeral,1,0.0
CHQs,1,0.0
overrepresenting,1,0.0
Intraclass,1,0.0
Laninamivir,1,0.0
octanoate,1,0.0
hydrate,1,0.0
710,1,0.0
372,1,0.0
1643,1,0.0
18141,1,0.0
indifferent,1,0.0
athero-stenotic,1,0.0
pretested,1,0.0
patient-identified,1,0.0
trainer,1,0.0
quoted,1,0.0
IL4,1,0.0
autosomic,1,0.0
locus,1,0.0
notions,1,0.0
mild-persistent,1,0.0
paramedic,1,0.0
dispatcher,1,0.0
suspecting,1,0.0
flow-based,1,0.0
paper-based,1,0.0
25-300,1,0.0
-1185,1,0.0
-152,1,0.0
artery-to-artery,1,0.0
MES,1,0.0
40-80,1,0.0
P0016,1,0.0
6294,1,0.0
1345-29457,1,0.0
P0019,1,0.0
6172,1,0.0
1235-3125,1,0.0
P0027,1,0.0
MES-positive,1,0.0
Ever,1,0.0
differentiates,1,0.0
post-developmental,1,0.0
birthed,1,0.0
myriad,1,0.0
vocabulary,1,0.0
fluctuations,1,0.0
eminently,1,0.0
6-15-fold,1,0.0
footing,1,0.0
8-level,1,0.0
Osnabrück,1,0.0
pride,1,0.0
desirability,1,0.0
cigarette-smoking,1,0.0
polycythemia,1,0.0
Quantitation,1,0.0
Benefit,1,0.0
Discontinuance,1,0.0
679,1,0.0
Cigarette,1,0.0
q-wave,1,0.0
intellectual,1,0.0
Coding,1,0.0
subtest,1,0.0
Wechsler,1,0.0
Intelligence,1,0.0
Children-Revised,1,0.0
subtests,1,0.0
Reading,1,0.0
Arithmetic,1,0.0
Spelling,1,0.0
Test-Revised,1,0.0
multiple-treatments,1,0.0
atorvastatin,1,0.0
pravastatin,1,0.0
carcinogenic,1,0.0
N-nitroso,1,0.0
job-related,1,0.0
infarciton,1,0.0
non-randomized,1,0.0
1297,1,0.0
GISN,1,0.0
consider--from,1,0.0
France--antigenic,1,0.0
shear-induced,1,0.0
transgenic,1,0.0
VWF--,1,0.0
hydrodynamic,1,0.0
VWF-encoding,1,0.0
Secreted,1,0.0
stroke-protective,1,0.0
GPIbalphaVWF,1,0.0
D1,1,0.0
PLD1,1,0.0
Mapping,1,0.0
bandwidth,1,0.0
ill-effects,1,0.0
80-250,1,0.0
nonfiltered,1,0.0
0181,1,0.0
0086,1,0.0
0138,1,0.0
0075,1,0.0
0031,1,0.0
0240,1,0.0
0076,1,0.0
0130,1,0.0
001ABSTRACT,1,0.0
32000,1,0.0
ionophore,1,0.0
A23187,1,0.0
Twice,1,0.0
Low-level,1,0.0
bicycle-exercise,1,0.0
Contractile,1,0.0
centThe,1,0.0
11195,1,0.0
stress-echocardiography,1,0.0
telephone-surveys,1,0.0
13010,1,0.0
household-interviews,1,0.0
74-88,1,0.0
114-144,1,0.0
ratio88,1,0.0
72-108,1,0.0
tracheitis,1,0.0
otolaryngology,1,0.0
Mitral,1,0.0
misuses,1,0.0
IKKNF-kappaB,1,0.0
NF-kappaB,1,0.0
5mgkgday,1,0.0
intraperitoneal,1,0.0
bioavailability,1,0.0
mgkgtwice,1,0.0
networked,1,0.0
agent-based,1,0.0
stylized,1,0.0
all-community,1,0.0
unmitigated,1,0.0
0-case,1,0.0
recurred,1,0.0
10-case,1,0.0
thwarted,1,0.0
Peridural,1,0.0
Swan-Ganz,1,0.0
conventially,1,0.0
waiting-list,1,0.0
ICER,1,0.0
expelled,1,0.0
talking,1,0.0
2019-novel,1,0.0
Well-understanding,1,0.0
treatmentsvaccines,1,0.0
genetic-related,1,0.0
Neurovascular,1,0.0
high-reward,1,0.0
TH,1,0.0
under-utilized,1,0.0
pharmaco-proteomic,1,0.0
widen,1,0.0
post-cardiac,1,0.0
2790,1,0.0
Asp614Gly,1,0.0
74922,1,0.0
non-H1,1,0.0
984,1,0.0
H1r,1,0.0
10-90,1,0.0
countriesterritories,1,0.0
Ala222Val,1,0.0
unsuspected,1,0.0
cirrhotic,1,0.0
decompensated,1,0.0
BLITZ-1,1,0.0
14-month,1,0.0
over-all,1,0.0
statutory,1,0.0
MEASURES,1,0.0
22-23,1,0.0
OUTCOME,1,0.0
strategys,1,0.0
355,1,0.0
Eighty-nine,1,0.0
Vigorous,1,0.0
SARS-CoV-2-causing,1,0.0
retrotransposon,1,0.0
pre-human,1,0.0
vector-based,1,0.0
food-ingested,1,0.0
RNADNA,1,0.0
Actual,1,0.0
adenoviral-based,1,0.0
Eventually,1,0.0
weighing,1,0.0
vaccine-associated,1,0.0
vector-carried,1,0.0
Informing,1,0.0
easing,1,0.0
lifted,1,0.0
nearing,1,0.0
perish,1,0.0
replications,1,0.0
experimenter,1,0.0
induced-asthma,1,0.0
Describe,1,0.0
CHSA-,1,0.0
DESIGN,1,0.0
SUBJECTS,1,0.0
INTERVENTION,1,0.0
migrant,1,0.0
Delhi,1,0.0
Galician,1,0.0
OMT,1,0.0
Δ-9-tetrahydrocannabinol,1,0.0
tract-level,1,0.0
Expanded,1,0.0
adversities,1,0.0
Routinely,1,0.0
Cause,1,0.0
action-centered,1,0.0
2006-2012,1,0.0
2008-2018,1,0.0
medicalization,1,0.0
stipulated,1,0.0
leveled,1,0.0
€15,1,0.0
€18,1,0.0
Stem-,1,0.0
Brief,1,0.0
bone-marrow-derived,1,0.0
credentialing,1,0.0
cannulated,1,0.0
experianced,1,0.0
anoxic,1,0.0
etexilate,1,0.0
low-power,1,0.0
Experiments,1,0.0
1110,1,0.0
parentage,1,0.0
flu-illness,1,0.0
hand-agitated,1,0.0
poly-gelin,1,0.0
colloid,1,0.0
Exhaustive,1,0.0
marijuana-associated,1,0.0
platform-based,1,0.0
816,1,0.0
meningococcal,1,0.0
wintertime,1,0.0
drug-refractory,1,0.0
defibrillating,1,0.0
cryoablation,1,0.0
ventriculoplasty,1,0.0
moderate-grade,1,0.0
IPH,1,0.0
sat,1,0.0
restrained,1,0.0
drum-like,1,0.0
drum,1,0.0
rightwards-leftwards,1,0.0
rod,1,0.0
-45,1,0.0
pushers,1,0.0
-85,1,0.0
-78,1,0.0
modalityies,1,0.0
VV,1,0.0
HV,1,0.0
thalamo-parietal,1,0.0
somaesthetic,1,0.0
graviceptive,1,0.0
Tilts,1,0.0
1718,1,0.0
erect,1,0.0
erroneous,1,0.0
sulphate,1,0.0
PTCRABSTRACT,1,0.0
κ07-09,1,0.0
Ali-Ibne-Abi,1,0.0
creep,1,0.0
defibrillation,1,0.0
fungibles,1,0.0
pointof-care,1,0.0
SC2,1,0.0
Entry,1,0.0
ADF,1,0.0
433,1,0.0
Code,1,0.0
incapacity,1,0.0
dangerously,1,0.0
5778,1,0.0
slowing,1,0.0
Mini-log,1,0.0
work-relatedness,1,0.0
Operations,1,0.0
weakest,1,0.0
porous,1,0.0
communicable,1,0.0
coinfer,1,0.0
within-country,1,0.0
bounds,1,0.0
2·5-,1,0.0
2·0-fold,1,0.0
nondisabling,1,0.0
nonobese,1,0.0
ClustalX183,1,0.0
MEGA40,1,0.0
AHK2132003,1,0.0
ATurkey655962006,1,0.0
QNG,1,0.0
147100000,1,0.0
229100000,1,0.0
156100000,1,0.0
133100000,1,0.0
κ01-06,1,0.0
observer-dependent,1,0.0
1918-1921,1,0.0
unevenly,1,0.0
tracheobronchitis,1,0.0
Histopathology,1,0.0
hypervirulent,1,0.0
RMS-ratio,1,0.0
scalar,1,0.0
TMA-time,1,0.0
RAEV-ratio,1,0.0
disproportion,1,0.0
cicatricial,1,0.0
faculties,1,0.0
plenty,1,0.0
Radiologists,1,0.0
V7,1,0.0
V9,1,0.0
anterior-wall,1,0.0
IVO,1,0.0
Dual,1,0.0
sustainably,1,0.0
5-2,1,0.0
PTCAstent,1,0.0
Restenosis,1,0.0
communitywide,1,0.0
Worcester,1,0.0
254100000,1,0.0
280100000,1,0.0
austerity,1,0.0
comfortable,1,0.0
colossal,1,0.0
rhythmic,1,0.0
magnesemia,1,0.0
smoke-free,1,0.0
laws,1,0.0
3-15,1,0.0
multi-factorial,1,0.0
disturb,1,0.0
Th,1,0.0
Th2-associated,1,0.0
mutually,1,0.0
warmer,1,0.0
arrthythmias,1,0.0
RKAS-1,1,0.0
Segments,1,0.0
rhythmogram,1,0.0
discrupted,1,0.0
6–86,1,0.0
RRsigma,1,0.0
P3,1,0.0
sensitised,1,0.0
Thursday,1,0.0
Tuesday,1,0.0
P-ECP,1,0.0
CD19,1,0.0
CD25,1,0.0
FACS,1,0.0
bedridden,1,0.0
H1N1-influenza,1,0.0
pharyngitis,1,0.0
bilobar,1,0.0
superinfection,1,0.0
hypomagnesemia,1,0.0
plasmatic,1,0.0
brazilians,1,0.0
post-vaccine,1,0.0
Rafsanjan,1,0.0
Alhydrogel®,1,0.0
cGMPs,1,0.0
1-L,1,0.0
5-L,1,0.0
Pichia,1,0.0
pastoris,1,0.0
liter,1,0.0
purity,1,0.0
SEC-HPLC,1,0.0
DLS,1,0.0
Yeast,1,0.0
Reproducibility,1,0.0
48-64,1,0.0
cross-neutralizing,1,0.0
AJapan3051957,1,0.0
Kong107399,1,0.0
AIndiana0811,1,0.0
KongG997,1,0.0
AchickenHong,1,0.0
KongSF401,1,0.0
H6N1,1,0.0
AShanghai213,1,0.0
ANetherlands21903,1,0.0
Titers,1,0.0
Serfling-type,1,0.0
Interferon,1,0.0
moderator,1,0.0
201718,1,0.0
piperacillin,1,0.0
tazobactam,1,0.0
long-term-,1,0.0
fascinating,1,0.0
non-adjuvanted,1,0.0
emulsion,1,0.0
MF59,1,0.0
broadens,1,0.0
LVMMs,1,0.0
26-year-old,1,0.0
110574,1,0.0
13157,1,0.0
42-79,1,0.0
0-2,1,0.0
Healths,1,0.0
NPSs,1,0.0
Phase-1,1,0.0
homogenization,1,0.0
phase-1,1,0.0
68240,1,0.0
897,1,0.0
phase-2,1,0.0
95189,1,0.0
characterising,1,0.0
sending,1,0.0
marking,1,0.0
Socio-economic,1,0.0
infarct-limiting,1,0.0
revitalizing,1,0.0
revascularizing,1,0.0
Exosomal,1,0.0
gene-modified,1,0.0
24–89,1,0.0
sin,1,0.0
Anti-neuraminidase,1,0.0
GISSI-3,1,0.0
receptor-blocking,1,0.0
ISIS-4,1,0.0
CCS-1,1,0.0
cardiac-rehabilitation,1,0.0
acknowledge,1,0.0
IEEE,1,0.0
Xplore,1,0.0
trans,1,0.0
1992-1995,1,0.0
Maryland,1,0.0
MSDB,1,0.0
21132,1,0.0
discriminating,1,0.0
11-74,1,0.0
CI12-93,1,0.0
hemineglect,1,0.0
Neuroendocrine,1,0.0
775,1,0.0
Angiotensin,1,0.0
T-waves,1,0.0
Grant,1,0.0
cysteinyl,1,0.0
CysLT2,1,0.0
anti-remodelling,1,0.0
LT,1,0.0
multibasic,1,0.0
organoids,1,0.0
cathepsin-mediated,1,0.0
endosomal,1,0.0
Blocking,1,0.0
low-high-highest-high-low,1,0.0
diffusions,1,0.0
Azerbaijan,1,0.0
parent-completed,1,0.0
Representation,1,0.0
ethnically,1,0.0
AIRS-S,1,0.0
Puerto,1,0.0
ED--discharge,1,0.0
hospitalization--after,1,0.0
84-100,1,0.0
85-100,1,0.0
Operating,1,0.0
Authority,1,0.0
Lodz,1,0.0
Economical,1,0.0
counteraction,1,0.0
program--Prevention,1,0.0
low-burden,1,0.0
subspecialists,1,0.0
High-Dose®,1,0.0
forbidden,1,0.0
kV,1,0.0
grouper,1,0.0
∼27,1,0.0
Å,1,0.0
high-end,1,0.0
Talos,1,0.0
Arctica,1,0.0
Macrobrachium,1,0.0
rosenbergii,1,0.0
nodavirus,1,0.0
sub-3Å,1,0.0
capsids,1,0.0
representations,1,0.0
Supporting,1,0.0
Idiopathic,1,0.0
controllerreliever,1,0.0
frequented,1,0.0
seasonal-influenza,1,0.0
FRagmin,1,0.0
Revascularisation,1,0.0
InStability,1,0.0
moderate-,1,0.0
juncture,1,0.0
affords,1,0.0
ad,1,0.0
reperfuse,1,0.0
neuroprotectant,1,0.0
ambitious,1,0.0
unachievable,1,0.0
unproven,1,0.0
Afferent,1,0.0
duplications,1,0.0
blindfolded,1,0.0
brain-damaged,1,0.0
sentence,1,0.0
copying,1,0.0
handwriting,1,0.0
dictation,1,0.0
write,1,0.0
Non-atopic,1,0.0
deliberate,1,0.0
Prescription,1,0.0
under-use,1,0.0
disodium,1,0.0
supervising,1,0.0
TEMs,1,0.0
germane,1,0.0
antiapoptotic,1,0.0
oxides,1,0.0
reception,1,0.0
mouthwashesgargles,1,0.0
Reductions,1,0.0
shampoo,1,0.0
rinse,1,0.0
2-min,1,0.0
mouthwashgargle,1,0.0
Listerine,1,0.0
Listerine-like,1,0.0
30-s,1,0.0
neurotransmitter,1,0.0
noise,1,0.0
Countermeasures,1,0.0
Resting-state,1,0.0
Probabilistic,1,0.0
Semantic,1,0.0
Fluency,1,0.0
Anesthetized,1,0.0
6-hour,1,0.0
bolus5,1,0.0
monastral,1,0.0
2350,1,0.0
1839,1,0.0
2583,1,0.0
1517,1,0.0
Th2-adaptive,1,0.0
glycoproteins,1,0.0
double-edged,1,0.0
sword,1,0.0
Wearing,1,0.0
dots,1,0.0
compartment,1,0.0
dendrimers,1,0.0
HDL-based,1,0.0
2942,1,0.0
hemichorea-hemiballism,1,0.0
CATHEPSINs,1,0.0
transcriptionally,1,0.0
AhR,1,0.0
promoters,1,0.0
conceptually,1,0.0
Kobe,1,0.0
rages,1,0.0
Chittagong,1,0.0
pathomechanism,1,0.0
Daniloski,1,0.0
CRISPR-based,1,0.0
repositioned,1,0.0
Self-collected,1,0.0
Meta-analyses,1,0.0
oxidativenitrosative,1,0.0
polymerase-1,1,0.0
PARP-1,1,0.0
macrodomain,1,0.0
glycohydrolase,1,0.0
melastatin,1,0.0
D3,1,0.0
trehalose,1,0.0
tannins,1,0.0
flufenamic,1,0.0
mefenamic,1,0.0
quenching,1,0.0
masquerading,1,0.0
venerability,1,0.0
Iraq,1,0.0
PRMTs,1,0.0
897-902,1,0.0
self-referred,1,0.0
1600,1,0.0
0800,1,0.0
Age-of-asthma,1,0.0
2921,1,0.0
age-of-onset,1,0.0
spirometrically,1,0.0
misconception,1,0.0
matinal,1,0.0
betablockers,1,0.0
symptom-based,1,0.0
24-68,1,0.0
methyltransferases,1,0.0
methylates,1,0.0
Fibrinolysis,1,0.0
motifs,1,0.0
lysine,1,0.0
5-UTR,1,0.0
HEK293,1,0.0
G3BP1,1,0.0
Methylation,1,0.0
R95K,1,0.0
N-mediated,1,0.0
coexpression,1,0.0
methylarginine,1,0.0
Tudor,1,0.0
quenched,1,0.0
protein-mediated,1,0.0
VeroE6,1,0.0
Thorax,1,0.0
Reed,1,0.0
09-21,1,0.0
Reproduction,1,0.0
attacksThe,1,0.0
TristaniaThe,1,0.0
polyvalent,1,0.0
squares,1,0.0
unbound,1,0.0
AFM,1,0.0
aptamer-modified,1,0.0
bronchofiberoscopy,1,0.0
invasiveness,1,0.0
pre-certification,1,0.0
surpass,1,0.0
recombinase-polymerase-amplification,1,0.0
025-25,1,0.0
RT-real-time,1,0.0
1818,1,0.0
19-37,1,0.0
78-year-old,1,0.0
Norrbotten,1,0.0
RT-qPCR-mediated,1,0.0
labor-extensive,1,0.0
one-tube,1,0.0
formamide,1,0.0
766,1,0.0
H1N1H3N2,1,0.0
ect,1,0.0
discriminates,1,0.0
oligemia,1,0.0
Thresholds,1,0.0
extant,1,0.0
10-years-olds,1,0.0
semi-Markov,1,0.0
costbenefit,1,0.0
simplifying,1,0.0
Approved,1,0.0
11761,1,0.0
Non-approved,1,0.0
8671,1,0.0
6316,1,0.0
6520,1,0.0
3116,1,0.0
3422,1,0.0
1619,1,0.0
287513685,1,0.0
5576999,1,0.0
23186686,1,0.0
48-117,1,0.0
1384,1,0.0
nurse-based,1,0.0
solicited,1,0.0
trustworthiness,1,0.0
17-year-old,1,0.0
epigastric,1,0.0
syndrome--but,1,0.0
Wuchang,1,0.0
postnasal,1,0.0
dripping,1,0.0
naso-bronchial,1,0.0
epiphenomenon,1,0.0
causable,1,0.0
ageenvironment,1,0.0
preschoolers,1,0.0
accumulates,1,0.0
1996-98,1,0.0
28126,1,0.0
momentary,1,0.0
RR19,1,0.0
AQLQ-S,1,0.0
recollections,1,0.0
bronchoconstrictive,1,0.0
hypocapnia,1,0.0
bronchodilatory,1,0.0
presupposes,1,0.0
filtering,1,0.0
facepiece,1,0.0
FFRs,1,0.0
FFR,1,0.0
reuse,1,0.0
biocidal,1,0.0
microwave-generated,1,0.0
steam,1,0.0
moist,1,0.0
germicidal,1,0.0
non-commercial,1,0.0
benchmarked,1,0.0
QIAcube,1,0.0
Comparable,1,0.0
pipetting,1,0.0
robot,1,0.0
convert,1,0.0
octogenarians,1,0.0
secondarily,1,0.0
adjusted-dose,1,0.0
Acetylsalicylic,1,0.0
Subdividing,1,0.0
≤48,1,0.0
Taleb,1,0.0
digits,1,0.0
pre-scientific,1,0.0
0169,1,0.0
7441,1,0.0
Expansion,1,0.0
H69V70,1,0.0
P681H,1,0.0
N439K,1,0.0
S98F,1,0.0
0574,1,0.0
0220,1,0.0
0972,1,0.0
0276,1,0.0
non-infarction,1,0.0
0504,1,0.0
0247,1,0.0
0815,1,0.0
0348,1,0.0
MiniPAQLQ,1,0.0
interdepartmental,1,0.0
embraces,1,0.0
annexes,1,0.0
Mississippi,1,0.0
deep-vein,1,0.0
setback,1,0.0
post-pathway,1,0.0
aspiring,1,0.0
summiteer,1,0.0
trekker,1,0.0
ChAdOx1nCoV-19,1,0.0
Travellers,1,0.0
wary,1,0.0
under-vaccinated,1,0.0
1148,1,0.0
B1129,1,0.0
1501,1,0.0
B1258,1,0.0
RNA-vaccines,1,0.0
immune-phenomena,1,0.0
destiny,1,0.0
Biomedical,1,0.0
Intellivax,1,0.0
FluINsure,1,0.0
Home-based,1,0.0
delineating,1,0.0
Tc,1,0.0
local-level,1,0.0
non-parametric,1,0.0
scaling,1,0.0
ecology,1,0.0
petrificate,1,0.0
softening,1,0.0
Connective,1,0.0
cardiomyocytic,1,0.0
AH5N1cases,1,0.0
4-slice,1,0.0
Occlusion,1,0.0
paucisymptomaticasymptomatic,1,0.0
antigenemia,1,0.0
misnomer,1,0.0
FebruaryMarch,1,0.0
high-coverage,1,0.0
birth-death,1,0.0
skyline,1,0.0
B1221,1,0.0
1537,1,0.0
Standardised,1,0.0
Representatives,1,0.0
guilty,1,0.0
Multi-Frequency,1,0.0
neurointensive,1,0.0
nonstatin,1,0.0
interconnectedness,1,0.0
pandemicepidemic,1,0.0
impact-,1,0.0
ICAI,1,0.0
high-level,1,0.0
List,1,0.0
susceptible-exposed-infectious-removed,1,0.0
compartmental,1,0.0
inbred,1,0.0
QTLs,1,0.0
narrowed,1,0.0
Impedance,1,0.0
HASU,1,0.0
PHEP,1,0.0
UCLH,1,0.0
kHz,1,0.0
Electroencephalography,1,0.0
streptokinase-treated,1,0.0
Swine-origin,1,0.0
emotionally-based,1,0.0
discredit,1,0.0
impedes,1,0.0
tightrope,1,0.0
push-pull,1,0.0
deter,1,0.0
one-quarter,1,0.0
023,1,0.0
2359,1,0.0
banking,1,0.0
cadaveric,1,0.0
corneal,1,0.0
nonselected,1,0.0
awardee,1,0.0
19992000,1,0.0
well-publicized,1,0.0
Christmas,1,0.0
holiday,1,0.0
Consultation,1,0.0
LCA,1,0.0
coronarycircumflex,1,0.0
ascertaining,1,0.0
1055,1,0.0
depicts,1,0.0
revolutionize,1,0.0
Mixovirus,1,0.0
mutagenic,1,0.0
VigiGripes,1,0.0
Yearly,1,0.0
Fore,1,0.0
Highlands,1,0.0
simplest,1,0.0
endsystolic,1,0.0
immunoturbidimetric,1,0.0
1520,1,0.0
broadening,1,0.0
associated-with-thromboembolic-event,1,0.0
Womens,1,0.0
WHI,1,0.0
Ad26,1,0.0
Spike-binding,1,0.0
3-9,1,0.0
Virus-like-Particle,1,0.0
subunit-vaccines,1,0.0
SARS-COV2,1,0.0
electrodynamics,1,0.0
Trinidadian,1,0.0
580,1,0.0
adenoviruses,1,0.0
Abdominal,1,0.0
Research-based,1,0.0
KCHS,1,0.0
une,1,0.0
socio-occupational,1,0.0
femtomolar,1,0.0
metasensor,1,0.0
exquisite,1,0.0
squeeze,1,0.0
electromagnetic,1,0.0
densities,1,0.0
robustly,1,0.0
Vaccinations,1,0.0
ultranarrow,1,0.0
lineshapes,1,0.0
terahertz,1,0.0
THz,1,0.0
quasi-infinite,1,0.0
judiciously,1,0.0
Possessing,1,0.0
envisage,1,0.0
Kenyan,1,0.0
604674,1,0.0
-196-591,1,0.0
fumes,1,0.0
070-355,1,0.0
≈7,1,0.0
neural-microglial,1,0.0
CX3CL1,1,0.0
fractalkine,1,0.0
precipitants,1,0.0
tradition,1,0.0
Apostle,1,0.0
evil,1,0.0
Codex,1,0.0
Calixtinus,1,0.0
xii,1,0.0
apostolic,1,0.0
theranostic,1,0.0
workloads,1,0.0
ultra-rapid,1,0.0
timeframes,1,0.0
rethinking,1,0.0
immovable,1,0.0
crippled,1,0.0
herhis,1,0.0
infectees,1,0.0
best-fitting,1,0.0
thrombolyis,1,0.0
026,1,0.0
preexistent,1,0.0
recruitable,1,0.0
KDPH,1,0.0
970,1,0.0
communicated,1,0.0
disinfect,1,0.0
dismissed,1,0.0
upwards,1,0.0
antigen-detection,1,0.0
weeks-a,1,0.0
lucky,1,0.0
defibrillator,1,0.0
contemplated,1,0.0
TMPG,1,0.0
leveling,1,0.0
bulge,1,0.0
bony,1,0.0
CBA,1,0.0
PCBA,1,0.0
NCBA,1,0.0
prometaphase,1,0.0
GG,1,0.0
DG,1,0.0
PN,1,0.0
controllability,1,0.0
ET-eligible,1,0.0
Life--optimally,1,0.0
GARCM,1,0.0
insist,1,0.0
quit,1,0.0
dislodgement,1,0.0
Devices,1,0.0
Volunteer,1,0.0
Beta-blockers,1,0.0
rampant,1,0.0
Growing,1,0.0
Bioactive,1,0.0
SARS-CoV-2-explicit,1,0.0
Mycobacterium,1,0.0
radiopharmaceuticals,1,0.0
8-year,1,0.0
Chuetsu,1,0.0
Earthquake,1,0.0
real‐life,1,0.0
post-PCI,1,0.0
5-25,1,0.0
Malta,1,0.0
05-1,1,0.0
eradicatedas,1,0.0
changeability,1,0.0
health--that,1,0.0
cheapest,1,0.0
Post-influenza,1,0.0
cardiotropic,1,0.0
commitments,1,0.0
multilayered,1,0.0
case-a,1,0.0
neighbors,1,0.0
asks,1,0.0
Cambodias,1,0.0
funders,1,0.0
Dentistry,1,0.0
Periodontology,1,0.0
Ludwig-Maximilians-University,1,0.0
LMU,1,0.0
middle-age,1,0.0
519,1,0.0
ex-smokers,1,0.0
15-24,1,0.0
Smoking-related,1,0.0
breathtaking,1,0.0
mankinds,1,0.0
lurks,1,0.0
background--a,1,0.0
ever-mutating,1,0.0
ESWIs,1,0.0
Reciprocal,1,0.0
downsloping,1,0.0
596,1,0.0
n66,1,0.0
non-cirrhotic,1,0.0
2003-2007,1,0.0
transdermal,1,0.0
TD1,1,0.0
scarring,1,0.0
autopsy-studied,1,0.0
Underlying,1,0.0
myocardiopathy,1,0.0
Mural,1,0.0
infaction,1,0.0
lodged,1,0.0
coronaries,1,0.0
altherosclerotic,1,0.0
lodging,1,0.0
n30,1,0.0
325-473,1,0.0
0-45h,1,0.0
FLAIR-negative,1,0.0
FLAIR-positive,1,0.0
diseaseMethods,1,0.0
pubmedorg,1,0.0
resultsResults,1,0.0
2152021,1,0.0
countriesExpert,1,0.0
authorize,1,0.0
2831,1,0.0
Figueroa,1,0.0
co-authors,1,0.0
industrialised,1,0.0
helper-2,1,0.0
cytolytic,1,0.0
biliary,1,0.0
maternal-fetal,1,0.0
spectrophotometrically,1,0.0
828-999,1,0.0
0963,1,0.0
0885-10,1,0.0
pauci-symptomatic,1,0.0
PaO2,1,0.0
aminotransferase,1,0.0
analgesics,1,0.0
seroprevalences,1,0.0
irreversibility,1,0.0
dyskinetic,1,0.0
irreversibly,1,0.0
Faculty,1,0.0
EPI-Info,1,0.0
523,1,0.0
9805,1,0.0
10957,1,0.0
8726,1,0.0
1714,1,0.0
1172,1,0.0
Highest,1,0.0
OctoberNovember,1,0.0
high-speed,1,0.0
GEMedical,1,0.0
HiSpeedZXi,1,0.0
nylon,1,0.0
Drug-delivery,1,0.0
4h,1,0.0
infused,1,0.0
1h,1,0.0
LVH,1,0.0
cis,1,0.0
IFN-induced,1,0.0
Apples,1,0.0
6346,1,0.0
organize,1,0.0
recognized-including,1,0.0
inflammatory-induced,1,0.0
MI-induced,1,0.0
COVID-19-convalescence,1,0.0
unmasks,1,0.0
prodrome,1,0.0
chiropractic,1,0.0
neutered,1,0.0
Shorthair,1,0.0
High-grade,1,0.0
non-Hodgkins,1,0.0
re-arrangements,1,0.0
euthanased,1,0.0
mAs,1,0.0
delayed-enhancement,1,0.0
indomethacin,1,0.0
Aerosolized,1,0.0
isonicotinate,1,0.0
verapamil,1,0.0
ketotifen,1,0.0
discontinuation,1,0.0
amounting,1,0.0
anginous,1,0.0
British-German,1,0.0
17q12,1,0.0
Aiolos,1,0.0
GSDML,1,0.0
ResearchKit,1,0.0
iPhone,1,0.0
IFN-independent,1,0.0
Discrepancies,1,0.0
SHCS,1,0.0
Transplant,1,0.0
STCS,1,0.0
founded,1,0.0
∼500000,1,0.0
Focal,1,0.0
IAV-susceptible,1,0.0
DBA2,1,0.0
NFkB-promoter,1,0.0
kinase-dead,1,0.0
hijacks,1,0.0
76-year-old,1,0.0
multimorbidity,1,0.0
1991-1993,1,0.0
Climatology,1,0.0
11-yr,1,0.0
1980-1990,1,0.0
coldest,1,0.0
Warm,1,0.0
cool,1,0.0
summers,1,0.0
oceanic,1,0.0
Oregon,1,0.0
Aerosol,1,0.0
contaminate,1,0.0
anesthetist,1,0.0
time-bound,1,0.0
surgeries,1,0.0
Hantavirus,1,0.0
735-992,1,0.0
345-490,1,0.0
1835,1,0.0
IL-6R,1,0.0
URTIs,1,0.0
28000,1,0.0
1975-6,1,0.0
regressors,1,0.0
incentives,1,0.0
Heterologous,1,0.0
polyfunctional,1,0.0
cytokine-producing,1,0.0
accuracies,1,0.0
antirheumatic,1,0.0
Methotrexate,1,0.0
Abatacept,1,0.0
Janus,1,0.0
interleukin-6R,1,0.0
IL-12IL-23,1,0.0
375-523,1,0.0
glimpses,1,0.0
patient-centred,1,0.0
Underpinned,1,0.0
selfmanagement,1,0.0
returnees,1,0.0
cargo,1,0.0
well-contained,1,0.0
Volume,1,0.0
pedicle,1,0.0
99m-labeled,1,0.0
sestamibi,1,0.0
nondiagnostic,1,0.0
Sleep-disordered,1,0.0
SDB,1,0.0
trough,1,0.0
substituting,1,0.0
childbirths,1,0.0
1975-90,1,0.0
biplane,1,0.0
concernedABSTRACT,1,0.0
symptomatically,1,0.0
thermometer-sales,1,0.0
Allegheny,1,0.0
second-degree,1,0.0
Mobitz,1,0.0
third-degree,1,0.0
Minimal,1,0.0
data-all,1,0.0
wise,1,0.0
multipronged,1,0.0
goal-directed,1,0.0
anti-ischaemic,1,0.0
Latinxs,1,0.0
preteen,1,0.0
teenaged,1,0.0
Ilorin,1,0.0
Hesitance,1,0.0
extirpating,1,0.0
prolonging,1,0.0
deterioate,1,0.0
beta-Blockers,1,0.0
bradycardiac,1,0.0
antagonistsABSTRACT,1,0.0
Therapeutics,1,0.0
immunomodulators,1,0.0
SnapShot,1,0.0
PDF,1,0.0
sleep-wake,1,0.0
SWD,1,0.0
disablement,1,0.0
screeningsurveillance,1,0.0
re-pooling,1,0.0
dilutional,1,0.0
intends,1,0.0
Forty-eight,1,0.0
0024,1,0.0
1684,1,0.0
1506,1,0.0
nongravid,1,0.0
bronchodilatorsreduction,1,0.0
Disposition,1,0.0
3-2,1,0.0
scars,1,0.0
AMIWe,1,0.0
ST-elevated,1,0.0
monthsPatients,1,0.0
symptom-to-intervention,1,0.0
Preinterventional,1,0.0
infarction-0-flow,1,0.0
3-vessel,1,0.0
5399,1,0.0
822-35463,1,0.0
Lucknow,1,0.0
Uttar,1,0.0
Pradesh,1,0.0
non-duplicated,1,0.0
n173,1,0.0
n163,1,0.0
pre-December,1,0.0
418-565,1,0.0
divisions,1,0.0
chyle,1,0.0
feminist,1,0.0
Pleurovenous,1,0.0
post-hospital,1,0.0
Procedure,1,0.0
SARS-CoV-19,1,0.0
Basque,1,0.0
entailed,1,0.0
19471,1,0.0
17260,1,0.0
firms,1,0.0
22696,1,0.0
7178,1,0.0
invalidity,1,0.0
socio-sanitary,1,0.0
factored,1,0.0
compliant,1,0.0
neutrophileosinophil,1,0.0
Hematological,1,0.0
systematized,1,0.0
non-LVO,1,0.0
NHS,1,0.0
cities--New,1,0.0
Haven,1,0.0
Connecticut--diverged,1,0.0
raged,1,0.0
situates,1,0.0
Progressive,1,0.0
faith,1,0.0
beta-coronaviruses,1,0.0
NIAID,1,0.0
non-unified,1,0.0
oropharyngeal-,1,0.0
httpsbitly372Xdhw,1,0.0
guideline-based,1,0.0
bibasilar,1,0.0
INTRODUCTION,1,0.0
OBJECTIVES,1,0.0
PATIENTS,1,0.0
Anatomical,1,0.0
DDD,1,0.0
antibacterials,1,0.0
2250,1,0.0
cefuroxime,1,0.0
coincidence,1,0.0
overuse,1,0.0
inactivity-related,1,0.0
Pyrexia,1,0.0
≥375°C,1,0.0
866,1,0.0
Rales,1,0.0
Model-based,1,0.0
Bronchoprovocation,1,0.0
Challenge,1,0.0
arena,1,0.0
AMP,1,0.0
re-hospitalizations,1,0.0
tradeoffs,1,0.0
desperate,1,0.0
infers,1,0.0
K403R,1,0.0
Arg-Gly-Asp,1,0.0
RGD-binding,1,0.0
Integrin,1,0.0
Cilengitide,1,0.0
in-silico,1,0.0
solubility,1,0.0
BFB-menthol—showed,1,0.0
two—BFB-borneol,1,0.0
whearas,1,0.0
14×104,1,0.0
43×103,1,0.0
Concentration,1,0.0
34×103,1,0.0
Brighton,1,0.0
Echocardiograms,1,0.0
Exaggerated,1,0.0
noninfarcted,1,0.0
whole-school,1,0.0
primaryjunior,1,0.0
spacer,1,0.0
Pupils,1,0.0
non-intervention,1,0.0
asthma-oriented,1,0.0
policiespractices,1,0.0
veincerebral,1,0.0
spleno-porto-mesenteric,1,0.0
small-bowel,1,0.0
gangrene,1,0.0
mesenteric,1,0.0
splenic,1,0.0
analogy,1,0.0
compound—,1,0.0
BFDBSC—can,1,0.0
anti-,1,0.0
compounds—FPBFDBSC,1,0.0
BFB-gallate—,1,0.0
effectsthan,1,0.0
BFDBSC,1,0.0
contagiousness,1,0.0
recursive,1,0.0
non-classical,1,0.0
extraction-free,1,0.0
picking,1,0.0
sternocleidomastoid,1,0.0
SCM,1,0.0
vestibulum,1,0.0
VEMP,1,0.0
restenotic,1,0.0
IIB,1,0.0
caesarean,1,0.0
haemodynamically,1,0.0
underscored,1,0.0
thermocyclers,1,0.0
Isothermal,1,0.0
amplification-based,1,0.0
B3,1,0.0
RT-LAMP-based,1,0.0
MOB,1,0.0
macro-environment,1,0.0
allergy-immunology,1,0.0
custom-tailored,1,0.0
Endotype,1,0.0
theratype,1,0.0
precisionpersonalized,1,0.0
patomechanisms,1,0.0
uderdiagnosis,1,0.0
every-day,1,0.0
networking,1,0.0
Transcranial,1,0.0
neuromodulatory,1,0.0
neuroplastic,1,0.0
sham-controlled,1,0.0
myogenic,1,0.0
Vestibular,1,0.0
NCT04358211FUNDINGDepartment,1,0.0
REGISTRATIONClinicalTrialsgov,1,0.0
CAMI,1,0.0
SERS-based,1,0.0
aptasensor,1,0.0
lysates,1,0.0
self-grown,1,0.0
sensible,1,0.0
lysate,1,0.0
commercialized,1,0.0
noticeably,1,0.0
dominating,1,0.0
individual-based,1,0.0
gm,1,0.0
emitters,1,0.0
uncompleted,1,0.0
augmenting,1,0.0
COVID-19-compatible,1,0.0
clothes,1,0.0
supermarket,1,0.0
petrol,1,0.0
sewage,1,0.0
copiesreaction,1,0.0
four-specimen,1,0.0
9775,1,0.0
congruence,1,0.0
BACKGROUNDCirculating,1,0.0
samplesMETHODSA,1,0.0
comparisonsRESULTSCRISPR-augmented,1,0.0
resultsCONCLUSIONResults,1,0.0
infectionTRIAL,1,0.0
58×104,1,0.0
neurotropism,1,0.0
disbalanced,1,0.0
Reviewing,1,0.0
ApaI,1,0.0
FokI,1,0.0
fourth-grade,1,0.0
9403,1,0.0
Croup,1,0.0
351,1,0.0
499,1,0.0
1480,1,0.0
Demonstration,1,0.0
retested,1,0.0
literature-based,1,0.0
AH1N1pdm2009,1,0.0
antigen-dependent,1,0.0
non-antigen-dependent,1,0.0
interconnection,1,0.0
Descriptions,1,0.0
radiosurgical,1,0.0
centromedian,1,0.0
nucleus,1,0.0
79-year-old,1,0.0
scalp,1,0.0
tactile,1,0.0
precluded,1,0.0
Minimally,1,0.0
isodose,1,0.0
4-mm,1,0.0
collimator,1,0.0
helmet,1,0.0
tolerate,1,0.0
encephalomalacia,1,0.0
BsmI,1,0.0
TaqI,1,0.0
2417,1,0.0
destinations,1,0.0
Dysphagia,1,0.0
exclusive,1,0.0
HVE,1,0.0
one-sixth,1,0.0
Palliative,1,0.0
PCU,1,0.0
Alcohol,1,0.0
gamma-glutamyltransferase,1,0.0
gamma-GT,1,0.0
reinfections,1,0.0
2601,1,0.0
2737,1,0.0
4110,1,0.0
1479,1,0.0
Spearmans,1,0.0
-047,1,0.0
non-contagious,1,0.0
April-May,1,0.0
zanamavir,1,0.0
echocarciographic,1,0.0
ice-pick,1,0.0
trivaccine-immunized,1,0.0
neuropathological,1,0.0
neuroinvasive,1,0.0
trans-neuronal,1,0.0
January-April,1,0.0
precisions,1,0.0
Haider,1,0.0
titled,1,0.0
irradiation-based,1,0.0
Thalamic,1,0.0
Neurosurgical,1,0.0
Nash,1,0.0
Muslim,1,0.0
HQoL,1,0.0
BVictoria-lineage,1,0.0
selects,1,0.0
composing,1,0.0
HA1-domain,1,0.0
BWisconsin012010-like,1,0.0
Northern-Hemisphere,1,0.0
EMAEuropean,1,0.0
Regulatory,1,0.0
MHRAStudy,1,0.0
Product,1,0.0
monographs,1,0.0
consumer,1,0.0
vaccinesData,1,0.0
sideadverseundesirable,1,0.0
tabulatedResults,1,0.0
paralysis,1,0.0
Bells,1,0.0
acknowledgement,1,0.0
EuropeConclusions,1,0.0
inconsistencies,1,0.0
Cardioplegia,1,0.0
crossclamp,1,0.0
nontotal,1,0.0
artery-specific,1,0.0
surpassing,1,0.0
circumventricular,1,0.0
rennin-angiotensin,1,0.0
utilitarian,1,0.0
pancreatitis,1,0.0
sea,1,0.0
pseudocyst,1,0.0
lions,1,0.0
subsistence,1,0.0
hunting,1,0.0
shoreline,1,0.0
habitat,1,0.0
mammal,1,0.0
Phocidae,1,0.0
Otariidae,1,0.0
juvenile,1,0.0
arteriopathies,1,0.0
leakiness,1,0.0
DallasFort,1,0.0
Worth,1,0.0
HEDIS,1,0.0
679631,1,0.0
request,1,0.0
medihalers,1,0.0
13426,1,0.0
infarction--including,1,0.0
Sørlandet,1,0.0
Arendal,1,0.0
immuno-deficient,1,0.0
poststress,1,0.0
ACCCORD,1,0.0
Subcortical,1,0.0
17114,1,0.0
respects,1,0.0
ACCORD,1,0.0
125-135,1,0.0
SARS-Co-V-2,1,0.0
toracostomy,1,0.0
High-altitude,1,0.0
tip,1,0.0
mixed-effects,1,0.0
binary,1,0.0
meta,1,0.0
offs,1,0.0
73-80,1,0.0
65-82,1,0.0
90-90,1,0.0
64-77,1,0.0
77-87,1,0.0
60-60,1,0.0
gut-lung,1,0.0
pectus,1,0.0
Nuss,1,0.0
tapes,1,0.0
curved,1,0.0
allergen-carrying,1,0.0
concave,1,0.0
notched,1,0.0
ADC,1,0.0
OPS,1,0.0
polymorphonuclear,1,0.0
closed-chest,1,0.0
endocardium,1,0.0
anatomically,1,0.0
24--96,1,0.0
Thunderstorms,1,0.0
prevalently,1,0.0
Napoli,1,0.0
Pollen,1,0.0
osmotic,1,0.0
QALY,1,0.0
commodities,1,0.0
commodity,1,0.0
life-years,1,0.0
outgrowth-associated,1,0.0
Overexpression,1,0.0
PC12,1,0.0
free-serum,1,0.0
34-54,1,0.0
malfunction,1,0.0
I559N,1,0.0
D641V,1,0.0
V729I,1,0.0
Han,1,0.0
180110,1,0.0
radiopacity,1,0.0
845,1,0.0
bronchus,1,0.0
fiberoptic,1,0.0
bronchoscope,1,0.0
carina,1,0.0
releaser,1,0.0
4880,1,0.0
apices,1,0.0
non-dipolar,1,0.0
arbitrarily,1,0.0
intramyocardial,1,0.0
predominates,1,0.0
Dipole,1,0.0
RDV,1,0.0
FPV,1,0.0
emphatically,1,0.0
tirofiban,1,0.0
respirable,1,0.0
starch,1,0.0
picardy,1,0.0
sneeze,1,0.0
equation,1,0.0
Enrolled,1,0.0
2080,1,0.0
3026,1,0.0
962Results,1,0.0
049Conclusions,1,0.0
Inborn,1,0.0
Errors,1,0.0
Immunity,1,0.0
group-at-risk,1,0.0
moderatesevere,1,0.0
implementedAreas,1,0.0
pandemicExpert,1,0.0
TMPRSS,1,0.0
enteroviral,1,0.0
05-25,1,0.0
paediatrician,1,0.0
20-MHz,1,0.0
Consonant,1,0.0
Statewide,1,0.0
460-466,1,0.0
480-487,1,0.0
490-491,1,0.0
490-492,1,0.0
494-496,1,0.0
abut,1,0.0
MHI,1,0.0
POP,1,0.0
Enzyme-linked,1,0.0
stand-alone,1,0.0
3145,1,0.0
Non-probability,1,0.0
vaccinationMethods,1,0.0
Behavior,1,0.0
pollinosis,1,0.0
thunderstorm-asthma,1,0.0
grasses,1,0.0
Dakar,1,0.0
CFA,1,0.0
Francs,1,0.0
Senegalese,1,0.0
currency,1,0.0
608,1,0.0
492,1,0.0
33573,1,0.0
12052,1,0.0
32614442,1,0.0
78426,1,0.0
18839,1,0.0
4954635,1,0.0
neuroradiology,1,0.0
19373172,1,0.0
8253246,1,0.0
Suwon,1,0.0
5865,1,0.0
960,1,0.0
96100,1,0.0
Cycle,1,0.0
test-positive,1,0.0
Ct≤30,1,0.0
correspondingly,1,0.0
15-56,1,0.0
Planned,1,0.0
Bioinformatics,1,0.0
transcription‑quantitative,1,0.0
synapse-associated,1,0.0
T705,1,0.0
zymosan,1,0.0
phagocytose,1,0.0
Hereditary,1,0.0
Clear,1,0.0
Connection,1,0.0
Becton,1,0.0
Dickinson,1,0.0
Cockeysville,1,0.0
Md,1,0.0
BaxterBartels,1,0.0
Issaquah,1,0.0
Wash,1,0.0
Nitazoxanide,1,0.0
DAS181,1,0.0
JNJ63623872,1,0.0
outgrowth,1,0.0
S-033188,1,0.0
Lyon,1,0.0
CMV,1,0.0
Baxter,1,0.0
IncDynPort,1,0.0
FP-01,1,0.0
FluGEM,1,0.0
Mucosis,1,0.0
BV,1,0.0
protein-1-altered,1,0.0
Vivaldi,1,0.0
Biosciences,1,0.0
PentaStaph,1,0.0
plc,1,0.0
phospholipid,1,0.0
thioglycolate-treated,1,0.0
caspase-dependent,1,0.0
AUdon72,1,0.0
Aisne,1,0.0
Oise,1,0.0
Somme,1,0.0
Departments,1,0.0
734,1,0.0
medicalised,1,0.0
ans,1,0.0
Heparin,1,0.0
centABSTRACT,1,0.0
sectional-analytic,1,0.0
2-14,1,0.0
gadolinium-diethylenetriaminepentaacetic,1,0.0
DTPA,1,0.0
mmolkg,1,0.0
single-level,1,0.0
s-1,1,0.0
Ultrafast,1,0.0
gadolinium-DTPA-enhanced,1,0.0
LAAO,1,0.0
Amplatzer™,1,0.0
Amulet™,1,0.0
occluder,1,0.0
new-acquired,1,0.0
Opponents,1,0.0
proponents,1,0.0
materialize,1,0.0
chuankezhi,1,0.0
SARs-CoV-2,1,0.0
S-gene,1,0.0
StaphVAX,1,0.0
Nabi,1,0.0
Biopharmaceuticals,1,0.0
testings,1,0.0
shelter-in-place,1,0.0
near-elimination,1,0.0
benchmarks,1,0.0
dichotomous,1,0.0
clinico-statistical,1,0.0
algetic,1,0.0
emergen-ce,1,0.0
perseverance,1,0.0
20172018,1,0.0
1560,1,0.0
decedents,1,0.0
HbS,1,0.0
inherits,1,0.0
hematologically,1,0.0
fibrinopeptid,1,0.0
molecule-1,1,0.0
electro-encephalographic,1,0.0
neuro-imaging,1,0.0
Hangzhou,1,0.0
Tailored,1,0.0
second-hand,1,0.0
daysweek,1,0.0
nightsmonth,1,0.0
more-severe,1,0.0
nuances,1,0.0
over-generalization,1,0.0
136-146,1,0.0
20-27,1,0.0
74-113,1,0.0
tenfold,1,0.0
Controlling,1,0.0
VCL-CB01,1,0.0
disagree,1,0.0
Vical,1,0.0
astuprotimut-r,1,0.0
utilises,1,0.0
co-cultures,1,0.0
immunophenotyping,1,0.0
IL-33,1,0.0
Adult-onset,1,0.0
biomass,1,0.0
Parenchymal,1,0.0
elasticity,1,0.0
exhalation,1,0.0
secondforced,1,0.0
overdiagnosis,1,0.0
Short-acting,1,0.0
Inhalers,1,0.0
Written,1,0.0
step-down,1,0.0
back-titration,1,0.0
log,1,0.0
non-AMI,1,0.0
065ABSTRACT,1,0.0
irregularities,1,0.0
Ventriculography,1,0.0
SARS-CoV-2-PCR,1,0.0
structure-based,1,0.0
immunizing,1,0.0
G614D,1,0.0
catch-22,1,0.0
withheld,1,0.0
Aerobic,1,0.0
vasoconstrictors,1,0.0
14-eicosatetraenoic,1,0.0
valuesConclusion,1,0.0
19875,1,0.0
23078,1,0.0
Gender,1,0.0
PCIs,1,0.0
077-095,1,0.0
070-082,1,0.0
tobacco-associated,1,0.0
Liverpool,1,0.0
reminiscent,1,0.0
Neurowave,1,0.0
systemMaterials,1,0.0
weekFindings,1,0.0
Intra,1,0.0
ERP,1,0.0
P300,1,0.0
vacillating,1,0.0
neurosensory,1,0.0
attentive,1,0.0
yolk,1,0.0
antigen-capture,1,0.0
epornitic,1,0.0
1524,1,0.0
pullet,1,0.0
broiler,1,0.0
flocks,1,0.0
Pathology,1,0.0
Bolton,1,0.0
Visitation,1,0.0
meso-,1,0.0
microlevels,1,0.0
42953,1,0.0
HUMIR,1,0.0
Clara,1,0.0
Villa,1,0.0
Everolimus,1,0.0
time-point,1,0.0
restrains,1,0.0
Allergen,1,0.0
Beclocort-Polfa,1,0.0
non-atopic,1,0.0
Bronchoscreen,1,0.0
Jaeger,1,0.0
thriceprior,1,0.0
intertwining,1,0.0
markerbiomarker,1,0.0
DNMDNB,1,0.0
tipping,1,0.0
DNM,1,0.0
DNM-based,1,0.0
unveils,1,0.0
begging,1,0.0
Haguenau,1,0.0
Alsace,1,0.0
mobilised,1,0.0
re-enroll,1,0.0
re-enrolled,1,0.0
inflate,1,0.0
re-enrollment,1,0.0
algebraic,1,0.0
pediatrician,1,0.0
Coma,1,0.0
Sneddons,1,0.0
Libman-Sacks,1,0.0
awaited,1,0.0
told,1,0.0
20-hydroxy-5,1,0.0
optical-chemical,1,0.0
ours,1,0.0
toilets,1,0.0
squat,1,0.0
intraseasonal,1,0.0
PAT,1,0.0
SAT,1,0.0
acutesubacute,1,0.0
small-size,1,0.0
molecularly,1,0.0
imprinted,1,0.0
polymer,1,0.0
nano-layer,1,0.0
UTM,1,0.0
NaCl,1,0.0
semi-experimental,1,0.0
Atherosclerotic,1,0.0
Tarapacá,1,0.0
6986,1,0.0
9961,1,0.0
9444,1,0.0
NPP,1,0.0
9722,1,0.0
bordercustoms,1,0.0
interregional,1,0.0
bus,1,0.0
48-hour,1,0.0
Laboratory-based,1,0.0
frame-1,1,0.0
3N,1,0.0
Balancing,1,0.0
Undocumented,1,0.0
potentiated,1,0.0
quiddity,1,0.0
co-delivery,1,0.0
spliced,1,0.0
neuroregeneration,1,0.0
proofs,1,0.0
point-of,1,0.0
Exposures,1,0.0
civilians,1,0.0
Soldiers,1,0.0
2013-February,1,0.0
1258,1,0.0
CVVs,1,0.0
manufactured,1,0.0
caregiver-directed,1,0.0
inhaling,1,0.0
Isosorbide,1,0.0
-08050,1,0.0
eosinophile,1,0.0
exoserosis,1,0.0
epithalaxia,1,0.0
guinea-pigs,1,0.0
lightened,1,0.0
isosoratory,1,0.0
Differentiating,1,0.0
Clues,1,0.0
Haemorrhagic,1,0.0
albicans,1,0.0
osteo-costochondromyelitis,1,0.0
rebuilding,1,0.0
Secretion,1,0.0
interleukin-1β,1,0.0
Ectopic,1,0.0
downregulates,1,0.0
host-Influenza,1,0.0
37-year,1,0.0
littermates,1,0.0
70±3,1,0.0
47±4,1,0.0
67±3,1,0.0
p025,1,0.0
microglial,1,0.0
adaptor,1,0.0
Iba1,1,0.0
Jun,1,0.0
JAB1,1,0.0
2-variable,1,0.0
inV1,1,0.0
3-variable,1,0.0
postolateral,1,0.0
CVID,1,0.0
Micro,1,0.0
determinate,1,0.0
predictivity,1,0.0
Florence,1,0.0
predicativity,1,0.0
advices,1,0.0
Characteristics,1,0.0
CincinnatiNorthern,1,0.0
post-coronavirus,1,0.0
rivalries,1,0.0
touchstone,1,0.0
multilateralism,1,0.0
diplomacy,1,0.0
arenas,1,0.0
Solidarity,1,0.0
Ovariectomized,1,0.0
29±3,1,0.0
infarct±SEM,1,0.0
72h,1,0.0
Herzinfarktverbund,1,0.0
Essen,1,0.0
5136,1,0.0
absorptiometry,1,0.0
261,1,0.0
adjustments,1,0.0
121-162,1,0.0
147-358,1,0.0
124-171,1,0.0
121-297,1,0.0
Breathmobile,1,0.0
specialty-based,1,0.0
SFD,1,0.0
unsupported,1,0.0
dispensability,1,0.0
well-accepted,1,0.0
Pathophysiologically,1,0.0
tragic,1,0.0
destroying,1,0.0
demolishing,1,0.0
ingenious,1,0.0
clinico-functional,1,0.0
535,1,0.0
sanatoria,1,0.0
out-patient,1,0.0
PwDs,1,0.0
MCAO90min,1,0.0
wildtype,1,0.0
knockout,1,0.0
Economy,1,0.0
Trade,1,0.0
Security,1,0.0
trivial,1,0.0
neuro,1,0.0
toxemia,1,0.0
attributions,1,0.0
Nile,1,0.0
legionellosis,1,0.0
roles—sources,1,0.0
groups—as,1,0.0
out-of-the-home,1,0.0
penicillinresistant,1,0.0
Anticipating,1,0.0
Nicholson,1,0.0
draft,1,0.0
“Pandemic,1,0.0
Plan”,1,0.0
comment,1,0.0
httpwwwhhsgovnvpopandemicplan,1,0.0
openness,1,0.0
fascial,1,0.0
anatomists,1,0.0
subdividing,1,0.0
medistinum,1,0.0
brachiocephalic,1,0.0
thymus,1,0.0
approch,1,0.0
thymic,1,0.0
defecationmicturition,1,0.0
toilet,1,0.0
toilet-related,1,0.0
Build-up,1,0.0
breach,1,0.0
devastation,1,0.0
negotiating,1,0.0
COVID-1,1,0.0
mindset,1,0.0
non-ischaemic,1,0.0
LAD-ligation,1,0.0
microvesicles,1,0.0
Rebuilding,1,0.0
catabolic,1,0.0
macromolecules,1,0.0
Atg,1,0.0
virus-regulated,1,0.0
Drop,1,0.0
mop,1,0.0
Fido,1,0.0
Patrick,1,0.0
Holts,1,0.0
allergy-free,1,0.0
tangled,1,0.0
underlies,1,0.0
Holt,1,0.0
pain-door,1,0.0
door-needle,1,0.0
door-balloon,1,0.0
855,1,0.0
Maybe,1,0.0
togheter,1,0.0
unawareness,1,0.0
antibody-laden,1,0.0
transcribrial,1,0.0
Naegleria,1,0.0
fowleri,1,0.0
opponents,1,0.0
influencers,1,0.0
2018-19,1,0.0
Initiatives,1,0.0
informations,1,0.0
regulations,1,0.0
deceleration,1,0.0
16117,1,0.0
667–671,1,0.0
IAH,1,0.0
jfoxupmc-biosecurityorg,1,0.0
Ig-E-mediated,1,0.0
diagnostical,1,0.0
Gravitation,1,0.0
PF-05,1,0.0
fractionator,1,0.0
rheologic,1,0.0
rheopolyglucin,1,0.0
Asian-Pacific,1,0.0
14-52,1,0.0
Alliance,1,0.0
APACI,1,0.0
advocacy,1,0.0
initiates,1,0.0
Winnipeg,1,0.0
Hamilton,1,0.0
Halifax,1,0.0
Prince,1,0.0
strabismus,1,0.0
diplopia,1,0.0
Origin,1,0.0
CLT,1,0.0
AMI-indicative,1,0.0
SATIS-Stroke,1,0.0
2019”,1,0.0
“coronavirus,1,0.0
aquired,1,0.0
2”,1,0.0
three9,1,0.0
Prep,1,0.0
Cartridge,1,0.0
orf1ab,1,0.0
PEDV,1,0.0
TGE,1,0.0
serviced,1,0.0
Lemierre,1,0.0
thrombophlebitis,1,0.0
Fusobacterium,1,0.0
necrophorum,1,0.0
May-June,1,0.0
close-ended,1,0.0
481,1,0.0
488,1,0.0
geared,1,0.0
circulations,1,0.0
hindbrain,1,0.0
forebrain,1,0.0
CFI,1,0.0
AGF,1,0.0
siphon,1,0.0
case-report,1,0.0
Hypoxaemia,1,0.0
3000,1,0.0
excesses,1,0.0
ARussia,1,0.0
dysphagiaaspiration,1,0.0
“severe,1,0.0
PRR,1,0.0
oligodendrocytes,1,0.0
Schwann,1,0.0
SCOPUS,1,0.0
ratio246,1,0.0
161-376,1,0.0
ratio207,1,0.0
136-317,1,0.0
ratio045,1,0.0
021-097,1,0.0
ratio049,1,0.0
030-081,1,0.0
I212,1,0.0
psychopathology,1,0.0
perceptionidentification,1,0.0
misidentification,1,0.0
confabulations,1,0.0
hallucinations,1,0.0
confusional,1,0.0
amotivational,1,0.0
athymhormia,1,0.0
mania,1,0.0
frontal-subcortical,1,0.0
manifests,1,0.0
emotionalism,1,0.0
psychomotor,1,0.0
assimilated,1,0.0
post-traumatic,1,0.0
VERIPRO®,1,0.0
Env,1,0.0
stainless-steel,1,0.0
ASCOD,1,0.0
hypertension-related,1,0.0
1102,1,0.0
III-type,1,0.0
ultraviolet-induced,1,0.0
PSD-95,1,0.0
Enterococcus,1,0.0
spp,1,0.0
trisodium,1,0.0
UV,1,0.0
illumination,1,0.0
red-colored,1,0.0
dissolved,1,0.0
facile,1,0.0
fg,1,0.0
μL-1,1,0.0
arrays,1,0.0
instantaneous,1,0.0
downsides,1,0.0
immunising,1,0.0
Multisystem,1,0.0
PIMS-TS,1,0.0
authorised,1,0.0
reactogenic,1,0.0
post-marketing,1,0.0
forged,1,0.0
risk-benefits,1,0.0
Alternatives,1,0.0
plus-strand,1,0.0
mid-1960s,1,0.0
enteric,1,0.0
Roundtable,1,0.0
NXY-059,1,0.0
ebselen,1,0.0
oxidases,1,0.0
field-deployable,1,0.0
11-82,1,0.0
2019-20,1,0.0
worker-led,1,0.0
sun,1,0.0
sunshine,1,0.0
cancers,1,0.0
passport,1,0.0
self-manage,1,0.0
10-19,1,0.0
high-tech,1,0.0
exercise-ECG,1,0.0
antimalarial,1,0.0
bromhexine,1,0.0
careplacebo,1,0.0
moderate-to-high,1,0.0
blinding,1,0.0
numbersThis,1,0.0
notorious,1,0.0
17-1064,1,0.0
helpless,1,0.0
Ontarios,1,0.0
Coagulation,1,0.0
sacrificed,1,0.0
pathomorphologically,1,0.0
histopathologically,1,0.0
light-microscopical,1,0.0
enzyme-histochemically,1,0.0
633,1,0.0
1995-2010,1,0.0
arterio-venous,1,0.0
Biphasic,1,0.0
conus,1,0.0
groupAcute,1,0.0
osteomalacia,1,0.0
rickets,1,0.0
bones,1,0.0
Role,1,0.0
influencer-driven,1,0.0
Comments,1,0.0
612,1,0.0
1512,1,0.0
3122,1,0.0
community-led,1,0.0
Dispatchers,1,0.0
EPI,1,0.0
Exogenous,1,0.0
β2-adrenergic,1,0.0
AMCC,1,0.0
Siriraj,1,0.0
Allen,1,0.0
Define,1,0.0
Arapahoe,1,0.0
enforcement,1,0.0
fire,1,0.0
multi-agent,1,0.0
two-route,1,0.0
impressive,1,0.0
resembling,1,0.0
realise,1,0.0
revisiting,1,0.0
Translation,1,0.0
DES,1,0.0
Rescue,1,0.0
reestablish,1,0.0
Endoscopic,1,0.0
bloc,1,0.0
biphasic,1,0.0
radiating,1,0.0
engendered,1,0.0
botulinum,1,0.0
embodying,1,0.0
poisons,1,0.0
16S,1,0.0
rRNAs,1,0.0
double-stranded,1,0.0
biotinylated,1,0.0
overhang,1,0.0
Fluorescence,1,0.0
instrument-free,1,0.0
dimensional,1,0.0
echocardiographicDoppler,1,0.0
echoDoppler,1,0.0
12-year,1,0.0
droplet-PCR,1,0.0
disquiets,1,0.0
hyposmia,1,0.0
hypopsia,1,0.0
enervating,1,0.0
Re-elevation,1,0.0
16-34,1,0.0
grave,1,0.0
antigen-presenting,1,0.0
Alarmin,1,0.0
Steroid,1,0.0
infection-precipitated,1,0.0
acrimonious,1,0.0
elaborates,1,0.0
insofar,1,0.0
sociodemographical,1,0.0
BACA,1,0.0
006-026,1,0.0
suppressants,1,0.0
Liver,1,0.0
justifiable,1,0.0
well-founded,1,0.0
profit,1,0.0
pros,1,0.0
cons,1,0.0
weighed,1,0.0
Effectively,1,0.0
Avoiding,1,0.0
PRoFESS,1,0.0
Atherothrombotic,1,0.0
Stabilization,1,0.0
CHARISMA,1,0.0
EuropeanAustralasian,1,0.0
ESPRIT,1,0.0
noninferior,1,0.0
aspirindipyridamole,1,0.0
casualties,1,0.0
herds,1,0.0
pathogen-free,1,0.0
heat-sterilized,1,0.0
sputa,1,0.0
Efficiency,1,0.0
cholera,1,0.0
toxin,1,0.0
somatotropin,1,0.0
milk-based,1,0.0
non-avian,1,0.0
hantavirus,1,0.0
antibiotic-resistant,1,0.0
macromoleculeligand,1,0.0
DHC,1,0.0
imaging-derived,1,0.0
well-child,1,0.0
104-fold,1,0.0
APuerto,1,0.0
Rico0834,1,0.0
glycocluster,1,0.0
common--and,1,0.0
treated--respiratory,1,0.0
forewarning,1,0.0
pandemic-2009,1,0.0
GenBank,1,0.0
polymorphic,1,0.0
isoelectric,1,0.0
hydrophobicity,1,0.0
PB1-F2,1,0.0
OPOs,1,0.0
HbA1c,1,0.0
infectionAim,1,0.0
lipokine,1,0.0
diet-induced,1,0.0
intricately,1,0.0
Costa,1,0.0
overwhelm,1,0.0
tPA-induced,1,0.0
phage-to-yeast,1,0.0
PtY,1,0.0
ChiCTR2100042150,1,0.0
reportedly,1,0.0
clinical-stage,1,0.0
macaque,1,0.0
of99mTc-MIBI18F-FDG-dual-isotope,1,0.0
DISA,1,0.0
strand,1,0.0
three-way,1,0.0
23-SL-modified,1,0.0
23-sialyllactose,1,0.0
checklists,1,0.0
split-virion,1,0.0
emulsion-based,1,0.0
antigen-sparing,1,0.0
amendment,1,0.0
rhythmological,1,0.0
co-culture,1,0.0
neurorecovery,1,0.0
polarity,1,0.0
Combine,1,0.0
Improve,1,0.0
canceling,1,0.0
Put,1,0.0
ban,1,0.0
hallways,1,0.0
loneliness,1,0.0
H1N1-related,1,0.0
proton,1,0.0
tesla,1,0.0
magnet,1,0.0
resonant,1,0.0
single-spin,1,0.0
Inversion,1,0.0
East-West,1,0.0
socialist,1,0.0
organizing,1,0.0
weaken,1,0.0
Budapest,1,0.0
Sialic,1,0.0
hemisphereGap,1,0.0
cobas6800Methodology,1,0.0
eighty-one,1,0.0
roadblock,1,0.0
anti-G2B3A,1,0.0
Catel,1,0.0
IPTA,1,0.0
appreciative,1,0.0
odynophagia,1,0.0
comor-bidity,1,0.0
pol-ymerase,1,0.0
immunostimulation,1,0.0
conduct-ing,1,0.0
Chloroquine,1,0.0
interferon-2b,1,0.0
taxonomic,1,0.0
propaga-tion,1,0.0
cytokinechemokine,1,0.0
to5,1,0.0
n43,1,0.0
Levins,1,0.0
tractability,1,0.0
generality,1,0.0
Feng,1,0.0
among-group,1,0.0
Nold,1,0.0
Jacquez,1,0.0
Glasser,1,0.0
grandchildren,1,0.0
omit,1,0.0
multi-level,1,0.0
two-level,1,0.0
Mossong,1,0.0
inter-generational,1,0.0
4741,1,0.0
Sixty-six,1,0.0
incentive,1,0.0
arsenal,1,0.0
assayResults,1,0.0
4223,1,0.0
Sars-CoV-2,1,0.0
respectivelyConclusion,1,0.0
overlooking,1,0.0
situationally,1,0.0
FV,1,0.0
oligosymptomatics,1,0.0
reevaluate,1,0.0
variablesstrategies,1,0.0
inquired,1,0.0
Smokers,1,0.0
agegroups,1,0.0
Hannover,1,0.0
thioldisulfide,1,0.0
TDR,1,0.0
Syntax,1,0.0
SXscore,1,0.0
survival-dependent,1,0.0
31-90,1,0.0
91-365,1,0.0
34866,1,0.0
5442,1,0.0
subendocardium,1,0.0
noninfarcting,1,0.0
infarcting,1,0.0
ravaged,1,0.0
planet,1,0.0
JAMA,1,0.0
Jadad,1,0.0
CASP,1,0.0
COSI,1,0.0
billions,1,0.0
vault,1,0.0
dispute,1,0.0
jugulars,1,0.0
cylindrical,1,0.0
symmetrically,1,0.0
purport,1,0.0
conical,1,0.0
leaflet,1,0.0
conceived,1,0.0
Mashhad,1,0.0
second-most,1,0.0
populous,1,0.0
subtype-specific,1,0.0
mass-produced,1,0.0
insurmountable,1,0.0
bend,1,0.0
Discrete,1,0.0
Caxias,1,0.0
Sul,1,0.0
re-adapted,1,0.0
immunotests,1,0.0
Independence,1,0.0
Youth,1,0.0
Isolation,1,0.0
tent,1,0.0
accommodating,1,0.0
TRACK,1,0.0
metalic,1,0.0
maneuveres,1,0.0
coronarygraphy,1,0.0
exits,1,0.0
steer,1,0.0
target-rich,1,0.0
landmarks,1,0.0
directindirect,1,0.0
push,1,0.0
sizeable,1,0.0
worriers,1,0.0
shielded,1,0.0
Hypereosinophilic,1,0.0
echocardiographies,1,0.0
cocaine-induced,1,0.0
Angiogenesis,1,0.0
It´s,1,0.0
129S6,1,0.0
cilengitide,1,0.0
mESC,1,0.0
steroides,1,0.0
mantained,1,0.0
stabilitation,1,0.0
monitered,1,0.0
simptoms,1,0.0
highlow,1,0.0
Databases,1,0.0
CINAHL,1,0.0
laterality,1,0.0
4502,1,0.0
134-219,1,0.0
133-384,1,0.0
118-565,1,0.0
006-069,1,0.0
non-focal,1,0.0
Bird,1,0.0
lessening,1,0.0
3221,1,0.0
frank,1,0.0
3-45h,1,0.0
CLEAN,1,0.0
stentrievers,1,0.0
Mismatch,1,0.0
Late-Presenting,1,0.0
Undergoing,1,0.0
Neurointervention,1,0.0
DAWN,1,0.0
Variations,1,0.0
Filipinos,1,0.0
Kona,1,0.0
newcomers,1,0.0
ERs,1,0.0
Hawaiis,1,0.0
Seroepidemiologic,1,0.0
butchering,1,0.0
host-to-host,1,0.0
laboratory-generated,1,0.0
od,1,0.0
arose,1,0.0
Mayor,1,0.0
Fibrolipoma,1,0.0
lipoma,1,0.0
fibrolipomas,1,0.0
eyelids,1,0.0
Psychogenic,1,0.0
pseudostroke,1,0.0
vis-à-vis,1,0.0
Akershus,1,0.0
hibernation,1,0.0
ECASS,1,0.0
GIHSN,1,0.0
subepicardiac,1,0.0
26-h,1,0.0
diuresis,1,0.0
estimable,1,0.0
unaltered,1,0.0
significative,1,0.0
ELSIA,1,0.0
dipeptides,1,0.0
dipeptide,1,0.0
fluorophore,1,0.0
quencher,1,0.0
N-,1,0.0
terminals,1,0.0
hydrolyzes,1,0.0
H-d,1,0.0
pfumL,1,0.0
Cystic,1,0.0
heterozygous,1,0.0
deltaF508,1,0.0
Orthomyxoviridae,1,0.0
Bursa,1,0.0
fundamentals,1,0.0
tenecteplase,1,0.0
Looking,1,0.0
GOF-type,1,0.0
well-studied,1,0.0
Scale-16,1,0.0
SIS-16,1,0.0
entry-related,1,0.0
Nondetectable,1,0.0
69-year-old,1,0.0
school-closures,1,0.0
“Spanish,1,0.0
1918–19,1,0.0
Circumstantial,1,0.0
APanama200799,1,0.0
Kong3302001,1,0.0
Kong14342002,1,0.0
thimerosal,1,0.0
mL-dose,1,0.0
httpwwwcdcgovncidoddiseasesflufluvirushtm,1,0.0
well-positioned,1,0.0
overloading,1,0.0
at-home,1,0.0
mass-fabricated,1,0.0
implementations,1,0.0
tonifying,1,0.0
Exposed,1,0.0
balloon-catheter,1,0.0
naysayers,1,0.0
Susceptibility,1,0.0
intensifies,1,0.0
sedatives,1,0.0
Locked-In,1,0.0
Willebrands,1,0.0
Haemostatic,1,0.0
PD--time,1,0.0
DD--time,1,0.0
HD--time,1,0.0
PD--95,1,0.0
DD--20,1,0.0
HD--35,1,0.0
anasarca,1,0.0
mgd,1,0.0
stabilisation,1,0.0
Caledonia2099,1,0.0
RR-31-31,1,0.0
200251,1,0.0
disseminators,1,0.0
antagonistically,1,0.0
whom--that,1,0.0
likeliest,1,0.0
chronology,1,0.0
simulator,1,0.0
conditionClinical,1,0.0
upsurge,1,0.0
COVID-19-induced,1,0.0
prior-season,1,0.0
Prior-season,1,0.0
HIVSIDA,1,0.0
visibility,1,0.0
rapidity,1,0.0
Resorting,1,0.0
Actor-Network,1,0.0
ANT,1,0.0
socio-technical,1,0.0
global-scale,1,0.0
lastly,1,0.0
panorama,1,0.0
Bruno,1,0.0
Latour,1,0.0
proposing,1,0.0
mens,1,0.0
SHERLOCK,1,0.0
DETECTR,1,0.0
Toehold,1,0.0
Switch,1,0.0
Stimulation,1,0.0
groups--133,1,0.0
obtains,1,0.0
AS03-adjuvanted,1,0.0
hilum,1,0.0
Seventy-eight,1,0.0
Interobserver,1,0.0
corrections,1,0.0
expert-vetted,1,0.0
NIfTI,1,0.0
httpsdoiorg107937tcia20206c7y-gq39,1,0.0
Tabular,1,0.0
detailing,1,0.0
sublethal,1,0.0
Dried,1,0.0
1-36,1,0.0
Elimination,1,0.0
Wild-silk,1,0.0
wild-growing,1,0.0
oak,1,0.0
silkworms,1,0.0
rugs,1,0.0
Influenza-like-Illness,1,0.0
country-wide,1,0.0
lab-based,1,0.0
Fatigue,1,0.0
distressing,1,0.0
meditated,1,0.0
Observations,1,0.0
liver1,1,0.0
COVID-1923,1,0.0
Histologic,1,0.0
subjects24,1,0.0
pathology23,1,0.0
nodules,1,0.0
atelectatic,1,0.0
One-dose,1,0.0
U-Net,1,0.0
14-59,1,0.0
952-979,1,0.0
710-905,1,0.0
admissionABSTRACT,1,0.0
Anti-asthmatic,1,0.0
diferuloylmethane,1,0.0
rhizomes,1,0.0
Curcuma,1,0.0
longa,1,0.0
constant-volume,1,0.0
p00399,1,0.0
p00043,1,0.0
OVA-sensitized,1,0.0
Accessory,1,0.0
ORF3b,1,0.0
ORF6,1,0.0
ORF9c,1,0.0
ORF3d,1,0.0
reassigned,1,0.0
knowns,1,0.0
unknowns,1,0.0
evading,1,0.0
Definition,1,0.0
Qwaves,1,0.0
timelines,1,0.0
infarction-associated,1,0.0
extravascular,1,0.0
non-small,1,0.0
Bilateral,1,0.0
Genetics,1,0.0
indooroutdoor,1,0.0
“consensus”,1,0.0
SGTF,1,0.0
anaetheta,1,0.0
gannets,1,0.0
Sula,1,0.0
leucogaster,1,0.0
short-tailed,1,0.0
tenuirostris,1,0.0
migrate,1,0.0
Ocean,1,0.0
waters,1,0.0
-coronavirus‑1,1,0.0
SARS-CoV‑1,1,0.0
cornea,1,0.0
studys,1,0.0
foothold,1,0.0
Yinghua,1,0.0
mini-monograph,1,0.0
Pinggan,1,0.0
Realtime,1,0.0
kg-1,1,0.0
endow,1,0.0
noticing,1,0.0
reconsider,1,0.0
STATEMENT,1,0.0
SIGNIFICANCE,1,0.0
beensubstantially,1,0.0
synthesizing,1,0.0
spawn,1,0.0
curing,1,0.0
SARS-related,1,0.0
anti-coronavirus,1,0.0
Sterna,1,0.0
bridled,1,0.0
coast,1,0.0
minutus,1,0.0
Myxoviruses,1,0.0
orthomyxoviruses,1,0.0
biologically,1,0.0
curious,1,0.0
Paramyxoviruses,1,0.0
shipping,1,0.0
NDV,1,0.0
fowl,1,0.0
pest,1,0.0
Yucaipavirus,1,0.0
Sendai,1,0.0
PVM,1,0.0
Nariva,1,0.0
bovinerespiratory,1,0.0
SV5,1,0.0
SV41,1,0.0
pelagic,1,0.0
Asian57,1,0.0
avidity,1,0.0
ABEL42,1,0.0
H0N1,1,0.0
AFM147,1,0.0
adsorption,1,0.0
ABEL,1,0.0
AFM1,1,0.0
wedge-tailed,1,0.0
pacificus,1,0.0
noddy,1,0.0
Anous,1,0.0
β-CoV-Bs,1,0.0
pan-CoV,1,0.0
Taubenberger,1,0.0
underperfused,1,0.0
68-year,1,0.0
middle-apical,1,0.0
Exploration,1,0.0
Grampian,1,0.0
Anistreplase,1,0.0
Syndromes,1,0.0
GUSTO-IIb,1,0.0
third-generation,1,0.0
c7E3,1,0.0
Fab,1,0.0
Preventing,1,0.0
thoughts,1,0.0
Impella™,1,0.0
intraprocedural,1,0.0
infarction-related,1,0.0
grounded,1,0.0
Etiology,1,0.0
1996-97,1,0.0
0639,1,0.0
0565-0722,1,0.0
1997-98,1,0.0
0601,1,0.0
0527-0687,1,0.0
epidemics-and,1,0.0
dynamics-modellers,1,0.0
draining,1,0.0
Particular,1,0.0
US-Russian,1,0.0
gastroenterological,1,0.0
Chance,1,0.0
revascularize,1,0.0
Tumpey,1,0.0
recatheterized,1,0.0
Fee-for-Service,1,0.0
FFS,1,0.0
45-day,1,0.0
pVAD,1,0.0
Concern,1,0.0
CP-,1,0.0
Passive,1,0.0
«serious,1,0.0
treatments»,1,0.0
SARS-CoV2The,1,0.0
compassionate,1,0.0
COVID-19-convalescent,1,0.0
Ethics,1,0.0
Committees,1,0.0
virus-related,1,0.0
GKGDFRI,1,0.0
Gly353,1,0.0
Ile359,1,0.0
ligand-binding,1,0.0
pseudovirion,1,0.0
μgmL,1,0.0
Inspiringly,1,0.0
easy-to-produce,1,0.0
buildup,1,0.0
could--through,1,0.0
immunity--significantly,1,0.0
subtly,1,0.0
mmyocardial,1,0.0
angina-free,1,0.0
proclaimed,1,0.0
Gyeonggi-do,1,0.0
treatment-resistant,1,0.0
electronegative,1,0.0
curriculum,1,0.0
sustainability,1,0.0
40-45,1,0.0
Bangabandhu,1,0.0
Sheikh,1,0.0
Mujib,1,0.0
BSMMU,1,0.0
Value,1,0.0
-0635,1,0.0
chameleon,1,0.0
chameleons,1,0.0
Influent,1,0.0
chlorination,1,0.0
200-5000,1,0.0
membrane-vortex,1,0.0
stands,1,0.0
pepper,1,0.0
mottle,1,0.0
NSarbeco,1,0.0
103-82,1,0.0
102-25,1,0.0
Västerås,1,0.0
Abbotts,1,0.0
re-sampled,1,0.0
high-exposure,1,0.0
knowl-,1,0.0
mentally,1,0.0
dif-,1,0.0
ferences,1,0.0
symp-,1,0.0
patient-oriented,1,0.0
educates,1,0.0
GeSa,1,0.0
partnership-based,1,0.0
pseudo-,1,0.0
E484KN501Y,1,0.0
three-dose,1,0.0
RBD-vaccines,1,0.0
third-dose,1,0.0
Ultrasound,1,0.0
277,1,0.0
32-point,1,0.0
gender-,1,0.0
Light,1,0.0
microscopical,1,0.0
mongrel,1,0.0
sham-operated,1,0.0
Infarcts,1,0.0
myofibers,1,0.0
myofibrillar,1,0.0
polymorphonucleosis,1,0.0
fuchsinorrhagia,1,0.0
Progression,1,0.0
soccer,1,0.0
matches,1,0.0
nationality,1,0.0
football,1,0.0
championship,1,0.0
Bochum,1,0.0
Help,1,0.0
volunteer-supported,1,0.0
Trained,1,0.0
helpers-a,1,0.0
toms,1,0.0
foetus,1,0.0
OSANG,1,0.0
doors,1,0.0
integumentary,1,0.0
Zhou,1,0.0
Hoffmann,1,0.0
angiotestin,1,0.0
IL-6-STAT3,1,0.0
Resilient,1,0.0
unwanted,1,0.0
immensely,1,0.0
9-21,1,0.0
Edinburgh,1,0.0
unrecognisable,1,0.0
operability,1,0.0
Sichuan,1,0.0
946,1,0.0
Pa,1,0.0
vaccine-specific,1,0.0
wastes,1,0.0
NISSS,1,0.0
1014,1,0.0
Prophylaxis,1,0.0
httpscoronavirusjhuedumaphtml,1,0.0
Nasopharyngealoropharyngeal,1,0.0
interchanged,1,0.0
pre-analytic,1,0.0
disadvantageous,1,0.0
Protocols,1,0.0
Periodicals,1,0.0
Low-throughput,1,0.0
EZ1,1,0.0
1-14,1,0.0
Under-recognition,1,0.0
731,1,0.0
exercise-wheezing,1,0.0
1856,1,0.0
pertussis,1,0.0
streptococcus,1,0.0
GBS,1,0.0
unsupervised,1,0.0
low-dimensional,1,0.0
between-scatter,1,0.0
Birds,1,0.0
slump,1,0.0
assiduous,1,0.0
Seaweed,1,0.0
foodstuff,1,0.0
imaging-defined,1,0.0
sponsors,1,0.0
enrol,1,0.0
oncological,1,0.0
Rat,1,0.0
fraction--by,1,0.0
Gas,1,0.0
quotient,1,0.0
carbohydrates,1,0.0
Supplemental,1,0.0
time-critical,1,0.0
payers,1,0.0
semiquantitative,1,0.0
932,1,0.0
outliers,1,0.0
6238,1,0.0
age-groups,1,0.0
4208,1,0.0
interrupting,1,0.0
abolish,1,0.0
242-244,1,0.0
existsin,1,0.0
doubtful,1,0.0
Congruity,1,0.0
graphically,1,0.0
0·77,1,0.0
0·71,1,0.0
0·74,1,0.0
genotype-phenotype,1,0.0
standardizing,1,0.0
haemostatic,1,0.0
Motivation,1,0.0
IL6,1,0.0
2000s,1,0.0
188-193,1,0.0
Non-ST,1,0.0
H5N1H9N2H7N7,1,0.0
complementarity,1,0.0
satisfied,1,0.0
aerosol-droplet,1,0.0
earthbound,1,0.0
1848,1,0.0
conundrum,1,0.0
Center-Myocardial,1,0.0
Team,1,0.0
20495,1,0.0
20722,1,0.0
22986,1,0.0
22400,1,0.0
Systolic,1,0.0
fifty-six,1,0.0
PCR-testing,1,0.0
subregions,1,0.0
2001-2014,1,0.0
00369,1,0.0
05708,1,0.0
Infants,1,0.0
airway-nervous,1,0.0
epithelia,1,0.0
nodose,1,0.0
intra-airway,1,0.0
neutrally,1,0.0
Intra-airway,1,0.0
Pairwise,1,0.0
scn10a,1,0.0
stat,1,0.0
isg15,1,0.0
LIBERTY,1,0.0
ASTHMA,1,0.0
ClinicalTrialsgov,1,0.0
NCT02414854,1,0.0
matched-volume,1,0.0
sand,1,0.0
unconvincing,1,0.0
demystified,1,0.0
symptoms-the,1,0.0
haulers,1,0.0
Dobutamine-induced,1,0.0
four-grade,1,0.0
summation,1,0.0
bpm,1,0.0
entrenched,1,0.0
1013,1,0.0
59019,1,0.0
08961,1,0.0
71111,1,0.0
640,1,0.0
99116,1,0.0
gowns,1,0.0
Yung,1,0.0
Lai,1,0.0
acrylic,1,0.0
vacuum,1,0.0
interactional,1,0.0
90-magnitude,1,0.0
tsunami,1,0.0
patient-based,1,0.0
Tohoku,1,0.0
keeps,1,0.0
Shortness,1,0.0
reawakening,1,0.0
cumbersome,1,0.0
clock,1,0.0
Camperdown,1,0.0
645,1,0.0
832,1,0.0
Chikwawa,1,0.0
Malawi,1,0.0
thematically,1,0.0
purchasing,1,0.0
groceries,1,0.0
suspicions,1,0.0
Gianturco,1,0.0
Roubin,1,0.0
nonelective,1,0.0
VDJ,1,0.0
K417NE484KN501Y,1,0.0
VH3-53VH3-66,1,0.0
Hsien,1,0.0
face-shields,1,0.0
853,1,0.0
glove,1,0.0
mount,1,0.0
Revascularization,1,0.0
2341,1,0.0
211833,1,0.0
anneal,1,0.0
apicomplexan,1,0.0
eminent,1,0.0
subunit-based,1,0.0
IChildrens,1,0.0
23-29,1,0.0
9-15,1,0.0
SLC-SiOH,1,0.0
impingement,1,0.0
pH1N1IFVA,1,0.0
H3N2IFVA,1,0.0
yamagataIFVB,1,0.0
victoriaIFVB,1,0.0
profiled,1,0.0
PREDAC-H1,1,0.0
Pubmed,1,0.0
methylphenidate,1,0.0
trazodone,1,0.0
nortriptyline,1,0.0
fluoxetine,1,0.0
levodopa,1,0.0
contradicting,1,0.0
neuromodulating,1,0.0
P2N95,1,0.0
glasses,1,0.0
High-throughput,1,0.0
Kingfisher,1,0.0
Flex,1,0.0
0197,1,0.0
self-help,1,0.0
unexpectedly,1,0.0
neuraminidase-inhibitor,1,0.0
0·05,1,0.0
existent,1,0.0
CARE,1,0.0
Telematics,1,0.0
sends,1,0.0
administrations,1,0.0
1993-94,1,0.0
telematics,1,0.0
unfrozen,1,0.0
±0019,1,0.0
freeze-thaw,1,0.0
±006,1,0.0
polarizing,1,0.0
deviated,1,0.0
sols,1,0.0
frogs,1,0.0
palates,1,0.0
ciliostasis,1,0.0
beating,1,0.0
HRCT,1,0.0
cute,1,0.0
Infant,1,0.0
Junior,1,0.0
Dealing,1,0.0
Headteacher-reported,1,0.0
asthma-trained,1,0.0
exerting,1,0.0
rateespecially,1,0.0
widowers,1,0.0
widows,1,0.0
spouse,1,0.0
TTR,1,0.0
stables,1,0.0
1361,1,0.0
71-81,1,0.0
bleedings,1,0.0
101-208,1,0.0
117-294,1,0.0
102-167,1,0.0
≥80,1,0.0
160-329,1,0.0
015-071,1,0.0
349-715,1,0.0
238,1,0.0
126-447,1,0.0
325-844,1,0.0
126-575,1,0.0
group70,1,0.0
groupunder,1,0.0
group608,1,0.0
719,1,0.0
angioplasty286,1,0.0
success748,1,0.0
death236,1,0.0
edema203,1,0.0
shock119,1,0.0
pneumonia173,1,0.0
delirium294,1,0.0
non-reperfused,1,0.0
bed-ridden,1,0.0
Elevation,1,0.0
diverging,1,0.0
stream,1,0.0
cardio-,1,0.0
Evidences,1,0.0
procession,1,0.0
denoted,1,0.0
individual-specific,1,0.0
EWI,1,0.0
Altitude,1,0.0
aero-allergens,1,0.0
grass,1,0.0
elicitating,1,0.0
castor,1,0.0
bean,1,0.0
soja,1,0.0
fixed-,1,0.0
four-chamber,1,0.0
Acute-onset,1,0.0
neuroimmune,1,0.0
immunodepression,1,0.0
syringe-needle,1,0.0
fixed-needle,1,0.0
µL,1,0.0
operator-dependent,1,0.0
halt,1,0.0
reinforcements,1,0.0
antiviral-based,1,0.0
Policy,1,0.0
Fluogen,1,0.0
FluShield,1,0.0
Masovia,1,0.0
GeneFinder™-COVID-19-Plus-RealAmpKit,1,0.0
AimsIntroduction,1,0.0
wages,1,0.0
prerolandic,1,0.0
workedweek,1,0.0
laypeople,1,0.0
4026,1,0.0
ignorance,1,0.0
Mandatory,1,0.0
complacent,1,0.0
resourced,1,0.0
excellence,1,0.0
intermixed,1,0.0
catastrophe,1,0.0
ill-health,1,0.0
saps,1,0.0
1948,1,0.0
Atlanta,1,0.0
WWW,1,0.0
Antananarivo,1,0.0
quantifiable,1,0.0
allergology,1,0.0
opposing,1,0.0
electromotive,1,0.0
spaciously,1,0.0
Essay,1,0.0
Multivalent,1,0.0
supramolecular,1,0.0
Polymers,1,0.0
inhalationnebulization,1,0.0
CoV-2Covid-19,1,0.0
multivalent,1,0.0
rightful,1,0.0
employability,1,0.0
groundbreaking,1,0.0
derivates,1,0.0
1-96,1,0.0
Hachim,1,0.0
revived,1,0.0
forty-three,1,0.0
Thiel-embalmed,1,0.0
non-anastomosing,1,0.0
coursing,1,0.0
costal,1,0.0
Anastomoses,1,0.0
thoracocentesis,1,0.0
cell-associated,1,0.0
immunosuppressing,1,0.0
appraisal,1,0.0
Infarct-avid,1,0.0
technetium-99m,1,0.0
IIb,1,0.0
Burbelo,1,0.0
N-acetylneuraminic,1,0.0
anti-nucleocapsidN,1,0.0
deleted,1,0.0
PRNT,1,0.0
Omalizumab,1,0.0
nonresponder,1,0.0
Production,1,0.0
lipooxygenase,1,0.0
Lipooxigenase-5,1,0.0
lipooxygenase-activating,1,0.0
protein-5,1,0.0
B4,1,0.0
leukocytic,1,0.0
chemoattractant,1,0.0
Sulfidopeptid,1,0.0
Morphological,1,0.0
stools,1,0.0
enteropathy,1,0.0
3-month-old,1,0.0
fluorochrome,1,0.0
angiocardiographic,1,0.0
Fran,1,0.0
Mihaljević,1,0.0
exhaustively,1,0.0
Otitis,1,0.0
rarest,1,0.0
ObjectiveIn,1,0.0
electroencephalography-functional,1,0.0
neurofeedback,1,0.0
cortices,1,0.0
interfaces,1,0.0
areasApproachWe,1,0.0
multisession,1,0.0
parametric,1,0.0
Bayes,1,0.0
areasMain,1,0.0
resultsOur,1,0.0
inter-hemispheric,1,0.0
self-inhibitory,1,0.0
taskSignificanceTo,1,0.0
4-8,1,0.0
Step-care,1,0.0
attaining,1,0.0
Pregnancies,1,0.0
parturients,1,0.0
volume-weighted,1,0.0
noncontrast,1,0.0
NCCT,1,0.0
D4,1,0.0
E4,1,0.0
irrespectively,1,0.0
specificnon-specific,1,0.0
anaphylatoxin,1,0.0
C5a,1,0.0
Mexicos,1,0.0
20162017,1,0.0
20202021,1,0.0
age-stratified,1,0.0
Mexico-specific,1,0.0
270596,1,0.0
102000,1,0.0
140062,1,0.0
3323,1,0.0
Mex214,1,0.0
US108,1,0.0
225497,1,0.0
85000,1,0.0
116718,1,0.0
2769,1,0.0
Mex178,1,0.0
US9,1,0.0
mismatched,1,0.0
highjacks,1,0.0
SARS-CoV-,1,0.0
bypasses,1,0.0
fuse,1,0.0
TMMPRSS2,1,0.0
BL,1,0.0
O-linked,1,0.0
molecules-ie,1,0.0
acidsN-glycolylneuraminic,1,0.0
assuage,1,0.0
highly-touted,1,0.0
ameliorates,1,0.0
hydroxychloroquineazithromycin,1,0.0
Fontan,1,0.0
quarantines,1,0.0
plasmid-based,1,0.0
symptom-driven,1,0.0
titration,1,0.0
localizes,1,0.0
Technetium-99m-glucarate,1,0.0
six-carbon,1,0.0
dicarboxylic,1,0.0
fructose,1,0.0
pinhole,1,0.0
glucarate,1,0.0
TTC,1,0.0
Intracranial,1,0.0
stenotic,1,0.0
theory-informed,1,0.0
10729,1,0.0
Toyama,1,0.0
Kendalls,1,0.0
tau-b,1,0.0
tables,1,0.0
onsets,1,0.0
genders,1,0.0
outdoors,1,0.0
menace,1,0.0
Amidst,1,0.0
failuresuncertain,1,0.0
anti-malarial,1,0.0
anti-malarialantibiotic,1,0.0
treatmentprophylaxis,1,0.0
